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Barcelona, Spain; 46Metabolism and Cancer Laboratory, Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut
d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; 47The Francis Crick Institute, Molecular Cell Biology of
Autophagy, London, UK; 48Cleveland Clinic, Department of Cancer Biology, Cleveland, OH, USA; 49University of the Basque Country, Instituto
Biofisika (UPV/EHU, CSIC), and Department of Biochemistry and Molecular Biology, Leioa, Spain; 50Instituto de Investigaciones en Ingeniería
Genética y Biología Molecular “Dr. Héctor N. Torres”, Laboratorio de señalización y mecanismos adaptativos en Tripanosomátidos, Buenos Aires,
Argentina; Universidad de Buenos Aires, Departamento de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Buenos
Aires, Argentina; 51Laboratory of Host-Pathogen Dynamics, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD,
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Boston, MA, USA; 178Sorbonne Université, CNRS UMR8226, Institut de Biologie Physico-Chimique, Laboratoire de Biologie Moléculaire et Cellulaire
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233
The Open University, School of Life, Health and Chemical Sciences, Faculty of Science, Technology, Engineering and Mathematics, Milton Keynes,
UK; 234Danish Cancer Society Research Center, Center for Autophagy, Recycling and Disease (CARD), Cell Stress and Survival Unit, Copenhagen,
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AUTOPHAGY

13

Medicine, Zuckerberg San Francisco General Hospital and TraumaCenter, San Francisco, CA, USA; 261University of Copenhagen, Department of
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NY, USA; 287Stockholm University, The Wenner-Gren Institute, Department of Molecular Biosciences, Stockholm, Sweden; 288University of Verona,
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293
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ABSTRACT

ARTICLE HISTORY

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this
topic has received increasing attention, and many scientists have entered the field. Our knowledge base
and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular
basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews,
there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in
multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret
methods to examine autophagy and related processes, and for reviewers to provide realistic and
reasonable critiques of reports that are focused on these processes. These guidelines are not meant
to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question
being asked and the system being used. Moreover, no individual assay is perfect for every situation,
calling for the use of multiple techniques to properly monitor autophagy in each experimental setting.
Finally, several core components of the autophagy machinery have been implicated in distinct auto
phagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block
autophagy should rely on targeting two or more autophagy-related genes that ideally participate in
distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also
regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for
bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and
the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical
innovation in the field.
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disease; PDT, photodynamic therapy; PE, phosphatidylethanolamine; PI, phosphoinositide; PI3K, phosphoinositide 3kinase; PMN, piecemeal microautophagy of the nucleus; PMSF, phenylmethylsulphonylfluoride; POFs, postovulatory
follicles; POS, photoreceptor outer segments; PPI, protein-protein interaction; PS, phosphatidylserine; PSSM, positionspecific scoring matrix; PtdIns3K, phosphatidylinositol 3-kinase; PtdIns3P, phosphatidylinositol-3-phosphate; PTECs,
proximal tubular epithelial cells; PTM, posttranslational modification; PVM, parasitophorus vacuole membrane; qPCR/
qRT-PCR, quantitative polymerase chain reaction; RBC, red blood cell; RCBs, Rubisco-containing bodies; RCD,
regulated cell death; Rluc, Renilla reniformis luciferase; ROS, reactive oxygen species; RPE, retinal pigment epithelium;
RT-PCR, reverse transcription polymerase chain reaction; S1P, sphingosine-1-phosphate; SD, standard deviation; SEM,
scanning electron microscopy; SINGD, stress-induced nascent granule degradation; SKL, serine-lysine-leucine (a
peroxisome targeting signal); SLE, systemic lupus erythematosus; SOD, superoxide dismutase; SVCV, spring viremia
of carp virus; TEM, transmission electron microscopy; tfLC3, tandem fluorescent LC3; TORC1, TOR complex I; TRFRET, time-resolved Förster resonance energy transfer; TVA, tubulovesicular autophagosome; UDS, UIM docking site;
UIM, ubiquitin-interacting motif; UPR, unfolded protein response; UPS, ubiquitin-proteasome system; V-ATPase,
vacuolar-type H+-translocating ATPase; VHSV, viral hemorraghic septicemia virus; WSM, water stress medium;
xLIR, extended LIR-motif; ZIKV, Zika virus

Introduction
Many researchers, especially those new to the field, need to
determine which criteria are essential for demonstrating au
tophagy, either for the purposes of their own research, or in
the capacity of a manuscript or grant review [1,2]. Acceptable
standards are an important issue, particularly considering that
each of us may have her/his own opinion regarding the
answer. Furthermore, as science progresses and the field
evolves, the answer is in part a “moving target” [3]. This
can be extremely frustrating for researchers who may think
they have met those criteria, only to find out that the
reviewers of their work disagree. Conversely, as a reviewer,
it is tiresome to raise the same objections repeatedly, wonder
ing why researchers have not fulfilled some of the basic
requirements for establishing the occurrence of an autophagic
process. In addition, drugs that potentially modulate autopha
gy are increasingly being used in clinical trials, and screens are
being carried out for new drugs that can modulate autophagy
for therapeutic purposes. Clearly, it is important to determine
whether these drugs are truly affecting autophagy, and which
step(s) of the process/es is/are affected, based on a set of
accepted criteria. To this aim, we describe here a basic set of
updated guidelines that can be used by researchers to plan
and interpret their experiments, by clinicians to evaluate the
literature with regard to autophagy-modulating therapies, and
by both authors and reviewers to justify or criticize an experi
mental approach.
Several fundamental points must be kept in mind as we
establish guidelines for the selection of appropriate methods
to monitor autophagy [2]. Importantly, there are no absolute
criteria for determining autophagic status that are applicable
in every single biological or experimental context. This is
because some assays are unsuitable, problematic or may not
work at all in particular cells, tissues or organisms [1–4]. For
example, autophagic responses to drugs may be different in
transformed versus nontransformed cells, in confluent versus
nonconfluent cells, or in cells grown with or without glucose
[5]. These guidelines are likely to evolve as new methodolo
gies are developed and current assays are superseded.

Nonetheless, it is useful to establish a reference for acceptable
assays that can reliably monitor autophagy in many experi
mental systems. It is important to note that in this set of
guidelines the term “autophagy” generally refers to macroau
tophagy; other autophagy-related processes are specifically
designated when appropriate.
For the purposes of this review, the autophagic compart
ments (Figure 1) are referred to as the sequestering (preautophagosomal) phagophore (PG; previously called the iso
lation or sequestration membrane [6, 7]) [8], the doublemembrane autophagosome (AP; generated by scission of the
phagophore membrane [9, 10]), the single-membrane amphi
some (AM; generated by the fusion of the outer autophago
somal membrane with endosomes) [11], the lysosome (LY),
the autolysosome (AL; generated by fusion of the outer auto
phagosomal membrane or amphisome with a lysosome), and
the autophagic body (AB; generated by fusion of the outer
autophagosomal membrane with, typically, the vacuole in
fungi and plants followed by the release of the internal auto
phagosomal compartment into the vacuole lumen). Except for
cases of highly stimulated autophagic sequestration (Figure 2),
autophagic bodies are not seen in animal cells, because lyso
somes/autolysosomes are typically smaller than autophago
somes [11]. One critical point is that autophagy is a highly
dynamic, multi-step process. Like other cellular pathways, it
can be modulated at several steps, both positively and nega
tively. An accumulation of autophagosomes measured by
transmission electron microscopy (TEM) image analysis
[12], identified as green fluorescent protein (GFP)MAP1LC3 (GFP-LC3) puncta under fluorescence micro
scopy, or as changes in the amount of lipidated LC3 (LC3II) on a western blot, could reflect a reduction in autophago
some turnover [13–15], or the inability of turnover to keep
pace with increased autophagosome formation (Figure 1B)
[16]. For example, inefficient fusion with endosomes and/or
lysosomes, or perturbation of the transport machinery [17],
would inhibit autophagosome maturation to amphisomes or
autolysosomes (Figure 1C), whereas decreased flux could also
be due to inefficient degradation of the cargo once fusion has
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Figure 1. Schematic model demonstrating the induction of autophagosome formation when turnover is blocked versus normal autophagic flux, and illustrating the
morphological intermediates of autophagy. (A) The initiation of autophagy includes the formation and expansion of the phagophore, the initial sequestering
compartment, which expands into an autophagosome. Completion of the autophagosome requires an intraphagophore membrane scission step and is followed by
fusion of the outer autophagosomal membrane with lysosomes and degradation of the contents, allowing complete flux, or flow, through the entire pathway. This is
a different outcome than the situation shown in (B) where induction results in the initiation of autophagy, but a defect in autophagosome turnover due, for example,
to a block in fusion with lysosomes or disruption of lysosomal functions will result in an increased number of autophagosomes. In this scenario, autophagy has been
induced, but there is no or limited autophagic flux. (C) An autophagosome can fuse with an endosome to generate an amphisome, prior to fusion with the lysosome.
(D) Schematic drawing showing the formation of an autophagic body in fungi. The large size of the fungal vacuole relative to autophagosomes allows the release of
the single-membrane autophagic body within the vacuole lumen. In cells that lack vacuolar hydrolase activity, or in the presence of inhibitors that block hydrolase
activity, intact autophagic bodies accumulate within the vacuole lumen and can be detected by light microscopy. The lysosome of most more complex eukaryotes is
too small to accommodate an autophagic body.

Figure 2. An autophagic body in a large lysosome of a mammalian epithelial cell
in a mouse seminal vesicle in vitro. The arrow shows the single limiting
membrane covering the sequestered rough ER. Image provided by A.L. Kovács.

occurred [18]. Moreover, GFP-LC3 puncta and LC3 lipidation
can reflect the induction of a different/modified pathway such
as LC3-associated phagocytosis (LAP) [19], or the noncano
nical destruction pathway of paternal mitochondria after egg
fertilization [20, 21].
Thus, the use of autophagy markers such as LC3-II must be
complemented by assays to estimate overall autophagic flux,
or flow, to permit a correct interpretation of the results. That
is, autophagic activity includes not just the increased synthesis
or lipidation of Atg8/LC3/GABARAP (LC3 and GABARAP
subfamilies constitute the mammalian homologs of yeast
Atg8), or an increase in the formation of autophagosomes,
but, most importantly, flux through the entire system, includ
ing lysosomes or the vacuole, and the subsequent release of
the breakdown products. Therefore, autophagic substrates
need to be monitored dynamically over time to verify that
they have reached the lysosome/vacuole, and whether or not
they are degraded. By responding to perturbations in the
extracellular environment, cells tune the autophagic flux to
meet intracellular metabolic demands and support repair
mechanisms. The impact of autophagic flux on cell death
and human pathologies, therefore, demands accurate tools to
measure not only the current flux of the system, but also its
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capacity [22], and its response time, when exposed to a
defined stress [23].
One approach to evaluate autophagic flux is to measure
the rate of general protein breakdown by autophagy [6, 24,
25]. It is possible to arrest the autophagic flux at a given
point, and then record the time-dependent accumulation
of an organelle, an organelle marker, a cargo marker, or
the entire cargo at the point of blockage; however, this
approach assumes there is no feedback of the accumulat
ing structure on its own rate of formation [26]. Thus, the
chase period should be kept short, ideally with more than
one time point. In an alternative approach, one can follow
the time-dependent decrease of an autophagy-degradable
marker following inhibition of protein synthesis (with the
caveat that the potential contribution of other proteolytic
systems needs to be experimentally addressed). A potential
complication here is that inhibition of protein synthesis,
for example, by cycloheximide (CHX), can activate
MTORC1 signaling, which in turn impairs autophagy
[27]. In theory, these nonautophagic processes can be
assessed if degradation persists after blocking autophagic
sequestration [13, 15, 28]. The key issue is to differentiate
between the often transient accumulation of autophago
somes due to increased induction, and their accumulation
due to inefficient clearance of sequestered cargos. This can
be done by both measuring the levels of autophagosomes
at static time points, and by measuring changes in the
rates of autophagic degradation of cellular components,
or, in neurons, by assaying autophagosome transport [18,
29]. Multiple strategies have been used to estimate “auto
phagy,” but unless the experiments can relate changes in
autophagosome quantity to a direct or indirect measure
ment for autophagic flux, the results may be difficult to
interpret [30]. A general caution regarding the use of the
term “steady state” is warranted at this point. It should
not be assumed that an autophagic system is at steady
state in the strict biochemical meaning of this term, as
this implies that the level of autophagosomes does not
change with time, and the flux through the system is
constant. In these guidelines, we use “steady state” to
refer to the baseline range of autophagic flux in a system
that is not subjected to specific perturbations that increase
or decrease that flux.
Autophagic flux refers to the entire process of autopha
gy over a period of time, which encompasses the selection
of cargo and its inclusion within the autophagosome, the
delivery of cargo to lysosomes (via fusion of the latter with
autophagosomes or amphisomes) and its subsequent
breakdown and release of the resulting macromolecules
back into the cytosol, which may be referred to as pro
ductive or complete autophagy. Thus, increases in the
level of phosphatidylethanolamine (PE)-modified Atg8family proteins (Atg8–PE, or LC3/GABARAP-II), or even
the appearance of autophagosomes, are not measures of
autophagic flux per se, but can reflect the induction of
autophagic sequestration and/or inhibition of autophago
some or amphisome clearance. Also, it is important to
realize that while formation of Atg8–PE (or LC3/
GABARAP-II) appears to correlate with the induction of
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autophagy, we do not know, at present, the actual
mechanistic relationship between Atg8–PE (or LC3/
GABARAP-II) formation and the rest of the autophagic
process; indeed, some variants of autophagy proceed in
the absence of LC3-II [31–35].
In addition, as the metabolic control of autophagy is
becoming increasingly clear, highlighting a tight network
between the autophagy machinery, energy sensing pathways
and the cell’s metabolic circuits [36, 37], mitochondrial
parameters such as fission and fusion rate and the cell’s
ATP demand should be monitored and correlated with
autophagic flux data. In this regard, the use of mitochon
dria-localized mCherry-GFP tandem reporters (such as the
mito-QC mouse [38]), may be important in understanding
how deregulated mitophagy affects the progression of meta
bolic disorders, including diabetes [39]. These types of stu
dies will provide a better understanding on the variability of
autophagy and cell death susceptibility.
As a final note, we also recommend that researchers refrain
from the use of the expression “percent autophagy” when
describing experimental results, as in “The cells displayed a
25% increase in autophagy.” Instead, it is appropriate to
indicate that the average number of GFP-Atg8-family protein
puncta per cell is increased or a certain percentage of cells
displayed punctate GFP-Atg8-family proteins that exceeds a
particular threshold (and this threshold should be clearly
defined in the Methods section), or that there is a specific
increase or decrease in the rate of cargo sequestration or the
degradation of long-lived proteins, when these are the actual
measurements being quantified.
In previous versions of these guidelines [1, 3], the methods
were separated into two main sections—steady state and flux.
In some instances, a lack of clear distinction between the
actual methodologies and their potential uses made such a
separation somewhat artificial. For example, fluorescence
microscopy was initially listed as a steady-state method,
although this approach can clearly be used to monitor flux
as described in this article, especially when considering the
increasing availability of new technologies such as microflui
dic chambers. Furthermore, the use of multiple time points
and/or lysosomal fusion/degradation inhibitors can turn even
a typically static method such as TEM into one that monitors
flux. Therefore, although we maintain the importance of
monitoring autophagic flux and not just induction, this
revised set of guidelines does not separate the methods
based on this criterion. Readers should be aware that this
article is not meant to present protocols, but rather guidelines,
including information that is typically not presented in pro
tocol papers. For detailed information on experimental pro
cedures we refer readers to various protocols that have been
published elsewhere [25, 40–56]. Finally, throughout the
guidelines we provide specific cautionary notes, and these
are important to consider when planning experiments and
interpreting data; however, these cautions are not meant to
be a deterrent to undertaking any of these experiments or a
hindrance to data interpretation.
Collectively, we propose the following guidelines for mea
suring various aspects of selective and nonselective autophagy
in eukaryotes.
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A. Nomenclature
To minimize confusion regarding nomenclature, we make the
following notes: In general, we follow the conventions estab
lished by the nomenclature committees for each model organ
ism whenever appropriate guidelines are available, and briefly
summarize the information here using “ATG1” as an example
for yeast and “ULK1” for mammals. The standard nomencla
ture of autophagy-related wild-type genes, mutants and pro
teins for yeast is ATG1, atg1 (or atg1∆ in the case of deletions)
and Atg1, respectively, according to the guidelines adopted by
the Saccharomyces Genome Database (https://www.yeastgen
ome.org/). For mammals we follow the recommendations of
the International Committee on Standardized Genetic
Nomenclature for Mice (http://www.informatics.jax.org/mgi
home/nomen/), which dictates the designations Ulk1, ulk1
and ULK1 (for all rodents), respectively, and the guidelines
for human genes established by the HUGO Nomenclature
Committee
(http://www.genenames.org/guidelines.html),
which states that human gene symbols are in the form
ULK1 and recommends that proteins use the same designa
tion without italics, as with ULK1; mutants are written for
example as ULK1−/− [57]. For simplicity unless referring to a
specific species, the human gene/protein symbols and defini
tions will be used throughout the guidelines.

B. Methods for monitoring autophagy
1. Transmission electron microscopy
Autophagy was first detected by TEM in the 1950s (reviewed
in ref. [6]). This process was originally observed as focal
degradation of cytoplasmic areas performed by lysosomes.
Later analysis revealed that autophagy starts with the seques
tration of portions of the cytoplasm by a special doublemembrane structure (termed the phagophore), which matures
into the autophagosome, also delimited by a double mem
brane. Subsequent fusion events expose the cargo to the lyso
some (or the vacuole in fungi or plants) for enzymatic
breakdown.
The importance of TEM in autophagy research lies in
several qualities. It is the only tool that reveals the morphol
ogy of autophagic structures at a resolution in the nm range;
shows these structures in their natural environment and posi
tion among all other cellular components; allows their exact
identification; and, in addition, can support quantitative stu
dies if the rules of proper sampling are followed [12].
Autophagy can be both selective and nonselective, and
TEM can be used to monitor both. In the case of selective
autophagy, the cargo is the specific substrate being targeted
for sequestration—bulk cytoplasm is essentially excluded. In
contrast, during nonselective autophagy, disposable cytoplas
mic constituents are sequestered. Sequestration of larger
structures (such as big lipid droplets, extremely elongated or
branching mitochondria or the entire Golgi complex) is rare,
indicating an apparent upper size limit for individual autop
hagosomes. However, it has been observed that under special
circumstances the potential exists for the formation of huge
autophagosomes, which can even engulf a complete nucleus
[28]. Cellular components that form large confluent areas

excluding bulk cytoplasm, such as organized, functional myo
fibrillar structures, do not seem to be sequestered by autopha
gy. The situation is less clear with regard to glycogen [58–60].
Plant cell-specific structures called provacuoles have a
striking similarity to a phagophore, but form in an autopha
gy-independent manner [61]. These structures have been
detected in cells undergoing major changes in vacuolar mor
phology, such as meristematic cells [62]. Thus, using TEM to
detect autophagosomes in plant cells must be done while
comparing with an appropriate autophagy-deficient control
sample.
After sequestration, the content of the autophagosome and
its bordering double membrane remain morphologically
unchanged, and recognizable for at least several minutes.
During this period, the membranes of the sequestered orga
nelles (for example the ER or mitochondria) remain intact,
and the electron density of ribosomes is conserved at normal
levels. Degradation of the sequestered material and the corre
sponding deterioration of ultrastructure commences and runs
to completion within the amphisome and the autolysosome
after fusion with a late endosome and lysosome (the vacuole
in fungi and plants), respectively (Figure 1) [63]. The sequen
tial morphological changes during the autophagic process can
be followed by TEM [64]. The maturation from the phago
phore through the autolysosome is a dynamic and continuous
process [65], and, thus, the classification of compartments
into discrete morphological subsets can be problematic; there
fore, some basic guidelines for such classifications are offered
below.
In the preceding sections the “autophagosome”, the
“amphisome” and the “autolysosome” were terms used to
describe or indicate three basic stages and compartments of
autophagy. It is important to make it clear that for instances
(which may be many) when we cannot or do not want to
differentiate among the autophagosomal, amphisomal and
autolysosomal stage we use the general term “autophagic
vacuole”. In the yeast autophagy field, the term “autophagic
vesicle” is used to avoid confusion with the primary vacuole,
and by now the two terms are used in parallel and can be
considered synonyms. It is strongly recommended, however,
to use only the term “autophagic vacuole” when referring to
autophagy
in
more
complex
eukaryotic
cells.
Autophagosomes, also referred to as initial autophagic
vacuoles (AVi), typically have a double membrane. This struc
ture is usually distinctly visible by TEM as two parallel mem
brane layers (bilayers) separated by a relatively narrower or
wider electron-translucent cleft, even when applying the sim
plest routine TEM fixation procedure (Figure 3A) [66, 67].
This electron-translucent cleft, however, is less visible in
freeze-fixed samples, suggesting it may be an artefact of sam
ple preparation (see Fig. S3 in ref. [68]). Amphisomes [69] can
sometimes be identified by the presence of small intralumenal
vesicles [70]. These intralumenal vesicles are delivered into
the lumen by fusion of the autophagosome/autophagic
vacuole (AV) limiting membrane with multivesicular endo
somes, and care should, therefore, be taken in the identifica
tion of the organelles, especially in cells that produce large
numbers of multivesicular body (MVB)-derived exosomes
(such as tumor or stem cells) [71]. Late/degradative
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Figure 3. TEM images of autophagic vacuoles in isolated mouse hepatocytes. (A)
One autophagosome or early autophagic vacuole (AVi) and one degradative
autophagic vacuole (AVd) are shown. The AVi can be identified by its contents
(morphologically intact cytoplasm, including ribosomes, and rough ER), and the
limiting membrane that is partially visible as two bilayers separated by a narrow
electron-lucent cleft, i. e., as a double membrane (arrow). The AVd can be
identified by its contents, partially degraded, electron-dense rough ER. The
vesicle next to the AVd is an endosomal/lysosomal structure containing 5-nm
gold particles that were added to the culture medium to trace the endocytic
pathway. (B) One AVi, containing rough ER and a mitochondrion, and one AVd,
containing partially degraded rough ER, are shown. Note that the limiting
membrane of the AVi is not clearly visible, possibly because it is tangentially
sectioned. However, the electron-lucent cleft between the two limiting mem
branes is visible and helps in the identification of the AVi. The AVd contains a
region filled by small internal vesicles (asterisk), indicating that the AVd has
fused with a multivesicular endosome. mi, mitochondrion. Image provided by E.L. Eskelinen.

autophagic vacuoles/autolysosomes (AVd or AVl) typically
have only one limiting membrane; frequently they contain
electron-dense cytoplasmic material and/or organelles at var
ious stages of degradation (Figure 3A and B) [63, 72]; how
ever, late in the digestion process they may contain only a few
membrane fragments and be difficult to distinguish from
lysosomes, endosomes, or tubular smooth ER cut in cross-
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section. It is not always easy to morphologically distinguish
amphisomes, autolysosomes and lysosomes, even for an
expert [6]. A simple solution to assess autophagy progression
is to group all of these structures, which are typically stained
dark in TEM samples, and define them as degradative com
partments/vacuoles. As autophagy induction leads to an
increase of autophagosomes, amphisomes and autolysosomes,
an increase of degradative compartments per cell area pro
vides a simple measurement to determine whether this degra
dative pathway is enhanced [73–75]. Unequivocal
identification of these structures and of lysosomes devoid of
visible content requires immuno-EM detection of a cathepsin
or other lysosomal hydrolase (e.g., ACP2 [acid phosphatase 2,
lysosomal] [76, 77]) that is detected on the limiting mem
brane of the lysosome [78]. Smaller, often electron dense,
lysosomes may predominate in some cells and exhibit hydro
lase immunoreactivity within the lumen and on the limiting
membrane [79].
In addition, structural proteins of the lysosome/late endo
somes, such as LAMP1 and LAMP2 or SCARB2/LIMP-2, can
be used for confirmation. No single protein marker, however,
has been effective in discriminating autolysosomes from the
compartments mentioned above, in part due to the dynamic
fusion and “kiss-and-run” events that promote interchange of
components that can occur between these organelle subtypes.
Rigorous further discrimination of these compartments from
each other and other vesicles ultimately requires demonstrat
ing the colocalization of a second marker indicating the pre
sence of an autophagic substrate (e.g., LC3 and CTSD
[cathepsin D] colocalization) or the acidification of the com
partment (e.g., mRFP/mCherry-GFP-LC3 probes or
LysoTracker™ dyes; see Tandem mRFP/mCherry-GFP fluores
cence microscopy), Keima probes, or BODIPY-pepstatin A that
allows detection of CTSD in an activated form within an
acidic compartment), and, when appropriate, by excluding
markers of other vesicular components [76, 80, 81].
The sequential deterioration of cytoplasmic structures
being digested can be used for identifying autolysosomes by
TEM. Even when the partially digested and destroyed struc
ture of the cytoplasmic cargo cannot be recognized in itself, it
can be traced back to earlier forms by identifying preceding
stages of sequential morphological deterioration. Degradation
usually leads first to the increased electron density of still
recognizable organelles, then to vacuoles with heterogeneous
density, which become more homogeneous and amorphous,
mostly electron dense, but sometimes light (i.e., electron
translucent). It should be noted that, in pathological states,
it is not uncommon that active autophagy of autolysosomes
and damaged lysosomes (“lysophagy”) may yield populations
of double-membrane limited autophagosomes containing par
tially digested amorphous substrate in the lumen. These struc
tures, which are enriched in hydrolases, are seen in swollen
dystrophic neurites in some neurodegenerative diseases, and
in cerebellar slices cultured in vitro and infected with prions.
Alternatively, it is possible to inhibit the fusion of autophago
somes and lysosomes using bafilomycin A1 (a vacuolar-type
H+-translocating ATPase [V-ATPase] inhibitor). It is then
possible to both visualize the cargo(s) that are being actively
sequestered within AVi structures during the chase period, as
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Figure 4. Autophagosomes with recognizable cargo are rare in cells. (A) To assess relative rates of autophagosome formation, the lysosomal inhibitor bafilomycin A1
(10 nM) was applied for 2 h prior to fixation with 2% glutaraldehyde in order to trap newly formed autophagosomes (note that whereas short-term treatment with
bafilomycin A1 in most cases primarily blocks autolysosomal degradation, it can also inhibit autophagosome-lysosome fusion). Two different PINK1 shRNA lines (A14
and D14) exhibit increased AV formation over 2 h compared to the control shRNA line. *, p < 0.05 vs. Control. (B) Autophagosomes in bafilomycin A1-treated control
cells contain a variety of cytoplasmic structures (left, arrow), whereas mitochondria comprise a prominent component of autophagosomes in bafilomycin A1-treated
(PINK1 shRNA) cells (right, arrow). Scale bar: 500 nm. These data indicate induction of selective mitophagy in PINK1-deficient cells. This figure was modified from
Figure 2 published in Chu CT. A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Human Molecular Genetics
2010; 19:R28-R37.

well as quantify their rates of formation provided the chase
period is kept short [82] (Figure 4).
It must be emphasized that in addition to the autophagic
input, other processes (e.g., endosomal, phagosomal, chaper
one-mediated) also carry cargo to the lysosomes [64,65], in
some cases through the intermediate step of direct endosome
fusion with an autophagosome to form an amphisome. This
process is exceptionally common in the axons of neurons [83,
84]. Therefore, strictly speaking, we can only have a lytic
compartment containing cargos arriving from several possible
sources; however, we still may use the term “autolysosome” if
the content appears to be overwhelmingly autophagic. Note
that the engulfment of dying cells via phagocytosis also pro
duces lysosomes that contain cytoplasmic structures, but in this
case, it originates from the dying cell [85]; hence the possibility
of an extracellular origin for such content must be considered
when monitoring autophagy in settings where apoptotic cell
death may be reasonably expected or anticipated.
For many physiological and pathological situations, the
examination of both early and late autophagic vacuoles yields
valuable data regarding the overall autophagy status in the
cells [16, 86]. Along these lines, it is possible to use immuno
cytochemistry to follow particular cytosolic proteins such as
SOD1/Cu,Zn-superoxide dismutase and CA (carbonic anhy
drase) to determine the stage of autophagy; the former is
much more resistant to lysosomal degradation [87].
In some autophagy-inducing conditions it is possible to
observe multi-lamellar membrane structures in addition to
the conventional double-membrane autophagosomes,
although the nature of these structures is not fully understood.
These multi-lamellar structures may indeed be multiple dou
ble layers of phagophores [88] and positive for LC3 [89], they
could be autolysosomes [90], or they may form as an artefact
of fixation. Depending on the cell type, it may be necessary to
distinguish these from myelin or surfactant, both of which are
also multilamellar. These multi-lamellar bodies are typical in
lysosomal storage diseases, such as Niemann-Pick disease type
I [91] and Parkinson disease (PD) [92–94]. In addition, cells
treated with U18666A, an inhibitor of cholesterol transport

[95, 96], or chloroquine (CQ) that induces phospholipidosis
[97], produce numerous large multi-lamellar bodies with con
centric membrane stacks that represent dysfunctional lyso
somes,
containing
undegraded
phospholipids
and
cholesterol. Multi-lamellar bodies are formed through cellular
autophagy, and the implication of various lysosomal enzymes
in their formation suggests a lysosomal nature. Initially, single
or multiple foci of lamella appear within an autophagic
vacuole and then progress into multi-lamellar structures [90,
93] as they are getting filled with lipids; these lipids are
cholesterol-containing rafts in late endocytic/lysosomes orga
nelles [94].
Special features of the autophagic process may be clarified
by immuno-TEM with gold-labeling [98, 99], using antibo
dies, for example, to cargo proteins of cytoplasmic origin and
to LC3 to verify the autophagic nature of the compartment.
LC3 immunogold labeling also enables the detection of novel
degradative organelles within autophagy compartments. This
is the case with the autophagoproteasome [100] that consists
of single-, double-, or multiple-membrane LC3-positive
autophagosomes costaining for specific components of the
ubiquitin-proteasome system (UPS). It may be that a rich
multi-enzymatic (both autophagic and UPS) activity takes
place within these organelles instead of being segregated
within different domains of the cell. Also in plants, TEM
immunogold labelling for ATG8 ultrastructural detection
can be performed. This can be approached using either antiGFP antibodies for GFP-ATG8 fusion proteins, or anti-ATG8
antibodies for direct labeling [101, 102]. Freeze-substitution
followed by cryo embedding in acrylic resins is the most
convenient and feasible processing method for ATG8 immu
nogold labelling in plant cells.
Although labeling of LC3 can be difficult, an increasing
number of commercial antibodies are becoming available,
including reagents that enable visualization of the GFP moiety
of GFP-LC3 reporter constructs [103]. It is important to keep
in mind that LC3 can be associated with nonautophagic
structures (see Xenophagy, and Noncanonical use of autopha
gy-related proteins), and that LC3 puncta can be observed in
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autophagy-deficient cells [104]. LC3 is involved in specialized
forms of endocytosis such as LC3-associated phagocytosis. In
addition, LC3 can decorate vesicles dedicated to exocytosis in
nonconventional secretion systems (reviewed in ref. [105,
106]). Antibodies against an abundant cytosolic protein will
result in high labeling all over the cytoplasm; however, orga
nelle markers work well. Because there are very few charac
terized proteins that remain associated with the closed
autophagosomes, the choices for confirmation of their autop
hagic nature are limited. Furthermore, autophagosome-asso
ciated proteins may be cell-, age-, sex- and/or conditionspecific. Sex-specific expression of autophagic markers are
observed both in humans and in rats [107–111]. At any rate,
the success of this methodology depends on the quality of the
antibodies and also on the TEM preparation and fixation
procedures utilized. With immuno-TEM, authors should pro
vide controls showing that labeling is specific. This may
require a quantitative comparison of labeling over different
cellular compartments not expected to contain antigen and
those containing the antigen of interest.
It is difficult to clearly monitor autophagy in tissues of
formalin-fixed and paraffin-embedded biopsy samples retro
spectively, because (a) tissues fixed in formalin have low or no
LC3 detectable by routine immunostaining, (b) because phos
pholipids melt together with paraffin during the sample pre
paration, and (c) immuno-EM of many tissues not optimally
fixed for this purpose (e.g., using rapid fixation) produces
low-quality images. Combining antigen retrieval with the
avidin-biotin peroxidase complex (ABC) method may be
quite useful for these situations. For example, immunohisto
chemistry can be performed using an antigen retrieval
method, and then tissues are stained by the ABC technique
using a labeled anti-human LC3 antibody. After imaging by
light microscopy, the same prepared slides can be remade into
sections for TEM examination, which can reveal peroxidase
reaction deposits in vacuoles within the region that is LC3immunopositive by light microscopy [112].
In addition, statistical information should be provided due
to the necessity of showing only a selective number of sections
in publications. Again, we note that for quantitative data it is
necessary to use proper volumetric analysis rather than just
counting numbers of sectioned objects. On the one hand, it
must be kept in mind that even volumetric morphometry/
stereology only shows either steady-state levels, or a snapshot
in a changing dynamic process. Such data by themselves are
not informative regarding autophagic flux, unless carried out
over multiple time points. Alternatively, investigation in the
presence and absence of flux inhibitors can reveal the
dynamic changes in various stages of the autophagic process
[13, 22, 55, 113, 114]. On the other hand, if the turnover of
autolysosomes is very rapid, a low number/volume in the
experimental compared to the basal condition, will not neces
sarily be an accurate reflection of low autophagic activity; as
with autophagosomes, a smaller number of autolysosomes can
reflect increased degradation or decreased formation.
However, quantitative analyses indicate that autophagosome
volume in many cases does correlate with the rates of protein
degradation [115–117]. One potential compromise is to per
form whole cell quantification of autophagosomes using
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fluorescence methods, with qualitative verification by TEM
[118], to show that the changes in fluorescent puncta reflect
corresponding changes in autophagic structures.
One additional caveat with TEM, and to some extent with
confocal fluorescence microscopy, is that the analysis of a
single plane within a cell can be misleading and may make
the identification of autophagic structures difficult. Confocal
microscopy and fluorescence microscopy with deconvolu
tion software (or with much more work, 3-dimensional
TEM) can be used to generate multiple/serial sections of
the same cell to reduce this concern; however, in many
cases where there is sufficient structural resolution, analysis
of a single plane in a relatively large cell population can
suffice given practical limitations. EM technologies, such as
focused ion beam scanning electron microscopy (SEM),
Serial Block Face-SEM, and Automatic Tape-collecting
Ultramicrotomy for SEM, should make it much easier to
apply 3-dimensional analyses. An additional methodology
to assess autophagosome accumulation is correlative light
and electron microscopy (CLEM), which is helpful in con
firming that fluorescent structures are autophagosomes
[119–122]. Along these lines, it is important to note that
even though GFP fluorescence will be quenched in the acidic
environment of the autolysosome, some of the GFP puncta
detected by fluorescence microscopy may correspond to
early autolysosomes prior to GFP quenching. These numbers
may increase substantially in pathological conditions where
lysosomal/autolysosomal acidification is impaired. The mini
Singlet Oxygen Generator (miniSOG) fluorescent flavopro
tein, which is less than half the size of GFP, provides an
additional means to genetically tag proteins for CLEM ana
lysis under conditions that are particularly suited to subse
quent TEM analysis [123], with the caveat that single oxygen
targets aromatic amino acids, promoting artefactual protein
damage as well as double bonds in lipids, promoting lipid
peroxidation [124]. Combinatorial assays using tandem
monomeric red fluorescent protein (mRFP)-GFP-LC3 (see
Tandem mRFP/mCherry-GFP fluorescence microscopy) or
other markers for acidic autophagic vacuoles (e.g., Keima)
along with static TEM images should help in the analysis of
flux and the visualization of cargo structures [125].
Another technique that has proven quite useful for analyz
ing the complex membrane structures that participate in
autophagy is 3-dimensional electron tomography [126–128],
and cryoelectron microscopy (cryo-EM; Figure 5) [129]. More
sophisticated, cryo-soft X-ray tomography (cryo-SXT) is an
emerging imaging technique used to visualize autophago
somes [130]. Cryo-SXT extracts ultrastructural information
from whole, unstained mammalian cells as close to the
“near-native” fully-hydrated (living) state as possible.
Correlative studies combining cryo-fluorescence and cryoSXT workflow (cryo-CLXM) have been applied to capture
early autophagosomes. In order to study the structural biology
of purified autophagy components and complexes, high-reso
lution cryo-EM combined with 3-dimensional structure deter
mination is also increasingly being used as an alternative to Xray crystallography or nuclear magnetic resonance (NMR)
spectroscopy [131, 132].
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Figure 5. Cryoelectron microscopy can be used as a three-dimensional approach to monitor the autophagic process. Computed sections of an electron tomogram of
the autophagic vacuole-rich cytoplasm in a hemophagocyte of a semi-thin section after high-pressure freezing preparation. The dashed area is membrane-free (A)
but tomography reveals newly formed or degrading membranes with a parallel stretch (B). Image published previously [4082] and provided by M. Schneider and P.
Walter.

Finally, although only as an indirect measurement, the
comparison of the ratio of autophagosomes to autolysosomes
by TEM can support alterations in autophagy identified by
other procedures [133]. In this case, it is important to always
compare samples to the control of the same cell type and in
the same growth phase, and to acquire data at different time
points, as the autophagosome:autolysosome ratio varies in
time in a cell context-dependent fashion, depending on their
clearance activity. An additional category of lysosomal com
partments, especially common in disease states and aged
postmitotic cells such as neurons, muscle cells and retinal
pigment epithelium, is represented by residual bodies. This
category includes ceroid and lipofuscin, lobulated vesicular
compartments of varying size composed of highly indigestible
complexes of protein and lipid, and abundant, mostly inac
tive, acid hydrolases. Reflecting end-stage unsuccessful incom
plete autolysosomal digestion, lipofuscin is fairly easily
distinguished from AVs and lysosomes by TEM but can be
easily confused with autolysosomes in immunocytochemistry
studies at the light microscopy level [76, 134]; lipofuscin has
broad spectral emission, and is the main cause of autofluor
escence in tissues.
TEM observations of platinum-carbon replicas obtained by
the freeze fracture technique can also supply useful ultrastruc
tural information on the autophagic process. In quickly frozen
and fractured cells the fracture runs preferentially along the
hydrophobic plane of the membranes, allowing characteriza
tion of the limiting membranes of the different types of
autophagic vacuoles, and visualization of their limited protein
intramembrane particles/integral membrane proteins (IMPs).
Several studies have been carried out using this technique on
yeast [135], as well as on mammalian cells or tissues including
the mouse exocrine pancreas [136], the mouse and rat liver
[137, 138], mouse seminal vesicle epithelium [28, 88], rat
tumor and heart [139], and cancer cell lines (e.g., breast
cancer MDA-MB-231) [140] to investigate the various phases
of autophagosome maturation, and to reveal useful details

about the origin and evolution of their limiting membranes
[6, 141–144].
The phagophore and the limiting membranes of autopha
gosomes contain few, or no detectable, IMPs (Figure 6A,B),
when compared to other cellular membranes and to the
membranes of lysosomes. In subsequent stages of the auto
phagic process the fusion of the autophagosome with an endo
some and a lysosome results in increased density of IMPs in the
membrane of the formed autophagic compartments (amphi
amphisomes, autolysosomes; Figure 6C) [6, 28, 135–138, 145,
146]. Autolysosomes are delimited by a single membrane
because, in addition to the engulfed material, the inner mem
brane is also degraded by the lytic enzymes. Similarly, the
limiting membrane of autophagic bodies in yeast (and presum
ably plants) is also quickly broken down under normal condi
tions. Autophagic bodies can be stabilized, however, by the
addition of phenylmethylsulphonylfluoride (PMSF) or geneti
cally by the deletion of the yeast PEP4 gene (see The Cvt
pathway, mitophagy, pexophagy, piecemeal microautophagy of
the nucleus and late nucleophagy in yeast and filamentous
fungi). Thus, another method to consider for monitoring auto
phagy in yeast (and potentially in plants) is to count autophagic
bodies by TEM using at least two time points [147]. The
advantage of this approach is that it can provide accurate
information on flux even when the autophagosomes are abnor
mally small [148, 149]. Thus, although a high frequency of
“abnormal” structures presents a challenge, TEM is still very
helpful in analyzing autophagy.
Cautionary notes: Despite the introduction of many new
methods, TEM maintains its special role in autophagy
research. There are, however, difficulties in utilizing TEM. It
is relatively time consuming and needs technical expertise to
ensure proper handling of samples in all stages of preparation
from fixation to sectioning and staining. It should be noted
that some of the hurdles linked to ultrathin section prepara
tion can be overcome by using focused ion beam scanning
electron microscopy (FIB-SEM) technology, which enables the
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Figure 6. Different autophagic vacuoles observed after freeze fracturing in cultured osteosarcoma cells after treatment with the autophagy inducer voacamine [143].
(A) Early autophagosome delimited by a double membrane. (B) Inner monolayer of an autophagosome membrane deprived of protein particles. (C) Autolysosome
delimited by a single membrane rich in protein particles. In the cross-fractured portion (on the right) the profile of the single membrane and the inner digested
material are easily visible. Images provided by S. Meschini, M. Condello and A. Giuseppe.

operator to selectively ablate in a nanometer scale a previously
marked region of the sample by using a focused ion current
from a gallium source. The milling process can be interrupted
every few nanometers to take high-resolution images of cross
sections by the SEM column [150]. Moreover, the prospects
for application of cryopreparation techniques have been
improved; the notoriously slow process of freeze substitution
of frozen samples can be accelerated tremendously by sample
agitation using either an experimental setup or agitation
modules within automated freeze-substitution units
[151, 152].
After the criteria for sample preparation are met, an
important problem is the proper identification of autophagic
structures. This is crucial for both qualitative and quantitative
characterization, and needs considerable experience, even in
the case of one cell type. The difficulty lies in the fact that
many subcellular components may be mistaken for autopha
gic structures. For example, some authors (or reviewers of
manuscripts) assume that almost all cytoplasmic structures
that, in the section plane, are surrounded by two (more or
less) parallel membranes are autophagosomes. Structures
appearing to be limited by a double membrane, however,
may include swollen mitochondria, plastids in plant cells,
cellular interdigitations, endocytosed apoptotic bodies, circu
lar structures of lamellar smooth endoplasmic reticulum (ER),
and even areas surrounded by rough ER. Endosomes, phago
somes and secretory vacuoles may have heterogeneous con
tent that makes it possible to confuse them with
autolysosomes. Additional identification problems may arise
from damage caused by improper sample collection or fixa
tion artefacts [66, 67, 153, 154].
Whereas fixation of in vitro samples is relatively straight
forward, fixation of excised tissues requires care to avoid
sampling a nonrepresentative, uninformative, or damaged
part of the tissue. For instance, if 95% of a tumor is necrotic,
TEM analysis of the necrotic core may not be informative,
and if the sampling is from the viable rim, this needs to be
specified when reported. Clearly, this introduces the potential
for subjectivity because reviewers of a paper cannot request
multiple images with a careful statistical analysis with these
types of samples. In addition, ex vivo samples are not typically

randomized during processing, further complicating the pos
sibility of valid statistical analyses. Ex vivo tissue should be
fixed immediately and systematically across samples to avoid
changes in autophagy that may occur simply due to the
elapsed time ex vivo. It is recommended that for tissue sam
ples, perfusion fixation should be used when possible. Rapid
freezing techniques such as high-pressure freezing followed by
freeze substitution (i.e., dehydration and chemical fixation at
low temperature) have a widely accepted potential for
improved sample preparation. Consequently, cryopreparation
protocols have been established for many molecular biological
model organisms and tissue culture [155]. Such cryoprepara
tion techniques have already proven especially useful for
elucidation of autophagy in yeast [156, 157].
Quantification of autophagy by TEM morphometry can be
very useful and accurate, but, unfortunately, unreliable proce
dures still continue to be used. For the principles of reliable
quantification and to avoid misleading results, excellent
reviews are available [12, 158–160]. In line with the basic
principles of morphometry we find it necessary to emphasize
here some common problems with regard to quantification.
Counting autophagic vacuole profiles in sections of cells (i.e.,
number of autophagic profiles per cell profile) may give
unreliable results, partly because both cell areas and profile
areas are variable and also because the frequency of section
profiles depends on the size of the vacuoles. However, estima
tion of the number of autophagic profiles per cell area is more
reliable and correlates well with the volume fraction men
tioned below [161]. There are morphometric procedures to
measure or estimate the size range and the number of sphe
rical objects by profiles in sections [160]; however, such
methods have been used in autophagy research only a few
times [42, 149, 162, 163].
Proper morphometric procedures return data as µm3
autophagic vacuole/µm3 cytoplasm for relative volume (also
called volume fraction or volume density), or µm2 autophagic
vacuole surface/µm3 cytoplasm for relative surface (surface
density). Examples of actual morphometric measurements
for the characterization of autophagic processes can be
found in several articles [22, 154, 160, 164, 165]. It is appro
priate to note here that a change in the volume fraction of the
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autophagic compartment may come from two sources; from
the real growth of its size in a given cytoplasmic volume, or
from the decrease of the cytoplasmic volume itself. To avoid
this so-called “reference trap,” the reference space volume can
be determined by different methods [158, 166]. If different
magnifications are used for measuring the autophagic
vacuoles and the cytoplasm (which may be practical when
autophagy is less intense) correction factors should always be
used.
In some cases, it may be prudent to employ tomographic
reconstructions of TEM images to confirm that the autopha
gic compartments are spherical and are not being confused
with interdigitations observed between neighboring cells,
endomembrane cisternae or damaged mitochondria with
similar appearance in thin-sections (e.g., see ref. [167]), but
this is obviously a time-consuming approach requiring
sophisticated equipment. In addition, interpretation of tomo
graphic images can be problematic. For example, starvationinduced autophagosomes should contain cytoplasm (i.e., cyto
sol and possibly organelles), but autophagosome-related
structures involved in specific types of autophagy should
show the selective cytoplasmic target, but may be relatively
devoid of bulk cytoplasm. Such processes include selective
peroxisome or mitochondria degradation (pexophagy or
mitophagy, respectively) [168, 169], targeted degradation of
pathogenic microbes (xenophagy) [170–175], a combination
of xenophagy and stress-induced mitophagy [176], as well as
the yeast biosynthetic cytoplasm-to-vacuole targeting (Cvt)
pathway [177]. Furthermore, some pathogenic microbes
express membrane-disrupting factors during infection (e.g.,
phospholipases) that disrupt the normal double-membrane
architecture of autophagosomes [178]. It is not even clear if
the sequestering compartments used for specific organelle
degradation or xenophagy should be termed autophagosomes
or if alternate terms such as pexophagosome [179], mitopha
gosome and xenophagosome should be used, even though the
membrane and mechanisms involved in their formation may
be identical to those for starvation-induced autophagosomes.
Indeed, the double-membrane vesicle of the Cvt pathway is
referred to as a Cvt vesicle [180].
The confusion of heterophagic structures with autophagic
ones is a major source of misinterpretation. A prominent
example of this is related to cell death. Apoptotic bodies
from neighboring cells can be readily phagocytosed by surviv
ing cells of the same tissue [181, 182]. Immediately after
phagocytic uptake of apoptotic bodies, phagosomes may
appear as double membraned. The inner one is the plasma
membrane of the apoptotic body and the outer one is that of
the phagocytizing cell. The early heterophagic vacuole formed
in this way may appear similar to an autophagosome or, in a
later stage, an early autolysosome in that it contains recogniz
able or identifiable cytoplasmic material. A major difference,
however, is that the surrounding membranes are the thicker
plasma membrane type, rather than the thinner sequestration
membrane type [153]. A good feature to distinguish between
autophagosomes and double plasma membrane-bound struc
tures is the lack of the distended empty space (characteristic
for the sequestration membranes of autophagosomes)
between the two membranes of the phagocytic vacuoles. In

addition, engulfed apoptotic bodies usually have a larger
average size than autophagosomes [183, 184]. The problem
of heterophagic elements interfering with the identification of
autophagic ones is most prominent in cell types with particu
larly intense heterophagic activity (such as macrophages, and
amoeboid or ciliate protists). Special attention has to be paid
to this problem in cell cultures or in vivo treatments (e.g.,
with toxic or chemotherapeutic agents) causing extensive cell
death.
The most common organelles confused with autophagic
vacuoles are mitochondria, ER, endosomes, and also (depend
ing on their structure) plastids in plants. Due to the cisternal
structure of the ER, double membrane-like structures sur
rounding mitochondria or other organelles are often observed
after sectioning [185], but these can also correspond to cis
ternae of the ER coming into and out of the section plane
[66]. If there are ribosomes associated with these membranes
they can help in distinguishing them from the ribosome-free
double-membrane of the phagophore and autophagosome.
Observation of a mixture of early and late autophagic vacuoles
that is modulated by the time point of collection and/or brief
pulses of bafilomycin A1 to trap the cargo in a recognizable
early state [55] increases the confidence that an autophagic
process is being observed. In these cases, however, the possi
bility that feedback activation of sequestration gets involved in
the autophagic process has to be carefully considered. To
minimize the impact of errors, exact categorization of auto
phagic elements should be applied. Efforts should be made to
clarify the nature of questionable structures by extensive pre
liminary comparison in many test areas. Elements that still
remain questionable should be categorized into special groups
and measured separately. Should their later identification
become possible, they can be added to the proper category
or, if not, kept separate.
For nonspecialists it can be particularly difficult to distin
guish among amphisomes, autolysosomes and lysosomes,
which are all single-membrane compartments containing
material that has been more or less degraded. Therefore,
we suggest in general to measure autophagosomes as a sepa
rate category for a start, and to compile another category of
degradative compartments (including amphisomes, autoly
sosomes and lysosomes). All of the autophagic compart
ments increase in quantity upon true autophagy induction;
however, in pathological states, it may be informative to
discriminate among these different forms of degradative
compartments, which may be differentially affected by dis
ease factors. By applying both immuno-TEM and Airyscan
confocal imaging, it is possible to obtain a comprehensive
and quantitative analysis of LAMP1 distribution in various
autophagic organelles in neurons [186, 187]. A significant
portion of LAMP1-labeled organelles lack major lysosomal
hydrolases, and LAMP1 intensity is not a sensitive readout to
assess autophagic deficits in familial amyotrophic lateral
sclerosis-linked motor neurons in vivo [188, 189]. Thus, cau
tion is warranted when interpreting LAMP1-labeled autolyso
somes and labeling a set of active lysosomal hydrolases
combined with various autophagic markers would be necessary
to assess degradative autolysosomes under physiological and
pathological conditions.
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A new and fast developing technique is combining the
temporal resolution of time-lapse fluorescence microscopy
with the spatial resolution of super-resolution microscopy.
HEK293 cells that express recombinant proteins of interest
fused to fluorescent tags are imaged live to capture the for
mation of autophagosomes, fixed on stage to “snap-freeze”
these structures, stained with appropriate antibodies, relo
cated, and imaged at super resolution by direct stochastic
optical reconstruction microscopy [190].
Super-resolution microscopy techniques at ∼20 nm spatial
resolution via 3-color, 3-dimensional super-resolution fluor
escence microscopy, makes it possible to image the structural
organization of the ULK1 complex that scaffolds the forma
tion of cup-like structures located at SEC12-enriched remo
deled ER-exit sites prior to LC3 lipidation. This cup scaffold
provides a structural asymmetry to enforce the directional
recruitment of downstream components, including the
ATG12–ATG5-ATG16L1 complex, WIPI2, and LC3, to the
convex side of the cup [191].
In yeast, it is convenient to identify autophagic bodies that
reside within the vacuole lumen, and to quantify them as an
alternative to the direct examination of autophagosomes.
However, it is important to keep in mind that it may not be
possible to distinguish between autophagic bodies that are
derived from the fusion of autophagosomes with the vacuole,
and the single-membrane vesicles that are generated during
microautophagy-like processes such as micropexophagy and
micromitophagy.
Conclusion: EM is an extremely informative and powerful
method for monitoring autophagy and is one of the few
techniques that shows autophagy in its complex cellular envir
onment with subcellular resolution. The cornerstone of suc
cessfully using TEM is the proper identification of autophagic
structures, which is also the prerequisite to get reliable quan
titative results by TEM morphometry. EM is best used in
combination with other methods to ensure the complex and
holistic approach that is becoming increasingly necessary for
further progress in autophagy research.
2. Atg8-family protein detection and quantification
Atg8 and the Atg8-family proteins are the most widely mon
itored autophagy-related proteins. In this section we describe
multiple assays that utilize these proteins.
a. Western blotting and ubiquitin-like protein conjugation
systems. Atg8 is a ubiquitin-like protein that can be conju
gated to PE (and possibly to phosphatidylserine [PS] [192]).
In yeast and several other organisms, the conjugated form is
referred to as Atg8–PE. The mammalian homologs of Atg8
constitute a family of proteins subdivided in two major sub
families: MAP1LC3/LC3 and GABARAP. The former consists
of LC3A (two splice variants), LC3B, LC3B2 and LC3C,
whereas the latter family includes GABARAP, GABARAPL1,
and GABARAPL2/GATE-16 [193]. After cleavage of the pre
cursor protein mostly by the cysteine protease ATG4B [194,
195], the nonlipidated and lipidated forms are usually referred
to respectively as LC3-I and LC3-II, or GABARAP and
GABARAP–PE, etc. The PE-conjugated form of Atg8-family
proteins, although larger in mass, shows faster electrophoretic
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mobility in SDS-PAGE gels, probably as a consequence of
increased hydrophobicity. The positions of both the unconju
gated (approximately 16-18 kDa) and lipid conjugated
(approximately 14-16 kDa) forms of the Atg8-family proteins
should be indicated on western blots whenever both are
detectable. The differences among the LC3/GABARAP pro
teins with regard to function and tissue-specific expression are
not well defined; however, new evidence suggests that LC3
proteins have distinct subcellular distributions and mediate
different types of selective autophagy [196, 197]. Therefore, it
is important to indicate the isoform being analyzed just as it is
for the GABARAP subfamily, and to specify which antibody is
being used.
The mammalian Atg8 homologs share from 29% to 94%
sequence identity with the yeast protein and have all been
demonstrated to be involved in autophagosome biogenesis
[198]. LC3 proteins are involved in autophagosome forma
tion, with participation of GABARAP subfamily members in
later stages of autophagosome formation [199]. Some evi
dence, however, suggests that, at least in certain cell types,
the LC3 subfamily may be dispensable for bulk autophagic
sequestration of cytosolic proteins, whereas the GABARAP
subfamily is absolutely required [32]. Also, PINK1-PRKNdependent mitophagy strongly requires the GABARAP sub
family, with little or no requirement for the LC3 subfamily
[34, 35]. Due to unique features in their molecular surface
charge distribution [200], emerging evidence indicates that
LC3 and GABARAP proteins may be involved in recognizing
distinct sets of cargoes for selective autophagy [201–203].
Nevertheless, in most published studies, LC3 has been the
primary Atg8-family homolog examined in mammalian cells
and the one that is typically characterized as an autophago
some marker per se. Note that although this protein is
referred to as “Atg8” in many other systems, we primarily
refer to it in this section as LC3 to distinguish it from the
yeast protein and from the GABARAP subfamily, whereas we
generally refer to the “Atg8-family proteins” throughout the
rest of these guidelines. LC3, like the other Atg8 homologs, is
initially synthesized in an unprocessed form, proLC3, which is
converted into a proteolytically processed form lacking amino
acids from the C terminus, LC3-I, and is finally modified into
the PE-conjugated form, LC3-II (Figure 7). Atg8–PE/LC3-II is
the only protein marker that is reliably associated with com
pleted autophagosomes, but is also localized to phagophores.
In yeast, Atg8 protein levels increase at least 10-fold when
autophagy is induced [204]. In mammalian cells, however, the
total levels of LC3 do not necessarily change in a predictable
manner, as there may be an increase in the conversion of
LC3-I to LC3-II, or a decrease in LC3-II relative to LC3-I if
degradation of LC3-II via lysosomal turnover is particularly
rapid (this can also be a concern in yeast with regard to
vacuolar turnover of Atg8–PE). Both of these events can be
seen sequentially in several cell types as a response to total
nutrient and serum starvation. It is also possible that follow
ing the induction of autophagy there is a decrease in both
LC3-I and LC3-II due to rapid LC3-I conversion together
with rapid LC3-II degradation [205]. In cells of neural lineage,
a high ratio of LC3-I to LC3-II is a common finding [206].
For instance, SH-SY5Y neuroblastoma cell lines display only a
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Figure 7. LC3-I conversion and LC3-II turnover. (A) Expression levels of LC3-I and LC3-II during starvation. Atg5+/+ (wild-type) and atg5−/− MEFs were cultured in
DMEM without amino acids and serum for the indicated times, and then subjected to immunoblot analysis using anti-LC3 antibody and anti-tubulin antibody. E-64d
(10 µg/ml) and pepstatin A (10 µg/ml) were added to the medium where indicated. Positions of LC3-I and LC3-II are marked. The inclusion of lysosomal protease
inhibitors reveals that the apparent decrease in LC3-II is due to lysosomal degradation as easily seen by comparing samples with and without inhibitors at the same
time points (the overall decrease seen in the presence of inhibitors may reflect decreasing effectiveness of the inhibitors over time). Monitoring autophagy by
following steady-state amounts of LC3-II without including inhibitors in the analysis can result in an incorrect interpretation that autophagy is not taking place (due
to the apparent absence of LC3-II). Conversely, if there are high levels of LC3-II but there is no change in the presence of inhibitors this may indicate that induction
has occurred but that the final steps of autophagy are blocked, resulting in stabilization of this protein. This figure was modified from data previously published in
ref. [30], and is reproduced by permission of Landes Bioscience, copyright 2007. (B) Lysates of four human adipose tissue biopsies were resolved on two 12%
polyacrylamide gels, as described previously [292]. Proteins were transferred in parallel to either a PVDF or a nitrocellulose membrane, and blotted with anti-LC3
antibody, and then identified by reacting the membranes with an HRP-conjugated anti-rabbit IgG antibody, followed by ECL. The LC3-II:LC3-I ratio was calculated
based on densitometry analysis of both bands. *, P< 0.05. (C) HEK 293 and HeLa cells were cultured in nutrient-rich medium (DMEM containing 10% fetal calf serum)
or incubated for 4 h in starvation conditions (Krebs-Ringer medium) in the absence (-) or presence (+) of E-64d and pepstatin at 10 µg/ml each (Inhibitors). Cells were
then lysed and the proteins resolved by SDS-PAGE. Endogenous LC3 was detected by immunoblotting. Positions of LC3-I and LC3-II are indicated. In the absence of
lysosomal protease inhibitors, starvation results in a modest increase (HEK 293 cells) or even a decrease (HeLa cells) in the amount of LC3-II. The use of inhibitors
reveals that this apparent decrease is due to lysosome-dependent degradation. This figure was modified from data previously published in ref. [240], and is
reproduced by permission of Landes Bioscience, copyright 2005. (D) Sequence and schematic representation of the different forms of LC3B. The sequence for the
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slight increase of LC3-II after nutrient deprivation, whereas
LC3-I is clearly reduced. This is likely related to a high basal
autophagic flux, as suggested by the higher increase in LC3-II
when cells are treated with NH4Cl [207, 208], although cellspecific differences in transcriptional regulation of LC3 may
also play a role. In fact, stimuli or stress that inhibit transcrip
tion or translation of LC3 might actually be misinterpreted as
inhibition of autophagy, and vice versa—stimuli or stress that
increase transcription or translation of LC3 might be misin
terpreted as activation of autophagy. The LC3-I:LC3-II ratio
can vary across brain cancer cells depending on the basal level
of autophagy, a phenomenon that can influence further ana
lysis of autophagy activation upon stressful conditions such as
hypoxia [209]. Importantly, in brain spinal cord and dorsal
root ganglia tissue, LC3-I is much more abundant than LC3-II
[210, 211] and the latter form is most easily discernible in
enriched fractions of autophagosomes, autolysosomes and ER,
and may be more difficult to detect in crude homogenate or
cytosol [212]. It is possible to readily detect both LC3-I and
LC3-II in brain and spinal cord lysates with the use of a gel
that allows sufficient separation of the LC3-I/LC3-II bands so
the strong LC3-I band does not interfere with detection of the
much weaker LC3-II band (e.g., a 4-20% gradient gel or a 412% Bis-Tris gel using MES buffer) [213, 214]. In studies of
the brain, immunoblot analysis of the membrane and cytosol
fraction from a cell lysate, upon appropriate loading of sam
ples to achieve quantifiable and comparative signals, can be
useful to measure LC3 forms. For more accurate quantifica
tion of LC3-I and LC3-II levels, a correction factor for differ
ential immunoreactivity of the two forms can be obtained
through analyses of LC3-I and LC3-II protein levels upon
ATG4-mediated delipidation [32].
The pattern of LC3-I to LC3-II conversion seems to be not
only cell specific, but also related to the kind of stress to which
cells are subjected. For example, SH-SY5Y cells display a
strong increase of LC3-II when treated with the proton gra
dient uncoupler CCCP, a well-known disruptor of the mito
chondrial membrane potential and inducer of mitophagy
(although it has also been reported that CCCP may actually
inhibit mitophagy [215]). Thus, neither assessment of LC3-I
consumption nor the evaluation of LC3-II levels would neces
sarily reveal a slight induction of autophagy (e.g., by rapamy
cin). Also, there is not always a clear precursor/product
relationship between LC3-I and LC3-II, because the conver
sion of the former to the latter is cell type-specific and depen
dent on the treatment used to induce autophagy.
Accumulation of LC3-II, which is generally proportional
with time, can be obtained through the following: i) By inter
rupting the autophagosome-lysosome fusion step (e.g., by
depolymerizing acetylated microtubules with vinblastine); ii)
by inhibiting the ATP2A/SERCA calcium pump with thapsi
gargin [216]; iii) by specifically inhibiting the V-ATPase with

55

bafilomycin A1 [217–219]; iv) or by raising the lysosomal pH
by the addition of CQ [220, 221]. It should be noted that some
of these treatments may increase autophagosome numbers by:
i) Disrupting the lysosome-dependent activation of MTOR
(mechanistic target of rapamycin kinase) complex 1
(MTORC1), a major suppressor of autophagy induction
[222, 223] (note that the original term “mTOR” was named
to distinguish the “mammalian” target of rapamycin from the
yeast proteins [224]); ii) by inhibiting lysosome-mediated
proteolysis (e.g., with a cysteine protease inhibitor such as
E-64d, the aspartic protease inhibitor pepstatin A, the
cysteine, serine and threonine protease inhibitor leupeptin
or treatment with bafilomycin A1, NH4Cl or CQ [220, 225–
227]); iii) by inhibiting autophagosome-lysosome fusion (by
treatment with bafilomycin A1 [218]). It should also be noted
that low concentration treatment with lysosomal inhibitors
increases lysosomal activity [228]. Western blotting can be
used to monitor changes in LC3 amounts (Figure 7) [30,
229]; however, even if the total amount of LC3 does increase,
the magnitude of the response is generally less than that
documented in yeast. It is worth noting that because the
conjugated forms of the GABARAP subfamily members are
usually undetectable without induction of autophagy in mam
malian and other vertebrate cells [230, 231], these proteins
might be more suitable than LC3 to study and quantify subtle
changes in autophagy induction.
As Atg8-family proteins are often synthesized with a Cterminal extension that is removed by Atg4, this processing
event can be used to monitor Atg4 activity. For example,
when GFP or tags such as HA, MYC or FLAG are fused at
the C terminus of Atg8 (Atg8-GFP, etc.), the epitope is
removed in the cytosol to generate free Atg8 and the corre
sponding tag. This processing can be easily monitored by
western blot [232, 233]. It is also possible to use assays with
an artificial fluorogenic substrate, or a fusion of LC3B to
PLA2 (phospholipase A2) that allows the release of the active
phospholipase for a subsequent fluorogenic assay [234], and
there is a Förster resonance energy transfer (FRET)-based
assay utilizing CFP- and YFP-tagged versions of LC3B and
GABARAPL2 that can be used for high-throughput screening
[235]. Another method to monitor ATG4 activity in vivo uses
the release of Gaussia luciferase from the C terminus of LC3
that is tethered to actin [236]. Note that there are 4 homologs
of yeast Atg4 in mammals, and they have different activities
with regard to the Atg8-family proteins [237]. ATG4A is able
to cleave the GABARAP subfamily, but has very limited
activity toward the LC3 subfamily, whereas ATG4B is appar
ently active against most or all of these proteins [194, 195].
The ATG4C and ATG4D isoforms have minimal activity for
any of the Atg8-family protein homologs. In particular,
because Atg4/ATG4 will cleave a C-terminal fusion immedi
ately, researchers should be careful to specify whether they are

Figure 7. (Continued).
nascent (proLC3) from mouse is shown. The glycine at position 120 indicates the cleavage site for ATG4. After this cleavage, the truncated LC3 is referred to as LC3-I,
which is still a soluble form of the protein. Conjugation to PE generates the membrane-associated LC3-II form (equivalent to Atg8–PE).
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using GFP-Atg8 (or GFP-LC3/GABARAP; an N-terminal
fusion, which can be used to monitor various steps of auto
phagy) or Atg8-GFP (or LC3/GBARAP-GFP; a C-terminal
fusion, which can only be used to monitor Atg4/ATG4 activ
ity) [238].
Cautionary notes: There are several important caveats
to using Atg8/LC3-II/GABARAP-II to visualize fluctua
tions in autophagy. First, changes in LC3-II amounts are
tissue- and cell context-dependent [239, 240]. Indeed, in
some cases, autophagosome accumulation detected by TEM
does not correlate well with the amount of LC3-II (Tallóczy
Z, de Vries RLA, and Sulzer D, unpublished results;
Eskelinen E-L, unpublished results). This is particularly
evident in those cells that show low levels of LC3-II
(based on western blotting) because of an intense autopha
gic flux that consumes this protein, or in cell lines having
high levels of LC3-II that are tumor-derived, such as HeLa
cells [240]. Conversely, the detectable formation of LC3-II
is not sufficient evidence for autophagy. For example,
homozygous deletion of Becn1 does not prevent the forma
tion of LC3-II in embryonic stem cells even though auto
phagy is substantially reduced, whereas deletion of Atg5
results in the complete absence of LC3-II (see Fig. 6A and
supplemental data in ref. [241]). The same is true for the
generation of Atg8–PE in yeast in the absence of VPS30/
ATG6 (see Fig. 7 in ref. [242]). Thus, it is important to
remember that not all of the autophagy-related proteins are
required for Atg8-family protein processing, including lipi
dation [242]. Fluctuations in the detection and amounts of
LC3-I versus LC3-II present technical problems. For exam
ple, LC3-I is very abundant in brain tissue, and the inten
sity of the LC3-I band may obscure detection of LC3-II,
unless the polyacrylamide crosslinking density is optimized,
or the membrane fraction of LC3 is first separated from the
cytosolic fraction [41]. Conversely, some cell lines have
much less visible LC3-I compared to LC3-II. In addition,
tissues may have asynchronous and heterogeneous cell
populations, and this variability may present challenges
when analyzing LC3 by western blotting.
Second, LC3-II also associates with the membranes of
nonautophagic structures. For example, some members of
the γ-protocadherin family undergo clustering to form intra
cellular tubules that emanate from lysosomes [243]. LC3-II is
recruited to these tubules, where it appears to promote or
stabilize membrane expansion. Furthermore, LC3 can be
recruited directly to apoptotic cell-containing phagosome
membranes [244, 245], macropinosomes [244], the parasito
phorous vacuole of Toxoplasma gondii [246], and singlemembrane entotic vacuoles [244], as well as to bacteria-con
taining phagosome membranes under certain immune acti
vating conditions, for example, toll-like receptor (TLR)mediated stimulation in LC3-associated phagocytosis [247,
248]. Importantly, LC3 is involved in secretory trafficking as
it has been associated with secretory granules in mast cells
[249] and PC12 hormone-secreting cells [250]. LC3 is also
detected on secretory lysosomes in osteoclasts [251] and in
amphisome-like structures involved in mucin secretion by
goblet cells [252]. Therefore, in studies of infection of mam
malian cells by bacterial pathogens, the identity of the LC3-II

labelled compartment as an autophagosome should be con
firmed by a second method, such as TEM. It is also worth
noting that autophagy induced in response to bacterial infec
tion is not directed solely against the bacteria but can also be a
response to remnants of the phagocytic membrane [253].
Similar cautions apply with regard to viral infection. For
example, coronaviruses induce autophagosomes during infec
tion through the expression of nsp6; however, coronaviruses
also induce the formation of double-membrane vesicles that
are coated with LC3-I, and this plays an autophagy-indepen
dent role in viral replication [254, 255]. Similarly, nonlipi
dated LC3 marks replication complexes in flavivirus (Japanese
encephalitis virus)-infected cells and is essential for viral
replication [256]. Along these lines, during herpes simplex
virus type 1 (HSV-1) infection, an LC3+ autophagosome-like
organelle that is derived from nuclear membranes and that
contains viral proteins is observed [257], whereas influenza A
virus directs LC3 to the plasma membrane via an LC3-inter
acting region (LIR) motif in its M2 protein [258]. In addition,
shedding microvesicles isolated from HSV-1-infected cells are
positive for LC3-II, suggesting a role for the autophagic path
way in microvesicle-mediated HSV-1 spread [259]. Moreover,
in vivo studies have shown that coxsackievirus (an entero
virus) induces formation of autophagy-like vesicles in pan
creatic acinar cells, together with extremely large autophagyrelated compartments that have been termed megaphago
somes [260]; the absence of ATG5 disrupts viral replication
and prevents the formation of these structures [261]. Of note,
LC3 not only attaches to membrane lipids, but can also be
covalently linked to other proteins [262], thus complicating
interpretation of its distribution in cells.
Third, caution must be exercised in general when evaluat
ing LC3 by western blotting, and appropriate standardization
controls are necessary. For example, LC3-I may be less sensi
tive to detection by certain anti-LC3 antibodies; antibodies
targeting the N-terminal region show lower binding efficiency
of LC3-I compared to polyclonal antibodies against the entire
protein, leading to a different interpretation of LC3 turnover
(Figure 8) (C. Leschczyk, P. Cebollada Rica, U.E. Schaible,
unpublished results) [263]. Moreover, LC3-I is more labile
than LC3-II, being more sensitive to freezing-thawing and to
degradation in SDS sample buffer. Therefore, fresh samples
should be boiled and assessed as soon as possible and should
not be subjected to repeated freeze-thaw cycles. Alternatively,
trichloroacetic acid precipitation of protein from fresh cell
homogenates can be used to protect against degradation of
LC3 by proteases that may be present in the sample. A general
point to consider when examining transfected cells concerns
the efficiency of transfection. A western blot will detect LC3 in
the entire cell population, including those that are not trans
fected. Thus, if transfection efficiency is too low, it may be
necessary to use methods, such as fluorescence microscopy,
that allow autophagy to be monitored in single cells. In
summary, the analysis of the gel shift of transfected LC3 or
GFP-LC3 can be employed to follow LC3 lipidation only in
highly transfectable cells [264].
When dealing with animal tissues, western blotting of LC3
should be performed on frozen biopsy samples homogenized
in the presence of general protease inhibitors (C. Isidoro,
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Figure 8. Different LC3B-I:LC3B-II ratios indicating turnover were assessed using
a mono- as well as polyclonal anti-LC3B antibody. Monocytes were isolated from
human whole blood and differentiated into monocyte-derived macrophages
(MDMs) by incubation in human CSF1/M-CSF for 1 week. To induce autophagy,
cells were starved by reducing the FCS concentration to 1% for one day.
Monocytes, and resting and starved MDMs were lysed with Laemmli buffer;
the proteins were separated by SDS-PAGE and analyzed by western blot.
Membranes were labeled using a monoclonal antibody to the N terminus of
LC3B (Novus, clone 1251D, NBP2-59800) or polyclonal antibodies (Sigma, L7543).
Relative intensity of LC3B-I and LC3B-II was quantified with Image Lab™ to
calculate LC3B-II:LC3B-I ratios.

personal communication; see also Human) [265]. Caveats
regarding detection of LC3 by western blotting have been
covered in a dedicated review [30]. For example, PVDF mem
branes may result in a stronger LC3-II retention than nitro
cellulose membranes, possibly due to a higher affinity for
hydrophobic proteins (Figure 7B; J. Kovsan and A. Rudich,
personal communication), and Triton X-100 may not effi
ciently solubilize LC3-II in some systems [266]. Heating in
the presence of 1% SDS, or analysis of membrane fractions
[41], may assist in the detection of the lipidated form of this
protein. This observation is particularly relevant for cells with
a high nucleocytoplasmic ratio, such as lymphocytes. Under
these constraints, direct lysis in Laemmli loading buffer, con
taining SDS, just before heating, greatly improves LC3 detec
tion on PVDF membranes, especially when working with a
small number of cells (F. Gros, unpublished observations)
[267]. Analysis of a membrane fraction is particularly useful
for brain, where levels of soluble LC3-I greatly exceed the level
of LC3-II.
One of the most important issues is the quantification of
changes in LC3-II, because this assay is one of the most widely
used in the field and is rather prone to misinterpretation.
Levels of LC3-II should be compared not to LC3-I (see the
caveat in the next paragraph), but ideally to more than one
“housekeeping” protein (HKP) such as ACTB/β-actin. Actin
and other HKPs, however, are usually abundant and can easily
be overloaded on the gel [268] such that their density is
saturated and, as such, they are not detected within a linear
range. Moreover, actin levels may decrease when autophagy is
induced in many organisms from yeast to mammals. Similar
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considerations apply to GAPDH, at least in some cell types (L.
Galluzzi, personal communication) [269]. For any proteins
used as “loading controls” (including actin, tubulin, MAPK1
[270–272] and GAPDH) multiple exposures of the western
blot are generally necessary to ensure that the signals are
detected in the linear range when using film. Alternatively,
the western blot signals can be detected using a gel imaging
system compatible with secondary antibodies with infrared
fluorescence, or an instrument that takes multiple chemilu
minescence exposures and automatically selects the optimal
exposure times. Another alternative approach is to stain for
total cellular proteins with Coomassie Brilliant Blue or
Ponceau Red [273] instead of using HKPs, but that approach
is generally less sensitive and may not reveal small differences
in protein loading. Stain-Free gels, which also stain for total
cellular proteins, have been shown to be an excellent alter
native to HKPs [274].
It is important to realize that ignoring the level of LC3-I in
favor of LC3-II normalized to HKPs may not provide the full
picture of the cellular autophagic response [239, 275]. For
example, in aging rat skeletal muscle, the increase in LC3-I
is at least as important as that for LC3-II [276, 277]. Yet in
other settings, autophagy induction triggers a significant
decrease in LC3-I levels, along with an increase in LC3-II
levels, presumably due to its increased conversion into LC3II [278]. Quantification of both isoforms is therefore informa
tive, but requires adequate conditions of electrophoretic
separation. This is particularly important for samples where
the amount of LC3-I is high relative to LC3-II (as in brain
tissues, where the LC3-I signal can be overwhelming). Under
such a scenario, it may be helpful to use 15% or 16% poly
acrylamide gels or gradient gels to increase the separation of
LC3-I from LC3-II. Furthermore, because the dynamic range
of LC3 immunoblots is generally quite limited, it is imperative
that other assays be used in parallel in order to draw valid
conclusions about changes in autophagy activity.
Fourth, in mammalian cells LC3 is expressed as multiple
isoforms (LC3A, LC3B, LC3B2 and LC3C [279, 280]), which
exhibit different tissue distributions and whose functions are
still poorly understood. A point of caution along these lines is
that the increase in LC3A-II versus LC3B-II levels may not
display equivalent changes in all organisms under autophagyinducing conditions, and it should not be assumed that LC3B
is the optimal protein to monitor [281]. A key technical
consideration is that the isoforms may exhibit different spe
cificities for antisera or antibodies. Thus, it is highly recom
mended that investigators report exactly the source and
catalog number of the antibodies used to detect LC3 as this
might help avoid discrepancies between studies (reporting
company and catalog number is a requirement for publishing
in the journal Autophagy [282]). The current commercialized
anti-LC3B antibodies also recognize LC3A, but do not recog
nize LC3C, which shares less sequence homology. It is impor
tant to note that LC3C possesses in its primary amino acid
sequence the DYKD motif that is recognized with a high
affinity by anti-FLAG antibodies. Thus, the standard antiFLAG M2 antibody can detect and immunoprecipitate over
expressed LC3C, and caution has to be taken in experiments
using FLAG-tagged proteins (M. Biard-Piechaczyk and L.
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Espert, personal communication). Note that according to
Ensembl there is no LC3C in mouse or rat.
In addition, it is important to keep in mind the other
subfamily of Atg8 proteins, the GABARAP subfamily (see
above) [198, 283]. Both starvation-induced autophagy and
PINK1-PRKN-dependent mitophagy, as noted above, predo
minantly require the GABARAP subfamily over the LC3 sub
family [32, 34, 35]. Moreover, certain types of mitophagy
induced by BNIP3L/NIX are highly dependent on
GABARAP and less dependent on LC3 proteins [284, 285].
Furthermore, commercial antibodies for GABARAPL1 also
recognize GABARAP [32, 193], which might lead to misinter
pretation of experiments, in particular those using immuno
histochemical techniques. Sometimes the problem with crossreactivity of the anti-GABARAPL1 antibody can be overcome
when analyzing these proteins by western blot because the
isoforms can be resolved during SDS-PAGE using high con
centration (15%) gels, as GABARAP migrates faster than
GABARAPL1 (M. Boyer-Guittaut, personal communication;
also see Fig. S4 in ref. [32]). Because GABARAP and
GABARAPL1 can both be proteolytically processed and lipi
dated, generating GABARAP-I or GABARAPL1-I and
GABARAP-II or GABARAPL1-II, respectively, this may lead
to a misassignment of the different bands. As soon as highly
specific antibodies that are able to discriminate between
GABARAP and GABARAPL1 become available, we strongly
advise their use; until then, we recommend caution in inter
preting results based on the detection of these proteins by
western blot. Antibody specificity can be assessed after com
plete inhibition of GABARAP (or any other Atg8-family pro
tein) expression by RNA interference [32, 231]. In general, we
advise caution in choosing antibodies for western blotting and
immunofluorescence experiments and in interpreting results
based on stated affinities of antibodies unless these have been
clearly determined.
As with any western blot, proper methods of quantification
must be used, which are, unfortunately, often not well dis
seminated; readers are referred to an excellent paper on this
subject (see ref. [286]). Unlike the other members of the
GABARAP family, almost no information is available on
GABARAPL3, perhaps because it is not yet possible to differ
entiate between GABARAPL1 and GABARAPL3 proteins,
which have 94% identity. As stated by the laboratory that
described the cloning of the human GABARAPL1 and
GABARAPL3 genes [283], their expression patterns are appar
ently identical. It is worth noting that GABARAPL3 is the only
gene of the GABARAP subfamily that seems to lack an ortho
log in mice [283]. GABARAPL3 might therefore be considered
as a pseudogene without an intron that is derived from
GABARAPL1. Hence, until new data are published,
GABARAPL3 should not be considered as the fourth member
of the GABARAP family. Another important consideration is
that lipidated LC3/GABARAP isoforms (particularly
GABARAP and GABARAPL1) can be unstable in non-dena
tured cell lysates due to ATG4B delipidation activity, even in
the presence of a protease inhibitor cocktail. This can result in
an underestimation of the true physiological levels of lipidated
LC3/GABARAP detected by western blotting. To avoid this
artefact, N-ethylmaleimide can be included in lysis buffer to

irreversibly inhibit ATG4B, or lysis can be performed under
reducing and denaturing conditions [287].
Fifth, in non-mammalian species, the discrimination of
Atg8–PE from the nonlipidated form can be complicated by
their nearly identical SDS-PAGE mobilities and the presence
of multiple isoforms (e.g., there are nine in Arabidopsis). In
yeast, it is possible to resolve Atg8 (the nonlipidated form)
from Atg8–PE by including 6 M urea in the SDS-PAGE
separating gel [288], or by using a 15% resolving gel without
urea (F. Reggiori, personal communication). Similarly, urea
combined with prior treatment of the samples with (or with
out) PLD (phospholipase D; that will remove the PE moiety)
can often resolve the ATG8 species in plants [289, 290]. It is
also possible to label cells with radioactive ethanolamine,
followed by autoradiography to identify Atg8–PE, and a Cterminal peptide can be analyzed by mass spectrometry (MS)
to identify the lipid modification at the terminal glycine
residue. Special treatments are not needed for the separation
of mammalian LC3-I from LC3-II. However, in human cells,
pro-LC3B and LC3B-II are indistinguishable by western blot
ting [291], and a PLD cleavage assay may be required to
discriminate between the two isoforms [287], which is parti
cularly important under conditions where ATG4 activity is
reduced.
Sixth, it is important to keep in mind that ATG8, and to a
lesser extent LC3, undergoes substantial transcriptional and
posttranscriptional regulation. Accordingly, to obtain an
accurate interpretation of Atg8-family protein levels it is also
necessary to monitor the mRNA levels. Without analyzing the
corresponding mRNA, it is not possible to discriminate
between changes that are strictly reflected in altered amounts
of protein versus those that are due to changes in transcrip
tion (e.g., the rate of transcription, or mRNA stability). For
example, in cells treated with the calcium ionophore A23187
or the ER calcium pump blocker thapsigargin, an obvious
correlation is found between the time-dependent increases
in LC3B-I and LC3B-II protein levels, as well as with the
observed increase in LC3B mRNA levels [216]. Clinically, in
human adipose tissue, protein and mRNA levels of LC3 in
omental fat are similarly elevated in obese compared to lean
individuals [292]. Post-translational modifications, such as
phosphorylation of LC3, may also affect its migration and/or
the avidity of certain antibodies [293].
Seventh, LC3-I can be fully degraded by the 20S protea
some or, more problematically, processed to a form (LC3-T)
appearing equal in size to LC3-II on a western blot; LC3-T
was identified in HeLa cells and is devoid of the ubiquitin
conjugation domain, thus lacking its adaptor function for
autophagy [294].
Eighth, although it is usually possible to distinguish the
nonlipidated (LC3-I) and lipidated (LC3-II) forms of LC3
using standard SDS-PAGE and western blotting (see above),
some other protein separation systems fail to differentiate
between them. For example, the widely used WES system,
based on capillary electrophoresis and Simple Western™ tech
nology (in which all assay steps, from protein separation,
immunoprobing, detection and analysis of data are fully auto
mated), can solve many problems found in traditional western
blotting [295]; however, using this system it is not possible to
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Figure 9. Detection of nonlipidated (LC3-I) and lipidated (LC3-II) forms of the
LC3 protein using (A) traditional SDS-PAGE and western blotting or (B) the WES
System (WES - Automated Western Blots with Simple Western; ProteinSimple,
San Jose, CA, USA). HEK 293 cells were cultured in DMEM medium, containing
10% fetal bovine serum and a penicillin-streptomycin mixture, at 37°C in a
humidified atmosphere with 5% CO2. Cell cultures were treated with medium
devoid of fetal bovine serum (-FBS) or with chloroquine (CQ; final concentration
10 µM) for 2 h. The forms of the LC3 protein were detected using anti-LC3
antibodies (MBL International, PM036). Materials from the same samples were
used in experiments presented in panels A and B. The LC3-I and LC3-II forms can
be effectively separated using traditional SDS-PAGE and western blotting,
whereas these two forms of LC3 cannot be distinguished by using the WES
system. Results provided by K. Pierzynowska, L. Gaffke and G. Wegrzyn.

distinguish LC3-I and LC3-II forms (see Figure 9 for compar
ison of separation of LC3 forms in traditional western blotting
and WES). Most likely, this is due to unusual (i.e., inconsis
tent with the actual molecular mass) migration of LC3-II in
SDS-PAGE which does not take place during gel-free capillary
electrophoresis [296]. Therefore, although the WES system is
excellent for rapid and accurate detection of the vast majority
of proteins, and makes it possible to avoid various technical
problems met in traditional western blotting, including those
met in studies on subjects related to autophagy (see for
example [297, 298]), it is not recommended for experiments
where it is important to resolve LC3-I and LC3-II. This
problem has been widely discussed with representatives of
the WES system manufacturer who confirmed that it is tech
nically not possible to separate these two forms of LC3 using
Simple Western™ technology (K. Pierzynowska and G.
Wegrzyn, personal communication). Nonetheless, the WES
system can still be used to monitor changes in the total
amount of LC3, and can thus provide useful information,
especially in conjunction with other assays.
Conclusion: Atg8-family proteins are often excellent mar
kers for autophagic structures; however, it must be kept in
mind that there are multiple LC3 isoforms, there is a second
family of mammalian Atg8-like proteins (GABARAPs), and
antibody affinity (for LC3-I versus LC3-II) and specificity (for
example, for LC3A versus LC3B) must be considered and/or
determined. Moreover, LC3/GABARAP levels on their own
do not address issues of autophagic flux. Finally, even when
flux assays are carried out, there is a problem with the limited
dynamic range of LC3/GABARAP immunoblots; accordingly,
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this method should not be used by itself to analyze changes in
autophagy.
b. Turnover of LC3-II/Atg8–PE: Autophagic flux.
Autophagic flux is often inferred on the basis of LC3-II turn
over, measured by western blot (Figure 7C) [240] in both the
presence and absence of lysosomal, or vacuolar degradation.
However, it should be cautioned that such LC3 assays are
merely indicative of autophagic “carrier flux”, not of actual
autophagic cargo/substrate flux. It has, in fact, been observed
that in rat hepatocytes, an autophagic-lysosomal flux of LC3-II
can take place in the absence of an accompanying flux of
cytosolic bulk cargo [299]. The relevant parameter in LC3
assays is the difference in the amount of LC3-II in both the
presence and absence of saturating levels of inhibitors, which
can be used to examine the transit of LC3-II through the
autophagic pathway; if flux is occurring, the amount of LC3II will be higher in the presence of the inhibitor [240].
Lysosomal degradation can be prevented through the use of
protease inhibitors (e.g., pepstatin A, leupeptin and E-64d),
compounds that neutralize the lysosomal pH such as bafilomy
cin A1, CQ or NH4Cl [17, 206, 220, 226, 300, 301], or by
treatment with agents that block the fusion of autophagosomes
with lysosomes (note that CQ blocks autophagy predominantly
by inhibiting autophagosome-lysosome fusion [302] and that
bafilomycin A1 will ultimately cause a fusion block as well as
neutralize the pH [218], but the inhibition of fusion may be
due to a block in ATP2A/SERCA activity [303]) [217–219,
304]. Alternatively, knocking down or knocking out LAMP2
(lysosomal associated membrane protein 2) represents a genetic
approach to block the fusion of autophagosomes and lysosomes
(for example, inhibiting LAMP2 in leukemic cells results in a
marked increase of GFP-LC3 puncta and endogenous LC3-II
protein compared to control cells upon autophagy induction
during myeloid differentiation [M.P. Tschan, unpublished
data], whereas in prostate cancer LNCaP cells, knocking
down LAMP2 prevents autophagy [305]) [306]. This approach,
however, is only valid when the knockdown of LAMP2 is
directed against the mRNA region specific for the LAMP2B
spliced variant, as targeting the region common to the three
variants would also inhibit chaperone-mediated autophagy
(CMA), which may result in the compensatory upregulation
of autophagy [133, 307, 308].
Increased levels of LC3-II in the presence of lysosomal
inhibition or interfering with autophagosome-lysosome fusion
alone (e.g., with bafilomycin A1), may be indicative of greater
induction and cargo sequestration, but to assess whether a
particular treatment alters complete autophagic flux through
substrate digestion, the treatment plus bafilomycin A1 must
be compared with results obtained with treatment alone as
well as with bafilomycin A1 alone. An additive or supraadditive effect in LC3-II levels may indicate that the treatment
enhances autophagic flux (Figure 7C). Moreover, higher LC3II levels with treatment plus bafilomycin A1 compared to
bafilomycin A1 alone may indicate that the treatment
increases the synthesis of autophagy-related membranes. If
the treatment by itself increases LC3-II levels, but the treat
ment plus bafilomycin A1 does not increase LC3-II levels
compared to bafilomycin A1 alone, this may indicate that
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the treatment induced a partial block in autophagic flux.
Thus, a treatment condition increasing LC3-II on its own
that has no difference in LC3-II in the presence of bafilomycin
A1 compared to treatment alone may suggest a complete
block in autophagy at the terminal stages [309]. This proce
dure has been validated with several autophagy modulators
[310]. With each of these techniques, it is essential to avoid
assay saturation. The duration of the bafilomycin A1 treat
ment (or any other inhibitor of autophagic flux such as CQ)
needs to be relatively short (1-4 h) [311] to allow comparisons
of the amount of LC3 that is lysosomally degraded over a
given time frame under one treatment condition to another
treatment condition. A concentration-curve and time-course
standardization for the use of autophagic flux inhibitors is
required for the initial optimization of the conditions to
detect LC3-II accumulation and avoid nonspecific or sec
ondary effects, and to exclude the possibility of a remaining
residual flux, if inhibition is incomplete [312]. By using a
rapid screening approach, such as a colorimetric based-plat
form method [313], it is possible to monitor a long time
frame for autolysosome accumulation, which closely associ
ates with autophagy activation [314–317]. Positive control
experiments using treatment with known autophagy indu
cers, along with bafilomycin A1 versus vehicle, are important
to demonstrate the utility of this approach in each experi
mental context.
In some circumstances it may be important to evaluate
alterations in autophagy flux once autophagy is induced by a
particular agent or genetic manipulation. In that case, steadystate measurements are not adequate. This can be useful for
example to evaluate if a gene modification by itself enhances
or impairs autophagosome synthesis or degradation quantita
tively (e.g., Clec16a [318–320]). With this aim, cells should be
treated with an autophagy inducer in the presence and
absence of a degradation inhibitor. As the LC3-II basal levels
in the steady state may be different, it is necessary to establish
a ratio to evaluate LC3-II synthesis and degradation flux.
Therefore, the synthesis ratio can be considered as the rate
of LC3-II levels in the presence of the inducer and the inhi
bitor divided by the LC3-II level in the presence of the
inhibitor alone. Similarly, the degradation ratio would be the
ratio of LC3-II levels in the cells treated with the inducer and
the inhibitor divided by the LC3-II levels in the presence of
the inducer alone. By comparing LC3-II synthesis and degra
dation ratios among different conditions, such as a gene
modification, we can evaluate whether autophagy flux is
modified by increasing or decreasing LC3-II synthesis or
degradation phases [321, 322]. Alternatively, the degradation
can be determined by calculating LC3-II levels in the presence
of inducer and the inhibitor minus the levels in the presence
of inducer alone [323].
The same type of assay monitoring the turnover of Atg8–PE
can be used to monitor flux in yeast, by comparing the amount
of Atg8 present in a wild-type versus a pep4∆ strain following
autophagy induction [324]; however, it is important to be aware
that the PEP4 knockout can influence yeast cell physiology (e.g.,
the inability to degrade and hence recycle autophagic cargo may
trigger a starvation response). PMSF, which inhibits the activity
of Prb1, can also be used to block Atg8–PE turnover.

Due to the advances in time-lapse fluorescence microscopy
and the development of photoswitchable fluorescent proteins,
autophagic flux can also be monitored by assessing the halflife of the LC3 protein [325, 326] post-photoactivation, by
quantitatively measuring the autophagosomal pool size and
its transition time [327], or by quantifying the rate of auto
phagosome formation [328]. Here, single-cell fluorescence
live-cell imaging-based approaches, in combination with
micropatterning, have shown accurate quantitative monitor
ing of autophagic flux that allows standardization of basal and
induced flux in key cell types and model systems [312, 329]
(Figure 10). These approaches deliver invaluable information
on the kinetics of the system and the time required to clear a
complete autophagosomal pool. Nonetheless, care must be
taken for this type of analysis as changes in transcriptional/
translational regulation of LC3 might also affect the readout.
Finally, autophagic flux can be monitored based on the
turnover of LC3-II, by utilizing a luminescence-based assay.
For example, a reporter assay based on the degradation of
Renilla reniformis luciferase (Rluc)-LC3 fusion proteins is well
suited for screening compounds affecting autophagic flux
[330]. In this assay, Rluc is fused N-terminally to either
wild-type LC3 or a lipidation-deficient mutant of LC3
(G120A). Because WT Rluc-LC3, in contrast to RlucLC3G120A, specifically associates with autophagosomal mem
branes, WT Rluc-LC3 is more sensitive to autophagic degra
dation. A change in autophagy-dependent LC3 turnover can
thus be estimated by monitoring the change in the ratio of
luciferase activities between the two cell populations expres
sing either WT Rluc-LC3 or Rluc-LC3G120A. In its simplest
form, the Rluc-LC3-assay can be used to estimate autophagic
flux at a single time point by defining the luciferase activities
in cell extracts. Moreover, the use of a live cell luciferase
substrate makes it possible to monitor changes in autophagic
activity in live cells in real time. This method has been
successfully used to identify positive and negative regulators
of autophagy from cells treated with microRNA, siRNA and
small molecule libraries [330–336].
Cautionary notes: The use of a radioactive pulse-chase
analysis, which assesses complete autophagic flux, provides
an alternative to lysosomal protease inhibitors [204].
Although such inhibitors should still be used to verify that
degradation is lysosome dependent. In addition, drugs must
be used at concentrations and for time spans that are effective
in inhibiting fusion or degradation, but that do not provoke
cell death. Thus, these techniques may not be practical in all
cell types or in tissues from whole organisms where the use of
protease inhibitors is problematic, and where pulse labeling
requires artificial short-term culture conditions that may
induce autophagy. Another concern when monitoring flux
via LC3-II turnover may be seen in the case of a partial
autophagy block; in this situation, agents that disrupt auto
phagy (e.g., bafilomycin A1) will still result in an increase in
LC3-II. Thus, care is needed in interpretation. For character
izing new autophagy modulators, it is ideal to test autophagic
flux at early (e.g., 4 h) and late (e.g., 24 h) time points, because
in certain instances, such as with calcium phosphate precipi
tates, a compound may increase or decrease flux at these two
time points, respectively [204]. Moreover, it is important to
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Figure 10. Measuring autophagic flux and pool size of pathway intermediates at the single-cell level: autophagosome, autolysosome and lysosome pool size and flux
data, characterizing MEF cells with a basal flux of 25 autophagosomes/h/cell, which increases upon rapamycin treatment to 105 autophagosomes/h/cell. Scale bar: 20
µm. This figure was previously published in ref. [312].

consider assaying autophagy modulators in a long-term
response in order to further understand their effects. Finally,
many of the chemicals used to inhibit autophagy, such as
bafilomycin A1, NH4Cl or CQ (see Autophagy inhibitors and
inducers), also directly inhibit the endocytosis/uncoating of
viruses (D.R. Smith, personal communication), and other
endocytic events requiring low pH, as well as exit from the
Golgi (S. Tooze, personal communication). As such, agents
that neutralize endosomal compartments should be used only
with extreme caution in studies investigating autophagy-virus
interactions. One means to address this is to carefully titrate
the amounts of inhibitors to use, because, for example, low
nanomolar amounts of bafilomycin A1 can affect autophagy
without apparently affecting acidification during influenza
virus infections [337].
One additional consideration is that it may not be absolutely
necessary to follow LC3-II turnover if other substrates are
being monitored simultaneously. For example, an increase in
LC3-II levels in combination with the lysosomal (or ideally
autophagy-specific) removal of an autophagic substrate (such
as an organelle [338, 339]) that is not a good proteasomal

substrate provides an independent assessment of autophagic
flux. However, it is probably prudent to monitor both turnover
of LC3-II and an autophagosome substrate in parallel, due to
the fact that LC3 might be coupled to endosomal membranes
and not just autophagosomes, and the levels of well-character
ized autophagosome substrates such as SQSTM1/p62 can also
be affected by proteasome inhibitors [340].
Another issue relates to the use of protease inhibitors (see
Autophagy inhibitors and inducers). When using lysosomal
protease inhibitors, it is of fundamental importance to assess
proper conditions of inhibitor concentration and time of preincubation to ensure full inhibition of lysosomal cathepsins.
In this respect, 1 h of pre-incubation with 10-20 µM E-64d is
sufficient in most cases, because this inhibitor is membrane
permeable and rapidly accumulates within lysosomes, but
another frequently used inhibitor, leupeptin, requires at least
6 h pre-incubation [78, 341]. Moreover, pepstatin A is mem
brane impermeable (ethanol or preferably DMSO must be
employed as a vehicle) and requires a prolonged incubation
(> 8 h) and a relatively high concentration (>50-100 µM) to
fully inhibit lysosomal CTSD (Figure 11). An incubation of

62

D. J. KLIONSKY ET AL.

A
Ctl

E-64d EtOH EtOH
Rap E-64d Rap DMSO Rap

Ctl

NH4+
Rap NH4+ Rap

LC3-I
LC3-II

Tubulin

LC3-I
LC3-II

Tubulin

B
Ctl

E64-d
Rap E64-d Rap Pst

Pst EtOH EtOH
Rap Rap DMSO

LC3-I
LC3-II

Tubulin
1-h pre-incubation
10 µg/ml Pst, 10 µg/ml E-64d

Ctl

NH4+
Rap NH4+ Rap Pst

Pst
Rap

Rap

DMSO
Rap

LC3-I
LC3-II

Tubulin
1-h pre-incubation
10 mM NH4+

4-h pre-incubation
68.6 µg/ml (100 µM) Pst

Figure 11. Effect of different inhibitors on LC3-II accumulation. SH-SY5Y human
neuroblastoma cells were plated and allowed to adhere for a minimum of 24 h,
then treated in fresh medium. Treatments were as follows: rapamycin (Rap), (A) 1
µM, 4 h or (B) 10 µM, 4 h; E-64d, final concentration 10 µg/ml from a 1 mg/ml
stock in ethanol (EtOH); NH4Cl (NH4+), final concentration 10 mM from a 1 M
stock in water; pepstatin A (Pst), final concentration 10 µg/ml from a 1 mg/ml
stock in ethanol, or 68.6 µg/ml from a 6.86 mg/ml stock in DMSO; ethanol or
DMSO, final concentration 1%. Pre-incubations in (B) were for 1 or 4 h as
indicated. 10 mM NH4Cl (or 30 µM CQ, not shown) were the most effective
compounds for demonstrating the accumulation of LC3-II. E-64d was also effec
tive in preventing the degradation of LC3-II, with or without a preincubation, but
ammonium chloride (or CQ) may be more effective. Pepstatin A at 10 µg/ml with
a 1-h pre-incubation was not effective at blocking degradation, whereas a 100
µM concentration with 4-h pre-incubation had a partial effect. Thus, alkalinizing
compounds are more effective in blocking LC3-II degradation, and pepstatin A
must be used at saturating conditions to have any noticeable effect. Images
provided by C. Isidoro. Note that the band running just below LC3-I at approxi
mately 17.5 kDa may be a processing intermediate of LC3-I; it is detectable in
freshly prepared homogenates, but is less visible after the sample is subjected to
a freeze-thaw cycle.

this duration, however, can be problematic due to indirect
effects (see GFP-Atg8-family protein lysosomal delivery and
partial proteolysis). At least in neurons, pepstatin A alone is
a less effective lysosomal proteolytic block, and combining a
lysosomal cysteine protease (i.e., cathepsin) inhibitor with it is
most effective [78]. Also, note that the relative amount of

lysosomal CTSB (cathepsin B) and CTSD is cell-specific and
changes with culture conditions. A possible alternative to
pepstatin A is the pepstatin A BODIPY® FL conjugate [342,
343], which is transported to lysosomes via endocytosis. In
contrast to the protease inhibitors, CQ (10-40 µM) or bafilo
mycin A1 (1-100 nM) can be added to cells immediately prior
to autophagy induction, although in some cases a pre-incuba
tion with bafilomycin A1 should be considered. bafilomycin
A1 requires ~30 min to increase lysosomal pH [226, 344];
therefore, a pre-incubation of 30 min is required in case of
short autophagy induction times. Because cysteine protease
inhibitors may upregulate CTSD and some such as E-64d and
its derivatives have potential inhibitory activity toward cal
pains, whereas bafilomycin A1 can have potential significant
cytotoxicity, especially in cultured neurons and pathological
states, the use of both methods may be important in some
experiments to exclude off-target effects of a single method.
Conclusion: It is important to be aware of the difference
between monitoring the steady-state level of Atg8-family pro
teins and autophagic flux. The latter may be assessed by
following Atg8-family proteins in the absence and presence
of autophagy flux inhibitors (such as lysosomal degradation
inhibitors), and by examining the autophagy-dependent
degradation of appropriate substrates. In particular, if there
is any evidence of an increase in LC3-II (or autophagosomes),
it is essential to determine whether this represents an induc
tion of autophagy and increased synthesis of LC3, or
decreased flux and the subsequent accumulation of LC3 due
to a block in fusion or degradation, through the use of
inhibitors such as CQ, bafilomycin A1 or lysosomal protease
inhibitors. In the case of a suspected impaired degradation,
assessment of lysosomal function (i.e., pH or activity of lyso
somal enzymes) is then required to validate the conclusion
and to establish the basis.
c. GFP-Atg8-family protein lysosomal delivery and partial
proteolysis. GFP-LC3B (hereafter referred to as GFP-LC3)
has also been used to follow flux. It should be cautioned
that, as with endogenous LC3, an assessment of autophagic
GFP-LC3 flux is a carrier flux that cannot be equated with,
and is not necessarily representative of, an autophagic cargo
flux. When GFP-Atg8 or GFP-LC3 is delivered to a lysosome/
vacuole, the Atg8-family protein part of the chimera is sensi
tive to degradation, whereas the GFP protein is relatively
resistant to hydrolysis (note, however, that GFP fluorescence
is quenched by low pH; see GFP-Atg8-family protein fluores
cence microscopy and Tandem mRFP/mCherry-GFP fluores
cence microscopy). Therefore, the appearance of free GFP on
western blots can be used to monitor lysis of the inner
autophagosome membrane and breakdown of the cargo in
metazoans (Figure 12A) [324, 345, 346], or the delivery of
autophagosomes to, and the breakdown of autophagic bodies
within, the fungal [347–349] and plant vacuole [289, 290, 324,
350]. Reports on Dictyostelium discoideum and mammalian
cells highlight the importance of lysosomal pH as a critical
factor in the detection of free GFP that results from the
degradation of fused proteins. In these cell types, free GFP
fragments are only detectable in the presence of nonsaturating
levels of lysosomotropic compounds (NH4Cl or CQ) or under
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Figure 12. GFP-LC3 processing can be used to monitor delivery of autophago
somal membranes. (A) atg5−/− MEFs engineered to express Atg5 under the
control of the Tet-off promoter were grown in the presence of doxycycline
(Dox; 10 ng/ml) for one week to suppress autophagy. Cells were then cultured
in the absence of drug for the indicated times, with or without a final 2-h
starvation. Protein lysates were analyzed by western blot using anti-LC3 and
anti-GFP antibodies. The positions of untagged and GFP-tagged LC3-I and LC3-II,
and free GFP are indicated. This figure was modified from data previously
published in ref. [346], FEBS Letters, 580, Hosokawa N, Hara Y, Mizushima N,
Generation of cell lines with tetracycline-regulated autophagy and a role for
autophagy in controlling cell size, pp. 2623-2629, copyright 2006, with permis
sion from Elsevier. (B) Differential role of unsaturating and saturating concentra
tions of lysosomal inhibitors on GFP-LC3 cleavage. HeLa cells stably transfected
with GFP-LC3 were treated with various concentrations of CQ for 6 h. Total
lysates were prepared and subjected to immunoblot analysis. (C) CQ-induced
free GFP fragments require classical autophagy machinery. Wild-type and atg5−/−
MEFs were first infected with adenovirus GFP-LC3 (100 viral particles per cell) for
24 h. The cells were then either cultured in regular culture medium with or
without CQ (10 µM), or subjected to starvation in EBSS buffer in the absence or
presence of CQ for 6 h. Total lysates were prepared and subjected to immunoblot
analysis. Panel B and C are modified from the data previously published in ref.
[351].

conditions that attenuate lysosomal acidity; otherwise, the
autophagic/degradative machinery appears to be too efficient
to allow the accumulation of the proteolytic fragment (Figure
12B,C) [40, 64, 351]. Hence, a reduction in the intensity of the
free GFP band may indicate reduced flux, but it may also be
due to efficient turnover. Using a range of concentrations and
treatment times of compounds that inhibit autophagy can be
useful in distinguishing between these possibilities [352].
Because the pH in the yeast vacuole is higher than that in
mammalian or D. discoideum lysosomes, the levels of free
GFP fragments are detectable in yeast even in the absence of
lysosomotropic compounds [52]. Additionally, in yeast the
diffuse fluorescent haze from the released GFP moiety within
the vacuole lumen can be observed by fluorescence
microscopy.
The dynamic movement to lysosomes of GFP-LC3, or of
its associated cargo, also can be monitored by time-lapse
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fluorescence microscopy, although, as mentioned above, the
GFP fluorescent signal is more sensitive to acidic pH than
other fluorophores (see GFP-Atg8-family protein fluorescence
microscopy). A time-course evaluation of the cell population
showing GFP-LC3 puncta can serve to monitor the autopha
gic flux, because a constant increase in the number of cells
accumulating GFP-LC3 puncta is suggestive of defective
fusion of autophagosomes with lysosomes. Conversely, a
decline implies that GFP-LC3 is delivered to properly acid
ified lysosomes and may, in addition, reflect proteolytic elim
ination within them, although the latter needs to be
independently established. In either case, it can be proble
matic to use GFP fluorescence to follow flux, as new GFP-LC3
is continuously being synthesized. A potential solution to this
problem is to follow the fluorescence of a photoactivatable
version of the fluorescent protein [353], which allows this
assay to be performed essentially as a pulse/chase analysis.
Another alternative to follow flux is to monitor GFP-LC3
fluorescence by adding lysosomal protease or fusion inhibitors
to cells expressing GFP-LC3 and monitoring changes in the
number of puncta. In this case, the presence of lysosomal
inhibitors should increase the number of GFP-LC3-positive
structures, and the absence of an effect on the total number of
GFP-LC3 puncta or on the percentage of cells displaying
numerous puncta is indicative of a defect(s) in autophagic
flux [64, 354]. The combination of protease inhibitors (to
prevent the degradation of GFP) or compounds that modify
lysosomal pH and/or block fusion of autophagosomes such as
NH4Cl, bafilomycin A1 or CQ, or compounds that block
fusion of autophagosomes with lysosomes such as bafilomycin
A1 or others (e.g., vinblastine) may be most effective in pre
venting lysosome-dependent decreases in GFP-LC3 puncta.
However, because the stability of GFP is affected by lysosomal
pH, researchers may also consider the use of protease inhibi
tors whether or not lysosomotropic compounds or fusion
inhibitors are included.
Cautionary notes: The GFP-Atg8 processing assay is used
routinely to monitor autophagy in yeast. One caveat, how
ever, is that this assay is not always carried out in a quanti
tative manner. For example, western blot exposures need to
be in the linear range. Accordingly, an enzymatic assay such
as the Pho8∆60 assay may be preferred (see Autophagic
protein degradation) [355, 356], especially when the differ
ences in autophagic activity need to be determined precisely
(note that an equivalent assay has not been developed for
more complex eukaryotic cells); however, as with any
enzyme assay, appropriate caution must be used regarding,
for example, substrate concentrations and linearity. The
Pho8∆60 assay also requires a control to verify equal
Pho8∆60 expression in the different genetic backgrounds
or conditions to be tested [356]; differences in Pho8∆60
expression potentially affect its activity and may thus cause
misinterpretation of results. Another issue to keep in mind is
that GFP-Atg8 processing correlates with the surface area of
the inner sphere of the autophagosome, and thus provides a
smaller signal than assays that measure the volume of the
autophagosome. Pgk1 (3-phosphoglycerate kinase)-GFP pro
cessing [52] is another assay that can be used to monitor
autophagy.
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A thorough analysis of GFP proteolysis in plant roots
reveals the importance of normalizing to tissue-specific repor
ter expression and autophagic activity range [102, 357]. For
instance, GFP-ATG8 expression in Arabidopsis thaliana is
typically highest in the root apical meristem, but the response
to the autophagy-inducing conditions in this root zone is
much lower compared to the rest of the root. Thus, excluding
this root zone from the samples for western blot provides a
much more reliable readout of the GFP-ATG8 proteolysis.
As a note of caution, GFP-LC3 has been demonstrated to
be present in protein aggregates in an autophagy-unrelated
manner and this association is dependent on its interaction
with SQSTM1. This interaction poses potential difficulties to
distinguish LC3 bound to aggregates from those on autopha
gosomes [358]. The main limitation of the GFP-LC3 proces
sing assay in mammalian cells is that its usefulness seems to
depend on cell type and culture conditions (N. Hosokawa and
N. Mizushima, unpublished data). Apparently, GFP is more
sensitive to mammalian lysosomal hydrolases than to the
degradative milieu of the yeast vacuole or the lysosomes in
Drosophila. Alternatively, the lower pH of mammalian lyso
somes relative to that of the yeast vacuole may contribute to
differences in detecting free GFP. Under certain conditions
(such as Earle’s balanced salt solution [EBSS]-induced starva
tion) in some cell lines, when the lysosomal pH becomes
particularly low, free GFP is undetectable because both the
LC3-II and free GFP fragments are quickly degraded [273].
Therefore, if this method is used it should be accompanied by
immunoblotting and include controls to address the stability
of nonlysosomal GFP such as GFP-LC3-I. It should also be
noted that free GFP can be detected when cells are treated
with nonsaturating doses of inhibitors such as CQ, E-64d and
bafilomycin A1. The saturating concentrations of these lyso
somal inhibitors vary in different cell lines, and it would be
better to use a saturating concentration of lysosomal inhibi
tors when performing an autophagic flux assay [273].
Therefore, caution must be exercised in interpreting the data
using this assay; it would be helpful to combine an analysis of
GFP-LC3 processing with other assays, such as the monitor
ing of endogenous LC3-II by western blot.
Along these lines, a caution concerning the use of the
EGFP fluorescent protein for microscopy is that this fluoro
phore has a relatively neutral pH optimum for fluorescence
[263], and its signal diminishes quickly during live cell ima
ging due to the acidic environment of the lysosome. It is
possible to circumvent this latter problem by imaging paraf
ormaldehyde-fixed cultures that are maintained in a neutral
pH buffer, which retains EGFP fluorescence (M. Kleinman
and J.J. Reiners, personal communication). Alternatively, it
may be preferable to use a different fluorophore such as
mRFP or mCherry, which retain fluorescence even at acidic
pH [341]. On the one hand, a putative advantage of mCherry
over mRFP is its enhanced photostability and intensity, which
are an order of magnitude higher (and comparable to GFP),
enabling acquisition of images at similar exposure settings as
are used for GFP, thus minimizing potential bias in interpre
tation [342]. On the other hand, caution is required when
evaluating the localization of mCherry fusion proteins during
autophagy due to the persistence of the mCherry signal in
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Figure 13. Movement of activated pDendra2-hp62 (SQSTM1; orange) from the
nucleus (middle) to an aggregate in ARPE-19 cells, revealed by confocal micro
scopy. Cells were exposed to 5 µM MG132 for 24 h to induce the formation of
perinuclear aggregates [4083]. The cells were then exposed to a UV pulse (the
UV-induced area is shown by red lines that are inside of the nucleus) that
converts Dendra2 from green to red, and the time shown after the pulse is
indicated. SQSTM1 is present in a small nuclear aggregate, and is shuttled from
the nucleus to a perinuclear large protein aggregate (detected as red). Scale bar:
5 µm. Image provided by K. Kaarniranta.

acidic environments; all tagged proteins are prone to show
enrichment in lysosomes during nonselective autophagy of
the cytoplasm, especially at higher expression levels. In addi
tion, red fluorescent proteins (even the monomeric forms)
can be toxic due to oligomer formation [343]; the tendency
to form abnormal accumulations may be a general feature of
coral- and anemone-derived fluorescent proteins. Dendra2 is
an improved version of the green-to-red photoswitchable
fluorescent protein Dendra, which is derived from the octo
coral Dendronephthya sp [344]. Dendra2 is capable of irrever
sible photoconversion from a green to a red fluorescent form,
but can be used also as normal GFP or RFP vector. This
modified version of the fluorophore has certain properties
including a monomeric state, low phototoxic activation and
efficient chromophore maturation, which make it suitable for
real-time tracking of LC3 and SQSTM1 (Figure 13; [359]). A
newer generation of photoswitchable proteins, EOS, are now
available that are brighter than Dendra2 and display more
efficient photoswitching (N.A. Castello and S. Finkbeiner, in
press). Another alternative to mRFP or mCherry is to use the
Venus variant of YFP, which is brighter than mRFP and less
sensitive to pH than GFP [345].
The pH optimum of EGFP is important to consider when
using GFP-LC3 constructs, as the original GFP-LC3 marker
[346] uses the EGFP variant, which may result in a reduced
signal upon the formation of amphisomes or autolysosomes.
An additional caveat when using the photoactivatable con
struct PA-GFP [301] is that the process of activation by
photons may induce DNA damage, which could, in turn,
induce autophagy. Also, GFP is relatively resistant to dena
turation, and boiling for 5 min may be needed to prevent the
folded protein from being trapped in the stacking gel during
SDS-PAGE.
As noted above (see Western blotting and ubiquitin-like
protein conjugation systems), Atg4/ATG4 cleaves the residue
(s) that follow the C-terminal glycine of Atg8-family proteins
that will be conjugated to PE. Accordingly, it is critical that
any chimeras should be constructed with the fluorescent tag at
the amino terminus of Atg8-family proteins (unless the goal is
to monitor Atg4/ATG4 activity).
Finally, lysosomal inhibition needs to be carefully con
trolled. Prolonged inhibition of lysosomal hydrolases (>6 h)
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is likely to induce a secondary autophagic response triggered
by the accumulated undigested autophagy cargo. This sec
ondary autophagic response can complicate the analysis of
the autophagic flux, making it appear more vigorous than it
would in the absence of the lysosomal inhibitors.
Conclusion: The GFP-Atg8 (or GFP-LC3/GABARAP)
processing assay, which monitors free GFP generated within
the vacuole/lysosome, is a convenient way to follow autopha
gy, but it does not work in all cell types, and is not as easy to
quantify as enzyme-based assays. Furthermore, the assay mea
sures the flux of an autophagic carrier, which may not neces
sarily be equivalent to autophagic cargo flux.
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d. HaloTag-LC3 autophagosome completion assay. Upon
phagophore closure, LC3-II on the convex side of the mem
brane is delipidated and recycled back into the cytosol, while
that on the concave side is sequestered within the vacuole and
delivered into the lysosome for degradation [240]. Exploiting
the topological property of LC3, the HaloTag-LC3 (HT-LC3)
assay is designed to analyze the process of phagophore closure
(Figure 14A) [360]. The HaloTag is a modified haloalkane
dehalogenase that covalently binds to synthetic HaloTag
ligands [361]. The HT-LC3 assay employs the HaloTag-con
jugated LC3 reporter in combination with membrane-perme
able and -impermeable HaloTag ligands labelled with two

Figure 14. The HaloTag-LC3 assay distinguishes phagophores, immature autophagosomes, and mature autophagosomes and autolysosomes. (A) Schematic diagram
of the HaloTag-LC3 (HT-LC3) assay. Cells expressing HT-LC3 are treated with a cholesterol-dependent plasma membrane permeabilizer to release cytosolic proteins
including HT-LC3-I and sequentially labeled with a saturated dose of membrane-impermeable HaloTag ligands (MILs) conjugated with Alexa Fluor 488 (or 660)
followed by membrane-permeable HaloTag ligands (MPLs) conjugated with tetramethylrhodamine to detect phagophores (MIL+ MPL−), immature autophagosomes
(iAP; MIL+ MPL+), and mature autophagosomes and autolysosomes (AP and AL; MIL− MPL+). (B) U-2 OS cells were stably transduced with HT-LC3-encoding
lentiviruses, incubated in starvation medium or control complete medium in the presence or absence of 100 nM bafilomycin A1 (BafA1) for 4 h, and subjected to the
HT-LC3 assay followed by confocal microscopy. Magnified images of the boxed (i) and arrow-indicated (ii-v) areas are shown in the right panels. Scale bars: 10 μm (1
μm in the magnified images).
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different fluorescent dyes to distinguish membrane-unen
closed and -enclosed HT-LC3-II. By sequentially incubating
plasma membrane-permeabilized HT-LC3-expressing cells
with a saturating dose of membrane-impermeable ligands
(MILs) followed by membrane-permeable ligands (MPLs),
phagophores, nascent autophagosomes, and mature autopha
gosomes or autolysosomes are visualized as MIL+ MPL−,
MIL+ MPL+, and MIL− MPL+ structures, respectively (Figure
14B). Because the cytosolic HT-LC3-I is released upon plasma
membrane permeabilization, the assay provides a superior
signal-to-noise ratio and the data can be semi-quantitatively
analyzed by confocal or fluorescence microscopy. As MPL
fluorescent signals are not retained in functional lysosomes,
autophagic flux can also be measured by monitoring MPL
signal accumulation upon exposure to a lysosomal inhibitor.
Moreover, the assay has been successfully adapted to a fluor
escence-activated cell sorting (FACS)-based high-throughput
platform to screen genes required for phagophore closure
[362].
Cautionary notes: Similar to fluorescent protein(s)-tagged
LC3 assays, the HT-LC3 assay requires a system amenable to
exogenous introduction. In addition, the assay requires
plasma membrane permeabilization. Therefore, it would be
challenging to use the assay in 3-dimensional-cultured cells,
tissue samples, or live-cell imaging. Moreover, the current
method employs cholesterol-dependent pore-forming agents
such as recombinant perfringolysin O [363] and digitonin to
permeabilize the plasma membrane. Therefore, it would also
be challenging when a treatment or gene manipulation per
turbs plasma membrane cholesterol distribution (e.g., pro
longed treatment with a lysosomal inhibitor [Y. Takahashi
and H.G. Wang, personal communication]). Along this line,
because the plasma membrane cholesterol concentration is
different among cell types, it is important to find an optimal
permeabilization condition. If plasma membrane permeabili
zation fails or is incomplete, diffuse MPL signals, which
represent cytosolic HT-LC3-I, will be detected in addition to
cytoplasmic HT-LC3-II foci. In addition, it is critical to ensure
the saturation of all available binding sites with each ligand. A
secondary incubation with the same type of ligands conju
gated with a different fluorophore (e.g., primary incubation
with Alexa Fluor 488-conjugated MILs followed by secondary
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incubation with Alexa Fluor 600-conjugated MILs) make it
possible to determine an appropriate staining condition.
Another concern for the assay is that the detection of mem
brane-unenclosed HT-LC3-II relies on the accessibility of
MILs. Therefore, if the pore size of the closure site is too
small to pass through MILs, HT-LC3-II on the concave side of
phagophores will be falsely negative for MILs; the structure
will be detected as MIL+ MPL+ in this case.
Conclusion: Using two HaloTag ligands with different
membrane permeability and fluorophores, the HT-LC3 assay
can determine each step of autophagy by distinguishing mem
brane-unenclosed and -enclosed HT-LC3-II. However, unlike
a fluorescent protein-tagged LC3 assay, the HT-LC3 assay
requires several optimization steps to ensure the staining
specificity. Once optimized, this assay provides a superior
signal-to-noise ratio and is compatible with high-throughput
screening platforms.
e. GFP-Atg8-family protein fluorescence microscopy. LC3B,
or the protein tagged at its N terminus with a fluorescent
protein such as GFP (GFP-LC3), has been used to monitor
autophagy through indirect immunofluorescence or direct
fluorescence microscopy (Figure 15), measured as an increase
in punctate LC3 or GFP-LC3 [364, 365]. The detection of
GFP-Atg8 (or GFP-LC3/GABARAP/LGG-1/2) is also useful
for in vivo studies using transgenic organisms such as
Saccharomyces cerevisiae [366], Aspergillus nidulans [348],
Caenorhabditis elegans [367], D. discoideum [368], filamen
tous ascomycetes [369–373], Ciona intestinalis [374],
Drosophila melanogaster [375–377], A. thaliana [378], Zea
mays [379], Trypanosoma brucei [380–382], Leishmania
major [383–385], Trypanosoma cruzi [386, 387], zebrafish
[328, 388] and mice [239]. “Super-resolution” fluorescence
images of GFP-LC3-positive phagophores have been shown
in platelets prepared from GFP-LC3 mice by “super-resolu
tion” microscopy (specifically, 3-dimensional structured illu
mination microscopy/3D-SIM) to be similar to what was
observed by TEM [389, 390]. It is also possible to use antiAtg8-family protein antibodies for immunocytochemistry or
immunohistochemistry (IHC) [265, 391–397], procedures
that have the advantages of detecting the endogenous protein,
obviating the need for transfection and/or the generation of a

Rapamycin

Rapamycin + 3-MA

Figure 15. Changes in the detection and localization of GFP-LC3 upon the induction of autophagy. U87 cells stably expressing GFP-LC3 were treated with PBS
(Control), rapamycin (200 nM), or rapamycin in combination with 3-MA (2 mM) for 24 h. Representative fluorescence images of cells counterstained with DAPI (nuclei)
are shown. Scale bar: 10 µm. This figure was modified from Figure 6 published in ref. [364], Badr et al. Lanatoside C sensitizes glioblastoma cells to tumor necrosis
factor–related apoptosis-inducing ligand and induces an alternative cell death pathway. Neuro-Oncology, 13(11):1213-24, 2011, by permission of Oxford University
Press.
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transgenic organism, as well as avoiding potential artefacts
resulting from overexpression. For example, high levels of
overexpressed GFP-LC3 can result in its nuclear localization,
although the protein can still relocate to the cytosol upon
starvation. The use of imaging cytometry allows rapid and
quantitative measures of the number of LC3 puncta and their
relative number in individual or mixed cell types, using com
puterized assessment, enumeration, and data display (e.g., see
refs. [41, 398]). In this respect, the alternative use of an
automated counting system may be helpful for obtaining an
objective number of puncta per cell. For this purpose, the
WatershedCounting3D plug-in for ImageJ may be useful [399,
400]. Changes in the number of GFP-Atg8 puncta can also be
monitored using flow cytometry (see Autophagic flux determi
nation using flow and multispectral imaging cytometry) [382].
An alternative way to quantify LC3 immunofluorescence
staining is to estimate the percentage of LC3 signals originat
ing from puncta over total LC3 signals in the same cell [401].
This approach is useful if it is difficult to define the number of
puncta per cell due to widely varying size or clustering of the
puncta. A key control to perform when using these
approaches is the use of a non-lipidatable mutant version of
the Atg8-family protein that does not associate with
autophagosomes.
LC3-positive autophagosomes can be quantified by confo
cal microscopy using a software program called Imaris
(Oxford Instruments). Confocal Z-stacks of samples immu
nolabeled with an antibody to LC3 are reconstructed into 3dimensional animations with the aid of Imaris software. The
Spot function in Imaris automatically locates and enumerates
autophagosomes within individual cells based on size and
intensity thresholds [402, 403].
Monitoring the endogenous Atg8-family proteins
obviously depends on the ability to detect these proteins in
the system of interest, which is not always possible. If the
endogenous amount is below the level of detection, the use of
an exogenous construct is warranted. In this case, it is impor
tant to consider the use of stable transformants versus tran
sient transfections. On the one hand, stable transformants
may have reduced background resulting from the lower gene
expression, and artefacts resulting from recent exposure to
transfection reagents (see below) are eliminated. Furthermore,
with stable transformants more cells can be easily analyzed
because nearly 100% of the population will express tagged
LC3. On the other hand, a disadvantage of stable transfectants
is that the integration sites cannot always be predicted, and
expression levels may not be optimal. Therefore, it is worth
considering the use of stable episomal plasmids that avoid the
problem of unsuitable integration [344]. An important advan
tage of transient transfection is that this approach is better for
examining the immediate effects of the transfected protein on
autophagy; however, the transient transfection approach
restricts the length of time that the analysis can be performed,
and consideration must be given to the induction of autopha
gy resulting from exposure to the transfection reagents (see
below). One word of caution is that optimizing the time of
transient expression of GFP-LC3 is necessary, as some cell
types (e.g., HeLa cells) may require 1 day for achieving opti
mal expression to visualize GFP-LC3 puncta, whereas
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neuronal cell lines such as SH-SY5Y cells typically need at
least 48 h of expression prior to performing GFP-LC3 puncta
analyses. In addition, a double transfection can be used (e.g.,
with GFP-LC3 and the protein of interest) to visually tag the
cells that express the protein being examined.
A disadvantage of transfecting GFP-LC3 with liposomes is
that frequently it leads to an unstable efficiency of transfec
tion, causing a reduction in the number of cells effectively
expressing GFP-LC3, and degradation of the plasmid, thus
decreasing the numbers of GFP-LC3 puncta. Stable cell lines
expressing GFP-LC3 can be generated using lentiviral systems
and efficiently selected through antibiotic resistance leading to
uniform and prolonged expression levels. These stable cell
lines are sensitive to autophagy inducers as measured by the
LC3-II:LC3-I ratio by western blot, and also show increased
numbers of cytoplasmic GFP-LC3 puncta upon autophagic
stimuli (unpublished results R. Muñoz-Moreno, R.I. Galindo,
L. Barrado-Gil and C. Alonso).
In conclusion, there is no simple rule for the use of stable
versus transient transfections. When stable transfections are
utilized through a nonlentiviral system it is worthwhile
screening for stable clones that give the best signal to noise
ratio; when transient transfections are used, it is worthwhile
optimizing the GFP-LC3 DNA concentration to give the best
signal-to-noise ratio (note potential problems with transfec
tions under Western blotting and ubiquitin-like protein con
jugation systems). In clones, the uniformity of expression of
GFP-LC3 facilitates “thresholding” when scoring punctapositive cells (see below). However, there is also a need to
be aware that a single cell clone may not be representative of
the overall pool. Using a pool of multiple selected clones
may reduce artefacts that can arise from the selection and
propagation of individual clones from a single transfected
cell (although the use of a pool is also problematic as its
composition will change over time). Another possibility is to
select a mixed stable population with uniform GFP-LC3
expression levels by the use of a fluorescence-activated cell
sorter (FACS) [404]. Optimization, together with including
the appropriate controls (e.g., transfecting GFP-LC3G120A as a
negative control), will help to overcome the effects of the
inherent variability in these analyses. For accurate interpreta
tions, it is also important to assess the level of overexpression of
the GFP-LC3 constructs relative to endogenous LC3 by western
blot. Finally, a recent advent of CRISPR-Cas9 gene-editing
technologies provides a promising alternative to overcome
potential pitfalls of GFP-LC3 overexpression—the generation
of knockin cell lines, in which the coding sequence of GFP is
added in frame with the 5ʹ sequence (encoding the N-terminal
part) of endogenous LC3 [120, 405].
An additional use of GFP-LC3 is to monitor colocalization
with a target during autophagy-related processes such as
organelle degradation or the sequestration of pathogenic
microbes [299-302]. Preincubation of cells stably expressing
GFP-LC3 with leupeptin can help stabilize the GFP-LC3 sig
nal during fluorescence microscopy, especially under condi
tions of induced autophagic flux. Leupeptin is an inhibitor of
lysosomal cysteine and serine proteases and will therefore
inhibit degradation of membrane-conjugated GFP-LC3 that
is present within autolysosomes.
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Cautionary notes: Quantification of autophagy by measur
ing GFP-LC3 puncta (or LC3 by immunofluorescence) can,
depending on the method used, be more tedious than mon
itoring LC3-II by western blot; however, the former may be
more sensitive and quantitative. Ideally, it is preferable to
include both assays and to compare the two sets of results.
In addition, if GFP-LC3 is being quantified, it is better to
determine the number of puncta corresponding to GFP-LC3
on a per cell basis (or per cell area basis) rather than simply
the total number (or percentage) of cells displaying puncta.
This latter point is critical because, even in nutrient-rich
conditions, cells display some basal level of GFP-LC3 puncta.
There are, however, practical issues with counting puncta
manually and reliably, especially if there are large numbers
per cell. Nevertheless, manual scoring may be more accurate
than relying on a software program, in which case it is
important to ensure that only appropriate puncta are being
counted (applicable programs include ImageJ, Imaris, and the
open-source software CellProfiler [406]). Moreover, when
autophagosome-lysosome fusion is blocked, larger autophago
somes are detected, possibly due to autophagosome-autopha
gosome fusion, or to an inability to resolve individual
autophagosomes when they are present in large numbers.
Although it is possible to detect changes in the size of GFPAtg8-family protein puncta by fluorescence microscopy, it is
not possible to correlate size with autophagy activity without
additional assay methods. Size determinations can be proble
matic by fluorescence microscopy unless careful standardiza
tion is carried out [407], and size estimation on its own
without considering puncta number per cell is not recom
mended as a method for monitoring autophagy; however, it is
possible to quantify the fluorescence intensity of GFP-Atg8family proteins at specific puncta, which does provide a valid
measure of protein recruitment [408].
In addition to autophagosome size, the number of puncta
visible to the eye will also be influenced by both the level of
expression of GFP-LC3 in a given cell (an issue that can be
avoided by analyzing endogenous LC3 by immunofluores
cence) and by the exposure time of the microscope, if using
widefield microscopy. Another way to account for differential
GFP-LC3 expression levels and/or exposure is to normalize
the intensity of GFP-LC3 present in the puncta to the total
GFP-LC3 intensity in the cell. This can be done either on the
population level [306] or individual cell level [404]. The
approach to measuring the proportion of total LC3 signals
originating from puncta is also suitable for quantification of
immunofluorescence staining of endogenous LC3. In many
cell types it may be possible to establish a threshold value for
the number of puncta per cell in conditions of “low” and
“high” autophagy [409]. This can be tested empirically by
exposing cells to autophagy-inducing and -blocking agents.
Thus, cell populations showing significantly greater propor
tions of cells with autophagosome numbers higher than the
threshold in perturbation conditions compared to the control
cells could provide quantitative evidence of altered autophagy.
It is then possible to score the population as the percentage of
cells displaying numerous autophagosomes. This approach
will only be feasible if the background number of puncta is
relatively low. For this method, it is particularly important to

count a large number of cells and multiple representative
sections of the sample. Typically, it is appropriate to score
on the order of 50 or more cells, preferably in at least three
different fields, depending on the particular system and
experiment, but the critical point is that this determination
should be based on statistical power analysis. Accordingly,
high-content imaging analysis methods enable quantification
of GFP-LC3 puncta (or overall fluorescence intensity) in
thousands of cells per sample (e.g., see refs. [334, 352, 410]).
When using automated analysis methods, care must be taken
to manually evaluate parameters used to establish background
threshold values for different treatment conditions and cell
types, particularly as many systems image at lower magnifica
tions that may be insufficient to resolve individual puncta.
Another note of caution is that treatments affecting cell mor
phology, leading to the “rounding-up” of cells for example,
can result in apparent changes in the number of GFP-LC3
puncta per cell. To avoid misinterpretation of results due to
such potential artefacts, manual review of cell images is highly
recommended. If cells are rounding up due to apoptosis or
mitosis, it is easy to automatically remove them from analysis
based on nuclear morphology (using DAPI or Hoechst stain
ing) or cell roundness. If levels of autophagy in the roundedup cells are of particular interest, images can be acquired as zstacks and either analyzed as a z-series or processed to gen
erate maximum projection or extended depth-of-field images
and then analyzed [411].
To allow comparisons by other researchers attempting to
repeat these experiments, it is critical that the authors also
specify the baseline number of puncta that are used to define
“normal” or “low” autophagy. Furthermore, the cells should
be counted using unbiased procedures (e.g., using a random
start point followed by inclusion of all cells at regular inter
vals), and statistical information should be provided for both
baseline and altered conditions, as these assays can be highly
variable. One possible method to obtain unbiased counting of
GFP-LC3 puncta in a large number of cells is to perform
multispectral imaging flow cytometry (see Autophagic flux
determination using flow and multispectral imaging cytometry)
[412, 413]. Multispectral imaging flow cytometry allows char
acterization of single cells within a population by assessing a
combination of morphology and immunofluorescence pat
terns, thereby providing statistically meaningful data [414].
This method can also be used for endogenous LC3, and,
therefore, is useful for nontransfected primary cells [415].
For adherent cell cultures, one caution for flow cytometry is
that the techniques necessary to produce single cell suspen
sions can cause significant injury to the cells, leading to
secondary changes in autophagy. Therefore, staining for
plasma membrane permeabilization (e.g., cell death) before
versus after isolation is an important control, and allowing a
period of recovery between harvesting the culture and stain
ing is also advisable [416].
An important caveat in the use of GFP-LC3 is that this
chimera can associate with aggregates, especially when
expressed at high levels in the presence of aggregate-prone
proteins, which can lead to a misinterpretation of the results
[417]. Of note, GFP-LC3 can associate with ubiquitinated
protein aggregates [418]; however, this does not occur if the
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GFP-LC3 is expressed at low levels (D.C. Rubinsztein, unpub
lished observations). These aggregates have been described in
many systems and are also referred to as aggresome-like
induced structures (ALIS) [418–420], dendritic cell ALIS/
DCALIS [421], SQSTM1 bodies/sequestosomes [422, 423]
and inclusions. Indeed, many microbe-associated molecular
patterns (MAMPs) described to induce the formation of
autophagosomes in fact trigger massive formation of
SQSTM1 bodies (L.H. Travassos, unpublished observations).
Inhibition of autophagy in vitro and in vivo leads to the
accumulation of these aggregates, suggesting a role for auto
phagy in mediating their clearance [418, 420, 422, 424, 425].
One way to control for background levels of puncta is to
determine fluorescence from untagged GFP.
The receptor protein SQSTM1 is required for the forma
tion of ubiquitinated protein aggregates in vitro (see SQSTM1
and related LC3 binding protein turnover assays) [423]. In this
case, the interaction of SQSTM1 with both ubiquitinated
proteins and LC3 is thought to mediate delivery of these
aggregates to the autophagy system [426, 427]. Many cellular
stresses can induce the formation of aggregates, including
transfection reagents [418], or foreign DNA (especially if the
DNA is not extracted free of endotoxin). SQSTM1-positive
aggregates are also formed by proteasome inhibition or pur
omycin treatment, and can be found in cells exposed to
rapamycin for extended periods where the rates of autophagy
are elevated [428]. Calcium phosphate transfection of COS7
cells or lipofectamine transfection of MEFs (R. PinkasKramarski, personal communication), primary neurons (A.
R. La Spada, personal communication) or neuronal cells (C.
T. Chu, personal communication; [429]) transiently increases
basal levels of GFP-LC3 puncta and/or the amount of LC3-II.
One solution to this artefact is to examine GFP-LC3 puncta in
cells stably expressing GFP-LC3; however, as transfectioninduced increases in GFP-LC3 puncta and LC3-II are often
transient, another approach is to use cells transfected with
GFP, with cells subjected to a mock time-matched transfec
tion as the background (negative) control. A lipidation-defec
tive LC3 mutant where glycine 120 is mutated to alanine is
targeted to these aggregates independently of autophagy
(likely via its interaction with SQSTM1, see above); as a result,
this mutant can serve as another specificity control [418].
When carrying out transfections it may be necessary to alter
the protocol depending on the level of background fluores
cence. For example, changing the medium and waiting 24 to
48 h after the transfection can help to reduce the background
level of GFP-LC3 puncta that is due to the transfection
reagent (M. I. Colombo, personal communication).
Similarly, when using an mCherry-GFP-SQSTM1 double tag
(see Tandem mRFP/mCherry-GFP fluorescence microscopy) in
transient transfections it is best to wait 48 h after transfection
to reduce the level of aggregate formation and potential inhi
bition of autophagy (T. Johansen, personal communication).
An additional consideration is that, in addition to transfec
tion, viral infection can activate stress pathways in some cells
and possibly induce autophagy. Influenza virus induces auto
phagy and autophagy is required for subsequent viral-induced
apoptosis [337]. Proteomic screens show that several viruses,
including influenza virus [430] and Zika virus [431], can
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significantly alter the expression of numerous proteins
involved in autophagy and other cell stress pathways. This
again emphasizes the importance of appropriate controls,
such as control viruses expressing GFP [432].
The formation and clearance of ubiquitinated protein
aggregates appear to represent a cellular recycling process.
Aggregate formation can occur when autophagy is either
inhibited or when its capacity for degradation is exceeded by
the formation of proteins delivered to the aggregates. In
principle, formation of GFP-LC3-positive aggregates repre
sents a component of the autophagy process. However, the
formation of GFP-LC3-positive ubiquitinated protein aggre
gates does not directly reflect either the induction of autopha
gy (or autophagosome formation) or flux through the system.
Indeed, formation of ubiquitinated protein aggregates that are
GFP-LC3 positive can occur in autophagy-deficient cells
[418]. Therefore, it should be remembered that GFP-LC3
puncta likely represent a mix of ubiquitinated protein aggre
gates in the cytosol, ubiquitinated protein aggregates within
autophagosomes and/or more “conventional” phagophores
and autophagosomes bearing other cytoplasmic cargo (this is
one example where CLEM could help in resolving this ques
tion [119]). In D. discoideum, inhibition of autophagy leads to
large ubiquitinated protein aggregates containing SQSTM1
and GFP-Atg8, when the latter is co-expressed [422]; the
large size of the aggregates makes them easily distinguishable
from autophagosomes. Saponin treatment has been used to
reduce background fluorescence under conditions where no
aggregation of GFP-LC3 is detected in hepatocytes, GFPLC3 stably-transfected HEK 293 [432] and human osteosar
coma cells, and in nontransfected cells [433]; however,
because treatment with saponin and other detergents can
provoke artefactual GFP-LC3 puncta formation [434], speci
ficity controls need to be included in such experiments. In
general, it is preferable to include additional assays that
measure autophagy rather than relying solely on monitoring
GFP-LC3. In addition, we recommend that researchers vali
date their assays by demonstrating the absence or reversal of
GFP-LC3 puncta formation in cells treated with pharmaco
logical or RNA interference-based autophagy inhibitors
(Table 1). For example, 3-methyladenine (3-MA) is com
monly used to inhibit starvation- or rapamycin-induced
autophagy [435], but it has no effect on BECN1-independent
forms of autophagy [118, 208], and some data indicate that
this compound can also have stimulatory effects on autopha
gy (see Autophagy inhibitors and inducers) [436, 437], as well
as induce cell death at progressively higher concentra
tions [438].
Another general limitation of the GFP-LC3 assay is that it
requires a system amenable to the introduction of an exogen
ous gene. Accordingly, the use of GFP-LC3 in primary nontransgenic cells is more challenging. Here again, controls need
to be included to verify that the transfection protocol itself
does not artefactually induce GFP-LC3 puncta or cause LC3
aggregation. Furthermore, transfection should be performed
with low levels of constructs, and the transfected cells should
be followed to determine: i) when sufficient expression for
detection is achieved, and ii) that, during the time frame of
the assay, basal GFP-LC3 puncta remain appropriately low. In
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Table 1. Genetic and pharmacological regulation of autophagy.2
Method
1. 3-methyladenine

Comments
A PtdIns3K inhibitor that effectively blocks an early stage of autophagy by inhibiting the class III PtdIns3K, but it is important to note that
it is not a specific autophagy inhibitor. 3-MA also inhibits the class I PI3K and can thus, at suboptimal concentrations in long-term
experiments, promote autophagy in some systems [436,437], as well as affect cell survival through AKT and other kinases. 3-MA does not
inhibit BECN1-independent autophagy.
2. 10-NCP
10-(4′-N-diethylamino)butyl)-2-chlorophenoxazine; an AKT inhibitor that induces autophagy in neurons [1950].
3. 17-AAG
An inhibitor of the HSP90-CDC37 chaperone complex; induces autophagy in certain systems (e.g., neurons), but impairs starvationinduced autophagy and mitophagy in others by promoting the turnover of ULK1 [647].
4. ABG33
ABG33 (7-aminobenzo[cd]indol-2-(1 H)-one 33 is a small molecule inhibitor of ATG4B enzymatic activity in vitro. In cells, ABG33 results in
a dose-dependent increase in LC3B-II levels [2576].
5. AC220/quizartinib
An FLT3 inhibitor that enhances the inhibitory activity of spautin-1. A70 is an improved derivative of AC220. Treatment sensitizes cancer
cells to autophagy inhibition [5].
6. ACY-1215/ricolinostat ACY-1215 is a selective HDAC6 inhibitor that inhibits the fusion of lysosomes with autophagosomes and abrogates the clearance of
autophagosomes [2577].
7. AZD8055
A catalytic MTOR inhibitor that acts as a potent autophagy inducer [2578].
8. Akti-1/2
An allosteric inhibitor of AKT1 and AKT2 that promotes autophagy in B-cell lymphoma [2579].
9. AR-12 (OSU-03012)
A broad-specificity anti-viral celecoxib-derivative that stimulates autophagosome formation and viral protein degradation [2580].
10. AR7
AR7 was developed as a highly potent and selective enhancer of CMA through antagonizing RARA/RARα; AR7 is the first small molecule
developed to selectively stimulate CMA without affecting autophagy [2581].
11. ARN5187
Lysosomotropic compound with a dual inhibitory activity against the circadian regulator NR1D2/REV-ERBβ and autophagy [2582].
12. AS-605,240
A selective PIK3CG/PI3Kγ inhibitor that activates autophagy in the heart [2583].
13. ATG4C74A
An active site mutant of ATG4 that is defective for autophagy [2584].
14. Autophinib
An autophagy inhibitor that targets the lipid kinase PIK3C3/VPS34 [2585].
15. Bafilomycin A1
A V-ATPase inhibitor that causes an increase in lysosomal/vacuolar pH, and, ultimately, blocks fusion of autophagosomes with the
vacuole; the latter may result from inhibition of ATP2A/SERCA [303].
16. Benzothiadiazole
A chemical analog of salicylic acid, which can be used to induce autophagy and autophagosome formation in plant cells including A.
thaliana [128,2586].
17. Betulinic acid
A pentacyclic triterpenoid that promotes parallel damage in mitochondrial and lysosomal compartments, and, ultimately, jeopardizes
lysosomal degradative capacity, which results in autophagy-associated cell death [314] or aging [315].
18. Butein
A plant-derived natural molecule that induces autophagy through the activation of AMPK [2587].
19. C12TPP
Dodecyltriphenylphosphonium is a penetrating cation that selectively accumulates in mitochondria, uncouples oxidative
phosphorylation and stimulates autophagy and mitophagy without inhibition of autophagosome-lysosome fusion, in contrast to
protonophores [2588].
20. Calcium
An intracellular signal that can promote autophagy at different steps. Calcium can be released from the ER upon physiological
stimulation or from lysosomal stores under stress conditions, or can enter from the extracellular space [2001]. However, calcium has a
complex effect as it can also inhibit autophagy, and the abrogation of calcium signaling can trigger autophagy [216,1990,1994,2589].
21. Carbamazepine
Induces autophagy by reducing inositol levels, and inhibits autophagy via neuronal voltage-gated sodium channels [1976,2590].
22. CB-5083
A selective inhibitor of VCP/p97-mediated protein degradation that activates autophagy in human cancer cells [2591,2592].
23. CCCP
Carbonyl cyanide m-chlorophenylhydrazone is a prototype protonophore, uncoupler of oxidative phosphorylation that stimulates
autophagy via the AMPK-ULK1 pathway [671,672] or alternative pathways [2593] and mitophagy [339], but inhibits autophagosomelysosome fusion due to the increase of intralysosomal pH [215].
24. Chloroquine, NH4Cl Lysosomotropic compounds that elevate/neutralize the lysosomal/vacuolar pH [225].
25. Cinacalcet HCl
A calcimimetic that increases the sensitivity of CASR (calcium sensing receptor) to extracellular calcium. In some models, cinacalcet
induces the formation of GFP-LC3 puncta [494] during starvation, whereas in others it causes an increase in LC3-II accumulation in basal
[1563,2594,2595] and CQ conditions [2594]. In a diabetic nephropathy model, the proposed pathway through cinacalcet-induced
autophagy is CAMKK2/CaMKKβ-STK11/LKB1-AMPK-PPARGC1A/PGC1α to decrease oxidative stress, which results in a decrease of
apoptosis (increased BCL2:BAX ratio) and increased autophagy (increase of BECN1 and LC3-I to LC3-II conversion) [2595]. Cinacalcet may
have a dual effect inducing autophagosome formation and inhibiting the late steps of autophagy.
26. Clonidine
Activates the imidazoline receptor, which decrease cAMP in cells. An MTOR-independent inducer of autophagy [1951]
27. Concanamycin A
A specific inhibitor of V-ATPases that reduces acidification of the lysosome or vacuole, and will block the degradation of autophagic
bodies within the vacuole [128,2586].
28. DFMO
α-difluoromethylornithine is an irreversible inhibitor of ODC1 (ornithine decarboxylase 1) that blocks spermidine synthesis and ATG gene
expression [2596].
29. DMMB
A photosensitizer derivative of methylene blue that promotes parallel damage in lysosomes and mitochondria after photoactivation with
red light, leading to accumulation of non-functional autolysosomes and autophagy-associated cell death [316].
30. Docosahexaenoic
An omega-3 polyunsaturated fatty acid, that has been described as acid (DHA) an activator of autophagy, which could potentially be
used in cancer therapy either alone or in combinatorial strategies, as well as in neurodegenerative, cardiovascular or infectious diseases
[2597-2599].
31. E-64c
A derivative of E-64, a cysteine protease inhibitor.
32. E-64d
A membrane-permeable cysteine protease inhibitor that can block the activity of a subset of lysosomal hydrolases; should be used in
combination with pepstatin A to inhibit lysosomal protein degradation. The ethyl ester of E-64c.
33. Eriocalyxin B
An autophagy inducer that exerts anti-tumor activity in breast cancer by inhibition of the AKT-MTOR-RPS6KB signaling pathway [2600].
(Continued )
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This table is not meant to be complete, as there are many compounds and genetic methods that regulate autophagy, and new ones are routinely being
discovered. See also [2575] for a partial listing of chemical and phytochemical modulators.
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Table 1. (Continued).
Method

Comments

34. ESC8

A cationic estradiol derivative that induces autophagy and apoptosis simultaneously by downregulating the MTOR kinase pathway in
breast cancer cells.
An inhibitor of MTORC1 that induces both autophagy and apoptosis in B-cell lymphoma primary cultures [2579].
A cholesterol absorption inhibitor that acts by binding to NPC1L1, which induces autophagy via MTORC1-dependent [2601] and
-independent [2602] pathways. Ezetimibe also activates TFEB and could potentially exert therapeutic effects on steatohepatitis and
fibrosis [2601,2602].
An inhibitor of ROCK (Rho associated coiled-coil containing protein kinase) enhancing autophagy via phosphorylation of MAPK8/JNK1
and BCL2, and promoting BECN1-PIK3C3/VPS34 complex formation; shRNA-mediated approaches to inhibiting ROCK have similar results
[2603-2605].
A large class of polyphenols that have been described as autophagy modulators, which could potentially constitute useful adjuvant
agents of conventional therapies for different human pathologies such as cancer, neurodegenerative, cardiovascular, hepatic or
infectious diseases [2606].
An inhibitor of ceramide synthesis that interferes with autophagy.
This method provides the most direct evidence for the role of an autophagic component; however, more than one gene involved in
autophagy should be targeted to avoid indirect effects.
Heparin-binding hemagglutinin of M. tuberculosis that inhibits autophagy. HBHA treatment inhibits LC3 expression and the maturation
of autophagosomes, eventually inducing apoptosis [2607].
Mitophagy and the formation of iron-containing cytoplasmic inclusions and corpora amylacea are accelerated in HMOX1-transfected rat
astroglia and astrocytes of GFAP HMOX1 transgenic mice. Heme-derived ferrous iron and carbon monoxide, products of the HMOX1
reaction, promote autophagy in these cells [2608,2609].
This method (including miRNA, RNAi, shRNA and siRNA) can be used to inhibit gene expression and provides relatively direct evidence
for the role of an autophagic component. However, the efficiency of knockdown varies, as does the stability of the targeted protein. In
addition, more than one gene involved in autophagy should be targeted to avoid misinterpreting indirect effects.
An MTOR inhibitor that binds the catalytic site and activates autophagy [453,2610].
An inhibitor of cysteine, serine and threonine proteases that can be used in combination with pepstatin A and/or E-64d to block
lysosomal protein degradation. Leupeptin is not membrane permeable, so its effect on cathepsins may depend on endocytic activity.
A small molecule inhibitor of ATG4A and ATG4B enzymatic activity in vitro. In cells, LV-320 results in a dose-dependent increase in LC3BII levels, reduces GABARAP levels and reduces autophagic flux [2611].
A phenothiazine photosensitizer that promotes specific photodamage in lysosomes when used at low doses and photoactivated with
red light. By targeting lysosomes to photodamage, MB can promptly switch autophagy to favor cell demise when parallel mitochondrial
membrane damage by hydrogen peroxide or rotenone occurs [316].
N-acetyl-5-methoxy tryptamine is a sleep–wake cycle regulating and antioxidant hormone that inhibits autophagy in animal models of
fibrosis [2612], cancer [2613] and acute organ failure [2614].
Activates both AMPK-dependent and -independent autophagy [2615-2617].
Can be used to reduce the levels of target mRNA(s) or block translation.
A small molecule inhibitor of AKT that is able to induce Autophagy independently of MTORC1 activity [973,2618].
A small molecule inhibitor of NAE (NEDD8 activating enzyme) [2619]; induces autophagy by blockage of MTOR activity via both DEPTOR
and the HIF1A-DDIT4/REDD1-TSC1/2 axis as a result of inactivation of cullin-RING ligases [2620].
A polyketide lactone and virulence exotoxin of Mycobacterium ulcerans that functions by blocking SEC61-dependent translocation of
proteins into the ER [2022]. Mycolactone induces the integrated stress response [2021] and autophagy [2020,2021].
Activates the lysosomal TPCN/two-pore channel and induces autophagy [1996].
Inhibits the lysosomal TPCN and NAADP-induced autophagy [1996].
A combination of acamprosate and ribavirin that activates SIRT1 and autophagy, promoting neuroprotection [2015,2016].
A small molecule inhibitor of ATG4B enzymatic activity in vitro [2576].
A dual inhibitor of PIK3CA/p110 and the MTOR catalytic site that activates autophagy [2621,2622].
Small peptide that inhibits LAMP2A overexpression in lupus B cells and binds to the NBD domain of HSPA8 [2623,2624]. Furthermore,
this drug has been described as a potent CMA inhibitor [2625].
Virally-encoded autophagy inhibitors including HSV-1 ICP34.5, Kaposi sarcoma-associated herpesvirus vBCL2, γ-herpesvirus 68 M11, ASFV
vBCL2, HIV-1 Nef and influenza A virus M2 [848,1418,1423,1424,1966].
An aspartyl protease inhibitor that can be used to partially block lysosomal degradation; should be used in combination with other
inhibitors such as E-64d. Pepstatin A is not membrane permeable.
SQSTM1/p62-mediated mitophagy inducer is a pharmacological activator of autophagic selection of mitochondria that operates without
collapsing the mitochondrial membrane potential (ΔΨm) and hence by exploiting the autophagic component of the process [714].
An inducer of autophagy that may be related with the classical autophagy pathway [2626].
These chemicals inhibit the degradation of autophagic substrates within the lysosome/vacuole lumen. A combination of inhibitors (e.g.,
leupeptin, pepstatin A and E-64d) is needed for complete blockage of degradation.
Binds to FKBP1A/FKBP12 and inhibits MTORC1; the complex binds to the FRB domain of MTOR and limits its interaction with RPTOR, thus
inducing autophagy, but only providing partial MTORC1 inhibition. Rapamycin also inhibits yeast TOR.
A natural polyphenol that affects many proteins [2627] and induces autophagy via activation of AMPK [2628, 2629].
Can be used to inhibit gene expression.
Synthetic small-molecule analogs of resveratrol that potently activate AMPK and induce autophagy [2630].
A natural small-molecule inhibitor of ATP2A/SERCA that induces autophagy and autophagy-dependent cell death in apoptosis-resistant
cells [1909].
A low-molecular-mass kinase inhibitor of PIK3C3/VPS34 that interacts within the ATP binding cleft of human PIK3C3 and inhibits
autophagy [1883].
Potent and selective PIK3C3/VPS34 inhibitor that binds in the active site of PIK3C3, thus inhibiting its catalytic function [2631].

35. Everolimus
36. Ezetimibe

37. Fasudil

38. Flavonoids

39. Fumonisin B1
40. Gene deletion
41. HBHA
42. HMOX1 induction

43. Knockdown

44. KU-0063794
45. Leupeptin
46. LV-320
47. MB

48. Melatonin
49.
50.
51.
52.

Metformin
microRNA
MK2206
MLN4924

53. Mycolactone
54.
55.
56.
57.
58.
59.

NAADP-AM
NED-19
NeuroHeal
NSC611216
NVP-BEZ235
p140/Lupuzor™

60. Pathogen-derived
factors
61. Pepstatin A
62. PMI
63. Propolis
64. Protease inhibitors
65. Rapamycin
66.
67.
68.
69.

Resveratrol
RNAi
RSVAs
Saikosaponin-d

70. SAR405
71. SB02024

(Continued )
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72. SBI-0206965

73. Sorafenib
74. SMER28
75. Spautin-1
76. Spermidine

77. Sulforaphane
78. Tat-beclin 1
79. Thapsigargin

80. TMS
81. Torin1
82. TPCK
83. TPPS2a
84. Trehalose
85. Tunicamycin
86. Vacuolin-1
87. Verteporfin
88. Vinblastine
89. VP2.51
90. VPS34-IN1
91. Wortmannin
92. Yessotoxin (YTX)

Comments
A highly selective ULK1 kinase inhibitor in vitro that suppresses ULK1-mediated phosphorylation events in cells, regulating autophagy
and cell survival [2632]. This compound is also an inhibitor of AMPK, competitively inhibiting ATP binding, and also inhibiting the
binding of AMPK to its substrates [2633].
An antitumoral inhibitor of tyrosine kinase receptors whose sustained administration induces a shift from early induction of survival
autophagy to apoptosis [2634].
An MTOR-independent inducer of autophagy [2013].
An autophagy inhibitor that acts via suppression of USP10 and USP13, and degradation of the PIK3C3/VSP34-BECN1 complex [2635].
A chemical originally isolated from semen and enriched in many food products; it promotes autophagy flux by depleting cytosolic
HDAC4 to enhance MAP1S-mediated autophagy [956]. Spermidine maintains basal autophagy in NIH 3T3 cells and B cells of mice or
humans via hypusination of EIF5A and subsequent upregulation of TFEB [958].
A natural isothiocyanate, alone and in combination with cytostatics induces cell death via autophagy, and elevates the level of LC3-II
[1905,2636,2637].
A cell penetrating peptide that potently induces autophagy [2004,2638].
An inhibitor of ATP2A/SERCA that inhibits autophagic sequestration through the depletion of intracellular calcium stores [216,2639];
however, thapsigargin may also block fusion of autophagosomes with endosomes by interfering with recruitment of RAB7, resulting in
autophagosome accumulation [2640].
Trans-3,5,4-trimethoxystilbene upregulates the expression of TRPC4, resulting in MTOR inhibition [2641].
A catalytic MTOR inhibitor that induces autophagy and provides more complete inhibition than rapamycin (it inhibits all forms of MTOR)
[802].
An inducer of autophagic cell death.
TPPS2a photoexcitation promotes mainly lysosomal damage leading to autophagy-associated cell death [317].
A membrane-protective agent [2642] and inducer of autophagy that may be relevant for the treatment of different neurodegenerative
diseases [973, 2036, 2643-2645].
A glycosylation inhibitor that induces autophagy due to ER stress [473,2646].
A RAB5A activator that reversibly blocks autophagosome-lysosome fusion [2647].
An FDA-approved drug; used in photodynamic therapy, but it inhibits the formation of autophagosomes in vivo without light activation
[2648].
A depolymerizer of both normal and acetylated microtubules that interferes with autophagosome-lysosome fusion [304].
A small molecule, ATP-competitive inhibitor of GSK3B enzymatic activity in vitro. In vivo, VP2.51 modulates autophagy and ameliorates
motor neuron disease [2649].
A low-molecular-mass kinase inhibitor of PIK3C3/VPS34 similar to SAR-405 that interacts within the ATP binding cleft of human PIK3C3
and inhibits autophagy [2650].
An inhibitor of PI3K and PtdIns3K that blocks autophagy, but is not a specific inhibitor (see 3-MA above).
A small molecule marine compound that can potentially induce autophagic-associated cell death [1515]. YTX can induce various cell
death modalites [2651]; its molecular target and mode of action are not yet clarified.

addition, the demonstration of a reduction in the number of
induced GFP-LC3 puncta under conditions of autophagy
inhibition is helpful. For some primary cells, delivering
GFP-LC3 to precursor cells by infection with recombinant
lentivirus, retrovirus or adenovirus [439], and subsequent
differentiation into the cell type of interest, is a powerful
alternative to transfection of the already differentiated cell
type [103].
To implement the scoring of autophagy via fluorescence
microscopy, one option is to measure pixel intensity. Because
the expression of GFP-LC3 may not be the same in all cells—
as discussed above—it is possible to use specific imaging
software to calculate the standard deviation (SD) of pixel
intensity within the fluorescence image and divide this by
the mean intensity of the pixels within the area of analysis.
This will provide a ratio useful for establishing differences in
the degree of autophagy between cells. Cells with increased
levels of autophagic activity, and hence a greater number of
autophagosomes in their cytosol, are associated with a greater
variability in pixel intensity (i.e., a high SD). Conversely, in
cells where autophagy is not occurring, GFP-LC3 is uniformly
distributed throughout the cytosol, and a variation in pixel
intensity is not observed (i.e., a low SD; M. Campanella,
personal communication).

Although LC3-II is primarily membrane-associated, it is
not necessarily associated with autophagosomes as is often
assumed; the protein is also found on phagophores, the pre
cursors to autophagosomes, as well as on amphisomes and
phagosomes (see Western blotting and ubiquitin-like protein
conjugation systems) [247, 440, 441]. Along these lines, yeast
Atg8 can associate with the vacuole membrane independent
of lipidation, so that a punctate pattern does not necessarily
correspond to autophagic compartments [442]. Thus, the use
of additional markers is necessary to specify the identity of an
LC3-positive structure; for example, ATG12–ATG5-ATG16L1
would be present on a phagophore, but not on an autophago
some, and thus colocalization of LC3 with any of these pro
teins would indicate the former structure. In addition, the site
(s) of LC3 conjugation to PE is not definitively known, and
levels of Atg8–PE/LC3-II can increase even in autophagy
mutants that cannot form autophagosomes [443]. One
method that can be used to examine LC3-II membrane asso
ciation is differential extraction in Triton X-114, which can be
used with mammalian cells [439], or western blot analysis of
total membrane fractions following solubilization with Triton
X-100, which is helpful in plants [289, 290]. Importantly, we
stress again that numbers of GFP-LC3 puncta, similar to
steady state LC3-II levels, reflect only a snapshot of the
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numbers of autophagy-related structures (e.g., autophago
somes) in a cell at one time, not autophagic flux. A potential
solution to determine the effect of a given perturbation on
flux, is to count GFP-LC3 puncta at various time points
following the addition of 3-MA (to prevent formation of
new puncta), with the rate of puncta disappearance essentially
indicting the flux of disposal [444].
GFP-LC3 expression can perturb autophagy and cellular
function, both in the basal state and disease models, as
found in the exocrine pancreas of GFP-LC3 mice [445].
Compared to the wild type, the pancreatic ATG4B level is
markedly decreased in GFP-LC3 mice, resulting in an
increase of the endogenous LC3-II. These effects are
organ specific (e.g., there are no effects on ATG4B and
LC3 levels in lung and spleen). Autophagic flux analysis
(using the lysosomal protease inhibitors E64d plus pepsta
tin A) indicate that in GFP-LC3 pancreatic acinar cells the
basal autophagosome formation is enhanced several-fold
but is not fully counterbalanced by increased autophagic
degradation. As a result, the exocrine pancreas of GFP-LC3
mice displays accumulation of enlarged autophagic
vacuoles. GFP-LC3 expression affects functional para
meters of acinar cells and worsens key pathological
responses in mouse models of acute pancreatitis. The
study referenced above demonstrates organ-specific effects
of GFP-LC3 expression and indicates that application of
GFP-LC3 mice in disease models should be done
cautiously.
Finally, we offer a general note of caution with regard to
GFP. First, the GFP tag is large, in particular relative to the
size of LC3; therefore, it is possible that a chimera may behave
differently from the native protein in some respects. Second,
GFP is not native to most systems, and as such (i) it may be
recognized as an aberrant protein and targeted for degrada
tion, which has obvious implications when studying autopha
gy, and (ii) it may elicit immune responses targeting GFPexpressing cells in vivo. Third, some forms of GFP tend to
oligomerize, which may interfere with protein function and/or
localization. Fourth, EGFP inhibits polyubiquitination [446],
and may cause defects in other cellular processes. Fifth, not all
LC3 puncta represent LC3-II and correspond to autophago
somes [255, 256, 447, 448]. Accordingly, it would be prudent
to complement any assays that rely on GFP fusions (to Atg8family proteins or any protein) with additional methods that
avoid the use of this fluorophore. Similarly, with the emer
gence of “super-resolution” microscopy methods such as
photoactivated localization microscopy (PALM), new tags
are being used (e.g., the EosFP green-to-red photoconvertible
fluorescent protein, or the Dronpa GFP-like protein) that will
need to be tested and validated [449].
Conclusion: GFP-LC3 provides a marker that is relatively
easy to use for monitoring autophagy induction (based on the
appearance of puncta), or colocalization with cargo; however,
monitoring this chimera does not determine flux unless uti
lized in conjunction with inhibitors of lysosomal fusion and/
or degradation. In addition, it is recommended that results
obtained by GFP-LC3 fluorescence microscopy are verified by
additional assays.
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f. Tandem mRFP/mCherry-GFP fluorescence microscopy. A
fluorescence assay that is designed to monitor flux relies on
the use of a tandem monomeric RFP-GFP-tagged LC3 (tfLC3;
Figure 16) [344]. The GFP signal is sensitive to the acidic and/
or proteolytic conditions of the lysosome lumen, whereas
mRFP is more stable. Therefore, colocalization of both GFP
and mRFP fluorescence indicates a compartment that has not
fused with a lysosome, such as a phagophore, an amphisome
or an autophagosome [450]. In a pathological state where
acidification mechanisms are impaired, fusion may occur
without GFP becoming quenched, and additional markers of
fusion must be applied [451]. Although inhibiting lysosomal
acidification may impede fusion in some cell types, fusion
may proceed in other cell types under these conditions
[218]. In contrast, an mRFP signal without GFP corresponds
to an autolysosome. Other fluorophores such as mCherry are
also suitable instead of mRFP [423], and an image-recognition
algorithm has been developed to quantify flux of the reporter
to acidified compartments [452–454]. One of the major
advantages of the tandem mRFP/mCherry-GFP reporter
method is that it enables simultaneous estimation of both
the induction of autophagy and flux through autophagic
compartments. However, determining the efficiency of the
actual degradation of the substrate or carrier in the lysosome
still requires the use of lysosomal protease inhibitors such as
E64d and pepstatin. The competence of lysosomal digestion of
the substrate requires additional analysis using methods
described above. The use of more than one time point allows
visualization of increased early autophagosomes followed by
increases in late autophagosomes as an additional assurance
that flux has been maintained [293]. In addition, this method
can be used to monitor autophagy in high-throughput drug
screening studies [453]. The quantification of “yellow” (where
the yellow signal results from merging the red and green
channels) and “red only” puncta in a stable tandem-fluores
cent LC3-reporter cell line can be automated by a Cellomics
microscope that can be used to assess a huge population of
cells (1,000 or more) over a large number of random fields of
view [311, 455]. In the presence of a lysosomal acidification
defect, additional markers of autophagosome-lysosome fusion
need to be applied to assess autophagy flux alterations [451].
The use of late inhibitors of autophagy such as CQ or bafilo
mycin A1, which prevent the formation of autolysosomes, is
recommended as a useful experimental control for the visua
lization of “yellow” puncta. Note that “green-only” dots may
occur under certain conditions due to more rapid maturation
of the GFP chromophore, allowing similar fusions to be used
as timers [456, 457]. Notably, organelle-specific variations of
the tandem mRFP/mCherry-GFP reporter system have suc
cessfully been used to analyze selective types of autophagy,
such as pexophagy [458, 459], mitophagy [460–463] and reti
culophagy [464, 465] in mammalian cells. This tandem repor
ter is technically less challenging in plant cells due to
accumulation of red fluorescent signal in the large relatively
static plant vacuoles instead of small mobile dot-like lyso
somes. Optimization of the tandem-tag assay for monitoring
autophagic activity in plant roots has been described, provid
ing a pipeline for automated high-throughput image analysis
[357]. Importantly, in vivo systems to detect mitophagy have
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Figure 16. The GFP and mRFP signals of tandem fluorescent LC3 (tfLC3, mRFP-GFP-LC3) show different localization patterns. HeLa cells were cotransfected with plasmids
expressing either tfLC3 or LAMP1-CFP. Twenty-four h after the transfection, the cells were starved in Hanks balanced salt solution for 2 h, fixed and analyzed by microscopy.
The lower panels are a higher magnification of the upper panels. Bar: 10 µm in the upper panels and 2 µm in the lower panels. Arrows in the lower panels point to (or mark
the location of) typical examples of colocalized signals of mRFP and LAMP1. Arrowheads point to (or mark the location of) typical examples of colocalized particles of GFP
and mRFP signals. This figure was previously published in ref. [344], and is reproduced by permission of Landes Bioscience, copyright 2007.

been generated employing Drosophila [466] and mouse mod
els [38].
An alternative dual fluorescence assay involves the Rosella
pH biosensor. This assay monitors the uptake of material to
the lysosome/vacuole and complements the use of the tandem
mRFP/mCherry-GFP reporter. The assay is based upon the
genetically encoded dual color-emission biosensor Rosella, a
fusion between a relatively pH-stable fast-maturing RFP var
iant, and a pH-sensitive GFP variant. When targeted to spe
cific cellular compartments or fused to an individual protein,

the Rosella biosensor provides information about the identity
of the cellular component being delivered to the lysosome/
vacuole for degradation. Importantly, the pH-sensitive dual
color fluorescence emission provides information about the
environment of the biosensor during autophagy of various
cellular components. In yeast, Rosella has been successfully
used to monitor autophagy of cytosol, mitochondria (mito
phagy) and the nucleus (nucleophagy) [156, 467, 468].
Furthermore, the Rosella biosensor can be used as a reporter
under various conditions including nitrogen depletion-
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dependent induction of autophagy [467, 468]. The Rosella
biosensor can also be expressed in mammalian cells to follow
either nonselective autophagy (cytoplasmic turnover), or
mitophagy [467, 469]. A Rosella-based mitophagy reporter
mouse line has been created to assess mitophagy activity in
the heart [470].
Cautionary notes: The motion of puncta corresponding to
Atg8-family proteins can complicate the use of tandem
mRFP/mCherry-GFP-Atg-family protein reporters in live
imaging experiments. As a consequence, conventional confo
cal microscopy may not allow visualization of colocalized
mRFP/mCherry-GFP puncta. In this case, mRFP/mCherryGFP colocalized puncta represent newly formed autophagic
structures whereas mRFP/mCherry-only puncta are ambigu
ous. Spinning disk confocal microscopy or rapid acquisition
times may be required for imaging tandem mRFP/mCherryGFP proteins, although these techniques require a brighter
fluorescent signal potentially associated with undesirably
higher levels of transgene expression. Overexpression of
these sensors can target the proteins to acidified lysosomes,
which also results in mRFP/mCherry-only puncta. A good
control is the non-lipidatable form of the sensor expressed
at the same levels as the wild-type experimental sensor, to
assess baseline targeting of the tandem proteins to lysosomes
[471]. Another optimization is to use the mTagRFPmWasabi-LC3 chimera [472, 473], as mTagRFP is brighter
than mRFP and mCherry, and mWasabi is brighter than
EGFP [474]. An improved version of tfLC3 is pHluorinmKate2-hLC3 reporter (PK-hLC3), because pHluorin is
more sensitive to acidic pH (pKa 7.6, quenched at pH 6.5)
than EGFP and mWasabi [450, 475]. In the latter case, how
ever, organelles that only achieve a lower level of acidification,
such as amphisomes, may not be differentiated from fully
acidified (i.e., mature) lysosomes [476]. A good quantitative
technique for cells in suspension, which also require identifi
cation by surface markers (such as immune cells), is the
detection of LC3-II by flow cytometry. Here LC3-I is washed
out after treatment with a mild detergent, and only mem
brane-bound LC3-II is retained for staining with an anti-LC3
antibody. Early fixation avoids the induction of artefacts due
to centrifugation or mixing. This approach has been estab
lished for both cell lines [433] and primary cells [477].
Another possibility is to use fixed cells; however, this pre
sents an additional concern: The use of tandem mRFP/
mCherry-GFP relies on the quenching of the GFP signal in
the acidic autolysosome; however, fixation solutions are often
neutral or weak bases, which will increase the pH of the entire
cell. Accordingly, the GFP signal may be restored after fixa
tion (Figure 17), which would cause an underestimation of the
amount of signal that corresponds only to RFP (i.e., in the
autolysosome). Thus, the tissue or cell samples must be prop
erly processed to avoid losing the acidic environment of the
autolysosomes. In addition, there may be weak fluorescence of
EGFP even in an acidic environment (pH between 4 and 5)
[439, 478]. Therefore, it may be desirable to choose a mono
meric green fluorescent protein that is more acid sensitive
than EGFP for assaying autophagic flux. For example, the
pHluorin-based probe (PK-hLC3) referred to above can
solve these problems [450]; in a PK-hLC3 transgenic mouse
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autophagic responses in the neurons are easily detectable,
whereas such responses in the neurons of a GFP-LC3 trans
genic mouse are hardly recognized [479]. pHluorin-LC3mCherry is also an improved autophagic flux probe variant
of GFP-LC3-RFP-LC3ΔG [480]. Finally, photobleaching,
light-induced degradation of fluorophores, is a significant
problem in live-cell imaging [481]. When examining live
tissue, it is important to remember that marker fluorescence,
particularly GFP fluorescence, can diminish rapidly with the
decay of cell physiology. The use of the minimal possible
exposure and light power level is therefore recommended. If
sequential acquisition of fluorescence emissions is needed,
they should be acquired in the order GFP then RFP, as RFP
exhibits higher photostability. The experimenter can also take
advantage of anti-fading media developed for live imaging
[482]. In some tissues (e.g., Drosophila brain) it may be
necessary to image each sample no more than 30-40 min
after dissection of the individual sample.
Another caution in the interpretation of the tandem fluor
escent marker is that an enhanced degree of colocalization of
GFP and mRFP/mCherry might also be seen in the case of
impaired proteolytic degradation within autolysosomes or
altered lysosomal pH. This limitation may be overcome by
incorporating two strategies in the experimental design: i)
direct measurement of lysosomal pH in the in vitro model
of interest, to discount lysosomal alkanization as a cause for
increased GFP+ RFP+ puncta [483–485], and ii)
Immunohistochemical analysis against lysosomal markers
such as CTSD and LAMP2. Whereas measuring lysosomal
pH or proteolytic activity in vivo or in fixed tissue is not
possible, colocalization of GFP+ RFP+ puncta, or target auto
phagic cargo with CTSD or LAMP2 may be indicative of
lysosomal dysfunction [485].
RFP-GFP-LC3 and GFP-LC3 (or other Atg8-family pro
teins) methodology, which involves in vitro or in vivo over
expression of the fluorescent construct, requires careful
microscopy by including a GFP-expressing control. A com
parable in vitro or in vivo system overexpressing GFP is
necessary to “titer” the minimum laser intensity, minimum
gain, and offset parameters on the confocal microscope that
are required to detect true GFP. Excessive laser intensity/gain
often leads to an undesirable increase in signal:background
ratio, may also contribute to increased false-positive counts,
and often leads to rapid photobleaching as well. The same
laser intensity/gain/offset setting to detect true GFP should
strictly be applied to the RFP-GFP-LC3-expressing in vitro or
in vivo system of interest. The other experimental positive
control is CQ or bafilomycin A1 treatment to induce lysoso
mal alkalinization. The intensity/gain settings (sufficient to
detect true GFP) should be minimally sufficient to detect
GFP+ RFP+ puncta in CQ-treated samples. Autophagosomes,
typically, are 900 nm to 1.5 µm in diameter. Low magnifica
tion images (using 20X/40X objectives) do not provide
enough resolution to obtain quantifiable data. Only higher
magnification images should be used to monitor autophagy.
Once the microscope “parameters” to detect GFP have been
determined (using a GFP-overexpressing control), it is impor
tant that the user captures the fluorescence images in the
green channel in experimental conditions, and the CQ
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Figure 17. GFP fluorescence in the autolysosome can be recovered upon neutralization of the pH. (A) GFP-LC3 emits green fluorescence in the autolysosomes of
post-mortem processed heart sections. Cryosections of 3.8% paraformaldehyde fixed ventricular myocardium from 3-week-old GFP-LC3 transgenic mice at the
baseline (Control) or starved for 24 h (Starved) were processed for immunostaining using a standard protocol (buffered at pH 7.4). Most of the GFP-LC3 puncta are
positive for LAMP1, suggesting that the autolysosomes had recovered GFP fluorescence. (B) Colocalization between GFP-LC3 direct fluorescence (green) and indirect
immunostaining for GFP (red). Sections processed as in (A) were immunostained for GFP using a red fluorescence-tagged secondary antibody, and the colocalization
with GFP fluorescence was examined by confocal microscopy. Almost all of the red puncta emit green fluorescence. Scale bar: 10 µm. Image provided by Xuejun
Wang.

treatment control, in a “blinded” manner; ImageJ, or other
equivalent software, should be used for objective quantifica
tion of GFP/RFP puncta (S. Ramachandra Rao and S.J.
Fliesler, upublished results).
Finally, expression of tandem mRFP-GFP-LC3 is toxic to
some cancer cell lines relative to GFP-LC3 or RFP-LC3 (K.S.
Choi, personal communication). By contrast, transgenic
expression of mRFP-GFP-LC3 in neurons, which generates
strong fluorescence signals at low levels of expression of the
reporter construct, exhibit no evident toxicity or effects on

baseline autophagy or lifespan [451]. The cytotoxicity of
DsRed and its variants such as mRFP is associated with
downregulation of BCL2L1/Bcl-XL [486]. In contrast to
mRFP-GFP-LC3, overexpression of mTagRFP-mWasabi-LC3
does not appear to be toxic to HeLa cells (J. Lin, personal
communication) or LNCaP cells (N. Engedal, personal
communication).
The Rosella assay has not been tested in a wide range of
mammalian cell types. Accordingly, the sensitivity and the
specificity of the assay must be verified independently until
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this method has been tested more extensively and used more
widely.
Finally, it may be desirable to capture the dynamic behavior
of autophagy in real time, to generate data revealing the rate of
formation and clearance of autophagosomes over time, rather
than single data points. For example, by acquiring signals from
two fluorescent constructs in real time, the rate of change in
colocalization signal as a measure of the fusion rate and recy
cling rate between autophagosomes and lysosomes can be
assessed [487]. Importantly, due to the integral dynamic rela
tionship of autophagic flux with the onset of apoptosis and
necrosis, it is advantageous to monitor cell death and autopha
gic flux parameters concomitantly over time, which FRETbased reporter constructs make possible [488].
Tandem fluorescent markers show real-time changes in
autophagosome fusion with lysosomes, due to entry into an
acidic environment; however, fusion is not definitive evidence
of substrate or carrier degradation. Lysosomes may be able to
fuse, but be unable to degrade newly delivered cargo, as
occurs in some lysosomal storage diseases and aging-related
neurodegenerative diseases. Best practice would be to perform
an autophagic flux assay in parallel with quantification of
tandem fluorescent markers to confirm completion of carrier
flux.
Conclusion: The use of tandem fluorescent constructs,
which display different emission signals depending on the
environment (in particular, GFP fluorescence is sensitive to
an acidic pH), provides a convenient way to monitor auto
phagic flux in many cell types.
g. Autophagic flux determination using flow and multispec
tral imaging cytometry. Whereas fluorescence microscopy, in
combination with novel autophagy probes, has permitted
single-cell analysis of autophagic flux, automation for allow
ing medium- to high-throughput analysis has been challen
ging. A number of methods have been developed that allow
the determination of autophagic flux using flow cytometry
[300, 414, 433, 489–492], and commercial kits are now avail
able for monitoring autophagy by flow cytometry. These
approaches make it possible to capture data or, in specialized
instruments, high-content, multiparametric images of cells in
flow (at rates of up to 1,000 cells/s for imaging, and higher in
nonimaging flow cytometers), and are particularly useful for
cells that grow in suspension. This quantitative method is
simple and can be used for high-content studies with simul
taneous analysis of multiple parameters. This is especially
useful for the study of complex mixtures of cell types, for
example in the analysis of immune cells where it might
require discrimination of the autophagic state of each cell
type or even subsets. The employment of a vital nuclear dye
in combination with other markers makes it possible not only
to exclude dead cells by detection of nuclear fragmentation,
but also to analyze a cell population in a specific cell cycle
phase. Notably, as living cells expressing fluorescence proteins
are amenable to analysis by flow cytometry, this method may
also be utilized to sort specific subpopulations for further
characterization.
Optimization of image analysis permits the study of cells
with heterogeneous LC3 puncta, thus making it possible to
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quantify autophagic flux accurately in situations that might
perturb normal processes (e.g., microbial infection or drug
treatment) [489, 493]. Because EGFP-LC3 is a substrate for
autophagic degradation, total fluorescence intensity of EGFPLC3 can be used to indicate levels of autophagy in living
mammalian cells [492]. When autophagy is induced, the
decrease in total cellular fluorescence can be precisely quanti
fied in large numbers of cells to obtain robust data; flux can
also be directly associated with an increase of detectable
puncta [413]. Moreover, current technology makes it possible
to investigate the colocalization of EGFP-LC3 puncta and
other specific proteins, identifying novel molecules degraded
during autophagic flux. In another approach, soluble EGFPLC3-I can be depleted from the cell by a brief saponin (or
digitonin) extraction so that the total fluorescence of EGFPLC3 then represents that of EGFP-LC3-II alone (Figure 18A)
[432, 433]. Because EGFP-LC3 transfection typically results in
high relative levels of EGFP-LC3-I, this treatment significantly
reduces the background fluorescence due to non-phagophore
and non-autophagosome-associated reporter protein. By com
paring treatments in the presence or absence of lysosomal
degradation inhibitors, subtle changes in the flux rate of the
GFP-LC3 reporter construct can be detected. If it is not
desirable to treat cells with lysosomal inhibitors to determine
rates of autophagic flux, a tandem mRFP/mCherry-EGFPLC3 (or similar) construct can also be used for autophagic
flux measurements in flow cytometry experiments (see
Tandem mRFP/mCherry-GFP fluorescence microscopy)
[473, 491].
These methods, however, require the cells of interest to be
transfected with reporter constructs. Because the saponin
extraction method can also be combined with intracellular
staining for endogenous LC3 protein, subtle changes in auto
phagic flux can be measured without the need for reporter
transfections (Figure 18B).
In addition to GFP-LC3, a novel probe has emerged in
recent years: GFP-LC3-RFP-LC3∆G and GFP-LC3-RFP
(without LC3∆G) that bypass the weaknesses of GFP-LC3
[494]. This probe is cleaved by endogenous ATG4 and
releases an equal amount of GFP-LC3 and RFP-LC3∆G (or
RFP) in the cells. While GFP-LC3 is lipidated and localizes to
phagophores and autophagosomes (as described previously),
the RFP-LC3∆G (or RFP) cannot be conjugated with PE and
remains in the cytoplasm, acting as an internal control. The
GFP-LC3:RFP-LC3∆G (or RFP) ratio (or GFP:RFP ratio)
indicates the autophagic flux. The advantage of this probe
compared to the “traditional” GFP-LC3 probe is that the
release of the internal control makes it possible to discrimi
nate the changes of overall GFP-LC3 levels caused by the
autophagic flux to the ones resulting from variation of gene
expression. The measurement of both GFP-LC3 and RFPLC3∆G (or RFP) can be performed in a high-throughput
manner using FACS for single-cell analysis or some plate
readers. The most precise way to monitor autophagy with
this probe is to use a single-cell derived colony of stable cell
lines, in order to have the most homogeneous population.
This is also because the DNA sequence corresponding to
GFP-LC3-RFP-LC3ΔG sometimes undergoes homologous
recombination between the two LC3-encoding fragments
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Figure 18. Saponin extraction allows quantification of LC3-II fluorescence by FACS. (A) Schematic diagram of the effects of the saponin wash. Due to the
reorganization of the EGFP-LC3 reporter protein, induction of autophagosome formation does not change the total levels of fluorescence in EGFP-LC3-transfected
cells. However, extraction of EGFP-LC3-I with saponin results in a higher level of fluorescence in cells with proportionally higher levels of EGFP-LC3-II-containing
autophagosomes. This figure was previously published in ref. [433]. (B) Saponin extraction can also be used to measure flux of endogenous LC3 protein. Human
osteosarcoma cells were starved of amino acids and serum by incubation in EBSS, for the indicated times in the presence or absence of a 1-h CQ (50 μM) treatment.
Cells were then washed with PBS containing 0.05% saponin and processed for FACS analysis for endogenous LC3. Image provided by K.E. Eng and G.M. McInerney.

during retrovirus infection (this does not occur with GFPLC3-RFP).
Cautionary notes: Care must be taken when applying flow
cytometry measurements to adherent cells, particularly neu
rons and other cells with interdigitated processes, as the pre
paration of single cell suspensions entails significant levels of
plasma membrane disruption and injury that can secondarily
induce autophagy.
Users of the saponin or digitonin extraction method
should carefully titrate detergent concentrations and times of
treatment to ensure specific extraction of LC3-I in their sys
tems. Also, it has been observed in some cell types that
saponin treatment can lead to nonautophagic aggregation of
LC3 [434], which should be controlled for in these assays (see
GFP-Atg8-family protein fluorescence microscopy). Similarly,
for treatment with other detergents, such as Triton X-100, it
is also important to carefully titrate the concentrations and
times of treatment.
Cell membrane permeabilization with digitonin and
extraction of the nonmembrane-bound form of LC3 allows
combined staining of membrane-associated LC3-II protein
and any markers for detection of autophagy in relation to
other cellular events/processes. Based on this approach, a
method for monitoring autophagy in different stages of the
cell cycle was developed [495]. Thus, the presence of basal or
starvation-induced autophagy is detected in G1, S, and G2/M
phases of the cell cycle in MEFs with doxycycline-regulated
ATG5 expression. In these experiments, cells were gated based
on their DNA content and the relative intensity of GFP-LC3II and LC3-II expression. This approach might also be used
for the detection of autophagic flux in different stages of the
cell cycle, or the subG1 apoptotic cell population by

measuring accumulation of LC3-II in the presence or absence
of lysosomal inhibitors.
Although GFP-LC3 can be used as a reporter for flow
cytometry, it is more stable (which is not necessarily ideal
for flux measurements) than GFP-SQSTM1 or GFP-NBR1
(NBR1 is an autophagy receptor with structural similarity
to SQSTM1 [496]). GFP-SQSTM1 displays the largest mag
nitude change following the induction of autophagy by
amino acid deprivation or rapamycin treatment, and may
thus be a better marker for following autophagic flux by
this method (confirmed in SH-SY5Y neuronal cell lines
stably expressing GFP-SQSTM1; E.M. Valente, personal
communication) [497]. In addition, to reduce/eliminate
potential effects on transcription or translation of the
reporter, a doxycycline-inducible version of GFP-SQSTM1
can be used [497]. Flow cytometry for LC3, SQSTM1 or
using commercial autophagy kits can also be used to mea
sure autophagy in a specific cell sub-population isolated
from tissue. For example, this approach can measure auto
phagy levels specifically in microglia and infiltrating
macrophages in the mouse brain after traumatic brain
injury (M. Lipinski, unpublished data).
Using purification of intracellular vesicles, flow cytometry
can be adapted for a deeper understanding and better char
acterization of individual autophagosomes. Single organelle
fluorescence analysis can be applied for the analysis of endo
somes [498], mitochondria [499], phagosomes [500], auto
phagosomes and lysosomes [501], using various fluorescent
probes.
Finally, probes measuring the autophagic flux without
requiring transfection or permeabilization have also been
developed. Such methods are based on dyes that selectively
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Figure 19. Assessing autophagy with multispectral imaging cytometry. (A) Bright Detail Intensity (BDI) measures the foreground intensity of bright puncta (that are 3
pixels or less) within the cell image. For each cell, the local background around the spots is removed before intensity calculation. Thus, autophagic cells with puncta
have higher BDI values. (B) Media control (untreated wild type), rapamycin-treated wild-type and atg5−/− MEFs were gated based on BDI. Representative images of
cells with high or low BDI values. Scale bar: 10 µm. Images provided by M.L. Albert.

label autophagic vesicles (autophagosomes and autolyso
somes) but not lysosomes, and are used for both primary
cells [502, 503] and cell lines [504, 505] from different species
(including non-mammals). See also: https://bio-protocol.org/
e1090.
Conclusion: Medium- to high-throughput analysis of au
tophagy is possible using flow and multispectral imaging
cytometry (Figure 19). The advantage of this approach is
that larger numbers of cells can be analyzed with regard to
GFP-LC3 puncta, cell morphology and/or autophagic flux,
and concomitant detection of surface markers can be
included, potentially providing more robust data than is
achieved with other methods. A major disadvantage, however,
is that flow cytometry only measures changes in total GFPLC3 levels, which can be subject to modification by changes in
transcription or translation, or by pH, and this approach
cannot accurately evaluate localization (e.g., to autophago
somes) or lipidation (generation of LC3-II) without further
permeabilization of the cell.
h. Autophagosome-lytic compartment fusion. Technical lim
itations have prevented insight into the mechanism of

autophagosome-lytic compartment fusion. Disrupting genes
encoding components that play a role in membrane fusion in
intact cells may not only affect autophagy directly but will
affect general vesicular trafficking, which can cause indirect
effects on autophagy. In addition, if a fusion component is
involved in early steps of autophagosome formation, this
requirement will mask its function in late stages of autophagy
such as fusion with the lytic compartment. As a result, it is
difficult to analyze the molecular mechanisms of autophago
some-lytic compartment fusion in intact cells.
In vitro reconstitutions of autophagosome-vacuole and
autophagosome-lysosome fusion have partially overcome
this problem and made it possible to identify relevant proteins
and their functions in this specific step of autophagy. Both
autophagosome-vacuole fusion in yeast and autophagosomelysosome fusion in mammals has been recently reconstituted,
using partially purified fractions of autophagosomes,
vacuoles/lysosomes and cytosol [506–508].
i. Immunohistochemistry and immunofluorescent staining.
Immunodetection of ATG and related proteins (particularly
LC3 and BECN1) has been reported as a prognostic factor in
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various human carcinomas, including lymphoma [265, 509],
breast carcinoma [510, 511], endometrial adenocarcinoma
[512, 513], head and neck squamous cell carcinoma [514–
516], hepatocellular carcinoma [517, 518], gliomas [519],
non-small cell lung carcinomas [520], pancreatic [521] and
colon adenocarcinomas [522–524], as well as in cutaneous
and uveal melanomas [525, 526]. Unfortunately, the reported
changes often reflect overall diffuse staining intensity rather
than appropriately compartmentalized puncta. Therefore, the
observation of increased levels of diffuse LC3 staining (which
may reflect a decrease in autophagy) should not be used to
draw conclusions that autophagy is increased in cancer or
other tissue samples [527]. Assessing LC3 puncta fails to
show prognostic significance in non-small cell lung cancer
[528, 529]. Importantly, this kind of assay should be per
formed
as
recommended
by
the
Reporting
Recommendations for Tumor Marker Prognostic Studies
(REMARK) [530]. As we identify new drugs for modulating
autophagy in clinical applications, this type of information
may prove useful in the identification of subgroups of patients
for targeted therapy [531–533].
In the brain of hypoxic-ischemic encephalopathy dead
human newborns, LC3 immunostaining on paraffin sections
has been used to quantify increased autophagosome presence
in dying neurons as shown by increased LC3-positive dots
[534, 535]. In mouse and rat tissues, endogenous LC3,
ATG4B, and ATG9A have been detected by immunohisto
chemical analyses using both paraffin sections and cryosec
tions [85, 391, 536–539]. When autophagosomes are absent,
the localization pattern of LC3 in the cells of various tissues
is diffuse and cytosolic. Moreover, intense fibrillary staining
of LC3 is detectable along dendrites of intact neurons,
whereas granular staining for LC3 appears mainly in the
perinuclear area of neurons in CTSD- or CTSB- and CTSL
(cathepsin L)-deficient mouse brains [393]. LC3 puncta are
also observed in mice in the peripheral nerves, specifically in
Schwann cells after neurodegeneration [540], and Paneth
cells of the small intestine from human Crohn disease
patients and mouse models of intestinal inflammation driven
by ER-stress and acute radiation injury exhibit strong LC3
puncta staining [541–543]. In various neurodegenerative
states, LC3 puncta may be numerous in neurites, especially
within dystrophic swellings and, in many cases, these
vacuoles are amphisomes or autolysosomes, reflecting the
delayed or inhibited degradation of LC3 despite the presence
of abundant hydrolase activity [76, 83]. In developing inner
ear and retinal tissue in chicken, BECN1 is detected by
immunofluorescence; in chick retina AMBRA1 is also
detected [393-395]. IHC using ABC and 3,3′-diamino-benzi
dine (DAB) as chromogen has also been used to detect
AMBRA1, thus accomplishing a complete map of AMBRA1
protein distribution in the mouse brain, and highlighting
differential expression in neuronal/glial cell populations.
Differences in AMBRA1 content have been related to speci
fic neuronal features and properties, particularly concerning
susceptibility to neurodegeneration, during aging and amy
loid pathology [544]. AMBRA1 and BECN1 IHC distribution

have also been studied in rat brain, after anti-NGF adminis
tration, which results in increased levels of autophagic pro
teins in specific brain regions (olfactory bulb, neocortex and
hippocampus), suggesting NGF-modulated autophagic path
ways [545]. In mouse platelets, endogenous PtdIns3P, the
product of the BECN1-PIK3C3/VPS34 protein complexmediated enzymatic reaction, can be detected using recom
binant GST-2×FYVE followed by anti-GST immunofluores
cence [389]. Finally, in non-mammalian vertebrates, BECN1
is detected during follicular atresia in the ovary of three fish
species using paraffin sections; a punctate immunofluores
cent staining for BECN1 is scattered throughout the cyto
plasm of the follicular cells when they are in intense
phagocytic activity for yolk removal [546].
Cautionary notes: One problem with LC3 IHC is that
in some tissues this protein can be localized in structures
other than autophagosomes. For example, in murine hepa
tocytes and cardiomyocytes under starved conditions,
endogenous LC3 is detected not only in autophagosomes
but also on lipid droplets [547]. In neurons in ATG7deficient mice, LC3 accumulates in ubiquitin- and
SQSTM1-positive aggregates [548]. In neurons in aging
or neurodegenerative disease states, LC3 is commonly
present in autolysosomes and may be abundant in lipo
fuscin and other lysosomal residual bodies [76]. Similarly,
accumulation of large LC3-positive puncta occurring dur
ing methamphetamine intoxication does not derive from
stagnant autophagic vacuoles. In fact, the polarization of
LC3 within granules is greatly reduced and LC3 IHC even
monitored by confocal microscopy demonstrates cytosolic
accumulation of the protein, which, despite being
increased, loses its polarization within autophagic granules
[549]. This is clearly demonstrated by counting stoichio
metrically immunogold-stained LC3 particles within the
cytosol compared with granules. Thus, immunodetection
of LC3 in cytoplasmic granules is not sufficient to monitor
autophagy in vivo. To evaluate autophagy by the methods
of IHC, it is necessary to identify the autophagosomes
directly using the ABC technique for TEM observation
(see Transmission electron microscopy) [77]. Peroxidase
depositions in the vacuoles indicate LC3 expression,
detected by IHC, and therefore identify those structures
as autophagic vacuoles [550].
Conclusion: It has not been clearly demonstrated that IHC
of ATG proteins in tissues corresponds to autophagy activity,
and this area of research needs to be further explored before
we can make specific recommendations.
j. LC3-HiBiT reporter assay. The Autophagy LC3-HiBiT
reporter assay system is a method that measures autophagic
flux by monitoring total LC3-reporter levels [551]. A plas
mid coding for a human LC3B is tagged to a HiBiT peptide
through a linker. The approach is based on the high affinity
of the HiBiT peptide to the inactive luciferase subunit
LgBiT, that, upon binding, produces an active NanoBiT
luciferase that generates luminescence proportional to the
amount of autophagy (Figure 20). It is recommended to
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Figure 20. HiBiT-LC3B imitates endogenous LC3B response upon autophagy perturbation. (A) Principle of the Autophagy LC3-HiBiT reporter assay system. (B) HCT116
(parent) and stable HCT116-LC3 HiBiT cell lines were exposed to vehicle control (Veh Ctrl), chloroquine (CQ; 25 μM) or the CSNK1A1/CK1α (casein kinase 1 alpha 1)
inhibitor D4476 (10 μM) for 24 h, which increases LC3 abundance [4084]. Cell lysates (30 μg) were resolved in 12% SDS-PAGE gels and transblotted to nitrocellulose
membranes. Nano-Glo HiBiT Blotting System (Promega, N2410) was used to detect HiBiT-LC3B (expected molecular size of 55 kDa) using Tris-buffered saline
supplemented with 0.1% Tween 20. The HiBiT-LC3B blot was imaged after 20 min incubation with the substrate. Loading control (KIF11/Eg5; Cell Signaling
Technology, 4203) and endogenous LC3B (Cell Signaling Technology, 2775) were detected via standard immunoblotting (leftmost lane in immunoblots: protein
ladder). Image provided by John J.E. Chua and Jit K. Cheong. (C) U2OS LC3 HiBiT cells treated with autophagy inducers or inhibitors. Effect on autophagic flux was
measured in cells incubated in normal or starvation medium (HBSS) alone or containing bafilomycin A1 (50 nM) or torin1 (25 nM) for 3 h using the HiBiT
luminescence assay. Bars are mean ± s.e.m. of triplicate samples. ***P < 0.001 vs. untreated normal media control; t-test. AU, arbitrary units. Image provided by Silvia
Vega-Rubin-de-Celis.

generate stable cell lines using G418 selection to avoid the
variability due to transfection efficiencies among different
cell lines and experiments. The amount of LC3-reporter
within the cell can be measured by the addition of lysis
buffer mixed with the LgBiT protein and the substrate.
After incubation at room temperature for 10 min, lumines
cence can be measured in a microplate reader (integration
time of 0.5–2 s) and it is stable for up to three h. Induction

of autophagy, such as through starvation, or MTORC1
inhibition via PP242 treatment or siRNA knockdown of
RPTOR, decrease luminescence readings. Conversely,
blockade of autophagy flux, for example by treatment
with CQ or bafilomycin A1, increases the luminescence
readings (Figure 20). A major advantage of this reporter
system is that it allows for determination of autophagic flux
upon exposure to a large number of conditions at the same
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time and, therefore, is suitable for large-scale screens using
96- or 386-well plate formats.
Cautionary notes: One caveat to the immunostaining vali
dation of cells that stably express LC3-HiBiT is the inability of
widely-used LC3 antibodies (such as the LC3B antibody from
Cell Signaling Technology [2775] that targets the N terminus
of LC3B) to recognize the amino terminal HiBiT-tagged LC3
resolved on protein blots. This limitation can be overcome by
the use of the Nano-Glo® HiBiT blotting system (Promega,
N2410) that detects the amino terminal HiBiT-tagged LC3B-I/
II as proteins of approximately 55 kDa (Figure 20). For con
ditions that might affect cell number/viability, it is recom
mended to prepare a separate culture plate(s) with an
identical treatment condition(s) in parallel for cell number/
viability measurement (e.g., using Hoechst staining of the
nucleus followed by quantification). Alternatively, the
Autophagy LC3-HiBiT reporter assay system could also be
multiplexed with the CellToxTM Green Cytotoxicity Assay
(Promega, G8741) for cell viability assessment within the
same sample well.
k. In vitro enzymatic lipidation of human Atg8-family pro
teins: Preparation of fluorescent Atg8–PE conjugates. After
activation by ATG4B, covalent attachment of an Atg8-family
protein to PE is mediated by a ubiquitin-like chain of enzy
matic steps involving the E1-like ATG7 and the E2-like
ATG3. These reactions can be reconstituted in vitro, using
recombinant purified proteins, liposomes and ATP. To study
the role of these protein-lipid complexes in membrane tether
ing and fusion processes, the enzymatically driven lipidation
reaction of the human Atg8-family proteins can be reconsti
tuted. Reaction systems including ATG7, ATG3, ATP, and
liposomes lead to the formation of a more rapidly migrating
band that is readily visualized by Coomassie Brilliant Blue
staining. To confirm the lipidation reaction, conjugation mix
tures are prepared with liposomes containing 10% of the
fluorescent phospholipid derivative NBD-PE. In each case,
reactions lead to the formation of fluorescent, faster-migrating
bands representing the lipidated products of Atg8-family pro
teins [552].
3. SQSTM1 and related LC3-binding protein turnover
assays
In addition to LC3, SQSTM1, or other receptors such as
NBR1, can also be used as protein markers, at least in certain
settings [30, 553]. For example, SQSTM1 can be detected as
puncta by IHC in cancer cells or primary neurons, similar to
LC3 [515]; however, note that it is critical to freshly cut
formalin fixed paraffin embedded/FFPE tissue before IHC
for LC3 [554, 555]. The SQSTM1 protein serves as a link
between LC3 and ubiquitinated substrates [119]. SQSTM1
and SQSTM1-bound polyubiquitinated proteins become
incorporated into the completed autophagosome and are
degraded in autolysosomes, thus serving as an index of auto
phagic degradation (Figure 21). In addition, SQSTM1 can also
bind RNA substrates, which controls RNA turnover via auto
lysosomes [556]. Inhibition of autophagy can correlate with
increased levels of SQSTM1 in mammals, C. elegans and

Figure 21. Regulation of the SQSTM1 protein during autophagy. (A) The level of
SQSTM1 during starvation. Atg5+/+ and atg5−/− MEFs were cultured in DMEM
without amino acids and serum for the indicated times, and then subjected to
immunoblot analysis using anti-SQSTM1antibody (Progen Biotechnik, GP62). This
figure was previously published in ref. [30], and is reproduced by permission of
Landes Bioscience, copyright 2007. (B) The level of SQSTM1 in the brain of
neural-cell specific atg5 knockout mice. Image provided by T. Hara.

Drosophila, suggesting that steady state levels of this protein
reflect the autophagic status [81, 536, 557–562]. Deficiency of
the LIR domain-containing, SQSTM1-interacting SPRED2
results in an accumulation of SQSTM1 in the heart in vivo,
accompanied by an altered LC3 turnover and reduced auto
phagy [563]. Similarly, decreased SQSTM1 levels are asso
ciated with autophagy activation; however, similar to LC3-II,
lysosomal inhibitors (such as CQ) can be used to assess
increased autophagy flux based on an accumulation of
SQSTM1 [86, 564]. The phosphorylation of SQSTM1 at
Ser403 appears to regulate its role in the autophagic clearance
of ubiquitinated proteins, and anti-phospho-SQSTM1 antibo
dies can be used to detect the modified form of the pro
tein [427].
Cautionary notes: SQSTM1 changes can be cell-type and
context specific. In some cell types, there is no change in the
overall amount of SQSTM1 despite strong levels of autophagy
induction, verified by the tandem mRFP/mCherry-GFP-LC3
reporter as well as ATG7- and lysosome-dependent turnover
of cargo proteins (C.T. Chu, personal observation). In other
contexts, a robust loss of SQSTM1 does not correlate with
increased autophagic flux as assessed by a luciferase-based
measure of flux [336]; a decrease of SQSTM1 can even relate
to a blockage of autophagy due to cleavage of the protein,
together with other autophagy proteins, by caspases or cal
pains [565].
In some systems, even transgenic constructs may not allow
reliable detection of SQSTM1. For instance, although very
informative to monitor autophagy levels in the C. elegans
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embryo, SQST-1::GFP (a tagged version of the C. elegans
SQSTM1 homolog) is not detectable in most adult tissues
unless it is stabilized with background mutations such as
rpl-43 (encoding the ribosomal protein RPL-43).
Stabilization of SQST-1::GFP via rpl-43 mutation does not
affect the degradation of the autophagy substrates so far
tested, and reduced SQST-1::GFP signal is observed in condi
tions of increased autophagic flux such as starvation [566];
however, animals show signs of generalized sickness, and
altered lifespan, and RNAi against some autophagy genes (e.
g., vps-34) leads to increased, instead of reduced, SQST-1::
GFP signal (E.J. O’Rourke, personal communication).
SQSTM1 changes can be treatment specific such that che
motherapy-induced autophagy increases LC3-II without
changing SQSTM1, whereas radiation-induced autophagy
increases LC3-II and decreases SQSTM1 in ERBB2/HER2overexpressing mouse mammary carcinoma cells [567].
SQSTM1 may be transcriptionally upregulated under some
conditions [419, 568–571], as observed in several C. elegans
longevity models [572, 573], further complicating the inter
pretation of results. For example, SQSTM1 upregulation, and
at least transient increases in the amount of SQSTM1, is seen
in some situations where there is an increase in autophagic
flux [574–576]. One such case is seen during retinoic acidinduced differentiation of acute myeloid leukemia (AML) cells
where SQSTM1 is upregulated [569] with concomitant
increased autophagic flux [577]. Synovial fibroblasts obtained
from patients with rheumatoid arthritis also exhibit a signifi
cant upregulation of SQSTM1 with concomitant increased
autophagy flux [578]. Activation of a signaling pathway, e.g.,
RAF1/Raf-MAP2K/MEK-MAPK/ERK, can also upregulate
SQSTM1 transcription [579]. SQSTM1 mRNA is also upregu
lated following prolonged starvation, which can restore the
SQSTM1 protein level to that before starvation [580, 581]. In
the same way, physical exercise, especially when performed
during starvation, increases the SQSTM1 mRNA level in ske
letal muscle, and can lead to an incorrect interpretation of
autophagic flux if only the protein level is measured [582,
583]. Another instance when both mRNA and protein levels
of SQSTM1 are elevated, even though autophagic flux is not
impaired, is observed in aneuploid human and murine cells
that are generated by introduction of one or two extra chro
mosomes [584, 585].
The SQSTM1 protein level also increases when autophagy
needs to be triggered. SQSTM1 expression can be positively
regulated post-transcriptionally by the ELAVL1/HuR protein
which binds to the SQSTM1 transcript in ARPE19 cells
exposed to 24-h MG132 treatment [359]. Two-h AICAR +
MG132 pro-autophagic cotreatment similarly induces the
binding of ELAVL1/HuR protein to SQSTM1 mRNA, its
loading on polysomes and its translation into de novo pro
tein, an effect that is required to trigger autophagy and is
prevented by the protein synthesis inhibitor puromycin
[586]. Moreover, SQSTM1 can be regulated by the integrated
stress response, which can promote accumulation of protein
in cells that is dependent on the EIF2S1/eIF2α pathway of
translational control (R.E. Simmonds, personal communica
tion). Thus, appropriate positive and negative controls are
needed prior to the use of SQSTM1 as a flux indicator in a
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particular cellular context, and we recommend monitoring
the SQSTM1 mRNA level as part of a complete analysis, or
determining the SQSTM1 protein level in the presence of the
transcription inhibitor actinomycin D or the p-EIF2S1
antagonist ISRIB.
Of interest, SQSTM1 overexpression at both the gene and
protein levels can be observed in muscle atrophy induced by
cancer, though not by glucocorticoids, suggesting that the
stimulus inducing autophagy may also be relevant to the
differential regulation of autophagy-related proteins [587].
One solution to problems relating to variations in SQSTM1
expression levels is to use a HaloTag®-p62 (SQSTM1) chimera
[588]. The chimeric protein can be covalently labeled with
HaloTag® ligands, and the loss of signal can then be mon
itored without interference by subsequent changes in protein
synthesis. Similarly, a stable cell line expressing EGFP-tagged
SQSTM1 under the control of an inducible promoter can be
used to assess the rates of SQSTM1 degradation, taking into
account the limitations outlined above (see Autophagic flux
determination using flow and multispectral imaging cytometry)
[497]. A similar system exists in Drosophila in which a GFPtagged ref(2)P/SQSTM1 can be expressed using the UASGAL4 system [589]. It is worth noting that tetracycline can
reduce autophagy levels; therefore, the appropriate control of
only tetracycline addition has to be included if using an
inducible promoter that responds to this drug [590].
Furthermore, the toxicity of tetracycline antibiotics toward
mitochondria is well known (these drugs induce a mitochon
drial unfolded protein response) [591], such that their use
may trigger mitophagy, or other mitochondrial signaling
events that interface with the autophagic machinery, thus
complicating the interpretation of any results. Yet another
solution is to employ a radioactive pulse-chase assay to mea
sure the rates of SQSTM1 degradation [592].
SQSTM1 contains a LIR as well as a ubiquitin binding
domain and appears to act by linking ubiquitinated substrates
with the autophagic machinery. Nonetheless, it would be
prudent to keep in mind that SQSTM1 contains domains
that interact with several signaling molecules [593], and
SQSTM1 may be part of MTORC1 [594]. Thus, SQSTM1
may have additional functions that need to be considered
with regard to its role in autophagy. In the context of auto
phagy as a stress response, the complexity of using SQSTM1
as an autophagy marker protein is underscored by its capacity
to modulate the NFE2L2/NRF2 anti-oxidant response path
way through a KEAP1 binding domain [595, 596]. In fact,
SQSTM1 may, itself, be transcriptionally induced by NFE2L2
[597]. Furthermore, it is preferable to examine endogenous
SQSTM1 because overexpression of this protein leads to the
formation of protein inclusions. In fact, even endogenous
SQSTM1 becomes Triton X-100-insoluble in the presence of
protein aggregates and when autophagic degradation is inhib
ited; thus, results with this protein are often contextdependent.
Indeed, there is a reciprocal crosstalk between the UPS and
autophagy, with SQSTM1 being a key link between them [598,
599]. First, SQSTM1 participates in proteasomal degradation,
and its level may also increase when the proteasome is inhib
ited [600]. Accordingly, the SQSTM1 degradation rate should
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be analyzed in the presence of a proteasomal inhibitor such as
epoxomicin or lactacystin to determine the contribution from
the proteasome (see Autophagy inhibitors and inducers for
potential problems with MG132) [601]. Second, the accumu
lation of SQSTM1 due to autophagy inhibition can impair
UPS function by competitively binding ubiquitinated pro
teins, preventing their delivery to, and degradation by, the
proteasome [602]. Inhibition of autophagy by treatment with
3-MA (5 mM, 4 h) increases the accumulation of MAPT/tau
oligomers within neurites of primary transgenic (prepared
from PS19 mouse embryos, expressing the frontotemporal
dementia P301S mutant MAPT [603]) cultured neurons,
reducing their access to the soma and lysosomes for degrada
tion [604]. Furthermore, USP14, a major proteasomal deubi
quitinase that regulates degradation through the proteasome,
interacts with the UBA domain of SQSTM1 as well as LC3. In
addition, levels as well as chromatin recruitment of USP14 are
upregulated in autophagy-deficient cells upon DNA damage,
and knockdown of SQSTM1 in autophagy-deficient cells
decreases USP14 levels [605, 606]. These data clearly indicate
that autophagy regulates USP14 degradation in an SQSTM1dependent manner. Accordingly, it may be advisable to mea
sure the UPS flux by using UbG76V-GFP, a ubiquitin-protea
some activity reporter [607], when SQSTM1 accumulation is
observed. Thus, it is very important to determine whether
autophagy alone or in conjunction with the UPS accounts
for substrate degradation induced by a particular biological
change. A number of stressors that impair the UPS induce the
aggregation/dimerization of SQSTM1, and this can be seen by
the detection of a high molecular mass (~150 kDa) protein
complex by western blot, which is recognized by SQSTM1
antibodies [564, 608, 609] Although the accumulation of this
protein complex can be related to the accumulation of ubi
quitinated SQSTM1-bound proteins, or the dimerization/
inactivation of SQSTM1 [564, 610], evaluation of the ratio
between SQSTM1 aggregates/dimers and SQSTM1 monomers
is likely a better measurement of changes in SQSTM1
dynamics linked to autophagy or the UPS.
SQSTM1 is also a substrate for CASP6 (caspase 6) and
CASP8 (as well as CAPN1 [calpain 1]), which may confound
its use in examining cell death and autophagy [611]. This is
one reason why SQSTM1 degradation should also be analyzed
in the presence of a pan-caspase inhibitor such as Q-VD-OPh
before concluding that autophagy is activated based on a
decrease of this protein [565]. Another issue is that some
phosphatidylinositol 3-kinase (PtdIns3K) inhibitors such as
LY294002, and to a lesser extent wortmannin (but apparently
not 3-MA) [435], can inhibit protein synthesis [612]; this
might in turn affect the turnover of SQSTM1 and LC3,
which could influence conclusions that are drawn from the
status of these proteins regarding autophagic flux or ALIS
formation. Accordingly, it may be advisable to measure pro
tein synthesis and proteasome activity along with autophagy
under inhibitory or activating conditions [613]. With regard
to protein synthesis, it is worth noting that this can be mon
itored through a nonradioactive method [614].
Western blot analysis of cell lysates prepared using NP40or Triton X-100-containing lysis buffers in autophagic condi
tions typically shows a reduction in SQSTM1 levels. However,

this does not necessarily indicate that SQSTM1 is degraded,
because SQSTM1 aggregates are insoluble in these detergent
lysis conditions [419, 615]. Moreover, in some instances
SQSTM1 levels do not change in the soluble fractions despite
autophagic degradation, a finding that might be explained by
simultaneous transcriptional and translational induction of
the gene encoding SQSTM1, because the soluble fraction
accounts only for the diffuse or free form of SQSTM1.
Accumulation of SQSTM1 in the Triton X-100-insoluble frac
tion can be observed when autophagy-mediated degradation
is inhibited. Under conditions of higher autophagic flux,
accumulation of SQSTM1 in Triton X-100-insoluble fractions
may not be observed, and SQSTM1 levels may be reduced or
maintained. The simplest approach to circumvent many of
these problems is using lysis buffer that allows identification
of the entire cellular pool of SQSTM1 (e.g., containing 1%
SDS); however, additional assessment of both Triton X-100soluble and -insoluble fractions will provide further informa
tion regarding the extent of SQSTM1 oligomerization [548].
Note, when performing a western blot using an SQSTM1
antibody, it is always a good idea to include a positive control
in which SQSTM1 accumulates, such as an atg8a mutant (e.g.,
see Fig. S3 in ref. [616]).
To conclusively establish SQSTM1 degradation by auto
phagy, SQSTM1 levels in both Triton X-100-soluble and
-insoluble fractions need to be determined upon treatment
with autophagy inducers in combination with autophagy
inhibitors, such as those that inhibit the autolysosomal
degradation steps (e.g., protease inhibitors, CQ or bafilomy
cin A1). Additionally, an alteration in the level of SQSTM1
may not be immediately evident with changes observed in
autophagic flux upon certain chemical perturbations (S.
Sarkar, personal communication). Whereas LC3 changes
may be rapid, clearance of autophagy substrates may require
a longer time. Therefore, if LC3 changes are assessed at six h
or 24 h after a drug treatment, SQSTM1 levels can be tested
not only at the same time points, but also at later time points
(24 h or 48 h) to determine the maximal impact on substrate
clearance. An alternative method is immunostaining, with
and without autophagy inhibitors, for SQSTM1, which will
appear as either a diffuse or punctate pattern. Experiments
with autophagy inducers and inhibitors, in combination with
western blot and immunostaining analyses, best establish
autophagic degradation based on SQSTM1 turnover. A
final point, however, is that empirical evidence suggests
that the species-specificity of antibodies for detecting
SQSTM1 must be taken into account. For example, some
commercial antibodies recognize both human and mouse
SQSTM1, whereas others detect the human, but not the
mouse protein [617]. Another issue with detecting
SQSTM1 in the context of human diseases is that it can be
mutated (e.g., in Paget disease of bone) [618]. Thus, care
should be taken to ensure that potential mutations are not
affecting the epitopes that are recognized by anti-SQSTM1
antibodies when using western blotting to detect this protein.
As an alternative, the SQSTM1:BECN1 protein level ratio can
be used as a readout of autophagy [619]. Because both decreased
SQSTM1 levels and increased BECN1 levels correlate with
enhanced autophagy, a decreased SQSTM1:BECN1 protein
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level ratio (when derived from the same protein extract) may,
cautiously, be interpreted as augmented autophagy, keeping in
mind that SQSTM1 gene expression varies significantly under
different conditions and may obscure the meaning of a change
in the amount of SQSTM1 protein. Another substantial alternate
is analysis of neomycinephosphotransferase II (NeoR) degrada
tion. NeoR is an exclusive autophagic substrate [620, 621].
NeoR-GFP degradation is completely blocked by autophagic
inhibitors such as 3-MA, but does not respond to inhibitors of
proteasomal degradation. Inhibition of autophagy leads to accu
mulation of NeoR-GFP, resulting in enhanced GFP fluorescence
[621]. NeoR-GFP gene expression is not affected by most auto
phagy inducers including H2O2 (that transcriptionally upregulate
SQSTM1), however, degradation can be evaluated by accumula
tion of NeoR-GFP puncta under confocal microscopy or by
analyzing total protein level by western blot of GFP.
As a general note, using ratios of the levels of proteins
changing in opposite directions, rather than the protein levels
themselves, could be beneficial because it overcomes the load
ing normalization issue. The often-used alternative approach
of housekeeping proteins to normalize for loading biases
among samples is sometimes problematic as levels of the
HKPs change under various physiological, pathological and
pharmacological conditions [269, 622–626].
Finally, a novel protein family of autophagy receptors,
named CUET (from Cue5/TOLLIP), was identified, which in
contrast to SQSTM1 and NBR1 has members that are present
in all eukaryotes [627, 628]. The CUET proteins also possess a
ubiquitin-binding CUE-domain and an Atg8-family interact
ing motif (AIM)/LIR sequence that interacts with Atg8-family
proteins. In their absence, cells are more vulnerable to the
toxicity resulting from aggregation-prone proteins, showing
that CUET proteins, and more generally autophagy, play a
critical evolutionarily conserved role in the clearance of cyto
toxic protein aggregates [627]. Experiments in yeast have
shown that Cue5 and the cytoplasmic proteins that require
this autophagy receptor for rapid degradation under starva
tion conditions could be potentially good marker proteins for
measuring autophagic flux [629]. Studies with mammalian
immune cells indicate that TOLLIP is primarily responsible
for the final step of autophagy, and facilitates the fusion of
lysosomes with autophagosomes, lipid droplets, or peroxi
somes [630]. TOLLIP may fulfill its critical function of lyso
some fusion through its interaction with phospholipid [631,
632]. TOLLIP-deficient monocytes are defective in lysosome
fusion and are programmed into an inflamed state with ele
vated CCR5 and enhanced expression of chemokines such as
CCL2/MCP1 [631, 633]. Pathologically, TOLLIP-deficient
mice tend to develop more severe atherosclerosis as well as
neurological defects [633, 634].
Another recent study demonstrated a functional link
between CLEC16A and disrupted mitophagy in murine sple
nic immune cells and showed that incomplete mitophagy
predisposes clec16a knockout mice to a cascade of altered
immune signaling functions resulting in pathogenic inflam
mation [319, 320].
Special caution must be taken when evaluating SQSTM1
levels in models of protein aggregation. Small protoaggregates
often stain positively for SQSTM1 and may be similar in size
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to autophagic puncta. Similarly, GFP-u/GFP-degron reporters
(designed as an unstable variant that undergoes proteasomedependent degradation) will mark SQSTM1-positive protein
inclusions [635]. Finally, some types of aggregates and inclu
sions will release soluble SQSTM1 or GFP-u/GFP-degron
under cell lysis or denaturing conditions, which can skew
the interpretation of soluble SQSTM1 and/or proteasomal
function, accordingly.
Conclusion: There is not always a clear correlation
between increases in LC3-II and decreases in SQSTM1.
Thus, although analysis of SQSTM1 can assist in assessing
the impairment of autophagy or autophagic flux, we recom
mend using SQSTM1 only in combination with other meth
ods detailed in these guidelines to monitor flux. See also the
discussion in Autophagic flux determination using flow and
multispectral imaging cytometry.
4. TOR/MTOR, AMPK and Atg1/ULK1
Atg1/ULK1 are central components in autophagy that likely
act at more than one stage of the process. There are multiple
ULK isoforms in mammalian cells including ULK1, ULK2,
ULK3, ULK4 and STK36 [636]. ULK3 is a positive regulator
of the Hedgehog signaling pathway [637], and its overexpres
sion induces both autophagy and senescence [638]. Along
these lines, ectopic ULK3 displays a punctate pattern upon
starvation-induced autophagy induction [638]. ULK3, ULK4
and STK36, however, lack the domains present on ULK1 and
ULK2 that bind ATG13 and RB1CC1/FIP200 [639]. Thus,
ULK3 may play a role that is restricted to senescence and
that is independent of the core autophagy machinery. ULK2
has a higher degree of identity with ULK1 than any of the
other homologs, but they may have both similar and distinct
functions that are tissue- or cell-type specific [640–644].
Specifically in relation to autophagy, pharmacological inhibi
tion of ULK1 and ULK2, with the compound MRT68921,
blocks the process, and expression of a drug-resistant ULK1
mutant is sufficient to rescue this block [457]. However, at
least in some cell types, ULK2 can likely compensate for loss
of ULK1. For instance, in LNCaP cells, combined knockdown
of ULK1 and ULK2 provides a substantially stronger inhibi
tion of basal and starvation-induced autophagic sequestration
and degradation activity than knockdown of ULK1 alone (N.
Engedal, personal communication). ULK1 activity can also be
inhibited by the expression of a dominant-negative ULK1
mutant [645, 646]. The stability and activation of ULK1, but
not ULK2, is dependent on its interaction with the HSP90CDC37 chaperone complex. Pharmacological or genetic inhi
bition of the chaperone complex increases proteasomemediated turnover of ULK1, impairing its kinase activity
and ability to promote both starvation-induced autophagy
and mitophagy [647]. In addition, ULK1 is ubiquitinated for
its activation through TRAF6-dependent K63-linked ubiqui
tination [501], or for degradation through CUL3-KLHL20dependent K48-linked ubiquitination [648]. GCA (grancalcin)
inhibits K48-linked ubiquitination and activates TRAF6dependent K63-linked ubiquitination of ULK1 to induce au
tophagy [649].
AMPK (AMP-activated protein kinase) is a multimeric serine/
threonine protein kinase comprised of PRKAA1/AMPKα1 or
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PRKAA2/AMPKα2 (α, catalytic), the PRKAB1/AMPKβ1 or
PRKAB2/AMPKβ2 (β, scaffold), and the PRKAG1/AMPKγ1,
PRKAG2/AMPKγ2 or PRKAG3/AMPKγ3 (γ, regulatory) sub
units. The enzyme activity of AMPK is dependent on phos
phorylation of the PRKAA2/α2-subunit on Thr172
(corresponds to Thr183 in α1) [459,460], and, therefore, can
be conveniently monitored by western blotting with a phos
phospecific antibody against this site. Depending on the sti
mulus and cell type, Thr172 is phosphorylated either by
CAMKK2/CaMKKβ, STK11/LKB1 or MAP3K7/TAK1.
Inhibition of AMPK activity is mediated primarily by
Thr172-dephosphorylating protein phosphatases such as
PPP1/PP1 (protein phosphatase 1) and PPP2/PP2A (protein
phosphatase 2) [650]. Thr172 dephosphorylation is modulated
by adenine nucleotides that bind competitively to regulatory
sites in the PRKAG/γ-subunit. AMP and ADP promote phos
phorylation and AMPK activity, whereas Mg2+-ATP has the
opposite effect [651]. Moreover, Thr172 phosphorylation and
AMPK activation can be enhanced by PRKDC (protein
kinase, DNA-activated, catalytic subunit)-mediated phosphor
ylation of PRKAG1/AMPKγ1, which promotes the lysosomal
localization of the AMPK complex [652]. Thus, AMPK acts as
a fine-tuned sensor of the overall cellular energy charge that
regulates cellular metabolism to maintain energy homeostasis.
Overexpression of a dominant negative mutant (R531G) of
PRKAG2, the γ−subunit isoform 2 of AMPK that is unable to
bind AMP, makes it possible to analyze the relationship
between AMP modulation (or alteration of energetic metabo
lism) and AMPK activity [653, 654]. Activation of AMPK is
also associated with the phosphorylation of downstream
enzymes involved in ATP-consuming processes, such as
fatty acid (ACAC [acetyl-CoA carboxylase]) and cholesterol
(HMGCR [3-hydroxy-3-methylglutaryl-CoA reductase])
biosynthesis.
The role of AMPK in autophagy is complex and highly
dependent on both cell type and metabolic conditions. In
yeast, the AMPK ortholog Snf1 shows autophagy inhibitory
functions dependent on its ability to inhibit cytosolic Acc1
(acetyl-CoA carboxylase)-mediated lipogenesis, which is
required for autophagy in stationary phase cells [655].
AMPK also exerts autophagy inhibitory effects through dis
tinct ULK1-dependent effects on autophagosome formation
and lysosomal acidification in cancer cell lines [656].
Furthermore, as noted above, there are two isoforms of the
catalytic subunit, PRKAA1/AMPKα1 and PRKAA2/AMPKα2,
and these may have distinct effects with regard to autophagy
(C. Koumenis, personal communication) [657]. In liver cells,
AMPK suppresses autophagy at the level of cargo sequestra
tion, as indicated by the rapid sequestration-inhibitory effects
of a variety of AMPK activators, whereas it appears to stimu
late autophagy in many other cell types, including fibroblasts,
colon carcinoma cells and skeletal muscle [658–667], and
there appears to be a completely AMPK-dependent type of
autophagy [668]. Autophagy-promoting effects of AMPK are
most evident in cells cultured in a complete medium with
serum and amino acids, where cargo sequestration is other
wise largely suppressed [664]. Amino acids acutely activate
AMPK, which sustains autophagy under nutrient sufficiency
[669]. Presumably, AMPK antagonizes the autophagy-

inhibitory effect of amino acids (at the level of phagophore
assembly) by phosphorylating proteins involved in MTORC1
signaling, such as TSC2 [670] and RPTOR/raptor [670] as
well as the MTORC1 target ULK1 (see below) [671–673].
Compound C is an effective and widely used inhibitor of
activated (phosphorylated) AMPK [674, 675]. However, being
a nonspecific inhibitor of oxidative phosphorylation [676,
677], this drug has been observed to inhibit autophagy
under conditions where AMPK is already inactive or knocked
out [678, 679], and it has even been shown to stimulate
autophagy by an AMP-independent mechanism [677, 680].
Compound C thus cannot be used as a stand-alone indicator
of AMPK involvement, but can be used along with shRNAmediated inhibition of AMPK.
TORC1 is an autophagy-suppressive regulator that inte
grates growth factor, nutrient and energy signals. In most
systems, inhibition of MTOR leads to induction of autophagy,
and AMPK activity is generally antagonistic toward MTOR
function. MTORC1 mediates the autophagy-inhibitory effect
of amino acids, which stimulate the MTOR protein kinase
through a RRAG GTPase heterodimer. INS (insulin) and
growth factors activate MTORC1 through upstream kinases
including AKT/protein kinase B and MAPK1/ERK2-MAPK3/
ERK1 when the energy supply is sufficient, whereas energy
depletion may induce AMPK-mediated MTORC1 inhibition
and autophagy stimulation, for example, during glucose star
vation. In contrast, amino acid starvation can strongly induce
autophagy even in cells completely lacking AMPK catalytic
activity [681]. The impact of MTORC1 on autophagy is
furthermore underlined in the pathological setting of a lyso
somal storage disease based on insufficient MTORC1 activa
tion and subsequent increased autophagosome formation due
to hereditary TBCK (TBC1 domain containing kinase) defi
ciency [682, 683].
MTORC1-mediated autophagy is negatively regulated by
SHOC2, a scaffold protein that activates the RAS-RAF-MAPK
signaling pathway [684, 685]. Specifically, SHOC2 binds to
RPTOR and dislodges it from MTORC1, leading to MTORC1
inactivation and autophagy induction [686, 687]. Thus,
MTORC1 signaling can be negatively regulated by MAPK
signaling.
AMPK and MTORC1 regulate autophagy through coordi
nated phosphorylation of ULK1. Under glucose starvation,
AMPK apparently promotes autophagy by directly activating
ULK1 through phosphorylation, although the exact AMPKmediated ULK1 phosphorylation site(s) remains controversial
(Table 2) [667, 671–673]. Under conditions of nutrient suffi
ciency, high MTORC1 activity prevents ULK1 activation by
phosphorylating alternate ULK1 residues and disrupting the
interaction between ULK1 and AMPK. There are commer
cially available phospho-specific antibodies that recognize dif
ferent forms of ULK1. For example, phosphorylation at
Ser556 in human (corresponds to Ser555 in mouse), an
AMPK site, is indicative of increased autophagy in response
to nutrient stress, whereas Ser758 in human (corresponds to
Ser757 in mouse) is targeted by MTOR to inhibit autophagy.
Even the autophagy-suppressive effects of AMPK could, con
ceivably, be mediated through ULK1 phosphorylation, for
example, at the inhibitory site Ser638 [688]. AMPK inhibits
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Table 2. Phosphorylation targets of AKT, AMPK, GSK3B, MTORC1, PKA and Atg1/ULK1.
Protein and
phosphorylation site
Acc1 (S1157 in yeast)
AMBRA1 S52
Atg1
Atg1
ATG4B S316
Atg9
ATG9 S14
ATG9 S761
Atg13

Snf1
MTORC1
TORC1
PKA
ULK1
Atg1
ULK1
AMPK
TORC1

Function
Inhibits de novo lipogenesis required for stationary phase autophagy
Inhibits AMBRA1-dependent activation of ULK1
Inhibits Atg1 kinase activity
Regulation of kinase activity
Inhibits ATG4B activity and LC3 processing
Recruitment of Atg protein to the PAS
Promotes ATG9 trafficking in response to starvation
Participates in the recruitment of lipids to the phagophore
Interaction with Atg1, assembly of Atg1 kinase complex

Atg13
ATG13 S318
ATG14 S29

PKA
ULK1
ULK1

Regulates localization to the PAS
Required for clearance of depolarized mitochondria
Promotes autophagy by increasing PtdIns3K complex activity

BECN1 S14
BECN1 S30

ULK1
ULK1

BECN1 S90
BECN1 S91, S94 (S93,
S96 in human)
BECN1 Y229, Y233
BECN1 S234, S295
BECN1 unknown site

MAPKAPK2-MAPKAPK3
AMPK

Increases the activity of the PtdIns3K
Activates the ATG14-containing PtdIns3K complex and stimulates autophagosome
formation in response to amino acid starvation, hypoxia, and MTORC1 inhibition.
Stimulates autophagy
Required for glucose starvation-induced autophagy

EGFR
AKT
ERBB2/HER2

Inhibits autophagy
Suppresses autophagy
Inhibits autophagy

Main kinase

Ref
[655]
[741]
[744]
[2652]
[708]
[2653]
[707]
[2654]
[744,
2655]
[2656]
[647]
[702,
2657]
[705]
[706]
[2658]
[868]

AMPK
ULK1
AKT
PKA
AKT
Autophosphorylation
GSK3A/B
MTORC1 (apparently indirect, through
reduction of dephosphorylation)
RPS6KB S371
GSK3B
RPTOR S792
AMPK
RUBCNL/Pacer S157
MTORC1
SQSTM1 S293
AMPK (S293/S294 in rat and human
sequence, respectively)
SQSTM1 S403
ULK1 (also TBK1, CSNK, CDK1)
TFEB S122, S142, S211 MTORC1

Stimulates interaction with CDK16 and promotes autophagy
Promotes mitophagy by enhancing FUNDC1 binding to LC3
Activates HTT clearance
Inhibits autophagy by reducing recruitment to phagophores
Correlates with the activity of MTORC1
Necessary for MTORC1 formation and kinase activity
Modulates protein aggregation
Necessary for protein activity

[775]
[774]
[2659,
2660]
[762]
[735]
[2661]
[293]
[2662]
[2663]
[2664]
[2665]

Necessary for T389 phosphorylation and the activity of RPS6KB
Suppresses MTORC1
Repress RUBCNL interaction with STX17 and HOPS complex
Promotes autophagic cell death

[2666]
[689]
[2667]
[657]

Promotes autophagic degradation of SQSTM1 and its substrates
Inhibits TFEB nuclear translocation

TFEB S467
TSC2
T1227, S1345
ULK1 S317, S555,
S574, S673
ULK1 S467, S777
(mouse)
ULK1 S757/S758
(mouse/human)
ULK1 S757
ULK1 S637
ULK1 (uncertain site
between 278 and
351)
USP14 S432
UVRAG S498
UVRAG S550, S571

AKT1
AMPK

Inhibits TFEB nuclear translocation
Negative regulator of MTORC1

[2668]
[970–
972,
2669]
[973]
[670]

AMPK

Required for mitophagy, mitochondrial homeostasis, and cell survival

[672]

AMPK

Increase the kinase activity of ULK1 and promote autophagy

MTORC1

Facilitates ULK1 interaction with AMPK

[672,
673]
[688]

MTORC1
MTORC1, AMPK
Autophosphorylation

Prevents ULK1 interaction with AMPK
Facilitates ULK1 interaction with AMPK
Modulates the conformation of the C-terminal tail and prevents its interaction with
ATG13

[673]
[688]
[646,
699]

AKT
MTORC1
MTORC1

Overcomes negative regulation of DNA repair
Negatively regulates autophagosome and endosome maturation
Activates the PtdIns3K-UVRAG complex to regulate autolysosomal tubulation

[2670]
[2671]
[2672]

CCNY (cyclin Y) S326
FUNDC1 S17
HTT S421
LC3 S12
MTOR S2448
MTOR S2481
NBR1 T586
RPS6KB T389

MTORC1 by phosphorylating and activating TSC2 [670], as
well as by phosphorylating the MTOR binding partner
RPTOR [689]. Therefore, AMPK is involved in processes

that synergize to activate autophagy, by directly activating
ULK1, and indirectly impairing MTOR-dependent inhibition
of ULK1. In addition, IPMK (inositol polyphosphate
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multikinase) can act as a scaffold protein to influence AMPKdependent ULK phosphorylation [690]. The identification of
ULK1 as a direct target of MTORC1 and AMPK represents a
significant step toward the definition of new tools to monitor
the induction of autophagy. ULK1 and ATG13 are also phos
phorylated by CCNB/cyclin B in mitosis to activate autopha
gy [691].
In addition to ULK1 regulation by AMPK and MTORC1
under conditions of glucose starvation, in skeletal muscle
ULK1 is activated by MAPK11/p38β in response to a tumor
burden through phosphorylation of Ser555 in mice. Despite
AMPK activation (phosphorylation on Thr172) by factors
released from tumor cells, inhibition of AMPK with com
pound C does not alter ULK1 phosphorylation on Ser555
and activation of autophagy in these conditions. Conversely,
MAPK11 gain- and loss-of-function assays indicate that
MAPK11 is a key activator of ULK1 and autophagy in the
cancer milieu [692].
Further studies directed at identifying physiological sub
strates of ULK1 will be essential to understand how ULK1
activation results in initiation of the autophagy program. So
far, several ULK1 substrates have been reported, and these can
be classified into 4 subgroups: 1) components of the ULK1
complex; 2) components of the class III PtdIns3K complex I;
3) other autophagy-related proteins; or 4) non-autophagyrelated proteins. Numerous groups have shown that ULK1
autophosphorylates and transphosphorylates its binding part
ners ATG13, RB1CC1, and ATG101 [646, 647, 693–701]. So
far, only the ULK1 autophosphorylation at Thr180 and
Ser1047, and the phosphorylation of ATG13 at Ser318
(human isoform 2) have been shown to be functionally rele
vant. ATG13 phosphorylation at Ser318 by ULK1 is required
for efficient clearance of damaged mitochondria [647]. The
functional relevance of ULK1-dependent phosphorylation of
RB1CC1 and ATG101 awaits further clarification. With
regard to the components of the class III PtdIns3K complex
I, ULK1-dependent phospho-acceptor sites have been identi
fied in PIK3C3/VPS34 (phosphatidylinositol 3-kinase catalytic
subunit type 3), BECN1, ATG14, and AMBRA1 [695, 702–
706]. Following amino acid starvation or MTOR inhibition,
the activated ULK1 phosphorylates ATG14 on Ser29 and
BECN1 on Ser14 and Ser30, enhancing the activity of the
complexes containing ATG14 and PIK3C3/VPS34. These
ATG14 and BECN1 phosphorylations by ULK1 are required
for full autophagic induction in response to amino acid star
vation or MTOR inhibition [702, 705]. ULK1-dependent
phosphorylation of BECN1 at Ser30 also stimulates autopha
gosome formation in response to hypoxia [706]. Next to the
two autophagy-initiating complexes, other ATG proteins have
been identified as ULK1 substrates, notably ATG4B, ATG9A,
and ATG16L1 [707–709]. Finally, there are several ULK1
substrates that are not specifically ATG proteins. These pro
teins are involved in the execution of autophagy, or fulfill
additional cellular functions. These substrates include
RPTOR, AMPK, SQSTM1, FUNDC1, DAPK3, MAPK14/
p38alpha, FLCN, enzymes involved in glucose metabolic
flux, DENND3, SMCR8, TBK1, PDPK1, SEC16A, SEC23A,
SEC23B, EXOC7, SDCBP, STING1/TMEM173, CDC37,
MAD1L1, VCP/p97, DVL1, NR3C2, YAP1, WWTR1, and

RIPK1 [710–735]. The ULK1-dependent phosphorylation of
RPTOR leads to inhibition of MTORC1 [711, 718], and the
ULK1-dependent inhibitory phosphorylation of AMPK sub
units appears to generate a negative feedback loop [710]. Note
that caution should be taken to use appropriate inhibitors of
phosphatases (e.g., sodium fluoride, and β-glycerophosphate)
in cell lysis buffer before analyzing the phosphorylation of
AMPK and ULK1 at serine and threonine sites.
MTORC1 activity can be monitored by following the phos
phorylation of its substrates, such as EIF4EBP1/4E-BP1/
PHAS-I and RPS6KB/p70S6 kinase or the latter’s downstream
target, RPS6/S6, for which good commercial antibodies are
available [736–738]. In mammalian cells, the analysis should
focus on the phosphorylation of S6K1 at Thr389, and
EIF4EBP1 at Ser65, a serum-responsive and rapamycin-sensi
tive site; phosphorylation of EIF4EBP1 at Thr37 and Thr46
primes the protein for phosphorylation at Ser65, and although
directly phosphorylated by MTORC1, the modifications at
Thr37 and Thr46 are only partially sensitive to serum and
rapamycin [739]. The MTORC1-dependent phosphorylation
of EIF4EBP1 can be detected as a molecular mass shift by
western blot [736]. Examining the phosphorylation status of
RPS6KB and EIF4EBP1 may be a better method for monitor
ing MTORC1 activity than following the phosphorylation of
proteins such as RPS6, because the latter is not a direct
substrate of MTORC1 (although RPS6 phosphorylation is a
good readout for RPS6KB1/2 activities, which are directly
dependent on MTOR), and it can also be phosphorylated by
other kinases such as RPS6KA/RSK. Whereas RPS6KB1/2
phosphorylates RPS6 at Ser235, Ser236, Ser240, and Ser244,
RPS6KA/RSK exclusively phosphorylates RPS6 at Ser235 and
Ser236 in vitro and in vivo in a manner independent of
MTORC1 [740]. Thus, the use of RPS6 phospho-Ser240/244
antibody is necessary for monitoring cellular MTORC1RPS6KB1/2 activity specifically in western blot or
immunocytochemistry.
Furthermore, the mechanisms that determine the selectiv
ity as well as the sensitivity of MTORC1 for its substrates
seem to be dependent on the integrity and configuration of
MTORC1. For example, rapamycin strongly reduces
RPS6KB1 phosphorylation, whereas its effect on EIF4EBP1
is more variable. In the case of rapamycin treatment,
EIF4EBP1 can be phosphorylated by MTORC1 until rapamy
cin disrupts MTORC1 dimerization and its integrity, whereas
RPS6KB1 phosphorylation is quickly reduced when rapamy
cin simply interacts with MTOR in MTORC1 (see Autophagy
inhibitors and inducers for information on catalytic MTOR
inhibitors such as torin1) [739]. Because it is likely that other
inhibitors, stress, and stimuli may also affect the integrity of
MTORC1, a decrease or increase in the phosphorylation sta
tus of one MTORC1 substrate does not necessarily correlate
with changes in others, including ULK1. Therefore, reliable
anti-phospho-ULK1 antibodies should be used to directly
examine the phosphorylation state of ULK1, along with addi
tional experimental approaches to analyze the role of the
MTOR complex in regulating autophagy. The MTORC1mediated phosphorylation of AMBRA1 on Ser52 has also
been described as relevant to ULK1 regulation and autophagy
induction [703, 741]. In line with what is described for ULK1,
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the anti-phospho-AMBRA1 antibody, which is commercially
available, could be used to indirectly measure MTORC1 activ
ity [741].
Activation/assembly of the Atg1 complex in yeast (com
posed of at least Atg1-Atg13-Atg17-Atg31-Atg29) or the
ULK1 complex in mammals (ULK1-RB1CC1-ATG13ATG101) is one of the first steps of autophagy induction.
Therefore, activation of this complex can be assessed to
monitor autophagy induction. In yeast, dephosphorylation of
Atg13 is associated with activation/assembly of the core com
plex that reflects the reduction of TORC1 and PKA activities.
Therefore, assessing the phosphorylation levels of this protein
by immunoprecipitation or western blotting [742–745] can be
used not only to follow the early steps of autophagy but also
to monitor the activity of some of the upstream nutrientsensing kinases. Because this protein is not easily detected
when cells are lysed using conventional procedures, a detailed
protocol has been described [746]. In addition, the auto
phosphorylation of Atg1 at Thr226 is required for its kinase
activity and for autophagy induction; this can be detected
using phospho-specific antibodies, by immunoprecipitation
or western blotting (Figure 22) [747, 748]. In Drosophila,
TORC1-dependent phosphorylation of Atg1 and Atg1-depen
dent phosphorylation of Atg13 can be indirectly determined
by monitoring phosphorylation-induced electromobility
retardation (gel shift) of protein bands in immunoblot images
[423,47509,510]. Nutritional starvation suppresses TORC1mediated Atg1 phosphorylation [423,509] while stimulating
Atg1-mediated Atg13 phosphorylation [589, 749, 750]. In
mammalian cells, the phosphorylation status of ULK1 at the
activating sites (Ser317, 777 [position in the murine sequence,
not conserved in human], 467, 556, 638, or Thr575 in the
human sequence) or dephosphorylation at inactivating sites
(Ser638, 758 in the human sequence) can be determined by
western blot using phospho-specific antibodies [672–674, 688,
751, 752]. In general, the core complex is stable in mamma
lian cells, although, as noted above, upstream inhibitors
(MTOR) or activators (AMPK) may interact dynamically
with it, thereby determining the status of autophagy.
Alternatively, the activation of the ULK1 complex can be
monitored by assessing the localization pattern of ATG13 by
immunofluorescence. In fact, following ULK1 complex activa
tion, ATG13 relocates to the omegasome, which results in a
punctate pattern [753, 754]. In mesothelioma ex vivo 3dimensional models, the percentage of tumor cells with
ATG13 puncta correlates with the level of autophagy, and
the analysis of ATG13 puncta has been proposed as an assay
to monitor autophagy in mesothelioma formalin-fixed,
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Figure 22. S. cerevisiae cells transformed with a plasmid encoding HA-Atg1 were
cultured to mid-log phase and shifted to SD-N (minimal medium lacking nitro
gen that induces a starvation response). Immunoblotting was done with anti-HA
antibody. The upper band corresponds to autophosphorylation of Atg1. This
figure was modified from data previously published in ref. [747], and is repro
duced by permission of the American Society for Cell Biology, copyright 2011.
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paraffin-embedded and 3-dimensional models [755]. In the
same model, the ULK1/2 inhibitor MRT68921 blocks both
autophagy and the formation of ATG13 puncta [756]. As a
cautionary note, ATG13 puncta do not reflect autophagy in
traditional monolayer cultures of mesothelioma cells.
Therefore, studies in 3-dimensional models of other tumors
are needed to confirm the validity of ATG13 as a marker of
autophagy.
One additional topic that bears on ULK1 concerns the
process of LC3-associated phagocytosis (see Noncanonical
use of autophagy-related proteins). LAP is a type of phagocy
tosis in macrophages that involves the conjugation of LC3 to
single-membrane pathogen-containing phagosomes, a process
that promotes phagosome maturation [247]. Although ULK1
is not required for the clearance of cell corpses by LAP, in
mammals [245], and UNC-51 (the Atg1/ULK1 homolog in C.
elegans) is not required for the clearance of neuroblast corpses
in larval worms or released cell fragments in worm embryos
[757, 758], it is important to note that an increased number of
apoptotic cell corpses persist during embryonic development
in unc-51 mutant worms [759], suggesting that UNC-51 could
have a role in cell death or cell corpse clearance. A recent
study shows that pancreatic acinar cells also have the ability to
process post-exocytic organelles via LAP [760]. LAP-deficient
tumor-associated macrophages also aid in promoting an antitumor response in T cells in a tumor microenviron
ment [761].
An additional substrate that is required for efficient
AMPK-induced autophagy is CCNY (cyclin Y)-CDK16
[762]. AMPK phosphorylates CCNY, which promotes its
interaction with CDK16, a PCTAIRE kinase family member.
The loss of CCNY-CDK16 impairs AMPK-stimulated auto
phagy, whereas overexpression of CCNY-CDK16 is sufficient
to induce autophagy. This outcome is dependent on the
catalytic activity of CCNY-CDK16, albeit the substrates of
this kinase have not been identified yet.
Cautionary notes: A decrease in TORC1 activity is a good
measure for autophagy induction; however, TORC1 activity
does not necessarily preclude autophagy induction because
there are TOR-independent mechanisms that induce autopha
gy both in mammals and yeast [763–767] Along these lines,
the disassociation of the AMPK-MTORC1 axis is observed in
some AML cells such as the KG-1 cell line, as well as in
primary AML cells treated with the specific AMPK agonist
GSK621 [768, 769]. The co-activation of AMPK and
MTORC1 in these cancer cells is associated with increased
autophagy flux, with AMPK as the major regulator of auto
phagy in these conditions [768, 769]. Whereas in most sys
tems inhibition of MTOR leads to the induction of autophagy,
there are instances in commonly used cancer cell lines and
influenza A virus-infected cells in which MTOR appears to be
a positive effector [770, 771]. Also, MTOR suppression does
not always induce autophagy, such as when BECN1 under
goes inhibitory phosphorylation by the growth factor signal
ing molecules EGFR and AKT, when microglia are activated
by lipopolysaccharide (LPS), a TLR4 ligand [772], or during
Salmonella infection [773–775]. Note that the effect of ever
olimus in EGFR-transgenic mice is not mainly attributable to
autophagy although it suppresses MTOR and induces
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autophagy in EGFR-driven lung cancer cell lines [776]. In
adult skeletal muscle, active MTORC1 phosphorylates ULK1
at Ser757 to inhibit the induction of autophagosome forma
tion. Thus, induction of autophagy requires inhibition of
MTORC1 and not of MTORC2 [777, 778]. There is also
evidence that inhibition of MTORC1 is not sufficient to
maintain autophagic flux, but requires additional activation
of FOXO transcription factors for the upregulation of auto
phagy gene expression [662]. In addition, MTORC1 is down
stream of AKT; however, oxidative stress inhibits MTOR, thus
allowing autophagy induction, despite the concomitant acti
vation of AKT [207]. For neural cells, following administra
tion of the class I phosphoinositide 3-kinase (PI3K) inhibitor
LY294002, the phosphorylation levels of AKT and MTOR
decrease, and the ratio of LC3-II:LC3-I is higher in the inhi
bitor-treated injury group than in the simple-injury group
[779]. Also, persistent MTORC1 inhibition can cause down
regulation of negative feedback loops on IRS-MTORC2-AKT
that results in the reactivation of MTORC2 under conditions
of ongoing starvation [581, 780, 781]. Along these lines, both
TORC1 and autophagy can be active in specific cell subpopu
lations of yeast colonies [763]. Similarly, mature autophago
somes and MTOR accumulate in the TOR-autophagy spatial
coupling compartment (TASCC) during RAS-induced senes
cence [782]. Thus, it is necessary to be cautious in deciding
how to monitor the TOR/MTOR pathway, and to verify that
the pathway being analyzed displays TOR/MTOR-dependent
inhibition.
Another point is that the regulation of autophagy by
MTOR can be ULK1-independent. During mycobacterial
infection of macrophages, MTOR induces the expression of
MIR155 and MIR31 to sustain the activation of the WNT5A
and SHH/sonic hedgehog pathways. Together, these pathways
contribute to the expression of lipoxygenases and downregu
lation of IFNG-induced autophagy [783]. Signaling pathways
can be monitored by western blotting, and TaqMan miRNA
assays are available to detect these miRNAs.
One problem in monitoring assembly of the ULK1 com
plex is the low abundance of endogenous ULK1 in many
systems, which makes it difficult to detect phospho-ULK1 by
western blot analysis. In addition, Atg1/ULK1 is phosphory
lated by multiple kinases, and the amount of phosphorylation
at different sites can increase or decrease during autophagy
induction. Thus, although there is an increase in phosphor
ylation at the activating sites upon induction, the overall
phosphorylation states of ULK1 and ATG13 are decreased
under conditions that lead to induction of autophagy; there
fore, monitoring changes in phosphorylation by following
molecular mass shifts upon SDS-PAGE may not be informa
tive. In addition, such phosphorylation/dephosphorylation
events are expected to occur relatively early (1-2 h) in the
signaling cascade of autophagy. Therefore, it is necessary to
optimize treatment time conditions. Finally, in Arabidopsis
and possibly other eukaryotes, the ATG1 and ATG13 proteins
are targets of autophagy, which means that their levels may
drop substantially under conditions that induce autophagic
turnover [350].
At present, the use of Atg1/ULK1 kinase activity as a tool
to monitor autophagy is limited because only a few

physiological substrates have been identified, and the impor
tance of Atg1/ULK1-dependent phosphorylation has not
always been determined. Nonetheless, Atg1/ULK1 kinase
activity appears to increase when autophagy is induced, irre
spective of the pathway leading to induction. As additional
physiological substrates of Atg1/ULK1 are identified, it will be
possible to follow their phosphorylation in vivo as is done
with analyses for MTOR. Nonetheless, it must be kept in
mind that monitoring changes in the activity of Atg1/ULK1
is not a direct assay for autophagy, although such changes
may correlate with autophagy activity. Furthermore, the
ULK1 substrates described above and additional ULK1-inter
acting proteins (e.g., PARP1) [784] already indicate that
ULK1—next to its essential role for the induction of autopha
gy—participates in several additional physiological processes
including axon guidance during brain development, type I
interferon production, ER-Golgi trafficking, regulation of cha
perone function, mitosis, stress granule dynamics, WNTCTNNB1/β-catenin signaling, NR3C2/mineralocorticoid
receptor signaling, and non-autophagic regulation of cell
death. In a C. elegans Parkinson disease model, RNAi knock
down of UNC-51/ULK1 results in the accumulation of a
human SNCA-GFP fusion [785]. Accordingly, the ULK activ
ity state may thus reflect its role in these processes [786–792].
Therefore, other methods as described throughout these
guidelines should also be used to follow autophagy directly.
Finally, there is not a complete consensus on the specific
residues of ULK1 that are targeted by AMPK or MTOR.
Similarly, apparently contradictory data have been published
regarding the association of AMPK and MTOR with the
ULK1 kinase complex under different conditions. Therefore,
caution should be used in monitoring ULK1 phosphorylation
or the status of ULK1 association with AMPK until these
issues are resolved.
Conclusion: Assays for Atg1/ULK1 can provide detailed
insight into the induction of autophagy, but they are not a
direct measurement of the process. Similarly, because MTOR
substrates such as RPS6KB1 and EIF4EBP1 are not recom
mended readouts for autophagy, their analysis needs to be
combined with other assays that directly monitor autophagy
activity.
5. Estimation of PtdIns3K (PIK3C3/VPS34) activity
PIK3C3/VPS34 is highly conserved through evolution, and
belongs to the class III PtdIns3K that phosphorylates the 3ʹOH position of phosphatidylinositol (PtdIns) to synthesize
PtdIns3P [793, 794]. PtdIns3P is essential for the regulation
of endocytic pathways and for the generation of various types
of autophagosomes and phagosomes. However, PIK3C3/
VPS34 cannot be found alone in the cell but mainly is present
in two types of mutually exclusive complexes, complexes I and
II. Complex I is composed of PIK3C3/VPS34, PIK3R4/VPS15/
p150, BECN1, ATG14 and NRBF2 for mammals, or Vps34,
Vps15, Vps30/Atg6, Atg14 and Atg38 for yeast. Complex II
replaces ATG14/Atg14 with UVRAG, or Vps38 for mammals
and yeast, respectively [795–799]. Complex I regulates auto
phagy, whereas complex II regulates endocytic pathways,
LAP, and cytokinesis [800–802]. Both in yeast and mammals,
PIK3C3/VPS34 shows higher activity in complexes than on its
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own. For example, yeast complexes I and II show higher
activity than a Vps34-Vps15 heterodimer [800], and human
PIK3C3 activity is increased by coexpressing it with PIK3R4/
VPS15 [803]. Also, various post-translational modifications of
the subunits of complexes I and II affect the kinase activ
ity [804].
The most commonly used method to estimate PIK3C3/
VPS34 activity is to immunoprecipitate the protein complex
from cells, immobilize it on beads, mix with the substrate
(PtdIns) and radioactive ATP, then measure the PtdIns3P
production by autoradiography. Furthermore, two commer
cial kits are available; an ELISA-based kit from Echelon (K3300), and a kit for measuring ADP generation from ATP
from Promega (V6930). The PIK3C3/VPS34 activity is
affected by enzyme concentration and substrate structure.
First, for all methods it is important to estimate the concen
tration and purity of immobilized PIK3C3/VPS34 complex
by Coomassie Brilliant Blue or silver staining. Second, the
PtdIns structure and the environment where PtdIns is sur
rounded such as the length of acyl chain, and the size and
composition of liposomes largely affect the activity. The
PtdIns provided with the Echelon kit is water-soluble diC8PtdIns. There are also PtdIns:phosphatidylserine mixture
substrates at a 1:9 molar ratio (Thermo Fisher, PV5122), or
at a 1:3 molar ratio (Promega, V1711). Although they are
good substrates for drug screening, they are not physiologi
cal. If researchers are examining the kinase activity to reflect
the intracellular conditions, it is recommended to make
liposomes that mimic the lipid compositions of the organelle
of interest. Therefore, it is necessary to describe the lipid
compositions of liposomes, the catalog number for each lipid
species, and procedures for making liposomes (just sonica
tion, or whether the liposome size was adjusted by extrud
ing) for publication.
For ADP-Glo assays, because it measures the ATP-ADP
conversion, if the purified enzyme is contaminated with cha
perones, the ATPase activities of the latter dominate the
values. Therefore, it is important to check the purity of the
purified enzyme in advance and additionally measure the
luminescence values of the enzyme without substrate. Also,
the measured luminescence values need to be subtracted by
the background values, which can be the intercept value of the
standard curve or the measured luminescence of a mixture of
0% ADP and 100% ATP (this should contain ATP in case of
impurities). This means that the enzyme concentration needs
to be adjusted high enough so that the luminescence values of
enzyme plus substrate are higher than the background values
(i.e., the measured luminescence values of enzyme without
substrate or the mixture of 0% ADP and 100% ATP). The
above points need to be considered not only for the PIK3C3/
VPS34 assays, but also for all lipid kinase and phosphatase
activity assays.
6. Additional autophagy-related protein markers
Although Atg8-family proteins have been the most extensively
used proteins for monitoring autophagy, other proteins can
also be used for this purpose. Here, we discuss some of the
more commonly used or better-characterized possibilities.
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a. Atg9/ATG9A. Atg9/ATG9A is the only integral mem
brane Atg protein that is essential for autophagosome forma
tion in all eukaryotes. Mammalian ATG9A displays partial
colocalization with GFP-LC3 [805], and ATG9A deficiency in
the mouse brain causes axon-specific lesions including neu
ronal circuit dysgenesis [806]. Perhaps the most unique fea
ture of Atg9, however, is that it localizes to multiple discrete
puncta, whereas most Atg proteins are detected primarily in a
single punctum or diffusely within the cytosol. Yeast Atg9
may cycle between the phagophore assembly site (PAS) and
peripheral reservoirs [807]; the latter correspond to tubulove
sicular clusters that are precursors to the phagophore [808].
Anterograde movement to the PAS is dependent on Atg11,
Atg23, Atg27 and actin. Retrograde movement requires Atg1Atg13, Atg2-Atg18 and the PtdIns3K complex I [809].
Mutants such as atg1∆ accumulate Atg9 primarily at the
PAS, and this phenotype forms the basis of the “transport of
Atg9 after knocking out ATG1” (TAKA) assay [148]. In brief,
this is an epistasis analysis in which a double-mutant strain is
constructed (one of the mutations being atg1∆) that expresses
Atg9-GFP. If the second mutated gene encodes a protein that
is needed for Atg9 anterograde transport, the double mutant
will display multiple Atg9-GFP puncta. In contrast, if the
protein acts along with or after Atg1, all of the Atg9-GFP
will be confined to the PAS. One such example is a septin
complex that regulates Atg9 retrograde transport. The tem
perature-sensitive point mutations in Cdc10 (P3S and G44D)
show accumulation of Atg9 at the PAS at non-permissive
temperatures [810]. Monitoring the localization of ATG9A
has not been used as extensively in more complex eukaryotes,
but this protein displays the same type of dependence on
Atg1/ULK1 and PtdIns3P for cycling as seen in yeast [805,
809], suggesting that it is possible to follow this ATG9A as an
indication of ULK1 and ATG13 function [646, 805, 809].
There are two conserved classical adaptor protein sorting
signals within the cytosolic N terminus of ATG9, which
mediate trafficking of ATG9 from the plasma membrane
and trans-Golgi network (TGN) via interaction with AP-1/2
[707, 811]. SRC phosphorylates ATG9 at Tyr8 to maintain its
endocytic and constitutive trafficking in unstressed condi
tions. In response to starvation, phosphorylation of ATG9 at
Tyr8 by SRC, and at Ser14 by ULK1, functionally cooperate to
promote interactions between ATG9 and the AP-1/2 complex,
leading to redistribution of ATG9 from the plasma membrane
and juxta-nuclear region to the peripheral pool for autophagy
initiation [707]. Furthermore, the localization of mammalian
ATG9A is regulated by cellular sphingomyelin levels. In cells
with excess sphingomyelin, ATG9A is trapped in juxtanuclear
recycling endosomes, and its failure to be recruited to autop
hagic membranes results in defective phagophore closure
[812]. In neurons ATG9 localizes to axons and presynaptic
sites, and requires active transport by the kinesin
motor KIF1A to direct its localization into distal neurites
[29, 537].
ATG9 is also conserved in plants including the model plant
A. thaliana. A protease protection assay with microsomes
isolated from A. thaliana cells shows that ATG9 has a similar
membrane topology, with its N- and C-termini facing the
cytosol [128]. Subcellular analysis indicates that A. thaliana
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Figure 23. Confocal microscopy image of HCT116 cells immunostained with antibody specific to human ATG12. Cells were starved for 8 h or treated with CQ (50 µM)
for 3 h. Scale bar: 10 µm. Image provided by M. Llanos Valero, M.A de la Cruz and R. Sanchez-Prieto.

ATG9 displays similar discrete puncta within the cytosol in
close proximity to the trans-Golgi network and late endo
somes, whereas ATG9-GFP fusion proteins show a transient
association with the autophagosomal marker ATG8. However,
in contrast to the yeast and mammalian atg9 mutants,
Arabidopsis atg9 mutants accumulate numerous abnormal
tubular autophagosomal structures, which are dynamically
associated with the ER membranes. Using 3-dimensional elec
tron tomography analysis, direct connections between these
ATG8-positive tubular structures and the ER have been
observed, implying that plant ATG9 plays an essential role
in autophagosome progression from the ER, particularly
under stress conditions [128]. Recently, the homotrimeric
structure of A. thaliana ATG9 was resolved by cryo-EM at
subnanometer resolution, which provides a structural basis
for future studies of ATG9 function in eukayotes [129].
b. Atg12–Atg5. ATG5, ATG12 and ATG16L1 associate with
the phagophore and have been detected by fluorescence and
immunofluorescence (Figure 23) [813, 814]. The endogenous
proteins form puncta that can be followed to monitor auto
phagy upregulation. Under non-stressed, nutrient-rich condi
tions, these proteins are predominantly diffusely distributed
throughout the cytoplasm. Upon induction of autophagy, for
example during starvation, there is a marked increase in the
proportion of cells with punctate ATG5, ATG12 and
ATG16L1. Furthermore, upstream inhibitors of autophago
some formation result in a block in this starvation-induced
puncta formation, and this assay is very robust in some
mammalian cells. Conversely, downstream inhibition of auto
phagy at the level of phagophore expansion, such as with
inhibition of LC3/GABARAP expression, results in an accu
mulation of the phagophore-associated ATG5, ATG12 and
ATG16L1 immunofluorescent puncta [815]. Moreover,
PLSCR1 (phospholipid scramblase 1) may play an inhibitory
role in the autophagic process interfering with ATG12–
ATG5-ATG16L1 complex formation and phagophore elonga
tion as shown through co-immunoprecipitation experiments.
Indeed, PLSCR1 binds the ATG12–ATG5 complex preventing
ATG16L1 association [413]; therefore, the evaluation of active

complexes by co-immunoprecipitation and subsequent
immunoblotting analysis can be a further indirect way to
evaluate autophagy activation.
ATG12–ATG5 conjugation has been used in some studies
to measure autophagy. In Arabidopsis and some mammalian
cells it appears that essentially all of the ATG5 and ATG12
proteins exist in the conjugated form, and the expression
levels do not change, at least during short-term starvation
[289, 813, 814, 816]. Therefore, monitoring ATG12–ATG5
conjugation per se may not be a useful method for following
the induction of autophagy. It is worth noting, however, that
in some cell lines free ATG5 can be detected [817], suggesting
that the amount of free ATG5 may be cell line-dependent; free
ATG5 levels also vary in response to stress such as DNA
damage [818]. Furthermore, free ATG12 can be detected in
some cell lines and tissues and has ATG5-independent roles
in cell signaling [819–821].One final parameter that may be
considered is that the total amount of the ATG12–ATG5
conjugate may increase following prolonged starvation as
has been observed in hepatocytes and both mouse and
human fibroblasts (A.M. Cuervo, personal communication;
S. Sarkar, personal communication), even though in these
conditions part of the ATG12–ATG5 population is secreted
in association with exosomes [822].
c. ATG14. Yeast Atg14 is the autophagy-specific subunit of
the Vps34 complex I [796], and a human homolog, named
ATG14/ATG14L/BARKOR, has been identified [795, 798,
799, 823]. ATG14 localizes primarily to phagophores. The
C-terminal fragment of the protein, named the BATS domain,
is able to direct GFP and BECN1 to autophagosomes in the
context of a chimeric protein [824]. ATG14-GFP or BATSGFP detected by fluorescence microscopy or TEM can be used
as a phagophore marker protein; however, ATG14 is not
localized exclusively to phagophores, as it can also be detected
on mature autophagosomes as well as the ER [824, 825].
Accordingly, detection of ATG14 should be carried out in
combination with other phagophore and autophagosome
markers. A good antibody that can be used to detect endo
genous ATG14 by immunostaining has been described [702].
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d. ATG16L1. ATG16L1 has been used to monitor the move
ment of plasma membrane as a donor for autophagy, and thus
an early step in the process. Indeed, ATG16L1 is located on
phagophores, but not on completed autophagosomes [455,
826]. ATG16L1 can be detected by immuno-TEM, by immu
nostaining of Flag epitope-tagged ATG16L1, and/or by the
use of GFP-tagged ATG16L1. ATG16L1 is phosphorylated on
a serine residue at amino acid position 278 by ULK1 under
autophagy-inducing conditions. Detection of endogenous
phospho-ATG16L1 [827] has been demonstrated as a novel
method to monitor autophagy induction. Because ATG16L1
is specifically located on phagophores but not complete
autophagosomes, phospho-ATG16L1-based autophagy assays
are predicted to be unaffected by a late stage autophagy block,
and thus able to circumvent a major caveat of LC3-based
assays while serving as an alternative tool with unique advan
tages to monitor autophagy.
ATG16L1 is ubiquitinated by the GAN (gigaxonin) E3
ligase, through interaction with the WD40 domain [828].
GAN causes the clearance of ATG16L1 in cell lines, whereas
its repression in primary neurons derived from the gan−/−
mouse induces an abnormal bundling of ATG16L1 within
the soma. Action of GAN is dynamic, as restoration of its
expression using lentiviral vector clears the aggregate and the
endogenous ATG16L1, respectively, in GAN mutant and
wild-type neurons. GAN mutant neurons exhibit a failure in
producing autophagosomes over time upon autophagy induc
tion, hence leading to a defective autophagic flux in subse
quent steps. Thus, GAN is the first E3 ligase fine-tuning
autophagosome production through ATG16L1.
Finally, the coding polymorphism of ATG16L1 (T300A,
rs2241880), which is associated with Crohn disease, renders
the protein sensitive to CASP3- and CASP7-mediated clea
vage in the WD40 domain; this leads to decreased ATG16L1
function and can be detected by western blot [829, 830].
Cautionary notes: The expression level of ATG16L1 does
not always correlate with other components of the autophagic
machinery, and in some cases may be altered in a manner that
is independent of autophagy; for example, this can be seen in
samples from patients with acute myeloid leukemia (P.
Ludovico, unpublished results).
e. Atg18/WIPI family. Yeast Atg18 [831, 832] and Atg21
[443] (or the mammalian WIPI homologs [833]) are required
for both autophagy (i.e., nonselective sequestration of cyto
plasm) and autophagy-related processes (e.g., the Cvt pathway
[834, 835], specific organelle degradation [168], and autopha
gic elimination of invasive microbes [171, 172, 174, 175, 836]).
These proteins bind PtdIns3P that is present at the phago
phore and autophagosome [837, 838] and also PtdIns(3,5)P2.
Furthermore, fluorescence stopped-flow [839] and chemical
cross-linking assays [840] show that Atg18 oligomerizes upon
membrane binding, whereas it is mainly monomeric when
unbound. Human WIPI1 and WIPI2 function downstream
of the class III phosphatidylinositol 3-kinase complex I
(PIK3C3/VPS34, BECN1, PIK3R4/VPS15, ATG14, NRBF2)
and upstream of both the ATG12 and LC3 ubiquitin-like
conjugation systems [837, 841, 842]. Upon the initiation of
the autophagic pathway, WIPI1 and WIPI2 bind PtdIns3P
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and accumulate at limiting membranes, such as those of the
ER, where they participate in the formation of omegasomes
and/or autophagosomes [843, 844]. On the basis of quantita
tive fluorescence microscopy, this specific WIPI protein loca
lization has been used as an assay to monitor autophagy in
human cells [838].
Using either endogenous WIPI1 or WIPI2, detected by
indirect fluorescence microscopy or EM, or transiently or
stably expressed tagged fusions of GFP to WIPI1 or WIPI2,
basal autophagy can be detected in cells that display WIPI
puncta at autophagosomal membranes. In circumstances of
increased autophagic activity, such as nutrient starvation or
rapamycin administration, the induction of autophagy is
reflected by the elevated number of cells that display WIPI
puncta when compared to the control setting. Also, in cir
cumstances of reduced autophagic activity such as upon wort
mannin treatment, the reduced number of WIPI punctapositive cells reflects the inhibition of autophagy. Basal,
induced and inhibited formation of WIPI puncta closely cor
relates with both the protein level of LC3-II and the formation
of GFP-LC3 puncta [838, 842]. Accordingly, WIPI puncta can
be assessed as an alternative to LC3. Automated imaging and
analysis of fluorescent WIPI1 (Figure 24) or WIPI2 puncta
represent an efficient and reliable opportunity to combine the
detection of WIPI proteins with other parameters. It should
be noted that there are two isoforms of WIPI2 (2B and 2D)
[842], and in C. elegans EPG-6/WDR45/WIPI4 has been
identified as the WIPI homolog required for autophagy
[845]. Thus, these proteins, along with the currently unchar
acterized WDR45B/WIPI3, provide additional possibilities for
monitoring phagophore and autophagosome formation.
Cautionary notes: With regard to detection of the WIPI
proteins, endogenous WIPI1 puncta cannot be detected in
many cell types [837], and the level of transiently expressed
GFP-WIPI1 puncta is cell context-dependent [837, 838].
However, this approach has been used in human and mouse
cell systems [664, 838] and mCherry-Atg18 also works well
for monitoring autophagy in transgenic Drosophila [183],
although one caution with regard to the latter is that GFPAtg18 expression enhances Atg8 lipidation in the fat body of
fed larvae. GFP-WIPI1 and GFP-WIPI2 have been detected
on the completed (mature) autophagosome by freeze-fracture
analysis [144], but endogenous WIPI2 has not been detected
on mRFP-LC3- or LAMP2-positive autophagosomes or auto
lysosomes using immunolabeling [837]. Accordingly, it may
be possible to follow the formation and subsequent disappear
ance of WIPI puncta to monitor autophagy induction and
flux using specific techniques. As with GFP-LC3, overexpres
sion of WIPI1 or WIPI2 can lead to the formation of aggre
gates, which are stable in the presence of PtdIns3K inhibitors.
f. BECN1/Vps30/Atg6. BECN1 (yeast Vps30/Atg6) and
PIK3C3/VPS34 are essential partners in the autophagy inter
actome that signals the onset of autophagy [796, 846, 847],
and many researchers use this protein as a way to monitor
autophagy. Binding to the anti-apoptotic protein BCL2 inhi
bits BECN1 [848]. BECN1 also binds other anti-apoptotic
BCL2-family members via its putative BH3 domain [849,
850]. Autophagy is induced by the release of BECN1 from
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Figure 24. Automated WIPI1 puncta image acquisition and analysis monitors the induction and inhibition of autophagy. Stable U2OS clones expressing GFP-WIPI1
were selected using 0.6 μg/ml G418 and then cultured in 96-well plates. Cells were treated for 3 h with nutrient-rich medium (Control), nutrient-free medium (EBSS),
or with 233 nM wortmannin. Cells were fixed in 3.7% paraformaldehyde and stained with DAPI (5 μg/ml in PBS). An automated imaging and analysis platform was
used to determine the number of both GFP-WIPI1 puncta-positive cells and the number of GFP-WIPI1 puncta per individual cell [664]. Cells without GFP-WIPI1 puncta
are highlighted in red (cell detection) and purple (nuclei detection), whereas GFP-WIPI1 puncta-positive cells are highlighted in yellow (GFP-WIPI1 puncta detection),
green (cell detection) and blue (nuclei detection). Bars: 20 µm. Images provided by S. Pfisterer and T. Proikas-Cezanne.

BCL2 by pro-apoptotic BH3 proteins, phosphorylation of
BECN1 by DAPK1 and DAPK2 (at Thr119, located in the
BH3 domain) [851, 852], or phosphorylation of BCL2 by
MAPK8/JNK1 (at Thr69, Ser70 and Ser87) [853, 854].
Release of BECN1 can also be achieved by the expression of
the F121A mutant, which leads to enhanced basal autophagy
in vivo [855]. The relationship between BECN1 and BCL2 is
more complex in developing cerebellar neurons, as it appears
that the cellular levels of BCL2 are, in turn, post-translation
ally regulated by an autophagic mechanism linked to a switch
from immaturity to maturity [856, 857]. It is important to be
aware, however, that certain forms of autophagy are induced
in a BECN1-independent manner and are not blocked by
PtdIns3K inhibitors [118, 858, 859]. Interestingly, caspasemediated cleavage of BECN1 inactivates BECN1-induced au
tophagy and enhances apoptosis in several cell types [860],
emphasizing that the crosstalk between apoptosis and auto
phagy is complex.
Although a population of BECN1 may localize in proxi
mity to the trans-Golgi network [861], it is also present at the
ER and mitochondria [848]. In keeping with these observa
tions, in cerebellar organotypic cultures BECN1 co-immuno
precipitates with BCL2 that is primarily localized at the
mitochondria and ER; and in a mouse model of neurodegen
eration, autophagic vacuoles in Purkinje neurons contain
partially digested organelles that are immunoreactive for
BCL2 [856, 862]. In addition, as BECN1-PIK3C3/VPS34 are
the major source of cellular PtdIns3P lipids and can be

present in multiple complexes that act during endosome
maturation in addition to autophagy [863], caution must be
exercised when monitoring localization. On induction of au
tophagy by various stimuli, the presence of BECN1- and
PIK3C3/VPS34-positive macroaggregates can be detected in
the region of the Golgi complex by immunofluorescence [207,
864]. Thus, BECN1-GFP puncta detected by fluorescence
microscopy or TEM may serve as an additional marker for
autophagy induction [865]; however, it should be noted that
caspase cleavage of BECN1 can be detected in normal culture
conditions (S. Luo, personal communication), and cleaved
BECN1 is translocated into the nucleus [866]. Thus, care
needs to be taken with these assays under stress conditions
in which more pronounced BECN1 cleavage occurs. In addi
tion, as with any GFP chimeras there is a concern that the
GFP moiety interferes with correct localization of BECN1.
To demonstrate that BECN1 or PtdIns3K macroaggregates
are an indirect indication of ongoing autophagy, it is manda
tory to show their specific association with the process by
including appropriate controls with inhibitors or preferably
by autophagy gene silencing. When a BECN1-independent
autophagy pathway is induced, such aggregates are not
formed regardless of the fact that the cell expresses BECN1
(e.g., as assessed by western blotting; C. Isidoro, personal
communication). As BECN1-associated PtdIns3K activity is
crucial in autophagosome formation in BECN1-dependent
autophagy, the measurement of PtdInsk3K in vitro lipid
kinase activity in BECN1 immunoprecipitates can be a useful
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technique to monitor the functional activity of this complex
during autophagy modulation [774, 775, 867]. It is important
to note that an in vitro lipid kinase assay with BECN1 immu
noprecipitates represents the total PtdIns3K activity and does
not make it possible to distinguish between the production of
PtdIns3P by PIK3C3/VPS34 in complex I versus that in com
plex II. Therefore, the most accurate measure of complexspecific activity of the class 3 PtdIns3K would be an in vitro
lipid kinase assay using ATG14 and UVRAG immunopreci
pitates [868, 869].
g. STX17. STX17 is a SNARE protein implicated in auto
phagosome-endolysosome fusion in cooperation with
SNAP29 and VAMP8 [795, 870]. STX17 was initially reported
to be recruited to completely sealed autophagosomes, but not
to phagophores [871–875]. STX17 as a competence factor may
be recruited just prior to fusion of autophagosomes with
lysosomes, and not all autophagosomes are positive for this
protein. However, later studies demonstrate that upon starva
tion STX17 colocalizes with the omegasome marker ZFYVE1/
DFCP1 [876, 877], consistent with the view that STX17 is also
implicated in autophagosome formation in starvation-induced
autophagy [872, 873, 877] and mitophagy [878, 879]. In fed
cells, STX17 principally localizes to the ER, mitochondriaassociated ER membranes (MAMs), and mitochondria [871–
873]. Some STX17 is phosphorylated by TBK1 at Ser202, and
the phosphorylated form localizes to the Golgi apparatus
[877]. STX17 also has a critical role in mediating the retro
grade transport of autophagosomes upon their fusion with
late endosome (LEs) in distal neuronal axons [880, 881].
Neurons are highly polarized cells with long axons, and thus
face special challenges to transport AVs toward the soma
where mature lysosomes are relatively enriched. LE-loaded
dynein-SNAPIN motor-adaptor complexes are recruited to
AVs upon STX17-mediated LE-AV fusion. This motor shar
ing ride-on service enables neurons to maintain effective
autophagic clearance in the soma, thus reducing autophagic
stress in axons.
h. TECPR1. TECPR1 binds ATG5 through an AFIM (ATG5
[five] interacting motif). TECPR1 competes with ATG16L1
for binding to ATG5, suggesting that there is a transition
from the ATG5-ATG16L1 complex that is involved in phago
phore expansion to an ATG5-TECPR1 complex that plays a
role in autophagosome-lysosome fusion [882]. TECPR1 thus
marks lysosomes and autolysosomes [883].
i. ZFYVE1/DFCP1. ZFYVE1 binds PtdIns3P that localizes
to the ER and Golgi. Starvation induces the translocation of
ZFYVE1 to punctate structures on the ER; the ER population
of ZFYVE1 marks the site of omegasome formation [884].
ZFYVE1 partially colocalizes with WIPI1 upon nutrient star
vation [842] and also with WIPI2 [837].
Conclusion: Components of the autophagic machinery
other than Atg8-family proteins can be monitored to follow
autophagy, and these can be important tools to define specific
steps of the process. For example, WIPI puncta formation can
be used to monitor autophagy, but, similar to Atg8-family
proteins, should be examined in the presence and absence of
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lysosomal inhibitors. Analysis of WIPI puncta should be
combined with other assays because individual members of
the WIPI family might also participate in additional, unchar
acterized functions apart from their role in autophagy. At
present, we caution against the use of changes in BECN1
localization as a marker of autophagy induction, given its
other cellular roles. It is also worth considering the use of
different markers depending on the specific autophagic
stimuli.
7. Sphingolipids
Sphingolipids are ubiquitous membrane lipids that can be
produced in a de novo manner in the ER and Golgi apparatus
or by cleavage involving phosphodiesterases (sphingomyeli
nases), hydrolases (glycosphingolipid glycosidases), sphingoli
pid ceramide N-deacylase (SCDase), phosphatases (acting on
sphingosine-1-phosphate [S1P] and ceramide-1-phosphate) or
lyases (e.g., SGPL1 [sphingosine-1-phosphate lyase 1]) [885–
887]. For instance, SGPL1 is a ubiquitiously expressed enzyme
having a wide-range of functions in different cellular pro
cesses, including proliferation, motility and death. Moreover,
SGPL1 is a critical determinant for the degredation of the
sphingolipid S1P. The S1P pathway is a crucial mechanism for
neuronal autophagy by providing PE for LC3 conjugation
[888, 889]. Ablation and deletion of Sgpl1 result in reduced
autophagic activity in mouse brain [888]. Likewise, mutations
in SGPL1 and alterations in neuronal autophagy lead to severe
neurodevelopmental phenotypes ranging from fetal hydrops
to congenital brain malformations and neuropathies in
humans [890]. The multiple different metabolites of the
sphingolipid pathway, which are distinct by even a single
double bond, carbon chain length of the fatty acid, or pre
sence of a phosphate group, can have quite varied cellular
functions. Sphingolipids were first recognized for their role in
the architecture of membrane bilayers affecting parameters
such as bilayer stiffness, neighboring lipid order parameter
and microdomain/raft formation. They also act as second
messengers in vital cellular signaling pathways and as key
determinants of cellular homeostasis in what is called a sphin
golipid rheostat [891]. Sphingolipids participate in the forma
tion of different membrane structures and subcellular
organelles, such as mitochondria and ER, and are also
involved in the fusion and biophysical properties of cell
membranes [892]. Moreover, they are constitutive compo
nents of MAMs, subdomains of the ER that interact with
mitochondria [893].
Ceramides, positioned at the core of sphingolipid metabo
lism, play several roles that affect multiple steps of autophagy,
by inhibition of nutrient transporters [894], by modulation of
BCL2-BECN1 association at the level of AKT signaling [895],
and by regulation of mitophagy [896]. The latter function
is regulated by a particular ceramide species, stearoyl
(C18:0)-ceramide, a sphingolipid generated by CERS1 (cera
mide synthase 1). C18-ceramide, in association with LC3-II,
targets damaged mitochondria for phagophore sequestration
in response to ceramide stress, leading to tumor suppression
[896–900]. The binding of ceramide to LC3-II can be
detected using anti-ceramide and anti-LC3 antibodies by
immunofluorescence and confocal microscopy, co-
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immunoprecipitation using anti-LC3 antibody followed by
liquid chromatography-tandem MS, using appropriate stan
dards (targeted lipidomics), or labeling cells with biotinsphingosine to generate biotin-ceramide, and immunopreci
pitation using avidin columns followed by western blotting to
detect LC3-II. It should be noted that inhibitors of ceramide
generation, mutants of LC3 with altered ceramide binding
(F52A or I35A), and/or that are conjugation defective (e.g.,
G120A), should be used as negative controls [901]. The gen
eration of C18-ceramide in the outer mitochondrial mem
brane, which recruits LC3-containing phagophores for
mitophagy induction, is regulated through the trafficking of
the metabolic enzyme CERS1 by RPL29P31/p17/PERMIT
[901]. shRNA-mediated knockdown or deletion of this gene
prevent mitophagy in response to cellular stress both in cul
tured cells and in knockout mice [901]. Thus, colocalization
of CERS1 or RPL29P31/p17/PERMIT with TOMM20 using
immunofluorescence can also be used to detect mitophagy
signals in response to acute or chronic stress in situ and in
vivo.
Other sphingolipids are also involved in autophagy. For
example, accumulation of endogenous sphingosine-1-phos
phate, a pro-survival downstream metabolite from cera
mide triggers ER-stress associated autophagy, by
activation of AKT [902], excess sphingomyelin inhibits
phagophore closure by disturbing the trafficking of
ATG9A [812], and SMPD1/acid sphingomyelinase inhibits
autophagy through the activation of the MTOR pathway
[903], whereas it is required for LC3-associated phagocyto
sis [904]. Likewise, dihydroceramides, the penultimate
metabolite of ceramide biosynthesis have been implicated
in the regulation of autophagy [905]. Specifically, changes
in the levels of C16:0 and C18:0 dihydroceramides cause the
destabilization of autolyososomal membranes thereby lead
ing to the induction of autophagy-associated cell death
[906]. In addition, gangliosides, have been implicated in
autolysosome morphogenesis [907]. Moreover, a molecular
interaction of the ganglioside GD3 with core-initiator pro
teins of autophagy, such as AMBRA1 and WIPI1, is
revealed within lipid microdomains in MAMs, indicating
that MAM raft-like microdomains can play a role in the
initial organelle scrambling activity that finally leads to the
formation of the autophagosome [908].
To analyze the role of gangliosides in autophagy, two
main technical approaches can be used: co-immunoprecipi
tation and Förster resonance energy transfer. For the first
method, lysates from untreated or autophagy-induced cells
have to be immunoprecipitated with an anti-LC3 polyclonal
antibody (a rabbit IgG isotypic antibody should be used as a
negative control). The obtained immunoprecipitates are sub
jected to ganglioside extraction, and the extracts run on an
HPTLC aluminum-backed silica gel and analyzed for the
presence of specific gangliosides by using monoclonal anti
bodies. Alternatively, the use of FRET by flow cytometry
appears to be highly sensitive to small changes in distance
between two molecules, and is thus suitable to study mole
cular interactions, for example, between ganglioside and
LC3. Furthermore, FRET requires ~10 times less biological
material than immunoprecipitation.

Conclusion: Sphingolipids are bioactive molecules that
play key roles in the regulation of autophagy at various stages,
including upstream signal transduction pathways to regulate
autophagy via transcriptional and/or translational mechan
isms, autolysosome morphogenesis, and/or targeting phago
phores to mitochondria for degradation via sphingolipid-LC3
association [276, 897, 899–901, 909].
8. Transcriptional and translational regulation
The induction of autophagy in certain scenarios is accom
panied by an increase in the mRNA levels of certain auto
phagy-related genes, such as ATG1 [910], ATG6 [911], ATG7
[912, 913], ATG8/Lc3 [64, 473, 914–916], GABARAPL1 [473,
916], ATG9 [917], Atg12 [918], ATG13 [473, 916], Atg14
[919], ATG29 [910], WIPI1 [473, 916], and SQSTM1 [64],
and an autophagy-dedicated microarray was developed as a
high-throughput tool to simultaneously monitor the tran
scriptional regulation of all genes involved in, and related to,
autophagy [920]. The mammalian gene that shows the great
est transcriptional regulation in the liver (in response to
starvation and circadian signals) is Ulk1, but others also
show more limited changes in mRNA levels including
Gabarapl1, Bnip3 and, to a minor extent, Lc3b [921]. In
skin cancer and HeLa cells ULK1 and ULK2 expression is
negatively regulated at the transcriptional level by the chro
matin non-histone protein HMGA1 (high mobility group
AT-hook 1) [922]. In several mouse and human cancer cell
lines, ER stress and hypoxia increase the transcription of
Lc3/LC3, GABARAPL1, Atg5/ATG5, Atg12/ATG12, ATG13,
and WIPI1 by a mechanism involving the unfolded protein
response (UPR). Similarly, a stimulus-dependent increase in
LC3B expression is detected in neural stem cells undergoing
autophagy induction [923]. The ATG9A promoter, similar to
those of BNIP3 and BNIP3L, but in contrast to other ATG
family members such as ATG5 and ATG7, contains HIF1Aresponsive elements and is transcriptionally activated in
hypoxic glioblastoma cells [209]. Increased expression of
Atg5 in vivo after optic nerve axotomy in mice [924] and
increased expression of Atg7, Becn1 and Lc3a during neuro
genesis at different embryonic stages in the mouse olfactory
bulb are also seen [925]. LC3 and ATG5 are not required for
the initiation of autophagy, but mediate phagophore expan
sion and autophagosome formation. In this regard, the tran
scriptional induction of LC3 may be necessary to replenish
the LC3 protein that is turned over during extensive ER
stress- and hypoxia-induced autophagy [918, 926]. Of note,
however, a recent study showed that although tunicamycininduced ER stress activates autophagy and triggers a strong
transcriptional increase in LC3 mRNA and protein levels
(via ATF4), depletion of LC3 does not reduce ER stressinduced autophagy [473].
In the clinical setting, tissue expression of ATG5, LC3A
and LC3B and their respective proteins accompanies elevated
autophagy flux in human adipose tissue in obesity [292, 927].
Thus, assessing the mRNA levels of LC3 and other autophagyrelated genes by northern blot or reverse transcriptase poly
merase chain reaction (RT-PCR) may provide correlative data
relating to the induction of autophagy; in addition, proteomic
profiling of de novo protein synthesis in starvation-induced
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autophagy using bioorthogonal noncanonical amino acid tag
ging can further validate the function of the corresponding
proteins in autophagy induction [928]. However, a time
course may be necessary to obtain accurate information
because mRNA levels are likely to change substantially over
time. In addition, mRNA may be sequestered in P-bodies,
resulting in suppression of protein translation and timedependent loss of autophagy-related proteins, as was shown
for AMBRA1 and BECN1 in cells exposed to the hypoxia
mimetic CoCl2 [929]. Downregulation of autophagy-related
mRNAs has been observed in human islets under conditions
of lipotoxicity [571] that impair autophagic flux [930]. It is
not clear if these changes are sufficient to regulate autophagy,
however, and therefore these are not direct measurements.
Several transcription factors of the nuclear receptor super
family modulate expression of genes related to autophagy. For
instance, NR1D1/Rev-erbα modulates autophagy-associated
genes in a tissue-specific manner. Whereas NR1D1 represses
Ulk1, Bnip3, Atg5, Becn1 and Prkn/park2/parkin gene expres
sion in mouse skeletal muscle [931] as well as ulk1a and
atp6v1d in zebrafish larvae [932] by directly binding to reg
ulatory regions in their DNA sequences, STRA8 suppresses
autophagy and at the same time transcriptionally represses
Nr1d1 and, thereby, inhibits the expression of Ulk1 in mouse
testis [933]. NR1D1 upregulates Ulk1 by direct engagement of
distal RAR-related orphan receptor DNA elements as evalu
ated in stra8−/− nr1d1−/− double-knockout mice. Moreover, in
human macrophages, NR1D1 promotes lysosome biogenesis
and autophagy, contributing to its antimicrobial properties
against M. tuberculosis [934]. Whereas NR1D1 represses
autophagic flux in skeletal muscles, it upregulates the expres
sion of autophagy- and lysosome-associated genes in mouse
testis and human macrophages. Furthermore, NR1D1 induces
mitochondrial biogenesis in skeletal muscles, leads to
improved oxidative capacity of cells, and induces lysosome
biogenesis in human macrophages, augmenting antimicrobial
properties.
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The nuclear receptors PPARA and NR1H4/FXR also reg
ulate hepatic autophagy in mice. Indeed, PPARA and NR1H4
compete for the control of hepatic lipophagy in response to
fasting and feeding nutritional cues, respectively [921]. In
addition, activation of PPARA-mediated autophagy and the
lysosomal pathway in the nervous system, contributes to Aβ
clearance, and thus reduces Alzheimer disease (AD)-like
pathology and cognitive decline in a mouse model [935].
NR1H4 may also inhibit autophagy via inhibition of CREBCRTC2 complex assembly [936]. Consistent with in vitro
studies utilizing human cancer cell lines [937, 938], in
human adipose tissue explants, E2F1 binds the LC3B promo
ter, in association with increased expression of several auto
phagy genes and elevated adipose tissue autophagic flux [292,
927]. In this instance, classical promoter analysis studies,
including chromatin immunoprecipitation and ATG promo
ter-luciferase constructs, provide insights into the putative
transcriptional regulation of autophagy genes by demonstrat
ing promoter binding in situ, and promoter activity in
vitro [927].
Of note, large changes in Atg gene transcription just prior
to Drosophila salivary gland cell death (that is accompanied
by an increase in autophagy) are detected for Atg2, Atg4, Atg5
and Atg7, whereas there is no significant change in Atg8a or
Atg8b mRNA [939, 940]. Autophagy is critical for Drosophila
midgut cell death, which is accompanied by transcriptional
upregulation of all of the Atg genes tested, including Atg8a
(Figure 25) [375, 941]. Similarly, in the silkworm (Bombyx
mori) larval midgut [942], fat body [943] and silk gland [944]
the occurrence of autophagy is accompanied by an upregula
tion of the mRNA levels of several Atg genes. Transcriptional
upregulation of Drosophila Atg8a and Atg8b is also observed
in the fat body following induction of autophagy at the end of
larval development [945], and these genes as well as Atg2,
Atg9 and Atg18 show a more than 10-fold induction during
starvation [946]. Atg5, Atg6, Atg8a and Atg18 are upregulated
in the ovary of starved flies [947], and an increase in

Figure 25. Clonal analysis of autophagy in the Drosophila larval midgut. Inhibition of autophagy in somatic clone cells marked by GFP (green, outlined) have
decreased levels of mCherry-Atg8a puncta (red) compared to the control wild-type cells (non-GFP) with nuclei in blue (merged image, right panel). Bar: 20 µm. Image
provided by D. Denton and S. Kumar.
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Drosophila Atg8b is observed in cultured Drosophila l(2)mbn
cells following starvation (S. Gorski, personal communica
tion). An upregulation of plant ATG8 may be needed during
the adaptation to reproductive growth; a T-DNA inserted
mutation of rice ATG8b blocked the change from vegetative
growth to reproductive growth in both homozygous and
heterozygous plant lines (M.-Y. Zhang, H. Budak, unpub
lished results).
Similarly, the upregulation of autophagy-related and -asso
ciated genes (Atg4b, Atg12, Atg13, Bnip3, Gabarapl1, Lc3,
WIPI1) has been documented at the transcriptional and trans
lational level in several other species (e.g., C. elegans [948],
mouse, rat, human [949], trout, Arabidopsis and maize) under
conditions of ER stress [473, 918], and diverse types of pro
longed (several days) catabolic situations including cancer
cachexia, diabetes mellitus, uremia and fasting [290, 662,
950–953]. Along these lines, the mRNA levels of atg1, atg8a/
b and sqstm1 increase in D. discoideum upon infection with
the fish and frog pathogen Mycobacterium marinum [64], a
close relative of M. tuberculosis. Similarly, ATG9 and
ATG16L1 are transcriptionally upregulated upon influenza
virus infection (H. Khalil, personal communication), and in
C. elegans, the FOXA transcription factor PHA-4 and the
TFEB (transcription factor EB) ortholog HLH-30 regulate
the expression of several autophagy-related genes (see
Methods and challenges of specialized topics/model systems.
C. elegans) [573, 948]. Such prolonged induction of the
expression of ATG genes has been thought to allow the
replenishment of critical proteins (e.g., LC3 and GABARAP)
that are destroyed during autophagosome fusion with the
lysosome [954].
The polyamine spermidine increases life span and induces
autophagy in cultured yeast and mammalian cells, as well as
in nematodes, flies and mice. In aging yeast, spermidine
treatment triggers epigenetic deacetylation of histone H3
through inhibition of histone acetyltransferases, leading to
significant upregulation of various autophagy-related tran
scripts [955]. In mammalian cells, spermidine promotes au
tophagy flux by depleting cytosolic HDAC4 to enhance the
acetylation and stability of MAP1S (microtubule-associated
protein 1S) to prolong mouse lifespan and prevent liver
fibrosis and hepatocellular carcinomas [956]; however, the
functional relevance of autophagy for liver fibrosis and can
cer is highly dependent on the cell type. Whereas autophagy
maintains cellular homeostasis in hepatocytes, Kupffer cells
(macrophages), and liver sinusoidal endothelial cells, thereby
counteracting fibrogenesis in the liver, it is the prime process
of providing energy for the activation of hepatic stellate cells,
which leads to collagen production and fibrogenesis [957].
Spermidine also drives the hypusination of the translation
factor EIF5A, which in turn controls the translation of TFEB
to rejuvenate B cell immunity [958]. In addition, spermidine
stimulates mitophagy in cardiomyocytes and prevents typical
age-related cardiac deterioration in an autophagy-dependent
manner [959]. IPMK, can alter histone H4 acetylation and
influence gene expression of LC3B, BNIP3, BNIP3L,
SQSTM1, GABARAPL1 and ATG12; loss of IPMK in liver
prevents lipophagy and liver regeneration [621, 690].

In addition to spermidine, melatonin, a hormone pre
sent in both mammals and plants, plays a critical role in
inducing the expression of ATG genes under heat stress in
tomato [960]. Both foliar application of an optimal dose of
melatonin and the overexpression of the ASMT (N-acetyl
serotonin O-methyltransferase) gene results in an upregu
lation of the expression of ATG genes and the formation of
autophagosomes leading to the degradation of denatured
proteins resulting from heat stress in tomato [960]. Under
cadmium stress, HSFA1A (heat shock factor 1A) promotes
the accumulation of melatonin through directly activating
the transcription of COMT1 (caffeate O-methyltransferase
1), a key gene in melatonin biosynthesis [961], indicating
that HSFA1A might mediate autophagy in response to
stress in plants. Indeed, silencing of HSFA1A completely
blocks drought stress-induced expression of ATG10 and
ATG18F, whereas the expression of these genes is increased
in HSFA1A-overexpressing plants [962]. An electrophoretic
mobility shift assay and ChIP-qPCR analysis show that
HSFA1A binds to the promoters of these two ATG genes
and directly regulates their expression to trigger autophagy
under drought stress in tomato plants [962]. Furthermore,
BZR1 (brassinazole-resistant 1), a phytohormone brassi
nosteroid-activated transcription factor, induces the
expression of ATG2 and ATG6 to form autophagosomes,
which mediate the response to nitrogen starvation in
tomato [963].
In addition to the ATG genes, transcriptional upregulation
of VMP1 can be detected in mammalian cells subjected to
rapamycin treatment or starvation, and in tissues undergoing
disease-induced autophagy such as cancer [964]. VMP1 is an
essential autophagy gene that is conserved from D. discoideum
to mammals [422, 965], and the VMP1 protein regulates early
steps of the autophagic pathway and is essential for correct
functioning of membrane contact sites between the ER and
other organelles including autophagosomes [841, 966]. VMP1
is poorly expressed in mammalian cells under nutrient-nor
mal conditions, but is highly upregulated in cells undergoing
autophagy, and the expression of VMP1 induces autophago
some formation. The GLI3 transcription factor is an effector
of KRAS that regulates the expression and promoter activity
of VMP1, using the histone acetyltransferase EP300/p300 as a
co-activator [967].
A gene regulatory network, named CLEAR (coordinated
lysosomal expression and regulation) that controls both lyso
some and autophagosome biogenesis was identified using a
systems-biology approach [949, 968, 969],635,636]. The basic
helix-loop-helix transcription factor TFEB acts as a master
gene of the CLEAR network and positively regulates the
expression of both lysosomal and autophagy genes, thus link
ing the biogenesis of two distinct types of cellular compart
ments (i.e., autophagosomes and lysosomes) that cooperate in
the autophagic pathway. TFEB activity is regulated by starva
tion and is controlled by both MAPK1/ERK2-, MTOR-, and
AKT-mediated phosphorylation at specific serine residues
[949, 970–973]; thus, it can serve as a new tool for monitoring
transcriptional regulation connected with autophagy. TFEB is
phosphorylated by MTORC1 on the lysosomal surface, pre
venting its nuclear translocation. A lysosome-to-nucleus
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signaling mechanism transcriptionally regulates autophagy
and lysosomal biogenesis via MTOR and TFEB [971]. TFEB
phosphorylation on specific residues also occurs in the
nuclear compartment and enables TFEB nuclear export
[974–976]. Thus, TFEB activity is tightly regulated by differ
ent phosphorylation events that control TFEB nuclear import
and export rates. Therefore, a very useful readout of endo
genous TFEB activity is the evaluation of TFEB subcellular
localization, as activation of TFEB correlates with its relocali
zation from the cytoplasm to the nucleus. This shift can be
monitored by immunofluorescence using antibodies against
TFEB. TFEB localization may also be studied to monitor
MTOR activity, as in most cases TFEB nuclear localization
correlates with inhibition of MTOR. However, due to the low
expression levels of TFEB in most cells and tissues, it may be
difficult to visualize the endogenous protein. Thus, a TFEB
nuclear translocation assay was developed in a HeLa cell line
stably transfected with TFEB-GFP. This fluorescence assay
can be used to identify the conditions and factors that pro
mote TFEB activation [971]. TFE3 and MITF, two other
members of the MiT/TFE family of transcription factors, in
some cases can compensate for TFEB and are regulated in a
similar manner [973, 977, 978]. In response to histone deace
tylase inhibitors, TFEB acetylation exerts an important func
tion in control of its transcriptional activity and lysosomal
function [979]. Finally, an AMPK-SKP2-CARM1 signaling
cascade has also been reported to play a role in transcriptional
regulation of autophagy [980]; CARM1 exerts a transcrip
tional coactivator function on autophagy and lysosomal
genes through TFEB.
Similar to TFEB, the erythroid transcription factor GATA1
and its coregulator ZFPM1/FOG1 as well as the myeloid
master regulator SPI1/PU.1 induce the transcription of multi
ple genes encoding autophagy components. This developmen
tally regulated transcriptional response is coupled to increases
in autophagosome number as well as the percent of cells that
contain autophagosomes [981–983]. FOXO transcription fac
tors, especially FOXO1 and FOXO3, also play critical roles in
the regulation of autophagy gene expression [662, 919, 984]. A
zinc finger family DNA-binding protein, ZKSCAN3, is a
master transcriptional repressor of autophagy and lysosome
biogenesis; starvation and MTOR inhibition with torin1
induce nucleus-to-cytoplasm translocation of ZKSCAN3
[985]. The expression of the transcription factor EGR1 (early
growth response 1) is rapidly increased upon nutrient depri
vation and can directly increase transcription of multiple
components of the autophagy machinery. The EGR1 DNAbinding motif is significantly enriched in the promoters/
enhancers of autophagy-associated genes; EGR1 positively
regulates the transcription of these genes (including ATG2A,
ATG14, ATG3, ATG13, ATG101, LC3B, PIK3C3, PPM1D,
ULK1, and ZFYVE1), and thereby increases the autophagic
flux [986]. Transcription factor NFE2L2/NRF2, considered as
the master regulator of cellular homeostasis, modulates the
expression of autophagy-related genes, including the already
mentioned Sqstm1 but also Atg2b, Atg4d, Atg5, Atg7,
Calcoco2/Ndp52, Gabarapl1 and Ulk1 [987]. Moreover,
NFE2L2/NRF2 is a regulator of Lamp2a transcription, and
therefore, it controls CMA [988]. This transcription factor
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may have a relevant role upon stressful conditions, including
proteotoxic or oxidative insults. Finally, CEBPB/C/EBPβ is a
transcription factor that regulates autophagy in response to
the circadian cycle in mice [989] and zebrafish [932].
Although less work has been done on post-transcriptional
regulation, several studies implicate microRNAs in controlling
the expression of proteins associated with autophagy [332–
334, 990–993]. In this context, an important player is repre
sented by MIR27A. Autophagy implementation is linked to
ATP and HMGB1 release and ecto-CALR (calreticulin) expo
sure in HCT116 colon cancer cells with knockdown of
MIR27A. This pathway is active in basal conditions, as indi
cated by the presence of the mature LC3-II form and acquisi
tion of autophagic morphological features (large bodies,
multiple or multilobated nuclei, cytosolic vacuoles and gran
ules) when compared to control and MIR27A-overexpressing
HCT116 cells. Methotrexate treatment triggers autophagy in
time-course experiments, as the mature LC3-II form rapidly
increases following MIR27A knockdown, whereas the change
is limited in control and MIR27A-overexpressing HCT116
cells. Treatment with the lysosomotropic agent CQ confirms
that the higher LC3-II levels reveal an augmented autophagic
flux leading to autophagosome development. The mature
LC3-II form shows a remarkable dose-dependent increase
upon MIR27A knockdown with respect to control and espe
cially MIR27A-overexpressing HCT116 cells [994].
Cautionary notes: Most of the ATG genes do not show
significant changes in mRNA levels when autophagy is induced.
Even increases in LC3 mRNA can be quite modest and are cell
type- and organism-dependent [995]. In addition, it is generally
better to follow protein levels, which, ultimately, are the signifi
cant parameter with regard to the initiation and completion of
autophagy. However, ATG protein amounts do not always
change significantly, and the extent of increase is again cell
type- and tissue-dependent. Finally, changes in autophagy pro
tein levels are not sufficient evidence of autophagy induction and
must be accompanied by additional assays as described herein.
Thus, monitoring changes in mRNA levels for either ATG genes
or autophagy regulators may provide some evidence supporting
upregulation of the potential to undergo autophagy, but should
be used along with other methods.
Another general caution pertains to the fact that in any
cell culture system mixed populations of cells (for example,
those undergoing autophagy or not) exist simultaneously.
Therefore, only an average level of protein or mRNA expres
sion can be evaluated with most methods. This means that
the results regarding specific changes in autophagic cells
could be hidden due to the background of the average data.
Along these lines, experiments using single-cell qPCR to
examine gene expression in individual cardiomyocytes with
and without signs of autophagy reveal that the transcription
of MTOR markedly and significantly increases in autophagic
cells in intact cultures (spontaneously undergoing autopha
gy) as well as in cultures treated with proteasome inhibitors
to induce autophagy (V. Dosenko, personal communica
tion). Finally, researchers need to realize that mammalian
cell lines may have mutations that alter autophagy signaling
or execution; this problem can be avoided by using primary
cells.
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Conclusion: Although there are changes in ATG gene
expression that coincide with, and may be needed for, auto
phagy, in most cases this has not been carefully studied
experimentally. Therefore, at the present time we do not
recommend the monitoring of ATG gene transcription as a
general readout for autophagy unless there is clear documen
tation that the change(s) correlates with autophagy activity.
9. Posttranslational modifications
Autophagy is controlled by posttranslational modification
(PTM) of ATG proteins such as phosphorylation, ubiquitina
tion, acetylation, O-GlcNAcylation, N6-methyladenosine
modification, oxidation and cleavage, which can be monitored
to analyze the status of the process [293, 611, 767, 775, 996–
1000]. The global deacetylation of proteins, which often
accompanies autophagy, can be conveniently measured by
quantitative immunofluorescence and western blotting with
antibodies specifically recognizing acetylated lysine residues
[1001]. Indeed, depletion of the nutrient supply causes auto
phagy in yeast or mammalian cells by reducing the nucleocytosolic pool of acetyl-coenzyme A, which provides acetyl
groups to acetyltransferases, thus reducing the acetylation
level of hundreds of cytoplasmic and nuclear proteins
[1002]. A global deacetylation of cellular proteins is also
observed in response to so-called “caloric restriction
mimetics”, that is, a class of pharmacological agents that
deplete the nucleo-cytosolic pool of acetyl-coenzyme A, inhi
bit acetyltransferases (such as EP300) or activate deacetylases
(such as SIRT1). All these agents reduce protein acetylation
levels in cells as they induce autophagy [1003]. One promi
nent ATG protein that is subjected to pro-autophagic deace
tylation is LC3 [1004, 1005]. Moreover, SIRT1 inhibition by
EX-527 decreases the lipidation of LC3 [1006]. Recently,
ULK1 O-GlcNAcylation was shown to be crucial for autopha
gy initiation [1007, 1008]; this modification potentiatiates
AMPK-dependent phosphorylation of ULK1 and allows bind
ing to and phosphorylation of ATG14, and subsequent activa
tion of PIK3C3/VPS34.
Another mechanism through which autophagy-related
proteins are regulated is by means of S-nitrosylation, the
covalent binding of nitric oxide (NO) to specific cysteine
residues [1009]. High levels of free NO have been linked to
an overall inhibitory effect on autophagic machinery [1010].
Conversely, the modulation of the amount of S-nitrosylated
proteins triggered by changes in the activity or expression of
the denitrosylase ADH5/GSNOR (alcohol dehydrogenase 5
[class III], chi polypeptide), seems to have no major effects
on nonselective autophagy, whereas there is an effect on the
recognition of damaged mitochondria to be targeted for selec
tive mitophagy [1011, 1012]. Persulfidation (S-sulfhydration)
plays an important role in mitophagy-related proteins such as
PRKN, whose catalytic activity is stimulated by persulfidation,
whereas nitrosylation inactivates it [1013]. Mitophagy is also
promoted by persulfidation of USP8 (ubiquitin specific pepti
dase 8), which enhances deubiquitination of PRKN [1014].
Other important autophagy-related proteins such as ATG3,
ATG5, ATG7 and ATG18A in plants are also targets for
persulfidation, but the role of this modification needs further
clarification [1015].

Phosphorylation of other autophagic proteins plays a cri
tical role in the regulation of autophagy activity. For example,
CSNK2 (casein kinase 2) and ULK1 induce phosphorylation
of SQSTM1 at serine 403 and serine 409, respectively, increas
ing the binding affinity of SQSTM1 for ubiquitin, and enhan
cing the autophagic degradation of ubiquitinated proteins
[427, 714]. Also, EGFR signaling induces multi-site tyrosine
phosphorylation of BECN1 to inhibit core autophagy machin
ery activation [775].
Finally, N6-methyladenosine (m6A) mRNA modification
plays an important role in regulating autophagy. ULK1
mRNA undergoes m6A modification in the 3ʹ UTR, and the
m6A-marked ULK1 transcripts can further be targeted for
degradation by YTHDF2 (YTH N6-methyladenosine RNA
binding protein 2). Moreover, FTO (FTO alpha-ketoglutarate
dependent dioxygenase) reverses the m6A mRNA modifica
tion of ULK1 transcripts, thereby promoting the initiation of
autophagy [1016].
10. Autophagic protein degradation
Protein degradation assays represent a well-established meth
odology for measuring autophagic flux, and they allow good
quantification. The general strategy is first to label cellular
proteins by incorporation of a radioactive amino acid (e.g.,
[14C]- or [3H]-leucine, [14C]-valine or [35S]-methionine;
although valine may be preferred over leucine due to the
strong inhibitory effects of the latter on autophagy), prefer
ably for a period sufficient to achieve labeling of the longlived proteins that best represent autophagic substrates, and
then to follow this with a long cold-chase so that the assay
starts well after labeled short-lived proteins are degraded
(which occurs predominantly via the proteasome). Next, the
time-dependent release of acid-soluble radioactivity from the
labeled protein in intact cells or perfused organs is measured
[4, 25, 1017]. Note that the inclusion of the appropriate
unlabeled amino acid (i.e., valine, leucine or methionine) in
the starvation medium at a concentration equivalent to that of
other amino acids in the chase medium is necessary; other
wise, the released [14C]-amino acid is effectively re-incorpo
rated into cellular proteins, which results in a significant
underestimation of protein degradation. A newer method of
quantifying autophagic protein degradation is based on Lazidohomoalanine (AHA) labeling [1018, 1019]. When
added to cultured cells, L-azidohomoalanine is incorporated
into proteins during active protein synthesis. After a click
reaction between an azide and an alkyne, the azide-containing
proteins can be detected with an alkyne-tagged fluorescent
dye, coupled with flow cytometry. The turnover of specific
proteins can also be measured in a pulse-chase regimen using
the Tet-ON/OFF or GeneSwitch systems and subsequent wes
tern blot analysis [1020–1022].
In this type of assay a considerable fraction of the mea
sured degradation will be nonautophagic, and thus it is
important to also measure, in parallel, cell samples treated
with autophagy-suppressive concentrations of 3-MA, SAR405, bafilomycin A1, CQ, ammonia, or amino acids, or gen
erated under conditions of amino acid depletion, or in sam
ples obtained from mutants missing central ATG
components; these values are then subtracted from the total
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readouts. The complementary approach of using compounds
that block other degradative pathways, such as proteasome
and ER-associated degradation (ERAD) inhibitors, can also
provide valuable information [216]. However, these inhibitors
may sometimes cause unexpected results and should be inter
preted with caution due to potential nonspecific effects and
crosstalk among the degradative systems. For example, block
ing proteasome function may activate autophagy [613, 1023–
1026], although those studies did not assess long-lived protein
degradation. Studies that have directly compared the effects of
proteasomal and lysosomal degradation inhibitors—alone and
in combination—on long-lived protein degradation have
demonstrated that proteasomal and lysosomal inhibitors
have near perfectly additive effects [216, 1027], thus suggest
ing that the crosstalk between the proteasomal and autophagic
systems does not appreciably affect the results obtained in the
long-lived protein degradation assay (although this does not
exclude the possibility that this may occur under other con
ditions, so this needs to be tested from case to case).
Conversely, interference with the CMA pathway does seem
to activate a compensatory form of autophagy that increases
the overall degradation of long-lived proteins [133, 307]. In
general, when using inhibitors, it is critical to know whether
the inhibitors being used alter autophagy in the particular cell
type and context being examined. In addition, because 3-MA
could have some autophagy-independent effects in particular
settings it is advisable to verify that the 3-MA-sensitive degra
dation is also sensitive to specific class III PtdIns3K inhibitors
such as SAR-405, and to general lysosomal inhibitors (such as
NH4Cl or leupeptin) [25, 216].
The use of stable isotopes, such as 13C and 15N, in quanti
tative MS-based proteomics allows the recording of degrada
tion rates of thousands of proteins simultaneously. These
assays may be applied to autophagy-related questions
enabling researchers to investigate differential effects in global
protein or even organelle degradation studies [1028, 1029].
Stable isotope labeling with amino acids in cell culture
(SILAC) can also provide comparative information between
different treatment conditions, or between a wild type and
mutant.
Another assay that could be considered relies on the lim
ited proteolysis of a BHMT (betaine–homocysteine S-methyl
transferase) fusion protein. The 44-kDa full-length BHMT
protein is cleaved in hepatocyte amphisomes in the presence
of leupeptin to generate 32-kDa and 10-kDa fragments [1030–
1033]. Accumulation of these fragments is time dependent
and is blocked by treatment with autophagy inhibitors. A
modified version of this marker, GST-BHMT, can be
expressed in other cell lines where it behaves similar to the
wild-type protein [1034]. Additional substrates may be con
sidered for similar types of assays. For example, the neomycin
phosphotransferase II-GFP (NeoR-GFP) fusion protein is a
target of autophagy [620]. Transfection of lymphoblastoid
cells with a plasmid encoding NeoR-GFP followed by incuba
tion in the presence of 3-MA leads to an accumulation of the
NeoR-GFP protein as measured by flow cytometry [1035].
A similar western blot assay is based on the degradation of
a cytosolic protein fused to GFP. This method has been used
in yeast and D. discoideum cells using GFP-Pgk1 and GFP-
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Tkt-1 (phosphoglycerate kinase and transketolase, respec
tively). In this case the relative amount of free GFP and the
complete fusion protein is the relevant parameter for quanti
fication; although it may not be possible to detect clear
changes in the amount of the full-length chimera, especially
under conditions of limited flux [40, 52]. As described above
for the marker GFP-Atg8-family proteins, nonsaturating
levels of lysosomal inhibitors are also needed in D. discoideum
cells to slow down the autophagic degradation, allowing the
accumulation and detection of free GFP. It should be noted
that this method monitors bulk autophagy because it relies on
the passive transit of a cytoplasmic marker to the lysosome.
Consequently, it is important to determine that the marker is
distributed homogeneously in the cytoplasm.
Recently, the fluorescent coral protein Keima, which is
resistant to lysosomal degradation, and which can be used to
measure autophagic cargo flux to acidic environments [1036]
has been fused (through genetic engineering) to a variety of
cellular proteins, for example ribosomal, proteasomal, mito
chondrial, or cytosolic proteins [1037]. These fusion proteins
are proteolytically cleaved off from Keima and degraded
(whereas Keima is stable). The cleavage can be detected by
western blotting for Keima, where an increase in non-fused
Keima reflects delivery of the fusion proteins to lysosomes.
Thus, this approach represents a very versatile method to
determine delivery of various cargo for lysosomal proteolysis
and thereby monitor both nonselective and selective autopha
gy [1037]. Generation of stable cell lines with inducible
expression of the Keima fusion proteins may provide a more
reliable result under certain conditions. For example, during
oxidative stress the expression of the Keima fusion proteins
themselves seem to be increased, possibly due to stressinduced activation of the CMV promoter. More reliable data
are produced, especially for the high-turnover probe KeimaLC3, by inducing expression of the Keima-probe prior to the
stimulus of interest, and then following the generation of
cleaved Keima during a chase period (M. Torgersen, unpub
lished results).
Of note, however, the assay only assesses proteolytic activity,
and cannot be used to tell whether the cargo has reached fully
active autolysosomes or whether the degraded cargo is recycled
to the cytosol. This is as opposed to the long-lived protein
degradation assay, which is a true end-point measurement of
autophagy, because it (with the inclusion of proper controls)
can measure the amount of degraded, free amino acids (and
short peptides) that have been released from the autolysosomes.
One of the most useful methods for monitoring autophagy
in S. cerevisiae is the Pho8∆60 assay. PHO8 encodes a vacuo
lar phosphatase, which is synthesized as a zymogen before
finally being transported to and activated in the vacuole
[1038]. A molecular genetic modification that eliminates the
first 60 amino acids prevents the mutant (Pho8∆60) from
entering the ER, leaving the zymogen in the cytosol. When
autophagy is induced, the mutant zymogen is delivered to the
vacuole nonselectively inside autophagosomes along with
other cytoplasmic material. The resulting activation of the
zymogen can be easily measured by enzymatic assays for
phosphatase activity [356]. To minimize background activity,
it is preferable to have the gene encoding the cytosolic Pho13
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phosphatase additionally deleted (although this is not neces
sary when assaying certain substrates).
Cautionary notes: Measuring the degradation of longlived proteins requires prior radiolabeling of the cells, and
subsequent separation of acid-soluble from acid-insoluble
radioactivity. The labeling can be done with relative ease
both in cultured cells and in live animals [4], and has recently
been scaled down to minimize the amount of radioactivity
needed in cell culture experiments [25]. In cells, it is also
possible to measure the release of an unlabeled amino acid
by chromatographic methods, thereby obviating the need for
prelabeling [1039]; however, it is important to keep in mind
that amino acid release is also regulated by protein synthesis,
which in turn is modulated by many different factors. In
either case, one potential problem is that the released amino
acid may be further metabolized. For example, branched
chain amino acids are good indicators of proteolysis in hepa
tocytes, but not in muscle cells where they are further oxi
dized (A.J. Meijer, personal communication). In addition, the
amino acid can be reincorporated into protein; for this reason,
such experiments can be carried out in the presence of CHX,
but this raises additional concerns (see Turnover of autophagic
compartments). In the case of labeled amino acids, a nonla
beled chase is added where the tracer amino acid is present in
excess (being cautious to avoid using an amino acid that
inhibits autophagy), or by use of single-pass perfused organs
or superfused cells [1040, 1041]. The perfused organ system
also allows for testing the reversibility of effects on proteolysis
and the use of autophagy-specific inhibitors in the same
experimental preparation, which are crucial controls for
proper assessment.
If the autophagic protein degradation is low (as it will be in
cells in replete medium), it may be difficult to measure it
reliably above the relatively high background of nonautopha
gic degradation. It should also be noted that the usual practice
of incubating the cells under “degradation conditions,” that is,
in a saline buffer, indicates the potential autophagic capacity
(maximal attainable activity) of the cells rather than the
autophagic activity that prevails in vivo or under rich-culture
conditions. Finally, inhibition of a particular degradative
pathway is typically accompanied by an increase in a separate
pathway as the cell attempts to compensate for the loss of
degradative capacity [1025]. This compensation might inter
fere with control measurements under conditions that attempt
to inhibit autophagy; however, as the latter is the major
degradative pathway, the contributions of other types of
degradation over the course of this type of experiment are
most often negligible. Another issue of concern, however, is
that most pharmacological protease inhibitors have “off tar
get” effects that complicate the interpretation of the data.
The Pho8∆60 assay requires standard positive and negative
(such as an atg1∆ strain) controls, and care must be taken to
ensure the efficiency of cell lysis. Glass beads lysis works well
in general, provided that the agitation speed of the instrument
is adequate. Instruments designed for liquid mixing with
lower speeds should be avoided. We also recommend against
holding individual sample tubes on a vortex, as it is difficult to
maintain reproducibility; devices or attachments are available
to allow multiple tubes to be agitated simultaneously. Finally,

it is also important to realize that the deletion of PHO8 can
affect yeast cell physiology, especially depending on the
growth conditions, and this may in turn have consequences
for the cell wall; cells under starvation stress generate thicker
cell walls that can be difficult to degrade enzymatically.
Conclusion: Measuring the turnover of long-lived proteins
is a standard method for determining autophagic flux. Newer
proteomic techniques that compare protein levels in autopha
gy-deficient animals relative to wild-type animals are promis
ing [1042, 1043], but the current ratiometric methods are
affected by both protein synthesis and degradation, and thus
analyze protein turnover, rather than degradation.
11. Selective types of autophagy
Although autophagy can be nonselective, in particular during
starvation, there are many examples of selective types of
autophagy.
a. The Cvt pathway, mitophagy, pexophagy, piecemeal
microautophagy of the nucleus and late nucleophagy in
yeast and filamentous fungi. The precursor form of amino
peptidase I (prApe1) is the major cargo of the Cvt pathway in
yeast, a biosynthetic autophagy-related pathway [177]. The
propeptide of prApe1 is proteolytically cleaved upon vacuolar
delivery, and the resulting shift in molecular mass can be
monitored by western blot. Under starvation conditions,
prApe1 can enter the vacuole through nonselective autophagy,
and thus has been used as a marker for both the Cvt pathway
and autophagy.
The yeast Cvt pathway is unique in that it is a biosynthetic
route that utilizes the autophagy-related protein machinery,
whereas other types of selective autophagy are degradative.
The latter include pexophagy, mitophagy, reticulophagy and
xenophagy, and each process has its own marker proteins,
although these are typically variations of other assays used to
monitor the Cvt pathway or autophagy. One common type of
assay involves the processing of a GFP chimera similar to the
GFP-Atg8 processing assay (see GFP-Atg8-family protein lyso
somal delivery and partial proteolysis). For example, yeast
pexophagy utilizes the processing of Pex14-GFP and Pot1/
Fox3/thiolase-GFP [1044, 1045], whereas mitophagy can be
monitored by the generation of free GFP from Om45-GFP,
Idh1-GFP, Idp1-GFP or mito-DHFR-GFP [1046–1050].
Important differences, however, can be observed between
GFP chimera of endogenous mitochondrial proteins and an
artificial construct such as mito-DHFR-GFP [1051]. In fila
mentous fungi, NBR1-dependent pexophagy can be moni
tored by inducing peroxisome proliferation through growth
in fatty acid-containing medium and shifting the mycelium
back to complete medium to visualize DsRED-labeled peroxi
some degradation in the vacuole [1052]. Localization of mito
chondrially-targeted proteins (or specific MitoTracker® dyes)
or similar organelle markers such as those for the peroxisome
(e.g., GFP-SKL with Ser-Lys-Leu at the C terminus that acts as
a peroxisomal targeting signal, Aox3 [acyl-CoA oxidase 3]EYFP that allows simultaneous observation of peroxisomevacuole dynamics with the single FITC filter set, or GFPCta1 [catalase A]) can also be followed by fluorescence micro
scopy [831, 1045, 1053–1055]. In addition, yeast mitophagy
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Figure 26. S. cerevisiae cells were cultured to mid-log phase and shifted to SD-N
for the indicated times. Samples were taken before (+) and at the indicated times
after (–) nitrogen starvation. Immunoblotting was done with anti-phospho-Slt2
and anti-phospho-Hog1 antibody. This figure was modified from data previously
published in ref. [747], and is reproduced by permission of the American Society
for Cell Biology, copyright 2011.

requires both the Slt2 and Hog1 signaling pathways; the
activation and phosphorylation of Slt2 and Hog1 can be
monitored with commercially available phospho-specific anti
bodies (Figure 26) [747]. It is also possible to monitor pex
ophagy in yeasts by the disappearance of activities of specific
peroxisome markers such as catalase, alcohol oxidase or
amine oxidase in cell-free extracts [1056], or permeabilized
cell suspensions. Catalase activity, however, is a useful marker
only when peroxisomal catalases are the only such enzymes
present or when activities of different catalases can be distin
guished. In S. cerevisiae there are two genes, CTT1 and CTA1,
encoding catalase activity, and only one of these gene pro
ducts, Cta1, is localized in peroxisomes. Activities of both
catalases can be distinguished using an in-gel activity assay
after PAGE under nondenaturing conditions by staining with
diaminobenzidine [1057, 1058]. Plate assays for monitoring
the activity of peroxisomal oxidases in yeast colonies are also
available [1054]. The decrease in the level of endogenous
proteins such as alcohol oxidase, Pex14 or Pot1 can be fol
lowed by western blotting [831, 1059–1062], TEM [1063],
fluorescence microscopy [831, 1064, 1065] or laser confocal
scanning microscopy of GFP-labeled peroxisomes [1066,
1067].
In yeast, nonselective autophagy can be induced by nitro
gen-starvation conditions, whereas degradative types of selec
tive autophagy generally require a carbon source change or
ER stress for efficient induction. For example, in S. cerevisiae,
to induce a substantial level of mitophagy, cells need to be
precultured in a nonfermentable carbon source such as lactate
or glycerol to stimulate the proliferation of mitochondria
(although this is not the case in Komagataella phaffii/Pichia
pastoris). After sufficient mitochondria proliferation, shifting
the cells back to a fermentable carbon source such as glucose
will cause the autophagic degradation of superfluous mito
chondria [1047]. It should be noted that in addition to carbon
source change, simultaneous nitrogen starvation is also
required for efficient mitophagy induction. This is possibly
because excessive mitochondria can be segregated into daugh
ter cells by cell division if growth continues [1047]. A similar
carbon source change from oleic acid or methanol to ethanol
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or glucose (with or without nitrogen starvation) can be used
to assay for pexophagy [1068]; whereas a shift to glucose
induces micropexophagy, a shift to ethanol induces macro
pexophagy [1061]. Mitophagy can apparently be induced in
Magnaporthe oryzae by treatment with ROS to induce mito
chondrial damage [1069]; however, ROS or mitochondrial
oxidative phosphorylation uncouplers such as CCCP do not
induce mitophagy in S. cerevisiae [1048, 1070]. Mitophagy can
be induced by culturing yeast cells in a nonfermentable car
bon source to post-log phase or before nitrogen starvation
[1070, 1071]. In this case, mitophagy may be induced because
the energy demand is lower at post-log phase and the mito
chondrial mass exceeds the cell’s needs [169, 1072, 1073]. It
has been suggested that this type of mitophagy, also known as
“stationary phase mitophagy,” reflects a quality-control func
tion that culls defective mitochondria that accumulate in
nondividing, respiring cells [1074]. Furthermore, there is
some evidence that mitophagy can be induced in cells cul
tured with a fermentable carbon source such as glucose by a
shift from nutrient-rich to nitrogen-starvation conditions,
which makes it possible to examine mitophagy even in
respiratory-deficient cells, although the amount of mitochon
drial turnover may be quite low [1075]. Similarly, pexophagy
can be induced by culturing the cells in a peroxisome prolif
eration medium to post-log phase (J.-C. Farré, unpublished
results). Along these lines, it should also be realized that some
types of selective autophagy continuously occur at a low level
under noninducing conditions. Thus, organelles such as per
oxisomes have a finite life span and are turned over at a slow
rate by autophagy-related pathways [1076].
Piecemeal microautophagy of the nucleus (PMN, also
termed micronucleophagy) is another selective autophagic
subtype, which targets portions of the nucleus for degradation
[157, 1077, 1078]. In S. cerevisiae, the nuclear outer mem
brane, which is continuous with the nuclear ER, forms contact
sites with the vacuolar membrane. These nucleus-vacuole
junctions (NVJs) are generated by interaction of the outer
nuclear membrane protein Nvj1 with the vacuolar protein
Vac8 [1079]. Nvj1 further recruits the ER-membrane protein
Tsc13, which is involved in the synthesis of very-long-chain
fatty acids (VLCFAs) and Swh1/Osh1, a member of a family
of oxysterol-binding proteins. Upon starvation the NVJs bulge
into the vacuole and subsequently a PMN-vesicle pinches off
into the vacuole. PMN vesicles thus contain nuclear material
and are limited by three membranes with the outermost
derived from the vacuole, and the two inner ones from the
nuclear ER. It is not clear which nuclear components are
removed by PMN, but because PMN is not a cell death
mechanism per se, it seems most likely that superfluous
material is recycled. During PMN the NVJs are selectively
incorporated into the PMN vesicles and degraded.
Accordingly, PMN can be monitored using the proteins that
are associated with the NVJs as markers. To quantitatively
follow PMN, an assay analogous to the above-described GFPAtg8 processing assay has been established using either GFPSwh1/Osh1 or Nvj1-GFP. These GFP chimeras are, together
with the PMN-vesicles, degraded in the vacuole. Thus, the
formation of the relatively proteolysis-resistant GFP detected
in western blots correlates with the PMN rate. In fluorescence
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microscopy, PMN can be visualized with the same constructs,
and a chimera of mCherry fused to a nuclear localization
signal (NLS-mCherry) can also be used. To assure that the
measured PMN rate is indeed due to selective PMN/micro
nucleophagy, appropriate controls such as cells lacking Nvj1
or Vac8 should be included. Detailed protocols for the
described assays are provided in ref. [1080].
Late nucleophagy (LN) is another type of selective degra
dation of the nucleus, which specifically targets bulk nucleo
plasm for degradation after prolonged periods (20-24 h) of
nitrogen starvation [721]. LN induction occurs in the absence
of the essential PMN proteins Nvj1 and Vac8 and, therefore,
the formation of NVJs. Although, some components of the
core Atg machinery are required for LN, Atg11 and the
Vps34-containing PtdIns3K complex I are not needed. LN
can be monitored by employing a nuclear-targeted version
of the Rosella biosensor (n-Rosella) and following either its
accumulation (by confocal microscopy), or degradation (by
immunoblotting), within the vacuole [1081]. Dual labeling of
cells with Nvj1-EYFP, a nuclear membrane reporter of PMN,
and the nucleoplasm-targeted NAB35-DsRed.T3 (NAB35 is a
target sequence for the Nab2 RNA-binding protein, and
DsRed.T3 is the pH-stable, red fluorescent component of nRosella) allows detection of PMN soon after the commence
ment of nitrogen starvation, whereas delivery to the vacuole of
the nucleoplasm reporter, indicative of LN, is observed only
after prolonged periods of nitrogen starvation. Few cells show
simultaneous accumulation of both reporters in the vacuole,
indicating that PMN and LN are temporally and spatially
separated [1081].
In contrast to unicellular yeasts, filamentous fungi form an
interconnected mycelium of multinucleate hyphae containing
up to 100 nuclei in a single hyphal compartment. A mycelial
colony grows by tip extension with actively growing hyphae at
the colony margin surrounded by an older, inner hyphal net
work that recycles nutrients to fuel the hyphal tips. By labeling
organelle markers with GFP it is possible to show in
Aspergillus oryzae that autophagy mediates degradation of
basal hyphal organelles such as peroxisomes, mitochondria
and entire nuclei [1082]. In contrast to yeast, PMN has not
been observed in filamentous ascomycetes. In M. oryzae,
germination of the condiospore and formation of the appres
sorium is accompanied by nuclear degeneration in the spore
[373]. The degradation of nuclei in spores requires the non
selective autophagy machinery, whereas conserved compo
nents of the PMN pathway such as Vac8 and Tsc13 are
dispensable for nuclear breakdown during plant infection
[1083]. Nuclei are proposed to function in storage of
growth-limiting nutrients such as phosphate and nitrogen
[1084, 1085]. Similar to nuclei, mitochondria and peroxi
somes are also preferentially degraded in the basal hyphae of
filamentous ascomycetes [373, 1082–1086].
Cautionary notes: The Cvt pathway has been demon
strated to occur only in yeast. In addition, the sequestration
of prApe1 is specific, even under starvation conditions, as it
involves the recognition of the propeptide by a receptor,
Atg19, which in turn interacts with the scaffold protein
Atg11 [1087, 1088]. Thus, unless the propeptide is removed
or the genes encoding Atg11 or Atg19 are deleted, prApe1 is

recognized as a selective substrate. Overexpression of prApe1
saturates import by the Cvt pathway, and the precursor form
accumulates, but is rapidly matured upon autophagy induc
tion [408]. In addition, mutants such as vac8∆ and tlg2∆
accumulate prApe1 under nutrient-rich conditions, but not
during autophagy [745, 1089]. Accordingly, it is possible to
monitor the processing of prApe1 when overexpressed, or in
certain mutant strains to follow autophagy induction.
However, under the latter conditions it must be kept in
mind that the sequestering vesicles are substantially smaller
than typical autophagosomes generated during nonselective
autophagy; the Cvt complex (prApe1 bound to Atg19) is
smaller than typical peroxisomes or mitochondrial fragments
that are subject to autophagic degradation. Accordingly, par
ticular mutants may display complete maturation of prApe1
under autophagy-inducing conditions, but may still have a
defect in other types of selective autophagy, as well as being
unable to induce a normal level of nonselective autophagy
[148]. For this reason, it is good practice to evaluate autopha
gosome size and number by TEM. Actually, it is much simpler
to monitor autophagic bodies (rather than autophagosomes)
in yeast. First, the vacuole is easily identified, making the
identification of autophagic bodies much simpler. Second,
autophagic bodies can be accumulated within the vacuole,
allowing for an increased sample size. It is best to use a strain
background that is pep4∆ vps4∆ to prevent the breakdown of
the autophagic bodies, and to eliminate confounding vesicles
from the multivesicular body pathway. One caveat to the
detection of autophagic bodies, however, is that they may
coalesce in the vacuole lumen, making it difficult to obtain
an accurate quantification. Finally, it is important to account
for biases in sample sectioning to obtain an accurate estimate
of autophagic body number or size [147].
In general, when working with yeast it is preferable to use
strains that have the marker proteins integrated into the
chromosome rather than relying on plasmid-based expres
sion, because plasmid numbers can vary from cell to cell.
The GFP-Atg8, or a similar, processing assay is easy to per
form and is suitable for analysis by microscopy as well as
western blotting; however, particular care is needed to obtain
quantitative data for GFP-Atg8, Pex14-GFP or Om45-GFP,
etc. processing assays (see cautionary notes for GFP-Atg8family protein lysosomal delivery and partial proteolysis).
A pHluorin-Atg8 chimera can be used to determine the
breakdown of autophagic bodies in budding yeast by live cell
fluorescence microscopy. In WT cells, fluorescence of
pHluorin-Atg8 is detectable at neutral pH in the cytosol and
at the PAS or on autophagosomes, but not at the lower pH
within the vacuole upon starvation. In mutants that are either
deficient in vacuolar peptidases (atg42∆, pep4∆, prb1∆, prc1∆)
or vacuolar acidification (vma4∆) pHluorin-Atg8 is not
quenched and pHluorin-Atg8-positive vesicular structures
are detected inside their vacuoles, suggesting that autophagic
bodies are not efficiently lysed. Hence, pHluorin-Atg8 is a
useful tool to detect defects in the breakdown of autophagic
bodies inside vacuoles [1090].
An alternative method to monitor selective autophagy is to
use an organelle-targeted Pho8∆60 assay. For example,
mitoPho8∆60 can be used to quantitatively measure
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mitophagy [1048]. In addition, for the GFP-Atg8 processing
assay, 2 h of starvation is generally sufficient to detect a
significant level of free (i.e., vacuolar) GFP by western blotting
as a measure of nonselective autophagy. For selective types of
autophagy, the length of induction needed for a clearly detect
able free GFP band will vary depending on the rate of cargo
delivery/degradation. Usually 6 h of mitophagy induction is
needed to be able to detect free GFP (e.g., from Om45-GFP)
by western blot under starvation conditions, whereas station
ary phase mitophagy typically requires 2 days before a free
GFP band is observed. However, as with animal systems (see
Animal mitophagy and pexophagy), it would be prudent to
follow more than one GFP-tagged protein, as the kinetics, and
even the occurrence of mitophagic trafficking, seems to be
protein species-dependent, even within the mitochondrial
matrix [1091]. The use of an artificial, non-mitochondrial
protein as a chimeric mitophagy reporter (such as mtDHFRGFP) can apparently be used as a reporter for “general”
mitophagy as it does not appear to have any endogenous
“selectivity” cues [1051].
b. Aggrephagy. Aggrephagy is the selective removal of aggre
gates by autophagy [1092]. This process can be followed in
vitro (in cell culture) and in vivo (in mice) by monitoring the
levels of an aggregate-prone protein such as an expanded
polyglutamine (polyQ)-containing protein or mutant MAPT/
tau or SNCA/α-synuclein (synuclein alpha). Levels are quan
tified by immunofluorescence, immunogold labeling, filtertrap assay or traditional immunoblot. In yeast, degradation
of SNCA aggregates can be followed by promoter shut-off
assays. Expression of the inducible GAL1 promoter of GFPtagged SNCA is stopped by glucose repression. The removal
of aggregates is thus monitored with fluorescence microscopy.
The relationship between SNCA clearnace and autophagy
has also been exploited in yeast studies during chronological
aging with SNCA expressed under the control of a constitu
tive promoter [347, 349, 366, 629]. In this model, SNCA
toxicity is dependent on Atg11 [366] and promotes cell cycle
re-entry, S-phase arrest, and DNA damage response activa
tion, which is responsible for a dramatic increase in autopha
gy [349]. This selective pathway of autophagy has been termed
genotoxin-induced targeted autophagy (GTA) and, in addi
tion to Atg11, requires the involvement of the Mec1 and
Rad53 kinases [1093].
The contribution of autophagy to SNCA aggregate clear
ance can be studied by the use of different autophagy mutants
or by pharmacological treatment with the proteinase B inhi
bitor PMSF [1094–1096]. Similarly, fluorescently tagged
aggregated proteins such as polyQ80-CFP can be monitored
via immunoblot and immunofluorescence. In addition to
fluorescence methods, aggregates formed by a splice variant
of CCND2 (cyclin D2) can also be monitored in electrondense lysosomes and autophagosomes by immunogold label
ing and TEM techniques [1097]. A polyQ80-luciferase repor
ter, which forms aggregates, can also be used to follow
aggrephagy [1098]. A nonaggregating polyQ19-luciferase or
untagged full-length luciferase serves as a control. The ratio of
luciferase activity from these two constructs can be calculated
to determine autophagic flux.
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Autophagic clearance of mutated human HTT (huntingtin)
protein with a polyQ expansion (HTT103Q) can also be
observed in budding yeast. After overnight induction from a
galactose inducible promotor, HTT103Q proteins form inclu
sion bodies in yeast cells. When glucose is added into the cell
culture to shut off HTT103Q expression, obvious vacuolar
localization of the protein is detected within 1 h, and this
localization depends on the core autophagy machinery.
Moreover, the absence of the ubiquilin protein Dsk2 and
some heat-shock proteins compromises the vacuolar localiza
tion of HTT103Q [1099, 1100]. Therefore, mutated HTT
protein can be used as a model substrate to study aggrephagy.
Autophagic degradation of endogenous aggregates such as
lipofuscin can be monitored in some cell types by fluorescence
microscopy, utilizing the autofluorescence of lipofuscin parti
cles. Although under normal conditions almost 99% of the
lipofuscin particles are located in autophagosomes or lyso
somes, an impairment of autophagy leads to free lipofuscin in
the cytosol [1101, 1102]. The amount of lipofuscin in primary
human adipocytes can be reduced by activation of autophagy,
and the amount of lipofuscin is dramatically reduced in adi
pocytes from patients with type 2 diabetes and chronically
enhanced autophagy [396]. Monitoring autophagy in tissues
with lipofuscin accumulation is not possible using a mouse
reporter model expressing GFP-LC3, because cytosolic lipo
fuscin appears as a hyperfluorescent punctum in the green
channel [485]. A tandem tagged LC3 reporter model (CAGmRFP-EGFP-LC3 [1103]) will be better suited to study
pathologies involving lipofuscin accumulation. ImageJ, or
other equivalent software, should be utilized to detect GFPpositive puncta that colocalize with RFP-positive structures.
Cytosolic lipofuscin will appear as an RFP-independent GFP
(green) punctum.
Similarly, TFEB overexpression either in neurons or oli
godendrocytes reduces neurodegeneration and the patholo
gical burden of SNCA in many experimental models of
synucleinopathies reported by independent investigators
[1104–1106].
Cautionary notes: Caution must be used when performing
immunoblots of aggregated proteins, as many protein aggre
gates fail to enter the resolving gel and are retained in the
stacking gel. This drawback can be bypassed by performing a
filter-trap assay in which protein extracts are forced by mild
suction through a nitrocellulose membrane, and protein
aggregates larger than the nitrocellulose pores are stuck on
the membrane and can then be detected by traditional immu
noblot [1107]. In addition, the polyQ80-luciferase in the
aggregated state lacks luciferase activity, whereas soluble
polyQ80-luciferase retains activity. Therefore, caution must
be used when interpreting results with these vectors, as treat
ments that increase aggrephagy or enhance protein aggrega
tion can lead to a decrease in luciferase activity [1108]. Finally,
soluble polyQ reporters can be degraded by the proteasome;
thus, changes in the ratio of polyQ19-luciferase:polyQ80-luci
ferase may also reflect proteasomal effects and not just
changes in autophagic flux.
c. Allophagy. In C. elegans, mitochondria, and hence pater
nal mitochondrial DNA, from sperm are eliminated by an
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autophagic process. This process of allogeneic (nonself) orga
nelle autophagy is termed “allophagy” [1109, 1110]. During
allophagy in C. elegans, both paternal mitochondria and
membranous organelles (a sperm-specific membrane com
partment) are eliminated by the 16-cell stage (100-120 min
post-fertilization) [1111, 1112]. The degradation process can
be monitored in living embryos with GFP::ubiquitin, which
appears in the vicinity of the sperm chromatin (labeled for
example with mCherry-histone H2B) on the membranous
organelles within 3 min after fertilization. GFP fusions and
antibodies specific for LGG-1 and LGG-2 (Atg8-family pro
tein homologs), which appear next to the sperm DNA, mem
branous organelles and mitochondria (labeled with CMXRos
or mitochondria-targeted GFP) within 15 to 30 min postfertilization, can be used to verify the autophagic nature of
the degradation. TEM [1113–1115] can also be utilized to
demonstrate the presence of mitochondria within autophago
somes in the early embryo. The respective functions of LGG-1
and LGG-2 have been addressed by RNAi depletion or
through the use of genetic loss-of-function mutants lgg-1
(tm3489) and lgg-2(tm5755). LGG-1 is essential for allophago
some formation, whereas LGG-2 contributes to their efficient
maturation [1114]. Ubiquitination of the substrates was first
described for the membranous organelles and not for sperminherited mitochondria [1111, 1112], but studies suggest that
ubiquitination of sperm-mitochondria could be required for
the initial step of allophagy [1116, 1117]. The autophagy
receptor ALLO-1 and its kinase IKKE-1 are required for the
recruitment of LGG-1 around sperm-inherited organelles
[1116]. This autophagy targeting requires both the ubiquiti
nation of substrates and the loss of sperm mitochondrial
membrane potential [1116, 1118, 1119].
Conclusion: There are many assays that can be used to
monitor selective types of autophagy, but caution must be
used in choosing an appropriate marker(s). The potential
role of other degradative pathways for any individual orga
nelle or cargo marker should be considered, and it is advisable
to use more than one marker or technique.
d. Animal mitophagy and pexophagy. There is no consensus
at the present time with regard to the best method for mon
itoring mitophagy in animal cells. As with any organellespecific form of autophagy, it is necessary to demonstrate: i)
increased levels of phagophores interacting with, or autopha
gosomes containing, mitochondria; ii) maturation of these
autophagosomes that culminates with mitochondrial degrada
tion, which can be blocked by specific inhibitors of autophagy
or of lysosomal degradation; and iii) whether the changes are
due to selective mitophagy or increased mitochondrial degra
dation during nonselective autophagy. Techniques to address
each of these points have been reviewed [55, 1120]. Note that
a common misconception is that mitophagy can be monitored
via RT-qPCR of mRNA transcripts encoding mitophagy-asso
ciated factors (e.g., PINK1, PRKN, etc.); in fact, changes in
mRNA levels of these factors do not necessarily reflect mito
phagic activity and should not be used to infer changes in
mitophagy in the absence of other assays.
The following methods can be used to follow all forms of
mitophagy: Ultrastructural analysis by TEM at early time

points can be used to establish selective mitophagy. It should
be noted that a detailed handbook on how to specifically
dissect the several phases of the mitophagic process by TEM
is not available. This should ideally include an initial phase of
mitochondrial fragmentation, followed by formation of a
double-layered membrane that expands around the selected
organelle to form a double-membrane mitophagosome that
contains mitochondria-like structure. TEM can be used to
demonstrate the presence of mitochondria within these vesi
cles, and this can be coupled with bafilomycin A1 or CQ
treatment to prevent fusion with the lysosome to trap early
autophagosomes with recognizable cargo [55] (Figure 4). In
the later phase, and in the absence of maturation inhibitors, it
might become difficult to clearly identify mitochondria-like
structures inside the mitophagosomes; however, these should
be appropriate in size, retain a double-membrane structure,
and contain remnants of mitochondrial cristae. Depending on
the use of specific imaging techniques, dyes for living cells or
antibodies for fixed cells have to be chosen. In any case,
transfection of the phagophore and autophagosome marker
GFP-LC3 to monitor the initiation of mitophagy, or RFP-LC3
to assess mitophagy progression, and visualization of mito
chondria (independent of their mitochondrial membrane
potential) makes it possible to determine the association of
these two cellular compartments. Qualitatively, this may
appear as fluorescence colocalization or as rings of GFP-LC3
surrounding mitochondria in higher-resolution images [201,
1113, 1121].
Care must be taken in interpreting these results, as some
data indicate that autophagosomes form at ER-mitochondria
contact sites [872]; hence, there will be some degree of colo
calization between forming (non-mitophagic) autophago
somes and mitochondria. Fluorescence microscopy-based
approaches for monitoring autophagosome or lysosome colo
calization with mitochondria in cells in which cytoplasm is
almost fully occupied by mitochondria, such as brown adipo
cytes, may be particularly challenging. Background thresholds
should be accurately set to avoid false positive results.
For live-cell imaging microscopy, mitochondria should be
labeled by a matrix-targeted fluorescent protein through
transfection or by the use of mitochondria-specific dyes.
When using matrix-targeted fluorophores for certain cell
lines (e.g., SH-SY5Y), it is important to allow at least 48 h
of transient expression for sufficient targeting/import of mito
chondrial GFP/RFP prior to analyzing mitophagy. Among the
MitoTracker® probes are lipophilic cations that include a
chloromethyl group and a fluorescent moiety. These probes
concentrate in mitochondria due to their negative charge and
react with the reduced thiols present in mitochondrial matrix
proteins [1122–1124]. After this reaction, the probe can be
fixed and remains in the mitochondria independent of sub
sequent alterations in mitochondrial function or mitochon
drial membrane potential [1123, 1125, 1126]. This method
can thus be used when cells remain healthy when the dye is
applied, as the dye will remain in the mitochondria and is
retained after fixation, although, as stated above, accumula
tion is dependent on the membrane potential. In addition, it
is important to note that the various mitochondrial dyes are
not identical in terms of their properties, and not all are
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suitable for use following fixation. For example, MitoTracker®
Green FM is not retained well after aldehyde fixation, whereas
MitoTracker® Red CMXRos works under these conditions.
Although in some cases it is convenient to utilize the fixation
step, it is possible to evaluate fresh, unfixed cells, and, conse
quently, with less manipulated mitochondria, obtain good
results with both flow cytometry and confocal microscopy
[1127]. Transfection with mitochondrially targeted fluorescent
proteins can also be used with similar results to MitoTracker®
Green FM [201]. Antibodies that specifically recognize mito
chondrial proteins such as VDAC, TOMM20/TOM20 (trans
locase of outer mitochondrial membrane 20), SOD2
(superoxide dismutase 2), HSPD1/HSP60 (heat shock protein
family D (Hsp60) member 1), HSPA9/mtHSP70 or COX4I1
(cytochrome c oxidase subunit 4I1) may be used to visualize
mitochondria in immunohistochemical experimental proce
dures [1128–1132] or in human patient samples [1133].
Colocalization analyses of mitochondria and autophago
somes provide an indication of the degree of autophagic
sequestration. To quantify early mitophagy, the percentage
of LC3 puncta (endogenous, RFP- or GFP-LC3 puncta) that
colocalize with mitochondria and the number of colocalizing
LC3 puncta per cell—as assessed by confocal microscopy—in
response to mitophagic stimuli can be employed as well
[1134]. Of note, PINK1-PRKN-dependent mitophagy is inde
pendent of the LC3 subfamily, but strongly requires the
GABARAPs [34, 35]. Conversely, LC3 is involved in cardioli
pin-mediated mitophagy [201]. Thus, monitoring of more
than on Atg8 subfamily may be necessary. In addition, the
percentage of lysosomes that colocalize with mitochondria
can be used to quantify autophagy-mediated delivery of mito
chondria. Furthermore, induction of mitophagy also pro
motes the formation of ring-shaped/spheroid mitochondria
interacting with structures positive for LC3 and lysosomal
proteins (based on immuno-EM). It is not clear whether
these structures represent forming autophagomes dedicated
to the degradation of mitochondria, or whether they represent
a distinct process of mitochondrial dynamics [1135, 1136].
Overall, it is important to quantify mitophagy at various
stages (initiation, progression, and late mitophagy) to identify
stimuli that elicit this process [1137, 1138].
The fusion process of mitophagosomes with hydrolasecontaining lysosomes represents the next step in the
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degradation process. To monitor the amount of fused orga
nelles via live cell imaging microscopy, MitoTracker® Green
FM and LysoTracker™ Red DND-99 may be used to visualize
the fusion process (Figure 27). Independent of the cell-type
specific concentration used for both dyes, we recommend
exchanging MitoTracker® Green FM medium with normal
medium (preferably phenol red-free and CO2 independent
to reduce unwanted autofluorescence) after incubation with
the dye, whereas it is best to maintain the LysoTracker™ Red
stain in the incubation medium during the acquisition of
images. Given that these fluorescent dyes are extremely sensi
tive to photobleaching, it is critical to perform live cell mito
phagy experiments via confocal microscopy, preferably by
using a spinning disc confocal microscope for long-term
imaging experiments. For immunocytochemical experiments,
antibodies specific for mitochondrial proteins and an anti
body against LAMP1 (lysosomal associated membrane protein
1) can be used. Overlapping signals appear as a merged color
and can be used as indicators for successful fusion of auto
phagosomes that contain mitochondria with lysosomal struc
tures [1139]. To measure the correlation between two
variables by imaging techniques, such as the colocalization
of two different fluorescent signals, we recommend some
form of correlation analysis to assess the value correlating
with the strength of the association. This may use, for exam
ple, ImageJ software or other colocalization scores that can be
derived from consideration not only of pixel colocalization,
but also from a determination that the structures have the
appropriate shape. During live-cell imaging, the two struc
tures (autophagosomes and mitochondria) should move
together in more than one frame. Mitophagy can also be
quantitatively monitored using a mitochondria-targeted ver
sion of the pH-dependent Keima protein [1036]. The peak of
the excitation spectrum of the protein shifts from 440 nm to
586 nm when mitochondria are delivered to acidic lysosomes,
which can provide a quantitative readout of mitophagy
(Figure 28). However, it should be noted that long exposure
time of the specimen to intense laser light leads to a similar
spectral change. mt-Keima in combination with flow cytome
try has been used to quantitatively monitor mitophagy flux
[1130, 1140, 1141].
It is important to note that in a process distinct from
mitophagy, mitochondria and lysosomes can also become
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Figure 27. Human fibroblasts showing colocalization of mitochondria with lysosomes. The degree of colocalization of mitochondria with lysosomes in human
fibroblasts was measured via live cell imaging microscopy at 37°C and 5% CO2 atmosphere using the ApoTome® technique. LysoTracker® Red DND-99 staining was
applied to mark lysosomal structures (red), and MitoTracker® Green FM to visualize mitochondria (green). Hoechst 33342 dye was used to stain nuclei (blue). A
positive colocalization is indicated by yellow signals (Merge) due to the overlap of LysoTracker® Red and MitoTracker® Green staining (white arrows). Scale bar: 10 μm.
Statistical evaluation is performed by calculating the Pearson’s coefficient for colocalizing pixels. Image provided by L. Burbulla and R. Krüger.
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Figure 28. Detection of mitophagy in primary cortical neurons using mitochondria-targeted Keima. Neurons transfected with mito-Keima were visualized using 458nm (green, mitochondria at neutral pH) and 561-nm (red, mitochondria in acidic pH) laser lines and 575-nm band pass filter. Compared with the control (A) wild-type
PINK1 overexpression (B) increases the number of the mitochondria exposed to acidic conditions. Scale bar: 2 µm. (C) Quantification of red puncta suggests increased
mitophagy in wild-type PINK1 but not in the kinase dead (kd) PINK1K219M-overexpressing neurons. Image provided by V. Choubey and A. Kaasik.

dynamically tethered to one another in a RAB7A-GTP hydro
lysis-dependent manner at inter-organelle mitochondria-lyso
some contact sites, which are important for regulating
mitochondrial dynamics [1142–1144]. Thus, high-resolution
microscopy and preferably live cell imaging are strongly
recommended to differentiate mitophagy (which results in
mitochondria engulfed within the lysosomal membrane)
from stably tethered mitochondria-lysosome contacts (mito
chondria that are in contact [<10 nm] from a lysosome and
can subsequently untether from one another without under
going bulk mitochondrial degradation).
Finally, a mitochondria-targeted version of the tandem
mCherry-GFP fluorescent reporter (see Tandem mRFP/
mCherry-GFP fluorescence microscopy) using a targeting
sequence from the mitochondrial membrane protein FIS1
[460, 461] can be used to monitor mitophagic flux [460]. In
addition, transgenic mice and Drosophila expressing mtKeima, mito-QC or mt-mCherry-GFP provide useful tools
for analysis of mitophagy in vivo in many physiological and
pathological conditions [38, 466, 1145–1148]. The tandem
fluorescent and the mitochondrially-targeted Keima fluores
cence microscopy approaches both assess delivery of mito
chondria to acidic (endo-lysosomal) environments. To
evaluate whether these acidic environments are proteolytically
active, the cleavage of ectopically expressed TOMM20-Keima
(or other mitochondria-targeted Keima fusion proteins) can
be followed by western blotting [1037]. Whereas TOMM20 is
sensitive to proteolytic enzymes, Keima is resistant, and thus
the appearance of free Keima in the western blot indicates
arrival of the mitochondria-targeted fusion protein to a pro
teolytic environment (lysosomes). The fold-change in
TOMM20-Keima cleavage upon treatment with an autophagic
stimulus can be compared with the fold change in the clea
vage of a cytosolic Keima fusion protein (e.g., LDHB-Keima),
to thereby assess the degree of selectivity of the autophagic
response towards mitochondria over cytosolic proteins.
The third and last step of monitoring the degradation
process is to examine the amount of remaining mitochondria
by analyzing the mitochondrial mass. This final step provides
the opportunity to determine the efficiency of degradation of
dysfunctional, aged or impaired mitochondria. Mitochondrial

mass can either be measured by a flow cytometry technique
using MitoTracker® Green FM (or MitoTracker® Deep Red
FM to monitor mitochondria with a polarized membrane)
[1123] on a single-cell basis, by either live cell imaging or
immunocytochemistry (using antibodies specifically raised
against different mitochondrial proteins or, less specifically,
by staining with acridine orange 10-nonyl bromide applied
after chemical fixation [1149, 1150]). Alternatively, mitochon
drial content in response to mitophagic stimuli (in the pre
sence and absence of autophagy inhibitors to assess the
contribution of mitophagy) in live or fixed cells can be quan
tified at the single-cell level as the percentage of cytosol
occupied by mitochondrial-specific fluorescent pixels using
NIH ImageJ [1138, 1151], specifically by using the MiNA
plugin [1152]. One caveat of the latter is that mitochondrial
mass may be overestimated when organelle swelling has
occurred. Immunoblot analysis of the levels of mitochondrial
proteins from different mitochondrial subcompartments is
valuable for validating the data from flow cytometry or micro
scopy studies, and it should be noted that OMM proteins,
such as MFNs (mitofusins), TOMM complex proteins, and
VDACs, but also PRKN, can be degraded by the proteasome,
especially in the context of mitochondrial depolarization
[1153–1155]. EM can also be used to verify loss of entire
mitochondria, and qPCR (or fluorescence microscopy) to
quantify mitochondrial DNA. A reliable estimation of
mtDNA copy number per cell can be performed by qPCR of
the MT-ND1 (mitochondrially encoded NADH dehydrogen
ase 1) or MT-ND2 gene expressed as a ratio of mtDNA:
nuclear DNA by normalizing to that of the single nuclearencoded PKM (pyruvate kinase M1/2) or TERT (telomerase
reverse transcriptase) genomic DNA [764]. The spectrophoto
metric measurement of the activity of CS (citrate synthase)
[1156], a mitochondrial matrix enzyme of the tricarboxylic
acid cycle, which remains highly constant in these organelles
and is considered a reliable marker of their intracellular con
tent, has been used as a marker of mitochondrial mass in a
variety of systems [1156–1159]. Mitophagy induction can also
be examined by using mitochondrial fractionation followed by
immunoblot to detect the levels of mitophagic or autophago
some-associated proteins (e.g., PRKN, LC3-II and SQSTM1)
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in the mitochondrial fraction. The levels of mitochondrialocalized DNM1L/Drp1 (dynamin 1 like), which is involved
in mitochondrial fission, could also be used to detect early
events of mitophagy induction, because mitochondrial fission
is required for mitophagy [1160], although mitochondrial
DNM1L levels do not necessarily reflect a change in
mitophagy.
Each of these techniques to monitor structures associated
with the different steps of mitophagy—whether by single-cell
analyses of Atg8-family protein mitochondrial colocalization
or by immunoblotting for mitochondrial markers—can be
combined with strategic use of inhibitors to determine
whether mitophagy is impaired or activated in response to
stimuli, and at which steps. Therefore, appropriate treatment
(pharmacological inhibition and/or siRNA-mediated knock
down of ATG genes) may be applied to prevent mitochondrial
degradation at distinct steps of the process. A recent method
using flow cytometry in combination with autophagy and
mitophagy inhibitors has been developed to determine mito
phagic flux using MitoTracker® probes [1123]. Alternatively,
mitophagic flux can be monitored by flow cytometry in cells
from mito-Keima mice. In this case, it is important to remove
dead cells on the basis of SYTOX Blue staining. As a positive
control of the assay, carbonyl cyanide p-trifluoromethoxyphe
nyl-hydrazone (FCCP) is a potent mitochondrial uncoupler
that stimulates mitophagic activity [1161].
Certain cellular models require stress conditions to measure
the mitochondrial degradation capacity, as basal levels are too
low to reliably assess organelle clearance. Exceptions include
developmental clearance of large amounts of mitochondria as
observed in erythrocyte maturation [1162], and during neuro
nal development where massive mitophagy is essential to pro
mote a metabolic change towards glycolysis that is required for
neurogenesis [1151]. Hence, it may be useful to treat cells with
uncoupling agents, such as CCCP, that stimulate mitochondrial
degradation and allow measurements of mitophagic activity. In
this scenario, it has recently been proposed that assessing the
amount of mitochondrial proteins through western blot at
basal level and after CCCP administration in human cells
may be useful to assess the mitophagic flux [1163, 1164];
however, it should be kept in mind that this treatment is not
physiological and promotes the rapid degradation of outer
membrane-localized mitochondrial proteins in addition to the
loss of mitochondrially-derived ATP used for cellular work. In
part for this reason a milder mitophagy stimulus has been
developed that relies on a combination of antimycin A
(AMA) and oligomycin, inhibitors of the electron transport
chain and ATP synthase, respectively [1165]; this treatment is
less toxic, and the resulting damage is time dependent.
However, this treatment not only blocks ATP production by
mitochondria but also substantially enhances mitochondrial
ROS production inducing mitochondrial damage. The pharma
cological compound PMI that pharmacologically induces mito
phagy without disrupting mitochondrial respiration [1166]
should provide further insight as it circumvents the acute,
chemically induced, blockade of mitochondrial respiration. In
addition, the molecule cloxyquin (not to be confused with
chloroquine) also induces mitophagy via a mild uncoupling
mechanism [444]. In certain conditions/cell types, mitophagy
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can be induced by NAD-boosting strategies [1167, 1168].
Another method to induce mitophagy is by the treatment of
cells with hypoxia-inducing and iron-deprivation agents.
Mitochondria are the major site for oxygen consumption, and
deprivation of oxygen induces receptor (FUNDC1, BNIP3,
BNIP3L)-dependent mitophagy [1169–1171] Treatment of ani
mals including mice, Drosophila and C. elegans [1145, 1148,
1172] under hypoxic conditions or by exposure to iron-depri
vation agents (deferiprone/DFP) induces mitochondrial degra
dation in different tissues, although the degrees of mitophagic
activation are not the same in different organs. More specific
induction of mitophagy can be achieved by expressing and
activating a mitochondrially-localized fluorescent protein
photosensitizer such as Killer Red [1173]. The excitation of
Killer Red results in an acute increase of superoxide, due to
phototoxicity, that causes mitochondrial damage resulting in
mitophagy [462]. The advantage of using a genetically encoded
photosensitizer is that it allows for both spatial and temporal
control in inducing mitophagy. The forced targeting of
AMBRA1 to the external mitochondrial membrane is sufficient
to induce mitophagy [1174], and expression of constitutively
active MAPK1 is sufficient to drive mitophagy in otherwise
uninjured tumor cells [1138]. Finally, mitophagy can also be
induced in vitro in different cell types by inhibiting the protea
some with the specific inhibitor IU1 [1175]. This type of
mitophagy is induced following proteasome recruitment to
mitochondria to expose the inner mitochondrial membrane
mitophagy receptor PHB2 [1176], and is PINK1- and PRKNindependent [1175].
Mitochondrial turnover, mitochondrial oxidative stress
and mitophagy can also be monitored through the use of
MitoTimer, a time-sensitive fluorescent protein that targets
to the mitochondrial matrix; the emission of MitoTimer shifts
from green to red over time [1177–1179]. A lentiviral induci
ble system encoding MitoTimer is available allowing the con
trolled expression of this transgene in a wide range of cells
[1180]. A constitutively active plasmid DNA encoding
MitoTimer as well as inducible transgenic flies and mice
allow quantification of mitochondrial structure (fluorescent
labeling of mitochondria), oxidative tension (red:green ratio)
and mitophagy (pure red puncta that are positive for the
mitochondrial protein COX4I1/Cox4 and the lysosomal mar
ker LAMP1) in a variety of tissues, organs and whole animals
[1177, 1179, 1181–1187]. Mitophagy can be monitored in
mouse primary cells by exploiting the mitoQC mouse
model, which ubiquitously expresses a GFP-mCherry tandem
protein targeting the mitochondrial outer membrane [38],
and the mt-Keima mouse model, which expresses a pH-sen
sitive protein targeting the mitochondrial matrix [1145].
It is important to keep in mind that there are multiple
distinct or partially overlapping pathways of cargo recognition
for selective mitophagy [1188]. These include PINK1-PRKNdependent pathways utilizing p-S65-Ub, receptor-mediated
mitophagy involving LIR-domain proteins, and the recogni
tion of mitochondrial phospholipids such as cardiolipin by
the LC3 phagophore system [201, 1189, 1190]; among others.
Thus, it would be inappropriate to conclude that selective
mitophagy is not occurring if markers of only one cargo
recognition system are considered.
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Figure 29. PINK1-dependent phosphorylation of ubiquitin (p-S65-Ub) upon mitophagic stress. (A) Human dermal fibroblasts from healthy controls or PD patients
carrying a PINK1 loss-of-function mutation (Q456X) were treated with valinomycin for the indicated times, and lysates were analyzed by western blot. The p-S65-Ub
signal is almost undetectable under nonstress conditions in controls, but is strongly induced in a PINK1 kinase-dependent manner during its stabilization on the
outer mitochondrial membrane. MFN2 serves as a control substrate and VCL (vinculin) as a loading control. (B) HeLa cells stably expressing GFP-PRKN (wild type)
were treated with CCCP for the indicated times, fixed and stained with p-S65-Ub (red) and GFP-PRKN (green) as well as mitochondrial (TOMM20, cyan) and nuclear
(Hoechst, blue) markers. The p-S65-Ub staining is almost undetectable in nonstressed cells, but rapidly accumulates on damaged mitochondria where it functions to
activate PRKN. On mitochondria, PINK1 and PRKN together amplify the p-S65-Ub signal. Scale bar: 10 µm. Image provided by F.C. Fiesel and W. Springer.

Antibodies against phosphorylated ubiquitin (p-S65-Ub)
have been described as novel tools to detect PINK1-PRKNmediated mitophagy [1191–1193]. p-S65-Ub is formed by the
kinase PINK1 specifically upon mitochondrial stress, and is
amplified in the presence of the E3 Ub ligase PRKN (reviewed
in [1194]) [1195]. p-S65-Ub antibodies have been used to
demonstrate stress-induced activation of PINK1 in various
cells including primary human fibroblasts (Figure 29) and
dopaminergic neurons differentiated from iPS cells [1193].
Phosphorylated poly-ubiquitin chains specifically accumulate
on damaged mitochondria, and staining with p-S65-Ub anti
bodies can be used, in addition to translocation of PRKN, to
monitor the initiation of mitophagy. Given the complete
conservation of the epitopes across species, mitochondrial pS65-Ub can also be detected in mouse primary neurons upon
mitochondrial depolarization and park/PRKN-deficient
Drosophila. Furthermore, the p-S65-Ub signal partially colo
calizes with mitochondrial, lysosomal, and total ubiquitin
markers in cytoplasmic granules that appear to increase with
age and disease in human postmortem brain samples [1191,
1193]. Examination of the phosphorylation status of outer
mitochondrial membrane (OMM) autophagy receptors such
as FUNDC1 and BNIP3L is also useful for measuring mito
phagy activity [1196, 1197]. Note that care should be taken
when choosing antibodies to assess the degree of mitochon
drial protein removal by autophagy; the quality and clarity of
the result may vary depending on the specifics of the anti
body. In testing the efficiency of mitophagy, clearer results
may be obtained by using antibodies against mitochondrial
DNA (mtDNA)-encoded proteins. This experimental precau
tion may prove critical to uncover subtle differences that

could be missed when evaluating the process with antibodies
against nuclear encoded, mitochondrially imported proteins
(M. Campanella, personal communication).
Stabilized, unprocessed PINK1 that accumulates on the
mitochondrial outer membrane in response to certain forms
of acute mitochondrial damage can be used to differentiate
between healthy mitochondria and those that have lost their
membrane potential. However, caution should be taken with
this approach in cells where mitochondria exhibit physiologi
cal uncoupling and lowered membrane potential, such as
thermogenic brown adipocytes. Similarly, redistribution of
cardiolipin to the OMM acts as an elimination signal to
trigger mitophagy induction in mammalian cells, including
primary neurons [201]. In addition, during CCCP-induced
mitophagy, the hexameric protein NME4/NDPKD/NM23H4 localizes to the mitochondrial intermembrane space,
binds cardiolipin and facilitates its redistribution to the
OMM [1189], and the ANXA5 (annexin A5) binding assay
for externalized cardiolipin can be used as a marker for
damaged mitochondria and early mitophagy [201]. The
charge of multiple anionic phospholipids present on the
OMM can change in response to mild alterations in mito
chondrial function. These signals are important to the regula
tion of protein signaling between mitochondria and the
cytosol. Changes in surface charge can be estimated by detect
ing the binding of ANXA5. Mild metabolic insults (e.g., a 50%
inhibition of the mitochondrial enzyme OGDH/ketoglutarate
dehydrogenase) increase ANXA5 binding nearly three-fold,
while stimulating translocation of DNM1L and LC3 to mito
chondria without altering cardiolipin translocation, ATP or
the mitochondrial membrane potential [1198]; DNM1L is a
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fundamental component of mitochondrial fission, which
helps facilitate mitophagy. Finally, many of the LIR domaincontaining mitophagy receptors undergo transcriptional upre
gulation during developmental stages when mitochondria are
eliminated, or during hypoxia [1151, 1188]. Changes in their
expression can be used to gauge the potential for undergoing
mitophagy, rather than as an estimate of mitophagy activity.
Previously, it was suggested that mitophagy can be divided
into three types [1199]; however, this was based largely upon
in vitro data. In vivo data from reporter animals suggests a
simpler classification that has reached consensus in the field.
In terms of mitophagy classifications in vitro: Type 1 mito
phagy, involves the formation of a phagophore, and typically
also requires mitochondrial fission; the PtdIns3K complex
containing BECN1 mediates this process. In contrast, type 2
mitophagy is independent of BECN1 and takes place when
mitochondria have been damaged [118], resulting in depolar
ization; sequestration involves the coalescence of GFP-LC3
membranes around the mitochondria rather than through
fission and engulfment within a phagophore. Receptor-depen
dent mitophagy is found in the BECN1-independent pathway.
In type 3 mitophagy, mitochondrial fragments or vesicles
from damaged organelles are sequestered through a micro
autophagy-like process named micromitophagy that is inde
pendent of ATG5 and LC3, but requires PINK1 and PRKN; in
mammals, this process occurs through the formation of mito
chondria-derived vesicles/MDVs, small vesicles delivering
damaged mitochondrial components to lysosomes for
degradation.
Although the process of pexophagy is prominent and well
described in yeast cells [1059, 1200], relatively little work has
been done in the area of selective mammalian peroxisome
degradation by autophagy (for a review see ref. [1201]).
Typically, peroxisomes are induced by treatment with hypo
lipidemic drugs such as clofibrate, ciprofibrate or dioctyl
phthalate, which bind to a subfamily of nuclear receptors,
referred to as PPARs (peroxisome proliferator activated recep
tors) [1202]. Of note, while inducing peroxisomal prolifera
tion, PPARA/PPARα may regulate neuronal autophagy, in
physiological or pathological settings, such as AD models
[921, 1203]. Degradation of excess organelles is induced by
drug withdrawal, although starvation without prior prolifera
tion can also be used. EPAS1 activation in liver-specific vhl−/−
and vhl−/− hif1a−/− mice reduces peroxisome abundance by
pexophagy, whereas ER and mitochondrial protein levels are
not affected [774]. Pexophagy can also be induced by amino
acid starvation, which induces the stabilization of the perox
isomal E3 ubiquitin ligase PEX2 [1204]. PEX2 is destabilized
by MTORC1 such that the overexpression of PEX2 can induce
pexophagy. PEX2 ubiquitinates PEX5 and ABCD3/PMP70
(ATP binding cassette subfamily D member 3), which then
recruit NBR1 to target the peroxisome for pexophagy [1204].
The action of PEX2 is counteracted by the deubiquitinating
enzyme USP30 [1205, 1206]. Pexophagy can also be induced
by the expression of a nondegradable active EPAS1 variant
[1207]. Induction of pexophagy in response to endogenous
and exogenous reactive oxygen species (ROS) and reactive
nitrogen species has been observed in mammalian cells. In
this setting, pexophagy is induced via ROS- or reactive
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nitrogen species-mediated activation of ATM/ataxia telangiec
tasia mutated (ATM serine/threonine kinase) [1208, 1209],
repression of MTORC1 and phosphorylation of PEX5 by
ATM [1210, 1211]; ATM phosphorylation of PEX5 at S141
triggers PEX5 ubiquitination and binding of SQSTM1 to
peroxisomes targeted for pexophagy [1211].
Loss of peroxisomes can be followed enzymatically or by
immunoblot, monitoring enzymes such as ACOX/fatty acylCoA oxidase (note that this enzyme is sometimes abbreviated
“AOX,” but should not be confused with the enzyme alcohol
oxidase that is frequently used in assays for yeast pexophagy)
or CAT (catalase), and also by EM, cytochemistry or immu
nocytochemistry [1212–1215]. Finally, a HaloTag®-PTS1 mar
ker that is targeted to peroxisomes has been used to
fluorescently label the organelle [1216]. An alternative
approach uses a peroxisome-specific tandem fluorochrome
assay (RFP-EGFP localizing to peroxisomes by the C-terminal
addition of the tripeptide SKL, or a peroxisomal membrane
protein tagged with mCherry-mGFP), which has been used to
demonstrate the involvement of ACBD5/Atg37, NBR1 and
SQSTM1 in mammalian and fungal pexophagy [458, 459,
1052]. By showing that PEX14 directly interacts with LC3-II,
which is competitively inhibited by PEX5, PEX14 is demon
strated to function in the dual processes of biogenesis and
degradation of peroxisomes with the coordination of PEX5 in
response to environmental changes [1217, 1218]. Peroxisomal
proteins are degraded preferentially over cytosolic proteins in
CHO-K1 cells when starved and then cultured in a normal
culture medium. Degradation of peroxisomes is dependent on
LC3 and PEX14 [1219]. By making use of autophagy inhibi
tors or siRNA against NBR1, ubiquitin- and NBR1-mediated
pexophagy is shown to be induced by increased expression of
PEX3 in mammalian cells, where ubiquitination of PEX3 is
dispensable for pexophagy [1220, 1221]. Another autophagic
receptor protein, SQSTM1, is required only for the clustering
of peroxisomes.
Cautionary notes: There are many assays that can be used
to monitor specific types of autophagy, but caution must be
used in choosing an appropriate marker(s). To follow mito
phagy it is required to monitor more than one protein and to
include an inner membrane and a matrix component (and
preferably encoded by the mitochondrial DNA) in the analysis
to evaluate mass, and not be biased by selective clearance of
proteins located in different submitochondrial compartments.
In this regard, it is not sufficient to follow a single mitochon
drial outer membrane protein because it can be degraded
independently of mitophagy through the UPS. Although the
localization of PRKN to mitochondria as monitored by fluor
escence microscopy is associated with the early stages of
CCCP-driven mitochondria degradation [339], this by itself
cannot be used as a marker for mitophagy, as these events can
be dissociated [1222]. Even with PRKN translocation and
ubiquitination, FCCP-induced donut mitochondria resist au
tophagy, by failing to recruit autophagy receptors
CALCOCO2/NDP52 and OPTN [1223]. Moreover, mito
phagy elicited in a number of disease models and by pharma
cological means [1224]) does not involve mitochondrial
PRKN translocation [201, 460, 1225]. Along these lines, recent
studies implicate an essential role for TRAF2, an E3 ubiquitin

112

D. J. KLIONSKY ET AL.

ligase, as a mitophagy effector in concert with PRKN in
cardiac myocytes; whereby mitochondrial proteins accumu
late differentially with deficiency of either, indicating nonre
dundant roles for these E3 ubiquitin ligases in mitophagy
[1226]. This finding necessitates an integrated approach to
assess mitophagy based on a broad evaluation of multiple
mitochondrial effectors and proteins. Because PINK1PRKN-dependent mitophagy can only be detected under cer
tain non-physiological conditions, it is a controversial matter
of debate as to the role of PINK1-PRKN during mitophagy,
and whether basal and stimulus (e.g., age)-induced mitophagy
are regulated through the same pathways or employ distinct
machineries [1227].
During canonical PRKN-mediated mitophagy, PRKN
translocates to damaged mitochondria and ubiquitinates a
wide range of outer membrane proteins including VDAC1,
MFN1/2 and TOMM20 [1128, 1153, 1154, 1228, 1229]. This
results in the preferential degradation of OMM proteins by
the proteasome, while inner membrane proteins and mito
chondrial DNA [1230] remain intact. Monitoring loss of a
single protein such as TOMM20 by western blot or fluores
cence microscopy to follow mitophagy may thus be mislead
ing, as noted above [1228]. Similarly, following the level of
DNM1L may provide some information with regard to mito
phagy, but it must be kept in mind that alterations in mito
chondrial dynamics and DNM1L recruitment to
mitochondria mostly occur in response to conditions other
than mitophagy, such as changing nutrient concentrations.
MitoTracker® dyes are widely used to stain mitochondria
and, when colocalized with GFP-LC3, they can function as
markers for mitophagy. However, staining with MitoTracker®
dyes depends on mitochondrial membrane potential
(although MitoTracker® Green FM is less sensitive to loss of
membrane potential), so that damaged, or sequestered non
functional mitochondria may not be stained. In vitro this can
be avoided by labeling the cells with MitoTracker® before the
induction by the mitophagic stimuli [1123]. One additional
point is that MitoTracker® dyes might influence mitochon
drial motility in axons (D. Ebrahimi-Fakhari, personal
communication).
Although it is widely assumed that autophagy is the major
mechanism for degradation of entire organelles, there are
multiple mitochondrial quality control mechanisms that may
account for the disappearance of mitochondrial markers.
These include proteasomal degradation of outer membrane
proteins and/or proteins that fail to correctly translocate into
the mitochondria, degradation due to proteases within the
mitochondria, and reduced biosynthesis or import of mito
chondrial proteins. PINK1 and PRKN are not essential for all
types of mitophagy in vitro or in vivo [466, 1188, 1231].
Moreover, these two proteins also participate in an ATG
gene-independent pathway for lysosomal degradation of
small mitochondria-derived vesicles [791]. An unbiased pro
teomic study in vivo shows that PRKN ubiquitinates not only
OMM proteins during mitophagy but also several proteins
that a priori are unrelated to mitophagy [1229]. Furthermore,
the PINK1-PRKN mitophagy pathway is also transcriptionally
upregulated in response to starvation-triggered generalized
autophagy, and is intertwined with the lipogenesis pathway

[1232–1235]. In addition to mitophagy, mitochondria can be
eliminated by extrusion from the cell (mitoptosis) [1112,
1128, 1139, 1236]. Transcellular degradation of mitochondria,
or transmitophagy, also occurs in the nervous system when
astrocytes degrade axon-derived mitochondria [1237]. Thus, it
is advisable to use a variety of complementary methods to
monitor mitochondria loss including TEM, single-cell analysis
of Atg-family protein fluorescent puncta that colocalize with
mitochondria, and western blot, in conjunction with flux
inhibitors and specific inhibitors of autophagy induction com
pared with inhibitors of the other major degradation systems
(see cautions in Autophagy inhibitors and inducers).
To monitor and/or rule out changes in cellular capacity to
undergo mitochondrial biogenesis, a process that is tightly
coordinated with mitophagy and can dictate the outcome
following mitophagy-inducing insults especially in primary
neurons and other mitochondria-dependent cells, colocaliza
tion analysis after double staining for the mitochondrial mar
ker TOMM20 and BrdU (for visualization of newly
synthesized mtDNA) can be performed (Figure 30).
Alternatively, direct assay for translation of mtDNA-encoded
proteins is a straightforward assay for mitochondrial biogen
esis, which can be combined with analysis of transcripts
driven by mtDNA promoters [1238, 1239].
Likewise, although the mechanism(s) of peroxisomal pro
tein degradation in mammals awaits further elucidation, it can
occur by both autophagic and proteasome-dependent
mechanisms [1219]. Thus, controls are needed to determine
the extent of degradation that is due to the proteasome.
Moreover, two additional degradation mechanisms have
been suggested: the action of the peroxisome-specific
LONP2/Lon (lon peptidase 2, peroxisomal) protease and the
membrane disruption effect of 15-lipoxygenase [1240].
e. Chlorophagy. Besides functioning as the primary
energy suppliers for plants, chloroplasts represent a
major source of fixed carbon and nitrogen to be remobi
lized from senescing leaves to storage organs and newly
developing tissues. As such, the turnover of these orga
nelles has long been considered to occur via an autopha
gy-type mechanism. However, while the detection of
chloroplasts within autophagic body-like vesicles or within
vacuole-like compartments has been observed for decades,
only recently has a direct connection between chloroplast
turnover and autophagy been made through the analysis
of atg mutants combined with the use of fluorescent
ATG8 reporters [1241–1244]. In fact, it is now clear that
chlorophagy, the selective degradation of chloroplasts by
autophagy, can occur via several routes, including the
encapsulation of whole chloroplasts by the tonoplast via
a microautophagy-type process [1244], or the budding of
chloroplast material into small distinct autophagic vesicles
called Rubisco-containing bodies (RCBs) and ATI1
(ATG8-interacting protein 1) plastid-associated (ATI-PS)
bodies, which then transport chloroplast cargo to the
vacuole [1241, 1245]. Chloroplasts produce long tubes
called stromules that project out from the organelle
outer membrane. Recent studies suggest that stromules
are part of the chlorophagy process, by which the
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Figure 30. Confocal microscopy deconvolved (AutoQuant X3) images and colocalization image analysis (ImageJ 1.47; Imaris 7.6) through a local approach showing
perinuclear mitochondrial biogenesis in hippocampal neuronal cultures. The upper channels show TOMM20 (green channel), BrdU (for visualization of newly
synthesized mitochondrial DNA, red channel), and merged fluorescence channels. Overlay, corresponds to the spatial pattern of software thresholded colocalized
structures (white spots) layered on the merged fluorescence channels. Surface Plot, or luminance intensity height, is proportional to the colocalization strength of the
colocalized structures (white spots). Plot Profile, corresponds to the spatial intensity profiles of the fluorescence channels of the white line positioned in the Merge
image. Yellow arrows indicate a qualitative evaluation of the spatial association trends for the fluorescence intensities. Arrows pointing up indicate an increase in the
colocalization, whereas arrows pointing down show a decrease. Scale bar: 2 μm. This figure was modified from previously published data [4085] and is provided by F.
Florenzano.

stromule tips, presumably containing unwanted or
damaged chloroplast material, are engulfed by autophagic
membranes using ESCRT-II endocytic machinery that
depends on ATG8 [1246]. Chloroplast morphology can
easily be monitored by TEM, whereas chloroplast abun
dance and association with autophagic membranes can be
studied by confocal fluorescence microscopy using chlor
ophyll autofluorescence in combination with appropriate
fluorescent protein markers (e.g., stromally-targeted GFP,
GFP-ATG8, or tonoplast markers such as GFP-TIP2/δTIP
or VHP1-GFP). The appearance of RCBs is tightly linked
with leaf carbon status, indicating that chlorophagy

through RCBs represents an important route for recycling
plant nutrients provided in plastid stores. As such, it is
critical to maintain consistent plant growth conditions,
particularly with respect to light quality and intensity,
and to take into account that different responses may be
observed depending on the time of day experiments are
performed.
f. Chromatophagy. Autophagy is best known for its prosurvival role in cells under metabolic stress and other condi
tions. However, excessively induced autophagy may be cyto
toxic and may lead to cell death (Figure 31) [1247].
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Figure 31. Pathways that follow DNA damage may result in PCD or cell survival through autophagy, or checkpoint deficiency. (A) DNA damage inhibits TOR signaling,
which promotes the formation of an ATG protein complex, thereby bringing about autophagy. Autophagy may contribute to cell survival as well as to cell death by
PCD. (B) DNA damage may cause mutations in genes encoding checkpoint RAD proteins and/or proteins involved in DNA replication initiation, as well as the
simultaneous deletion of genes encoding checkpoint kinases. Such protein defects lead to deficient checkpoints, thereby causing cells to enter M-phase prematurely
with damaged DNA or incompletely replicated DNA, resulting in ROS generation, mitotic catastrophe, and subsequently PCD. This figure was previously published in
ref. [1247].
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Chromatophagy (chromatin-specific autophagy) comes into
view as one of the autophagic responses that can contribute
to cell death [1248]. Chromatophagy can be seen in cells
during nutrient depletion, such as arginine starvation, and
its phenotype consists of giant-autophagosome formation,
nucleus membrane rupture and histone-associated-chroma
tin/DNA leakage that is captured by phagophores. Arginine
starvation can be achieved by adding purified arginine deimi
nase to remove arginine from the culture medium, or by using
arginine-dropout medium. The degradation of leaked nuclear
DNA/chromatin can be observed by fluorescence microscopy;
with GFP-LC3 or anti-LC3 antibody, and LysoTracker™ Red
or anti-LAMP1, multiple giant autophagosomes or autolyso
somes containing leaked nuclear DNA can be detected. In
addition, the chromatophagy-related autophagosomes also
contain parts of the nuclear outer-membrane, including
NUP98 (nucleoporin 98 and 96 precursor), indicating that
the process involves a fusion event [1248].
g. Clockophagy. Clockophagy is the process of selective
autophagic degradation of the key circadian clock protein
ARNTL/BMAL1 (aryl hydrocarbon receptor nuclear translo
cator-like) during RSL3-induced ferroptosis in Calu-1 and
HT1080 cells [1249]. SQSTM1 is a cargo receptor responsible
for clockophagy-dependent ARNTL degradation during fer
roptosis. Clockophagy-dependent ARNTL degradation dra
matically promotes ferroptotic cancer cell death through
EGLN2/PHD1 (egl-9 family hypoxia-inducible factor 2)mediated oxidative injury in vitro and in vivo. The interac
tome map of the arntl/bmal1−/− mouse, an arrhythmic circa
dian rhythms model, reveals significant loss of genes encoding
proteins such as COL6A/collagen VI and autophagy-related
genes such as SQSTM1 [1250]. Given the importance of the
accumulated data from both mice and human studies, dereg
ulation of Clock genes might lead to enhanced autophagy
through ATG14, whereas downregulated autophagy through
the AKT pathway may be involved in the pathogenesis of
COL6A myopathy and potentially contribute to other mus
cle-wasting diseases.
h. Crinophagy and the SINGD pathway. Distinct from
cargo disposal that involves autophagosomes, crinophagy,
the degradation of secretory granules via direct fusion with
lysosomes, was discovered in the 1960s as a pituitary gland
response to the inhibition of exocytosis [1251]. Crinophagy
has been observed in different types of secretory cells includ
ing cells of the anterior pituitary gland, pancreatic α cells and
β cells [1251–1254]. Traditionally, crinophagy was monitored
using electron microscopy and immunoelectron microscopy.
Newer molecular biology techniques have been employed to
study crinophagy in the salivary gland of Drosophila [1255]
and in mammalian pancreatic β cells [1256]. In Drosophila,
reporter lines expressing granule and lysosomal markers with
fluorescent tags have been used to assess crinophagic degra
dation of glue granules at different time points and elucidate
the molecular mechanisms of this pathway [1255]. In β cells,
short-term nutrient deprivation evokes rapid autophagy-inde
pendent lysosomal degradation of nascent INS (insulin) secre
tory granules, the pathway termed “stress-induced nascent

granule degradation” (SINGD; pronounced ˈsindi). SINGD
occurs via crinophagy and counters autophagy through loca
lized activation of MTORC1; the depletion of secretory gran
ules together with the inhibition of autophagy protect against
unwanted INS release during fasting [120]. The major regu
lator of secretory granule biogenesis at the trans-Golgi net
work, PRKD (protein kinase D), controls SINGD, thus
routing secretory granules to secretion or degradation
depending on the nutrient availability. Furthermore, erro
neous activation of the SINGD pathway contributes to β cell
failure in type 2 diabetes [1256]. To further characterize the
dynamics of the crinophagic SINGD pathway in β cells, the
sequences coding fluorescent tags have been inserted directly
into the endogenous loci of the secretory granule marker
PTPRN2/Phogrin and the lysosomal protein CD63 using
CRISPR-Cas9 gene-editing. This tool makes it possible to
follow crinophagy in real time using several imaging techni
ques, including live-cell imaging combined with CLEM (liveCLEM). In addition, 3-dimensional reconstruction of large
cellular volumes achieved by FIB-SEM is particularly helpful
to detect crinophagic events in primary islets.
i. Doryphagy. Centriolar satellites (CSs) are protein com
plexes associated with microtubules and clustering around
the centrosome. Whereas CSs have long been described as
the structures regulating centrosome composition, the
mechanisms controlling CS homeostasis and function are
not yet understood in detail [1257]. A process targeting CSs
for selective autophagy has been identified and termed “dor
doryphagy”, from the Greek word “doryphoros” for satellites
[1258]. Of note, the selective degradation of CSs is achieved
by a LIR-mediated interaction between PCM1, a component
of CSs, and GABARAPs. As a consequence of CS function in
regulating centrosomes, disruption of doryphagy results in
centrosome abnormalities and aberrant mitosis.
j. Ferritinophagy. Ferritinophagy is a selective form of auto
phagy that functions in intracellular iron processing [805].
Iron is recruited to ferritin for storage and to prevent the
generation of oxygen free radicals through the Fenton and
Haber-Weiss reactions [806,807]. Because ferritin is largely
degraded by autophagy [1259, 1260] the ferritin status can
be used as a marker of the autophagic flux in a given cell. To
release iron from ferritin, the iron-bound form is sequestered
within an autophagosome [1261]. Fusion with a lysosome
leads to breakdown of ferritin and release of iron.
Furthermore, iron can be acidified in the lysosome, convert
ing it from an inactive state of Fe3+ to Fe2+ [809,810]. Iron can
be detected in the autolysosome via TEM [809].
Colocalization of iron with autolysosomes may also be deter
mined utilizing calcein AM to tag iron [1262, 1263]. NCOA4
is a cargo receptor that recruits ferritin to the autophagosome
[1264]. NCOA4-dependent ferritinophagy promotes ferropto
sis, an iron-dependent form of regulated cell death (RCD)
[1265, 1266], by the degradation of ferritin in multiple cells
[1267] as discussed below. Note that ferritinophagy can be coopted by pathogens for their own survival. For example,
uropathogenic E. coli persist in host cells by taking advantage
of ferritinophagy. Iron overload in urothelial cells induces
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ferritinophagy in a NCOA4-dependent manner causing
increased iron availability for uropathogenic E. coli to over
grow, which can be reversed by inhibition of autophagy
[1268].
Ferroptosis is currently defined as a form of programmed
cell death initiated by oxidative perturbations of the intracel
lular microenvironment, that is under constitutive control by
GPX4. This form of programmed cell death may be accom
panied by excessive autophagy initiated after administration
of erastin and glutamate, which results in inactivation of
SLC7A11/cystine transporter/xCT. Uptake of cystine is essen
tial for glutathione synthesis, and, therefore, a deficient
SLC7A11 transporter will promote lipid peroxidation due to
depletion of GPX4 (glutathione peroxidase 4) protein and
activity [1269]. Cysteine deprivation also causes endoplasmic
reticulum stress resulting in induction of DDIT4/REDD1
[1270]. DDIT4 acts as an inducer of autophagy by binding
and inhibiting YWHA/14-3-3, which otherwise inhibits the
TSC1-TSC2 complex, and ultimately leads to inhibition of
MTOR. Increased autophagy induced by DDIT4 causes ferri
tin to be degraded and iron released to promote ferroptosis,
whereas inhibition of autophagy protects against ferroptosis
[1267]. Recent reports indicate that GPX4 depletion is facili
tated by CMA involving HSP90. Inhibition of HSP90 using 2amino-5-chloro-N,3-dimethylbenzamide (CDDO) can spare
GPX4 depletion and rescue erastin-mediated cell death
[1271]. Moreover, upregulation of the RNA-binding protein
ELAVL1/HuR promotes BECN1 production via binding to
the AU-rich elements (AREs) in the 3ʹ UTR of BECN1
mRNA, thus triggering autophagy activation, promoting
autophagic ferritin degradation, and eventually leading to
iron-dependent ferroptosis [1272]. Conversely, upregulation
of the RNA-binding protein ZFP36 (ZFP36 ring finger pro
tein) can result in ATG16L1 mRNA decay via binding to the
AREs in the 3ʹ UTR, thus triggering autophagy inactivation,
blocking autophagic ferritin degradation, and eventually con
ferring resistance to ferroptosis [1273].
k. Granulophagy. Granulophagy is a term generally applic
able to the autophagic clearance of mRNA-protein granules in
eukaryotic cells. First termed to describe the clearance of
stress granules in S. cerevisiae and human cell lines [1274],
other mRNP granules subject to autophagic clearance include
P-bodies in mammalian cells [1275] and P-granules in C.
elegans [1276]. Evidence that granulophagy is a selective
autophagic process includes the identification of granule-spe
cific autophagic receptor proteins, including SQSTM1 for
stress granules in human cells, CALCOCO2 for P-bodies in
human cells and SEPA-1 for P-granules in C. elegans [1275,
1276]. In all cases, the receptor proteins colocalize in their
respective mRNP granules while autophagic clearance occurs,
and the absence of said receptor proteins leads to accumula
tion of the mRNP granule. SQSTM1- and LC3-adorned
bodies resembling stress granules also localize in autophago
somes as revealed by electron microscopy [1277].
Granulophagy studies with stress granules suggest induc
tion varies depending on cellular context. For example, yeast
stress granules induced by transient nutrient deprivation or
oxidative stress are not targeted by granulophagy, whereas
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diauxic shift and inhibition of mRNA decay do induce gran
ulopahgy [1274]. Additionally, studies involving various stress
stimuli (e.g., heat shock, proteasome inhibition, or arsenite
stress) in human cell lines reveal differing degrees of impor
tance of autophagic versus chaperone-based mechanisms in
the disassembly or degradation of stress granules [1274, 1275,
1277–1279]. Stress granule clearance following heat shock
may involve migration via microtubules of stress granules to
aggresomes, based on colocalization studies in the presence
and absence of autophagic inhibitors [1279]. Thus, granulo
phagy and aggrephagy mechanisms may overlap in at least
some cases. Moreover, stalled 48S translation pre-initiation
complexes, forming stress granules upon accumulation and
condensation, are found within exosomes secreted by cells
submitted to prolonged serum starvation, a process enhanced
by ATG5 depletion [822].
Granulophagy may affect the pathology of amyotrophic
lateral sclerosis (ALS). Aberrant persistence or formation of
stress granules has been hypothesized to facilitate formation
of toxic cytoplasmic aggregates containing TARDBP or FUS
RNA-binding proteins [1280]. Mutations in VCP that are
associated with ALS onset also impair granulophagy and
lead to persistence of TARDBP-containing stress granules in
human cell models [1274]. ALS-mutant forms of FUS also
induce aberrant stress granule assembly in neuronal cells, and
lead to increased stress granule association with autophago
somes versus stress granules formed in control cells, suggest
ing granulophagy exerts selective clearance of potentially
pathological stress granules [1281]. Finally, the most com
monly mutated gene in ALS patients, C9orf72, may also func
tion with SQSTM1 in autophagic clearance of FUS-containing
stress granules. Supporting this, C9orf72 physically interacts
with SQSTM1 and localizes in stress granules, and its deple
tion impairs stress granule clearance following arsenite stress
[1277].
l. Intraplastidial autophagy. Intraplastidial autophagy is a
process whereby plastids of some cell types adopt autophagic
functions, engulfing and digesting portions of the cytoplasm.
These plastids are characterized by formation of invaginations
in their double-membrane envelopes that eventually generate
a cytoplasmic compartment within the plastidial stroma, iso
lated from the outer cytoplasm. W. Nagl coined the term
plastolysome to define this special plastid type [1282].
Initially, the engulfed cytoplasm is identical to the outer
cytoplasm, containing ribosomes, vesicles and even larger
organelles. Lytic activity was demonstrated in these plastids,
in both the cytoplasmic compartment and the stroma.
Therefore, it was suggested that plastolysomes digest them
selves together with their cytoplasmic cargo, and transform
into lytic vacuoles. Intraplastidial autophagy has been
reported in plastids of suspensor cells of Phaseolus coccineus
[1282] and Phaseolus vulgaris [1283], where plastids trans
formed into autophagic vacuoles during the senescence of
the suspensor. This process was also demonstrated in petal
cells of Dendrobium [1284], and in Brassica napus micro
spores experimentally induced towards embryogenesis
[1285]. All these reports established a clear link between
these plastid transformations and their engagement in
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autophagy. At present, descriptions of this process are limited
to a few, specialized plant cell types. However, pictures of
cytoplasm-containing plastids in other plant cell types have
been occasionally published, although the authors did not
make any mention of this special plastid type. For example,
this has been seen in pictures of fertile and Ogu-INRA male
sterile tetrads of Brassica napus [1286], and Phaseolus vulgaris
root cells [1287]. Possibly, this process is not as rare as
initially thought, but authors have only paid attention to it
in those cell types where it is particularly frequent.
m. Lipophagy. The specific autophagic degradation of lipid
droplets represents another type of selective autophagy
[1288]. Lipophagy requires the core autophagic machinery
and can be monitored by following triglyceride content, or
total lipid levels using BODIPY 493/503 or HCS LipidTOX
neutral lipid stains with fluorescence microscopy, cell staining
with Oil Red O, the cholesterol dye filipin III [1289], or ideally
label-free techniques such as coherent anti-stokes Raman
scattering/CARS or spontaneous Raman scattering/SRS
microscopy. BODIPY 493/503 should be used with caution,
however, when performing costains (especially in the green
and red spectra) because this commonly used fluorescent
marker of neutral lipids is highly susceptible to bleed-through
into the other fluorescence channels (hence often yielding
false positives), unlike the LipidTOX stain that has a narrow
emission spectrum [1290]. In addition, BODIPY 493/503
cannot be used to monitor lipophagy in C. elegans because it
stains both lipid droplets and the lysosome [1291]. TEM can
also be used to monitor lipid droplet size and number, as well
as lipid droplet-associated double-membrane structures,
which correspond to autophagosomes [1288, 1292, 1293].
The transcription factor TFEB positively regulates lipo
phagy [948], and promotes fatty acid β-oxidation [1294],
thus providing a regulatory link between different lipid degra
dation pathways [1295]. Accordingly, TFEB overexpression
rescues fat accumulation and metabolic syndrome in a dietinduced model of obesity [1294, 1296] and in alcohol-induced
fatty liver in mice [1297]. As a coactivator for TFEB and
PPARG, CARM1 regulates lysosome biogenesis and lipid
metabolism through processes that are partially dependent
on lipophagy [980, 1298]. Under conditions of nutrient star
vation, CARM1-TFEB-mediated lipophagy is regulated by
C9orf72 [1299, 1300]. Genetic mutations in C9orf72 are
linked to neurodegenerative diseases including ALS and fron
totemporal dementia (FTD) [1301, 1302]. Spermidine can also
stimulate autophagy in adipose tissue, reducing visceral fat
and obesity-associated alterations upon hypercaloric regimens
[1303]. Expression of the C. elegans lysosomal lipases lipl-1,
lipl-3, and lipl-4 tightly correlates with activation of autophagy
in the conditions so far tested [948, 1304, 1305], and this
transcriptional activation is necessary for optimal lipid mobi
lization in conditions of autophagy activation such as fasting
[948, 1304].
The antioxidant enzyme PRDX1 (peroxiredoxin 1) is
expressed most highly in macrophages, and plays an essential
role in regulation of lipophagic flux and maintenance of
cholesterol homeostasis against oxidative stress within ather
osclerotic macrophages [1306]. The regulation of expression

of lipid droplet regulators (such as the PLIN/perilipin family)
and of autophagy adaptors (such as the TBC1D1 family)
during starvation and disease deserves further exploration
[1307–1309]. Members of the PNPLA (patatin like phospho
lipase domain containing) protein family, PNPLA1 [1310],
PNPLA2 [1311, 1312] and PNPLA3 [1313], as lipid droplet
residents, play essential roles in lipophagy by regulating lipid
droplet size and autophagic flux. Although a physiological
receptor protein and specific induction signal for lipophagy
are poorly understood, expression of a fusion protein of
SQSTM1 and a lipid droplet-binding domain can induce
forced lipophagy to promote the breakdown of lipid droplets
[1314]. Coating PLINs (perilipins) can also be degraded
through CMA, facilitating access of cytosolic lipases to the
esterified lipids stored in the droplet [1315]. Lipophagy is
often monitored in vitro using cell culture media supplemen
ted with fatty acids to promote the formation of intracellular
lipid droplets. Caution should be taken with the assessment
and interpretation of lipophagy data in adipocytes. This cell
type shows spontaneous physiological accumulation of lipid
droplets, in contrast with cells in which lipid droplet accumu
lation is experimentally forced and is associated with
lipotoxicity.
Cautionary notes: With regard to changes in the cellular
neutral lipid content, the presence and potential activation of
cytoplasmic lipases that are unrelated to lysosomal degrada
tion must be considered. Caution should also be taken when
interpreting lipophagy data using autophagy-related gene
knockout mice. In response to fasting or diet-induced obesity,
liver-specific rb1cc1, atg7 or atg5 knockout mice have
decreased hepatic lipid accumulation, which is likely due to
an adaptive response that includes increased FGF21 produc
tion and NFE2L2 activation in these knockout mice as a result
of chronic impaired hepatic autophagy [1316–1318].
n. Lysophagy. Lysophagy is a selective autophagy process
that participates in cellular quality control through lysosome
turnover. By eliminating ruptured lysosomes, lysophagy pre
vents the subsequent activation of the inflammasome complex
and innate response [1319–1321]. The conserved autophagy
machinery of D. discoideum also localizes at lysosomes
damaged by lysosomotropic agents such as LLOMe (polymers
of Leu-Leu-OMe). It has been proposed that autophagy,
which also occurs at damaged compartments containing the
bacterial pathogen M. marinum, plays a role in both the repair
of the damaged compartment and its total engulfment for
degradation [1322].
o. Myelinophagy. Myelinophagy or Schwann cell autophagy
refers to selective autophagic degradation of myelin from
Schwann cells in order to avoid or to reduce myelin debris
and aggregates following peripheral nerve injury [1323]. An
efficient Schwann cells myelin clearance, an early event in
Wallerian degeneration, counteracts inflammatory processes
facilitating recovery and nerve regeneration [1324, 1325].
Schwann cells form autophagosomes in response to nerve
injury. Inhibition of autophagy using both pharmacological
inhibitors or genetic manipulation of autophagic genes (such
as Ambra1 and Atg7) leads to a severe neuropathy in response
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to injury, in vitro and in vivo [540, 1326, 1327]. A funda
mental role of myelinophagy in peripheral neurodegeneration
(i.e., demyelinating diseases) has been recognized [1328].
p. Nucleophagy. Nuclear autophagy is a mechanism by
which cells maintain cellular homeostasis and ensure nuclear
integrity, stability and correctness of gene expression.
Targeted removal of nuclear material, part of or the entire
nucleus, from a cell by autophagy (i.e., nucleophagy) has been
reported as a selective mode occurring by autophagy as well as
microautophagy [4]. The nuclear membrane may contribute
to the phagophore membrane in addition to being an auto
phagic target. In autophagy, phagophores can sequester the
nucleus-derived cargo, and autophagosomes subsequently
merge with the vacuole or lysosomes, leading to the degrada
tion of their contents [1329–1331]. In micronucleophagy,
satellite nuclei are formed due to stress or genome instability
and then engulfed directly [1077, 1332, 1333]. An alternative
mechanism of nucleophagy has been reported in
Saccharomyces cerevisiae, which is mediated by Atg39, a
nuclear envelope receptor inducing autophagic sequestration
of localized parts of the nucleus [1334].
The autophagy marker LC3 is expressed in the nucleus of
human primary fibroblasts where it can directly interact with
the nuclear lamina protein LMNB1 (lamin B1) [1335]; this
process is associated with extensive DNA damage, and is
triggered by oncogenic insult and senescence. The interaction
of LC3 with LMNB1 does not downregulate LMNB1 during
starvation, but can mediate its degradation upon oncogenic
stress, providing a general mechanism to protect the cells
from oncogene-induced senescence and tumorigenesis.
Nucleophagy can thus be monitored through a quantification
of the colocalization between LMNB1 and (GFP)-LC3 in
puncta in the cytoplasm and in the nucleus, or through a
dual fluorescent RFP-GFP-LMNB1 [1335].
q. Oxiapoptophagy. There are now several lines of evidence
indicating that autophagy is an essential process in vascular
and neurological functions. Autophagy can be considered as
atheroprotective in the early stages of atherosclerosis, and
dysfunctional in advanced atherosclerotic plaques [1336]. A
deregulated, amplified or attenuated autophagy process at
different levels of the activation pathway appears to be asso
ciated with several neurodegenerative diseases [1337].
Currently, little is known about the molecules that promote
autophagy on the cells of the vascular wall and on neural cells
(glial and microglial cells, neurons). As increased levels of
cholesterol oxidation products (named oxysterols) are found
in atherosclerotic lesions [1338], and in the brain, cerebro
spinal fluid and/or plasma of patients with neurodegenerative
diseases [1339], the part taken by these molecules has been
investigated, and several studies support the idea that some of
them could contribute to the induction of autophagy [1339–
1342]. There are several lines of evidence that oxysterols,
especially 7-ketocholesterol and 7β-hydroxycholesterol,
which can be increased under various stress conditions in
several age-related diseases including vascular and neurode
generative diseases [1339], could trigger a particular type of
autophagy termed oxiapoptophagy (OXIdation + APOPTOsis
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+ autoPHAGY) [1343] characterized by the simultaneous
induction of oxidative stress associated with apoptosis, and
autophagic criteria in different cell types from different spe
cies [1344–1346]. As oxiapoptophagy has also been observed
with 7β-hydroxycholesterol and 24(S)-hydroxycholesterol,
which are potent inducers of cell death, it is suggested that
oxiapoptophagy could characterize the effect of cytotoxic
oxysterols [1344]. In addition, following treatment with 7βhydroxycholesterol, in 158N murine oligodendrocytes, there
is evidence of a link between 7β-hydroxycholesterol-induced
oxiapoptophagy and inflammation [1346, 1347].
In any case, care must be taken in assigning an autophagy
activating role to cholesterol-related compounds. Most of
these studies usually consider such compounds as autophagy
inducers because of their ability to convert LC3-I to LC3-II.
However, the conversion of LC3 and/or the accumulation of
LC3-labeled autophagosomes might be due to the blockade of
this pathway at a later stage, as happens for some autophagy
blockers such as CQ [302, 1348, 1349]. Furthermore, an
increase in ROS generation is also commonly reported in
these studies, which other authors have associated with lyso
somal pH increases that ultimately prevent the fusion of
lysosomes with autophagosomes [1348]. In this context, it is
notable that the imbalance of membrane cholesterol has
already been described to induce the generation of ROS
[1350, 1351].
r. Proteaphagy. The autophagic degradation of 26S protea
some complexes has been reported in plants [1352–1354],
yeast [1355, 1356], and humans [1357]. Two pathways for
degradation have been reported: an ATG1-dependent path
way triggered by nutrient starvation, and an ATG1-indepen
dent pathway stimulated by chemical or genetic inhibition
[1352, 1353]. Starvation-induced proteaphagy occurs in
response to nitrogen but not carbon starvation in
Arabidopsis and yeast [1355], as carbon starvation instead
triggers relocalization of proteasomes into cytoplasmic protea
some storage granules that offer protection against autophagy
[1358]. However, if proteasome storage granule formation is
blocked, proteaphagy also becomes the default response to
carbon starvation. While little is currently known about the
selectivity of starvation-induced proteaphagy in plants and
yeast, in humans it appears to involve subunit ubiquitination
and the autophagy receptor SQSTM1 [1357].
Inhibitor-induced proteaphagy also involves extensive ubi
quitination of proteasome subunits to facilitate binding of
autophagy receptors. In yeast, proteasomes first aggregate in
the cytosol in an Hsp42-dependent manner, before the recep
tor Cue5 tethers the ubiquitinated, aggregated proteasomes to
the expanding phagophore [1353]. In Arabidopsis, RPN10
instead acts as the receptor [1352]. RPN10 is a ubiquitin
receptor within the proteasome regulatory particle, but is an
unusual proteasome subunit as it also exists as a free form in
the cytosol. The free form can bind ubiquitinated proteasome
subunits via a standard ubiquitin-interacting motif (UIM),
and also binds ATG8 via a related UIM-like sequence, rather
than a canonical AIM/LIR [1359]. This casts RPN10 as the
founding member of a new class of UIM-containing autopha
gy adaptors and receptors that are conserved across

118

D. J. KLIONSKY ET AL.

kingdoms. The exact subunits and residues to be ubiquiti
nated during proteaphagy, and the E3 ligases involved, are
currently unknown.
As with other types of selective autophagy, proteaphagy
can easily be monitored using fluorescently tagged protea
some subunits. Numerous core protease and regulatory par
ticle subunits have been successfully tagged [1360], although
care should be taken to ensure that the tag does not interfere
with incorporation of the subunit into the proteasome parti
cle. Once tagged, proteasome delivery to the vacuole can be
studied by both confocal fluorescence microscopy, and by
monitoring the release of free fluorescent protein by immu
noblot. It is important to note that proteasome subunit levels
do not necessarily correlate with levels of proteaphagy, parti
cularly when studying the inhibitor-induced pathway. This is
because synthesis of proteasome subunits is strongly induced
upon proteasome inhibition by transcriptional feedback loops
involving Rpn4 in yeast, NRF1 in humans and AT5G04410/
NAC78 and AT3G10500/NAC53 in Arabidopsis [1360].
When yeast are grown under very low levels of glucose,
proteasomes are also taken up directly into vacuoles by micro
autophagy [1361]. Microautophagy appears biased toward
aberrant or inactive proteasomes, with functional proteasomes
accumulating in proteasome storage granules. AMPK and
ESCRT factors are required for proteasome microautophagy
and also affect proteasome storage granule dissipation and
nuclear reimport of proteasomes upon glucose refeeding.
s. Reticulophagy. Starvation in yeast induces a type of selec
tive autophagy of the ER [1362], which depends on the
autophagy receptors Atg39 and Atg40 [1334]. ER stress also
triggers an autophagic response [1363], which includes the
formation of multi-lamellar ER whorls and their degradation
by a microautophagic mechanism [1364]. ER-selective auto
phagy has been termed reticulophagy/ER-phagy [1365].
Selective autophagy of the ER has also been observed in
mammalian cells [1366], where multiple receptors have been
recently characterized [1367–1369]. Reticulophagy receptors
are selective not only for the ER itself, but they can also lead
to the degradation of specific ER subdomains [1370].
RETREG1/FAM134B was the first ER protein identified as
an ER-specific autophagy receptor specific for ER sheets
[74]. RTN3 and ATL3 have been described as reticulophagy
receptors committed to the degradation of ER tubules ([1371,
1372]; whereas TEX264 is mainly located in the ER 3-way
junctions [464, 1373]. SEC62 and CCPG1 are two other reti
culophagy receptors with a broader ER distribution. SEC62 is
involved in a particular form of reticulophagy (recovER reti
culophagy), which reduces the ER size to a normal level after
an ER stress is resolved via ESCRT-III driven microreticulo
phagy [1374, 1375]. In contrast, CCPG1 is activated directly
under ER stress conditions [1376]. Because reticulophagy is
selective, it is able to act in ER quality control [1370, 1377,
1378], and eliminate protein aggregates that cannot be
removed in other ways. In the clearance of specific protein
aggregates, the reticulophagy receptors cooperate with other
ER proteins such as specific chaperones or elements of the
COPII complex [1379–1382]. Moreover, reticulophagy func
tions to sequester parts of the ER that are damaged by the

presence of pathogens such as viruses and bacteria [1383,
1384]. The acetylation of ATG9A within the ER lumen
seems to regulate its ability to interact with RETREG1/
FAM134B and SEC62, and induce reticulophagy [1385,
1386], a process that might be involved in the maintenance
of proteostasis within the ER [1386, 1387]. Reticulophagy can
be monitored using reticulophagy reporters such as eGFPmCherry-SERP1/RAMP4
[465],
mCherry-GFP-REEP5
[1372], and ssRFP-GFP-KDEL [464]. These tandem fluores
cent protein reporters are detected as yellow signals in the ER,
but when they are delivered to lysosomes by autophagy, they
become red, as the GFP signal is quenched. Cleavage of these
reporters in lysosomes can also be monitored by
immunoblotting.
The COPII complex has also been associated with an
additional, less understood pathway involving noncanonical,
microautophagy-like degradation of ER exit sites (ERES) con
taining misfolded procollagen [1388]. This pathway is char
acterized by cargo colocalization with COPII proteins and
lysosomal markers without ER membrane or lumen markers;
the colocalization is further enhanced by lysosomal hydrolase
inhibitors. Cargo selectivity and activation mechanisms for
this recently identified pathway have not yet been established.
t. Ribophagy. Autophagy has been reported for the selective
removal of ribosomes in yeast, particularly upon nitrogen
starvation [1389]; however, it remains unclear whether yeast
has a dedicated ribophagy pathway that is activated under
conditions of nitrogen starvation. Published papers monitor
this process by western blot, following the generation of free
GFP from Rpl5-GFP or Rpl25-GFP [1390], or the disappear
ance of ribosomal subunits such as Rps3. Vacuolar localiza
tion of Rpl5-GFP or Rpl25-GFP can also be seen by
fluorescence microscopy. The Rkr1/Ltn1 ubiquitin ligase is
reported to act as an inhibitor of 60S ribosomal subunit
ribophagy via, at least, Rpl25 as a target, and is antagonized
by the deubiquitinating Ubp3-Bre5 complex [1389, 1390].
Rkr1/Ltn1 and Ubp3-Bre5 are proposed to contribute to
adapt ribophagy activity to both nutrient supply and protein
translation. Ribophagy has also been observed in animal cells,
for instance in arsenite-treated mammalian cells, as was
demonstrated with Ribo-Keima flux assays alongside a variety
of other Keima-based flux assays [1037].
u. RNA-silencing components. Several components of the
RNA-silencing machinery are selectively degraded by auto
phagy in different organisms. This was first shown for the
plant AGO1/ARGONAUTE1 protein, a key component of the
Arabidopsis RNA-induced silencing complex (RISC) that,
after ubiquitination by a virus encoded F-box protein, is
targeted to the vacuole [1391]. AGO1 colocalizes with
Arabidopsis ATG8a-positive bodies, and its degradation is
impaired by various drugs such as 3-MA and E64d, or in
Arabidopsis mutants in which autophagy is compromised
such as the TOR-overexpressing mutant line G548 or the
atg7-2 mutant allele [1391]. Moreover, this pathway also
degrades AGO1 in a nonviral context, especially when the
production of miRNAs is impaired. Defects in miRNA bio
genesis also cause autophagic degradation of Drosophila
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AGO1 [1392]. In mammalian cells, not only the main miRNA
effector AGO2, but also the miRNA-processing enzyme
DICER1, is degraded as a miRNA-free entity by selective
autophagy [1393]. Chemical inhibitors of autophagy (bafilo
bafilomycin A1 and CQ) and, in HeLa cells, depletion of key
autophagy components ATG5, BECN1 or ATG7 using short
interfering RNAs, blocks the degradation of both proteins.
Electron microscopy shows that DICER1 is associated with
membrane-bound structures having the hallmarks of autop
hagosomes. Moreover, the selectivity of DICER1 and AGO2
degradation might depend on the autophagy receptor
CALCOCO2, at least in these cell types. Finally, in C. elegans,
AIN-1, a homolog of mammalian TNRC6A/GW182 that
interacts with AGO and mediates silencing, is also degraded
by autophagy [1394]. AIN-1 colocalizes with the C. elegans
SQSTM1 homolog SQST-1 that acts as a receptor for autop
hagic degradation of ubiquitinated protein aggregates, and
also directly interacts with Atg8-family proteins contributing
to cargo specificity.
v. RNautophagy and DNautophagy. RNautophagy and
DNautophagy are non-macroautophagic pathways, where
RNA and DNA, respectively, are taken up by lysosomes
directly [1395–1398]. LAMP2C, one of the LAMP2 isoforms,
can function as an RNA/DNA receptor in RNautophagy and
DNautophagy. SIDT2 is another molecule that has been iden
tified to mediate nucleic acid transport during RNautophagy
and DNautophagy [1399–1401]. SIDT2 is a lysosomal multi
pass transmembrane protein, and a vertebrate ortholog of the
C. elegans RNA transporter SID-1.
RNautophagy and DNautophagy were first discovered
using in vitro assays with isolated lysosomes derived from
mouse brains [1395, 1397], and are also confirmed in isolated
lysosomes from HeLa, Neuro2a cells, and MEFs. In vitro
assays can be used to detect the activity of RNautophagy or
DNautophagy in isolated lysosomes. The activity of
RNautophagy at the cellular level can be detected in mamma
lian cells using a pulse-chase assay [1400]. For example, over
expression of SIDT2 in Neuro2a cells remarkably promotes
lysosomal degradation of RNA at the cellular level [1401].
Knockdown of SIDT2 significantly inhibits lysosomal degra
dation of cellular RNA in MEFs [1400]. Currently, it remains
unclear whether there is a SIDT2-independent pathway in
RNautophagy and DNautophagy. The activity of
DNautophagy at the cellular level has not been reported to
date. G/dG sequences in nucleic acids could be motifs that are
recognized by RNautophagy and DNautophagy, because polyG/dG are a substrate of RNautophagy and DNautophagy in
vitro, but poly-C/dC, poly-A/dA, poly-U or poly-T are not
[1398].
Conclusion: Currently, RNautophagy and DNautophagy
activities can be significantly manipulated only by knockdown
or overexpression of SIDT2. Identification of nucleic acid
sequences that are recognized by RNautophagy or
DNautophagy, or specific inhibitors of these pathways,
would contribute to the development of novel methods that
can monitor RNautophagy and DNautophagy more
accurately.
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w. Vacuole import and degradation pathway. In yeast, glu
coneogenic enzymes such as Fbp1/FBPase (fructose-1,6bisphosphatase), Mdh2 (malate dehydrogenase), Icl1 (isoci
trate lyase) and Pck1 (phosphoenolpyruvate carboxykinase)
constitute the cargo of the vacuole import and degradation
(Vid) pathway [1402]. These enzymes are induced when yeast
cells are glucose starved (grown in a medium containing 0.5%
glucose and potassium acetate). Upon replenishing these cells
with fresh glucose (a medium containing 2% glucose), these
enzymes are degraded in either the proteasome [1403–1405]
or the vacuole [1402, 1406] depending on the duration of
starvation. Following glucose replenishment after 3 days of
glucose starvation, the gluconeogenic enzymes are delivered
to the vacuole for degradation [1407]. These enzymes are
sequestered in specialized 30- to 50-nm Vid vesicles [1408].
Vid vesicles can be purified by fractionation and gradient
centrifugation; western blotting analysis using antibodies
against organelle markers and Fbp1, and the subsequent ver
ification of fractions by EM facilitate their identification
[1408]. Furthermore, the amount of marker proteins in the
cytosol compared to the Vid vesicles can be examined by
differential centrifugation. In this case, yeast cells are lysed
and subjected to differential centrifugation. The Vid vesicleenriched pellet fraction and the cytosolic supernatant fraction
are examined with antibodies against Vid24, Vid30, Sec28 and
Fbp1 [1409–1411].

x. Virophagy
Virophagy is a type of xenophagy, and refers to the autopha
gic clearance of viruses. An important point when considering
the convergence of autophagy and viral infection is that some
viruses have evolved mechanisms to block autophagy or to
subvert the process to promote viral replication. For example,
infection of a cell by influenza and dengue viruses [1415,
1416] or enforced expression of the hepatitis B virus X protein
[1417] have profound consequences for autophagy, as viral
proteins such as NS4A stimulate autophagy and protect the
infected cell against apoptosis, thus extending the time in
which the virus can replicate. Conversely, the HSV-1
ICP34.5 protein inhibits autophagy by targeting BECN1
[1418]. Whereas the impact of ICP34.5’s targeting of BECN1
on viral replication in cultured permissive cells is minimal, it
has a significant impact upon pathogenesis in vivo, most likely
through interfering with activation of CD4+ T cells [1419,
1420], and through cell-intrinsic antiviral effects in neurons
[1421]. In addition, the ICP0 protein of HSV-1 downregulates
major autophagy receptors such as SQSTM1 and OPTN dur
ing the early stages of HSV-1 infection. This could be a
mechanism of HSV-1 to counteract the pleiotropic functions
of these autophagy receptors, because in SQSTM1-overexpres
sing cells HSV-1 yields decrease [1422]. Also, viral BCL2
proteins, encoded by large DNA viruses, are able to inhibit
autophagy by interacting with BECN1 [848] through their
BH3 homology domain. Examples of these include γ-herpes
virus 68 [1423], Kaposi sarcoma-associated herpesvirus [848]
and African swine fever virus (ASFV) vBCL2 homologs
[1424]. ASFV encodes a protein homologous to HSV-1
ICP34.5, which, similar to its herpesvirus counterpart, inhibits
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the ER stress response activating PPP1/protein phosphatase 1;
however, in contrast to HSV-1 ICP34.5 it does not interact
with BECN1. ASFV vBCL2 strongly inhibits both autophagy
(reviewed in ref. [1425]) and apoptosis [1426]. The polyQ
repeats in some viral proteins could also affect BECN1mediated autophagy and play a role in virus survival [1427].
HIV has evolved to employ different strategies to finely
regulate autophagy to favor its replication and dissemination.
In particular, the HIV proteins TAT, NEF and ENV are
involved in this regulation by either blocking or stimulating
autophagy through direct interaction with autophagy proteins
and/or modulation of the MTOR pathway [1428, 1429].
Autophagy contributes to limiting viral pathogenesis in
HIV-1 nonprogressor-infected patients by targeting viral
components for degradation [1430]. Innate immune stimula
tion induces antiviral autophagy against Rift Valley fever virus
from insects to humans [1431]. One of the Fanconi anemia
(FA) genes, Fancc, is required for virophagy of two genetically
distinct viruses, Sindbis virus and HSV-1ΔICP34.5BBD, but
not for starvation-induced autophagy. Knockout of Fancc in
mice increases susceptibility to lethal viral encephalitis [1432]
In the case of Epstein-Barr virus (EBV), several EBV pro
teins including EBNA1, EBNA3C, LMP1, LMP2A and Rta/Zta
interact with the autophagy machinery in B cells. Autophagy
is involved in the processing and MHC-II presentation of
EBNA1 [1433]. Conversely, EBNA3C, LMP1, LMP2A and
Rta initiate and accelerate autophagy progression [1434–
1437]. Moreover, autophagy inhibition by 3-MA or ATG5
knockdown diminishes EBV lytic protein expression and
viral particle production in B cells [1438]. Autophagy also
plays a key role in B-cell proliferation and survival early
after infection [1439].
Adenoviruses rupture the endosomal membrane upon
entry, thereby triggering antiviral autophagy mediated by
LGALS8/galectin-8 (lectin, galactoside-binding, soluble, 8).
Adenovirus subsequently limit the autophagic response by
recruiting the cellular ubiquitin ligase NEDD4L/NEDD4.2
and escape from the endosome into the cytosol [1440]. In
addition, autophagosomes may fuse with intermediate endo
somes in response to certain specific viral infections, thus
forming amphisomes [1441–1443].
Care must be taken in determining the role of autophagy in
viral replication, as some viruses such as vaccinia virus use
double-membrane structures that form independently of the
autophagy machinery [1444]. Similarly, dengue virus replica
tion, which appears to involve a double-membrane compart
ment, requires the ER rather than autophagosomes [1445,
1446], whereas coronaviruses and Japanese encephalitis virus
use a nonlipidated version of LC3 (see Atg8-family protein
detection and quantification) [255, 256]. Yet another type of
variation is seen with hepatitis C virus, which requires
BECN1, ATG4B, ATG5 and ATG12 for initiating replication,
but does not require these proteins once an infection is
established [1447].
Autophagy has been highlighted as a critical player in the
process of Zika virus (ZIKV) infection and pathogenesis,
particularly during pregnancy [1448]. In mammals, autophagy
activation is triggered by ZIKV infection likely due to inhibi
tion of the AKT-MTOR pathway, which is co-opted to

facilitate viral entry, replication, and release [1448–1450].
Pharmacological blockade of autophagy activity, for example,
treatment with lysosomotropic agents (especially hydroxy
chloroquine [HCQ]), is proposed as a promising therapeutic
to counteract ZIKV infection and limit vertical transmission
[1448].
After viral hemorraghic septicemia virus (VHSV) entry
into rainbow trout red blood cells, autophagy is induced as
a mechanism for viral protein degradation. VHSV triggers an
increase of LC3A/B protein levels and upregulation of auto
phagy-related genes such as ULK1, BECN1, and ATG9A,
whereas SQSTM1 undergoes degradation early after VHSV
exposure. Inhibition of autophagosome degradation with
niclosamide results in intracellular VHSV and SQSTM1 accu
mulation [1451].
y. Xenophagy. Xenophagy refers to the autophagic pathway
for the capture and lysosomal degradation of cytosolic patho
gens, and pathogens in damaged intracellular vacuoles. Many
in vitro and in vivo studies have demonstrated that genes
encoding autophagy components are required for host
defense against infection by bacteria, parasites and viruses.
In a quest for survival, microbial pathogens have evolved
strategies to overcome xenophagic clearance. The interactions
of these pathogens with the host autophagy system are com
plex and have been the subject of several excellent reviews
[170–175, 628, 1452–1460]. There are a few key considera
tions when studying interactions of microbial pathogens with
the autophagy system [1461]. Importantly, autophagy should
no longer be considered as strictly antibacterial, and several
studies have described the fact that autophagy may serve to
either restrict or promote bacterial replication both in vivo
[1462] and in vitro (reviewed in refs. [1463, 1464]). Moreover,
special care should be taken when evaluating bacterialinduced specific autophagy and autophagic flux, because an
increased basal autophagy and flux perceived by western blot
may be unlinked to the cellular compartment of the bacterial
vacuole, which can be revealed by careful examination of the
bacterial compartment using IHC and colocalization studies
[1465]. For example, autophagy has been proposed to both
support the survival of intraphagosomal M. marinum, by
providing cytosolic material and/or membranes to the bac
teria-containing compartment, and to restrict the prolifera
tion of the cytosolic mycobacteria in D. discoideum [64, 1322].
In addition to pathogenic bacteria, autophagy can be induced
by beneficial bacteria, contributing to alleviation of the hepa
totoxicity induced by acetaminophen, in vitro [1466].
LC3 is commonly used as a marker of autophagy.
However, studies have established that LC3 can promote
phagosome maturation independently of autophagy through
LC3-associated phagocytosis (see cautionary notes in Atg8family protein detection and quantification, and
Noncanonical use of autophagy-related proteins). Other studies
show that autophagy of Salmonella enterica serovar
Typhimurium (S. Typhimurium) is dependent on ATG9, an
essential autophagy protein, whereas LC3 recruitment to a
bacteria-containing phagosome does not require ATG9
[1467]. In contrast, autophagy of these bacteria requires either
glycan-dependent binding of LGALS8 to damaged
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membranes and subsequent recruitment of the cargo receptor
CALCOCO2 [1468], or ubiquitination of target proteins (not
yet identified) and recruitment of at least four different ubi
quitin-binding receptor proteins, SQSTM1 [1469],
CALCOCO2 [1470], TAX1BP1/CALCOCO3 [1471] and
OPTN [1472]. In fibroblasts, S. Typhimurium triggers the
formation of host endomembrane-containing aggresomes
that are further captured together with intravacuolar bacteria
by phagophores harboring LC3 and SQSTM1, but devoid of
CALCOCO2 and ubiquitin [1473]. Therefore, the available
criteria to differentiate LAP from autophagy include: i) LAP
involves LC3 recruitment to a bacteria-containing phagosome
in a manner that requires ROS production by an NADPH
oxidase. It should be noted that most cells express at least one
member of the NADPH oxidase family. Targeting expression
of the common CYBA/p22phox subunit is an effective way to
disrupt the NADPH oxidases. Scavenging of ROS by antiox
idants such as NAC, resveratrol and alpha-tocopherol is also
an effective way to inhibit LAP. ii) Autophagy of bacteria
requires ATG9, whereas LAP apparently does not [1467]. iii)
LAP involves single-membrane structures surrounding the
bacterial cargo. CLEM is expected to show single-membrane
structures that are LC3+ with LAP [247]. In contrast, auto
phagy is expected to generate double-membrane structures
surrounding cargo (which may include single-membrane pha
gosomes, giving rise to triple-membrane structures around
the bacterial membrane(s), corresponding to an autophagoly
sosome [1467]). It is anticipated that more specific markers of
LAP will be identified as these phagosomes are further char
acterized. In vivo xenophagy studies in mice show that S.
Typhimurium reduces the level of basal autophagy in tissues
such as intestine as seen by LC3-II levels at later times of
infection [1474]. This suggests that pathogens have the ability
to decrease host autophagy for their survival. Recently identi
fied xenophagy-enhancing compounds show enhanced cap
ture and degradation of S. Typhimurium in both cellular and
in vivo models with enhanced LC3-II levels in tissues [1475].
Elegant mechanisms that differentiate autophagy from LAP
have emerged that demonstrate that there are mechanistic
differences between these processes. For example, ATG16L1
recruitment to the phagosome in Salmonellae-infected cells
occurs through a carboxy-terminal WD40 domain that binds
to the V-ATPase on the phagosome, which is dispensable for
canonical autophagy [1476, 1477]. This domain is also
required in influenza infection [1478]. These studies illustrate
that while LC3 targeting of a pathogen-containing vacuole
uses components shared with canonical autophagy, it utilizes
a distinct mechanism.
Nonmotile Listeria monocytogenes can be targeted to pha
gophores upon antibiotic treatment [883], which indicates
that autophagy serves as a cellular defense against microbes
in the cytosol. However, subsequent studies have revealed that
autophagy can also target pathogens within phagosomes,
damaged phagosomes or the cytosol, as illustrated by the
various phases of infection of M. marinum in D. discoideum
[1322, 1459]. Therefore, when studying microbial interactions
by EM, many structures can be visualized, with any number of
membranes encompassing microbes, all of which may be
LC3+ [1479, 1480]. As discussed above, single-membrane
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structures that are LC3+ may arise through LAP, and we
cannot rule out the possibility that both LAP and autophagy
may operate at the same time to target the same phagosome.
Indeed, autophagy may facilitate phagocytosis and subsequent
bacterial clearance [1481]. Autophagy is not only induced by
intracellular bacteria, but also can be activated by extracellular
bacteria such as Pseudomonas aeruginosa and Klebsiella pneu
moniae, which may involve complex mechanisms [1482–
1484]. Furthermore, autophagy can be induced by Gramnegative bacteria via a common mechanism involving natu
rally-produced bacterial outer membrane vesicles [1485,
1486]; these vesicles enter human epithelial cells, resulting in
autophagosome formation and inflammatory responses
mediated via the host pathogen recognition receptor NOD1
[1485, 1487]. In addition, highly purified outer membrane
proteins from bacteria and mitochondria can trigger autopha
gy [1488]. Upon specific stimulation, NOD1 binds to LC3
inducing an increased autophagy flux and autolysosome for
mation, and LC3-NLRP3 inflammasome interaction, in
epithelial Sertoli cells [1489]. The ability of NOD1 to sense
ER stress and cell damage and induce pro-inflammatory sig
naling is regulated by ATG16L1 [1490], implicating autopha
gy and inflammasomes in environmental stress responses.
NOD2 also regulates autophagy upon stimulation by danger/
damage-associated molecular patterns (DAMPs) such as the
bacterial NOD2 ligand sulfatide. NOD2 connects inflamma
tion hypoxia and autophagy, as NOD2 is a direct transcrip
tional target of HIF1A, the main oxygen sensor in mammalian
cells induced by reduced oxygen. Hypoxia-induced NOD2
functions upstream of CQ and directly binds to the VATPAse complex, regulating vesicular pH [1491].
Viruses can also be targeted by autophagy, and in turn can
act to inhibit autophagy (see Virophagy). Xenophagy has also
been observed with intracellular parasites. Mice deficient in
autophagy develop a more severe Trypanosoma cruzi infec
tion, characterized by higher peaks of parasitemia, higher
cardiac amastigote nests and premature death, compared to
controls. Peritoneal macrophages from these mice display
higher levels of infection that correlate with the minor recruit
ment of LC3 and other proteins, such as CALCOCO2 and
SQSTM1, to amastigotes, observed in the cytoplasm of RAW
cells in the presence of inhibitors of autophagy [1492].
Finally, it is important to realize that there may be other
autophagy-like pathways that have yet to be characterized. For
example, in response to cytotoxic stress (treatment with eto
poside), autophagosomes are formed in an ATG5- and ATG7independent manner (see Noncanonical use of autophagyrelated proteins) [31]. While this does not rule out involve
ment of other autophagy regulators/components in the for
mation of these autophagosomes, it does establish that the
canonical autophagy pathway involving LC3 conjugation is
not involved. In contrast, RAB9 is required for this alternative
pathway, potentially providing a useful marker for analysis of
these structures. Returning to xenophagy, M. marinum can be
targeted to phagophores in an ATG5-independent manner
[1493]. Furthermore, up to 25% of intracellular S. typhimur
ium are observed in multi-lamellar membrane structures
resembling autophagosomes in atg5−/− MEFs [1469]. These
findings indicate that an alternate autophagy pathway is
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relevant to host-pathogen interactions. Moreover, differences
are observed that depend on the cell type being studied.
Yersinia pseudotuberculosis is targeted to autophagosomes
where it can replicate in bone marrow-derived macrophages
[1494], whereas in RAW 264.7 and J774 cells, bacteria are
targeted both to autophagosomes, and LC3-negative, singlemembrane vacuoles (F. Lafont, personal communication).
One key consideration has recently emerged in studying
xenophagy. Whereas the basal autophagic flux in most cells is
essential for their survival, infecting pathogens can selectively
modulate antibacterial autophagy (i.e., xenophagy) without
influencing basal autophagy. This may help pathogens ensure
prolonged cellular (i.e., host) survival. Thus, in the case of
xenophagy it would be prudent to monitor substrate (patho
gen)-specific autophagic flux to understand the true nature of
the perturbation of infecting pathogens on autophagy [1495,
1496]. Furthermore, this consideration particularly limits the
sensitivity of LC3 western blots for use in monitoring auto
phagy regulation, and stresses that other techniques such as
those enabling subcellular analysis of the pathogen-specific
compartment/vacuole are additionally used. For instance, to
verify that the effect of a total reduction in LC3-II during
autophagy induction by western blot also extends to the sub
cellular compartment of the pathogen/bacterial vacuole by
using LC3-based microscopy [1465].
z. Zymophagy. Zymophagy was originally defined as a spe
cific mechanism that eliminates zymogen granules in the
pancreatic acinar cells and, thus, prevents deleterious effects
of prematurely activated and intracellularly released proteoly
tic enzymes, when impairment of secretory function occurs
[1497]. Therefore, zymophagy is primarily considered to be a
protective mechanism implemented to sustain secretory
homeostasis and to mitigate pancreatitis. The presence of
zymogen granules, however, is not only attributed to pancrea
tic acinar cells. Thus, zymophagy was also reported in acti
vated secretory Paneth cells of the crypts of Lieberkühn in the
small intestine [542]. Note that one of the major functions of
Paneth cells is to prevent translocation of intestinal bacteria
by secreting hydrolytic enzymes and antibacterial peptides to
the crypt lumens. The similarity in mechanisms of degrada
tion of secretory granules in these two different types of
secretory cells sustains the concept of the protective role of
autophagy when “self-inflicted” damage may occur due to
overreaction and/or secretory malfunction in specialized cells.
Zymophagy can be monitored by TEM, identifying auto
phagosomes containing secretory granules, by following
SQSTM1 degradation by western blot, and by examining the
subcellular localization of VMP1-EGFP, which relocates to
granular areas of the cell upon zymophagy induction.
Colocalization of PRSS1/trypsinogen (which is packaged
within zymogen granules) and LC3, or of GFP-ubiquitin
(which is recruited to the activated granules) with RFP-LC3
can also be observed by indirect or direct immunofluores
cence microscopy, respectively. Active trypsin is also detect
able in zymophagosomes and participates in the early onset of
acute pancreatitis (F. Fortunato et al., unpublished data). In
addition, isolated zymogen granules from alcohol-fed mouse
pancreas also contain LC3-II based on western blot analysis,

which may also serve as another indirect quantitative marker
for zymophagy [1498].
Of note, studies from the past decade have shown an
essential role of autophagy in maintaining pancreatic acinar
cell homeostasis and function, and strongly implicate
impaired autophagy in initiation and development of pan
creatitis (see Large animals and rodents). In particular, immu
nofluorescence data [1499] indicate autolysosomes as one
compartment in which trypsinogen activation occurs in pan
creatitis, as evidenced by colocalization of LC3-II and LAMP2
with trypsinogen activation peptide (an oligopeptide cleaved
off trypsinogen in the process of its conversion to active
trypsin). Impaired TFEB-mediated lysosomal biogenesis has
also been shown to promote cerulein or alcohol-induced
pancreatitis in mice. In addition to experimental pancreatitis,
acinar cell nuclear TFEB staining markedly decreased in both
human alcoholic and non-alcoholic pancreatitis, supporting a
critical role of autophagy and lysosomal biogenesis in the
pathogenesis of pancreatitis [1498, 1500].
12. Autophagic sequestration assays
Although it is useful to employ autophagic markers such as
LC3 in studies of autophagy, LC3-II levels or LC3 puncta
cannot quantify actual autophagic activity, because LC3-II is
not involved in all cargo sequestration events, and LC3-II can
be found on phagophores and nonautophagosomal mem
branes in addition to autophagosomes. Thus, quantification
of autophagic markers such as LC3 does not tell how much
cargo material has actually been sequestered inside autopha
gosomes. Moreover, LC3 and several other autophagic mar
kers cannot be used to monitor noncanonical autophagy.
Autophagic sequestration assays constitute marker-indepen
dent methods to measure the sequestration of autophagic
cargo into autophagosomal compartments, and are among
the few functional autophagy assays described to date.
Autophagic cargo sequestration activity can be monitored
using either an (electro)injected, inert cytosolic marker such
as [3H]-raffinose [1501] or an endogenous cytosolic protein
such as LDH (lactate dehydrogenase) [1502], in the latter case
along with treatment with a protease inhibitor (e.g., leupeptin)
or other inhibitors of lysosomal activity or autophagosomelysosome fusion (e.g., bafilomycin A1, concanamycin A, or
CQ) [216, 302, 1503] to prevent intralysosomal degradation of
the protein marker. The assay simply measures the transfer of
cargo from the soluble (cytosol) to the insoluble (sedimenta
ble) cell fraction (which includes autophagic compartments),
with no need for a sophisticated subcellular fractionation.
Electrodisruption of the plasma membrane followed by cen
trifugation through a density cushion was originally used to
separate cytosol from sedimentable cell fractions in primary
hepatocytes [1504]. This method has also been used in various
human cancer cell lines and mouse embryonic fibroblasts,
where the LDH sequestration assay has been validated with
pharmacological agents as well as genetic silencing or knock
out of key factors of the autophagic machinery (N. Engedal,
unpublished results) [32, 56, 216, 473, 1503, 1505]. Moreover,
a downscaling and simplification of the method that avoids
the density cushion has been introduced and validated [56,
473, 1503, 1506]. Homogenization and sonication techniques
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have also been successfully used for the LDH sequestration
assay [1017, 1507]. The endogenous LDH cargo marker can
be quantified by an enzymatic assay, or by western blotting. In
principle, any intracellular component can be used as a cargo
marker, but cytosolic enzymes having low sedimentable back
grounds are preferable. Membrane-associated markers are less
suitable, and proteins such as LC3, which are part of the
sequestering system itself, will have a much more complex
relationship to the autophagic flux than a pure cargo marker
such as LDH.
In yeast, sequestration assays are typically done by mon
itoring protease protection of an autophagosome marker or a
cargo protein. For example, prApe1, and GFP-Atg8 have been
used to follow completion of the autophagosome [1508]. The
relative resistance or sensitivity to an exogenous protease in
the absence of detergent is an indication of whether the
autophagosome (or other sequestering vesicle) is complete
or incomplete, respectively. Thus, this method also distin
guishes between a block in autophagosome formation versus
fusion with the vacuole. The critical issues to keep in mind
involve the use of appropriate control strains and/or proteins,
and deciding on the correct reporter protein. In addition to
protease protection assays, sequestration can be monitored by
fluorescence microscopy during pexophagy of methanolinduced peroxisomes, using GFP-Atg8 as a pexophagosome
marker and BFP-SKL to label the peroxisomes. The vacuolar
sequestration process during micropexophagy can also be
monitored by formation of the vacuolar sequestering mem
brane stained with FM 4-64 [1053].
Sequestration assays can be designed to measure flux
through individual steps of the autophagy pathway. For exam
ple, whereas electroinjected [3H]-raffinose or endogenous
LDH can be used to measure the sequestration step, electro
injected [14C]-lactose can be used to monitor cargo flux to
amphisomes and proteolytically active autolysosomes (as
explained below). Whereas [3H]-raffinose is completely resis
tant to (auto)lysosomal degradation, the [14C]-lactose that
reaches active autolysosomes is rapidly hydrolyzed into
[14C]-glucose and galactose (by GLB1/beta-galactosidase),
measurable by chromatography. [14C]-lactose thus marks pre
lysosomal compartments (autophagosomes and amphisomes),
whereas [14C]-glucose marks the autolysosomal compartment.
Experimental conditions or treatments that block autophago
some-lysosome fusion (e.g., asparagine or the microtubule
inhibitor vinblastine) lead to an accumulation of lactose in
prelysosomal compartments [11, 1509]. By adding exogenous
beta-galactosidase (that is endocytosed by the cells) in the
presence of asparagine (which blocks autophagosome-lyso
some fusion), the fusion of autophagosomes with endosomes
(thus producing amphisomes) can be studied. In fact, this was
the experimental approach that first identified the amphi
some [11].
One caveat with using lysosome or autophagosome-lyso
some inhibitors is that they may affect sequestration indir
ectly, for example, by modifying the uptake and metabolism
(including protein synthesis) of autophagy-suppressive amino
acids (see Autophagy inhibitors and inducers). Therefore, the
time period of treatment with the inhibitor should be as short
as possible (typically 2-3 h). Note that for measuring
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autophagic sequestration and degradation activity with elec
troinjected [3H]-raffinose or [14C]-lactose, respectively, no
inhibitors are needed. Also note that the LDH sequestration
assay, when used without addition of lysosomal degradation
inhibitors, can be used to identify treatments or conditions
that block autophagic flux at a post-sequestration step. For
instance, autophagically sequestered LDH accumulates in cells
depleted of RAB7A (but not RAB7B) [1505], thus confirming
the role of RAB7A in autophagosome-lysosome fusion [344,
1510, 1511].
A variation of this approach applicable to mammalian cells
includes live cell imaging. Autophagy induction is monitored as
the movement of cargo, such as mitochondria, to GFP-LC3colocalizing compartments, and then fusion/flux is measured
by delivery of cargo to lysosomal compartments [439, 1512]. In
addition, sequestration of fluorescently tagged cytosolic pro
teins into membranous compartments can be measured, as
fluorescent puncta become resistant to the detergent digitonin
[1513]. Use of multiple time points and monitoring colocaliza
tion of a particular cargo with GFP-LC3 and lysosomes can also
be used to assess sequestration of cargo with autophagosomes
as well as delivery to lysosomes [1138]. Moreover, colocaliza
tion of cargo with endogeneous LC3 puncta using immuno
fluorescent staining can be used [606].
Time-lapse microscopy allows direct visualization of vacuole
transfer from mother cells to their daughters as seen for A549
lung cancer cells exposed to yessotoxin (YTX) [1514]. Such
effects on downstream lineages may be significant for the
interpretation of observations related to autophagy signaling
especially for cells in environments where the stress varies.
Autophagic activity caused by this toxin results in the seques
tration and degradation, by an autophagic-like process, of
ribosomes and lipid droplets associated with autophagic com
partments and lamellar bodies in BC3H1 cells [1515].
In the Drosophila fat body, the localization of free cytosolic
RFP-family proteins changes from a diffuse to a punctate
pattern in an Atg gene-dependent manner, and these
mCherry puncta colocalize with the lysosomal marker
Lamp1-GFP during starvation [1516]. Thus, the redistribution
of free cytosolic mCherry may be used to follow bulk, non
selective autophagy due to its stability and accumulation in
autolysosomes.
Cautionary notes: The electro-injection of radiolabeled
probes is technically demanding, but the use of an endogen
ous cytosolic protein probe is very simple and requires no
pretreatment of the cells other than with a protease inhibitor.
Another concern with electro-injection is that it can affect
cellular physiology, so it is necessary to verify that the cells
behave properly under control situations such as amino acid
deprivation. An alternate approach for incorporating exogen
ous proteins into mammalian cell cytosol is to use “scrapeloading,” a method that works for cells that are adherent to
tissue culture plates [1517]. Finally, these assays work well
with hepatocytes but may be problematic with other cell types,
and it can be difficult to load the cell while retaining the
integrity of the compartments in the post-nuclear supernatant
(S. Tooze, unpublished results). General points of caution to
be addressed with regard to live cell imaging relate to photo
bleaching of the fluorophore, cell injury due to repetitive
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imaging, autofluorescence in tissues containing lipofuscin,
and the pH sensitivity of the fluorophore.
There are several issues to keep in mind when monitoring
sequestration by the protease protection assay in yeast [1508].
First, as discussed in Selective types of autophagy, prApe1 is
not an accurate marker for nonselective autophagy; import of
prApe1 utilizes a receptor (Atg19) and a scaffold (Atg11) that
make the process specific. In addition, vesicles that are sub
stantially smaller than autophagosomes can effectively seques
ter the Cvt complex. Another problem is that prApe1 cannot
be used as an autophagy reporter for mutants that are not
defective in the Cvt pathway, although this can be bypassed by
using a vac8∆ background [1518]. At present, the prApe1
assay cannot be used in any system other than yeast. The
GFP-Atg8 protease protection assay avoids these problems,
but the signal-to-noise ratio is typically substantially lower. In
theory, it should be possible to use this assay in other cell
types, and protease protection of GFP-LC3 and GFP-SQSTM1
has been analyzed in HeLa cells [1519]. Finally, tendencies of
GFP-LC3 and particularly GFP-SQSTM1 to aggregate may
make LC3 and SQSTM1 inaccessible to proteases.
Conclusion: Sequestration assays represent the most direct
method for monitoring autophagy, and in particular for dis
criminating between conditions where the autophagosome is
complete (but not fused with the lysosome/vacuole) or open
(i.e., a phagophore). These assays can also be modified to
measure autophagic flux.
13. Turnover of autophagic compartments
Inhibitors of autophagic sequestration (e.g., amino acids, 3MA, wortmannin, SAR-405, BAPTA-AM, MRT67307, or
thapsigargin) [32, 56, 216, 299, 1032, 1503, 1520] can be
used to monitor the disappearance of autophagic elements
(phagophores, autophagosomes, autolysosomes) to estimate
their half-life by TEM morphometry/stereology. The turnover
of the autophagosome or the autolysosome will be differen
tially affected if fusion or intralysosomal degradation is inhib
ited [13, 15, 28, 1521]. The duration of such experiments is
usually only a few hours; therefore, long-term side effects or
declining effectiveness of the inhibitors can be avoided. It
should be noted that fluorescence microscopy has also been
used to monitor the half-life of autophagosomes, monitoring
GFP-LC3 in the presence and absence of bafilomycin A1 or
following GFP-LC3 after starvation and recovery in amino
acid-rich medium (see Atg8-family protein detection and
quantification) [17, 1522].
Cautionary notes: The inhibitory effect must be strong,
and the efficiency of the inhibitor needs to be tested under the
experimental conditions to be employed. Cycloheximide is
sometimes used as an autophagy inhibitor, but its use in
long-term experiments is problematic because of the many
potential indirect effects. CHX inhibits translational elonga
tion, and therefore protein synthesis. In addition, CHX
decreases the efficiency of protein degradation in several cell
types (A.M. Cuervo, personal communication) including
hematopoietic cells (A. Edinger, personal communication).
Treatment with CHX causes a potent increase in MTORC1
activity, which can decrease autophagy in part as a result of
the increase in the amino acid pool resulting from suppressed

protein synthesis (H.-M. Shen, personal communication; I.
Topisirovic, personal communication) [27, 1523]. In addition,
at high concentrations (in the millimolar range) CHX inhibits
complex I of the mitochondrial respiratory chain [1524,
1525], but this is not a problem, at least in hepatocytes, at
low concentrations (10 -20 µM) that are sufficient to prevent
protein synthesis (A.J. Meijer, personal communication).
Conclusion: The turnover of autophagic compartments is
a valid method for monitoring autophagic-lysosomal flux, but
CHX must be used with caution in long-term experiments.
14. Autophagosome-lysosome colocalization and
dequenching assay
Another method to demonstrate the convergence of the auto
phagic pathway with a functional degradative compartment is
to incubate cells with the bovine serum albumin derivative
dequenched (DQ)-BSA that is labeled with the red-fluorescent
BODIPY TR-X dye; this conjugate will accumulate in lyso
somes. The labeling of DQ-BSA is so extensive that the fluor
ophore is self-quenched. Proteolysis of this compound results
in dequenching and the release of brightly fluorescent frag
ments. Thus, DQ-BSA is useful for detecting intracellular pro
teolytic activity as a measure of a functional lysosome [1526].
Furthermore, DQ-BSA labeling can be combined with
GFP-LC3 to monitor colocalization, and thus visualize the
convergence, of amphisomes with a functional degradative
compartment (DQ-BSA is internalized by endocytosis). This
method can also be used to visualize fusion events in real-time
experiments by confocal microscopy (live cell imaging). Along
similar lines, other approaches for monitoring convergence
are to follow the colocalization of RFP-LC3 and LysoSensor
Green (M. Bains and K.A. Heidenreich, personal communica
tion), mCherry-LC3 and LysoSensor Blue [441], or tagged
versions of LC3 and LAMP1 (K. Macleod, personal commu
nication) or CD63 [439] as a measure of the fusion of auto
phagosomes with lysosomes. It is also possible to trace
autophagic events by visualizing the pH-dependent excitation
changes of the coral protein Keima [1036]. This quantitative
technique is capable of monitoring the fusion of autophago
somes with lysosomes, that is, the formation of an autolyso
some, and the assay does not depend on the analysis of LC3.
Cautionary notes: Some experiments require the use of
inhibitors (e.g., 3-MA or wortmannin) or overexpression of
proteins (e.g., RAB7 dominant negative mutants) that may
also affect the endocytic pathway or the delivery of DQ-BSA
to lysosomes (e.g., wortmannin causes the swelling of late
endosomes [1527]). In this case, the lysosomal compartment
can be labeled with DQ-BSA overnight before treating the
cells with the drugs, or prior to the transfection.
Conclusion: DQ-BSA provides a relatively convenient means
for monitoring lysosomal protease function and can also be used
to follow the fusion of amphisomes with the lysosome.
Colocalization of autophagosomes (fluorescently tagged LC3)
with lysosomal proteins or dyes can also be monitored.
15. Tissue fractionation
The study of autophagy in the organs of larger animals, in
large numbers of organisms with very similar characteristics,
or in tissue culture cells provides an opportunity to use tissue
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fractionation techniques as has been possible with autophagy
in rat liver [50, 69, 1528–1533]. Because of their sizes (smaller
than nuclei but larger than membrane fragments [micro
somes]), differential centrifugation can be used to obtain a
subcellular fraction enriched in mitochondria and organelles
of the autophagy-lysosomal system, which can then be sub
jected to density gradient centrifugation to enrich autophago
somes, amphisomes, autolysosomes and lysosomes [50, 69,
1533–1537]. Please see previous versions of the guidelines
[1, 2] for a discussion of the uses and limitations of tissue
fractionation.
16. In vitro determination of autophagosome formation
Mobilization of membranes from intracellular resources is
required for autophagosome biogenesis. A cell-free assay
was established to identify organelle membranes that form
a precursor for autophagosome formation. The membrane
from ATG5 mutant cells is defective in autophagosome
formation in vivo during starvation [814]. In the cell-free
assay, membranes from atg5 knockout MEFs are mixed
with cytosolic fractions from starved or untreated wildtype cells. These cytosolic fractions include a high amount
of LC3-I and lack the lipidated form, LC3-II, which is
sedimented with the membrane. The reaction is performed
in the presence of GTP and an ATP regeneration system.
The assay measures cell-free LC3 lipidation by the forma
tion of LC3-II [1538]. The reaction thus identifies mem
branes responsible for LC3-II generation. A three-step
membrane fractionation is performed along with monitor
ing of lipidation enrichment with respect to different mem
brane markers. First, differential centrifugation is
performed to obtain four membrane pellets with different
markers. The 25K fraction reveals the highest lipidation
activity and includes peroxisomes (ABCD3/PMP70), late
endosomes (LAMP2), cis-Golgi (GOLGA2/GM130) ERGolgi intermediate compartment (ERGIC; SEC22B and
LMAN1/ERGIC53), plasma membrane/early endosomes
(TFRC), ER (RPN1), ER exit sites (ERES, active sites on
the ER that generate COPII-coated vesicles; PREB/SEC12),
lysosomes (CTSD), and ATG9 vesicles. The 25K membrane
is further fractionated using step-gradient ultracentrifuga
tion, where the fraction with higher lipidation activity is
determined to include ERGIC, cis-Golgi, ATG9 vesicles and
plasma membrane/early endosomes.
This assay recapitulates the early cellular steps of autopha
gosome formation in different aspects. The cells are stimu
lated by starvation, and rapamycin or torin1 treatment and
are inhibited in the absence of ULK1, which reflects the
involvement of the MTORC1 pathway. PtdIns3K inhibitors
abolish the LC3 lipidation, and LC3 lipidation is prohibited in
the absence of ATG proteins such as ATG3, ATG5 or ATG7
[1539].
The contribution of different organelles to autophagosome
biogenesis was tested using different fractionation and purifi
cation steps to obtain the ERGIC, which represents a primary
membrane determinant that triggers LC3 lipidation. The
ERGIC is a recycling compartment located in the ER and
cis-Golgi compartments. PtdIns3K is activated upon starva
tion, and this enzyme facilitates the recruitment of COPII
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proteins to the ERGIC membrane. Subsequently, the
ERGIC-derived COPII vesicles form a potential membrane
source of the autophagosome and LC3 lipidation vesicles
[1540].
A COPII vesicle-labelling system using the transmembrane
cargo protein Axl2 was investigated by immuno-EM in yeast,
showing that COPII acts as precursor for the formation of the
autophagosome membrane [1541]. Another study employing
super-resolution microscopy showed that starvation results in
ER-exit site enlargement. COPII production served as positive
control, and demonstrated contribution to autophagosome
formation [1542].
Conclusion: The cell-free assay implicates the ERGIC as
one of the primary cellular membrane determinants that
facilitates LC3 lipidation. Further application of this method
may reveal more with regard to functional forms of the
cytosol and the triggering factors for autophagosome mem
brane formation.

17. Analyses in vivo
Monitoring autophagic flux in vivo or in organs is one of the
least developed areas at present, and ideal methods relative to
the techniques possible with cell culture may not exist.
Importantly, the level of basal autophagy, time course of
autophagic induction, and the bioavailability of autophagystimulating and -inhibiting drugs is likely tissue specific.
Moreover, basal autophagy or sensitivity to autophagic induc
tion may vary with animal age, sex or strain background.
Therefore, methods may need to be optimized for the tissue
of interest. One method for in vivo studies is the analysis of
GFP-Atg8-family proteins (see GFP-Atg8-family protein fluor
escence microscopy). Autophagy can be monitored in tissue (e.
g., skeletal muscle, heart, kidney, liver, brain, spinal cord,
dorsal root ganglia, peripheral nerve, retina and platelets) in
vivo in transgenic mice and zebrafish systemically expressing
GFP-LC3 [109, 210, 214, 239, 388, 390, 540, 561, 924, 1543,
1544], or in other models by transfection with GFP-LC3encoding plasmids or in transgenic strains that possess either
mCherry- or GFP-Atg8-family proteins under the control of
either inducible or Atg8-family protein gene promoter
sequences [375, 662]. All of these in vivo approaches require
appropriate negative controls for Atg8-family protein locali
zation to autophagosomes, through the use of point mutants
that cannot be lipidated or associated with the autophago
somes [1545] or, in genetically tractable systems, mutations
that predictably disrupt their association with autophago
somes [562].
It should be noted that tissues such as white adipose tissue,
ovary, and testes, and some brain regions such as the
hypothalamus, do not appear to express the Actb promoterdriven GFP-Lc3 transgene strongly enough to allow detection
of the fluorescent protein [239]. In addition, tissue-specific
GFP-LC3 mice have been generated for monitoring cardiac
myocytes [1546, 1547]. In these settings, GFP fluorescent
puncta are indicative of autophagic structures; however, the
use of a lysosomal fusion or protease inhibitor would be
needed to assess flux. Cleavage of GFP-LC3 to generate free
GFP can be evaluated as one method to monitor the
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completion of autophagy. This has been successfully per
formed in mouse liver [351], suggesting the GFP-LC3 clea
vage assay may also be applied to in vivo studies. Note that
the accumulation of free GFP in the mouse brain is minimal
after autophagy is induced with rapamycin (autophagy induc
tion based on GFP-LC3 imaging and SQSTM1 IHC; M.
Lipinski, personal communication), but significant when
autophagic flux is partially blocked after traumatic brain
injury [214]. Thus, caution needs to be taken when interpret
ing results of these assays in different tissues. We also recom
mend including a control under conditions known to induce
autophagic flux such as starvation.
A simple methodology to measure autophagic flux in the
brain was described [1548]. This strategy combines the gen
eration of adeno-associated virus and the use of the dynamic
fluorescent reporter mCherry-GFP-LC3 that allows an
extended transduction and stable expression of mCherryGFP-LC3 after intracerebroventricular injection in newborn
animals. With this approach, a widespread transduction level
is achieved along neurons at the central nervous system when
newborn pups are injected, including pyramidal cortical and
hippocampal neurons, Purkinje cells, and motor neurons in
the spinal cord and also, to a lesser extent, in oligodendrocytes
[1548]. The different serotypes of adeno-associated virus can
be used to transduce other cell types at the CNS [1548–1550].
This methodology allows a reproducible and sensitive
mCherry-GFP-LC3 detection, and a strong LC3 flux when
animals are treated with autophagy inducers including rapa
mycin and trehalose [1550, 1551]. Therefore, using these
combined strategies can be applied to follow autophagy activ
ity in mice or rats and can be particularly useful to evaluate it
in animal models of diseases affecting the nervous system
[1548–1550]. A transgenic mouse with a low level neuronspecific expression of mCherry-RFP-GFP-LC3 was generated
that has possible advantages over viral-expression models in
achieving a relatively uniform expression reproducibly in a
given mouse throughout its life or among different experi
mental groups of mice [451]. Alternatively, confocal laser
scanning microscopy, which makes it possible to obtain
numerous sections and substantial data about spatial localiza
tion features, can be a suitable system for studying autophagic
structures (especially for whole mount embryo in vivo analy
sis) [1552]. In addition, this method can be used to obtain
quantitative data through densitometric analysis of fluores
cent signals [1553].
A number of transgenic autophagy mouse and Drosophila
models have now been generated that rely on the expression
of pH-sensitive fluorophores as mentioned above. In terms of
monitoring general autophagy, mice stably expressing mRFP/
mCherry-GFP-LC3, from the ubiquitous ROSA26 locus, allow
monitoring of autophagic flux in multiple organs [1103,
1231]. When combined with immunohistochemical staining
using cell-specific markers, autophagy can be quantified in
distinct cell types within tissues. As with utilization of this
marker in cell lines (see above), the same caveats apply, and
care must be taken to maintain pH during fixation [1554].
Similar fluorescence methodology has been used to mea
sure mitophagy in mouse and Drosophila tissue, either using
mitochondrial matrix-localized mt-Keima [1145, 1147] or

OMM-localized mCherry-GFP in the case of the mito-QC
mouse [38]. mito-QC is very similar to the mCherry-GFPLC3 mouse (only differing in the fluorophore-targeting pep
tide), and thus allows an in vivo comparison between auto
phagy and mitophagy, which do not necessarily occur under
the same conditions [1146, 1231]. The mito-QC mouse has
been used to monitor mitophagy in disease models, as shown
with diabetes through the generation of mito-QC Ins2Akita
mice [39]. Analyses of tissues from both mito-QC and mtKeima demonstrate the basal nature of mammalian mito
phagy in vivo and its conservation to Drosophila. An impor
tant distinction between these mitophagy reporter mouse
models is that tissues from the mito-QC mouse are compa
tible with fixation, whereas fluorescence in cells and tissues
from the mt-Keima mouse is lost upon fixation [1554]. This
difference has implications for applications where high
throughput analyses of mitophagy in tissues and cells are
required. Furthermore, because mito-QC is compatible with
fixation, it is also possible to confirm the lysosomal localiza
tion of mCherry puncta using the mito-QC approach [38,
1554]. Similarly, Drosophila harboring GAL4/UAS responsive
transgenes for mt-mCherry-GFP (mito-QC) or mt-Keima
have been developed, which allows spatiotemporal restricted
expression analysis [466]. Utilizing such mitophagy reporters
in Drosophila is particularly useful for rapidly and economic
ally screening putative genetic or pharmacological regulators
of mitophagy in vivo.
Another possibility is immunohistochemical staining, an
important procedure that may be applicable to human studies
as well, considering the role of autophagy in neurodegenera
tion, myopathies and cardiac disease where samples may be
limited to biopsy/autopsy tissue. In this sense, special atten
tion should be taken in the sample extraction and preserva
tion,
as
LC3B-II
could
undergo
degradation.
Immunodetection of LC3 as definite puncta is possible in
paraffin-embedded tissue sections and fresh frozen tissue, by
either IHC or immunofluorescence [265, 1555–1562].
Immunostaining of LC3 puncta in peripheral nerve has been
initially evaluated and compared to that obtained in GFP-LC3
mice (measured by means ImageJ RGB pixels analysis, which
automatically converts pixels in brightness values) [540]. This
method is, therefore, widely utilized in this kind of tissue
[1327, 1563, 1564]; however, this methodology has not
received extensive evaluation, and does not lend itself well
to dynamic assays.
Other autophagic substrates can be evaluated via IHC and
include SQSTM1, NBR1, ubiquitinated inclusions and protein
aggregates [1562]. Similarly, autophagy can be evaluated by
measuring levels of these autophagic substrates via traditional
immunoblot; however, their presence or absence needs to be
cautiously interpreted as some of these substrates can accu
mulate with either an increase or a decrease in autophagic flux
(see SQSTM1 and related LC3 binding protein turnover
assays). Bone marrow transfer has been used to document in
vivo the role of autophagy in the reverse cholesterol transport
pathway from peripheral tissues or cells (e.g., macrophages) to
the liver for secretion in bile and for excretion [966], and a
study shows that TGM2 (transglutaminase 2) protein levels
decrease in mouse liver in vivo upon starvation in an
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autophagy-dependent manner (and in human cell lines in
vitro in response to various stimuli; M. Piacentini, personal
communication), presenting additional possible methods for
following autophagy activity. In that respect, it is noteworthy
to mention that TGM2 can also inhibit autophagic flux at the
level of autophagosome-lysosome fusion by modifying ITPR1
(inositol 1,4,5-trisphosphate receptor, type 1) and suppressing
its calcium-release activity [1565].
It is also possible to analyze tissues ex vivo, and these
studies can be particularly helpful in assessing autophagic
flux as they avoid the risks of toxicity and bioavailability of
compounds such as bafilomycin A1 or other autophagy inhi
bitors. Along these lines, autophagic flux can be determined
by western blot in retinas placed in culture for 4 h with
protease inhibitors [968,969]. This method could be used in
tissues that can remain “alive” for several hours in culture
such as the retina [1566–1568], brain slices [214, 1569] (par
ticularly organotypic brain slices that can be cultured in vitro
for weeks, allowing for treatments with autophagy stimulators
or inhibitors for long periods [1570]), and spinal cord slices
[1571]. Ex vivo tumors are relevant models of autophagy in
mesothelioma. In these models, basal autophagy and its mod
ulation can be measured by immunofluorescence to assess the
presence of LC3 puncta when combined with lysosomal inhi
bitor treatment, or of ATG13 puncta without lysosomal inhi
bition [755, 756, 1572].
Several studies have demonstrated the feasibility of mon
itoring autophagic flux in vivo in skeletal muscle. Starvation is
one of the easiest and most rapid methods for stimulating the
autophagic machinery in skeletal muscles. Twelve h of fasting
in mice may be sufficient to trigger autophagy in muscle
[1573–1575], but the appropriate time should be determined
empirically. It is also important to consider that the expres
sion of autophagy-related factors, as well as the autophagic
response to various stimuli and disease states, can differ
between muscles of different fiber type, metabolic, and con
tractile properties [239, 1576–1579]. Thus, which muscle(s) or
portion of muscle(s) used for analysis should be carefully
considered and clearly outlined. Moreover, given that skeletal
muscle properties can change during stress, exercise, and
disease, attention should be given to the potential influence
of these changes on the observed autophagic expression/sig
naling (J. Quadrilatero, personal communication). Although
food deprivation does not induce detectable autophagy in the
brain, it induces autophagy in the retina, and by the use of in
vivo injection of leupeptin autophagic flux can be evaluated
with LC3 lipidation by western blot [1567]. Although difficult
to standardize and multifactorial, exercise may be a particu
larly appropriate stimulus to use for assessing autophagy in
skeletal muscle [1543, 1580]. Data about the autophagic flux
can be obtained by treating mice or rats with, for example, CQ
[86, 1574], leupeptin [1567, 1581] or colchicine [301] and
then monitoring the change in accumulation of LC3 (see
cautionary notes). It should be noted, however, that surgery
itself profoundly affects intracellular signaling pathways such
as those involving MTOR, MAPK/ERK, and autophagic flux
itself (C.N. Brown and C.L. Edelstein, personal communica
tion). Thus, proper validation of such models should be care
fully conducted before their use can be accepted. This type of
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flux analysis can also be done with liver, by comparing the
LC3-II level in untreated liver (obtained by a partial hepatect
omy) to that following subsequent exposure to CQ (V. Skop,
Z. Papackova and M. Cahová, personal communication).
Moreover, after peripheral nerve degeneration, to verify
whether the increase in rapamycin-induced Schwann cell au
tophagy, can be attributed to increased autophagosome for
mation, the lysosomal inhibitor CQ can be injected both in
vehicle- and rapamycin-treated mice, and 3 h after the injec
tion, LC3 conversion is measured in sciatic nerves by western
blot. [540].
Additional reporter assays to monitor autophagic flux in
vivo need to be developed, including tandem fluorescent-LC3
transgenic mice, expressing the construct in specific cell types
beyond the existing neuron-specific model [451], or viral
vectors to express this construct in vivo in localized areas.
Moreover, LC3-independent approaches are also needed. The
LDH sequestration assay is an LC3-independent method that
may be useful to study autophagic sequestration activity in
vivo, and which does not require any genetic modification of
the experimental animals. Indeed, injection of leupeptin in
rats results in accumulation of LDH within autophagic
vacuoles in hepatocytes [1582]. One of the challenges of
studying autophagic flux in intact animals is the demonstra
tion of cargo clearance, but studies of fly intestines that
combine sophisticated mosaic mutant cell genetics with ima
ging of mitochondrial clearance reveal that such analyses are
possible [1162].
Another organ particularly amenable to ex vivo analysis is
the heart, with rodent hearts easily subjected to perfusion by
the methods of Langendorff established in 1895 (for review
see [1583]). Autophagy has been monitored in perfused hearts
[1584], where it is thought to be an important process in
several modes of cardioprotection against ischemic injury
[1585]. It should be noted that baseline autophagy levels (as
indicated by LC3-II) appear relatively high in the perfused
heart, although this may be due to perceived starvation by the
ex vivo organ (e.g., the lack of protein in the perfusion
medium may result in osmotic stress and edema, which
could trigger a starvation-like stress that accelerates autopha
gy), highlighting the need to ensure adequate delivery of
metabolic substrates in perfusion media, which may include
the addition of INS (insulin). Another concern may be that
the high partial pressure of oxygen of the perfusate (e.g.,
buffer perfused with 95%:5% [O2:CO2]) used in the
Langendorff method makes this preparation problematic for
the study of autophagy because of the high levels of oxidation
(redox disturbances) that could result from the preparation.
However, the absence of hemoglobin means that even at a
high partial pressure of oxygen these hearts may be at the
limit of oxygen availability, and perfused hearts have normal
levels of glutathione, NADH and other measures of redox.
Due to these potential effects, great caution should be exer
cised in interpretation of these results. As a guide to correct
interpretation of these data, we recommend a review that
covers the diverse array of “state of the art” methods to
analyze autophagy in cardiac physiopathology [1586].
The role of autophagy in pregnancy has been extensively
reviewed [1587, 1588], and human placenta represents an
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organ suitable for ex vivo studies, such as to investigate
pregnancy outcome abnormalities. Autophagy has been eval
uated in placentae from normal pregnancies [1589–1591]
identifying a baseline autophagy level (as indicated by LC3II) in uneventful gestation. In cases with abnormal pregnancy
outcome, LC3-II is increased in placentae complicated by
intrauterine growth restriction in cases both from singleton
pregnancies [1592] and from monochorionic twins pregnan
cies [1593]. Moreover, placentae from pregnancies compli
cated by preeclampsia show a higher level of LC3-II than
normal pregnancies [1594]. Finally, placentae from acidotic
newborns developing neonatal encephalopathy exhibit a
higher IHC LC3 expression than placentae from newborn
without neonatal encephalopathy [1595]. For this reported
association, further investigations are needed to assess if au
tophagy protein expression in placentae with severe neonatal
acidosis could be a potential marker for poor neurological
outcome.
The retina is a very suitable organ for ex vivo as well as in
vivo autophagy determination. The retina is a part of the
central nervous system, is readily accessible and can be main
tained in organotypic cultures for some time, allowing treat
ment with protease and autophagy inhibitors. This allows
determination of autophagic flux ex vivo in adult and
embryonic retinas by western blot [1566, 1596, 1597] as well
as by flow cytometry and microscopy analysis [1567, 1597].
Moreover, only 4 h of leupeptin injection in fasted mice
allows for autophagic flux assessment in the retina [1567]
indicating two things: first, food deprivation induces autopha
gy in selected areas of the central nervous system; and second,
leupeptin can cross the blood-retinal barrier. Accordingly, the
intravitreal injection of beta-adrenergic receptor blockers in a
mouse model of oxygen-induced retinopathy stimulates
autophagic turnover of retinal neurons [1598].
In vivo analysis of the autophagic flux in the brain tissue of
neonatal rats can also be performed. These studies use the
intraperitoneal administration of the acidotropic dye mono
dansylcadaverine (MDC) to pup rats 1 h before sacrifice,
followed by the analysis of tissue labeling through fluores
cence or confocal laser scanning microscopy (365/525-nm
excitation/emission filter). This method was adapted to
study autophagy in the central nervous system after its valida
tion in cardiac tissue [1599]. MDC labels acidic endosomes,
lysosomes, and late-stage autophagosomes, and its labeling is
upregulated under conditions that increase autophagy [1600].
In a neonatal model of hypoxic-ischemic brain injury, where
autophagy activation is a direct consequence of the insult
[1601], MDC labeling is detectable only in the ischemic tissue,
and colocalizes with LC3-II [1602]. The number of MDC- and
LC3-II-positive structures changes when autophagy is phar
macologically up- or downregulated [1601, 1602]. Whether
this method can also be used in adult animals needs to be
determined. Furthermore, it should be kept in mind that
staining with MDC is not, by itself, a sufficient method for
monitoring autophagy in live cells (see Acidotropic dyes). A
better alternative approach in live cells is the MDC derivative
monodansylpentane (MDH) which stains lipid-containing
vacuoles such as late autophagic vacuoles [1603]. In

formaldehyde-fixed cells MDC and MDH both stain lipidcontaining vacuoles/late autophagosomes.
Cell-type specific observation of autophagy flux in vivo in
adult brain and spinal cord is possible. Adult mice can be
stereotaxically injected with lentivirus expressing mRFP-GFPLC3 under the control of the Nes promoter in hippocampus.
Using this approach, it was demonstrated that restraint stress
increases autophagy flux in adult hippocampal neural stem
cells, and induces autophagic death of neural stem cells with
out signs of apoptosis [1604]. Intrathecal injection of adenoas
sociated viral vector AAV9rh10, that infects spinal
motoneurons, and expressing the mCherry-GFP-LC3 repor
ter, can be used to demonstrate autophagy flux blockage in
the neurodegenerative process after proximal axotomy or
nerve root avulsion [1550].
Another approach that can be used in vivo in brain tissue is
to stain for lysosomal enzymes. In situations where an increase
in autophagosomes has been shown (e.g., by immunostaining
for LC3 and immunoblotting for LC3-II), it is important to
show whether this is due to a shutdown of the lysosomal
system, causing an accumulation of autophagosomes and/or
incompletely acidified autolysosomes, or whether this is due
to a true increase in autophagic flux. The standard methods
described above for in vitro research, such as the study of
clearance of a substrate, are difficult to use in vivo, but if it
can be demonstrated that the increase in autophagosomes is
accompanied by an increase in lysosomes, this makes it very
likely that there has been a true increase in autophagic flux
[1605]. Conversely, a decrease in lysosomal enzyme levels and
activity can indicate that accumulation of autophagosomes is
caused by lysosomal damage and a consequent decrease in flux
[1606, 1607]. Lysosomal enzymes can be detected by IHC (e.g.,
for LAMP1 or CTSD) or by classical histochemistry to reveal
their activity (e.g., ACP/acid phosphatase or HEX/β-hexosami
nidase) [1608, 1609]. It should be noted, however, that this
combination of measures will not exclude a defect in lysosomal
acidification, increasingly reported in several major neurode
generative diseases [1610]. In this situation, flux is blocked, and
incompletely acidified autolysosomes accumulate, which can
not be discriminated from autophagosomes using the
mCherry/RFP-GFP-LC3 probe (or other measures of LC3)
because both vesicle types will fluoresce yellow. Only by apply
ing a third fluorescent marker for lysosomes (e.g., CTSD,
CTSB) by IHC can the deacidified autolysosomes be identified
[451]. Lysosomal enzyme activity can be also separately
assessed in lysosomes and cytosol following tissue fractionation.
In this case, a decrease in enzyme activity in the lysosomal
fraction accompanied by an increase in the cytosol can indicate
lysosomal membrane permeabilization (LMP) as a potential
cause for lysosomal dysfunction. LMP may also be detected
in vivo in the brain by comparing the pattern of IHC staining
for lysosomal membrane proteins (such as LAMP1/2) to solu
ble lysosomal enzymes (such as CTSB, CTSD or CTSL) [1606,
1611].
Some biochemical assays may be used to at least provide
indirect correlative data relating to autophagy, in particular
when examining the role of autophagy in cell death. For
example, cellular viability is related to high CTSB activity
and low CTSD activities [1612]. Therefore, the appearance
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of the opposite levels of activities may be one indication of the
initiation of autophagy (lysosome)-dependent cell death. The
question of “high” versus “low” activities can be determined
by comparison to the same tissue under control conditions, or
to a different tissue in the same organism, depending on the
specific question.
Cautionary notes: The major hurdle with most in vivo
analyses is the identification of autophagy-specific substrates
and the ability to “block” autophagosome degradation with a
compound such as bafilomycin A1. Regardless, it is still essen
tial to adapt the same rigors for measuring autophagic flux in
vitro to measurements made with in vivo systems. Moreover,
as with cell culture, to substantiate a change in autophagic
flux it is not adequate to rely solely on the analysis of static
levels or changes in LC3-II protein levels on western blot
using tissue samples. To truly measure in vivo autophagic
flux using LC3-II as a biomarker, it is necessary to block
lysosomal degradation of the protein. Several studies have
successfully done this in selected tissues in vivo. Certain gen
eral principles need to be kept in mind: (a) Any autophagic
blocker, whether leupeptin, bafilomycin A1, CQ or microtu
bule depolarizing agents such as colchicine or vinblastine,
must significantly increase basal LC3-II levels in control
cells or tissues. The turnover of LC3-II or rate of basal autop
hagic flux is not known for tissues in vivo, and therefore short
treatments (e.g., 4 h) may not be as effective as blocking for
longer times (e.g., 12 to 24 h). (b) The toxicity of the blocking
agent needs to be considered (e.g., treating animals with doses
higher than 2 mg/kg bafilomycin A1 for 2 h can be quite
toxic), and food intake must be monitored. If long-term
treatment is needed to see a change in LC3-II levels, then
confirmation that the animals have not lost weight may be
needed. Mice may lose a substantial portion of their body
weight when deprived of food for 24 h, and starvation is a
potent stimulus for the activation of autophagy. (c) The bioa
vailability of the agent needs to be considered. For example,
many inhibitors such as bafilomycin A1 or CQ have relatively
poor bioavailability to the central nervous system. To over
come this problem, intracerebroventricular injection can be
performed.
A dramatic increase of intracellular free poly-unsaturated
fatty acid levels can be observed by proton nuclear magnetic
resonance spectroscopy in living pancreatic cancer cells within
4 h of autophagy inhibition by omeprazole, which interacts
with the V-ATPase and probably inhibits autophagosome-lyso
some fusion [1613]. Omeprazole is one of the most frequently
prescribed drugs worldwide and shows only minor side effects
even in higher doses. Proton nuclear magnetic resonance spec
troscopy is a noninvasive method that can also be applied as
localized spectroscopy in magnetic resonance tomography, and
therefore opens the possibility of a noninvasive, clinically
applicable autophagy monitoring method, although technical
issues still have to be solved [1614].
In terms of measuring mitophagy in tissues, recently devel
oped reporter systems represent a more rigorous choice than
monitoring any particular pathway. This is especially true for
stress-induced PINK1-dependent PRKN phosphorylation,
where KO-validated reagents to monitor this signaling path
way in mice have only just become available. It is important to
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note that despite a plethora of publications, many commer
cially available anti-PINK1 and anti-PRKN antibodies are not
specific; that is, although it is possible to run a western blot
with these reagents and detect a band at the predicted size, it
is highly likely that this band will also be present in KO tissue
(especially for endogenous mouse PINK1). The first endogen
ous detection of mouse PINK1 from tissues verified using KO
controls and mass spectrometry has been published [1231].
Readers should be aware that the detection of bona fide
PINK1 is technically challenging, and the current state of
the art necessitates an immunoprecipitation-immunoblot
approach to ensure optimal results. This approach has been
successfully replicated in other mouse cell types. In cells,
researchers also use the PINK1-dependent phosphorylation
of PRKN or ubiquitin at Ser65 to monitor pathway activation.
Monitoring PRKN substrate ubiquitination is another useful
approach. While these methods are tractable for in vitro
paradigms, the activation of this pathway requires substantial
levels of stress (often treatment with harsh mitochondrial
uncouplers). Thus, PINK1-mediated generation of phosphoubiquitin, phospho-PRKN or substrate ubiquitination can be
difficult to detect without mitochondrial depolarization.
Nonetheless, the activation of this endogenous pathway has
been performed in mature primary neurons using a combina
tion of ubiquitin-enrichment and highly specific antibodies
[1615]. Researchers should also be mindful that while detec
tion of Pink1 or Prkn mRNA may seem like a useful approach,
changes in the levels of these genes do not infer any reliable
alterations in mitophagy.
When analyzing autophagic flux in vivo, one major limita
tion is the variability between animals. Different animals do
not always activate autophagy at the same time. To improve
the statistical relevance and avoid unclear results, these
experiments should be repeated more than once, with each
experiment including several animals; it may also be impor
tant to consider age and gender [1616] as additional variables.
Induction of autophagy in a time-dependent manner by fast
ing mice for different times requires appropriate caution.
Mice are nocturnal animals, so they preferentially move and
eat during the night, while they mostly rest during daylight.
Therefore, in such experiments it is better to start food depri
vation early in the morning, to avoid the possibility that the
animals have already been fasting for several hours. The use of
CQ is technically easier, because it only needs one intraper
itoneal injection per day, but the main concern is that CQ has
some toxicity (mouse intraperitoneal LD50: 68 mg/kg). CQ
suppresses the immunological response in a manner that is
not due to its pH-dependent lysosomotropic accumulation
(CQ interferes with LPS-induced Tnf/Tnf-α gene expression
by a nonlysosmotropic mechanism) [1617], as well as through
its pH-dependent inhibition of antigen presentation [1433].
Therefore, CQ treatment should be used for short times and
at doses that do not induce severe collateral effects, which
may invalidate the measurement of the autophagic flux, and
care must be exercised in using CQ for studies on autophagy
that involve immunological aspects.
It is also important to have time-matched controls for in
vivo analyses. That is, having only a zero-hour time point
control is not sufficient because there may be substantial
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diurnal changes in basal autophagy [989]. For example, varia
tions in basal flux in the liver associated with circadian
rhythm may be several fold [989], which can equal or exceed
the changes due to starvation. Along these lines, to allow
comparisons of a single time-point it is important to specify
what time of day the measurement is taken and the lighting
conditions under which the animals are housed. It is also
important that the replicate experiments are conducted at
the same time of day. Controlling for circadian effects can
greatly reduce the mouse-to-mouse variability in autophagy
markers and flux [1618]. Note, when handling litters, auto
phagy flux should be analyzed within a restricted range of
weight; nursing mothers have a limited production of nutri
ents, and therefore an increased variability is detected between
groups of big and small litter number.
When analyzing the basal autophagic level in vivo using
GFP-LC3 transgenic mice [239], one pitfall is that GFP-LC3
expression is driven by the Cmv/cytomegalovirus enhancer
and Actb/β-actin (CAG) promoter, so that the intensity of
the GFP signal may not always represent the actual autopha
gic activity, but rather the CAG promoter activity in indivi
dual cells. For example, GFP-LC3 transgenic mice exhibit
prominent fluorescence in podocytes, but rarely in tubular
epithelial cells in the kidney [239], but a similar GFP pattern
is observed in transgenic mice carrying CAG promoter-driven
non-tagged GFP [1619]. Furthermore, proximal tubule-speci
fic ATG5-deficient mice [1620] display a degeneration phe
notype earlier than podocyte-specific ATG5-deficient mice
[1621], suggesting that autophagy, and hence LC3 levels,
might actually be more prominent in the former.
One caution in using approaches that monitor ubiquiti
nated aggregates is that the accumulation of ubiquitin may
indicate a block in autophagy or inhibition of proteasomal
degradation, or it may correspond to structural changes in the
substrate proteins that hinder their degradation. In addition,
only cytosolic and not nuclear ubiquitin is subject to auto
phagic degradation. It is helpful to analyze aggregate degrada
tion in an autophagy-deficient control strain, such as an
autophagy mutant mouse, whenever possible to determine
whether an aggregate is being degraded by an autophagic
mechanism. This type of control will be impractical for
some tissues such as those of the central nervous system
because the absence of autophagy leads to rapid degeneration.
Accordingly, the use of Atg16l1 hypomorphs, Becn1 hetero
zygotes or Atg4b homozygotes, with systemic autophagy
impairment, may help circumvent this problem.
Conclusion: Although the techniques for analyzing auto
phagy in vivo are not as advanced as those for cell culture, it is
still possible to follow this process (including flux) by mon
itoring, for example, GFP-LC3 or mCherry/RFP-GFP-LC3 by
fluorescence microscopy, and SQSTM1 and NBR1 by IHC
and/or western blotting.
18. Proteomic readouts of autophagy
An alternate approach for evaluating autophagy is with pro
teomics, which enables the identification of hundreds to thou
sands of protein species in a sample. The main advantage of
proteomics is that it provides a direct, holistic readout of how
autophagic activity affects the protein composition of a cell.

Proteomics also avoids an assumption of common “markerbased” autophagy assays (LC3B-based or otherwise)—that
dynamic changes to either the abundance or localization of
a marker protein is generally reflective of total autophagic
activity. Although proteomics requires specialized equipment
and data processing, gradual improvements in technology,
declining cost, and availability through core facilities and
companies are making proteomics increasingly accessible.
Over the last decade, dozens of studies employing proteo
mics to examine autophagic activity have been published, and
the pace of novel publications is accelerating [1622, 1623].
While these studies differ significantly in their technical
execution (on-label versus label free, instrumentation, sample
processing, and quantification), conceptually they can be sub
divided into three general experimental approaches. In the
first approach, proteomics is used to examine changes to
total cellular protein composition in the setting of autophagy
inhibition or stimulation. As an example, an on-label proteo
mic approach known as stable isotope labeling by amino acids
in cell culture (SILAC) has been used to analyze cells sub
jected to autophagy activation by amino acid starvation
[1029]. The results indicate that autophagy activation is
accompanied by an orderly progression of substrates that are
targeted for disposal, starting with cytosolic proteins and
followed later by mitochondrial and other organellar proteins.
This kind of whole cell proteomics analysis provides a holistic
picture of how autophagy affects cellular proteostasis, but it
does not distinguish between proteins that are directly
degraded by autophagy and proteins whose steady-state levels
change through indirect effects (regulation of transcription,
translation, or export) or through off-pathway functions of
ATG proteins.
Another example is seen from experiments conducted in
maize, where the protein composition in autophagy mutants
was determined using a label-free MS analysis of the total
protein extract [1624]. One remarkable observation was the
~2-fold increase in protein content/fresh weight in the
absence of autophagy, which was at least partially due to a
retention of various organelles. Global comparisons between
affected transcript and protein abundances, made it possible
to pinpoint putative autophagic cargo (solely elevated protein
levels) and proteins that are actively engaged (elevated tran
script and protein levels). Although protein-transcript com
parisons are potentially flawed due to misassigned proteincoding mRNAs (due to homology), or due to differences in
translation efficiencies, consistent trends were observed for
several protein groups. For example, strong increases of per
oxisomal, endoplasmic reticulum, Golgi, ribosomal and pro
teasomal proteins are evident without any associated
transcripts being affected, indicating that these organelles
and protein complexes are autophagic targets. In contrast,
proteins involved in secondary, amino acid, glutathione and
lipid metabolism are elevated in both protein and correspond
ing mRNA abundances, which strongly correlate with altera
tions in associated metabolites, indicative of an active
response to restore cellular homeostasis.
In the second approach, proteomics is used to catalog the
composition of autophagosomes or autolysosomes that are
isolated using biochemical fractionation or affinity
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purification. This approach can identify specific autophagy
substrates, and through these substrates it can suggest cellular
functions that autophagy is affecting. To cite some examples,
label-free proteomics of biochemically fractionated autolyso
somes was used to identify the cargo receptor NCOA4 that
regulates iron homeostasis by recruiting ferritin to phago
phores [1264] (see Ferritinophagy). Another study [1625]
used label-free proteomics to compare the substrates of
CMA-competent versus CMA-incompetent lysosomes in
mouse liver, thereby inferring unique substrate specificity of
CMA compared to autophagy. A novel chemical labeling
approach [1626] transfected APEX-Atg8-family fusion pro
teins into cells, which enables the biotinylation and subse
quent purification of autophagosome contents using
streptavidin resin. Combined with a SILAC-based proteomics
analysis, this technique identified a novel PRKN-independent
mitophagy mechanism that is dependent on LC3C.
In the third approach, proteomics is used in a quantitative
or semi-quantitative manner to measure autophagic flux. This
approach enables simultaneous examination of how a stimu
lus affects the rate of autophagic activity and the composition
of the autophagy substrate proteome. For example, SILAC
was used to conduct a pulse-chase experiment in human
fibroblasts, enabling the proteome-wide calculation of protein
half-lives under basal conditions [1627]. By comparing cells
with atg5 or atg7 deletion to wild-type cells, they were able to
infer degradation rates via autophagy in many hundreds of
proteins simultaneously. In another example, a label-free
approach was used to examine circadian variations in autop
hagic flux in mouse liver [1618].
Cautionary notes: Current proteomic platforms identify
on the order of 104 to 105 protein spectra (similar in concept
to RNA sequencing reads) per sample. By comparison, RNA
sequencing provides on the order of 107 reads per sample,
although it does not specifically address the issue of RNA
turnover. The limited sensitivity of proteomics means that
the technique favors detection of abundant proteins and is
less reliable for reproducibly detecting rarer protein species.
To some extent this can be overcome by reducing the com
plexity of the sample being analyzed (for example, by analyz
ing purified autolysosomes rather than whole cell
homogenates), but it is routine for non-abundant proteins to
be detected in some biological replicates but not in others.
Because cellular material must be homogenized, proteomic
readouts do not preserve subcellular localization information
precisely, even when samples are carefully biochemically frac
tionated. Particularly with human biological samples, care
must be taken to avoid contamination with exogenous
human proteins, especially with samples that have small quan
tities of protein to begin with [1628].
In proteomics, proteins are identified by matching peptide
sequences against a database (akin to RNA sequencing). In
some instances, peptides can be misassigned to a protein
because the peptide sequence in question maps to a conserved
region shared by multiple different protein species. Finally,
the sensitivity of proteomic detection depends on the ioniz
ability of different oligopeptides which varies from protein to
protein. As a result, the linear relationship between a proteo
mic metric such as spectral counts, and absolute protein
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abundance varies in slope from protein species to protein
species. What this means is that while shotgun proteomics
can distinguish between the relative amounts of a given pro
tein in different samples, it cannot reliably compare the
abundances of two different protein species without the addi
tion of reference protein standards of known quantity.
Conclusion: Even with all the technical caveats, proteomics
is unique in allowing the application of “omics” approaches to
autophagy measurement and can be used to validate the
conclusions of marker-based autophagy assays. As the tech
nology continues to improve and as the costs of experiments
decline, proteomics is likely to become an increasingly stan
dard approach to examining the role of autophagy in cellular
physiology and pathophysiology.
19. Metabolic markers of autophagy
Metabolites play an essential role in autophagy regulation and
therefore constitute key targets for the understanding of bio
logical processes that are involved in autophagy and are mis
regulated in autophagy-related diseases. Recent metabolomics
approaches have been developed in order to identify the key
metabolites involved in the regulation of autophagy [1629].
These approaches rely on two main and complementary
methods, which are MS and NMR spectroscopy. On the one
hand, NMR provides access to unique structural information,
is quantitative and highly reproducible. On the other hand,
MS is more sensitive than NMR, but suffers from the ambi
guity of spectral signatures.
The regulation of autophagy is mediated by various con
ditions including (a) starvation and (b) protein acetylation
status. Under normal growth conditions, associated with
abundant nutrients, autophagy is kept at a basal level making
it possible to maintain essential cellular processes such as the
turnover of damaged cellular organelles and the degradation
of proteins. Under conditions of nutrient starvation, autopha
gy is further induced to provide cells with additional internal
nutrient supplies and is associated with a dramatic change in
the cellular metabolome profile. Indeed, low glucose levels
result in decreased cellular capacity to convert ATP to
cAMP and are therefore linked to a decreased activation of
autophagy-related proteins via the PRKA/cAMP-dependent
protein kinase A pathway [36, 1629]. Therefore, monitoring
the levels of glucose and cAMP as well as the AMP:ATP ratio
are efficient readouts associated with autophagic capacity, and
these can be quantitatively detected using both NMR spectro
scopy and MS approaches.
Several studies underlined the role of protein acetylation in
the regulation of autophagy, and show that a decreased cel
lular acetylation level is associated with increased autophagy
[996, 1630]. For instance, Atg proteins mediate autophagy via
formation of autophagosomes only in their de-acetylated state
[1631, 1632]. Protein acetylation status is regulated by the
cellular balance between acetyltransferases and deacetylases,
which use acetyl-CoA and NAD+ as cofactors, respectively.
Therefore, monitoring acetyl-CoA and NAD+ metabolites are
efficient readouts of protein acetylation marks and associated
autophagic flux. Several studies also underline the role of
polyamines, spermidine and spermine in the regulation of
autophagy via inhibition of histone-acetyltransferases [1633–
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1636]. Nevertheless, the exact cellular mechanisms linking
histone deacetylation and autophagy regulation are still
unclear but likely involve a transcription-dependent activa
tion/repression of autophagy-related genes. The cellular
NAD+ and spermidine levels can be detected by both MS
and NMR spectroscopy, whereas, due to its low cellular
abundance, acetyl-CoA can only be detected using MS.
Other metabolites also reflect the autophagic capacity of
the cell. As previously mentioned, autophagy allows protein
turnover via activation of proteolysis. Therefore, levels of free
amino acids, which are building blocks of proteins are suitable
markers for (in)activation of autophagy and can be quantita
tively detected using NMR spectroscopy and MS [1637, 1638].
Finally, elevated levels of free fatty acids or triglycerides as
well as production of PtdIns3P are linked to induction of
autophagy [36]. Detection and quantification of this complex
class of lipids is usually performed using MS [1639], as NMR
spectroscopy provides mainly information regarding the che
mical nature of apolar metabolites.
In conclusion, metabolomics studies provide essential
information in the field of autophagy and contribute to the
deep-understanding of its complex regulatory mechanisms in
living cells and organisms. Given the recent advances in
method development using NMR and MS metabolomics
approaches, it is to be expected that more metabolites
involved in autophagy regulation [1640–1642] will be identi
fied in the coming years.
20. Clinical setting
Altered autophagy is clearly relevant in neurodegenerative dis
eases, as demonstrated by the accumulation of protein aggregates
and gene dysregulation, for example in AD [1643, 1644], adult
brain ischemia [1645, 1646], PD [1647], Huntington disease
(HD) and other polyglutamine repeat expansion diseases [1648,
1649], muscle diseases [1650, 1651], and ALS [1652]. Elevated
levels of autophagosomes or mitophagosomes have been identi
fied ultrastructurally in aging, brain ischemia, vacuolar myopa
thies, PD, AD and Lewy body dementia [79, 1133, 1188, 1653].
Of note, depending on the disease being considered, autophagy
is not necessarily impaired but could be, in particular conditions,
excessively activated (i.e., an increase in the autophagic flux)
such as in neonatal models of cerebral ischemia [1608, 1654,
1655]. Autophagy defects with autophagosome accumulation are
also associated with different forms of hereditary spastic para
plegia/HSP [1656]. Of note, the expression levels of ATG5 and
the ratio between LC3A and LC3B significantly increase in
3xTgAD mouse brain, following treatment with near infrared
light, thus emphasizing the involvement of autophagic machin
ery in the degradation of dysfunctional MAPT protein [1657].
Further evidence comes from the observations that the stressinducible mitophagy regulators PINK1 and PRKN show loss-offunction mutations in autosomal recessive juvenile parkinsonism
[1658]. Along these lines, it is important to dissociate the clinical
significance of these PD-associated loci in patients from the
depolarization-induced “PINK1-PRKN signaling pathway” as it
is traditionally studied in cultured cells.
A very useful nonspecific indicator of deficient aggrephagy
in autopsy brain or biopsy tissue is SQSTM1 IHC [1659,
1660]. For clinical attempts to monitor autophagy alterations

in peripheral tissues such as blood, it is important to know
that eating behavior may be altered as a consequence of the
disease [1661], resulting in a need to control feeding-fasting
conditions during the analyses. Recently, altered autophagy
was also implicated in schizophrenia, with BECN1 transcript
levels decreasing in the postmortem hippocampus in compar
ison to appropriate controls [1662]. In the same hippocampal
postmortem samples, the correlation between the RNA tran
script content for ADNP (activity-dependent neuroprotective
homeobox) and its sister protein ADNP2 is deregulated
[1663], and ADNP as well as ADNP2 RNA levels increase in
peripheral lymphocytes from schizophrenia patients com
pared to matched healthy controls, suggesting a potential
biomarker [1662].
Over the past decade, our depth of knowledge and under
standing on therapeutic potentials of autophagy inhibition for
treating cancer has been vastly improved. Particularly, after
tumors have been formed, cancer cells actively undergo auto
phagy to survive and grow under conditions of nutrient
limitation and hypoxia. Therefore, autophagy inhibitors are
becoming emerging therapeutics to combat cancer [1664,
1665]. To this end, more pharmacological molecules that are
designed to suppress autophagy have been examined for clin
ical use such as 3-MA, wortmannin, LY294002, CQ, and HCQ
[1665]. For example, class III PtdIns3K inhibitors including 3MA, wortmannin and LY294002 prevent autophagosome for
mation, and thus inhibit autophagy. However, these inhibitors
are not specific for inhibiting autophagy and can activate
autophagy at higher doses. Thus, the PtdIns3K inhibitors are
not suitable for clinical settings. Other commonly used auto
phagy inhibitors such as CQ and its derivative HCQ that are
FDA approved anti-malaria drugs, have been extensively stu
died and tested in clinical trials. Although CQ and HCQ show
moderate anti-neoplastic effects, these largely come from the
modulation of pathways other than autophagy inhibition per
se [1666, 1667]. Moreover, the mechanism by which CQ and
HCQ inhibit autophagy is still not fully understood.
Therefore, developing molecules that specifically regulate au
tophagy will surely broaden clinical utility in combating
cancer.
In addition to neurodegenerative diseases, alterations in
autophagy have also been implicated in other neurological
diseases including some epilepsies, neurometabolic and neu
rodevelopmental disorders [1569, 1668–1670], and inherited
autophagic vacuolar myopathies (including Danon disease,
acid maltase deficiency/Pompe disease, X-linked myopathy
with excessive autophagy/XMEA, etc.), which are character
ized by lysosomal defects and an accumulation of autophagic
vacuoles [1671]. Autophagic vacuolar myopathies and cardi
omyopathies can also be secondary to treatment with auto
phagy-inhibiting drugs (CQ, HCQ and colchicine), which are
used experimentally to interrogate autophagic flux and clini
cally to treat malaria, rheumatological diseases, and gout
[1561]. Autophagy impairment has also been implicated in
the pathogenesis of inclusion body myositis, an age-associated
inflammatory myopathy that is currently refractory to any
form of treatment [1672–1675], along with some muscular
dystrophies such as tibial muscular dystrophy [1676]. In all
these striated muscle disorders, accumulated autophagic
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vacuoles can be seen by electron microscopy, or, alternatively,
LC3 and/or SQSTM1 can be detected by IHC [1560, 1561,
1651, 1677]. In addition, autophagy defects can also lead to
the formation of an eosinophilic cytoplasmic inclusion, which
is a round to oval homogeneous cytoplasmic eosinophilic
globule composed of protein aggregates and/or organelles;
SQSTM1, BECN1, NBR1, LC3 and/or peroxisomes are depos
ited in the inclusion, and both the proteins and organelles can
be detected by IHC, immunofluorescence, or TEM [1678].
Whereas autophagosomes and autolysosomes are not
always distinguishable using only morphological methods to
confirm whether or not an autophagic structure has fused
with a lysosome, “autophagic vacuoles” are easily recognized
by electron microscopy in the cardiomyocytes of patients with
dilated cardiomyopathy [550]. Autophagic vacuoles are easily
observed not only in secondary cardiomyopathy but also in
failing cardiomyocytes of dilated cardiomyopathy [550].
These vacuoles display LC3 expression by using the ABC
technique for TEM observation (see Transmission electron
microscopy) [112]. Dilated cardiomyopathy with autophagic
vacuoles indicates a good prognosis, confirming that autopha
gy resists cardiomyocyte degeneration. In dilated cardiomyo
pathy, it is suggested that autophagy is not always the cause of
the disease but also a process that occurs to prevent the
disease.
In addition, altered basal autophagy levels are seen in
rheumatoid arthritis [1028,1029], systemic lupus erythemato
sus (SLE) [1679–1681], and osteoarthritis [1682]. Other
aspects of the immune response associated with dysfunctional
autophagy are seen in neutrophils from patients with familial
Mediterranean fever [1683] and in monocytes from patients
with TNF receptor-associated periodic syndrome [1684], two
autoinflammatory disorders. Aberrant elevation of IL17A
plays a critical role in the pathogenesis of pulmonary fibrosis
through suppressing the autophagic degradation of collagen
in fibrotic lung tissue [1685]. In lung epithelial cells, IL17Aactivated PIK3CA inhibits the kinase activity of GSK3B by
stimulating its phosphorylation at Ser9, which consequently
attenuates activation of an autophagic core complex via inhi
biting the ubiquitination-dependent degradation of BCL2 and
its interaction with BECN1 [1686]. ANXA2 is identified as a
specific bleomycin target linked to interstitial pulmonary
fibrosis as bleomycin binding to ANXA2 impedes TFEBinduced autophagic flux to cause pulmonary fibrosis prolif
eration [1687].
Moreover, autophagy regulates an important neutrophil
function, the generation of neutrophil extracellular traps
(NETs) [1674, 1688]. The important role of autophagy in
the induction of NET formation has been studied in several
neutrophil-associated disorders such as gout [1689] and other
IL1B autoinflammatory disorders [1690–1692], ulcerative
colitis [1693], sepsis [1694], thromboinflammation [1695,
1696] and lung fibrosis [1697], including the inflammatory
remodeling associated with systemic sclerosis [1698]. The
prototypical DAMP and autophagy inducer, HMGB1,
released by activated platelets appears to play a role in neu
trophil autophagic flux induction [1674, 1698, 1699], and
studies of patients with systemic sclerosis have shown that
platelet-derived, microparticle-associated HMGB1 promotes
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neutrophil autophagy, as evidenced by Cyto-ID labeling, lead
ing to the production of NETs [1698].
Furthermore, there is an intersection between autophagy
and the secretory pathway in mammalian macrophages for
the release of IL1B [1700], demonstrating a possible alterna
tive role of autophagy for protein trafficking. This role has
also been implied in neutrophils through exposure of protein
epitopes on NETs by acidified LC3-positive vacuoles in sepsis
[1694] and anti-neutrophil cytoplasmic antibody associated
vasculitis [1701]. Patients with chronic kidney disease also
have impaired autophagy, which results in NLRP3 activation,
IL1B release and leukocyte influx. However, autophagy was
also shown to play an important role in the development in
vitro of giant phagocytes, a long-lived neutrophil subpopula
tion, derived from neutrophils of healthy individuals [1702,
1703]. Recently, evidence from genetic, cell biology and ani
mal models suggests that autophagy plays a pivotal role in the
occurrence and development of SLE. For example, altered
basal autophagy levels are seen in immune cells, such as B
cells, T cells, and neutrophils in SLE [1679]. There is also
evidence for altered autophagy in pancreatic beta cells [1704,
1705], and in adipocytes [292, 396, 1706] of patients with type
2 diabetes [1707].
Photodynamic therapy (PDT), an FDA-approved antican
cer therapy, is based on electromagnetic radiation and has
applications in the selective eradication of delineated tumor
lesions and infection sites. It is a two-step process whereby
cells are first incubated with photosensitizers and then
exposed to light, usually in the red spectral region. Although
these components (i.e., photosensitizers and light) are harm
less alone, when combined they provide a localized therapeu
tic archetype avoiding attack to healthy cells and preventing
side effects [1708, 1709]. This combination results in the
generation of singlet oxygen (1O2) and other ROS that can
cause cancer cell death [1710]. PDT can prompt AKT-MTOR
pathway downregulation and stimulate autophagy in eukar
yotic cells [1711]. The mechanism of PDT that modulates
autophagy depends on several factors, such as photosensitizer
molecular properties and concentrations, light dose and the
preferential intracellular target of the photosensitizers.
Particularly, photosensitizers that target lysosomes (e.g.,
chlorophyllin e4, chlorophyllin f, NPe6, WST11, TPPS2a,
MB, and DMMB) can modulate autophagy [316, 317, 1712–
1715]. PDT fulfills the need to merge a direct cytotoxic action
on tumor cells with potent immunostimulatory effects (i.e.,
immunogenic cell death, ICD) [1716]. A few photosensitizers,
such as Photofrin, hypericin, Foscan, 5-ALA and Rose Bengal
acetate, are associated with DAMP exposure and/or release
that is a requisite to elicit ICD. Rose Bengal acetate PDT is the
first treatment to induce autophagic HeLa cells to express and
release DAMPs, thus suggesting a possible role of the autop
hagic cells in ICD induction [1717]. Similarly, the photosen
sitizer hypocrellin B-acetate is able to induce autophagy at
very low concentrations [1718].
A crucial role for therapy-induced autophagy in cancer
cells has recently emerged, in modulating the interface of
cancer cells and the immune system [1719]; primarily, by
affecting the nature of danger signaling (i.e., the signaling
cascade that facilitates the exposure and/or release of danger
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signals) associated with ICD [1716, 1719–1722]. This is an
important point considering the recent clinical surge in the
success of cancer immunotherapy in patients, and the emer
ging clinical relevance of ICD for positive patient prognosis.
Several notorious autophagy-inducing anticancer therapies
induce ICD including mitoxantrone, doxorubicin, oxaliplatin,
radiotherapy, certain oncolytic viruses and hypericin-based
photodynamic therapy (Hyp-PDT) [1709, 1722–1724]. In
fact, in the setting of Hyp-PDT, ER stress-induced autophagy
in human cancer cells suppresses CALR (calreticulin) surface
exposure (a danger signal crucial for ICD) thereby leading to
suppression of human dendritic cell maturation and human
CD4+ and CD8+ T cell stimulation [1724]. Similarly, ATG5and ATG7-dependent autophagic responses limit the secre
tion of type I interferon by cancer cells undergoing radio
therapy-driven ICD, largely as a consequence of decreased
cytosolic accumulation of mitochondrial DNA and conse
quent inhibition of CGAS-STING1 signaling [1725].
Conversely, chemotherapy (mitoxantrone or oxaliplatin)induced autophagy facilitates ATP secretion (another crucial
ICD-associated danger signal) thereby facilitating ICD and
anti-tumor immunity in the murine system, the first docu
mented instance of autophagy-based ICD modulation [1726].
The role of ATP as a DAMP becomes clear when the extra
cellular concentration of ATP becomes high and elicits activa
tion of the purinergic receptor P2RX7. P2RX7 is involved in
several pathways, including the sterile immune response, and
its activation induces cancer cell death through PI3K, AKT
and MTOR [1727, 1728]. In addition, cells lacking the essen
tial CMA gene LAMP2A fail to expose surface CALR after
treatment with both Hyp-PDT and mitoxantrone [1729].
Although autophagy has been linked to fibrosis in many
tissues, not much is known about it with regard to respiratory
diseases per se. Initial observations have demonstrated that
there is an increased formation of autophagosomes in
mesenchymal cells from asthmatic donors with an increase
in ATG5 in the lung [1730, 1731]. Basal autophagy markers
can be measured using IHC in the lung tissue, and with this
approach it is possible to measure expression of BECN1,
ATG5, LC3B and SQSTM1 in the airway epithelium and
mesenchymal layer (airway wall) of asthmatic and non-asth
matic human tissues in both small and large airways [1732].
The actual expression of these markers may vary in the airway
wall and is largely dependent upon cell type as observed in the
lung tissue; however, these observations provide a tool to
monitor basal autophagy in health vs disease and can provide
useful information on how it varies from one cell type to
another in a clinical setting.
Finally, it is important to note that disease-associated au
tophagy defects are not restricted to macroautophagy but also
concern other forms of autophagy. CMA impairment, for
instance, is associated with several disease conditions, includ
ing neurodegenerative disorders [307, 1733], lysosomal sto
rage diseases [1734, 1735], nephropathies [1736] and diabetes
[1737]. In addition, it is very important to keep in mind that
although human disease is mostly associated with inhibited
autophagy, enhanced autophagy has also been proposed to
participate in, and even contribute to, the pathogenesis of
human diseases, such as chronic obstructive pulmonary

disease [1738], adipocyte/adipose tissue dysfunction in obesity
[292, 396] and bilirubin-induced neurotoxicity [1739]. Along
these lines, CQ was reported to decrease diabetes risk in
patients treated with the drug for rheumatoid arthritis [1740].
A set of recommendations regarding the design of clinical
trials modulating autophagy can be found in ref. [1741].
Cautionary notes: Although the protein products of sev
eral genes mutated in different neurodegenerative diseases are
involved in regulating selective autophagy [1188], several of
these gene products also act together to regulate other impor
tant aspects of neuronal structure and function. For example,
PINK1 (implicated in mitophagy) interacts with VCP/p97
(implicated in ribophagy and granulophagy) to promote the
growth and extension of neuronal processes through activa
tion of PRKA/PKA signaling, and not via degradative
mechanisms [1742]. To establish a role for autophagy in
disease states, whether neurodegenerative or immunological,
specific tests need to be performed where genes encoding
autophagy-relevant components (e.g., ATG5, ATG7 or
BECN1) have been knocked down through RNA silencing or
other protein- or gene-specific targeting technologies [1724,
1726, 1729]. Usage of chemical inhibitors such as bafilomycin
A1, 3-MA or CQ can create problems owing to their off-target
effects, especially on immune cells, and thus their use should
be subjected to due caution, and relevant controls are critical
to account for any off-target effects. In the context of ICD,
consideration should be given to the observations that auto
phagy can play a context-dependent role in modulating dan
ger signaling [1724, 1726, 1729]; and thus, all the relevant
danger signals (e.g., surface exposed CALR or secreted ATP)
should be (re-)tested for new agents/therapies in the presence
of targeted ablation of autophagy-relevant proteins/genes,
accompanied by relevant immunological assays (e.g., in vivo
rodent vaccination/anti-tumor immunity studies or ex vivo
immune cell stimulation assays), in order to imply a role for
autophagy in regulating ICD or general immune responses.
21. Cell death and autophagy
Autophagy is often seen in tumor tissue accompanying cell
death; however, the function of autophagy mediating cell
death is more limiting, and mostly confined to specific set
tings [1743–1745]. It is important to carefully establish the
contribution of autophagy to the execution of cell death
before making claims that autophagy is involved in the cell
death process. Published literature often suffer from ambig
uous use of the term “autophagic cell death,” which was
coined in the 1970s [1746] in a purely morphological context
to refer to cell death with autophagic features (especially the
presence of numerous secondary lysosomes); this was some
times taken to suggest a role of autophagy in the cell death
mechanism, but death-mediation was not part of the defini
tion [1747]. Recent nomenclature guidelines suggest that au
tophagy-dependent cell death (ADCD) is a distinct
mechanism of cell death, independent of apoptosis or necrosis
[1266]. Additional contributions of autophagy to cell death
can be: (a) autophagy-associated cell death, where autophagy
accompanies other cell death modalities and (b) autophagymediated cell death (AMCD), which could involve a standard
mechanism of cell death such as apoptosis, but triggered by
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autophagy. The contribution of autophagy to cell death needs
to be established by genetic and pharmacological means
where autophagy inhibition blocks or reduces cell death,
especially when distinct pathways of cell death appear to be
simultaneously triggered by certain events [1748, 1749].
However, while evidence for the need of autophagy in the
context of cell death alone may support the definition of
autophagy-mediated cell death, it is important when establish
ing ADCD that further proof is required that other established
modes of programmed (or regulated) cell death do not con
tribute to cellular demise. It is preferable to use the term
AMCD when it is proven that autophagy is a pre-requisite
for the occurrence of cell death, but it is not proven that
autophagy mechanistically mediates the switch to cell death
[1750].
Inhibition of the full autophagy degradation cycle has also
been proposed to lead to specific forms of autophagy-asso
ciated cell death, such as karyoptosis, involving the nucleo
phagy machinery and clearance by expulsion into the
extracellular space [1750–1752]. Induction of the autophagy
degradation cycle also promotes other cell death pathways,
such as apoptosis, and cell cycle arrest [1753, 1754]. It is
important to note that a stress stimulus can in many circum
stances induce different cell death pathways at the same time,
which might lead to a “type” of cell death with mixed pheno
types [678, 1755–1757]. Here, autophagy can be one of a
range of adaptive mechanisms induced in the face of cellular
stress, which precedes cell death if the stress cannot be over
come. Furthermore, inhibition of one cell death pathway (e.g.,
apoptosis) can either induce the compensatory activation of a
secondary mechanism (e.g., necrosis) [1758, 1759], or attenu
ate a primary mechanism (e.g., liponecrosis) [1755].
The role of autophagy in the death of plant cells is well
established, because plants are devoid of the apoptotic
machinery and use lytic vacuoles to disassemble dying cells
from inside [1760]. This mode of cell death governs many
plant developmental processes, as well as stress-induced cell
death in some plant systems [911] and was named “vacuolar
cell death” [1761]. Recent studies have revealed a key role of
autophagy in the execution of vacuolar cell death, where
autophagy sustains the growth of lytic vacuoles [1762, 1763].
Besides being an executioner of vacuolar cell death, autophagy
can also play an upstream, initiator role in immunity-asso
ciated cell death related to the pathogen-triggered hypersen
sitive response [1760, 1764].
Upon induction by starvation of multicellular development
in the protist D. discoideum, autophagy (or at least Atg1) is
required to protect against starvation-induced cell death,
allowing vacuolar developmental cell death to take place
instead [1765, 1766]. Autophagy may be involved not only
in allowing this death to occur, but also, as during vacuolar
cell death in plants, in the vacuolization process itself [1767].
D. discoideum provides the ability to rapidly identify and
characterize defects in lysosomal activity and autophagic
degradation in relation to model diseases, such as a nonproteolytic activity for the gamma secretase complex [1768,
1769].
The best known physiologically relevant demonstration of
cell death that involves autophagy, and not apoptosis, is
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during Drosophila development. Drosophila is a powerful
genetically amenable model system to study ADCD, as the
process of autophagy and the function of Atg genes are highly
conserved, enabling genetic analysis of the autophagy machin
ery components and interactions with other pathways (see
Drosophila melanogaster). During Drosophila metamorphosis
temporal increases in the steroid hormone ecdysone trigger
the degradation of obsolete larval tissues including the midgut
and salivary gland. Larval midgut degradation is dependent
on autophagy and not apoptosis, as the inhibition of autopha
gy significantly delays midgut degradation whereas in the
absence of apoptosis degradation occurs normally [375].
Many Atg genes are transcriptionally upregulated immediately
prior to larval midgut degradation in an ecdysone receptordependent manner [375, 1770]. Yet only a subset of the multisubunit complexes that are required for autophagy induced
during cell survival are essential for ADCD [1162, 1771]. In
contrast to the midgut, destruction of the salivary gland
requires both caspase-dependent apoptosis and autophagy in
parallel [1772–1774]. Inhibition of either autophagy or apop
tosis alone results in a partial block in degradation, whereas
combined inhibition completely blocks salivary gland degra
dation [1772]. As in the midgut, in response to ecdysone the
expression of several Atg and apoptosis genes increase during
salivary gland degradation [939, 940, 1775]. Although larval
midgut and salivary gland degradation utilize autophagy for
cell death, there are clear differences in the requirement of
other cell death pathways between these tissues.
While there are numerous examples where autophagy pro
motes cell death in cultured cells, evidence for the physiolo
gical roles of ADCD in mammals have been more difficult to
establish. The first description of autophagic cell death under
physiological conditions in mammals is the terminal cell
death in keratinocyte lineage cells of the skin [1776]. Under
pathological conditions, an authentic case of autophagic cell
death is the death of adult hippocampal neural stem cells
following chronic restraint stress or injection of corticoster
one, a stress-mediating hormone in mice [1777].
Along these lines, recent evidence suggests that ferroptosis is
a type of autophagy-dependent cell death with increased autop
hagic flux [1778]. Mechanistically, NCOA4-facilitated ferritino
phagy [1267, 1272], RAB7A-dependent lipophagy [1779],
BECN1-mediated SLC7A11/system xc- inhibition [1780,
1781], STAT3-induced lysosomal membrane permeabilization
[1782], HSP90-associated CMA [1271], and SQSTM1-depen
dent clockophagy [1249] can trigger ferroptosis through
increasing iron accumulation or lipid peroxidation.
Another programmed death pathway, paraptosis [1783], is
non-apoptotic in nature and has been linked to autophagy.
There are several reports showing continuous increase in the
autophagy marker protein LC3 and in SQSTM1 in ER stressinduced paraptosis [1784–1791]; in particular LC3 is indis
pensable for paraptosis as its knockdown significantly abro
gates the cell death process [1784]. Pretreatment with
autophagy inhibitors cannot interrupt, but rather enhances,
the induction of cytoplasmic vacuolization and cell death
during paraptosis. Increased SQSTM1 levels clearly indicate
that the autophagy is impaired or inhibited during paraptosismediated cell death [1792]. Wheat germ agglutinin- and 8-p-
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hydroxybenzoyl tovarol-induced autophagy can antagonize
paraptosis in cancer cells [1793, 1794]. In contrast, a mito
phagy-dependent pathway plays a crucial role in paraptosis
induction by activating PINK1 [1795]. TEM analysis would be
the best way to characterize the big empty vacuoles observed
during paraptosis.
Cautionary notes: In brief, rigorous criteria must be met
in order to establish a death-mediating role of autophagy
(AMCD or ADCD), as this process typically promotes cell
survival. These include a clear demonstration of autophagic
flux as described in this article, as well as verification that
inhibition of autophagy prevents cell death (if using a knock
down approach, multiple ATG genes should be targeted), and
that, in the case of ADCD, other mechanisms of cell death are
not responsible. It is imperative to assess the genetic inhibi
tion of autophagy using multiple ATG gene ablation, espe
cially given the emerging non-autophagy role of ATG proteins
[1796, 1797]. Another caution concerns the stability of ATG
proteins; for some proteins the half-life may exceed several
days, making a 24- to 48-h knockdown experiment proble
matic. In addition, depending on the experimental model
system, appropriate protocols are needed to determine cellular
viability or cell death. For example, long-term clonogenic
assays should be employed when possible to measure the
effective functional survival of cells. Together, care is needed
to establish that the cell death is primarily dependent on
autophagy rather than contributions from other modes of
cell death.
Conclusion: In most systems, ascribing death to autophagy
based solely on morphological criteria is insufficient; ADCD
can only be demonstrated as death that is suppressed by the
inhibition of autophagy, through either genetic and/or che
mical means, noting that there a very few pharmacological
inhibitors of autophagy induction [1798].
22. Chaperone-mediated autophagy
The primary characteristic that makes CMA different from
the other autophagic variants described in these guidelines is
that it does not require formation of intermediate vesicular
compartments (autophagosomes or microvesicles) for the
import of cargo into lysosomes [1799, 1800]. Instead, the
CMA substrates are translocated across the lysosomal mem
brane through the action of HSPA8/HSC70 (heat shock pro
tein family A (Hsp70) member 8) located in the cytosol and
lysosome lumen, and the lysosome membrane protein
LAMP2A. This machinery makes CMA unique and distinct
from the other two major types of autophagy [1801, 1802].
CMA was originally identified in mammalian cells, and this
section refers only to studies in mammals; however, this
process has now been investigated in birds [1803], fish
[1804, 1805], Drosophila [1806] and C. elegans [1807]; in C.
elegans, the process may actually be ESCRT-mediated sorting
at the endosome, also referred to as endosomal microauto
phagy (e-MI), because the lmp-1 and lmp-2 genes are more
closely related to mammalian LAMP1. In fact, in a large
variety of fish species there exist expressed sequences display
ing high homology with mammalian LAMP2A, suggesting
that a functional CMA activity might not be solely restricted
to mammals and birds, and therefore likely appeared much

earlier during evolution than initially thought [1805]. Along
these lines, a CMA activity is indeed present in fish [1808].
These data provide new information on the evolution of
CMA, and also bring new perspectives on the possible use
of complementary genetic models, such as zebrafish or
medaka for studying CMA function from a comparative
angle.
Furthermore, a complete in silico analysis has shed further
light on the definition of CMA-competent and -incompetent
species. In this case, the authors used two essential features
that differentiate the LAMP2A splice variant from the other
two LAMP2 variants, which are the presence of (a) three to
four basic amino acids in the C-terminal proximal region of
the cytosolic tail [1806] and (b) the sequence GYEQF at the C
terminus of the LAMP2A protein [1809]. Following these
systematic approaches, CMA-competent species include
mammals, some types of birds [1810], reptiles [1809] and
fish [1808]. Interestingly, not all the mammalian species can
perform CMA, such as the Methateria, which could indicate a
diversified evolution for autophagy in this branch of the
mammalian kingdom [1809]. It should also be noted that
although most teleost fish display the consensus sequence
GYXXF, the divergence of that motif in zebrafish, encoding
an additional C-terminal amino acid, raises questions about
the ability of this species to specifically perform CMA, and
deserves special attention. Therefore, CMA-competent species
should at present be restricted to mammals, some birds, fish
and reptiles, until convincing data are provided regarding the
presence of LAMP2A homologs in other species.
The following section discusses methods commonly uti
lized to determine if a protein is a CMA substrate (see ref.
[1811] for experimental details):
a. Analysis of the amino acid sequence of the protein to
identify the presence of a KFERQ-related motif, which is
recognized by HSPA8, and is an absolute requirement for all
CMA substrates [1812]. A free web-based resource is available
to perform searches for KFERQ-like motifs in proteins [1809].
Modifications by signaling or stress may generate a novel
CMA motif in proteins without such a motif and then make
them suitable to be degraded via CMA. For example, acetyla
tion can make the lysine (K) mimic a glutamine (Q), leading
to a new CMA substrate motif in the protein, which is acces
sible for recognition by the CMA chaperone protein [1813].
In experimental CMA activity assays, mutation of the
KFERQ-related motif in a protein substrate of interest to
alter its physical properties for CMA recognition is one of
the strategies to elucidate the specificity of CMA-mediated
protein degradation [1814].
b. Colocalization studies with lysosomal markers (typically
LAMP2A and/or LysoTracker™) to identify a fraction of the
protein associated with lysosomes. The increase in association
of the putative substrate under conditions that upregulate
CMA (such as prolonged starvation) or upon blockage of
lysosomal proteases (to prevent the degradation of the pro
tein) helps support the hypothesis that the protein of interest
is a CMA substrate. However, association with lysosomes is
necessary, but not sufficient, to consider a protein an authen
tic CMA substrate, because proteins delivered by other path
ways to lysosomes will also behave in a similar manner. A
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higher degree of confidence can be attained if the association
is preferentially with the subset of lysosomes active for CMA
(i.e., those containing HSPA8 in their lumen), which can be
separated from other lysosomes following published proce
dures [1815].
c. Co-immunoprecipitation of the protein of interest with
cytosolic HSPA8. Due to the large number of proteins that
interact with this chaperone, it is usually better to perform
affinity isolation with the protein of interest and then analyze
the isolated proteins for the presence of HSPA8 rather than
vice versa.
d. Co-immunoprecipitation of the protein of interest with
LAMP2A [1816]. Due to the fact that the only antibodies
specific for the LAMP2A variant (the only one of the three
LAMP2 variants involved in CMA [133, 1817]) are generated
against the cytosolic tail of LAMP2A, where the substrate also
binds, it is necessary to affinity isolate the protein of interest
and then analyze for the presence of LAMP2A. Immunoblot
for LAMP2A in the precipitate can only be done with the
antibodies specific for LAMP2A and not just those that recog
nize the lumenal portion of the protein that is identical in the
other LAMP2 variants. If the protein of interest is abundant
inside cells, co-immunoprecipitations with LAMP2A can be
done in total cellular lysates, but for low-abundance cellular
proteins, preparation of a membrane fraction (enriched in
lysosomes) by differential centrifugation may facilitate the
detection of the population of the protein bound to LAMP2A.
e. Selective upregulation and blockage of CMA to demon
strate that degradation of the protein of interest changes with
these manipulations. Selective chemical inhibitors for CMA
are not currently available. Note that general inhibitors of
lysosomal proteases (e.g., bafilomycin A1, NH4Cl, leupeptin)
also block the degradation of proteins delivered to lysosomes
by other autophagic and endosomal pathways. The most
selective way to block CMA is by knockdown of LAMP2A,
which causes this protein to become a limiting factor [133].
The other components involved in CMA, including HSPA8,
HSP90AA1, GFAP, and EEF1A/eF1α, are all multifunctional
cellular proteins, making it difficult to interpret the effects of
knockdowns. Overexpression of LAMP2A [1816] is also a
better approach to upregulate CMA than the use of chemical
modulators. The two compounds demonstrated to affect
degradation of long-lived proteins in lysosomes [1818], 6aminonicotinamide and geldanamycin, lack selectivity, as
they affect many other cellular processes. In addition, in the
case of geldanamycin, the effect on CMA can be the opposite
(inhibition rather than stimulation) depending on the cell
type (this is due to the fact that the observed stimulation of
CMA is actually a compensatory response to the blockage of
HSP90AA1 in lysosomes, and different cells activate different
compensatory responses) [1819].
f. The most conclusive way to prove that a protein is a
CMA substrate is by reconstituting its direct translocation
into lysosomes using a cell-free system [1811]. This method
is only possible when the protein of interest can be purified,
and it requires the isolation of the population of lysosomes
active for CMA. Internalization of the protein of interest
inside lysosomes upon incubation with the isolated organelle
can be monitored using protease protection assays (in which
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addition of an exogenous protease removes the protein bound
to the cytosolic side of lysosomes, whereas it is inaccessible to
the protein that has reached the lysosomal lumen; note that
pre-incubation of lysosomes with lysosomal protease inhibi
tors before adding the substrate is required to prevent the
degradation of the translocated substrate inside lysosomes)
[1820]. The use of exogenous protease requires numerous
controls (see ref. [1811]) to guarantee that the amount of
protease is sufficient to remove all the substrate outside lyso
somes, but will not penetrate inside the lysosomal lumen
upon breaking the lysosomal membrane.
The difficulties in the adjustment of the amount of pro
tease have led to the development of a second method that is
more suitable for laboratories that have no previous experi
ence with these procedures. In this case, the substrate is
incubated with lysosomes untreated or previously incubated
with inhibitors of lysosomal proteases, and then uptake is
determined as the difference of protein associated with lyso
somes not incubated with inhibitors (in which the only
remaining protein will be the one associated with the cytosolic
side of the lysosomal membrane) and those incubated with
the protease inhibitors (which contain both the protein bound
to the membrane and that translocated into the lumen)
[1821].
Confidence that the lysosomal internalization is by CMA
increases if the uptake of the substrate can be competed with
proteins previously identified as substrates for CMA (e.g.,
GAPDH [glyceraldehyde-3-phosphate dehydrogenase] or
RNASE1 [ribonuclease A family member 1, pancreatic],
both commercially available as purified proteins), but is
not affected by the presence of similar amounts of nonsub
strate proteins (such as SERPINB/ovalbumin or PPIA/cyclo
philin A). Blockage of uptake by pre-incubation of the
lysosomes with antibodies against the cytosolic tail of
LAMP2A also reinforces the hypothesis that the protein is
a CMA substrate. It should be noted that several commer
cially available kits for lysosome isolation separate a mixture
of lysosomal populations and do not enrich in the subgroup
of lysosomes active for CMA, which limits their use for
CMA uptake assays.
Further to the limitations in purifying CMA-active lyso
somes for cell-free assays, CMA activity of these lysosomes
may be blocked by proteins that bind abnormally to LAMP2A
on the lysosomal surface, e.g., mutant LRRK2 [1733]. Such
protein binding, which happens in vivo, may be inadvertently
removed during stringent washes and centrifugation during
the lysosome isolation and purification processes. Hence,
assaying the degradation of an artificial CMA substrate in
isolated lysosomes may not necessarily reflect the in vivo
CMA activity [1814].
In other instances, rather than determining if a particular
protein is a CMA substrate, the interest may be to analyze
possible changes in CMA activity under different conditions
or in response to different modifications. We enumerate here
the methods, from lower to higher complexity, that can be
utilized to measure CMA in cultured cells and in tissues (see
ref. [1811] for detailed experimental procedures).
a. Measurement of changes in the intracellular rates of
degradation of long-lived proteins, when combined with
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inhibitors of other autophagic pathways, can provide a first
demonstration in support of changes that are due to CMA.
For example, CMA is defined in part as lysosomal degradation
upregulated in response to serum removal but insensitive to
PtdIns3K inhibitors.
b. Measurement of levels of CMA components is insuffi
cient to conclude changes in CMA because this does not
provide functional information, and changes in CMA compo
nents can also occur under other conditions. However, ana
lysis of the levels of LAMP2A can be used to support changes
in CMA detected by other procedures. Cytosolic levels of
HSPA8 remain constant and are not limiting for CMA, thus
providing no information about this pathway. Likewise,
changes in total cellular levels of LAMP2A do not have an
impact on this pathway unless they also affect their lysosomal
levels (i.e., conditions in which LAMP2A is massively over
expressed lead to its targeting to the plasma membrane where
it cannot function in CMA). It is advisable that changes in the
levels of these two CMA components are confirmed to occur
in lysosomes, either by colocalization with lysosomal markers
when using image-based procedures or by performing immu
noblot of a lysosomal enriched fraction (purification of this
fraction does not require the large amounts of cells/tissue
necessary for the isolation of the subset of lysosomes active
for CMA).
Given that specific LAMP2A antibody is available for
immunohistochemistry, comparison of puncta sizes from
LAMP2A-positive lysosomes under different conditions pro
vides useful information on the availability of LAMP2A at
lysosomal levels. Although LAMP2A plays a key role in CMA
activity, an increased LAMP2A level does not necessarily
reflect increased CMA activity. Blockage of substrate translo
cation and disassembly of LAMP2A-binding complexes can
result in accumulation of lysosomal LAMP2A, thus impairing
LAMP2A turnover and CMA activity [1814].
c. Tracking changes in the subset of lysosomes active for
CMA. This group of lysosomes is defined as those containing
HSPA8 in their lumen (note that LAMP2A is present both in
lysosomes that are active or inactive for CMA, and it is the
presence of HSPA8 that confers CMA capability).
Immunogold or immunofluorescence against these two pro
teins (LAMP2A and HSPA8) makes it possible to quantify
changes in the levels of these lysosomes present at a given
time, which correlates well with CMA activity [1815].
d. Analysis of lysosomal association of fluorescent artificial
CMA substrates. Two different fluorescent probes have been
generated to track changes in CMA activity in cultured cells
using immunofluorescence or flow cytometry analysis [1815].
These probes contain the KFERQ and context sequences in
frame with photoswitchable or photoactivated fluorescent
proteins. Activation of CMA results in the mobilization of a
fraction of the cytosolic probe to lysosomes and the subse
quent change from a diffuse to a punctate pattern. CMA
activity can be quantified as the number of fluorescent puncta
per cell or as the decay in fluorescence activity over time
because of degradation of the artificial substrate. Because the
assay does not allow measuring accumulation of the substrate
(which must unfold for translocation), it is advisable to per
form a time-course analysis to determine gradual changes in

CMA activity. Antibodies against the fluorescent protein in
combination with inhibitors of lysosomal proteases can be
used to monitor accumulation of the probe in lysosomes
over a period of time, but both the photoswitchable and the
unmodified probe will be detected by this procedure [1822].
As for any other fluorescence probe based on analysis of
intracellular “puncta” it is essential to include controls to
confirm that the puncta are indeed lysosomes (colocalization
with LysoTracker™ or LAMPs and lack of colocalization with
markers of cytosolic aggregation such as ubiquitin) and do
not reach the lysosomes through other autophagic pathways
(insensitivity to PtdIns3K inhibitors and sensitivity to
LAMP2A knockdown are good controls in this respect).
e. Direct measurement of CMA using in vitro cell-free
assays. Although the introduction of the fluorescent probes
should facilitate measurement of CMA in many instances,
they are not applicable for tissue samples. In addition, because
the probes measure binding of substrate to lysosomal mem
branes it is important to confirm that enhanced binding does
not result from defective translocation. Last, the in vitro
uptake assays are also the most efficient way to determine
primary changes in CMA independently of changes in other
proteolytic systems in the cells. These in vitro assays are the
same ones described in the previous section on the identifica
tion of proteins as substrates of CMA, but are performed in
this case with purified proteins previously characterized to be
substrates for CMA. In this case the substrate protein is
always the same, and what changes is the source of lysosomes
(from the different tissues or cells that are to be compared).
As described in the previous section, binding and uptake can
be analyzed separately using lysosomes previously treated or
not with protease inhibitors. The analysis of the purity of the
lysosomal fractions prior to performing functional analysis is
essential to conclude that changes in the efficiency to take up
the substrates results from changes in CMA rather than from
different levels of lysosomes in the isolated fractions. Control
of the integrity of the lysosomal membrane and sufficiency of
the proteases are also essential to discard the possibility that
degradation is occurring outside lysosomes because of leak
age, or that accumulation of substrates inside lysosomes is due
to enhanced uptake rather than to decreased degradation.
f. Time-course analysis to determine CMA activity in live
cells. Cells of interest can be developed to express a photo
activatable fluorescent reporter protein (e.g., PA-mCherry)
conjugated to
a
KFERQ-like
recognition
motif.
Photoactivation induces emission of fluorescence of reporter
substrates already expressed in the cells. Any decline in sub
strate fluorescence levels after photoactivation can be moni
tored and quantified at different time points using flow
cytometry. It is crucial that the culture medium be refreshed
prior to photoactivation (typically 2 to 4 h) to minimize the
confounding effects of basal autophagy due to depletion of
nutrients in the old culture medium. Furthermore, CMA
reference substrates may be degraded via non-CMA pathways.
To confirm whether the degradation of the substrate is CMAspecific, it is important to include a control assay after lamp2a
knockdown [1814].
Cautionary notes: The discovery of a new selective form of
protein degradation in mammals named endosomal
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microautophagy [1823] has made it necessary to reconsider
some of the criteria that applied in the past for the definition
of a protein as a CMA substrate. The KFERQ-like motif,
previously considered to be exclusive for CMA, is also used
to mediate selective targeting of cytosolic proteins to the sur
face of late endosomes. For example, MAPT containing the
KFERQ-like motifs has been found to be a CMA substrate
[1824]; however, it was also revealed to be a substrate of e-MI
[1825]. Once there, substrates can be internalized in micro
vesicles that form from the inward invagination of the limit
ing membrane of these organelles in an ESCRT-dependent
manner. HSPA8 has been identified as the chaperone that
binds this subset of substrates and directly interacts with
lipids in the late endosomal membrane, thus acting as a
receptor for cytosolic substrates in this compartment [1826];
accordingly, e-MI is a variation of the MVB pathway, and as
such can be referred to as ESCRT-mediated sorting at the
endosome. At a practical level, to determine if a KFERQcontaining protein is being degraded by CMA or e-MI the
following criteria can be applied: (a) Inhibition of lysosomal
proteolysis (for example with NH4Cl and leupeptin) blocks
degradation by both pathways. (b) Knockdown of LAMP2A
inhibits CMA but not e-MI. (c) Knockdown of components of
ESCRT-I and ESCRT-II (e.g., VPS4 and TSG101) inhibits eMI but not CMA. (d) Interfering with the capability to unfold
the substrate protein blocks its degradation by CMA, but does
not affect e-MI of the protein. In this respect, soluble proteins,
oligomers and protein aggregates can undergo e-MI, but only
soluble proteins can be CMA substrates. (e) In vitro uptake of
e-MI substrates can be reconstituted using isolated late endo
somes whereas in vitro uptake of CMA substrates can only be
reconstituted using lysosomes. e-MI has also been described
in Drosophila neuromuscular junctions and fat body. Using
photoactivatable PA-mCherry or split-GFP sensors it was
shown to genetically depend on Hsc70-4, a homolog of
HSPA8, and components of the ESCRT machinery [1806,
1827].
Another pathway that needs to be considered relative to
CMA is chaperone-assisted selective autophagy (CASA)
[1828]. CASA is dependent on HSPA8 and LAMP2
(although it is not yet known if it is dependent solely on
the LAMP2A isoform). Thus, a requirement for these two
proteins is not sufficient to conclude that a protein is
degraded by CMA.
It should also be noted that LAMP1 and LAMP2 share
common function as revealed by the embryonic lethal pheno
type of lamp1−/− lamp2y/− double-deficient mice [1829].
LAMP2 is involved in the fusion of late endosomes and
autophagosomes or phagosomes [1830, 1831]. LAMP2C, one
of the LAMP2 isoforms, can also function as an RNA/DNA
receptor in RNautophagy and DNautophagy pathways, where
RNA or DNA is taken up directly by lysosomes in an ATPdependent manner [1395–1398]. Whereas LAMP2A and
LAMP2B are expressed in most mammalian cells, LAMP2C
is selectively expressed in different tissues and cell types.
Increased expression of LAMP2C is induced in human lym
phocytes upon cellular exposure to inflammatory stimuli, with
ectopic LAMP2C expression disrupting CMA [1832]. In
human melanoma tumors, increased cellular LAMP2C
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reduces the expression of LAMP2A and LAMP2B, disrupting
CMA and autophagy, as well as cell cycle progression and
tumor growth in vivo [1833]. Finally, LAMP1 and LAMP2
deficiency does not necessarily affect protein degradation
under conditions when CMA is active [1829], and the expres
sion levels of neuronal CMA substrates does not change upon
loss of LAMP2 [1397, 1834, 1835].
Conclusion: One of the key issues with the analysis of
CMA is verifying that the protein of interest is an authentic
substrate. Methods for monitoring CMA that utilize fluores
cent probes are available that eliminate the need for the
isolation of CMA-competent lysosomes, one of the most
difficult aspects of assaying this process.
23. Chaperone-assisted selective autophagy
CASA is a specialized form of macroautophagy whereby sub
strate proteins are ubiquitinated and targeted for lysosomal
degradation by chaperone and co-chaperone proteins [1828].
The substrate protein does not require a KFERQ motif, which
differentiates CASA from CMA. In addition, in CASA the
cargo protein destined for degradation is delivered to the
phagophore instead of directly to the lysosome as occurs in
CMA. In CASA the substrate protein is recognized by the
CASA complex that is formed by the assembly of the cochaperone BAG3, which forms a multidomain complex with
HSPA8, the small heat shock proteins HSPB6 and HSPB8, the
ubiquitin ligase STUB1/CHIP, and the receptor proteins
SYNPO2/myopodin (synaptopodin 2) and SQSTM1. The cochaperone DNAJB6 also interacts with the core CASA
machinery [1836], although its precise role in the pathway
awaits confirmation. Following ubiquitination, the substrate
protein is loaded onto the CASA machinery. SYNPO2 and
SQSTM1 then bind to core components of the phagophore
(VPS18 and LC3, respectively) resulting in sequestration of
the substrate protein and associated multidomain complex
within the autophagosome, and subsequent lysosomal degra
dation [1828, 1837]. Note that association of BAG1 with
STUB1/CHIP and HSPA8, displacing or preventing the asso
ciation of HSPA8 with BAG3, causes the cargoes to be rerouted from CASA to the proteasome [1838–1841]. Along
these lines, BAG3 Pro209 mutants, associated with neuromus
cular diseases and peripheral neuropathies, relocate chaper
ones of the CASA complex to aggresomes; the mutant BAG3
protein traps ubiquitinated client proteins at the aggresome
preventing their efficient clearance [1842]. Finally, CASA has
been observed primarily in mammalian cells, but is also found
in Aspergillus [1843]. See also Filamentous fungi.
Conclusion: Given that the autophagy machinery involved
in CASA is very similar to that in other forms of autophagy
there are currently no specific markers or inhibitors available
to study this process specifically, but the involvement of
HSPA8, BAG3 and ubiquitination of client proteins is highly
suggestive of CASA activity.
24. Microautophagy
Microautophagy is a category of autophagic pathway that is
driven by morphological changes of the lysosomal (vacuolar)
or endosomal membrane. Protrusion (type 1) or invagination
(type 2) of the lysosomal membrane leads to an uptake of the
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cytoplasmic components, while invagination of the endosomal
membrane producing multivesicular bodies is also known to
transport cytoplasmic components into the organelle lumen
(type 3), and eventually to the lysosomal lumen [1844]. This
category encompasses both bulk and selective autophagic path
ways; several of the latter, termed micropexophagy (selective
microautophagy of peroxisomes) in the yeast Komagataella
phaffii/Pichia pastoris, and PMN in Saccharomyces cerevisiae,
have been extensively studied [157, 1061]. Whereas both
micropexophagy and PMN are dependent on “core” Atg pro
teins [1845] responsible for the biogenesis of autophagic mem
brane structures [1846, 1847], recent studies identified several
microautophagic pathways independent of such Atg proteins,
that function in selective degradation of lipid droplets (micro
lipophagy) in the yeast S. cerevisiae [1848, 1849] or in the
formation of anthocyanin vacuole inclusions in A. thaliana
[1850]. Endosomal microautophagy (type 3) requires ESCRT
and HSPA8-family proteins, and similar pathways have been
found in Schizosaccharomyces pombe [1851] and D. melanoga
ster [1827].
Because microautophagy accompanies incorporation of
part of the lysosomal membrane into the organelle lumen
together with the cargo (target) components, the most
authentic method to monitor microautophagy is detection of
transport of lysosomal transmembrane proteins into the
lumen. In yeast studies, the vacuolar transmembrane protein
Vph1 can be expressed with a C-terminal GFP, and subjected
to immunoblot analysis for the detection of the cleaved GFP
moiety produced in the vacuolar lumen through microauto
phagic activity [1849, 1852, 1853]. For specific monitoring of
selective microautophagy, similar detection of free GFP from
GFP-tagged, organelle-specific proteins have been utilized for
monitoring their activity. For example, Nvj1 or Swh1/Osh1
can be used for monitoring PMN [1847]; and Erg6 [1854,
1855], Faa4 [1856], or Ldo16/Osw5 [1849] are useful for the
detection of microlipophagy. For in vitro detection of bulk
microautophagic activity in S. cerevisiae, luciferase incorpora
tion into the purified vacuole fraction can be monitored
[1857]. In mammalian cells, exosomes correspond to intralu
menal vesicles (ILVs) of multivesicular endosomes (MVEs)
that are secreted in the extracellular space upon fusion of
MVEs with the plasma membrane instead of lysosomes.
Exosome analysis can be used as a readout of ILV biogenesis
[1858]. Some elements of commonality are achieved between
exosome/ILV biogenesis (type 3) and vacuolar microauto
phagy (type 2), such as lipid domain and ESCRT involvement
[1859]. Moreover, a crosstalk exists between the exosomal and
autophagic pathways allowing cell clearance of unwanted
components [822].
Cautionary notes: It should be noted that these assay
systems monitoring the dynamics of organelle-specific pro
teins other than lysosomal transmembrane proteins, do not
discriminate between autophagic and microautophagic activ
ities, and thus the data should be interpreted in combination
with other morphological analyses or immunoblot data from
the lysosomal membrane protein(s). In monitoring microli
pophagy, care should be taken for the choice of the lipid
droplet marker proteins for the immunoblot analysis, as sev
eral of the marker proteins, e.g., Erg6, exhibit dual localization

to the ER and lipid droplets, depending on culture conditions
[1849]; the use of such dual-localized marker proteins makes
it difficult to discriminate reticulophagy and (micro)lipo
phagy. It also should be noted that overexpression of lipid
marker proteins easily leads to release of the proteins into the
cytosol, which renders the degradation dependent on bulk
autophagy and “core” Atg factors, because all of the lipid
droplet proteins are peripherally associated with the organelle
surface.
C. Comments on additional topics
1. Acidotropic dyes
Among the older methods for following autophagy is staining
with acidotropic dyes such as MDC [1603], acridine orange
[1860], neutral red [1552], LysoSensor Blue [1861] and
LysoTracker™ Red [377, 1862]. It should be emphasized that,
whereas these dyes are useful to identify acidified vesicular
compartments, they should not be relied upon to compare
differences in endosomal or lysosomal pH between cells due
to variables that can alter the intensity of the signal. For
example, excessive incubation time and/or concentrations of
LysoTracker™ Red can oversaturate labeling of the cell and
mask differences in signal intensity that reflect different
degrees of acidification within populations of compartments
[1863]. Use of these dyes to detect, size, and quantify numbers
of acidic compartments must involve careful standardization
of the conditions of labeling and ideally should be confirmed
by ancillary TEM and/or immunoblot analysis. Reliable mea
surements of vesicle pH require ratiometric measurements of
two dyes with different peaks of optimal fluorescence (e.g.,
LysoSensor Blue and LysoSensor Yellow), or the use of a
molecule with two emission wavelengths that are differentially
affected by pH to exclude variables related to uptake and cell
size [80, 1863, 1864]. Another method to validate the fluor
escent signal of an acidotropic dye is by defining a cut-off
level for the net fluorescence intensity resulting from each
dye’s incorporation in acidic lysosomes. Coupling acidotropic
dye staining with flow cytometric analysis is highly recom
mended for a numerically validated and objective determina
tion of autophagy, and the use of a control such as CQ or
HCQ will further validate this inexpensive and convenient
technique [1865].
Finally, degradation of lysosomal cargo depends on acid
ification which leads to enzyme activation. Most cathepsins
are abundant and activated at the low pH of the lysosomal
lumen. For validation of cathepsin activation, and thus valida
tion of functional lysosomes, co-staining with Magic Red dye
and a lysosomal marker such as LAMP2 is recommended.
Selective inhibitors of cathepsin, such as E64d for cathepsin
B, must be included as an experimental control for Magic Red
specificity.
Cautionary notes: Although MDC was first described as a
specific marker of autophagic vacuoles [1866] subsequent
studies have suggested that this, and other acidotropic dyes,
are not specific markers for early autophagosomes [439], but
rather label later stages in the degradation process. For exam
ple, autophagosomes are not acidic, and MDC staining can be
seen in autophagy-defective mutants [814] and in the absence
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Starved

Figure 32. LysoTracker™ Red stains lysosomes and can be used to monitor autophagy in Drosophila. Live fat body tissues from Drosophila were stained with
LysoTracker™ Red (red) and Hoechst 33342 (blue) to stain the nucleus. Tissues were isolated from fed (left) or 3-h starved (right) animals. Bar: 25 µm. This figure was
modified from data presented in ref. [377], Developmental Cell, 7, Scott RC, Schuldiner O, Neufeld TP, Role and regulation of starvation-induced autophagy in the
Drosophila fat body, pp. 167-78, copyright 2004, with permission from Elsevier.

of autophagy activation [1867]. MDC may also show con
founding levels of background labeling unless narrow band
pass filters are used. However, in the presence of vinblastine,
which blocks fusion with lysosomes, MDC labeling increases,
suggesting that under these conditions MDC can label latestage autophagosomes [1600]. Along these lines, cells that
overexpress a dominant negative version of RAB7 (the T22N
mutant) show colocalization of this protein with MDC; in this
case fusion with lysosomes is also blocked [1510] indicating
that MDC does not just label lysosomes. Nevertheless, MDC
labeling could be considered as an indicator of autophagy
when the increased labeling of cellular compartments by this
dye is prevented by treatment with specific autophagy
inhibitors.
Overall, staining with MDC or its derivative monodansyl
pentane [1603] is not, by itself, a sufficient method for mon
itoring autophagy. Similarly, LysoTracker™ Red, neutral red
and acridine orange are not ideal markers for autophagy
because they primarily detect lysosomes, and an increase in
lysosome size or number could reflect an increase in nonpro
fessional phagocytosis (often seen in embryonic tissues
[1868]) rather than autophagy. These markers are, however,
useful for monitoring selective autophagy when used in con
junction with protein markers or other dyes. For example,
increased colocalization of mitochondria with both GFP-LC3
and LysoTracker™ Red can be used as evidence of autophagic
cargo delivery to lysosomes. Moreover, LysoTracker™ Red has
been used to provide correlative data on autophagy in D.
melanogaster fat body cells (Figure 32) [376, 377]. However,
additional assays, such as GFP-Atg8-family protein fluores
cence and EM, should be used to substantiate results obtained
with acidotropic dyes whenever possible to rule out the pos
sibility that LAP is involved (see Noncanonical use of auto
phagy-related proteins). Finally, one important caution when
co-imaging with LysoTracker™ Red and a green-fluorescing
marker (e.g., GFP-LC3 or MitoTracker™ Green) is that it is

necessary to control for rapid red-to-green photoconversion
of the LysoTracker™, which can otherwise result in an incor
rect interpretation of colocalization [1869].
Some of the confusion regarding the interpretation of
results with these dyes stems in part from the nomenclature
in this field. Indeed, the discussion of acidotropic dyes points
out why it is advisable to differentiate between the terms
“autophagosome” and “autophagic vacuole,” although they
are occasionally, and incorrectly, used interchangeably. The
autophagosome is the sequestering compartment generated by
the phagophore. The fusion of an autophagosome with an
endosome or a lysosome generates an amphisome or an
autolysosome, respectively [1480]. The early autophagosome
is not an acidic compartment, whereas amphisomes and auto
lysosomes are acidic. As noted in the section Transmission
electron microscopy, earlier names for these compartments are
“initial autophagic vacuole (AVi),” “intermediate or inter
mediate/degradative autophagic vacuole (AVi/d)” and “degra
dative autophagic vacuole (AVd),” respectively. Thus,
acidotropic dyes can stain late autophagic vacuoles (in parti
cular autolysosomes), but not the initial autophagic vacuole,
the early autophagosome.
A recently developed dye for monitoring autophagy, CytoID (Enzo Life Sciences), stains vesicular structures shortly
after amino acid deprivation, which extensively colocalize
with RFP-LC3-positive structures, while colocalizing partially
with lysosomal probes [1870]. Moreover, unlike MDC, CytoID does not show background fluorescence under control
conditions and the two dyes colocalize only marginally.
Furthermore, the Cyto-ID signal responds to well-known
autophagy modulators. Therefore, this amphiphilic dye,
which partitions in hydrophobic environments, may prove
more selective for autophagic vacuoles than the previously
discussed lysosomotropic dyes.
With the above caveats in mind, the combined use of
early and late markers of autophagy is highly encouraged,
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and, when quantifying mammalian lysosomes, it is impor
tant to note that increases in both lysosome size and
number are frequently observed. Finally, to avoid confu
sion with the plant and fungal vacuole, the equivalent
organelle to the lysosome, we recommend the use of the
term “autophagosome” instead of “autophagic vacuole”
when possible, that is, when the specific nature of the
structure is known.
Conclusion: Given the development of better techniques
that are indicators of autophagy, relying entirely on the use of
acidotropic dyes to study this process is not acceptable.
2. Autophagy inhibitors and inducers
In many situations it is important to demonstrate an effect
resulting from inhibition or stimulation of autophagy (see ref.
[1871] for a partial listing of regulatory compounds), and a
few words of caution are worthwhile in this regard. Most
chemical inhibitors of autophagy are not entirely specific,
and it is important to consider possible dose- and timedependent effects. Accordingly, it is generally preferable to
analyze specific loss-of-function Atg mutants. However, it
must be kept in mind that some apparently specific Atg
gene products may have autophagy-independent roles (e.g.,
ATG5 in cell death, and the PIK3C3/VPS34-containing com
plexes—including BECN1—in apoptosis, endosomal function
and protein trafficking), or may be dispensable for autophagy
(see Noncanonical use of autophagy-related proteins) [31, 817,
860, 1550, 1872–1875]. Therefore, the experimental condi
tions of inhibitor application and their side effects must be
carefully considered.
In addition, it must be emphasized once again that auto
phagy, as a multistep process, can be inhibited at different
stages. Sequestration inhibitors, including 3-MA, LY294002
and wortmannin, inhibit class I PI3Ks as well as class III
PtdIns3Ks [181, 437, 1876]. The class I enzymes generate
products such as PtdIns(3,4,5)P3 that inhibit autophagic
sequestration, whereas the class III product (PtdIns3P) gen
erally stimulates autophagic sequestration. The overall effect
of these inhibitors is typically to block autophagy because the
class III enzymes that are required to activate autophagy act
downstream of the negative regulatory class I enzymes,
although cell death may ensue in cell types that are dependent
upon high levels of AKT for survival. The effect of 3-MA (but
not that of wortmannin) is further complicated by the fact
that it has different temporal patterns of inhibition, causing a
long-term suppression of the class I PI3K, but only a transient
inhibition of the class III enzyme. In cells incubated in a
complete medium for extended periods of time, 3-MA may,
therefore (particularly at suboptimal concentrations), promote
autophagy by inhibition of the class I enzyme [436, 437].
Thus, wortmannin may be considered as an alternative to 3MA for autophagy inhibition [437]. However, wortmannin
can induce the formation of vacuoles that may have the
appearance of autophagosomes, although they are swollen
late endocytic compartments [1527]. In addition, treatment
of human alveolar macrophages with wortmannin or 3-MA in
complete medium or HBSS results in increased levels of LC3-I
and LC3-II as detected by western blotting. Neither wortman
nin nor 3-MA blocks rapamycin-induced conversion of LC3-I

to LC3-II in these cells; rather there seems to be an additive
effect. Consequently, these inhibitors should be used with
caution when investigating autophagy in macrophages (M.
O’Sullivan and S. O’Leary, unpublished observation).
Furthermore, studies have demonstrated that inhibition of
autophagy with 3-MA or wortmannin can have effects on
cytokine transcription, processing and secretion, particularly
of IL1 family members [1877–1879], but 3-MA and wortman
nin also inhibit the secretion of some cytokines and chemo
kines (e.g., TNF, IL6, CCL2/MCP-1) in an autophagyindependent manner (J. Harris, unpublished observations)
[1877, 1880]. Moreover, 3-MA inhibits the production of
nitric oxide in IFNG-activated bone-marrow derived macro
phages [1881]. Thus, in studies where the effect of autophagy
inhibition on specific cellular processes is being investigated,
it is important to confirm results using other methods, such as
RNA silencing. Due to these issues, it is of great interest that
inhibitors with specificity for the class III PtdIns3Ks, and their
consequent effects on autophagy, have been described [331,
1882, 1883]. For instance, the selective class III PtdIns3K
inhibitor SAR405 is an efficient blocker of autophagic
(LDH) sequestration and (long-lived protein) degradation
activity [25, 56, 302]. Finally, it is important to stress that
the efficacy of wortmannin as an inhibitor of PI3Ks and
PtdIns3Ks may be decreased by its non-enzymatic covalent
binding to free amino acids [1884, 1885].
A mutant mouse line carrying a floxed allele of Pik3c3 has
been created [1886]. This provides a useful genetic tool that
will help in defining the physiological role of the class III
PtdIns3K with bona fide specificity by deleting the class III
kinase in a cell type-specific manner in a whole animal using
the Cre-LoxP strategy. For example, the phenotype resulting
from a knockout of Pik3c3 specifically in the kidney glomer
ular podocytes (pik3c3 [pdKO]) indicates that there is no
compensation by other classes of PtdIns3Ks or related Atg
genes, thus highlighting the functional specificity and physio
logical importance of the class III PtdIns3K in these cells.
CHX, a commonly used protein synthesis inhibitor in
mammals, is also an inhibitor of sequestration in vivo [13–
15, 113, 1522, 1887–1890], and in various cell types in vitro
[216, 660, 1891], and it has been utilized to investigate the
dynamic nature of the regression of various autophagic ele
ments [13–15, 28, 113, 1887, 1888]. The mechanism of action
of CHX in short-term experiments is not clear, but it has no
direct relation to the inhibition of protein synthesis [660].
This latter activity, however, may complicate certain types of
analysis when using this drug.
A significant challenge for a more detailed analysis of the
dynamic role of autophagy in physiological and pathophysio
logical processes, for instance with regard to cancer and
cancer therapy, is to find more specific inhibitors of autopha
gy signaling which do not affect other signaling cascades
(reviewed in ref. [527]). For example, in the context of cellular
radiation responses it is well known that PI3Ks, in addition to
signaling through the PI3K-AKT pathway, have a major role
in the regulation of DNA-damage repair [1891]. However, 3MA, which is a nonspecific inhibitor of these lipid kinases,
can alter the function of other classes of this enzyme, which
are involved in the DNA-damage repair response. This is of
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particular importance for investigations into the role of radia
tion-induced autophagy in cellular radiation sensitivity or
resistance [1892, 1893]. CQ, through the induction of ROS,
increases DNA damage and can be used to synergistically
enhance the therapeutic effect of otherwise toxic NOTCH
and gamma secretase inhibitors that target the oncogenic
NOTCH signaling pathway [1894].
Most other inhibitory chemicals act at post-sequestration
steps. These types of agents have been used in many experi
ments to both inhibit endogenous protein degradation and to
increase the number of autophagic compartments. These che
micals cause the accumulation of sequestered material in either
autophagosomes or autolysosomes, or both, because they allow
autophagic sequestration to proceed. The main categories of
these types of inhibitors include the vinca alkaloids (e.g., vin
blastine) and other microtubule poisons that inhibit fusion,
inhibitors of lysosomal enzymes (e.g., leupeptin, pepstatin A
and E-64d), and compounds that elevate lysosomal pH (e.g.,
inhibitors of V-ATPases such as bafilomycin A1, concanamycin
A and concanamycin B [64], and weak base amines including
methyl- or propylamine, CQ, and neutral red, some of which
slow down fusion). Ammonia is a very useful agent for the
elevation of lysosomal pH in short-term experiments, but it has
been reported to cause a stimulation of autophagy during longterm incubation of cells in a full medium [1895], under which
conditions a good alternative might be methylamine or propy
lamine [1896]. Along these lines, it should be noted that the
half-life of glutamine in cell culture media is approximately two
weeks due to chemical decomposition, which results in media
with lowered glutamine and elevated ammonia concentrations
that can affect the autophagic flux (either inhibiting or stimu
lating autophagy, depending on the concentration [1897]).
Thus, to help reduce experimental variation, the use of freshly
prepared cell culture media with glutamine is advised.
Alternatively, GlutaMAX is recommended for culture media
without glutamine [1898].
A special note of caution is also warranted in regard to
CQ. Although this chemical is commonly used as an auto
phagy inhibitor, CQ may initially stimulate autophagy (F.C.
Dorsey, personal communication; R. Franco, personal com
munication). In addition, culture conditions requiring acidic
media preclude the use of CQ because intracellular accumu
lation of the chemical is dramatically reduced by low pH
[1899]. To overcome this issue, it is possible to use acid
compounds that modulate autophagy, such as betulinic
acid and its derivatives [314, 1900–1902]. Betulinic acid
damages lysosomal function differing from traditional inhi
bitors (e.g., CQ, NH4Cl or bafilomycin A1) that raise the
lysosomal pH; betulinic acid interacts with pure phospholi
pid membranes [314,1170], and is capable of changing mem
brane permeability [314, 1903, 1904]. The lysosomal damage
mediated by betulinic acid is capable of compromising auto
phagy without any incremental damage when lysosomal
function is altered by lysosomal inhibitors (e.g., CQ or bafi
lomycin A1) [314]; however, betulinic acid is not lysosome
specific, and will affect other organelles such as
mitochondria.
Other natural compounds, such as sulforaphane (in breast
cancer MDA-MB-231 cell line), the Phellinus linteus fungus
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extract (in the breast cancer MDA-MB-231 cell line) and
neferine (in the lung adenocarcinoma A549 cell line) com
bined with anticancer drugs synergistically induce autophagic
cell death [1905]. Dehydroandrographolide and polyphyllin G
trigger activation of MAPK8/9 and an inhibition of AKT and
MAPK/p38, inducing oral cancer autophagic cell death [1906,
1907]. Notably, a significant number of natural compounds
have been identified to overcome drug-resistant or apoptosisresistant cancer via induction of autophagic cell death: For
example, an ATP2A/SERCA inhibitor, saikosaponin-d, N-des
methyldauricine and celastrol [1908–1911]; a group of AMPK
activators (liensinine, isoliensinine, dauricine, cepharanthine,
hernandezine and thalidezine) [1912–1915]; and the PRKCA/
PKC-α inhibitor, tetrandrine [1916]. Other natural smallmolecules, such as thonningianin A from Penthorum chinense
Pursh, steroidal saponin and polyphyllin VI from Trillium
tschonoskii Maxi were reported to show their anti-oxidative
effect via autophagy induction [1917].
Some data suggest that particular nanomaterials may also
be novel modulators of autophagy, by as yet unidentified
mechanisms [1918, 1919] (See Nanoparticles).
It is worth noting that lysosomal proteases fall into three
general groups, cysteine, aspartic acid and serine proteases.
Therefore, the fact that leupeptin, a serine and cysteine pro
tease inhibitor, has little or no effect does not necessarily
indicate that lysosomal degradation is not taking place; a
combination of leupeptin, pepstatin A and E-64d may be a
more effective treatment. However, it should also be pointed
out that these protease inhibitors can exert inhibitory effects
not only on lysosomal proteases, but also on cytosolic pro
teases; that is, degradation of proteins might be blocked
through inhibition of cytosolic instead of lysosomal proteases.
Conversely, it should be noted that MG132 (Z-leu-leu-leu-al)
and its related peptide aldehydes are commonly used as pro
teasomal inhibitors, but they can also inhibit certain lysoso
mal hydrolases such as cathepsins and calpains [1920]. Thus,
any positive results using MG132 do not rule out the possi
bility of involvement of the autophagy-lysosomal system.
Therefore, even if MG132 is effective in inhibiting autophagy,
it is important to confirm the result using more specific
proteasomal inhibitors such as lactacystin or epoxomicin.
Finally, there are significant differences in cell permeability
among protease inhibitors. For example, E-64d is membrane
permeable, whereas leupeptin and pepstatin A are not
(although there are derivatives that display greater permeabil
ity such as pepstatin A methyl ester) [1921]. Thus, when
analyzing whether a protein is an autophagy substrate, caution
should be taken in utilizing these protease inhibitors to block
autophagy.
As with the PtdIns3K inhibitors, many autophagy-suppres
sive compounds are not specific. For example, okadaic acid
[1922] is a powerful general inhibitor of both type 1 (PPP1)
and type 2A (PPP2) protein phosphatases [1923]. Bafilomycin
A1 and other compounds that raise the lysosomal pH may
have indirect effects on any acidified compartments.
Moreover, treatment with bafilomycin A1 for extended peri
ods (18 h) can cause significant disruption of the mitochon
drial network in cultured cells (M.E. Gegg, personal
communication), and either bafilomycin A1 or concanamycin
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A cause swelling of the Golgi in plants [1924], and increase
cell death by apoptosis in cancer cells (V.A. Rao, personal
communication) [216]. Furthermore, bafilomycin A1 may
have off-target effects on the cell, particularly on MTORC1
[781, 1925, 1926]. Bafilomycin A1 is often used at a final
concentration of 100 nM, but much lower concentrations
such as 1 nM may be sufficient to inhibit autophagic-lysoso
mal degradation and are less likely to cause indirect effects
[300, 1927]. For example, in pulmonary A549 epithelial cells
bafilomycin A1 exhibits concentration-dependent effects on
cellular morphology and on protein expression; at concentra
tions of 10 and 100 nM the cells become more rounded
accompanied by increased expression of VIM (vimentin)
and a decrease in CDH1/E-cadherin (B. Yeganeh, M. Post
and S. Ghavami, unpublished observations). Thus, appropri
ate inhibitory concentrations should be empirically deter
mined for each cell type [309]. As elaborated earlier in these
guidelines, there is a lacuna in the field due to lack of specific
autophagy inhibitors. Nonetheless, a small molecule inhibitor
of autophagosome-lysosome fusion, EACC (ethyl [2-{5nitrothiophene-2-carboxamido} thiophene-3-carbonyl] carba
mate), has been identified [1928]. This molecule selectively
blocks autophagic flux by inhibiting STX17 translocation onto
autophagosomes.
Although these various agents can inhibit different steps of
the autophagic pathway, their potential side effects must be
considered in interpretation of the secondary consequences of
autophagy inhibition, especially in long-term studies. For
example, lysosomotropic compounds can increase the rate of
autophagosome formation by inhibiting MTORC1, as activa
tion of lysosomally localized MTORC1 depends on an active
V-ATPase (as well as RRAG GTPases [223]) [1925, 1929].
Along these lines, CQ treatment may cause an apparent
increase in the formation of autophagosomes possibly by
blocking fusion with the lysosome (F.C. Dorsey and J.L.
Cleveland, personal communication). This conclusion is sup
ported by the finding that CQ reduces the colocalization of
LC3 and LysoTracker™ despite the presence of autophago
somes and lysosomes (A.K. Simon, personal communication).
In addition, CQ, but not bafilomycin A1, blocks autophago
some-lysosome fusion in U2OS, HeLa and MEFs [302]. This
mechanism might be cell-type specific, as other studies report
that CQ prevents autolysosome clearance and degradation of
cargo content, but not autophagosome-lysosome fusion
[1930–1933]. Concanamycin A blocks sorting of vacuolar
proteins and diverts the route of autophagy in plant cells
along with inhibiting vacuolar acidification [1934, 1935].
Furthermore, in addition to causing the accumulation of
autophagic compartments, many of these drugs seem to sti
mulate sequestration in many cell types, especially in vivo
[114, 432, 1521, 1582, 1887, 1890, 1936–1939]. Although it
is clear why these drugs cause the accumulation of autophagic
compartments, it is not known why they stimulate sequestra
tion. One possibility, at least for hepatocytes, is that the
inhibition of protein degradation reduces the intracellular
amino acid pool, which in turn upregulates sequestration. A
time-course study of the changes in both the intra- and
extracellular fractions may provide accurate information
regarding amino acid metabolism. For these various reasons,

it is important to include appropriate controls; along these
lines, MTOR inhibitors such as rapamycin or amino acid
deprivation can be utilized as positive controls for inducing
autophagy. In many cell types, as well as in D. discoideum
[1940], however, the induction of autophagy by rapamycin is
relatively slow, or transient, allowing more time for indirect
effects.
Amino acid starvation induces autophagy through deactiva
tion of MTOR. Whereas autophagy is induced equally well by
pharmacological inhibition of MTOR and amino acid starva
tion, amino acid starvation additionally causes depletion of
intracellular amino acids, which strongly repress protein synth
esis. For that reason, the protein expression levels of classical
substrates of autophagy (e.g., SQSTM1-like receptors [SLRs])
decrease more rapidly during amino acid starvation than dur
ing pharmacological inhibition of MTOR. Additionally, endo
somal microautophagy, which also targets SLRs and certain
Atg8-family protein homologs, is also active during amino
acid starvation contributing to the overall decreased expression
of many classical substrates of autophagy [1941].
Several small molecule inhibitors, including torin1, PP242,
KU-0063794, PI-103 and NVP-BEZ235, have been developed
that target the catalytic domain of MTOR in an ATP-compe
titive manner [300, 802, 1942–1945]. In comparison to rapa
mycin, these catalytic MTOR inhibitors are more potent, and
hence are stronger autophagy agonists in most cell lines [453,
802, 1946]. The use of these second-generation MTOR inhi
bitors may reveal that some reports of MTOR-independent
autophagy may actually reflect the use of the relatively weak
inhibitor rapamycin. Furthermore, the use of these com
pounds has revealed a role for MTORC1 and MTORC2 as
independent regulators of autophagy [1947].
Neurons, however, seem to be a particular case in regard to
their response to MTOR inhibitors. Rapamycin may fail to
activate autophagy in cultured primary neurons, despite its
potent stimulation of autophagy in some cancer cell lines
[106, 818, 1948]. Interestingly, both rapamycin and catalytic
MTOR inhibitors do not induce a robust autophagy in either
cultured primary mouse neurons or human neuroblastoma
SH-SY5Y cells, which can differentiate into neuron-like cells,
whereas the drugs do elicit a potent autophagic response in
cultured astrocytes (J. Diaz-Nido and R. Gargini, personal
communication). This observation suggests a differential reg
ulation of autophagy in neurons. It has been suggested that
control of neuronal autophagy may reflect the particular phy
siological adaptations and metabolic requirements of neurons,
which are very different from most peripheral cell types
[1949]. For example, acute starvation in transgenic mice
expressing GFP-LC3 leads to a potent induction of autophagy
in the liver, muscle and heart but not in the brain [239].
Along these lines, glucose depletion may be much more
efficient at inducing autophagy than rapamycin or amino
acid starvation in neurons in culture (M. Germain and R.
Slack, personal communication). Indeed, treatment of cul
tured primary mouse neurons and human neuroblastoma
SH-SY5Y cells with 2-deoxy-glucose, which hampers glucose
metabolism and leads to activation of AMPK, results in robust
autophagy induction (J. Diaz-Nido and R. Gargini, personal
communication). A number of compounds can also be quite
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efficient autophagy inducers in neurons including the CAPN
(calpain) inhibitor calpeptin [1950–1952]. Thus, it has been
suggested that autophagy induction in neurons may be
achieved by molecular mechanisms relying on AMPK or
increases in intracellular calcium concentration [1949]. An
example where changes in cytosolic calcium levels, due to
the incapacity of the mitochondria to buffer calcium release,
result in an increase in autophagy is seen in a cellular model
of the neurodegenerative disease Friedreich ataxia, based on
FXN (frataxin) silencing in SH-SY5Y human neuroblastoma
cells [1953].
Finally, a specialized class of compounds with α,β-unsatu
rated ketone structure tends to induce autophagic cell death,
accompanied by changes in mitochondrial morphology.
Because the cytotoxic action of these compounds is efficiently
blocked by N-acetyl-L-cysteine, the β-position in the structure
may interact with an SH group of the targeted molecules
[1954]. Due to the potential pleiotropic effects of various
drug treatments, it is incumbent upon the researcher to
demonstrate that autophagy is indeed inhibited, by using the
methodologies described herein. Accordingly, it is critical to
verify the effect of a particular biochemical treatment with
regard to its effects on autophagy induction or inhibition
when using a cell line that was previously uncharacterized
for the chemical being used. Similarly, cytotoxicity of the
relevant chemical should be assessed.
The use of gene deletions/inactivations (e.g., in primary or
immortalized atg−/− MEFs [814], plant T-DNA or transposon
insertion mutants [378, 1955], or in vivo using transgenic
knockout models [1956, 1957] including Cre-lox based “condi
tional” knockouts [424, 425]) or functional knockdowns (e.g.,
with RNAi against ATG genes) is the preferred approach when
possible because these methods allow a more direct assessment
of the resulting phenotype; however, different floxed genes are
deleted with varying efficiency, and the proportion deleted
must be carefully quantified [1958]. Studies also suggest that
microRNAs may be used for blocking gene expression [332–
335, 990, 991, 1959]. In most contexts, it is advisable when
using a knockout or knockdown approach to examine multiple
autophagy-related genes to exclude the possibility that the
phenotype observed is due to effects on a nonautophagic func
tion(s) of the corresponding protein, especially when examin
ing the possibility of autophagic cell death. This is particularly
the case in evaluating BECN1, which interacts with anti-apop
totic BCL2 family proteins [848], or when low levels of a target
protein are sufficient for maintaining autophagy as is the case
with ATG5 [346]. With regard to ATG5, a better approach may
be to use a dominant negative (K130R) version [1875, 1948,
1960]. Also noteworthy is the role of ATG5 in mitotic cata
strophe [818] and several other nonautophagic roles of ATG
proteins (see Noncanonical use of autophagy-related proteins)
[106]. Along these lines, and as stated above for the use of
inhibitors, when employing a knockout or especially a knock
down approach, it is again incumbent upon the researcher to
demonstrate that autophagy is actually inhibited, by using the
methodologies described herein.
Finally, we note that the long-term secondary conse
quences of gene knockouts or knockdowns are likely much
more complex than the immediate effects of the actual
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autophagy inhibition. To overcome this concern, inducible
knockout systems might be useful [346, 559]. One additional
caveat to knockdown experiments is that PAMP recognition
pathways can be triggered by double-stranded RNAs
(dsRNA), such as siRNA probes, or the viral vector systems
that deliver shRNA [1961]. Some of these, including TLRmediated RNA recognition [1962], can influence autophagy
by either masking any inhibitory effect or compromising
autophagy independent of the knockdown probe. Therefore,
nontargeting (scrambled) siRNA or shRNA controls should
be used with the respective transfection or transduction meth
ods in the experiments that employ ATG knockdown.
Another strategy to specifically interfere with autophagy is
to use dominant negative inhibitors. Delivery of these agents
by transient transfection, adenovirus, or TAT-mediated pro
tein transduction offers the possibility of their use in cell
culture or in vivo [1960]. However, because autophagy is an
essential metabolic process for many cell types and tissues,
loss of viability due to autophagy inhibition always has to be a
concern when analyzing cell death-unrelated questions. In
this respect it is noteworthy that some cell-types of the
immune system such as dendritic cells [440] seem to tolerate
loss of autophagy fairly well, whereas others such as T and B
cells are compromised in their development and function
after autophagy inhibition [1963, 1964].
In addition to pharmacological inhibition, RNA silencing,
gene knockout and dominant negative RAB and ATG protein
expression, pathogen-derived autophagy inhibitors can also be
considered for use in manipulating autophagy. Along these
lines ICP34.5, viral BCL2 homologs and viral FLIP of herpes
viruses block autophagosome formation [848, 1418, 1965],
whereas M2 of influenza virus and HIV-1 Nef block autopha
gosome degradation [493, 1966]. However, as with other tools
discussed in this section, transfection or transduction of viral
autophagy inhibitors should be used in parallel with other
means of autophagy manipulation, because these proteins are
used for the regulation of usually more than one cellular path
way by the respective pathogens. Finally, RavZ is an example of
a bacterial protein that blocks autophagy. RavZ is a Legionella
effector that inhibits host autophagy by irreversible deconjuga
tion of LC3 [1967]. RavZ has 3 LIR motifs in its N- and Cterminal regions for interacting with LC3 [1968] and a catalytic
cysteine protease domain that cleaves the peptide bond
between the PE-modified C-terminal glycine residue and the
adjacent aromatic residue in Atg8-family proteins [1967]. In
addition, all Legionella pneumophila strains sequenced to date
[1969] encode a homolog of the eukaryotic enzyme SGPL1
(sphingosine-1-phosphate lyase 1) that was named LpSPL for
Legionella pneumophila SPL. This gene was most likely
acquired from a protist host [1970]. The translocated LpSPL
effector protein targets host sphingosine biosynthesis to curtail
autophagy. LpSPL activity alone is sufficient to prevent an
increase in sphingosine levels in infected host cells and to
inhibit autophagy during macrophage infection [1971].
There are fewer compounds that act as inducers of auto
phagy, but the initial characterization of this process was due
in large part to the inducing effects of glucagon, which
appears to act through indirect inhibition of MTOR via the
activation of STK11/LKB1-AMPK [1531, 1532, 1972]. Recent
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studies demonstrate that glucagon directly induces the
CAMK2-OGT-ULK cascade that potentiates AMPK-depen
dent ULK phosphorylation [1007]. Currently, the most com
monly used inducer of autophagy is rapamycin, an allosteric
inhibitor of MTORC1 (although as mentioned above, catalytic
inhibitors such as torin1 are increasingly being used).
Nevertheless, one caution is that MTOR is a major regulatory
protein that is part of several signaling pathways, including
for example those that respond to INS (insulin), EGF (epi
dermal growth factor) and amino acids, and it thus controls
processes other than autophagy, so rapamycin will ultimately
affect many metabolic pathways [744, 1973–1975]. In parti
cular, the strong effects of MTOR on protein synthesis may be
a confounding factor when analyzing the effects of rapamycin.
MTOR-independent regulation can be achieved through
lithium, sodium valproate and carbamazepine, compounds
that lower the myo-inositol 1,4,5-triphosphate levels [1976],
as well as FDA-approved compounds such as verapamil, tri
fluoperazine and clonidine [1977, 1978]. Regarding trifluoper
azine, studies have shown that other structurally related
antipsychotic phenothiazine derivatives, such as chlorproma
zine and thioridazine, induce autophagy in tumor cells in
vitro through the inhibition of AKT-MTOR [1979, 1980]
and by modulating the WNT-CTNNB1/β-catenin signaling
pathway [1981] in glioma cells. The antihistamine phenothia
zine derivative promethazine also induces autophagy-asso
ciated cell death in a Philadelphia chromosome-positive
chronic myeloid leukemia model (K562) mediated by activa
tion of AMPK [1982].
In vivo treatment of embryos with cadmium results in an
increase in autophagy, probably to counter the stress, allowing
cell survival through the elimination/recycling of damaged
structures [1552]. Autophagy may also be regulated by the
release of calcium from the ER under stress conditions [216,
1922, 1983–1987]. Studies have demonstrated that a natural
compound, celastrol, inhibits ATP2A/SERCA, a sarcoplasmic/
endoplasmic reticulum calcium-ATPase pump to induce au
tophagy-dependent cytotoxicity in rheumatoid arthritis syno
vial fibroblasts and rheumatoid arthritis fibroblast-like
synoviocytes via the CAMK2B (calcium/calmodulin depen
dent kinase kinase II beta)-AMPK-MTOR pathway [1988].
Conversely, some compounds can achieve their biological
effect by inhibition of calcium-regulated autophagy. For
instance, 2-aminoethoxydiphenylborane sensitizes the antitumor effect of bortezomib via suppression of calciummediated autophagy [1989].
ITPRs as ER-resident intracellular calcium-release chan
nels, which also localize at MAMs, have a dual role in auto
phagy [1990]. In non-starved conditions, ITPRs appear to
suppress basal autophagy by funneling calcium into the mito
chondria, thereby promoting mitochondrial bio-energetics
[668]. Upon starvation, ITPRs are involved in the augmented
autophagic flux through the CAMK2-OGT-ULK cascade as
well as a process that involves ITPR sensitization through the
recruitment of BECN1 [1007, 1983]. The essential role of
ITPRs and/or intracellular calcium signaling to drive autop
hagic flux has also been observed after treatment with rapa
mycin [1985], resveratrol [1991] or some chemical inducers of
ER stress [1992]. Confluency-induced differentiation of Caco-

2 cells increases the expression of the master transcriptional
regulator HNF4A/HNF4α, which in turn induces ER stress via
the increased the expression of XBP1 and ATF6, accompanied
by an increase in the intracellular calcium levels and autopha
gy [1993]. However, additional calcium signals from other
stores such as lysosomes could also play an important role
in autophagy induction [1994]. The activation of the lysoso
mal TPCN/two-pore channel (two pore segment channel), by
nicotinic acid adenine dinucleotide phosphate (NAADP)
induces autophagy through an AMPK-ACAC pathway inde
pendently of MTORC1 in neural cells [1995]. Autophagosome
formation mediated by NAADP can be selectively inhibited
by the TPCN blocker NED-19, by pre-incubation with a cellpermeable acetoxymethyl ester version of BAPTA (BAPTAAM), or in cells overexpressing TPCN2 mutated within the
putative pore region (TPCN2L265P), indicating that lysosomal
calcium selectively induces autophagy [1996]. Furthermore, a
possible NAADP-agonist, glutamate, is able to induce auto
phagy via a TPC1/2-AMPK-ACAC pathway [1995].
Lysosomal cation-permeable channels such as TPCN2
associate with MTORC1, a key nutrient sensor and upstream
control mechanism of autophagy, to regulate autophagy flux
[1997]. Lysosomal calcium release via TPCN2 occurs upon
inhibition of MTOR in response to starvation or rapamycin
treatment and is an essential component to drive autophagic
flux in these conditions. In addition to MTORC1 control of
TPCN2 activity, calcium release via TPCN2 also supports
MTORC1 activity [1998]. Furthermore, upon starvation,
MCOLN1 (mucolipin 1) also contributes to lysosomal calcium
release. This release results in the calcium-dependent activa
tion of PPP3/calcineurin, which dephosphorylates TFEB, trig
gering its nuclear translocation. In the nucleus, TFEB
upregulates several autophagy and lysosomal biogenesis
genes. MCOLN1-mediated calcium release also contributes
to the reactivation of MTORC1 in conditions of prolonged
starvation via a mechanism that requires the calcium-binding
protein CALM (calmodulin) [1999]. As such, the dynamic
nature of calcium signaling involving ER, mitochondria and
lysosomes contribute to the fine-tuned control of autophagic
flux [2000, 2001]. The use of BAPTA-AM to implicate calcium
signaling in autophagy comes with a caution, as intracellular
BAPTA can also exert calcium-independent effects, such as
inhibition of the Na+/K+ ATPase [2002, 2003] as well as auto
phagy [1994]. Along these lines, it is becoming increasingly clear
that BAPTA, and related molecules such as calcium indicator
dyes, have cellular effects that are not related to calcium buffer
ing [2002, 2003]. Low-affinity analogs of BAPTA (e.g., dibromoand difluoro-BAPTA) can inhibit autophagy triggered by PP242
(M.D. Bootman, personal communication).
Cell-penetrating autophagy-inducing peptides, such as TatvFLIP or Tat-beclin 1, are also potent inducers of autophagy
in cultured cells as well as in mice [1965, 2004]. Other cellpenetrating peptides, such as Tat-wtBH3D or Tat-dsBH3D,
designed to disrupt very specific regulatory interactions such
as the BCL2-BECN1 interaction, are potent, yet very specific,
inducers of autophagy in cultured cells [2005].
In contrast to other PtdIns3K inhibitors, caffeine induces
autophagy in the food spoilage yeast Zygosaccharomyces bailii
[2006], mouse embryonic fibroblasts [2007], and S. cerevisiae
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[2008] at millimolar concentrations. In more complex eukar
yotes, this is accompanied by inhibition of the MTOR path
way. Similarly, in budding yeast caffeine is a potent TORC1
inhibitor suggesting that this drug induces autophagy via
inhibition of the TORC1 signaling pathway; however, as
with other PtdIns3K inhibitors caffeine targets other proteins,
notably Mec1/ATR and Tel1/ATM, and affects the cellular
response to DNA damage.
Another autophagy inducer is the histone deacetylase inhi
bitor valproic acid [2009, 2010]. The mechanism by which
valproic acid stimulates autophagy is not entirely clear but
may occur due to inhibition of the histone deacetylase Rpd3,
which negatively regulates the transcription of ATG genes
(most notably ATG8 [2011]) and, via deacetylation of Atg3,
controls Atg8 lipidation [2012]. SMER28 is an MTOR-inde
pendent inducer of autophagy that acts through largely
unknown mechanisms [2013]. Dasatinib, a dual SRC and
BCR-ABL kinase inhibitor, also stimulates autophagy through
unknown mechanisms to further induce myeloid differentia
tion of AML cells [2014].
A new promising drug, NeuroHeal, has emerged that acti
vates autophagy through a SIRT1-dependent mechanism
[2015, 2016]. NeuroHeal treatment protects from ER-stress
and promotes in vivo neuroprotection in several models
where neurons remain isolated and disconnected from their
targets, a common characteristic in any neurodegenerative
process [2017, 2018]. An efficient high-throughput method
for screening of autophagy modulators has been carried out
employing a dual-luciferase assay. In this case, degradation of
the individual luciferases indicates the degradation of general
cytoplasmic contents and the selective degradation of specific
cargoes. The levels of cytosolic Renilla luciferase, and targeted
firefly luciferase, which can be delivered to a specific cargo
(such as peroxisomes), is measured and interpreted as rates of
general and selective autophagy flux, respectively [2019].
Induction of autophagy can also be involved in virulence
mechanisms for infection; the Buruli ulcer causative agent
Mycobacterium ulcerans produces an exotoxin, mycolactone,
that induces autophagy [2020, 2021]. The mechanism is most
likely a protective response to mycolatone’s inhibition of
SEC61A1, the major subunit of the SEC61 translocon (R.E.
Simmonds, personal communication), which causes the accu
mulation of mislocalized proteins in the cytosol [2022] and a
consequent integrated stress response [2021]. Notably, poly
morphisms in autophagy-related genes may be involved in the
risk of acquiring M. ulcerans infection from the environment
[2023].
It is also possible, depending on the organism or cell
system, to modulate autophagy through transcriptional con
trol. For example, this can be achieved either through over
expression or post-translational activation of TFEB (see
Transcriptional and translational regulation), a transcriptional
regulator of the biogenesis of both lysosomes and autophago
somes [947, 949]. Along these lines, inhibition or genetic
deletion of CTSB downregulates MTOR, causing TFEB to
activate autophagy [2024]. Similarly, adenoviral-mediated
expression of the transcription factor CEBPB induces auto
phagy in hepatocytes [989]. Either the genetic ablation or the
knockdown of the nucleolar transcription factor RRN3/TIF-
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IA, a crucial regulator of the recruitment of POLR1 (RNA
polymerase I) to ribosomal DNA promoters, induces auto
phagy in neurons and in MCF-7 cancer cells, respectively,
linking ribosomal DNA transcription to autophagy [2025,
2026]. Likewise, inhibition of POLR1 by the small molecule
inhibitor CX-5461 induces autophagy. A growing body of
evidence suggests the involvement of nucleolar ribosome bio
genesis factors and the so-called nucleolar stress response in
autophagy [2027, 2028]. A class of diseases connected to
impaired ribosome biogenesis, termed ribosomopathies,
reveal activation of autophagy (see Erythroid cells).
Nucleolar-stress induced autophagy seems to engage both
TP53-dependent as well as -independent mechanisms. Also,
induction of autophagy is commonly connected to MTOR
signaling in this context. However, the underlying mechan
isms connecting nucleolar stress and autophagy have to be
better elucidated in future studies.
Relatively little is known about direct regulation via the
ATG proteins, but there is some indication that tamoxifen
acts to induce autophagy by increasing the expression of
BECN1 in MCF7 cells [2029]. However, BECN1 does not
appear to be upregulated in U87MG cells treated with tamox
ifen, whereas the levels of LC3-II and SQSTM1 are increased,
while LAMP2B is downregulated and CTSD and CTSL activ
ities are almost completely blocked (K.S. Choi, personal com
munication). Thus, the effect of tamoxifen may differ
depending on the cell type. Other data suggest that tamoxifen
acts by blocking cholesterol biosynthesis, and that the sterol
balance may determine whether autophagy acts in a protective
versus cytotoxic manner [2030, 2031]. Finally, screens have
identified small molecules that induce autophagy indepen
dently of rapamycin and allow the removal of misfolded or
aggregate-prone proteins [1978, 2032], suggesting that they
may prove useful in therapeutic applications.
One novel autophagy inducer that does not target MTOR,
is KYP-2047, a small-molecule inhibitor for PREP (prolyl
endopeptidase), a serine protease belonging to the prolyl
oligopeptidase family (clan SC) [2033]. Although the exact
mechanism as to how PREP regulates autophagy is not
clear, PREP inhibition by KYP-2047 elevates BECN1 mRNA
and protein levels in HEK 293 cells after a 24-h incubation.
This inhibition results in decreased aggregation-prone protein
levels in several cellular and animal models [2034]. Moreover,
removal of PREP from HEK 293 cells induces autophagic flux,
and also decreases proteasomal activity [2035]. However, cau
tion should be taken because of the crosstalk between auto
phagy and the proteasomal system. For example, trehalose, an
MTOR-independent autophagy inducer [2036], can compro
mise proteasomal activity in cultured primary neurons [2037].
Trehalose activates autophagy by inhibiting AKT-mediated
phosphorylation of TFEB, thereby promoting TFEB nuclear
translocation and subsequent activation of CLEAR-regulated
autophagy and lysosomal genes in cells and in vivo [973]. For
experiments in cells, it must be considered that at the con
centration usually tested (>mM) trehalose effects can be
potentially ascribed to hyperosmotic signaling (R. Franco,
personal communication). Trehalose treatment also results
in subtle lysosomal damage (possibly because of an osmotic
shock to this organelle), which causes activation of PPP3/
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calcineurin, a calcium-dependent phosphatase capable of
dephosphorylating and activating TFEB [2038]. This activa
tion permits enhanced lysophagy to degrade damaged lyso
somes, but at the same time enhances the overall autophagic
capacity of trehalose-treated cells. Lysosomal impairment by
trehalose might underlie observations that cell treatment with
this disaccharide can decrease degradation of APP in lyso
somes [2039], increase GFP:RFP ratios using the GFP-LC3RFP-LC3∆G fluorescent probe [494], or result in the accumu
lation of autophagosomes [2040]. Finally, several diseasecausing and aggregation-prone proteins in the secretory path
way that are targeted for autophagy are also targeted for
ERAD, which requires proteasome function [2041].
Another autophagy inducer, genistein (trihydroxyisofla
vone or 5, 7-dihydroxy-3-[4-hydroxyphenyl]-4H-1-benzo
pyran-4-one), has been suggested previously to stimulate
autophagy in various cancer cell lines, including ovarian can
cer [2042], colon cancer [2043], breast cancer [2044], pan
creatic cancer [2045], and uterine leiomyoma cells [2046].
Other studies demonstrate that this isoflavone effectively
induces autophagy in cellular and animal models of HD and
AD, respectively [2047, 2048]. Such genistein-mediated auto
phagy stimulation is responsible for correction of phenotypes
of these diseases through degradation of pathological protein
aggregates, which otherwise accumulate in cells and organs. In
fact, induction of autophagy by this isoflavone has been pro
posed as a therapeutic approach in various genetic and neu
rodegenerative disorders caused by accumulation of
undegraded proteins or other macromolecules [2049, 2050].
The molecular mechanism of genistein-mediated induction of
autophagy is not clear, however, it appears that inhibition of
MTOR and subsequent activation of TFEB contributes sig
nificantly to this process [2051–2053].
While likely to be nonspecific, inhibition of NFKB activa
tion—through either an NKFBIA/IκBα kinase inhibitor or
SERPINA1/alpha-1-antitrypsin—may augment autophagy in
macrophages infected with mycobacteria [2054, 2055]. One
possible mechanism is the inhibition of NFKB-mediated
induction of TNFAIP3/A20, a deubiquitinating enzyme that
normally deactivates BECN1; hence, by sequentially inhibiting
NFαB activation and TNFAIP3/A20 expression, a pathway
that inhibits BECN1 is mitigated [2054].
Because gangliosides are implicated in autophagosome
morphogenesis, pharmacological or genetic impairment of
gangliosidic compartment integrity and function can provide
useful information in the analysis of autophagy. To deplete
cells of gangliosides, an inhibitor of CERS (ceramide
synthase), such as a fungal metabolite produced by
Fusarium moniliforme (fumonisin B1), or, alternatively,
siRNA to CERS or ST8SIA1, can be used [907].
Antimicrobial peptides (AMPs) were originally described
for their activity in killing microbes; however, they also have a
role in immune system modulation [2056]. Autophagy induc
tion produces AMPs by proteolysis of cytosolic proteins of
infected cells [2057, 2058]). Furthermore, three AMPs (indo
licidin, and two peptides derived from PYY2/Seminalplasmin)
induce autophagy in Leishmania cells [2059], and the antimicrobial peptide LL-37 induces autophagy in human cells as
a way to eliminate tuberculosis infection [2060].

Finally, in addition to genetic and chemical compounds, it
was reported that electromagnetic fields can induce autophagy
in mammalian cells. Studies of biological effects of novel
therapeutic approaches for cancer therapy based on the use
of noninvasive radiofrequency fields reveal that autophagy,
but not apoptosis, is induced in cancer cells in response to
this treatment, which leads to cell death [2061]. This effect is
tumor specific and different from traditional ionizing radia
tion therapy that induces apoptosis in cells.
Conclusion: Considering that pharmacological inhibitors
or activators of autophagy have an impact on many other
cellular pathways, the use of more than one methodology,
including molecular methods, is desirable. Rapamycin is less
effective at inhibiting MTOR and inducing autophagy than
catalytic inhibitors; however, it must be kept in mind that
catalytic inhibitors also affect MTORC2. The main concern
with pharmacological manipulations is pleiotropic effects of
the compound being used. Accordingly, genetic confirmation
is preferred whenever possible. Alternatively, pharmacological
compounds that do not target cell survival and maintenance
pathways such as MTOR, can be used for temporal regulation
of autophagy [2062].
3. Basal autophagy
Basal levels of LC3-II or GFP-LC3 puncta may change accord
ing to the time after addition of fresh medium to cells, and
this can lead to misinterpretations of what basal autophagy
means. This is particularly important when comparing the
levels of basal autophagy between different cell populations
(such as knockout versus wild-type clones). If cells are very
sensitive to nutrient supply and display a high variability of
basal autophagy, the best experimental condition is to moni
tor the levels of basal autophagy at different times after the
addition of fresh medium. One example is the chicken lym
phoma DT40 cells (see Chicken B-lymphoid DT40 cells) and
their knockout variant for all three ITPR isoforms [668, 1990,
2063]. In these cells, no differences in basal levels of LC3-II
can be observed up to 4 h after addition of fresh medium, but
differences can be observed after longer times (J.M. Vicencio
and G. Szabadkai, personal communication). This concept
should also be applied to experiments in which the effect of
a drug upon autophagy is the subject of study. If the drugs are
added after a time in which basal autophagy is already high,
then the effects of the drug can be masked by the cell’s basal
autophagy, and wrong conclusions may be drawn. To avoid
this, fresh medium should be added first (followed by incuba
tion for 2-4 h) in order to reduce and equilibrate basal
autophagy in cells under all conditions, and then the drugs
can be added. The basal autophagy levels of the cell under
study must be identified beforehand to know the time needed
to reduce basal autophagy.
A similar caution must be exercised with regard to cell
culture density and hypoxia. When cells are grown in nor
moxic conditions at high cell density, HIF1A/HIF-1α is stabi
lized at levels similar to that obtained with low-density
cultures under hypoxic conditions [2064]. This results in the
induction of BNIP3 and BNIP3L and “hypoxia”-induced au
tophagy, even though the conditions are theoretically
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normoxic [1170]. Therefore, researchers need to be careful
about cell density to avoid accidental induction of autophagy.
It should be realized that in yeast species, medium changes
can trigger a higher “basal” level of autophagy in the cells. In
the methylotrophic yeast species K. phaffii/P. pastoris and
Hansenula polymorpha, a shift of cells grown in batch from
glucose to methanol results in stimulation of autophagy [2065,
2066]. A shift to a new medium can be considered a stress
situation. Thus, it appears to be essential to cultivate the yeast
cells for a number of hours to stabilize the level of basal
autophagy before performing experiments intended to study
levels of (selective) autophagy (e.g., pexophagy). Finally, plant
root tips cultured in nutrient-sufficient medium display con
stitutive autophagic flux (i.e., a basal level), which is enhanced
in nutrient-deprived medium [2067–2069].
Conclusion: The levels of basal autophagy can vary sub
stantially and can mask the effects of the experimental para
meters being tested. Changes in media and growth conditions
need to be examined empirically to determine effects on basal
autophagy and the appropriate times for subsequent
manipulations.
4. Experimental systems
Throughout these guidelines we have noted that it is not
possible to state explicit rules that can be applied to all
experimental systems. For example, some techniques may
not work in particular cell types or organisms. In each case,
efficacy of autophagy promotors, inhibitors and measurement
techniques must be empirically determined, which is why it is
important to include appropriate controls. Differences may
also be seen between in vivo or perfused organ studies and cell
culture analyses. For example, INS (insulin) has no effect on
proteolysis in suspended rat hepatocytes, in contrast to the
result with perfused rat liver. The INS effect reappears, how
ever, when isolated hepatocytes are incubated in stationary
dishes [2070, 2071] or are allowed to settle down on the
matrix (D. Häussinger, personal communication). The reason
for this might be that autophagy regulation by INS and some
amino acids requires volume sensing via integrin-matrix
interactions and also intact microtubules [2072–2074]. Along
these lines, the use of whole embryos makes it possible to
investigate autophagy in multipotent cells, which interact
among themselves in their natural environment, bypassing
the disadvantages of isolated cells that are deprived of their
normal network of interactions [1552]. In general, it is impor
tant to keep in mind that results from one particular system
may not be generally applicable to others.
Conclusion: Although autophagy is conserved from yeast
to human, there may be tremendous differences in the specific
details among systems. Thus, results based on one system
should not be assumed to be applicable to another.
5. Bimolecular fluorescence complementation
Bimolecular fluorescence complementation (BiFC) may be
useful to study protein-protein interactions in the autophagic
pathway [2075] In this assay, a protein of interest is cloned
into a vector containing one half of a fluorescent reporter (e.
g., YFP), while a second protein is cloned into a different
vector containing the other half of the reporter. Constructs
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are cotransfected into cells. If the two proteins of interest
interact, the two halves of the reporter are brought into
close proximity and a fluorescent signal is reconstituted,
which can be monitored by confocal microscopy. This assay
can be used to determine protein interactions without prior
knowledge of the location or structural nature of the interac
tion interface. Moreover, this approach is applicable to living
cells, and relatively low concentrations of recombinant pro
tein are required to generate a detectable signal. One issue
with BiFC is that once the two halves of the fluorophore
interact with each other the binding is extremely stable,
which can result in the amplification of weak signals. For
the same reason, the localization of the BiFC interaction
may not represent the normal physiological site. Conversely,
the stable nature of this interaction may be utilized as an
alternative to chemical cross-linking for studying proteinprotein interactions.

6. Nanoparticles
Nanoparticles (NPs) are tiny particulate materials, ranging in
size from 1 to 100 nm in diameter. Due to their physicochem
ical properties and small size, some NPs may cross biological
membranes and are often used to deliver a cytotoxic agent or
as a tool to modulate cellular processes [2076]. NPs may act
both as inhibitors and inducers of autophagy [1919]. Indeed,
most endocytic routes of NP uptake converge on the lyso
some, making this organelle a common site of NP sequestra
tion and degradation [2077]. Autophagy induction is of
relevance for NPs due to the similarities in sizes and shapes
between NPs and pathogens [2078]. The exact mechanism of
autophagy induction by NPs is not well understood, although
studies have shown that the surface properties including sur
face charge, may play a decisive role, as shown in studies
using ammonium-functionalized gold NPs [2079]. For exam
ple, the positively charged surface of cationic NPs might
facilitate their interaction with the negatively charged plasma
or endolysosomal membranes harboring the members of the
MTOR signaling pathway. Moreover, lysosomal alkalinization
by the “proton sponge” effect of cationic NPs could cause
lysosomal dysfunction and subsequent defects in lysosomal
recruitment and activation of MTORC1 [2080].
NPs also promote autophagy through specific modulation
of lysosomal pH. Biodegradable nanoparticles such as photoactivable NPs (paNPs) and poly (lactide-co-glycotide) (PLGA)
NPs induce autophagy through acidification of the lysosomal
environment in cellular models of type II diabetes [2081,
2082], AD [80] and PD [2083, 2084]. In pancreatic beta cells
under lipotoxicity or PC-12 cells under MPP+ neurotoxin
treatment, lysosomal pH is elevated and autophagy is inhib
ited due to impaired fusion between lysosomes and autopha
gosomes. PLGA NPs and paNPs localize to lysosomes, and
lower lysosomal pH in both types of cellular models, thereby
restoring autophagy and cellular functions. Of note, the
paNPs are stimuli-responsive NPs that can acutely release
acids to lower lysosomal pH only upon application of UV
light. This allows for paNPs to be a useful tool that can
temporally control the outcomes of autophagy by an external
stimulus [2081].

150

D. J. KLIONSKY ET AL.

ROS production by NPs may also play a role in autophagy
induction [2085, 2086]. Furthermore, NPs with ROS-quench
ing capacity (e.g., non-photo-excited graphene quantum dots)
induce subsequent tolerogenic effects in human dendritic cells
in an autophagy-dependent manner, and this is reversed by
ATG5 silencing [2087]. Conversely, LC3 silencing reduces the
oxidative stress-dependent cytotoxicity of photoexcited gra
phene quantum dots, indicating a role of autophagy in their
photodynamic anticancer activity [2088]. Nitrogen-doped TiO2
NPs can induce autophagy-dependent differentiation or auto
phagy-associated cell death in leukemia cells, depending on the
dose of the NPs, and pre-incubation of leukemic cells with ROS
scavengers diminishes the effect of the NPs [2089]. Expansile
nanoparticles/eNPs can also induce autophagy-associated cell
death through disruption of autophagosomal trafficking, and
offer a new opportunity to develop autophagy modulators for
cancer therapy when used in conjugation with a chemothera
peutic [2090]. Using a combinatorial library of multi-walled
carbon nanotubes (CNTs), it is possible to show that autophagy
induction can be “tuned” by varying surface ligands on the
CNTs [2091]. Furthermore, the autophagy-inducing activity of
certain metallic NPs can be modulated through surface coating
with specific peptides [2092]. Size-dependent autophagy induc
tion has also been observed [2093], and it is suggested that
quantum dots (i.e., semiconductor crystals) may serve as poten
tially useful probes for autophagy studies, in light of their
unique optical properties [2094].
It should be noted that NPs may also block autophagy, and
shape-related targeting of lysosomes may explain NP-mediated
inhibition of autophagic flux [2095]. It is important to distin
guish between autophagosome accumulation resulting from
blockade of autophagic flux as opposed to the induction of
autophagy, and, as with other areas of study, the failure to
distinguish one from the other may result in the misinterpreta
tion of NP effects on cells [2096]. Silica (SiO2) NPs are among
the most widely produced and most intensively studied nano
materials, and the persistent presence of enlarged autolysosomes
is seen in hepatocytes after exposure to SiO2 NPs [2097]. This
accumulation is due to a defect in the autophagy termination
process known as autophagic lysosome reformation (ALR).
Similarly, the blockade of autophagic flux by SiO2 NPs was
reported in lung epithelial cells, and evidence was provided for
a suppressive effect of the NPs on lysosomal acidification,
thereby contributing to the decreased autophagic degradation
in these cells [2097]. Others have shown that SiO2 NPs induce
autophagosome accumulation in hepatocytes via the activation
of the EIF2AK3- and ATF6-dependent UPR pathways [2098].
To further compound the situation, autophagic cell death induc
tion was shown, in a study of single-walled CNTs, to occur
through the AKT-TSC2-MTOR pathway. Inhibition of autopha
gy using both pharmacological and genetic approaches signifi
cantly reduces the CNT-induced autophagic cell death as well as
the acute lung injury evidenced in mice [2099].
Graphene oxide combined with cisplatin (GO-CDDP) not
only elicits autophagy, but induces the nuclear import of
cisplatin as well as LC3 [2100]. The nuclear LC3 does not
colocalize with SQSTM1 or LAMP2, and blocking autolyso
some formation does not significantly hinder the nuclear
import of LC3-CDDP, indicating that autophagosome and

autolysosome formation is dispensable. Furthermore, direct
binding between silica nanoparticles and LC3 and SQSTM1
was demonstrated in osteoblast cells [2101].
ATG4 proteases are essential enzymes in the autophagic
process, and ATG4B appears to be most relevant for autopha
gy. Several peptide-conjugated polymeric nanoprobes have
been developed for real-time monitoring of ATG4B activity
in vitro and in vivo. There is an “in vivo self-assembly”-based
nanoprobe that consists of a TFGF peptide (a peptide from
LC3, which specifically responds to ATG4B), an aggregationinduced emission molecule and a hydrophilic carrier, that in
situ self-assembles into new nanostructures that “turn on”
signals in the presence of ATG4B [2102, 2103]. These nano
probes do not induce autophagy at the used dose and can be
applied for real-time and quantitative evaluation of ATG4B in
living tumor cells, as well as the zebrafish and mouse models.
Another probe is a FRET-based nanoparticle that uses the
fluorescent dye FITC and the quencher BHQ1 attached to
the TFGF peptide, which is nonfluorescent, but fluoresces in
autophagy-inducing cells [2104].
To summarize, careful, case-by-case evaluation of the role
of autophagy for each NP is required, and a direct interaction
between NPs and the cellular autophagic machinery seems
possible. In addition, it is important to determine whether
each type of NP alters the net autophagic degradation capacity
by employing one of the functional assays described in these
guidelines. This will provide a more comprehensive picture
than merely determining the levels of autophagic markers and
the number of autophagosomes.
NPs may provide useful tools with which to study auto
phagy, as suggested in early work on quantum dots and using
photo-activated nanoparticles [2081, 2093]. NPs can either
induce or inhibit autophagy; thus, the autophagy-inducing/
inhibiting efficacy of nanoprobes should be carefully explored
before using them in vivo or in clinical research.
Another example of the use of NPs to study autophagy is
seen with nanotubes (NTs) in the study of ATG3-membrane
interaction. As shown in flotation studies with sonicated uni
lamellar vesicles, ATG3 increases its binding to neutral mem
branes when vesicle size decreases. To visualize this effect
under the microscope, lipid NTs can be generated, starting
from a compositionally well-defined unilamellar membrane
system, such as SUPER templates [2105]. The formed NTs are
thin tubules with high membrane curvature, reported to be a
powerful tool to analyze curvature-dependent binding of pro
teins. ATG3-Alexa Fluor 488 interacts with electrically neutral
(PC:DOPE) NTs, whereas GABARAP does not exhibit any
binding to NTs with similar curvature [2106].
7. Nomenclature
8. General considerations for experimental manipulations
One general issue with regard to any assay is that experimen
tal manipulation could introduce some type of stress—for
example, mechanical stress due to lysis, temperature stress
due to heating or cooling a sample, or oxidative stress on a
microscope slide, which could lead to potential artefacts
including the induction of autophagy—even maintaining
cells in higher than physiologically normal oxygen levels can
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be a stress condition [2107, 2108]. Special care should be
taken with cells in suspension, as the stress resulting from
mixing and/or centrifugation can induce autophagy. This
point is not intended to limit the use of any specific metho
dology, but rather to note that there are no perfect assays.
Therefore, it is important to verify that the positive (e.g.,
treatment with rapamycin, torin1 or other inducers) and
negative (e.g., inhibitor treatment) controls behave as
expected in any assays being utilized.
Similarly, plasmid transfection or nucleofection can result in
the potent induction of autophagy (based on increases in LC3II or degradation of SQSTM1), and certain transfection agents
promote selective autophagy [429]. In some cell types, the
amount of autophagy induced by transfection of a control
empty vector may be so high that it is virtually impossible to
examine the effect of enforced gene expression on autophagy
(B. Levine, personal communication). It is thus advisable to
perform time-course experiments to determine when the trans
fection effect returns to acceptably low levels and to use appro
priate time-matched transfection controls (see also the
discussion in GFP-Atg8-family protein fluorescence microscopy).
This effect is generally not observed with siRNA transfection;
however, it is an issue for plasmid expression constructs includ
ing those for shRNA and for viral delivery systems. The use of
endotoxin-free DNA reduces, but does not eliminate, this pro
blem. In many cells the cationic polymers used for DNA
transfection, such as liposomes and polyplex, induce large
tubulovesicular autophagosomes (TVAs) in the absence of
DNA [2109]. These structures accumulate SQSTM1 and fuse
slowly with lysosomes. In addition, these TVAs appear to
reduce gene delivery, which increases 8-10 fold in cells that
are unable to make TVAs due to the absence of ATG5.
Finally, the precise composition of media components and
the density of cells in culture can have profound effects on
basal autophagy levels and may need to be modified empiri
cally depending on the cell lines being used. Along these lines
various types of media, in particular those with different
serum levels (ranging from 0-15%), may have profound effects
with regard to how cells (or organs) perceive a fed versus
starved state. For example, normal serum contains significant
levels of cytokines and hormones that likely regulate the basal
levels of autophagy and/or have an impact upon its modula
tion by additional stress or stimuli; thus, the use of dialyzed
serum might be an alternative for these studies. In addition,
the amino acid composition of the medium/assay buffer may
have profound effects on initiation or progression of autopha
gy. For example, in the protist parasite Trypanosoma brucei
starvation-induced autophagy can be prevented by addition of
histidine to the incubation buffer [382]. For these reasons, the
cell culture conditions should be fully described. It is also
important to specify duration of autophagy stimulation, as
long-term autophagy can modify signal transduction path
ways of importance in cell survival [780].
D. Methods and challenges of specialized topics/model
systems
There are now a large number of model systems being used to
study autophagy. These guidelines cannot cover every detail,
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and as stated in the Introduction, this article is not meant to
provide detailed protocols. Nonetheless, we think it is useful
to briefly discuss what techniques can be used in these sys
tems and to highlight some of the specific concerns and/or
challenges. We also refer readers to the three volumes of
Methods in Enzymology that provide additional information
for “nonstandard” model systems [46–48].
1. Caenorhabditis elegans
C. elegans has a single ortholog of most yeast Atg proteins;
however, two nematode homologs exist for Atg4, Atg8 and
Atg16 [1477, 2110, 2111]. Multiple studies have established C.
elegans as a useful multicellular genetic model to delineate the
autophagy pathway and associated functions (see for example
refs. [367, 965, 1109, 1112, 1276]). The LGG-1/Atg8 reporter is
the most commonly used tool to detect autophagy in C. elegans.
Similar to Atg8, which is incorporated into the double mem
brane of autophagic vacuoles during autophagy [204, 365, 914],
the C. elegans LGG-1 localizes into cytoplasmic puncta under
conditions known to induce autophagy. Fluorescent reporter
fusions of LGG-1/Atg8 with GFP, DsRED or mCherry have
been used to monitor autophagosome formation in vivo, in the
nematode. These reporters can be expressed either in specific
cells and tissues or throughout the animal [367, 1112, 2112,
2113]. Caution should be taken, however, when using protein
markers fused to mCherry in worms. mCherry can accumulate
in lysosomes [471] and might aggregate in autophagy-inducing
conditions, such as fasting, even if not fused to LGG-1 or other
autophagy markers (E. O’Rourke, personal communication);
therefore, caution should be employed when using mCherry
puncta as a readout to monitor autophagy in C. elegans. LGG2 is the second LC3 homolog and is also a convenient marker for
autophagy either using specific antibodies [1111] or fused to
GFP [2114], especially when expressed from an integrated trans
gene to prevent its germline silencing [1111]. The exact function
of LGG-1 versus LGG-2 remains to be addressed [1115].
For observing autophagy by GFP-LC3 fluorescence in C.
elegans, it is best to use integrated versions of the marker
[1111, 1112, 2115] (GFP::LGG-1 and GFP::LGG-2; Figure
33) rather than extrachromosomal transgenic strains [367,
2114] because the latter show variable expression among
different animals or mosaic expression (C. Kang, personal
communication; V. Galy, personal communication; [2116]).
Integration of the markers requires mutagenesis, and care
should be taken to outcross the strains to ensure that any
remaining background mutations do not affect the examined
phenotypes by, for example, examining the phenotypes in
independent integrants. However, it is important to note
that some integrated strains overexpress these chimeras
because they are driven by heterologous promoters. One
approach to overcome this problem is to monitor cleavage
of a dual fluorescent protein marker consisting of tandem
monomeric RFP (mRFP) joined by a flexible linker and
attached to LGG-1 [2117]. Autophagic flux can be monitored
as the ratio of free mRFP (mFP) to the uncleaved full-length
protein (dFP) normalized to a loading control (i.e., actin or
tubulin). However, this readout needs to be used with caution
in the adult worm. Although relative mFP abundance is
reported to change in L3-L4 larvae treated with RNAi against
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Figure 33. GFP::LGG-1 and GFP::LGG-2 are autophagy markers in C. elegans. (A-F) Animals were generated that carry an integrated transgene expressing a GFPtagged version of lgg-1, the C. elegans ortholog of mammalian MAP1LC3. Representative green fluorescence images in the pharyngeal muscles of (A) control RNAi
animals without starvation, (B) control RNAi animals after 9 d of starvation, (C) atg-7 RNAi animals after 9 d of starvation, (D) starvation-hypersensitive gpb-2 mutants
without leucine after 3 d of starvation, and (E) gpb-2 mutants with leucine after 3 d of starvation. The arrows show representative GFP::LGG-1-positive punctate areas
that label pre-autophagosomal and autophagosomal structures. (F) The relative levels of PE-conjugated and unconjugated GFP::LGG-1 were determined by western
blotting. These figures were modified from data previously published in ref. [2115], Kang, C., Y.J. You, and L. Avery. 2007. Dual roles of autophagy in the survival of C.
elegans during starvation. Genes & Development. 21:2161-2171, Copyright © 2007, Genes & Development by Cold Spring Harbor Laboratory Press, and ref. [4086], Kang,
C., and L. Avery. 2009. Systemic regulation of starvation response in C. elegans. Genes & development. 23:12-17, Copyright © 2011, Genes & Development by Cold
Spring Harbor Laboratory Press, www.genesdev.org. (G-H) GFP:LGG-2 serves as a marker for autophagosomes in early C. elegans embryos. (G) GFP::LGG-2 expressed in
the germline from an integrated transgene reveals the formation of autophagosomes (green) around sperm-inherited membranous organelles (red). DNA of the two
pronuclei is stained (blue). (H) Later during development, GFP::LGG-2-positive structures are present in all cells of the embryo. Scale bar: 10 µm. Images provided by
V. Galy.
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essential autophagy genes (i.e., bec-1) or CQ, and in 5-days
starved L1 larvae [2117], no changes are observed in 6- to 12h fasted adults, even when increased autophagic flux can be
detected in aliquots of the same samples when using antiLGG-1 antibodies (V.K. Mony, personal communication).
Furthermore, the original studies characterizing this readout
reported dFP-to-mFP cleavage in animals incubated for 18 h
in a concentrated suspension of E. coli in M9 with or without
CQ, an incubation condition that activates caloric restriction
responses including autophagy (V. K. Mony, personal com
munication). Therefore, further validation of the dFP-mFP
readout may be necessary to confidently use it in adult C.
elegans.
To increase signal to noise, it is also possible to carry out
indirect immunofluorescence microscopy using antibodies
against endogenous LGG-1 [965, 1112], or LGG-2 [1111];
however, anti-LGG-1 and anti-LGG-2 antibodies are not
commercially available. In addition, with the integrated ver
sion, or with antibodies directed against endogenous LGG-1,
it is possible to perform a western blot analysis for lipidation,
at least in embryos (LGG-1-I is the nonlipidated soluble form
and LGG-1-II/LGG-1–PE is the lipidated form) [965, 1112,
2115]. In contrast to the yeast and mammalian autophagoso
mal membrane proteins Atg8 and LC3, lipidation of the C.
elegans ortholog LGG-1 with phosphatidylethanolamine has
rarely been investigated by western blotting; this is likely due
to technical problems with separating the nonlipidated from
the lipidated LGG-1 protein by gel electrophoresis. A new
protocol for western blot analysis, taking advantage of
improved antibodies to LGG-1 and SQST-1/SQSTM1, is
applicable for both the detection of transgenic and endogen
ous proteins and provides a quantifiable method to assess
autophagic flux [2118].
The LGG-1 precursor accumulates in the atg-4.1 mutant,
but is undetectable in wild-type embryos [1261]. In fact,
LGG-1 phenotypes vary in atg-4.1 and atg-4.2 mutants,
indicative of distinct functions for these two genes [471].
Moreover, the banding pattern of LGG-1 or LGG-1 fused to
fluorescent proteins in western blots may not be easy to
interpret in larvae or the adult C. elegans because enrich
ment for a fast running band (the lipidated form) is not
observed in some autophagy-inducing conditions including
fasting (E.J. O’Rourke, personal communication). In the
embryos of some autophagy mutants, including epg-3, epg4, epg-5, and epg-6 mutants, levels of LGG-1-I and LGG-1II are elevated [845, 965]. In an immunostaining assay,
endogenous LGG-1 forms distinct punctate structures,
mostly at the ~64- to 100-cell embryonic stage. LGG-1
puncta are absent in atg-3, atg-7, atg-5 and atg-10 mutant
embryos [965], but dramatically accumulate in other auto
phagy mutants [845, 965]. The widely used GFP::LGG-1
reporter forms aggregates in atg-3 and atg-7 mutant
embryos, in which endogenous LGG-1 puncta are absent,
indicating that GFP::LGG-1 could be incorporated into
protein aggregates during embryogenesis. Immunostaining
for endogenous VPS-34 is also a useful marker of autopha
gy induction in C. elegans embryos [1271].
A variety of protein aggregates, including PGL granules
(PGL-1-PGL-3-SEPA-1) and the C. elegans SQSTM1 homolog
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SQST-1, are selectively degraded by autophagy during embry
ogenesis; impaired autophagy activity results in their accumu
lation and the generation of numerous aggregates [965]. Thus,
degradation of these autophagy substrates can also be used to
monitor autophagy activity, with similar cautionary notes to
those described in section A3 (see SQSTM1 and related LC3
binding protein turnover assays) for the SQST-1 turnover
assay. Similar to mammalian cells, the total amount of GFP::
LGG-1 along with SQST-1::GFP transcriptional expression
coupled with its posttranscriptional accumulation can be
informative with regard to autophagic flux in the embryo
(again with the same cautionary notes described in section
A3) [573].
As with its mammalian counterpart, loss of the C. ele
gans TP53 ortholog, cep-1, increases autophagosome accu
mulation [2119] and extends the animal’s life span [2120].
bec-1- and cep-1-regulated autophagy is also required for
optimal life-span extension. However, non-autophagic roles
for bec-1 and cep-1 have been reported. Hence, bec-1 or
cep-1 inactivation is insufficient to define a longevity
mechanism as autophagy dependent. The TFEB ortholog
HLH-30 transcriptionally regulates autophagy including
the expression of bec-1 [948, 1294], and life-span analyses
uncovered an anti-aging role for HLH-30/TFEB in C. ele
gans, and possibly in mammals [573, 948, 1294]. However,
it remains to be definitively demonstrated whether HLH30/TFEB longevity is exclusively, or even mostly, mediated
by activation of autophagy. bec-1- and cep-1 are also
required to reduce lipid accumulation in response to silen
cing FRH-1/FXN, a protein involved in mitochondrial
respiratory chain functionality [2121]. FRH-1 silencing
also induces mitophagy in an evolutionarily conserved
manner [1172]. Moreover, the products of C. elegans mito
phagy regulatory gene homologs (PDR-1/PRKN, PINK-1/
PINK1, DCT-1/BNIP3, and SQST-1/SQSTM1) are required
for induction of mitophagy (monitored through the Rosella
biosensor [2122]) and life-span extension following FRH-1
silencing and iron deprivation [1172]. HLH-30/TFEB tran
scriptionally regulates autophagy and promotes lipid degra
dation [948, 1294], and life-span analyses uncovered a
direct role for HLH-30/TFEB in aging in C. elegans, and
possibly in mammals [573, 948, 1294].
C. elegans body wall muscle is a useful tissue for studying
autophagy. In addition to the methods discussed above, in this
tissue transgenic reporter proteins can be used to monitor
rates of protein degradation in specific subcellular compart
ments [2123], mutations in at least two signaling pathways
can be used to modulate autophagy [2124], drugs can be used
to inhibit autophagy [2125], and mutations and drugs can be
used to inhibit the proteasome [2126], calpains [2125], and
caspases [2127] thus allowing both positive and negative con
trols. Finally, knockdown of a substantial number of kinases
[2128] and phosphatases [2129] appears to induce autophagy,
potentially enabling further study of the upstream signals that
modulate this process.
For a more complete review of methods for monitoring
autophagy in C. elegans see ref. [562]. These approaches can
be used to monitor autophagy in embryos, early larval stages,
and adult C. elegans, including during aging [2130].
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2. Chicken B-lymphoid DT40 cells, retina and inner ear
The chicken B-lymphoid DT40 cell line represents a suitable
tool for the analysis of autophagic processes in a nonmamma
lian vertebrate system. In DT40 cells, foreign DNA integrates
with a very high frequency by homologous recombination
compared to random integration. This feature was—prior to
the CRISPR-Cas9 era—employed in order to generate cellular
gene knockouts. Different Atg-deficient DT40 cell lines
already exist, including atg13−/−, ulk1−/−, ulk2−/−, and ulk1−/−
ulk2−/− [693]. Many additional non-autophagy-related gene
knockout DT40 cell lines have been generated and are com
mercially available [2131].
DT40 cells mount an autophagic response upon starvation
in EBSS [693], and autophagy can be analyzed by a variety of
assays in this cell line. Steady state methods that can be used
include TEM, LC3 western blotting and fluorescence micro
scopy; flux measurements include monitoring LC3-II turn
over and tandem mRFP/mCherry-GFP-LC3 fluorescence
microscopy. Using atg13−/− and ulk1−/− ulk2−/− DT40 cells,
it was shown that ATG13 and its binding capacity for
RB1CC1 are mandatory for both basal and starvation-induced
autophagy, whereas ULK1/2 and in vitro-mapped ULK1dependent phosphorylation sites of ATG13 appear to be dis
pensable for these processes [693].
Another useful system is chick retina, which can be used
for monitoring autophagy at different stages of development.
For example, lipidation of LC3 is observed during starvation,
and can be blocked with a short-term incubation with 3-MA
[1596, 2132]. LEP-100 antibody is commercially available for
the detection of this lysosomal protein. In the developing
chicken inner ear, LC3 flux can be detected in otic vesicles
cultured in a serum-free medium exposed to either 3-MA or
CQ [2133].
One of the salient features of chicken cells, including
primary cells such as chicken embryo fibroblasts, is the capa
city of obtaining rapid, efficient and sustained transcript/pro
tein downregulation with replication-competent retrovirus for
shRNA expression [2134]. In chicken embryo fibroblasts,
nearly complete and general (i.e., in nearly all cells) protein
downregulation can be observed within a few days after
transfection of the shRNA retroviral vector [231].
Cautionary notes: It is possible that there is some diver
gence within the signaling pathways between mammalian and
nonmammalian model systems. One example might be the
role of ULK1/2 in starvation-induced autophagy described
above. Additionally, DT40 cells represent a transformed cell
line, being derived from an avian leukosis virus-induced bur
sal lymphoma. Thus, DT40 cells release avian leukosis virus
into the medium, and the 3ʹ-long terminal repeat has inte
grated upstream of the MYC gene, leading to increased MYC
expression [2135]. Both circumstances might influence basal
and starvation-induced autophagy.
3. Chlamydomonas
The unicellular green alga Chlamydomonas reinhardtii is an
excellent model system to investigate autophagy in photosyn
thetic eukaryotes. Most of the ATG genes that constitute the
autophagy core machinery including the ATG8 and ATG12
ubiquitin-like systems are conserved as single-copy genes in

the nuclear genome of this model alga. Autophagy can be
monitored in Chlamydomonas by western blotting through
the detection of Atg8 lipidation as well as an increase in the
abundance of this protein in response to autophagy activation
[397]. Localization of Atg8 by immunofluorescence micro
scopy can also be used to study autophagy in
Chlamydomonas because the cellular distribution of this pro
tein changes drastically upon autophagy induction. The Atg8
signal is weak and usually detected as a single spot in non
stressed cells, whereas autophagy activation results in the
localization of Atg8 in multiple spots with a very intense
signal [397, 2136, 2137]. A red fluorescent protein
(mCherry) tagged-Atg8 has been developed that allows the
observation of autophagosomes in living microalgal cells
[2138]. Autophagic flux can also be monitored in
Chlamydomonas by analyzing the abundance and lipidation
of Atg8 protein in cells treated with the vacuolar-type ATPase
inhibitor concanamycin A. Inhibition of autophagic flux
results in the accumulation of total Atg8 and detection of
the Atg8 lipidated form [2139]. Finally, enhanced expression
of ATG8 and other ATG genes has also been reported in
stressed Chlamydomonas cells [2136, 2140]. These methodo
logical approaches have been used to investigate the activation
of autophagy in Chlamydomonas under different stress con
ditions including nutrient (nitrogen or carbon) limitation,
rapamycin treatment, ER stress, oxidative stress, photo-oxida
tive damage or high light stress [397, 2136, 2137].
4. Drosophila melanogaster
Drosophila provides an excellent and highly amenable system
for in vivo analysis of autophagy as the machinery is highly
conserved with well-characterized functions in several tissues
including oocyte, embryo, larval/pupal fat body, midgut, sali
vary gland and imaginal disc, larval motor neurons and adult
neurons [183, 1744, 2141–2144]. The advantage of using
Drosophila as a model is the ability to undertake genetic
analysis of individual components of the autophagy machin
ery [1771, 2141]. Another major advantage of Drosophila is
that the problem of animal-to-animal variability can be cir
cumvented by the use of clonal mutant cell analysis [183,
2141, 2143, 2145]. In this scenario, somatic clones of cells are
induced that either overexpress the gene of interest, or silence
the gene through expression of a transgenic RNA interference
construct, or gene mutation/deletion. These gain- or loss-offunction clones are surrounded by wild-type cells, which serve
as an internal control for autophagy induction. In such an
analysis, autophagy in these genetically distinct cells is always
compared to neighboring cells of the same tissue, thus elim
inating most of the variability and also ruling out potential
non-cell-autonomous effects that may arise in mutant animals
(Figure 25). Along these lines, clonal analysis should be an
integral part of in vivo Drosophila studies when possible.
Multiple steps of the autophagic pathway can be monitored
in Drosophila due to the development of useful markers,
corresponding to every step of the process. Interested readers
may find further information in several reviews with a
detailed discussion of the currently available assays and
reagents for the study of autophagy in Drosophila [183,
2141, 2146]. For example, the level of autophagy can be
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examined live in vivo using transgenic lines that express
fluorescently-tagged specific components of the autophagy
pathway. Moreover, fluorescent reporters for components of
the autophagy pathway can be used in genetic screens for new
regulators of autophagy [2147]. The expression of fluores
cently tagged Atg8a from the endogenous Atg8a promoter is
a useful reporter, that does not require a driver line [375,
2148]. In addition, autophagy has been successfully monitored
in Drosophila expressing various components of the pathway
including (but not limited to) human UAS-GFP-LC3 [123,
376, 2149], UAS-GFP-Atg8a [2150], UAS-mCherry-Atg8a
[589], mCherry-Atg18 [2151], UAS-GFP-Atg5 [376], UASRFP-Atg5 [947], UAS-GFP-Atg6 [2152], UAS-GFP-DFCP1
[2153], UAS-GFP-ref(2)P (corresponding to the Drosophila
SQSTM1 homolog) [589], and the tandem fluorescent repor
ter UASp-GFP-mCherry-Atg8a [2154, 2155], with an increas
ing list of addition transgenic fluorescence reagents, including
protein traps, that are being made available through the
Drosophila stock centers.
There are also a limited number of commercially available
antibodies, including a rabbit monoclonal anti-GABARAP
antibody and a rabbit polyclonal anti-ref(2)P antibody that
can be used to detect endogenous levels of Drosophila Atg8a
and ref(2)P, respectively, in both immunostaining and immu
noblotting experiments [560, 2141, 2156, 2157]. The advantage
of UAS-ref(2)P-GFP over the antibody against endogenous ref
(2)P is that its accumulation is independent of ref(2)P promoter
regulation and unambiguously reflects autophagy impairment
[557, 2155]. Of note, immunoblot analysis of ref(2)P levels
should include both soluble and insoluble fractions [557,
2157]. Several laboratories have also generated antibodies,
including those against Atg8a and ref(2)P [560, 2149, 2158].
Finally, it is worth noting that a commercial Atg5 antibody can
also be used for Drosophila [750, 2159].
Cultured Drosophila (S2) cells can also be stably transfected
with GFP fused to Drosophila Atg8a, which generates easily
resolvable GFP-Atg8a and GFP-Atg8a–PE forms that respond
to autophagic stimuli (S. Wilkinson, personal communication);
stable S2 cells with GFP-Atg8a under the control of a 2-kb
Atg8a 5ʹ UTR are also available [2160]. Similarly, cultured
Drosophila cells (l[2]mbn or S2) stably transfected with
EGFP-HsLC3B respond to autophagy stimuli (nutrient depri
vation) and inhibitors (3-MA, bafilomycin A1) as expected, and
can be used to quantify GFP-LC3 puncta, which works best
using fixed cells with the aid of an anti-GFP antibody [2161].
The selective degradation of cargo can also be used to assay
for autophagy in this system. The Drosophila components of
the IKK complex, key/kenny and IKKβ/ird5, are selectively
degraded by autophagy, and transgenic lines are available
(UAS-GFP-key/kenny, UAS-mCherry-IKKβ/ird5 and UASmCherry-GFP-IKKβ/ird5) to follow key and ird5 expression
and localization [2162].
With the distinct morphology of autophagy, TEM is also
an indispensable and reliable method for monitoring auto
phagy in Drosophila. Finally, in addition to genetic analysis,
pharmacological modulation of autophagy can be examined
in Drosophila. For example, rapamycin can be fed to larvae or
adults to induce autophagy, and CQ can be used to block
lysosomal degradation [589, 1770, 2141].
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Cautionary notes: In the Drosophila eye, overexpression
of GFP-Atg8 results in a significant increase in Atg8–PE
based on immunoblot, and this occurs even in control flies
in which punctate GFP-Atg8 is not detected by immuno
fluorescence (M. Fanto, personal communication/unpub
lished results), and in transfected Drosophila Kc167 cells,
uninducible but persistent GFP-Atg8 puncta are detected
(A. Kiger, personal communication/unpublished results). In
contrast, expression of GFP-LC3 under the control of the
ninaE/rh1 promoter in wild-type flies does not result in the
formation of LC3-II detectable by immunoblot, nor the
formation of punctate staining; however, increased GFPLC3 puncta by immunofluorescence or LC3-II by immuno
blot are observed upon activation of autophagy [616].
Finally, most Drosophila food contains the anti-fungal
nipagin (methylparaben), which has certain redox and
anti-oxidant effects; these could interfere with particular
experiments.
5. Erythroid cells
The unique morphology of red blood cells (RBCs) is instru
mental to their function. The bi-concave shape provided by a
highly flexible membrane and the absence of organelles is
critical to their long lifespan in the peripheral circulation
(120 days), allowing unimpeded circulation of the RBC even
through the thinnest blood vessels, thereby delivering O2 to all
the tissues of the body. Erythroid cells acquire this unique
morphology upon terminal erythroid maturation, which com
mences in the bone marrow with the release of reticulocytes
that become mature RBCs in the peripheral circulation. This
process involves extrusion of the pyknotic nucleus through a
specialized form of asymmetric division, and degradation of
the ribosome and mitochondria machinery along with a
reduction in cell volume via a specialized form of autophagy
(Figure 34). In the context of RBC biogenesis, autophagy

Figure 34. Transmission electron micrograph of erythroblasts obtained from the
blood of regular donors after ten days of culture in the presence of KITLG/SCF,
IL3, EPO and dexamethasone. Original magnification 3000X. This figure shows
two erythroblasts containing autophagic vacuoles. One erythroblast (red arrow)
has the morphology of a live cell with several autophagic vacuoles that have
engulfed cytoplasmic organelles. The other erythroblast (black arrow) has the
electron-dense cytoplasm characteristic of a dead cell and is in the process of
shedding its autolysosomes from the cytoplasm to the extracellular space. Image
provided by A.R. Migliaccio and M. Zingariello.
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exerts a unique function to sculpt the cytoplasm, with the
mature autophagic vacuoles engulfing and degrading orga
nelles, such as mitochondria and ribosomes, whose presence
would impair the flexibility of the cells.
Another unique feature of erythropoiesis is that expres
sion of genes required for autophagosome assembly/func
tion, such as LC3B, does not appear to be regulated by
nutrient deprivation, but rather is upregulated by the ery
throid-specific transcription factor GATA1 [981]. FOXO3, a
transcription factor that modulates RBC production based
on the levels of O2 present in the tissues [2163], amplifies
GATA1-mediated activation of autophagy genes [981] and
additional genes required for erythroid maturation [2164].
Furthermore, lipidation of the cytosolic form of LC3B into
the lipidated LC3-II form is controlled by EPO (erythro
poietin), the erythroid-specific growth factor that ensures
survival of the maturing erythroid cells. The fact that the
genes encoding the autophagic machinery are controlled by
the same factors that regulate expression of genes encoding
important red cell constituents (such as red blood cell
antigens and cytoskeletal components, globin, and proteins
mediating heme biosynthesis) [2165–2167], ensures that the
process of terminal maturation progresses in a highly
ordered fashion.
The importance of autophagy for RBC production has
been established through the use of mutant mouse strains
lacking genes encoding proteins of the autophagy machin
ery (BNIP3L, ULK1, ATG7) [2168–2171]. These mutant
mice exhibit ineffective erythropoiesis with erythroid cells
blocked at various stages of terminal erythroid maturation
and anemia. Abnormalities of the autophagic machinery
are also linked to erythroid disorders such as DiamondBlackfan anemia or myelodysplastic syndrome, which are
characterized by either congenic or acquired loss-of-func
tion mutations of genes encoding ribosomal proteins
(ribosomopathies), and involve erythroid progenitors. As
in other cell types, in erythroid cells TP53 activation may
influence the functional consequences of autophagy—to
determine cell death rather than maturation. TP53,
through MDM2, is the gatekeeper to ensure normal ribo
some biosynthesis by inducing death of cells lacking suffi
cient levels of ribosomal proteins. In these disorders,
activated TP53 and abnormally high levels of autophagic
death of erythroid progenitors, promote anemia and bone
marrow failure. Glucocorticoids might improve anemia in
some Diamond-Blackfan anemia patients by inhibiting TP53
activity. Of note, impairment of autophagy in the late phase of
erythropoiesis, involving erythroid precursors, has been
reported in hereditary red cell disorders such as β-thalassemic
syndromes, characterized by ineffective erythropoiesis [2172,
2173], or in chorea-acanthocytosis, a neurodegenerative dis
order linked to VPS13 mutations and characterized by circu
lating acanthocytes containing multivesicular bodies and
double-membrane remnants [2174]. Recent evidence also
links the abnormal regulation of the redox sensitive transcrip
tion factor NFE2L2 to ineffective erythropoiesis and impair
ment of autophagy, with accumulation in erythroid precursors
of non-functional proteins, further amplifying oxidation and
promoting cell apoptosis [2175].

6. Filamentous fungi
As in yeast, autophagy is involved in nutrient recycling during
starvation [369, 373, 2176–2182]. In addition, autophagy
seems to be involved in many normal developmental pro
cesses such as sexual and asexual reproduction, where there
is a need for reallocation of nutrients from one part of the
mycelium to another to supply the developing spores and
spore-bearing structures [369, 1086, 2176, 2177, 2179, 2183–
2186]. Similarly, autophagy also affects conidial germination
under nitrogen-limiting conditions [369]. In Podospora anser
ina, autophagy has been studied in relation to incompatibility
reactions between mating strains where it seems to play a
prosurvival role [372, 2183]. During aging of this long-stand
ing aging model, autophagy is increased (based on numbers of
GFP-Atg8 puncta and increased autophagy-dependent degra
dation of a GFP reporter protein) and acts as a prosurvival
pathway [2187]. Moreover, mitophagy has been demonstrated
to exert pro-survival effects under mild stress conditions,
while displaying Atg1-dependent pro-death features under
elevated stress.
In Sordaria macrospora, the pexophagy receptor Nbr1 is
involved in fruiting-body development and maturation of
sexual ascospores [1052]. Of special interest to many research
ers of autophagy in filamentous fungi has been the possible
involvement of autophagy in plant and insect pathogen infec
tion and growth inside the host [373, 1069, 1078, 2176, 2177,
2188–2193]. For example, treatment with amiodarone pro
motes movement of the blast fungus M. oryzae between living
rice cells during the early biotrophic stage of infection when
the fungus inhabits epidermal cells but before symptoms
develop, whereas inhibiting autophagy with 3-MA attenuates
cell-to-cell movement and disrupts the biotrophic interface
between the fungus and living host rice cells. In conjunction
with the analysis of a mutant strain impaired in autophagy
induction, these results suggest a fundamental role for auto
phagy in mediating intracellular host-microbe interactions
[2193]. Autophagy also appears to be necessary for the devel
opment of aerial hyphae [369, 2176, 2182, 2183, 2189], and for
appresorium function in M. oryzae, Colletotrichum orbiculare
and Metarhizium robertsii [373, 2188, 2189, 2191, 2194]. In
particular, invasion-associated ER stress can promote auto
phagy to enhance the cell wall integrity-associated MAPK
pathway in order to help with infection by M. oryzae [2195].
Some of these effects could be caused by the absence of
autophagic processing of storage lipids (lipophagy) to gener
ate glycerol for increasing turgor and recycling the contents of
spores into the incipient appressorium, as a prerequisite to
infection [2176, 2189, 2190].
Methods for functional analysis of autophagy have been
covered in a review article (see ref. [2196]). Most studies on
autophagy in filamentous fungi have involved deleting some
of the key genes necessary for autophagy, followed by an
investigation of what effects this has on the biology of the
fungus. Most commonly, ATG1, ATG4, ATG8 and/or ATG9
have been deleted [373, 1843, 2176, 2177, 2179, 2180, 2183,
2186, 2189, 2191, 2197, 2198]. To confirm that the deletion(s)
affects autophagy, the formation of autophagic bodies in the
wild type and the mutant can be compared. In filamentous
fungi the presence of autophagic bodies can be detected using
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MDC staining [373, 2176], TEM [373, 2177] or fluorescence
microscopy to monitor Atg8 tagged with a fluorescent protein
[369, 2179, 2183, 2186]. This type of analysis is most effective
after increasing the number of autophagic bodies by starva
tion or alternatively by adding the autophagy-inducing drug
rapamycin [369, 2176], in combination with decreasing the
degradation of the autophagic bodies through the use of the
protease inhibitor PMSF [373, 2177, 2179, 2183]. In filamen
tous fungi it might also be possible to detect the accumulation
of autophagic bodies in the vacuoles using differential inter
ference contrast microscopy, especially following PMSF treat
ment [2179, 2183]. Additional information regarding the
timing of autophagy induction can be gained by monitoring
transcript accumulation of ATG1 and/or ATG8 using qPCR
[2177].
Autophagy has been investigated intensively in Aspergilli,
and in particular in the genetically amenable species
Aspergillus nidulans, which is well suited to investigate intra
cellular traffic [1843, 2199, 2200]. In A. oryzae, autophagy has
been monitored by the rapamycin-induced and Atg8-depen
dent delivery of DsRed2, which is normally cytosolic, to the
vacuoles [369]. In A. nidulans, the more “canonical” GFPAtg8 proteolysis assays have been used, by monitoring the
delivery of GFP-Atg8 to the vacuole (by time-lapse micro
scopy), and by directly following the biogenesis of GFP-Atg8labeled phagophores and autophagosomes [1843], which can
be tracked in large numbers using kymographs traced across
the hyphal axis. In these kymographs, the autophagosome
cycle starting from a PAS “draws” a cone whose apex and
base correspond to the “parental” PAS punctum and to the
diameter of the “final” autophagosome, respectively [348].
Genetic analyses revealed that autophagosomes normally
fuse with the vacuole in a Rab7-dependent manner.
However, should Rab7 fusogenic activity be mutationally
inactivated, autophagosomes can traffic to the endosomes in
a RabB/Rab5- and CORVET-dependent manner [348]. An
important finding was that RabO/Rab1 plays a key role in
A. nidulans autophagy (and actually can be observed on the
phagophore membranes). This finding agrees with previous
work in S. cerevisiae demonstrating that Ypt1 (the homolog of
RAB1) is activated by the Trs85-containing version of
TRAPP, TRAPPIII, for autophagy [2201, 2202]. This crucial
involvement of RabO/Ypt1 points at the ER as one source of
membrane for autophagosomes.
In A. nidulans, specific misfolded transporters, which are
retained in the ER, are degraded by chaperone-assisted selec
tive autophagy. The chaperone involved was identified as
BsdA, which is an ER transmembrane protein acting as an
adaptor for the recruitment of the HECT-type ubiquitin ligase
HulA (NEDD4/Rsp5 type), which ubiquitinates the misfolded
transporter and elicits its recognition by maturing autophago
somes. The process involves Atg8 and Atg9. Epifluorescence
microscopy has shown that the misfolded transporter tagged
with GFP colocalizes with Atg8-RFP and vacuoles stained
with CMAC, revealing a direct translocation from the ER to
the vacuole via autophagosomes. Knockout of the gene encod
ing the BsdA chaperone allows the misfolded transporter to
escape autophagy and be sorted to the plasma membrane.
Distinct homologs of BsdA might be present in metazoa.
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Based on the present guidelines the Aspergillus example clas
sifies as CASA rather than CMA.
The suitability of A. nidulans for in vivo microscopy has
been exploited to demonstrate that nascent phagophores are
cradled by ER-associated structures resembling mammalian
omegasomes [348]. The autophagic degradation of whole
nuclei that has been observed in A. oryzae [1082] might be
considered as a specialized version of reticulophagy. Finally,
autophagosome biogenesis has also been observed using a
PtdIns3P-binding GFP-tagged FYVE domain probe in mutant
cells lacking RabB/Rab5. Under these genetic conditions
Vps34 cannot be recruited to endosomes and is entirely at
the disposition of autophagy [348], such that PtdIns3P is only
present in autophagic membranes.
Mitophagy has been studied in M. oryzae, by detecting the
endogenous level of porin (a mitochondrial outer membrane
protein) by western blot, and by microscopy observation of
vacuolar accumulation of mito-GFP [1069]. Mitophagy is
involved in regulating the dynamics of mitochondrial mor
phology and/or mitochondrial quality control, during asexual
development and invasive growth in M. oryzae. Pexophagy
has also been studied in rice-blast fungus and it serves no
obvious biological function, but is naturally induced during
appressorial development, likely for clearance of excessive
peroxisomes prior to cell death [2203]. In turn, normal mito
chondrial and peroxisomal fission is also essential for mito
phagy and pexophagy [2204]. Methods to monitor pexophagy
in M. oryzae include microscopy observation of the vacuolar
accumulation of GFP-SRL (peroxisome-localized GFP), and
detection of the endogenous thiolase [2203], or Pex14 levels.
The existence of crosstalk between autophagy and endocy
tosis has been explored in M. oryzae, by analyzing the biolo
gical functions of Vps9-domain containing proteins [2205,
2206]. Pyricularia oryzae (the asexual stage of, and hence
essentially a synonym of, M. oryzae) Vps9 recruits PoVps34
and targets it to endosomes by activating PoVps21; PoAtg6 is
then recruited by PoVps34 under the action of PoVps38 to
target endosomes in endocytosis. Additionally, PoAtg6 is
recruited to the PAS by PoVps34 to participate in autophagy
by activating PoVps21. Methods to monitor the crosstalk
include microscopy observation of the endosomes and auto
phagosomes, affinity isolation and co-IP.
7. Food biotechnology
Required for yeast cell survival under a variety of stress con
ditions, autophagy has the potential to contribute to the out
come of many food fermentation processes. For example,
autophagy induction is observed during the primary fermen
tation of synthetic grape must [2207] and during sparkling
wine production (secondary fermentation) [2208]. A number
of genome-wide studies have identified vacuolar functions
and autophagy as relevant processes during primary wine
fermentation or for ethanol tolerance, based on gene expres
sion data or cell viability of knockout yeast strains [2207,
2209–2213]. However, determining the relevance of autopha
gy to yeast-driven food fermentation processes requires
experimentation using some of the methods available for S.
cerevisiae as described in these guidelines.
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Autophagy is a target for some widespread food preserva
tives used to prevent yeast-dependent spoilage. For example,
the effect of benzoic acid is exacerbated when concurrent with
nitrogen starvation [2214]. This observation opened the way
to devise strategies to improve the usefulness of sorbic and
benzoic acid, taking advantage of their combination with
stress conditions that would require functional autophagy
for yeast cell survival [2006]. Practical application of these
findings would also require extending this research to other
relevant food spoilage yeast species, which would be of
obvious practical interest.
In the food/health interface, the effect of some food bioac
tive compounds on autophagy in different human cell types
has already attracted some attention [2215, 2216]. Interpreting
the results of this type of research, however, warrants two
cautionary notes [2217]. First, the relationship between health
status and autophagic activity is obviously far from being
direct. Second, experimental design in this field must take
into account the actual levels of these molecules in the target
organs after ingestion, as well as exposure time and their
transformations in the human body. In addition, attention
must be paid to the fact that several mechanisms might con
tribute to the observed biological effects. Thus, relevant con
clusions about the actual involvement of autophagy on the
health-related effect of food bioactive compounds would only
be possible by assaying the correct molecules in the appro
priate concentrations.
8. Honeybee
The reproductive system of bees, or insects whose ovaries
exhibit a meroistic polytrophic developmental cycle can be a
useful tool to analyze and monitor physiological autophagy.
Both queen and worker ovaries of Africanized A. mellifera
display time-regulated features of cell death that are linked to
external stimuli [2218]. Features of apoptosis and autophagy
are frequently associated with the degeneration process in bee
organs, but only more recently has the role of autophagy been
highlighted in degenerating bee tissues. The primary method
currently being used to monitor autophagy is to follow the
formation of autophagosomes and autolysosomes by TEM.
This technique can be combined with cytochemical and
immunohistochemical detection of acid phosphatase as a
marker for autolysosomes [2219, 2220]. Acidotropic dyes
can also be used to follow autophagy in bee organs, as long
as the cautions noted in this article are followed. The honey
bee genome has been sequenced, and differential gene expres
sion has been used to monitor Atg18 in bees parasitized by
Varroa destructor [2221].
9. Human
Considering that much of the research conducted today is
directed at understanding the functioning of the human body,
in both normal and disease states, it is pertinent to include
humans and primary human tissues and cells as important
models for the investigation of autophagy. Although clinical
studies are not readily amenable to these types of analyses, it
should be kept in mind that the MTORC1 inhibitor rapamy
cin, the lysosomal inhibitors CQ and HCQ, and the micro
tubule depolymerizing agent colchicine are all available as

clinically approved drugs. However, these drugs are not highly
selective, having numerous off-targets, and have serious side
effects, which often impede their clinical use to study auto
phagy (e.g., severe immunosuppressive effects of rapamycin;
gastrointestinal complaints, bone marrow depression, neuro
pathy and rhabdomyolysis induced by colchicine; gastroin
testinal complaints, neuropathy and convulsions, retinopathy
and heart disease induced by HCQ). These side effects may in
part be exacerbated by potential inhibition of autophagy tself
by these drugs [2222]. In cancer treatment, for example,
autophagy-inhibiting drugs are used in combination with
other anticancer drugs to increase their potency. Conversely,
normal tissues such as kidney induce autophagy in response
to anticancer drugs to resist against their toxicity [2223];
additional blockade of autophagy could worsen normal tissue
toxicity and cause serious side effects. Therefore, the potential
for serious adverse effects and toxicity of these drugs warrants
caution, especially when studying a role of autophagy in highrisk patients, such as the critically ill.
Fortunately, it is possible to obtain fresh biopsies of some
human tissues. Blood, in particular, as well as samples of
adipose and muscle tissues, can be obtained from needle
biopsies or from elective surgery. For example, in a large
study, adipocytes were isolated from pieces of adipose tissue
(obtained during surgery) and examined for INS (insulin)
signaling and autophagy. It was demonstrated that autophagy
was strongly upregulated (based on LC3 flux, EM, and lipo
fuscin degradation) in adipocytes obtained from obese
patients with type 2 diabetes compared with nondiabetic sub
jects [396]. In another study utilizing human adipose tissue
biopsies and explants, elevated autophagic flux in obesity was
associated with increased expression of several autophagy
genes [292, 927, 2224]. Conversely, by using fibroblasts from
a patient with X-linked myopathy with excessive autophagy, it
was shown that deficiency of VMA21 blocks vacuolar ATPase
assembly and causes autophagic vacuolar myopathy due to
increased pH of lysosomes, reduced lysosomal protein degra
dation and enhanced macroautophagy [2225].
The study of autophagy in the blood has revealed that
SNCA may represent a further marker to evaluate the auto
phagy level in T lymphocytes isolated from peripheral blood
[2226]. In these cells it has been shown that (a) knocking
down the SNCA gene results in increased autophagy, (b)
autophagy induction by energy deprivation is associated
with a significant decrease of SNCA levels, (c) autophagy
inhibition (e.g., with 3-MA or knocking down ATG5) leads
to a significant increase of SNCA levels, and d) SNCA levels
negatively correlate with LC3-II levels. Thus, SNCA, and in
particular the 14-kDa monomeric form, can be detected by
western blot as a useful tool for the evaluation of autophagy in
primary T lymphocytes. In contrast, the analysis of SQSTM1
or NBR1 in freshly isolated T lymphocytes fails to reveal any
correlation with either LC3-II or SNCA, suggesting that these
markers cannot be used to evaluate basal autophagy in these
primary cells. Conversely, LC3-II upregulation is correlated
with SQSTM1 degradation in neutrophils, as demonstrated in
a human sepsis model [1694].
A major caveat of the work concerning autophagy in
human tissue is the problem of tissue heterogeneity,
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Figure 35. A large dystrophic neurite from a brain biopsy of a patient with Gerstmann-Sträussler-Scheinker disease not unlike those reported for AD [79]. This
structure is filled with innumerable autophagic vacuoles, some of which are covered by a double membrane. Electron dense lysosomal-like structures are also visible.
The red arrow points to a double-membrane autophagic vacuole. Scale bar: 200 nm. Image provided by P. Liberski.

postmortem times, agonal state, genetic heterogeneity, pre
mortem clinical history (medication, diet, etc.) and tissue
fixation. Time to fixation is typically longer in autopsy mate
rial than when biopsies are obtained. For tumors, careful
sampling to avoid necrosis, hemorrhagic areas and non-neo
plastic tissue is required. The problem of fixation is that it can
diminish the antibody binding capability; in addition, espe
cially in autopsies, material is not obtained immediately after
death [2227, 2228]. The possibilities of postmortem autolysis
and fixation artefacts must always be taken into consideration
when interpreting changes attributed to autophagy [2229].
Analyses of these types of samples require not only special
antigen retrieval techniques, but also histopathological experi
ence to interpret autophagy studies by IHC, immunofluores
cence or TEM. Nonetheless, at least one recent study
demonstrated that LC3 and SQSTM1 accumulation can be
readily detected in autopsy-derived cardiac tissue from
patients with CQ- and HCQ-induced autophagic vacuolar
cardiomyopathy [1559]. Despite significant postmortem inter
vals, sections of a few millimeters thickness cut from fresh
autopsy brain and fixed in appropriate glutaraldehyde-forma
lin fixative for EM, can yield TEM images of sufficient ultra
structural morphology to discriminate different autophagic
vacuole subtypes and their relative regional abundance in
some cases (R. Nixon, personal communication).
The situation is even worse with TEM, where postmortem
delays can cause vacuolization. Researchers experienced in the
analysis of TEM images corresponding to autophagy should
be able to identify these potential artefacts because autophagic
vacuoles should contain cytoplasm. While brain biopsies may
be usable for high quality TEM (Figures 35, 36), this depends
upon proper handling at the intraoperative consultation stage,
and such biopsies are performed infrequently except for brain
tumor diagnostic studies. Conversely, biopsies of organs such
as the digestive tract, the liver, muscle and the skin are
routinely performed and thus nearly always yield high-quality
TEM images. When possible, nonsurgical biopsies are

Figure 36. A high-power electron micrograph from a brain biopsy showing
autophagic vacuoles in a case of ganglioglioma. Scale bar: 200 nm. Image
provided by P. Liberski.

preferable because surgery is usually performed in anesthe
tized and fasting patients, two conditions possibly affecting
autophagy. Moreover, certain surgical procedures require tis
sue ischemia-reperfusion strategies that can also affect auto
phagy level [2230]. An analysis that examined liver and
skeletal muscle from critically ill patients utilized tissue biop
sies that were taken within 30 ± 20 min after death and were
flash-frozen in liquid nitrogen followed by storage at -80°C
[2231]. Samples could subsequently be used for EM and
western blot analysis.
A major limitation of studying patient biopsies is that only
static measurements can be performed. This limitation does
not apply, however, for dynamic experiments on tissue biop
sies or cells derived from biopsies, as described above [396].
Multiple measurements over time, especially when deep (vital)
organs are involved, are impossible and ethically not justifi
able. Hence, quantitative flux measurements are virtually
impossible in patients. To overcome these problems to the
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extent possible and to gain a more robust picture of the
autophagic status, observational studies need to include two
different aspects. First, a static marker for phagophore or
autophagosome formation needs to be measured. This can
be done by assessing ultrastructural changes with TEM and/
or on the molecular level by measuring LC3-II protein levels.
Second, accumulation of autophagy substrates, such as
SQSTM1 and (poly)ubiquitinated proteins, can provide infor
mation on the overall efficacy of the pathway and can be a
surrogate marker of the consequences of altered autophagic
flux, especially when autophagy is insufficient, although these
changes can also be affected by the ubiquitin-proteasome
system as mentioned above.
In addition, and even more so when problems with selec
tive pathways are suspected (e.g., mitophagy), specific sub
strates of these pathways should be determined. Again, none
of these measurements on its own provides enough informa
tion on (the efficacy of) autophagy, because other processes
may confound every single parameter. However, the combi
nation of multiple analyses should be informative. Of note,
there has been interest in assessing markers of autophagy and
autophagic flux in right atrial biopsy samples obtained from
patients undergoing cardiac surgery [2232, 2233]. Evidence to
date suggests that cardiac surgery may be associated with an
increase in autophagic flux, and that this response may pro
tect the heart from perioperative cardiac ischemia-reperfusion
injury [2232]. The autophagy deficiency also correlates with
the decline of serum testosterone in some hypogonadism
patients, as the LC3 expression and puncta number per square
micrometer are significantly decreased in the Leydig cells
from the patients compared with those of the control group
[2234]. In the brain of hypoxic-ischemic encephalopathy
human neonates, punctate LC3 labelling combined with
increased number and size in CTSD- and LAMP1-positive
dots (presumably autolysosomes) and decreased SQSTM1
expression is detected in dying neurons, suggesting that the
autophagy flux is enhanced and associated with neuronal
death occurring in neonatal brain injury [534, 535].
Although still in its infancy with regard to autophagy, it is
worth pointing out that mathematical modeling has the power
to bridge whole body in vivo data with in vitro data from
tissues and cells. The usefulness of so-called hierarchical or
multilevel modeling has been demonstrated when examining
the relevance of INS (insulin) signaling to glucose uptake in
primary human adipocytes compared with whole-body glu
cose homeostasis [2235].
In contrast to tissue samples, blood samples for autophagy
study can be more easily obtained from living donors, from
non-diseased donors, and from a wide age range including
infants up to adults. However, current medication history is
especially important in blood samples, as high concentrations
of medications that can alter autophagy may be present. For
example, in patients with cystic fibrosis (CF) repurposed
medications such as cysteamine are undergoing clinical trial
evaluation. Cysteamine improves autophagy in CF [2236–
2238], whereas other chronic medications such as azithromy
cin may suppress autophagy. Therefore a careful record of
daily and study medications should be accounted for when
examining human blood cells. Further, many autophagy

regulators are differentially expressed across human sample
and cell types. This was shown for CF sputum, where high
expression of a microRNA cluster that regulates autophagy
was found, in contrast to low expression in the blood [2239].
It is recommended that autophagy studies in humans account
for multiple biological sources (including cells from the
affected tissues or organs) when making definitive conclu
sions about the state of overall autophagy under- or over
expression. Likewise, therapeutic testing of new compounds
in human samples ex vivo should be validated in multiple
sample types. In the case of CF, this is often done in local
tissues such as airway epithelial brushings, and validated in
blood cells that are recruited to the local site of action [2240].
Autophagy studies in CF models can be easily adopted for
other disease states. Alternatively, several pathologies with an
aberrant autophagy process have been identified in humans
through genome-wide studies. Cells derived from the affected
tissues of such patients could be used for testing the thera
peutic potency of new molecules.
A stepwise process can be proposed for linking changes in
the autophagic pathway to changes in disease outcome. First,
in an observational study, the changes in the autophagic path
way should be quantified and linked to changes in disease
outcome. To prove causality, a subsequent autophagy-mod
ifying intervention should be tested in a randomized study.
Before an intervention study is performed in human patients,
the phenotype of (in)active autophagy contributing to poor
outcome should be established in a validated animal model of
the disease. For the validation of the hypothesis in an animal
model, a similar two-step process is suggested, with the assess
ment of the phenotype in a first stage, followed by a proof-ofconcept intervention study (see Large animals).
10. Hydra
Hydra is a freshwater cnidarian animal that provides a unique
model system to test autophagy. The process can be analyzed
either in the context of nutrient deprivation, as these animals
easily survive several weeks of starvation [2241], or in the
context of regeneration, because in the absence of protease
inhibitors, bisection of the animals leads to an uncontrolled
wave of autophagy. In the latter case, an excess of autophagy
in the regenerating tip immediately after amputation is dele
terious [2242, 2243]. Most components of the autophagy and
MTOR pathways are evolutionarily conserved in Hydra
[2244]. For steady-state measurements, autophagy can be
monitored by western blot for Atg8-family proteins, by
immunofluorescence (using antibodies to Atg8-family pro
teins, lysobisphosphatidic acid or RPS6KA/RSK), or with
dyes such as MitoFluor™ Red 589 and LysoTracker™ Red.
Flux measurements can be made by following Atg8-family
protein turnover using lysosomal protease inhibitors (leupep
tin and pepstatin A) or in vivo labeling using LysoTracker™
Red. It is also possible to monitor MTOR activity with phos
phospecific antibodies to RPS6KB and EIF4EBP1 or to exam
ine gene expression by semiquantitative RT-PCR, using
primers that are designed for Hydra. Autophagy can be
induced by RNAi-mediated knockdown of Kazal1 [2242,
2243], or with rapamycin treatment, and can be inhibited
with wortmannin or bafilomycin A1 [2241, 2244].
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In situ hybridization shows high expression of ATG12
transcripts specifically in nematoblasts, and of ATG5 in the
budding region and growing buds. The utilization of both
knockdown and RNAi approaches indicates a crucial role of
autophagy in various developmental and physiological pro
cesses, including the regeneration processes in adults [2245].
11. Induced pluripotent stem cells
Previous studies typically used patient biopsies and post-mor
tem tissues to investigate the role of autophagy in the patho
genesis of human disease. Nonetheless, the availability,
preparation, and fixation of human biopsied tissues and
organs, as well as the quantity and quality of biopsies, limit
the dynamic measurement of autophagic flux. Furthermore,
insufficiency of tissue biopsies from healthy controls for com
parison challenges the snapshot results obtained from patient
biopsies. To overcome the limitation of sample sources for
investigating autophagy in human disease, various animal
models and immortalized cell lines have been used to repre
sent these diseases. Valuable results from these model systems
have provided a fundamental pathomechanism for the role of
autophagy in various human diseases; however, the species
discrepancy between animal and human, and the tumorous
genetic background of cell lines elicit concerns for the impli
cations of the results as they pertain to humans.
Recently, the development of induced pluripotent stem
(iPS) cells provides a valuable experimental system to uncover
disease mechanisms and novel therapeutic strategies in
human disease [2246, 2247]. Diverse tissue-specific cells dif
ferentiated from iPS cells offer great potential to model dif
ferent systemic diseases. Furthermore, the unique genetic and
molecular signature of the affected individuals allows
researchers to address disorder-relevant phenotypes at a cel
lular level. Multiple somatic cell sources such as skin, adipose
tissues and peripheral blood for reprogramming to iPS cells
can be obtained in non-invasive procedures. Thus, both dis
ease and control iPS cells can be made available for
comparison.
iPS cells modeling mitochondrial disease have been used
for investigating the impact of mtDNA mutation on autopha
gy [2252]. Both isogenic iPS cell clones with high mutant
mtDNA burden and without mtDNA mutation can be iso
lated simultaneously during cell passages. Thus, the impact of
mtDNA heteroplasmy on autophagy involving pathogenesis
of mitochondrial diseases can be observed directly. iPS cells
with high mutant mtDNA burden modeling mitochondrial
encephalomyopathy, lactic acidosis, and stroke-like episodes
(MELAS) syndrome show elevated levels of autophagy, super
oxide, intracellular calcium and mitochondrial depolarization
at basal conditions in comparison with control iPS cells
[2252]. It is noted that oxidative stress exacerbates the accu
mulation of autophagosomes and autolysosomes, increases
levels of superoxide and enhances calcium flux into the cyto
plasm, leading to robust depolarization of mitochondrial
membrane potential and enhanced mitophagy in MELASiPS cells. Mitophagy is very scarce in MELAS-iPS cells at the
basal condition, consistent with previous observations that
selective elimination of mitochondria containing pathogenic
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mtDNA is spared in mitochondrial diseases under physiolo
gical conditions [2252, 2253].
Moreover, work describing the changes occurring in long-term
cultures of iPS cells, suggest this as a suitable model to study aging
processes. In this context, autophagy increases in senescent cells
(Figure 37), so that identifying autophagic mechanisms triggered
by cellular senescence could suggest potential therapeutic strate
gies against premature aging [150, 2254].
Cumulative evidence from emerging research indicates that
the iPS cellular model is a useful and promising tool to
recapitulate the pathogenesis of human diseases, allowing
better understanding of the mechanism, and facilitating devel
opment of potential therapeutic targets.
Large animals and rodents. This section refers in particu
lar to mammals other than humans. Assessment of autophagy
(and, in particular, autophagic flux) in clinically relevant large
animal models is critical in establishing its (patho)physiologi
cal role in multiple disease states. For example, evidence
obtained in swine suggests that upregulation of autophagy
may protect the heart against damage caused by acute myo
cardial infarction/heart attack [2255]. Ovine models of pla
cental insufficiency leading to intrauterine growth restriction
have shown that there is no change in the expression of
markers of autophagy in the fetus in late gestation [2256] or
in the lamb at 21 days after birth [2257]. Furthermore, there is
an increase in markers of autophagy in the placenta of human
intrauterine growth restriction pregnancies [2258]. Studies in
rabbits suggest a protective role of upregulated autophagy
against critical illness-induced multiple organ failure and
muscle weakness [2259, 2260], which is corroborated by
human studies [2231, 2261]. Conversely, autophagy may con
tribute to the pathogenesis of some types of tissue injury, at
least in the lung [2262, 2263] and different regions of the CNS
[39, 86, 539]. Similarly, autophagy may play different roles in
ischemic stroke as ischemia progresses [2264], or during subse
quent reperfusion [2265]. For example, studies in rats demon
strate that activation of autophagy [539] and disruption of
autophagosome-lysosome fusion [86] may induce ischemic neu
ronal damage in the hippocampal CA1 region after transient
global cerebral ischemia. The autophagic flux was also demon
strated to be activated, and an autophagic mechanism may
contribute to ischemic neuronal injury in rats subjected to
focal ischemia [2266] and neonatal cerebral hypoxic ischemia
[535, 2267]. Dysregulation of autophagy and mitophagy genes
with parallel Casp3 gene expression is observed in rats after
complete cerebral ischemia with survival of 2-30 days after
ischemia, and post-ischemic studies in rats suggest a lack of a
protective role of the dysregulated autophagy in the brain as
assessed by the expression of the Bace1 gene [1645, 1646]. In the
mouse retina, mitophagy is dramatically impaired during pro
longed diabetes, suggesting a pathogenic role in the development
of neurovascular complications and premature senescence [39].
Finally, there is an increase in LC3-II in the kidney in normal
wild-type mice treated with bafilomycin A1, but no increase in
LC3-II in mice with polycystic kidney disease, suggesting sup
pressed autophagic flux in cys1/cpk mouse kidneys [2268].
Studies in rodent and cellular models have shown a critical
role of dysregulated autophagy in pancreatitis [1499, 2269].
Experimental
pancreatitis
stimulates
autophagosome
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Figure 37. FIB-SEM images showing ultrastructural details of aging iPS cells. Arrows indicate autophagosomes containing mitochondria or other partially digested
cytoplasmic material. E, exosomes; g, Golgi apparatus; m, mitochondrion; N, nucleus; RER, rough endoplasmic reticulum. Scale bars: 1 µm. Image provided by F.
Colasuonno, modified from ref. [150].

formation, but at the same time inhibits autophagic degrada
tion, resulting in impaired autophagic flux evidenced by accu
mulation of enlarged autolysosomes, decreased rate of longlived protein degradation in pancreatic acinar cells, and
increases in both LC3-II and SQSTM1. Mice with pancreasspecific ablation of Atg5 or Atg7, double knockout of Tfeb and
Tfe3, or Lamp2 knockout, all develop spontaneous pancreati
tis. Further, manifestations of impaired autophagy are promi
nent in human pancreatitis, such as acinar cell vacuolization
(a long-noted, but poorly understood hallmark response of
this disease), increases in pancreatic LC3-II and SQSTM1, and
decreases in LAMP2 and TFEB.
Autophagy also plays an important role in the development
and remodeling of the bovine mammary gland. In vitro stu
dies with the use of a 3-dimensional culture model of bovine
mammary epithelial cells (MECs) have shown that this pro
cess is involved in the formation of fully developed alveoli-like
structures [2270]. Earlier studies show that intensified

autophagy is observed in bovine MECs at the end of lactation
and during the dry period, when there is a decrease in the
levels of lactogenic hormones, increased expression of auto/
paracrine apoptogenic peptides, increased influence of sex
steroids and enhanced competition between the intensively
developing fetus and the mother organism for nutritional and
bioactive compounds [2271, 2272]. These studies were based
on some of the methods described elsewhere in these guide
lines, including GFP-Atg8-family protein fluorescence micro
scopy, TEM, and western blotting of LC3 and BECN1.
Creation of a specific GFP-LC3 construct by insertion of
cDNA encoding bovine LC3 into the pEGFP-C1 vector
makes it possible to observe induction of autophagy in bovine
MECs in a more specific manner than can be achieved by
immunofluorescence techniques, in which the antibodies do
not show specific reactivity to bovine cells and tissues [2270,
2272]. However, it is important to remember that definitive
confirmation of cause-and-effect is challenging for studies on
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large animals, given the lack or poor availability of specific
antibodies and other molecular tools, the frequent inability to
utilize genetic approaches, and the often prohibitive costs of
administering pharmacological inhibitors in these transla
tional preparations.
In contrast with cell culture experiments, precise monitor
ing of autophagic flux is practically impossible in vivo in large
animals. Theoretically, repetitive analyses of small tissue biop
sies should be performed to study ultrastructural and mole
cular alterations over time in the presence or absence of an
autophagy inhibitor (e.g., CQ). However, several practical
problems impede applicability of this approach. First, repeti
tive sampling of small needle biopsies in the same animal (a
major challenge by itself) could be assumed to induce artefacts
following repetitive tissue destruction, especially when deep
(vital) organs are involved. In addition, chemical inhibitors of
autophagy have considerable side effects and toxicity, ham
pering their usage. Also, the general physical condition of an
animal may confound results obtained with administration of
a certain compound, for instance altered uptake of the com
pound when perfusion is worse.
Therefore, in contrast to cells, where it is more practical to
accurately document autophagic flux, we suggest the use of a
stepwise approach in animal models to provide a proof of
concept with an initial evaluation of sequelae of (in)active
autophagy and the relation to the outcome of interest.
First, prior to an intervention, the static ultrastructural and
molecular changes in the autophagic pathway should be docu
mented and linked to the outcome of interest (organ function,
muscle mass or strength, survival, etc.). These changes can be
evaluated by light microscopy, EM and/or by molecular mar
kers such as LC3-II. In addition, the cellular content of spe
cific substrates normally cleared by autophagy should be
quantified, as, despite its static nature, such measurement
could provide a clue about the results of altered autophagic
flux in vivo. These autophagic substrates can include SQSTM1
and (poly)ubiquitinated substrates or aggregates, but also
specific substrates such as damaged mitochondria. As noted
above, measurement of these autophagic substrates is mainly
informative when autophagic flux is prohibited/insufficient,
and, individually, all have specific limitations for interpreta
tion. As mentioned several times in these guidelines, no single
measurement provides enough information on its own to
reliably assess autophagy, and all measurements should be
interpreted in view of the whole picture. In every case, both
static measurements reflecting the number of autophago
somes (ultrastructural and/or molecular) and measurements
of autophagic substrates as surrogate markers of autophagic
flux need to be combined. Depending on the study hypoth
esis, essential molecular markers can further be studied to
pinpoint at which stage of the process autophagy may be
disrupted.
Second, after having identified a potential role of autopha
gy in mediating an outcome in a clinically relevant large
animal model, an autophagy-modifying intervention should
be tested. For this purpose, an adequately designed, rando
mized controlled study of sufficient size on the effect of a
certain intervention on the phenotype and outcome can be
performed in a large animal model. Alternatively, the effect of
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a genetic intervention can be studied in a small animal model
with clinical relevance to the studied disease.
As mentioned above, exact assessment of autophagic flux
requires multiple time points, which cannot be done in the
same animal. Alternatively, different animals can be studied
for different periods of time. Due to the high variability
between animals, however, it is important to include an
appropriate control group, and a sufficiently high number of
animals per time point as corroborated by statistical power
analyses. This requirement limits feasibility and the number
of time points that can be investigated. The right approach to
studying autophagy in large animals likely differs depending
on the question that is being addressed. Several shortcomings
regarding the methodology, inherent to working with large
animals, can be overcome by an adequate study design. As for
every study question, the use of an appropriate control group
with a sufficient number of animals is crucial in this regard.
12. Lepidoptera
Some of the earliest work in the autophagy field was carried
out in the area of insect metamorphosis. Microscopy and
biochemical research revealed autophagy during the meta
morphosis of American silkmoths and the tobacco hornworm,
Manduca sexta, and included studies of the intersegmental
muscles, but they did not include molecular analysis of auto
phagy [2273]. Overall, these tissues cannot be easily main
tained in culture, and antibodies against mammalian proteins
do not often work. Accordingly, these studies were confined
to biochemical measurements and electron micrographs.
During metamorphosis, the bulk of the larval tissue is
removed by autophagy and other forms of proteolysis
[2274]. Bombyx mori is now used as a representative model
among Lepidoptera, for studying not only the regulation of
autophagy in a developmental setting, but also the relations
between autophagy and apoptosis. The advantages of this
model are the large amount of information gathered on its
developmental biology, physiology and endocrinology, the
availability of numerous genetic and molecular biology tools,
and a completely sequenced genome [2275]. The basic studies
of B. mori autophagy have been mainly carried out in four
larval organs: the silk gland, the fat body, the midgut and the
ovary.
The techniques used for these studies are comparatively
similar, starting from EM, which is the most widely used
method to follow the changes of various autophagic structures
and other features of the cytosol and organelles that are
degraded during autophagy [942, 2276–2279]. ImmunoTEM also can be used, when specific antibodies for autopha
gic markers are available. As in other model systems the use of
Atg8 antibodies has been reported in Lepidoptera. In B. mori
midgut [942, 2280], fat body [943] and silk gland [944] as well
as in various larval tissues of Galleria mellonella [2281] and
Helicoverpa armigera [2282], the use of both custom and
commercial antibodies makes it possible to monitor Atg8
conversion to Atg8–PE by western blotting. Moreover, trans
fection of GFP-Atg8 or mCherry-GFP-Atg8 has been used to
study autophagy in several lepidopteran cell lines [2282]. In
addition, an antibody against Sqstm1 was generated, and it is
efficient in detecting its autophagic degradation during

164

D. J. KLIONSKY ET AL.

autophagic processes in B. mori [2283, 2284]. Activation of
MTOR can be monitored with an antibody against pEIF4EBP1 [943, 2280, 2284]. Acidotropic dyes such as MDC
and LysoTracker™ Red staining have been used as markers for
autophagy in silkmoth egg chambers, always combined with
additional assays [2276, 2277]. Acid phosphatase also can be
used as a marker for autolysosomal participation in these
tissues [942, 2278, 2285]. Systematic cloning and analysis
revealed that homologs of most of the Atg genes identified
in other insect species such as Drosophila are present in B.
mori, and 15 Atg genes have now been identified in the silk
worm genome, as well as other genes involved in the TOR
signal transduction pathway [2286–2288]. Variations in the
expression of several of these genes have been monitored not
only in silkworm larval organs, where autophagy is associated
with development [942, 944, 2286, 2287, 2289], but also in the
fat body of larvae undergoing starvation [2286, 2290].
In the IPLB-LdFB cell line, derived from the fat body of the
caterpillar of the gypsy moth Lymantria dispar, indirect
immunofluorescence experiments have demonstrated an
increased number of Atg8-positive dots in cells with increased
autophagic activity; however, in contrast to larval tissues,
western blotting did not reveal the conversion of Atg8 into
Atg8–PE. In fact, a single band with an approximate molecu
lar mass of 42 kDa was observed that was independent of the
percentage of cells displaying punctate Atg8 (D. Malagoli,
unpublished results). Thus, the utility of monitoring Atg8 in
insects may depend on the species and antibody.
13. Marine invertebrates
The invaluable diversity of biological properties in marine
invertebrates offers a unique opportunity to explore the dif
ferent facets of autophagy at various levels from cell to tissue,
and throughout development and evolution. For example,
work on the tunicate Ciona intestinalis has highlighted the
key role of autophagy during the late phases of development
in lecithotrophic organisms (those in which the larvae during
metamorphosis feed exclusively from the egg yolk resources)
[374, 2291]. This work has also helped in pinpointing the
coexistence of autophagy and apoptosis in cells, as well as
the beneficial value of combining complementary experimen
tal data such as LC3 immunolabeling and TUNEL detection.
This type of approach could shed a new light on the close
relationship between autophagy and apoptosis, and provide
valuable information about how molecular mechanisms con
trol the existing continuum between these two forms of pro
grammed cell death. Autophagy also appears to play a role in
the cell renewal process observed during the regeneration of
the carnivorous sponge Asbestopluma hypogea [2292].
The identification of a growing number of autophagyrelated sequences in different species has opened a much
wider scenario for investigating the molecular mechanisms
of autophagy and its role in a variety of processes. For exam
ple, in the “living fossil”, the sponge Astrosclera willeyana,
molecular, histochemical, and morphological evidence indi
cate that specialized cells involved in the formation of a highly
calcified skeleton actively degrade their intracellular microbial
community using the autophagy pathway (namely ATG8)
[2293]. This is the first observation suggesting an association

between the process of autophagy and biomineralization in a
metazoan. Analysis of the expression patterns of 13 genes
involved in autophagy and apoptosis in the sea urchin
Paracentrotus lividus highlights the simultaneous involvement
of both processes in early embryo development [2294].
Bivalve molluscs provide useful models for studying auto
phagic function [2295]. Autophagy plays a key role in the
resistance to nutritional stress as is known to be the case in
many Mediterranean bivalve molluscs in the winter. For
example, the European clam Ruditapes decussatus is able to
withstand strict fasting for two months, and this resistant
characteristic is accompanied by massive autophagy in the
digestive gland (Figure 38). This phenomenon, observed by
TEM, demonstrates once again the advantage of using this
classical ultrastructural method to study autophagy in uncon
ventional biological models for which molecular tools may
not be operational. Autophagy has been also demonstrated by
different types of lysosomal reactions in digestive gland cells
in response to a variety of environmental stressors (starvation,
salinity change, hyperthermia, hypoxia, pollutant-induced
stress). In the Mediterranean mussel Mytilus galloprovincialis,
dephosphorylation of MTOR, evaluated by immunohisto
chemistry with antibodies generated to the mammalian pro
tein, contributes to increased lysosomal membrane
permeability and autophagy induced by contaminant expo
sure [2296].
Autophagy also plays a role during pathogen infections, as
has been observed in the Pacific oyster, Crassostrea gigas. In
the mantle of this bivalve mollusc, autophagy is modulated in
response to a viral (Ostreid herpesvirus 1 [OsHV-1]) and a
bacterial (Vibrio aestuarianus) infection [2297]. Autophagy
may therefore play a protective role in oysters against infec
tions as suggested by a survival assay when autophagy is
inhibited by NH4Cl treatment or induced by carbamazepine
or starvation. Furthermore, autophagy occurs in the

Figure 38. Autophagy in the digestive gland of Ruditapes decussatus (Mollusca,
Bivalvia) subjected to a strict starvation of 2 months. Image provided by S.
Baghdiguian.
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hemocytes of the Pacific oyster [502], which are the main
effectors of its immune system, and thus play a key role in
the defense against pathogens. Hemocyte autophagy activity
characterized by flow cytometry, fluorescence microscopy and
TEM analysis shows the importance of combining different
approaches to investigate autophagy in marine invertebrate
models.
Although the different facets of autophagy are increasingly
studied, the molecular mechanism of autophagy is still poorly
understood in these models. For the first time, an identifica
tion of the ATG proteins that constitute the core molecular
machinery of autophagy in a bivalve mollusc, C. gigas, has
been established [502]. The autophagy machinery in this
organism is conserved with other eukaryotic organisms.
These results will provide new possibilities to better under
stand the autophagy processes and mechanism in marine
invertebrates.
At present, the use of TEM still represents a unique tool to
confirm the presence of autophagic structures in bivalves at
the subcellular level [502, 2297, 2298]. In M. galloprovincialis
hemocytes, rapid autophagosome formation is observed
within 5-15 min of in vitro challenge with Vibrio tapetis
[2298]. This observation, together with increased LC3-II
expression, decreased levels of phosphorylated MTOR and
of SQSTM1, represents the first direct evidence for modula
tion of autophagic processes induced in bivalve immune cells
by bacterial challenge.
Genome sequencing and transcriptomic data in different
bivalve species are revealing a growing number of autophagyrelated genes that are involved in the immune response [2299,
2300]. Overall, available data in bivalves underlines the point
that autophagy is not involved in pathogen degradation, but
in protection against viral and bacterial infection.
A relationship between autophagy and resistance to disease
has also been described in corals. Comparison of transcrip
tomics data on the immune response of four coral species,
with a range of disease susceptibility, shows activation of
apoptosis and autophagic pathways prevailing, respectively,
in susceptible species (Orbicella faveolata) and disease-toler
ant species (Porites porites and P. astreoides), indicating that
apoptotic and autophagic pathways might have a significant
impact on the susceptibility of corals to disease [2301].
In crustaceans, gene expression, miRNA silencing and
proteome analysis are revealing the role of autophagy-related
mechanisms in immune and stress responses. Different
miRNAs play key roles in immunity and host autophagy
after infection by white spot syndrome virus, one of the
main causes of disease in aquacultured species [2302, 2303].
In the crab Eirocheir sinensis, EsBECN1 (Vps30/Atg6) is
involved in regulating the expression of antimicrobial pep
tides in the immune responses to bacterial infection [2304]. In
copepods, ocean acidification enhances lysosome-autophagy
pathway proteomes that are responsible for repairing and
removing proteins and enzymes damaged under stress, possi
bly mitigating mercury-induced toxicity [2305].
The intralysosomal subcellular distribution of C60 fullerene
nanoparticles in digestive gland cells of the marine mussel (M.
galloprovincialis), following experimental exposure to C60
nanoparticles in seawater results in lysosomal membrane
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permeabilization and inhibition of MTOR, and provokes an
excessive induction of autophagy [2296, 2306]. The effects of
C60 fullerene nanoparticles indicate that moderate to severe
ROS production and oxidative damage are not necessary
under these conditions to inhibit the MTOR pathways,
although lysosomal membrane permeabilization, probably
caused by lysosomal overload of foreign material (i.e., C60
fullerene), will result in release of intralysosomal iron that
will produce ROS [2077]. Consequently, autophagic induction
by C60 (as for other nanoparticles [2077, 2094]), may repre
sent a protective degradation in autolysosomes of material
that is recognized by the cell as foreign or aberrant, such as
pathogens or damaged intracellular proteins and membranes.
The cytoskeletal alterations induced by C60 fullerene nano
particles may impair the growth of the cells and their organi
zation in the digestive tubules of the digestive gland. Overall,
dysregulation of MTORC1 and MTORC2 may reduce the
capacity of the cells, and organisms, to properly grow and
reproduce. Consequently, MTOR dephosphorylation should
be considered a diagnostic biomarker for the toxic effects of
the C60 nanoparticles and polycyclic aromatic hydrocarbons
as previously demonstrated [2296]; and, under chronic stress
ful conditions, prognostic for potential harmful effects at the
whole animal and population level.
Overall, knowledge on the autophagic machinery in marine
invertebrates will help not only in elucidating the molecular
networks that regulate autophagy within an evolutionary
framework; this information will also contribute to under
standing the response to infection of those species that are
affected by pathogen-induced mass mortalities or other envir
onmental stressors, also in the context of rapid global changes
that affect their survival and distribution in oceans.
14. Neotropical teleosts
In tropical environments, fish have developed different repro
ductive strategies, and many species have the potential for use
as a biological model in cell and molecular biology, especially
for studying the mechanisms that regulate gametogenesis and
embryo development. In these fish, the ovary is a suitable
experimental model system for studying autophagy and its
interplay with cell death programs due to the presence of
postovulatory follicles (POFs) and atretic follicles, which fol
low different routes during ovarian remodeling after spawn
ing [2307]. In fish reproductive biology, POFs are excellent
morphological indicators of spawning, whereas atretic follicles
are relevant biomarkers of environmental stress. In addition,
many freshwater teleosts of commercial value do not spawn
spontaneously in captivity, providing a suitable model for
studying the mechanisms of follicular atresia under controlled
conditions [2308]. When these species are subjected to
induced spawning, the final oocyte maturation (resumption
of meiosis) occurs, and POFs are formed and quickly reab
sorbed in ovaries after spawning [2309]. Assessment of auto
phagy in fish has been primarily made using TEM at different
times of ovarian regression [2310]. Due to the difficulty of
obtaining antibodies specific for each fish species, immuno
detection of ATG proteins (mainly LC3 and BECN1) by IHC
associated with analyses by western blotting can be performed
using antibodies that are commercially available for other
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vertebrates [546]. Such studies suggest dual roles for autopha
gy in follicular cells [2307]; however, evaluation of the autop
hagic flux in different conditions is critical for establishing its
physiological role during follicular regression and ovarian
remodeling after spawning. Given the ease of obtaining sam
ples and monitoring them during development, embryos of
these fish are also suitable models for studying autophagy that
is activated in response to different environmental stressors,
particularly in studies in vivo.
15. Odontoblasts
Odontoblasts are long-lived dentin-forming postmitotic cells,
which evolved from neural crest cells early during vertebrate
evolution. These cells are aligned at the periphery of the
dental pulp and are maintained during the entire healthy life
of a tooth. As opposed to other permanent postmitotic cells
such as cardiac myocytes or central nervous system neurons,
odontoblasts are significantly less protected from environ
mental insults such as dental caries and trauma. Mature
odontoblasts develop a well-characterized autophagy-lysoso
mal system, including a conspicuous autophagic vacuole that
ensures turnover and degradation of cell components.
Immunocytochemical and TEM studies make it possible to
monitor age-related changes in autophagic activity in human
odontoblasts [2311]. Tooth pulp cells, in contrast, process
minor autophagic activities; however, the autophagy level in
those cells can be highly induced in stress conditions [2312].
Furthermore, in the periodontal ligament mesenchymal cells,
increased autophagy has a protective role in apoptosis pre
vention [2313], and it plays a role in healing of the oral
mucosa [2314].
16. Parasitic helminths
Parasitic helminths comprise parasitic flatworms (Monogenea,
Trematoda [flukes], and Cestoda [tapeworms] of the class
Neodermatans [2315]) that infect vertebrates and cause certain
human neglected tropical diseases such as neurocysticercosis and
taeniasis (Taenia sp.), echinococcosis (Echinococcus sp.), schisto
somiasis (Schistosoma sp.), fascioliasis (Fasciola hepatica), clo
norchiasis (Clonorchis sinensis) and opisthorchiasis (Opisthorchis
viverrini) among others [2316]. Although autophagy is a funda
mental catabolic pathway conserved from yeast to mammals, it
remains understudied in these parasites. Since the 1960s, autopha
gy and particularly glycophagy have been described via TEM for
these parasitic helminths through ultrastructural changes in the
syncytial tegument of larval stages and adult worms during in
vitro and in vivo drug chemotherapy [2317–2320]. In addition,
data obtained by TEM analysis led to the proposal that specialized
biomineralized cells, termed calcareous corpuscles, are the result
of continuous cytoplasmic autophagy in tapeworms [2320, 2321].
These cells show multi-lamellar structures coincident with the
typical ultrastructure of autophagy activation induced by endo
plasmic reticulum stress, and different from that seen in cells
deprived of nutrients (Figure 39A) [2322]. The calcareous corpus
cles play key roles in the physiology of tapeworms; they are
involved in bioaccumulation of ions (calcium, magnesium, carbo
nate and phosphate, and traces of aluminum, boron, copper and
iron), metamorphosis of parasitic tissues (the corpuscles are
formed, reorganized and resorbed in different hosts) and they

correlate with previous or ongoing active metabolic activity (high
content of carbohydrate metabolism enzymes and glycogen)
[2323]. Studies carried out with confocal IHC using a commercial
polyclonal antibody directed against the N terminus of human
LC3, make it possible to verify the autophagy activity of calcareous
corpuscles in Echinococcus granulosus larval stages exposed to
arsenic trioxide, metformin and rapamycin (Figure 39B) [2324].
Currently, the availability of genome sequences together
with the extensive transcriptomic and/or expressed sequence
tag (EST) data allow in silico confirmation of the occurrence
of the autophagy-related genes for the parasitic flatworms that
cause the most serious problems among 50 helminth genome
draft assemblies [2325–2328]. Most components of the auto
phagy core machinery and related key signaling pathways
such as those involving AKT, PI3K, TOR, AMPK, FOXO
and TFEB are evolutionarily preserved in these parasitic flat
worms; however, only in some parasites such as Echinococcus
sp. has the autophagy pathway been formally analyzed [2324,
2329]. Basic studies performed in metacestodes and protosco
leces, larval forms of the cestode Echinococcus that can
develop in humans, allow the detection of active basal auto
phagy both in cellular systems and during the vesicular dedifferentiation of protoscolex to metacestode [2324]. All Atg
homologs (encoded by fourteen genes including two paralogs
for Atg8) involved in induction, vesicle nucleation, autopha
gosome expansion and membrane recycling (except Atg10,
which was also not identified in D. melanogaster nor in Apis
mellifera [2]) have been found in Echinococcus sp. [2324].
These autophagy-related proteins conserve all domains corre
sponding to specific functions, including the key amino acids
involved
in
protein-protein
or
protein-membrane
interactions.
Autophagy in Echinococcus can be regulated by transcrip
tion-dependent upregulation via FOXO and non-transcrip
tional inhibition through TOR [2330] (J. Loos and V.
Dávila, personal communication). As in other invertebrates,
a single FOXO transcription factor is identified in the cestode.
Likewise, the consensus core recognition motif for FOXO
binding (TTGTTTAC) is conserved in autophagy genes
(atg8 and atg12). Furthermore, it has been demonstrated
that rapamycin, metformin and bortezomib are able to induce
autophagy, dose-dependent pharmacological effects and death
in these parasites even under nutrient-rich conditions. These
results were verified by detection of diverse autophagic struc
tures through TEM (including the phagophore, autophago
somes, autolysosomes with lamellar stacks, and glycogen
surrounded by double-membrane vesicles), Atg8 punctate
images detected by confocal microscopy, conversion of Atg8
to the Atg8–PE conjugate by western blotting, and an increase
in the mRNA levels of autophagy genes (atg5, atg6, atg8,
atg12, atg16 and atg18) by RT-PCR, proportional to the
drug concentration employed [2324, 2329–2331]). Although
autophagy is predominantly a homeostatic mechanism, druginduced excessive autophagy might also play a role in cell
death. Therefore, from a therapeutic perspective, it will be of
great importance to understand how autophagy can be phar
macologically manipulated to favor pro-death signaling in
these parasites. The establishment of new molecular tools
and studies involving specific related atg mutants would be
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Figure 39. Detection of autophagy in Echinococcus granulosus larval stage. (A) Scanning electron micrographs of a sectioned larva (or protoscolex) (i) showing big
oval-shaped cells named calcareous corpuscles (red arrowheads) developed by cytoplasmic autophagy. Ultrastructural details of different developmental stages of
these parenchymatic cells showing a central vacuole (ii-iii) at the initial development phase and concentric membranes that marginalize a thin layer of cytoplasm in
mature corpuscles at the end of the autophagic process (iv-v). Energy-dispersive X-ray elemental microanalysis of the calcareous corpuscles in a sectioned
protoscolex demonstrates the colocalization of accumulated ions into corpuscles: calcium (vi), phosphorus (vii). Scale bar: 10 µm. (B) Optical transmission (i) and
confocal (ii-iv) microscopy images of a protoscolex treated with metformin (10 mM) for 48 h (i-iii) and an untreated microcyst (or metacestode) (iv) incubated with an
anti-LC3 antibody and revealed with an antibody conjugated with Alexa Fluor 488 (green fluorescence) and counterstained with propidium iodide (red fluorescence)
to observe cell nuclei under optimal contrast conditions. Fluorescent punctate images are often detected in the tegument of rapamycin-treated protoscoleces (ii-iii)
and microcysts originated by vesicular de-differentiation from protoscoleces (iv) with high Atg8 polypeptide levels within the free cytoplasmic matrix of these cells,
demonstrating pharmacological autophagy induction in corpuscles (ii-iii) and basal autophagy in small cysts in development even under nutrient-rich conditions (iv).
Scale bar: 100 µm. Inset images correspond to TEM. bo, body; gl, germinal layer; su, sucker; tg, tegument. Images provided by A. C. Cumino and J. A. Loos. Only
images in panel B were previously published in ref. [327].

of great value in order to get insights into the role of auto
phagy in parasitic flatworms.
17. Planarians
Because planarians are one of the favorite model systems in
which to study regeneration and stem cell biology, these flat
worms represent a unique model where it is possible to

investigate autophagy in the context of regeneration, stem
cells and growth. Currently the method used to detect auto
phagy is TEM. A detailed protocol adapted to planarians has
been described [2332, 2333]. However, complementary meth
ods to detect autophagy are also needed, because TEM cannot
easily distinguish between activation and blockage of autopha
gy, which would both be observed as an accumulation of

168

D. J. KLIONSKY ET AL.

A

B
N

N

V

V

AP

V

V
N

N
Induced

P

ER

CW

Control

Figure 40. Detection of autophagy in tobacco BY-2 cells. (A) Induction of autophagosomes in tobacco BY-2 cells expressing YFP-NtAtg8 (shown in green for ease of
visualization) under conditions of nitrogen limitation (Induced). Arrowheads indicate autophagosomes that can be seen as a bright green dot. No such structure was
found in cells grown in normal culture medium (Control). Bar: 10 µm. N, nucleus; V, vacuole. (B) Ultrastructure of an autophagosome in a tobacco BY-2 cell cultured
for 24 h without a nitrogen source. Bar: 200 µm. AP, autophagosome; CW, cell wall; ER, endoplasmic reticulum; P, plastid. Image provided by K. Toyooka.

autophagosomes. Other methods to detect autophagy are
being developed (C. González-Estévez, personal communica
tion), including IHC and western blotting approaches for the
planarian homolog of LC3. Several commercial antibodies
against human LC3 have been tried for cross-reactivity with
out success, and three planarian-specific antibodies have been
generated. Some preliminary results show that LysoTracker™
Red can be a useful reagent to analyze whole-mount planar
ians. Most of the components of the autophagy and MTOR
signaling machinery are evolutionarily conserved in planar
ians. Whether autophagy genes vary at the mRNA level dur
ing starvation and after depletion of MTOR signaling
components is still to be determined.
18. Plants
As stated above with regard to other organisms, staining with
MDC or derivatives (such as monodansylamylamine) is not
sufficient for detection of autophagy, as these stains also
detect vacuoles. The same is the case with the use of
LysoTracker™ Red, neutral red or acridine orange. The fluor
ophore of the red fluorescent protein shows a relatively high
stability under acidic pH conditions. Thus, chimeric RFP
fusion proteins that are sequestered within autophagosomes
and delivered to the plant vacuole can be easily detected by
fluorescence microscopy. Furthermore, fusion proteins with
some versions of RFP tend to form intracellular aggregates,
allowing the development of a visible autophagic assay for
plant cells [2334]. For example, fusion of cytochrome b5 and
the original (tetrameric) RFP generate an aggregated cargo
protein that displays cytosolic puncta of red fluorescence and,
following vacuolar delivery, diffuse staining throughout the
vacuolar lumen. However, it is not certain whether these
puncta represent autophagosomes or small vacuoles, and
therefore these data should be combined with immuno-TEM
or with conventional TEM using high-pressure frozen and
freeze-substituted samples [2335].
In plant studies, GFP-Atg8 fluorescence is typically
assumed to correspond to autophagosomes; however, as
with other systems, caution needs to be exercised because it
cannot be ruled out that Atg8 is involved in processes other
than autophagy. Immunolabeled GFP-Atg8 can be detected
3
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both on the inner and outer membrane of an autophagosome
in an Arabidopsis root cell, using chemical fixation (see Fig.
6b in ref. [2336]), suggesting that it will be a useful marker to
monitor autophagy. Arabidopsis cells can be stably transfected
with GFP fused to plant ATG8, and the lipidated and non
lipidated forms can be separated by SDS-PAGE [289].
Furthermore, the GFP-ATG8 processing assay is particularly
robust in Arabidopsis and can be observed by western blotting
[290, 350]. Two kinds of GFP-ATG8 transgenic seeds are
currently available from the Arabidopsis Biological Resource
Center, each expressing similar GFP-ATG8A transgenes but
having different promoter strength. One transgene is under
the control of the stronger Cauliflower mosaic virus 35S pro
moter [816], whereas the other uses a promoter of the
Arabidopsis AT4G05320.2/ubiquitin10 gene [2337]. In the
GFP-ATG8 processing assay, the former has a higher ratio
of GFP-ATG8A band intensity to that of free GFP than does
the latter [2337]. Because free GFP level reflects vacuolar
delivery of GFP-ATG8, the ubiquitin promoter line may be
useful when studying an inhibitory effect of a drug/mutation
on autophagic delivery. Likewise, the 35S promoter line may
be used for testing potential autophagy inducers. GFPATG8CL Nicotiana benthamiana seeds are also available
upon request3 (unpublished). The transgene is under a 35S
promoter, and the plants can be used for both confocal
microscopy and western blotting to monitor autophagic flux
and image autophagosomes in vivo. Immunofluorescence
with anti-ATG8 antibodies followed by confocal microscopy
imaging has been also used to visualize autophagic structures
in plant cells, during developmental events, from tissue differ
entiation [2338] to senescence [2339], as well as in stresstreated barley microspores [911].
Thus, as with other systems, autophagosome formation in
plants can be monitored through the combined use of fluor
escent protein fusions to ATG8, immunolabeling and TEM
(Figure 40). A tandem fluorescence reporter system is also
available in Arabidopsis [2340]. The number of fluorescent
ATG8-labeled vesicles can be increased by pretreatment with
concanamycin A, which inhibits vacuolar acidification [1763,
2336]; however, this may interfere with the detection of MDC
and LysoTracker™ Red. It is also possible to use plant and
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fungal homologs of SQSTM1 and NBR1 in Arabidopsis [1052,
2340] (the NBR1 homolog is called JOKA2 in tobacco [2341])
as markers for selective autophagy when constructed as fluor
escent chimeras. In addition, detection of the NBR1 protein
level by western blot, preferably accompanied by qPCR ana
lysis of its transcript level, provides reliable semi-quantitative
data about autophagic flux in plant cells [2342].
Another approach for assessing autophagic flux is based on
the observation that autophagy mutants in Arabidopsis exhi
bit peroxisomal abnormalities [2343, 2344]. Consequently,
peroxisome abundance can provide information on autopha
gic flux. Peroxisome abundance can be measured in total
tissue extracts by spectrofluorometry using the small fluores
cent probe Nitro-BODIPY [2345, 2346]. This approach
demonstrates that knockout of Arabidopsis ATG5 correlates
with both a greater number of peroxisomes per cell and
higher Nitro-BODIPY fluorescence in the total extracts from
leaves [2345]. Although, low cost and ease of the procedure
makes the Nitro-BODIPY assay applicable for the identifica
tion of autophagy mutants in large populations, direct mar
kers should be used to examine autophagic flux in the
identified genotypes.
Hydrotropism determines the degree of root bending
towards the water source, which consequently compensates
for the effects of drought. Hydrotropism modulates the devel
opment of the root system, and it has an effect on plant
support, as well as water and nutrient intake. A water poten
tial gradient system (using a water stress medium [WSM])
[2347] can be used to demonstrate that autophagy is required
for the hydrotropic response. Looking for autophagosome
accumulation in the root bending zone, 4-days-post germina
tion 35S-ATG8A seedlings [378] are transferred to the WSM,
and accumulation of autophagosomes is followed from 0 to 6
h by confocal microscopy using a 40X dry objective in order
to avoid manipulation that may affect the root bending.
During this time the root bending is achieved and autophago
some accumulation can be observed in the bending zone.
Autophagosomes accumulate in the epidermal cells of the
root bending zone 2 h after the transfer of seedlings to
WSM. WSM supplemented with CQ can be used to monitor
the requirement of autophagy flux. Several ATG mutants do
not show hydrotropic curvature in WSM [2348]. Thus, the
WSM system also allows the observation of autophagosomes
in situ using confocal microscopy without seedling
manipulation.
It has been assumed that, just as in yeast, autophagic
bodies are found in the vacuoles of plant cells, because both
microautophagy and autophagy are detected in these cells
[2349]. The data supporting this conclusion are mainly
based on EM studies showing vesicles filled with material in
the vacuole of the epidermis cells of Arabidopsis roots; these
vesicles are absent in ATG4A and ATG4B mutant plants
[378]. However, it cannot be excluded that these vacuolar
vesicles are in fact cytoplasmic/protoplasmic strands, or that
they arrived at the vacuole independent of autophagy;
although the amount of such strands would not be expected
to increase following treatment with concanamycin.
Immunolabeling with an antibody to detect ATG8 could
clarify this issue.
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The Phytophthora infestans RXLR effector PexRD54 has
been published as an inducer of ATG8CL autophagosome
formation and can be used in N. benthamiana as a tool to
transiently activate autophagy [2350]. ATG4 and ATG9 RNAi
constructs can also be used to knock down gene expression of
the core autophagy components and transiently suppress au
tophagy in N. benthamiana [2351].
Other methods described throughout these guidelines can
also be used in plants [2352]. For example, in tobacco cells
cultured in sucrose starvation medium, the net degradation of
cellular proteins can be measured by a standard protein assay;
this degradation is inhibited by 3-MA and E-64c (an analog of
E-64d), and is thus presumed to be due to autophagy [1862,
2353].
Cautionary notes: Although the detection of vacuolar RFP
can be applied to both plant cell lines and to intact plants, it is
not practical to measure RFP fluorescence in intact plant
leaves, due to the very high red autofluorescence of chloro
phyll in the chloroplasts. Furthermore, different autophagic
induction conditions cause differences in protein synthesis
rates; thus, special care should be taken to monitor the effi
ciency of autophagy by quantifying the intact and processed
cargo proteins.
19. Protists
An essential role of autophagy during the differentiation of
some parasitic protists (formerly called protozoa) is clearly
emerging. Only a few of the known ATG genes are present in
these organisms, which raises the question about the minimal
system that is necessary for the normal functioning of auto
phagy. The reduced complexity of the autophagic machinery
in many protists provides a simplified model to investigate the
core mechanisms of autophagosome formation necessary for
selective proteolysis; accordingly, protist models have the
potential to open a completely new area in autophagy
research. Some of the standard techniques used in other
systems can be applied to protists including indirect immuno
fluorescence using antibodies generated against ATG8 and the
generation of stable lines expressing mCherry- or GFP-fused
ATG8 for live microscopy and immuno-TEM analyses.
Extrachromosomal constructs of GFP-ATG8 also work well
with less complex eukaryotes [384, 385, 2354], as do other
fluorescently-tagged ATG proteins including ATG5 and
ATG12.
The unicellular amoeba D. discoideum provides another
useful system for monitoring autophagy [1940, 2355]. The
primary advantage of D. discoideum is that it has a unique
life cycle that involves a transition from a unicellular to a
multicellular form. Upon starvation, up to 100,000 single cells
aggregate by chemotaxis and form a multicellular structure
that undergoes morphogenesis and cell-type differentiation.
Development proceeds via the mound stage, the tipped aggre
gate and a motile slug, and culminates with the formation of a
fruiting body that is composed of a ball of spores supported
by a thin, long stalk made of vacuolized dead cells.
Development is dependent on autophagy and, at present, all
of the generated mutants in D. discoideum autophagy genes
display developmental phenotypes of varying severity [628,
2356]. D. discoideum is also a versatile model to study
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infection with human pathogens and the role of autophagy in
the infection process. The susceptibility of D. discoideum to
microbial infection and its strategies to counteract pathogens
are similar to those in more complex eukaryotes [1460, 2357].
Along these lines, D. discoideum utilizes some of the proteins
involved in autophagy that are not present in S. cerevisiae
including ATG101 and VMP1, in addition to the core Atg
proteins. The classical markers GFP-ATG8 and GFP-ATG18
can be used to detect autophagosomes by fluorescence micro
scopy [64]. Flux assays based on the proteolytic cleavage of
cytoplasmic substrates are also available [40, 422].
One cautionary note with regard to the use of GFP-ATG8
in protists is that these organisms display some “nonclassical”
variations in their ATG proteins (see LC3-associated apico
plast) and possibly a wide phylogenetic variation because they
constitute a paraphyletic taxon [2358]. For example,
Leishmania contains many apparent ATG8-like proteins (the
number varying per species; e.g., up to 25 in L. major)
grouped in four families, but only one labels true autophago
somes even though the others form puncta [384], and ATG12
requires truncation to provide the C-terminal glycine before it
functions in the canonical manner. Unusual variants in pro
tein structures also exist in other protists, including apicom
plexan parasites, for example, the malaria parasite
Plasmodium spp. or T. gondii, which express ATG8 with a
terminal glycine not requiring cleavage to be membrane asso
ciated [2359]. Thus, in each case care needs to be applied and
the use of the protein to monitor autophagy validated. In
addition, due to possible divergence in the upstream signaling
kinases, classical inhibitors such as 3-MA or wortmannin, or
inducers such as rapamycin, must be used with caution.
Although they are not as potent for T. brucei [2360] or
apicomplexan parasites as in mammalian cells or yeast (I.
Coppens, personal communication) [2354]; they are efficient
for T. cruzi [2361]. Likewise, RNAi knockdown of TORC1 (e.
g., TOR1 or RPTOR) is effective in inducing autophagy in
trypanosomes. Conversely, the inhibitory effect of bafilomycin
A1 on trypanosome autophagy seems to occur during forma
tion, resulting in a low number of ATG8-positive compart
ments, in contrast to what occurs in mammalian cells [2361,
2362]. In addition, small molecule inhibitors of the proteinprotein interaction of ATG8 and ATG3 in Plasmodium falci
parum have been discovered that are potent in cell-based
assays and useable at 1-10 µM final concentration [2363,
2364]. Note that although the lysosomal protease inhibitors
E64 and pepstatin block lysosomal degradative activity in
Plasmodium, these inhibitors do not affect ATG8 levels and
associated structures, suggesting a need for alternate meth
odologies to investigate autophagy in this model system
[2365].
In conventional autophagy, the final destination of auto
phagosomes is their fusion with lysosomes for intracellular
degradation. However, certain stages of Plasmodium (insect
and hepatic) lack degradative lysosomes, which makes ques
tionable the presence of canonical autophagosomes and a
process of autophagy in this parasite. Nevertheless, if protists
employ their autophagic machineries in unconventional man
ners, studies of their core machinery of autophagy will pro
vide information as to how autophagy has changed and

adapted through evolution. For example, although lysosomelike structures were not observed initially in the apicomplexa
T. gondii, it is now clear that this protist harbors an organelle,
named the vacuolar compartment/VAC or plant-like vacuole/
PLV, with the characteristics of an acidic degradative com
partment similar to lysosomes [2366, 2367]. Autophagic mar
kers, such as the T. gondii ortholog of ATG8 and ATG9,
colocalize with the vacuolar compartment markers CPL and
CRT, indicating that in T. gondii autophagosomes fuse with
this lysosome-like organelle [2368, 2369]. The ability of T.
gondii to sustain prolonged extracellular stress relies on a
functional autophagic machinery, although autophagy is dis
pensable for tachyzoite intracellular growth in normal in vitro
culture conditions [2368]. The chronic form of this parasite,
the bradyzoite stage, requires a basal autophagy flux for sur
vival also when intracellular, perhaps because of reduced
access to host cell nutrient due to the thick wall surrounding
the vacuole containing the bradyzoites [2369, 2370].
The scuticociliate Philasterides dicentrarchi has proven to
be a good experimental organism for identifying autophagyinducing drugs or for autophagy initiation by starvation-like
conditions, because this process can be easily induced and
visualized in this ciliate [2371]. In scuticociliates, the presence
of autophagic vacuoles can be detected by TEM, fluorescence
microscopy or confocal laser scanning microscopy by using
dyes such as MitoTracker® Deep Red FM and MDC.
Finally, a novel autophagy event has been found in
Tetrahymena thermophila, which is a free-living ciliated pro
tist. A remarkable, virtually unique feature of the ciliates is
that they maintain spatially differentiated germline and
somatic nuclear genomes within a single cell. The germline
genome is housed in the micronucleus, while the somatic
genome is housed in the macronucleus. These nuclei are
produced during sexual reproduction (conjugation), which
involves not only meiosis and mitosis of the micronucleus
and its products, but also degradation of some of these nuclei
as well as the parental old macronucleus. Hence, there should
be a mechanism governing the degradation of these nuclei.
The inhibition of PtdIns3Ks with wortmannin or LY294002
results in the accumulation of additional nuclei during con
jugation [2372]. During degradation of the parental old
macronucleus, the envelope of the nucleus becomes MDCand LysoTracker™ Red-stainable without sequestration of the
nucleus by a double membrane, and with the exposure of
certain sugars and PS on the envelope [2373]. Subsequently,
lysosomes fuse only to the old parental macronucleus, but
other co-existing nuclei such as developing new macro- and
micronuclei are unaffected [2373]. Using gene technology, it
has been shown that ATG8 and VPS34 play critical roles in
nuclear degradation [1330, 2373]. Knockout mutations of the
corresponding genes result in a block in nuclear acidification,
suggesting that these proteins function in lysosome-nucleus
fusion. In addition, the envelope of the nucleus in the VPS34
knockout mutant does not become stainable with MDC. This
evidence suggests that selective autophagy may be involved in
the degradation of the parental macronucleus and implies a
link between VPS34 and ATG8 in controlling this event. In
Trypanosoma cruzi, there is a complex consisting of the
PtdIns3K TcVPS34 and the serine-threonine kinase
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TcVPS15, which participates in autophagy. It has also been
observed that TcVPS34 participates in fundamental processes
for T. cruzi such as endocytosis, osmoregulation and acidifi
cation [387, 2374].
20. Rainbow trout
Salmonids (e.g., salmon, rainbow trout) experience long per
iods of fasting often associated with seasonal reductions in
water temperature and prey availability or spawning migra
tions. As such, they represent an interesting model system for
studying and monitoring the long-term induction of autopha
gy. Moreover, the rainbow trout (Oncorhynchus mykiss) dis
plays unusual metabolic features that may allow us to gain a
better understanding of the nutritional regulation of this
degradative system (i.e., a high dietary protein requirement,
an important use of amino acids as energy sources, and an
apparent inability to metabolize dietary carbohydrates). It is
also probably one of the most deeply studied fish species with
a long history of research carried out in physiology, nutrition,
ecology, genetics, pathology, carcinogenesis and toxicology
[2375]. Its relatively large size compared to model fish, such
as zebrafish or medaka, makes rainbow trout a particularly
well-suited alternative model to carry out biochemical and
molecular studies on specific tissues or cells that are impos
sible to decipher in small fish models. The genomic resources
in rainbow trout are now being extensively developed; a highthroughput DNA sequencing program of ESTs has been
initiated associated with numerous transcriptomics studies
[2376–2379], and the full genome sequence is now available.
Most components of the autophagy and associated signal
ing pathways (AKT, TOR, AMPK, FOXO) are evolutionarily
conserved in rainbow trout [952, 2380–2382]; however, not all
ATG proteins and autophagy-regulatory proteins are detected
by the commercially available antibodies produced against
their mammalian orthologs. Nonetheless, the EST databases
facilitate the design of targeting constructs. For steady-state
measurement, autophagy can be monitored by western blot or
by immunofluorescence using antibodies to Atg8-family pro
teins [2380]. Flux measurements can be made in a trout cell
culture model (e.g., in primary culture of trout myocytes) by
following Atg8-family protein turnover in the absence and
presence of bafilomycin A1. It is also possible to monitor the
mRNA levels of ATG genes by qPCR using primer sequences
chosen from trout sequences available in the above-men
tioned EST database. A major challenge in the near future
for this model will be to develop the use of RNAi-mediated
gene silencing to analyze the role of some signaling proteins
in the control of autophagy, and also the function of autopha
gy-related proteins in this species.
21. Retinal pigment epithelium
The retinal pigment epithelium (RPE) is a single polarized
layer of cells that form the outer blood retinal barrier and play
a central role in maintaining metabolic homeostasis in the
outer retina through transport of nutrients and waste pro
ducts. These terminally differentiated cells also phagocytose
lipid and protein-rich photoreceptor outer segments (POS)
derived from the underlying photoreceptor cells on a daily
basis. RPE develops a well-characterized autophagy-lysosomal
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system as well as a LAP pathway that ensures the turnover
and degradation of cell content, and the daily degradation of
ingested POS lipids, respectively [2383]. The RPE may be the
only example in which autophagy and LAP are regulated in a
light- and circadian-dependent manner that is postulated to
occur through RUBCN [2384]. Immuno-histochemical, bio
chemical and TEM studies make it possible to monitor both
circadian and age-related changes in autophagy activity in
mouse models [2385–2389]. Moreover, lipidomic and meta
bolism studies have highlighted the critical role played by
LC3-associated processes in RPE health and photoreceptor
function [2390]. Lowering of lysosomal pH in diseased cells
through pharmacological means or using acidic nanoparticles
can enhance autophagic turnover [2391–2393]. The P2Y12
antagonist ticagrelor can reduce loss of photoreceptors and
visual function when added to food; the decreased lysosomal
pH and autofluorescent lipofuscin waste are consistent with
enhanced lysosomal function [2394, 2395].
Autophagy plays an important role in maintaining retinal
functions. Excessive upregulation of autophagy or depletion
of key proteins for autophagy will disrupt functions of photo
receptor cells. Haploinsufficiency of TUBGCP4 (tubulin,
gamma complex associated protein 4) impairs assembly of
TUBG/γ-tubulin ring complexes and disturbs autophagy
homeostasis of the retina. TUBGCP4 can inhibit autophagy
by competing with ATG3 to interact with ATG7, thus inter
fering with lipidation of LC3B. Both cytoplasmic and nuclear
autophagy have been observed in photoreceptor cell segments
[2396, 2397].
POS phagocytosis shares functional similarity with effero
cytosis, the ingestion and degradation of dead cell corpses (or
apoptotic cells). On a molecular level, both processes rely on
PS as an “eat me” signal [245, 2398]. Upon ingestion, both
dead cells and POS stimulate the recruitment of LC3B via
LAP [245, 2389, 2399, 2400]. The extent of LC3B association
with phagosomes in the RPE remains unclear, and the percent
of LAPosomes is an open question; in vitro [2389] and in vivo
studies [2390, 2401] suggest that ~ 30-45% of ingested phago
somes are LC3B positive. In those studies, the levels of endo
genous LC3B associated with OPN (opsin)-positive
phagosomes were analyzed. Higher percentages are observed
when GFP-LC3B is expressed in vitro in ARPE19 cells
(between 80-90%) or in GFP-LC3B mice overexpressing this
tag [2400] where almost 90% of OPN-containing structures
are also GFP-LC3B positive. Further studies using DQ-BSA
quantified the extent of LAPosome-lysosome association in
vitro [2388]. An assessment of LAPosome levels in models of
age-related retinal disease would provide valuable insight into
the balance between two LC3-requiring processes—stressmediated autophagosome formation and OS degradation.
Aberrant MTORC1 signaling has been implicated in
aging and age-related degeneration of the human RPE
[2387]. The phagocytosed POS serve as a physiological sti
mulus of MTORC1 activation through lysosome-indepen
dent mechanisms in the RPE [2402]. Whereas synchronized
photoreceptor disk shedding and RPE phagocytosis activate
MTORC1 during the morning burst, this is subsequently
followed by MTORC1 inactivation and maintenance of ret
inal homeostasis. Reports suggest that excessive and
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sustained activation of MTORC1 in response to stress and
independent of nutrient stimulation, leads to RPE cell death
and senescence. Furthermore, genetic ablation of RPE mito
chondrial oxidative phosphorylation in mice activates the
AKT-MTOR pathway leading to dedifferentiation and
hypertrophy of the RPE [2386], suggesting that inhibition
of MTORC1 could protect the RPE against chronic meta
bolic stress and acute oxidative stress. It is well known that
proteins of the autophagic machinery in the RPE participate
in POS trafficking through a non-canonical autophagy path
way independent of the ULK1 complex, namely LAP [2400].
These studies showed that the MTORC1-independent inter
play between autophagy and phagocytosis in the RPE is
critical for POS degradation.
The cancer stem cell biomarker PROM1/CD133 (promi
nin 1), was demonstrated to play a critical role in maintain
ing RPE homeostasis through regulation of autophagy flux
[2403]. Whereas overexpression of PROM1 increases auto
phagy flux, genomic deletion of PROM1 (using CRISPRCas9) in the RPE blocks autophagy through both upstream
activation of MTORC1/2 and downstream disruption of a
macromolecular complex involving PROM1, SQSTM1, and
HDAC6 in the forming autophagosome. These findings have
important implications because defective autophagosomallysosomal-phagocytic pathways can lead to ineffective clear
ance of POS and damaged organelles, all of which have been
linked to the pathogenesis of retinal diseases, including agerelated macular degeneration/AMD. Therefore, PROM1mediated targeting of MTORC1/2 signaling in the RPE,
could provide a therapeutic strategy for retinal degenerative
diseases.
22. Sea urchin
Sea urchin embryo is an appropriate model system for study
ing and monitoring autophagy and other defense mechanisms
activated during physiological development and in response
to stress [1552]. This experimental model offers the possibility
of detecting LC3 through both western blot and immuno
fluorescence in situ analysis. Furthermore, in vivo staining
of autolysosomes with acidotropic dyes can also be carried
out. Studies on whole embryos make it possible to obtain
qualitative and quantitative data for autophagy and also to
get information about spatial localization aspects in cells that
interact among themselves in their natural environment.
Furthermore, because embryogenesis of this model system
occurs simply in a culture of sea water, it is very easy to
study the effects of inducers or inhibitors of autophagy by
adding these substances directly into the culture. Exploiting
this potential, it has recently been possible to understand the
functional relationship between autophagy and apoptosis
induced by cadmium stress during sea urchin development.
In fact, inhibition of autophagy by 3-MA results in a con
current reduction of apoptosis; however, using a substrate for
ATP production, methyl pyruvate, apoptosis (assessed by
TUNEL assay and cleaved CASP3 immunocytochemistry) is
substantially induced in cadmium-treated embryos where au
tophagy is inhibited. Therefore, autophagy could play a cru
cial role in the stress response of this organism because it
could energetically contribute to apoptotic execution through

its catabolic role [2404]. Cautionary notes include the stan
dard recommendation that it is always preferable to combine
molecular and morphological parameters to validate the data.
23. Ticks
In the hard tick Haemaphysalis longicornis, endogenous auto
phagy-related proteins (Atg6 and Atg12) can be detected by
western blotting and/or by immunohistochemical analysis of
midgut sections [2405, 2406]. It is also possible to detect
endogenous Atg3 and Atg8 by western blotting using anti
bodies produced against the H. longicornis proteins (R.
Umemiya-Shirafuji, unpublished results). Commercial antibo
dies against mammalian ATG orthologs (ATG3, ATG5, and
BECN1) can also be used for western blotting. However, when
the tick samples include blood of a host animal, the animal
species immunized with autophagy-related proteins should be
checked before use to avoid nonspecific background crossreactivity.
In addition to these methods, TEM is recommended to
detect autophagosomes and autolysosomes. Although acidotro
pic dyes can be useful as a marker for autolysosomes in some
animals, careful attention should be taken when using the dyes
in ticks. Because the midgut epithelial cells contain acidic
organelles (e.g., lysosomes) that are related to blood digestion
during blood feeding, this method may cause confusion. It is
difficult to distinguish between autophagy (autolysosomes) and
blood digestion (lysosomes) with acidotropic dyes.
Another available monitoring method is to assess the
mRNA levels of tick ATG genes by qPCR [2407, 2408].
However, this method should be used along with other
approaches such as western blotting, immunostaining, and
TEM as described in this article. Unlike model insects, such
as Drosophila, powerful genetic tools to assess autophagy
are still not established in ticks. However, RNAi-mediated
gene silencing is now well established in ticks [2409], and is
being developed to analyze the function of autophagyrelated genes in ticks during nonfeeding periods (R.
Umemiya-Shirafuji, unpublished results) and in response
to pathogen infection. Recently, “omics” technologies such
as transcriptomics and proteomics have been applied to the
study of apoptosis pathways in Ixodes scapularis ticks in
response to infection with Anaplasma phagocytophilum
[2410]. I. scapularis, the vector of Lyme disease and
human granulocytic anaplasmosis, is the only tick species
for which genome sequence information is available
(assembly JCVI_ISG_i3_1.0; http://www.ncbi.nlm.nih.gov/
nuccore/NZ_ABJB000000000). For related tick species such
as I. ricinus, mapping to the I. scapularis genome sequence
is possible [2411], but for other tick species more sequence
information is needed for these analyses.
24. Zebrafish (Danio rerio)
Zebrafish have many characteristics that make them a valu
able vertebrate model organism for the analysis of autophagy.
For example, taking advantage of the transparency of
embryos, autophagosome formation can be visualized in
vivo during development using transgenic GFP-Lc3 and
GFP-Gabarap fish [44, 2412, 2413] and in specific cell types
such as neurons [328]. It has been reported that conventional
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anti-pigmentation strategies including 1-phenyl-2-thiourea/
PTU treatment and genetic targeting of TYR (tyrosinase)
induce autophagy in various tissues; however, in vivo visuali
zation of later-stage embryos can still be performed using
light-sheet fluorescence microscopy, and image quality is
only minimally affected by developed pigments (X.K. Chen,
J.S. Kwan, R.C. Chang and A.C. Ma, in press). Lysosomes can
also be readily detected in vivo by the addition of
LysoTracker™ Red to fish media prior to visualization.
Additionally, protocols have been developed to monitor the
rate of autophagosome accumulation in vivo [328], and Lc3
protein levels and conjugation to PE by western blot analysis
using commercially available Lc3 antibodies [44, 388]. It
should be noted that in addition to Lc3-I and Lc3-II, a
third, lower-sized protein product is frequently evident fol
lowing western blot analysis in zebrafish [2414].
Because of their translucent character and external fertili
zation and development, zebrafish have proven to be an
exceptional choice for developmental research. In situ hybri
dization of whole embryos can be performed to determine
expression patterns. Knockdown of gene function is per
formed by treatment with morpholinos; the core autophagy
machinery proteins Gabarap [2415], Atg5 [2416, 2417] and
Atg13 [2418], and regulatory proteins such as the phosphoi
nositide phosphatase Mtmr14 [2419], Rubcn [2418], Raptor
and Mtor [2420], have all been successfully knocked down by
morpholino treatment. However, a number of papers have
raised concerns about the cellular stress pathway inducing,
off-target effects of this approach [2421–2423], therefore,
validation of these phenotypes in bona fide mutants is neces
sary. The CRISPR-Cas9 system has been used for efficient
targeted gene deletions of Epg5, Sqstm1, Optn and Snap29
[2424–2426] and should continue to be of great help in future
analyses [2427].
It is well known that the aquatic environment is frequently
compromised by the action of chemical substances and/or
their metabolites. According to a study that applied a compu
tational model for investigating biocidal compounds, approxi
mately 50–60% of those substances are highly toxic for
different aquatic compartments and organisms [2428]. For
this reason, zebrafish are ideal organisms for in vivo drug
discovery and/or verification because of their relatively small
size allowing easy handling, and several chemicals have been
identified that modulate zebrafish autophagy activity [388].
Many chemicals can be added to the media and are absorbed
directly through the skin. Because of simple drug delivery and
rapid embryonic development, zebrafish are a promising
organism for the study of autophagy’s role in disease includ
ing HD [1951], AD [2429], PD [2430] and myofibrillar myo
pathy [2431–2433]. In the case of infection, studies in
zebrafish have made important contributions to understand
ing the role of bacterially- [2418, 2425, 2434, 2435] and virally
[2436–2438]-induced autophagy. In vivo zebrafish studies
have also contributed to understanding the role of autophagy
in different aspects of development, including cardiac mor
phogenesis, caudal fin regeneration [2439], and muscle and
brain development [2412, 2440, 2441].
In vitro studies in the zebrafish cell line ZF4 (zebrafish
embryonic fibroblast) [2442] show that autophagy is required
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for fish rhabdovirus (spring viremia of carp virus, SVCV)
replication [1351, 2443]. In fact, several standardized auto
phagy blockers (also including cholesterol-related molecules
such as C-reactive protein, 25-hydroxycholesterol, methylbeta-cyclodextrin and cholesterol itself) inhibit SVCV infec
tivity in this cell line [1351, 2444]. Moreover, the glycoprotein
G of viral hemorrhagic septicemia (rhabdo)virus/VHSV and
SVCV induce a cell’s antiviral autophagic program in ZF4
cells [2438, 2443]. In this regard, autophagy is also induced in
GFP-LC3 transgenic zebrafish that are experimentally infected
with SVCV [2436].
E. Noncanonical use of autophagy-related proteins
Multiple components of the autophagy machinery mediate
non-autophagic functions [1797], as described here below.
1. LC3-associated phagocytosis (LAP)
Although the lipidation of LC3 to form LC3-II is a commonly
used marker of autophagy, studies have established that LC3II can also be present on phagosomes, acting to promote
maturation independently of traditional autophagy, in a non
canonical autophagic process termed LC3-associated phago
cytosis [2, 30, 2445, 2446]. LAP requires RUBCN and occurs
upon engulfment of particles (such as dead cells, and patho
gens including Aspergillus fumigatus, Burkholderia pseudomal
lei, Bacteroides fragilis, and Yersinia pestis) that engage a
receptor-mediated signaling pathway, resulting in the recruit
ment of some but not all of the autophagic machinery to the
phagosome. LAP requires the association of RUBCN with the
UVRAG-containing class III PtdIns3K complex, and it facil
itates generation and localization of PtdIns3P. This PtdIns3P
then binds and stabilizes the CYBB/NOX2/gp91phox complex
resulting in ROS production for processing the engulfed cargo
[245, 801, 2447]. These autophagic components facilitate
rapid phagosome maturation and degradation of engulfed
cargo, and play roles in the generation of signaling molecules
and regulation of immune responses [244, 245, 904, 2448,
2449]. LAP thus represents a unique process that marries
the ancient pathways of phagocytosis and autophagy.
Despite overlap in molecular machinery, there currently
exist several criteria by which to differentiate LAP from auto
phagy: (a) Whereas LC3-decorated autophagosomes can take
hours to form, LC3 can be detected on LAP-engaged phago
somes as early as 10 min after phagocytosis, and PtdIns3P can
also be seen at LAP-engaged phagosomes minutes after pha
gocytosis [245, 247, 2448]. (b) EM analysis reveals that LAP
involves single-membrane structures [247]. In contrast, auto
phagy is expected to generate double-membrane structures
surrounding cargo. However, this can be confusing if the
engulfed structure already possesses a membrane before
engulfment, as in the case of cell corpses [244, 2450, 2451].
(c) Whereas most of the core autophagy components are
required for LAP, the two processes can be distinguished by
the involvement of the pre-initiation complex. RB1CC1,
ATG13, ULK1 and ULK2 are dispensable for LAP, which
provides a convenient means for distinguishing between the
two processes [245, 2448]. (d) LAP requires the WD repeats of
ATG16L1, whereas autophagy does not have this requirement
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[1477, 1478]. (e) LAP involves LC3 recruitment in a manner
that requires ROS production by the NADPH oxidase family,
notably CYBB/NOX2/gp91phox. It should be noted that most
cells express at least one member of the NADPH oxidase
family. Silencing of the common subunits, CYBB or CYBA/
p22phox, is an effective way to disrupt NADPH oxidase activity
and therefore LAP. It is anticipated that more specific markers
of LAP will be identified as this process is further character
ized. (f) In human macrophages infected with Mycobacterium
tuberculosis, MORN2 (MORN repeat containing 2) is
recruited at the phagosome membrane containing M. tuber
culosis to induce the recruitment of LC3, and subsequent
maturation into phagolysosomes. In addition, MORN2 drives
trafficking of M. tuberculosis to a single-membrane compart
ment. Thus, in certain conditions, MORN2 can be used to
help to make the distinction between autophagy and LAP
[2452].
Of note, an ATG5- and CTSL-dependent cell death process
has been reported that can be activated by the small molecule
NID-1; this process depends on PtdIns3K signaling, generates
LC3B puncta and single-membrane vacuoles, and results in
the clearance of SQSTM1. Thus, LAP and/or related processes
can be co-opted to cause cell death in some cases [2453].
A very similar process to LAP occurs during the cell
cannibalism process of entosis. After engulfment of an epithe
lial cell by a neighboring cell, LC3 is recruited on the single
membrane entotic vacuole before lysosome fusion and death
of the inner cell [244]. It is worth noting that many lysoso
motropic compounds, including CQ, activate a LAP-like non
canonical autophagy pathway that drives LC3 lipidation on
endolysosomal membranes and potentially interferes with the
interpretation of LC3 lipidation data [2454, 2455]. In a zebra
fish model, LAP in macrophages is important in clearing
intracellular bacteria such as Salmonella [2418]. LAP-like
non-canonical autophagy is also observed in pancreatic acinar
cells and involves LC3-conjugation to the membrane of endo
cytic vacuoles (organelles formed as a consequence of com
pound exocytosis followed by compensatory membrane
retrieval) [760].
Mouse models have also been developed to study LAP in
vivo. RUBCN stabilizes the CYBA/p22PHOX-CYBB/NOX2/
gp91phox complex during LAP [2456] allowing ROS to induce
binding of ATG16L1 to endo-lysosome membranes [801].
rubcn−/− mice [2457] have systemic loss of LAP and have
been useful as a source of LAP-deficient cells for “in vitro”
studies, and for “in vivo” studies of autoimmunity and βamyloid trafficking [2457, 2458]. RUBCN is a multidomain
adaptor protein that suppresses NFKB signaling and proinflammatory responses [2456]. Exaggerated proinflammatory
responses mean that rubcn−/− mice are difficult to use in
infection studies. The mice also fail to gain weight and have
defects in the clearance of dying and apoptotic cells, leading to
autoimmune disease that resembles systemic lupus erythema
tosus [2457]. An alternative approach to the study of LAP “in
vivo” has targeted pathways downstream of RUBCN [2459].
LAP and autophagy require the E3-ligase like activity of the
ATG12–ATG5-ATG16L1 complex, but conjugation of LC3 to
endo-lysosome membranes during LAP requires the WD
domain of ATG16L1 [1478]. This has led to the generation

of mice lacking the WD and linker domain of ATG16L1,
which have been developed to study the role played by noncanonical autophagy in vivo. These mice have systemic loss of
LAP and LC3-associated endocytosis (termed LANDO)
[2459], but retain the N-terminal CCD and ATG5-binding
domains of ATG16L1 required for conventional autophagy.
This allows the mice to activate autophagy, grow normally
and maintain tissue homeostasis. These mice also maintain
inflammatory and immunological homeostasis and can be
used to study the role played by LAP and LANDO during
infection in vivo.
2. LC3-associated apicoplast
In several important parasitic protists of the phylum
Apicomplexa (e.g., T. gondii and Plasmodium spp.), the single
ATG8 homolog localizes to an endosymbiotic nonphotosyn
thetic plastid, called the apicoplast [2359, 2460–2463]. This
organelle is the product of a secondary endosymbiotic event,
by which a red alga was endocytosed by an auxotrophic
eukaryote (the ancestor Apicomplexa); the apicoplast is the
main remnant of this red alga. This organelle is approximately
300 nm in diameter, and is composed of four membranes that
trace their ancestry to three different organisms. The succes
sive endosymbiotic events that led to its incorporation into an
ancestor of the Apicomplexa imply that its outermost mem
brane could be of phagosomal origin, although it might also
have incorporated elements of the host ER. It is possible that
ATG8-containing vesicles are generated from apicoplastic
membranes to form phagophores, as evidenced in
Plasmodium liver forms. Interestingly, it has been shown
that in a parasite strain of Plasmodium overexpressing
ATG8, the apicoplast forms an abnormally large, reticulate
network that ultimately collapses, leading to poorly infectious
parasites [2464]. This finding suggests that ATG8 may supply
the apicoplast with lipids, controlling the maintenance and
homeostasis of this organelle. On the apicoplast of T. gondii,
ATG8 plays a role in the centrosome-mediated inheritance of
the organelle in daughter cells during parasite division, which
highlights unconventional functions of ATG8 in protists
[2465]. Interestingly, both ATG8 and PtdIns3P-binding
PROPPINs of the WIPI/Atg18 family are essential for apico
plast function [2466, 2467]. Because of this peculiar ATG8
localization and potential morphological similarities between
the multi-membrane apicoplast and stress-induced autopha
gosomes, caution must be taken when identifying these struc
tures by electron microscopy or by fluorescence microscopy
with ATG8 labeling in these parasites.
3. LC3 conjugation system for IFNG-mediated pathogen
control
Similar to LAP, LC3 localizes on the parasitophorus vacuole
membrane (PVM) of T. gondii [246]. The parasitophorus
vacuole is a vesicle-like structure formed from host plasma
membrane during the invasion of T. gondii, and it seques
ters and protects the invasive T. gondii from the hostile host
cytoplasm. The cell-autonomous immune system uses
IFNG-induced effectors, such as immunity-related
GTPases and guanylate binding proteins (GBPs), to attack
and disrupt this type of membrane structure; consequently,
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naked T. gondii in the cytoplasm are killed by a currently
unknown mechanism. Intriguingly, proper targeting of
these effectors onto the PVM of T. gondii requires the
autophagic ubiquitin-like conjugation system, including
ATG7, ATG3, and the ATG12–ATG5-ATG16L1 complex
[2468], although the necessity of LC3-conjugation itself for
the targeting is not yet clear [2469]. In contrast, up- or
downregulation of canonical autophagy using rapamycin,
wortmannin, or starvation do not significantly affect the
IFNG-mediated control of T. gondii. Furthermore, the
degradative function or other components of the autophagy
pathway, such as ULK1/2 and ATG14, are dispensable.
Many groups have confirmed the essential nature of the
LC3-conjugation system for the control of T. gondii [2470–
2472], and the same or a similar mechanism also functions
against other pathogens such as murine norovirus and
Chlamydia trachomatis [1958, 2470]. Although topologi
cally and mechanistically similar to LAP, the one notable
difference is that the parasitophorous vacuole of T. gondii is
actively made by the pathogen itself using host membrane,
and the LC3-conjugation system-dependent targeting hap
pens even in nonphagocytic cells. GBP-mediated lysis of
pathogen-containing vacuoles is important for the activa
tion of noncanonical inflammasomes [2473], but the target
ing mechanism of GBPs to the vacuoles is unknown.
Considering the necessity of the LC3-conjugation system
to target GBPs to the PVM of T. gondii, this system may
play crucial roles in the general guidance of various effector
molecules to target membranes, as well as in selective pha
gophore-dependent sequestration, phagophore membrane
expansion and autophagosome maturation.
4. Intracellular trafficking of bacterial pathogens
Some ATG proteins are involved in the intracellular trafficking
and cell-to-cell spread of bacterial pathogens by noncanonical
autophagic pathways. For example, ATG9 and WIPI1, but not
ULK1, BECN1, ATG5, ATG7 or LC3B are required for the
establishment of an endoplasmic reticulum-derived replicative
niche after cell invasion with Brucella abortus [2474]. In addi
tion, the cell-to-cell transmission of B. abortus seems to be
dependent on ULK1, ATG14 and PIK3C3/VPS34, but inde
pendent of ATG5, ATG7, ATG4B and ATG16L1 [2475].
5. Exocytosis with LC3-associated membranes
The Atg8-family protein lipidation machinery is also involved
in non-canonical secretion and exocytosis of extracellular vesi
cles [105, 106]. This role has been initially described for yeast
Acb1 [2476, 2477] and IL1B and CFTR in more complex
eukaryotes [1700, 2478, 2479]. In addition to Atg8-family pro
tein lipidation, this pathway seems to require Golgi reassemblystacking proteins (GORASPs) and components of ESCRT com
plexes [2480, 2481]. The associated release of extracellular
vesicles with Atg8-family protein-conjugated membranes is
also hijacked by viruses for their efficient exocytosis [2482–
2484]. In the filamentous fungus Aspergillus nidulans, a protein
denoted AN4171/BapH (BAR- and PH domain-containing) is
an effector of RAB11 that binds PtdIns(4,5)P2 and localizes to
exocytic membranes. In mutants lacking BapH, basal autopha
gy under nitrogen-replete conditions is increased, suggesting
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that it acts as a liaison between exocytosis/endocytic recycling
and autophagy [2200].
6. Other processes
ATG proteins are involved in various other nonautophagic
processes, particularly apoptosis, membraneless organelle
dynamics, COPII-mediated ER export, and noncanonical pro
tein secretion, as discussed in various papers [31, 105, 106,
818, 858, 2399, 2448, 2485–2489]. For example, ATG5 and
RUBCN, but not RB1CC1, are required for LC3-associated
endocytosis (LANDO), identified in microglial cells and the
macrophage RAW264.7 cell line [2458], whereas the require
ment of ATG5, RUBCN, and the lack of a requirement for
RB1CC1 are well-established for the non-canonical function
of autophagy proteins in the LAP pathway. LANDO is also
required for the recycling of putative beta-amyloid receptors
(CD36, TREM2, and TLR4) from internalized endosomes to
the plasma membrane.
F. Interpretation of in silico assays for monitoring
autophagy
The increasing availability of complete (or near-complete)
genomes for key species spanning the eukaryotic domain
provides a unique opportunity for delineating the spread of
autophagic machinery components in the eukaryotic world
[2490, 2491]. Fast and sensitive sequence similarity search
procedures are already available; an increasing number of
experimental biologists are now comfortable “BLASTing”
their favorite sequences against the ever-increasing sequence
databases for identifying putative homologs in different spe
cies [2492]. Nevertheless, several limiting factors and potential
pitfalls need to be taken into account.
In addition to sequence comparison approaches, a number
of computational tools and resources related to autophagy
have become available online. All the aforementioned meth
ods and approaches may be collectively considered as “in
silico assays” for monitoring autophagy, in the sense that
they can be used to identify the presence of autophagy com
ponents in different species and provide information on their
known or predicted associations.
In the following sections we briefly present relevant in
silico approaches, highlighting their strengths while under
scoring some inherent limitations, with the hope that this
information will provide guidelines for the most appropriate
usage of these resources.
1. Sequence comparison and comparative genomic
approaches
Apart from the generic shortcomings when performing
sequence comparisons (discussed in ref. [2493]), there are
some important issues that need to be taken into account,
especially for autophagy-related proteins. Because autophagy
components seem to be conserved throughout the eukaryotic
domain of life, the deep divergent relations of key subunits
may reside in the so called “midnight zone” of sequence
similarity: i.e., genuine orthologs may share even less than
10% sequence identity at the amino acid sequence level
[2494]. This is the case with autophagy subunits in protists
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[2495, 2496] and with other universally conserved eukaryotic
systems, as for example the nuclear pore complex [2497]. This
low sequence identity is especially pronounced in proteins
that contain large intrinsically disordered regions [2498]. In
such cases, sophisticated (manual) iterative database search
protocols, including proper handling of compositionally
biased subsequences and considering domain architecture
may assist in eliminating spurious similarities or in the iden
tification of homologs that share low sequence identity with
the search molecule [2496–2498].
Genome-aware comparative genomics methods [2499] can
also provide invaluable information on yet unidentified com
ponents of autophagy. However, care should be taken to avoid
possible Next Generation Sequencing artefacts (usually incor
rect genome assemblies): these may directly (via a similarity to
a protein encoded in an incorrectly assembled genomic
region) or indirectly (via propagating erroneous annotations
in databases) give misleading homolog assignments [2500]. In
addition, taking into account other types of high-throughput
data available in publicly accessible repositories (e.g., EST/
RNAseq data, expression data) can provide orthogonal evi
dence for validation purposes when sequence similarities are
marginal [2497].
2. Web-based resources related to autophagy
A number of autophagy-related resources are now available
online, providing access to diverse data types ranging from
gene lists and sequences to comprehensive catalogs of physical
and indirect interactions. In the following we do not attempt
to review all functionalities offered by the different servers,
but to highlight those that (a) offer possibilities for identifying
novel autophagy-related proteins, or (b) characterize features
that may link specific proteins to autophagic processes. Two
comments regarding biological databases in general also apply
to autophagy-related resources as well: (a) the need for regular
updates, and (b) data and annotation quality. Nevertheless,
these issues are not discussed further herein.
a. The
THANATOS
database. THANATOS
(THe
Apoptosis, Necrosis, AuTophagy OrchestratorS) is a compre
hensive data resource developed by the CUCKOO
Workgroup, which contains 191,543 proteins potentially asso
ciated with autophagy and cell death pathways in 164 eukar
yotes [2501]. THANATOS was started from the manual
collection of 4,237 experimentally identified proteins regu
lated in autophagy and cell death pathways from the litera
ture, whereas potential orthologs of these known proteins
were computationally detected. Besides sequence data,
known PTMs, protein-protein interactions (PPIs) and func
tional annotations are also integrated. A simple web interface
assists in data retrieval, using keyword searches, browsing by
species and cell death type, performing BLAST searches with
user-defined sequences, and by requesting the display of
orthologs among predefined species. Using the data in
THANATOS, an evolutionary analysis demonstrates that the
machinery of the autophagy pathway is highly conserved
across eukaryotes, whereas statistical analyses suggest human
autophagy proteins are enriched among cancer gene products
and drug targets. A reconstruction of a kinase-substrate

phosphorylation network for ATG proteins supports a critical
role of phosphorylation in regulating autophagy. The
THANATOS database is publicly available online at the
URL http://thanatos.biocuckoo.org/.
With the help of THANATOS, a network-based algorithm
of in silico Kinome Activity Profiling/iKAP was designed to
computationally infer protein kinases differentially regulated
by two natural neuroprotective autophagy enhancers, cory
noxine (Cory) and corynoxine B (Cory B) [2502]. This algo
rithm predicted and verified that two kinases, MAP2K2/
MEK2 (mitogen-activated protein kinase kinase 2) and PLK1
(polo like kinase 1), are essential for Cory-induced autophagy
to promote the clearance of AD-associated APP (amyloid beta
precursor protein) and PD-associated SNCA/α-synuclein
(synuclein alpha). The CUCKOO workgroup is mainly
focused on PTM bioinformatics, and has developed fourteen
PTM site predictors, five tools for biological data analysis, and
twelve PTM-related databases at the URL http://www.bio
cuckoo.org/, including DeepPhagy (deep learning for auto
phagy) for quantitatively analyzing four types of autophagic
phenotypes in Saccharomyces cerevisiae, including the vacuo
lar targeting of GFP-Atg8, the targeting of Atg1-GFP to the
vacuole, the vacuolar delivery of GFP-Atg19, and the disin
tegration of autophagic bodies indicated by GFP-Atg8 [2503].
DeepPhagy was implemented in a 5-layer convolutional
neural network framework, containing three connected con
volutional blocks and two fully connected layers, and is freely
available online at the URL http://deepphagy.biocuckoo.org/.
This workgroup also developed CGDB, the Circadian Gene
DataBase at URL http://cgdb.biocuckoo.org/ [2504] (see
Clockophagy).
b. The human autophagy database (HADb). The human
autophagy
database,
developed
in
the
Tumor
Immunotherapy and Microenvironment (TIME) group at
the Luxembourg Institute of Health, lists over 200 human
genes/proteins related to autophagy [920]. These entries
have been manually collected from the biomedical literature
and other online resources. An update of the initially pub
lished list is currently underway. For each gene there exists
information on its sequence, transcripts and isoforms (includ
ing exon boundaries) as well as links to external resources.
HADb provides basic search and browsing functionalities and
is publicly available online at the URL http://autophagy.lu/.
c. The autophagy database. The Autophagy Database is a
multifaceted online resource providing information for pro
teins related to autophagy and their homologs across several
eukaryotic species, with a focus on functional and structural
data [2505]. It is developed by the National Institute of
Genetics (Japan) under the Targeted Proteins Research
Program of the Ministry of Education, Culture, Sports,
Science and Technology (http://www.tanpaku.org/). This
resource is regularly updated and as of August 2014 contained
information regarding 312 reviewed protein entries; when
additional data regarding orthologous/homologous proteins
from more than 50 eukaryotes is considered, the total number
of entries reaches approximately 9,000. In addition to the
browse functionalities offered under the “Protein List” and
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the “Homologs” menus, an instance of the NCBI-BLAST soft
ware facilitates sequence-based queries against the database
entries. Moreover, interested users may download the gene list
or the autophagy dump files licensed under a Creative
Commons Attribution-ShareAlike 2.1 Japan License. The
Autophagy Database is publicly available online at the URL
http://www.tanpaku.org/autophagy/index.html.

research groups have described this peptide as the LIR
[423], the LC3 recognition sequence (LRS) [1020], or the
AIM [2509]. Two independent efforts resulted in the first
online available tools for identification of these motifs (LIRmotifs for brevity) in combination with other sequence fea
tures, which may signify interesting targets for further valida
tion (see below).

d. The Autophagy Regulatory Network (ARN). Another
addition to the web-based resources relevant to autophagy
research is the Autophagy Regulatory Network (ARN), ori
ginally developed at the Eötvös Loránd University and
Semmelweis University (Budapest, Hungary) in collaboration
with the Quadram Institute and the Earlham Institute
(Norfolk, UK). Maintenance and hosting the ARN resource
is secured at The Genome Analysis Centre until at least 2022.
ARN is an integrated systems-level resource aiming to collect
and provide an interactive user interface enabling access to
validated or predicted protein-protein, transcription factorgene and miRNA-mRNA interactions related to autophagy
in human [2506]. ARN contains data from 26 resources,
including an in-house extensive manual curation, the dataset
of a ChIP-MS study [658], ADB and ELM. As of June 2020, a
total of more than 15,000 proteins and 800 miRNAs and
lncRNAs are included in ARN, including 38 core autophagy
proteins with more than 500,000 transcriptional, post-tran
scriptional and post-translational interactions. Importantly, all
autophagy-related proteins are linked to major signaling path
ways. A flexible—in terms of both content and format—
download functionality enables users to locally use the ARN
data under the Creative Commons AttributionNonCommercial-ShareAlike 3.0 Unported License. The auto
phagy regulatory network resource is publicly available online
at the URL http://autophagyregulation.org.

f. The iLIR server. The iLIR server is a specialized web
server that scans an input sequence for the presence of a
degenerate version of LIR, the extended LIR-motif (xLIR)
[2510]. Currently, the server also reports additional matches
to the “canonical” LIR motif (WxxL), described by the simple
regular expression x(2)-[WFY]-x(2)-[LIV]. A position-specific
scoring matrix (PSSM) based on validated instances of the LIR
motif has also been compiled, demonstrating that many of the
false positive hits (i.e., spurious matches to the xLIR motif)
are eliminated when a PSSM score >15 is sought. In addition,
iLIR also overlays the aforementioned results to segments that
reside in or are adjacent to disordered regions and are likely
to form stabilizing interactions upon binding to another
globular protein as predicted by the ANCHOR package
[2511]. A combination of an xLIR match with a high PSSM
score (>13) and/or an overlap with an ANCHOR segment
gives reliable predictions [2510]. It is worth mentioning that,
intentionally, iLIR does not provide explicit predictions of
functional LIR motifs but rather displays all the above infor
mation accompanied by a graphical depiction of query
matches to known protein domains and motifs; it is up to
the user to interpret the iLIR output. As mentioned in the
original iLIR publication, a limitation of this tool is that it
does not handle any noncanonical LIR motifs at present. The
iLIR server was jointly developed by the University of
Warwick and University of Cyprus and is freely available
online at the URL http://repeat.biol.ucy.ac.cy/iLIR. A similar
web-based AIM prediction tool termed high-fidelity AIM
(hfAIM) was also developed by scientists at the Weizmann
Institute and Ghent University [2512], and is freely available
online at the URL http://bioinformatics.psb.ugent.be/hfAIM/.
iLIR database: Using the iLIR server, a database of puta
tive LIR-containing proteins (LIRCPs) has been created. The
iLIR database (https://ilir.warwick.ac.uk) lists all the putative

e. Prediction of Atg8-family interacting proteins. Being cen
tral components of the autophagic core machinery, Atg8family members (e.g., LC3 and GABARAP subfamilies in
mammals) and their interactome have attracted substantial
interest [658, 2507, 2508]. During the last decade, a number
of proteins have been shown to interact with Atg8 homologs
via a short linear peptide; depending on context, different
Table 3. Eukaryotic linear motif entries related to the LIR motif.4

4

ELM identifier
LIG_LIR_Gen_1

ELM
[EDST].{0,2}[WFY]..[ILV]

LIG_LIR_Apic_2

[EDST].{0,2}[WFY]..P

LIG_LIR_Nem_3

[EDST].{0,2}[WFY]..[ILVFY]

LIG_LIR_LC3C_4

[EDST].{0,2}LVV

LIG_AIM

[WY]..[ILV]

LIG_LIR

WxxL or [WYF]xx[LIV]

LIG_GABARAP

W.FL

Obtained from http://elm.eu.org

Description
Canonical LIR motif that binds to Atg8-family protein members to mediate processes
involved in autophagy.
Apicomplexa-specific variant of the canonical LIR motif that binds to Atg8-family
protein members to mediate processes involved in autophagy.
Nematode-specific variant of the canonical LIR motif that binds to Atg8-family
protein members to mediate processes involved in autophagy.
Noncanonical variant of the LIR motif that binds to Atg8-family protein members to
mediate processes involved in autophagy.
Atg8-family protein interacting motif found in Atg19, SQSTM1, ATG4B and CALR
(calreticulin), involved in autophagy-related processes.
The LIR might link ubiquitinated substrates that should be degraded to the
autophagy-related proteins in the phagophore membrane.
GABAA receptor binding to clathrin and CALR; possibly linked to trafficking.

Status
ELM
ELM
ELM
ELM
Candidate
Candidate
Candidate
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canonical LIRCPs identified in silico in the proteomes of
eight model organisms combined with a Gene Ontology/
GO term analysis. Additionally, a curated text-mining ana
lysis of the literature suggests novel putative LIRCPs in
mammals that have not previously been associated with
autophagy [2513].
iLIR@viral: The iLIR@viral database (http://ilir.uk/virus/)
lists all the putative canonical LIR motifs identified in viral
proteins, using the iLIR server. Curated text-mining analysis
of the literature suggests the presence of novel putative
LIRCPs in viruses [2514].
g. The Eukaryotic Linear Motif resource (ELM). The
Eukaryotic Linear Motif resource [2515] is a generic resource
for examining functional sites in proteins in the form of short
linear motifs, which have been manually curated from the lit
erature. Sophisticated filters based on known (or predicted)
query features (such as taxonomy, subcellular localization, struc
tural context) are used to narrow down the results lists, which
can be very long lists of potential matches due to the short
lengths of ELMs. This resource has incorporated four entries
related to the LIR-motif (since May 2014; http://elm.eu.org/
infos/news.html), while another three are being evaluated as
candidate ELM additions (Table 3). Again, the ELM resource
displays matches to any motifs and users are left with the
decision as to which of them are worth studying further. ELM
is developed/maintained by a consortium of European groups
coordinated by the European Molecular Biology Laboratory and
is freely available online at the URL http://elm.eu.org.
h. Molecular modeling of interactions between Atg8-family
proteins and LIR-containing proteins. The availability of sev
eral sets of experimental data on LIR-containing proteins, the
3-dimensional structure of their complexes, and sequencebased predictors such as iLIR [2513], has been providing the
foundations to apply molecular modeling and simulations to
the study of the complexes between members of the Atg8family proteins and LIR-containing proteins. This class of
methods can help autophagy research at different levels: i)
to provide information on the role of the residues N- and Cterminal from the core LIR motifs for which coordinates are
often missing in the available experimental structures; ii) as a
guide for experiments to suggest the residue to mutate to
validate structure-based hypotheses; iii) to provide a struc
ture-based rationale of available experimental data and shed
light on determinants of specificity towards different mem
bers of the Atg8-family proteins; and iv) to help in the
identification of the best LIR-containing candidates for
experimental validation in case of multi-domain proteins
with several predicted LIRs [1258, 2516, 2517]. In approach
ing modeling and simulations studies of the Atg8-family pro
tein-LIR complexes, it is important to have a careful design of
the modeling and simulation protocol, selection of the physi
cal model (i.e., force field) to employ to describe the complex
structure and dynamics, and use, where possible, multiple
models with different conformations of the LIR-containing
region in the Atg8-family protein binding pockets to avoid

limitation due to the sampling of the conformational space
accessible to classical molecular dynamics simulations.
i. The
ncRNA-associated
cell
death
database
(ncRDeathDB). The noncoding RNA (ncRNA)-associated
cell death database (ncRDeathDB) [2518], most recently
developed at the Harbin Medical University (Harbin, China)
and Shantou University Medical College (Shantou, China),
documents a total of more than 4,600 ncRNA-mediated pro
grammed cell death entries. Compared to previous versions of
the miRDeathDB [2519–2521], the ncRDeathDB further col
lected a large amount of published data describing the roles of
diverse ncRNAs (including microRNA, long noncoding RNA/
lncRNA and small nucleolar RNA/snoRNA) in programmed
cell death for the purpose of archiving comprehensive
ncRNA-associated cell death interactions. The current version
of ncRDeathDB provides an all-inclusive bioinformatics
resource on information detailing the ncRNA-mediated cell
death system and documents 4,615 ncRNA-mediated pro
grammed cell death entries (including 1,817 predicted entries)
involving 12 species, as well as 2,403 apoptosis-associated
entries, 2,205 autophagy-associated entries and 7 necrosisassociated entries. The ncRDeathDB also integrates a variety
of useful tools for analyzing RNA-RNA and RNA-protein
binding sites and for network visualization. This resource
will help researchers to visualize and navigate current knowl
edge of the noncoding RNA component of cell death and
autophagy, to uncover the generic organizing principles of
ncRNA-associated cell death systems, and to generate valuable
biological hypotheses. The ncRNA-associated cell death inter
actions resource is publicly available online at the URL http://
www.rna-society.org/ncrdeathdb.
j. Predicting impact for autophagy-related gene copy number
alterations in cancer. Autophagy is tumor suppressive, yet can
also exert pro-survival effects once tumors have been established.
The HAPTRIG R tool developed at UCSD uses a curated data
set of autophagy genes to predict the functional impact of
increases and decreases of genes in the autophagy pathway in
cancer [2522]. This tool is useful for determining deficiencies in
autophagy among tumor types, as well as for individual tumors
within a tumor type. The tool also can prioritize which genes
most influence autophagy within a dataset based on proteinprotein interactions and haploinsufficiency data. These priori
tized genes can then be the subject of further experimentation.
The Shiny application of this tool is available at the URL https://
delaney.shinyapps.io/haptrig_single_pathway_networks.
k. KFERQ finder. There is a growing interest in studying CMA
due to its fundamental regulatory role in the physiopathology of
diverse cellular processes [2523]. Substrate selectivity is one of the
main features of CMA, which relies on the recognition by HSPA8
of KFERQ-like motifs in the sequence of the proteins to be
degraded [2524]. Therefore, a reliable, quick and high-throughput
method has been developed to find these motifs. This tool
(KFERQ finder) allows the identification of KFERQ-like motifs
in any given protein of the human, mouse and rat proteomes
using their Uniprot ID. Furthermore, multiple proteins can be
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analyzed uploading the Uniprot IDs in a .csv file, and, finally, the
search can be also performed in protein sequences [1809]. The
KFERQ finder is available at the URL http://tinyurl.com/kferq.
l. Autophagy to Disease (ATD). Autophagy to Disease
(ATD) is a comprehensive bioinformatics resource for deci
phering the association of autophagy and diseases. The Liao
group developed ATD (http://auto2disease.nwsuaflmz.com)
to archive autophagy-associated diseases. This resource pro
vides a bioinformatics annotation system about genes, chemi
cals, autophagy and human diseases by extracting results from
previous studies with text mining technology. Based on ATD,
some classes of disease tend to be related with autophagy,
including respiratory diseases, cancer, urogenital diseases and
digestive system diseases. In addition, some classes of auto
phagy-related diseases have a strong association among each
other and constitute modules. Furthermore, by extracting
autophagy-disease-related genes from ATD, a novel algorithm
was generated, Optimized Random Forest with Label model,
to predict potential autophagy-disease-related genes. This
bioinformatics annotation system about autophagy and
human diseases may provide a basic resource for the further
detection of the molecular mechanisms of autophagy as they
relate to disease.
m. LysoQuant. A seven-layer convolutional network with UNet architecture was trained by Molinari’s lab to perform seg
mentation and classification of individual lysosomes from con
focal images with human-level accuracy. This approach, termed
LysoQuant, offers quantitative analyses of lysosome number, size,
shape, position and occupancy with cargo (i.e., proteins or orga
nelles to be cleared from cells). These parameters eventually
inform on activity of lysosome-driven pathways including auto
phagy at the molecular level and on consequences of genetic or
environmental modifications [2525]. LysoQuant is freely available
at http://www.imaging.irb.usi.ch/lysoquant.
3. Mathematical models of autophagy dynamics
The idea of using mathematical modeling to characterize the
population dynamics of autophagosomes and other vesicles
involved in autophagy (e.g., autolysosomes) was discussed as
early as 1975 [1529, 1530]. However, realization of this idea
occurred only much later, after methods became available to
precisely monitor changing autophagic vesicle populations in
individual cells [2526, 2527]. Present and increasing opportunities
to generate quantitative data make further modeling work timely,
as do compelling needs to better understand the spatiotemporal
dynamics of the subcellular structures affected by and mediating
autophagy as well as the system-level behaviors of the molecular
networks that regulate autophagy, which contain numerous
potential drug targets relevant for diverse diseases [2528].
Because even simple mathematical models have proven to be
powerful aids for reasoning about biological systems [2529], we
strongly encourage greater use of mathematical modeling in stu
dies of autophagy.
In recent years, several autophagy-relevant mathematical
models have been developed and analyzed to study a range of
subjects, including the cell fate decision between autophagy
and apoptosis [2530–2532], the role of feedback loops in
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cellular regulatory networks and the possibility of bifurcations
in qualitative system-level behavior [2533–2535], autophagyrelated gene expression dynamics [2536], mitophagy [2537,
2538], pexophagy [2539], and the design of drug interventions
for manipulating autophagy [2540].
Mathematical modeling can be, and is, pursued through a rich
variety of techniques [2541], and new methods, together with
enabling software tools [2542], continue to emerge regularly.
The method that one selects for a particular study should be
well-matched to the question(s) being asked; the appropriate
level of abstraction is invariably context-dependent. Methods
specialized for modeling dynamic compartments [2543] and bio
molecular site dynamics [2544] may be of special interest in
autophagy studies.
Although these modeling processes carry limitations in
terms of complexity and portraiture of the realistic biological
phenomenon, they can simultaneously be used to study a
biological system where the goal is to unveil the underlying
principles that are veiled at different levels of description.
Various types of mathematical models can be used to study
the autophagy process that includes ordinary, partial and
stochastic differential equations. Ordinary differential equa
tions/ODE are the simplest form to model a biological system
where the focus is to study autophagy dynamics with respect
to change in the protein/metabolite concentration [2530,
2532, 2540, 2545–2548]. Partial differential equations/PDE
can be an important approach to model autophagy-dependent
processes such as autophagy-dependent motility, an area yet
to be explored in autophagy. To study the randomness
imposed by the generation and variability of different stresses
and continuous fluctuations in cellular energy levels, stochas
tic modeling techniques can be applied [2527, 2549].
Autophagy dynamics can also be studied in a discrete-based
approach using agent-based modeling [2526, 2537]. Another
useful modeling tool is petri net (place/transition) [2550],
which is capable of modeling both discrete and continuous
types of autophagy in cellular biochemical reactions [2551].
In brief, some of the most important, general guidelines for
good modeling practice are as follows: Whenever possible, model
development and analysis should be tightly integrated with experi
mental efforts [2552], and model analysis should be directed at
generating non-obvious insights and testable predictions, not
simply at reproducing phenomenology. Of course, models have
purposes beyond prediction, for example, in capturing knowledge
and providing explanations, in exposing knowledge gaps, and in
determining the logical consequences of assumptions [2553–
2555]. Models should be made shareable and reusable—for this
purpose, standardized model-definition formats [2556, 2557],
means for encoding simulation protocols [2558, 2559], and online
databases [2560] have been developed. The problem of estimating
the values of model parameters is an incessant concern of mode
lers. Some have recommended that this task is best accomplished
through curve fitting versus direct measurement [2561, 2562]. In
any case, uncertainties of parameter estimates and model predic
tions should be quantified, which is, arguably, best accomplished
via Bayesian methods [2563, 2564]. These methods are not always
practical because of their computational expense; however, alter
native, less computationally expensive approaches are available
[2565]. Reproducibility of modeling, a growing concern [2566,
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Table 4. Recommended methods for monitoring autophagy.5
Method

Description

1

Atg8-family protein western blotting

Western blot. The analysis is carried out in the absence and presence of lysosomal protease or fusion inhibitors
to monitor flux; an increase in the LC3-II amount in the presence of the inhibitor is usually indicative of flux.

2

Atg18 oligomerization

FRET stopped-flow assay, chemical cross-linking, mass spectrometry.

3

Autophagic protein degradation

Turnover of long-lived proteins to monitor flux.

4

Autophagic sequestration assays

Accumulation of cargo in autophagic compartments in the presence of lysosomal protease or fusion inhibitors
by biochemical or multilabel fluorescence techniques.

5

Autophagosome quantification

FACS/flow cytometry.

6

Autophagosome-lysosome colocalization
and dequenching assay

Fluorescence microscopy.

7

Bimolecular fluorescence complementation

Can be used to monitor protein-proteim interaction in vivo.

8

Degradation of endogenous lipofuscin

Fluorescence microscopy.

9

Electron microscopy

Quantitative electron microscopy, immuno-TEM; monitor autophagosome number, volume, and content/cargo.

10 FRET

Interaction of LC3 with gangliosides to monitor autophagosome formation.

11 GFP-Atg8-family protein fluorescence
microscopy

Fluorescence microscopy, flow cytometry to monitor vacuolar/lysosomal localization. Also, increase in punctate
GFP-Atg8-family protein or Atg18/WIPI, and live time-lapse fluorescence microscopy to track the dynamics of
GFP-Atg8-family protein-positive structures.

12 GFP-Atg8-family protein lysosomal delivery
and proteolysis

Western blot +/- lysosomal fusion or degradation inhibitors; the generation of free GFP indicates lysosomal/
vacuolar delivery.

13 Immunofluorescence for endogenous LC3
puncta

Can be used to identify autophagosomes in cells difficult to transfect with a GFP-LC3 chimera.

14 Keima

Confocal microscopy, flow cytometry, western blotting to monitor transfer of Keima or various Keima fusion
variants to acidic and proteolytically active environments.

15 MTOR, AMPK and Atg1/ULK1 kinase activity Western blot, immunoprecipitation or kinase assays.
16 Pex14-GFP, GFP-Atg8, Om45-GFP,
mitoPho8Δ60

A range of assays can be used to monitor selective types of autophagy. These typically involve proteolytic
maturation of a resident enzyme or degradation of a chimera, which can be followed enzymatically or by
western blot.

17 Sequestration and processing assays in
plants

Chimeric RFP fluorescence and processing, and light and electron microscopy.

18 SQSTM1- and related LC3-binding protein
turnover

The amount of SQSTM1 increases when autophagy is inhibited and decreases when autophagy is induced, but
the potential impact of transcriptional and/or translational regulation or the formation of insoluble aggregates
should be addressed in individual experimental systems.

19 Tandem mRFP/mCherry-GFP fluorescence
microscopy, Rosella

Flux can be monitored as a decrease in green/red (yellow) fluorescence (phagophores, autophagosomes) and
an increase in red fluorescence (autolysosomes).

20 Tissue fractionation

Centrifugation, western blot and electron microscopy.

21 Transcriptional and translational regulation

Northern blot, or RT-PCR, autophagy-dedicated microarray.

22 Turnover of autophagic compartments

Electron microscopy with morphometry/stereology at different time points.

23 WIPI fluorescence microscopy

Quantitative fluorescence analysis using endogenous WIPI proteins, or GFP- or MYC-tagged versions. Suitable
for high-throughput imaging procedures.

2567], is enhanced when general-purpose software compatible
with established standards is used for simulations, curve fitting,
uncertainty quantification, etc.
For the beginner, excellent, fairly comprehensive introduc
tions to systems biology modeling are available [2568, 2569],
and short courses are also available [2570].
As one specific example, mathematical models minimizing
the membrane bending energy show that phagophore expansion,
which elongates the length of the energetically expensive phago
phore edge, is sufficient to drive remodeling of the initially flat
phagophore into a curved shape [2571]. Furthermore, geometric
5

This table is not meant to provide a comprehensive list.

considerations indicate that several hundred or thousands of
vesicles are required to form a single autophagosome [2572].
The absence of comparable vesicle numbers implies that vesicles
provide a minor autophagosomal membrane source.

3. Conclusions and Future Perspectives
There is no question that research on the topic of autophagy
has expanded dramatically since the publication of the first set
of guidelines [3]. To help keep track of the field we have
published a glossary of autophagy-related molecules and
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processes [2573, 2574], and now include the glossary as part
of these guidelines.
With this continued influx of new researchers, we think it
is critical to try to define standards for the field. Accordingly,
we have highlighted the uses and caveats of an expanding set
of recommended methods for monitoring autophagy in a
wide range of systems (Table 4). Importantly, investigators
need to determine whether they are evaluating levels of early
or late autophagic compartments, or autophagic flux. If the
question being asked is whether a particular condition
changes autophagic flux (i.e., the rate of delivery of autophagy
substrates to lysosomes or the vacuole, followed by degrada
tion and efflux), then assessment of steady state levels of
autophagosomes (e.g., by counting GFP-LC3 puncta, moni
toring the amount of LC3-II without examining turnover, or
by single time point electron micrographs) is not sufficient as
an isolated approach. In this case it is also necessary to
directly measure the flux of autophagosomes and/or autopha
gy cargo (e.g., in wild-type cells compared to autophagydeficient cells, the latter generated by treatment with an auto
phagy inhibitor or resulting from ATG gene knockdowns or
knockouts). Collectively, we strongly recommend the use of
multiple assays whenever possible, rather than relying on the
results from a single method.
As a final reminder, we stated at the beginning of this article
that this set of guidelines is not meant to be a formulaic compila
tion of rules, because the appropriate assays depend in part on the
question being asked and the system being used. Rather, these
guidelines are presented primarily to emphasize key issues that
need to be addressed such as the difference between measuring
autophagy components, and flux or substrate clearance; they are
not meant to constrain imaginative approaches to monitoring
autophagy. Indeed, it is hoped that new methods for monitoring
autophagy will continue to be developed, and new findings may
alter our view of the current assays. This is a dynamic field, much
like the process of autophagy, and we need to remain flexible in
the standards we apply.
For those on the move, a Quick Guide to autophagy is
provided below.

Glossary
2-D08: An inhibitor of protein SUMOylation that induces
autophagy-mediated cancer cell death [2673].
2-Methoxyestradiol (2-ME): 2-ME is a natural metabolite of
estrogen that prevents angiogenesis and tumor progression. 2ME regulates autophagy through mechanisms that involve
both ROS production [2674] and MAPK/JNK-DRAM path
way activation [2675].
3-MA: See 3-methyladenine.
3-Methyladenine (3-MA): An inhibitor of class I PI3K and
class III PtdIns3K, which results in autophagy inhibition due
to suppression of class III PtdIns3K [435], but may under
some conditions show the opposite effect [436, 437, 1749]. At
concentrations >10 mM 3-MA inhibits other kinases such as
AKT (Ser473), MAPK/p38 (Thr180/Tyr182) and MAPK/JNK
(Thr183/Tyr185) [2676].
3BDO (3-benzyl-5-[[2-nitrophenoxy} methyl]–dihydro
furan-2[3h]-one): A novel MTOR activator that occupies the
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rapamycin-binding site and blocks the interaction between
rapamycin and FKBP1A, and then activates the MTOR signal
ing pathway to inhibit autophagy initiation [2677].
11ʹ-deoxyverticillin A (C42): An epipolythiodioxopiperazine
fungal secondary metabolite that is used as an anticancer drug;
it triggers apoptotic and necrotic cell death, and enhances
autophagy through the action of PARP1 and RIPK1 [2678].
12-ylation: The modification of substrates by covalent con
jugation to ATG12, first used to describe the autocatalytic
conjugation of ATG12 to ATG3 [2679]. See also LC3/
GABARAP-ylation.
14-3-3ç: See YWHAZ.
AAK1 (AP2 associated kinase 1): A cellular serine-threonine
protein kinase that functions as a key regulator of clathrinmediated endocytosis and interacts with LC3B [2680].
ABT737: A BH3 mimetic that competitively disrupts the
interaction between BECN1 and BCL2 or BCL2L1, thus
inducing autophagy [2681]. It should be noted, however,
that by its inhibitory action on the anti-apoptotic BCL2
family members, ABT737 also leads to apoptosis
[2682].
ABTL0812 (2-hydroxylinoleic acid): ABTL0812 is in clinical
development for the treatment of endometrial and lung cancer.
ABTL0812 shows anticancer activity in several animal models
of cancer by stimulating autophagy-mediated cancer cell death.
This effect occurs via activating PPARA (peroxisome prolifera
tor activated receptor alpha) and PPARG, as well as via trigger
ing the ER stress-related response. Both effects synergize to
inhibit the AKT-MTORC1 axis [2683, 2684].
ACBD5 (acyl-CoA binding domain containing 5):
ACBD5 is the human ortholog of fungal KpAtg37. ACBD5
localizes on peroxisomes and, via its interaction with the
VAPA/B ER proteins, mediates physical contact between per
oxisomes and the ER in humans [2685]; ACBD5 is required
for pexophagy [458, 2686]. See also Atg37.
ACBP (acyl-CoA-binding type 2 protein): ACBP transports
acyl-CoA esters, and is involved in the elongation of fatty
acid. In the filamentous fungus Aspergillus oryzae, ACBP
moves in the cytoplasm in a microtubule-dependent manner,
and is transported to vacuoles via the autophagy machinery
[2687].
Acetyl-coenzyme A: A central energy metabolite that
represses autophagy if present in the cytosol [2688, 2689].
Acinus: A protein that in Drosophila regulates both endocy
tosis and autophagy; the acn mutant is defective in autopha
gosome maturation, whereas stabilization of endogenous Acn
by mutation of its caspase cleavage site [2690] or by CDK5mediated phosphorylation [2691], or overexpression of Acn
leads to excessive autophagy [2692]. Note that Acn can also
induce DNA condensation or fragmentation after its activa
tion by CASP3 in apoptotic cells.
ACSL1 (acyl-CoA synthetase long chain family member
1): An isozyme of the long-chain fatty-acid-coenzyme A
ligase family that converts fatty acids to acyl-CoAs. It is the
major long-chain mammalian ACSL isoform in the heart.
The knockdown of the ACSL1 gene indirectly impairs cardiac
autophagy through MTORC1 activation [2693].
ActA: A L. monocytogenes protein that recruits the Arp2/3
complex and other actin-associated components to the cell
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surface to evade recognition by xenophagy; this effect is
independent of bacterial motility [2694].
ACY-1215/Ricolinostat: ACY-1215 is an orally bio-avail
able, selective HDAC6 inhibitor (with an IC50 in the
nanomolar range in vitro), which abrogates the autopha
gic clearance of aggresomes. Consequently, ACY-1215
treatment results in accumulation of misfolded protein
aggregates, as reported in multiple myeloma and mantle
cell lymphoma [2577, 2695].
Adaptophagy: Selective degradation of signaling adaptors
downstream of TLRs or similar types of receptor families
[2696].
ADH5/GSNOR (alcohol dehydrogenase 5 [class III], chi
polypeptide): A denitrosylase that catalyzes the reduction of
the S-nitrosylated form of glutathione formed by the exchange
of NO with S-nitrosylated proteins. ADH5/GSNOR expression
declines during age in mammals and affects the efficiency of
selective mitophagy of damaged mitochondria, being, in this
manner, implicated in cell senescence and aging [1011, 1012].
ADIPOQ (adiponectin, C1Q and collagen domain contain
ing): An adipocytokine that induces cytotoxic autophagy by
activating the STK11 tumor suppressor [2697].
ADNP (activity-dependent neuroprotective homeobox): A
protein that interacts with LC3B and shows an increased
expression in lymphocytes from schizophrenia patients
[1662]. When mutated de novo, ADNP causes an autism
spectrum disorder, the ADNP syndrome, exhibiting intellec
tual disabilities (see also https://www.orpha.net/consor/cgibin/OC_Exp.php?lng=EN&Expert=404448).
Aduk (Another Drosophila Unc-51-like kinase): A ULK3
homolog that is required for normal lifespan and autophagy
induction in response to chemical stress but not nutrient or
developmental cues [2698].
AEG-1: See MTDH.
AEN/ISG20L1 (apoptosis enhancing nuclease): A protein
that localizes to nucleolar and perinucleolar regions of the
nucleus, which regulates autophagy associated with genotoxic
stress; transcription of AEN is regulated by TP53-family mem
bers [2699].
AFIM (ATG5 [five] interacting motif): A peptide motif
forming an α-helical structure that interacts with ATG5,
which has a conserved sequence, W-x(3)-I-x(3)-L-x(2)-R-x
(2)-[QE] [882].
AGER/RAGE (advanced glycosylation end-product specific
receptor): A member of the immunoglobulin gene superfam
ily that binds the HMGB1 (high mobility group box 1) chro
matin binding protein [2700], AGER overexpression enhances
autophagy and reduces apoptosis. This can occur in response
to ROS, resulting in the upregulation of autophagy and the
concomitant downregulation of apoptosis, favoring tumor cell
survival in response to anticancer treatments that increase
ROS production. In addition, autophagy is involved in the
removal of advanced glycation end products, further linking
this process to age-related diseases [2701]. See also HMGB1.
Aggrephagy: The selective removal of aggregates by a auto
phagy-like process [1092].
AGS3: See GPSM1.
Aggresome: An aggregation of misfolded proteins formed by
a highly regulated process mediated by HDAC6 or BAG3

[1838, 2702]. This process requires protein transport by a
dynein motor and microtubule integrity. Aggresomes form
at the microtubule-organizing center and are surrounded by
a cage of the intermediate filament protein VIM (vimentin).
Note that not all proteins that aggregate and form filaments
like HTT or MAPT form aggresomes. HDAC6 recognizes
ubiquitin chains through a UBD domain. HDAC6 interacts
with both Lys48 and Lys63 linkages, with preference for
Lys63. Proteostat is a molecular probe that emits a strong
fluorescent signal upon binding to β-sheet structures in mis
folded protein aggregates [2703]. Proteostat staining coloca
lizes with LC3B puncta and can therefore be used to stain
intracellular protein aggregates as well as aggresomes [2704].
AHA (L-azidohomoalanine): An amino acid analog used for
labeling newly synthesized protein and monitoring autophagic
protein degradation [1018].
AICAR (aminoimidazole-4-carboxamide riboside): Cell
permeable nucleotide analog that is an activator of AMPK;
inhibits autophagy [666] through mechanisms that are not
related to its effect on AMPK [679, 2705].
AICD (APP intracellular domain): The C-terminal fragment
of APP (amyloid beta precursor protein) derived from
gamma-secretase cleavage. This fragment has been described
as a transcription factor [2706]. AICD controls PINK1mediated mitophagy by upregulating its transcription in a
FOXO3-dependent manner [2707].
AIM (Atg8-family interacting motif): A short peptide motif
that allows interaction with Atg8 by binding at the LIR/AIM
docking site [2509]. See also WXXL motif, LIR/LRS and LDS.
AKT/PKB (AKT serine/threonine kinase): A serine/threo
nine kinase that negatively regulates autophagy in some cel
lular systems.
Alfy: See WDFY3.
ALIS (aggresome-like induced structures): These structures
may function as protein storage compartments and are
cleared by autophagy [418]. SQSTM1 may regulate their for
mation and autophagic degradation [419]. See also DALIS.
Allophagy: The selective degradation of sperm components
by autophagy; this process occurs in C. elegans [1109–1112].
See also post-fertilization sperm mitophagy.
ALLO-1 (ALLOphagy defective): ALLO-1 is a C. elegans pro
tein acting as an autophagy receptor required for LGG-1 recruit
ment and degradation of sperm-inherited organelles [1116].
ALOX5 (arachidonate 5-lipoxygenase): See lipoxygenases.
ALOX15 (arachidonate 15-lipoxygenase): See lipoxygenases.
ALR: See autophagic lysosome reformation.
ALS2/alsin (alsin Rho guanine nucleotide exchange factor
ALS2): A guanine nucleotide exchange factor for the small
GTPase RAB5 that regulates endosome and autophagosome
fusion and trafficking; loss of ALS2 accounts for juvenile
recessive ALS, juvenile primary lateral sclerosis, and infan
tile-onset ascending hereditary spastic paralysis [2708, 2709].
ALS-FTD (amyotrophic lateral sclerosis-frontotemporal
dementia): See C9orf72.
AMBRA1 (autophagy and beclin 1 regulator 1): A positive
regulator of autophagy and a mitophagy receptor. AMBRA1
interacts with both BECN1 and ULK1, modulating their
activity [703, 741, 1956]. Also, a role in both PRKN-depen
dent and -independent mitophagy has been described for
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AMBRA1 [1174], and its mitophagy function is controlled by
the E3 ubiquitin ligase HUWE1 and the CHUK/IKKα kinase
[2516]. AMBRA1 activity is regulated by dynamic interactions
with DDB1 and ELOB/TCEB2 (elongin B), the adaptor pro
teins of the E3 ubiquitin ligase complexes containing CUL4
(cullin 4) and CUL5, respectively [2710]. Finally, AMBRA1 is
the autophagy adaptor linking this process to cell prolifera
tion, by negatively regulating the oncogene MYC through the
latter’s phosphorylation status [2711].
AMFR/gp78 (autocrine motility factor receptor): An ERassociated E3 ubiquitin ligase that degrades the MFN (mito
fusin) mitochondrial fusion proteins and induces mitophagy
[2712].
Amino acid analogs: Mimics of natural amino acids that
induce the formation of protein aggregates and activate the
autophagic flux in an NFKB-dependent manner [1107].
Amiodarone: An FDA-approved antiarrhythmic drug that
induces autophagic flux via AMPK- and AKT-mediated
MTOR inhibition [2713]. Amiodarone exerts severe side
effects that include lung and liver toxicity where amiodar
one-induced autophagy plays context- and organ-specific
roles [2713–2715].
Amphisome (AM): Intermediate compartment formed by the
fusion of an autophagosome with an endosome (this compart
ment can be considered a type of autophagic vacuole and may
be equivalent to a late autophagosome, and as such has a
single limiting membrane); the amphisome has not yet fused
with a lysosome [2716]. Amphisomes can also fuse with the
plasma membrane to release the autophagic cargo (exosomal
pathway). See also exophagy.
AMPK (AMP-activated protein kinase): A sensor of energy
level that is activated by an increase in the AMP:ATP ratio
via the STK11/LKB1 kinase. Phosphorylates the MTORC1
subunit RPTOR to cause induction of autophagy. AMPK
also activates the TSC1/2 complex (thus inhibiting RHEB),
and binds and directly phosphorylates (and activates) ULK1
as part of the ULK1 kinase complex, which includes ATG13,
ATG101 and RB1CC1 [672, 673]. The yeast homolog of
AMPK is Snf1 [666, 2717]. Conversely, ULK1 can phosphor
ylate AMPK through a negative feedback loop [710]. AMPK
is a heterotrimeric enzyme composed of the PRKAA1/
AMPKα1 or PRKAA2/AMPKα2 subunit, the PRKAB1/
AMPKβ1 or PRKAB2/AMPKβ2 subunit and the PRKAG1/
AMPKγ1,
PRKAG2/AMPKγ2
or
PRKAG3/AMPKγ
subunits.
Ams1/α-mannosidase: A resident vacuolar hydrolase that is a
cargo of the Cvt pathway; Ams1 forms an oligomer in the
cytosol similar to prApe1 [2718]. See also Atg11 and Atg19.
AMSH1/3: Two Arabidopsis deubiquitinating enzymes that
have been linked to plant autophagy [2719, 2720].
AN4171/BapH: An effector of Aspergillus nidulans RAB11
that connects exocytic membranes with basal autophagy.
AN4171/BapH contains BAR and PH domains; the PH
domain is essential for membrane targeting [2200].
Antimycin A (AMA): A mitophagy inducer; antimycin A
inhibits mitochondrial electron transport chain complex III,
leading to increased ROS generation and a relatively limited
dissipation of mitochondrial transmembrane potential;
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therefore, it is often used in combination with oligomycin
[1224]. See also oligomycin.
Antiviral innate immune response: A process of establishing
an antiviral state through DDX58/retinoic acid-inducible gene
I-like receptor-mediated production of IFNs (interferons) in
virus-infected cells. The IFNs ultimately trigger the expression
of IFN-stimulated genes that suppress viral replication [2721].
Autophagy suppresses the antiviral innate immune response
by targeting the adaptor proteins of DDX58-IFN signaling
[2722, 2723].
ANXA5/annexin V (annexin A5): ANXA5 is one member of
the family of calcium and phospholipid-binding proteins.
Early ellipsometry studies that focused on PS demonstrate
that adsorption of proteins is calcium-dependent and is com
pletely reversible upon calcium depletion. Treatments that
alter membrane phospholipids and/or their charge will alter
ANXA5 binding. Cells undergoing apoptosis lose plasma
membrane asymmetry, such that high levels of PS become
exposed on the cell surface. These cells can be recognized by
staining with ANXA5, which binds to PS with high affinity.
Increased ANXA5 binding to the outer mitochondrial mem
brane has been related to the induction of mitophagy. The
molecules responsible for ANXA5 binding to mitochondrial
membranes are not extensively studied. Diminished mito
chondrial OGDH (oxoglutarate dehydrogenase) complex/
alpha-ketoglutarate dehydrogenase complex may increase the
levels of various metabolites prior to the OGDH complex. For
example, loss of FH (fumarate hydratase) activity causes accu
mulation of intracellular fumarate, which can directly modify
cysteine residues to form 2-succinocysteine through succina
tion, and this could alter the surface charge on the mitochon
dria. The OGDH complex can also modify lysine groups by
succinylation, which changes the charge and shape of mole
cules [1198].
AP2 (adaptor related protein complex 2): AP2 is a hetero
tetrameric clathrin adaptor complex comprised of four sub
units (AP2A/α, AP2B1/β2, AP2M1/μ2, AP2S1/σ2). Apart
from its canonical function in endocytosis, AP2 facilitates
retrograde transport of signaling autophagosomes containing
active NTRK2/neurotrophin receptor TrkB in developing
neurons. This mechanism involves the direct binding of a
LIR motif within the AP2A subunit of AP2 to LC3 and
complex formation of AP2 with DCTN1/p150Glued [2724].
AP4 (adaptor related protein complex 4): AP4 is a clathrinindependent heterotetrameric adaptor complex comprised of
four subunits (AP4E1/ε, AP4B1/β4, AP4M1/µ4, AP4S1/σ4).
Mutations in all four subunits can lead to complicated forms
of hereditary spastic paraparesis [2725–2727]. AP4 mediates
export of ATG9A from the trans-Golgi network to promote
autophagosome formation [2728], and AP4 loss leads to
depletion of ATG9A and disrupted autophagosome biogenesis
in the distal axon [2729].
AP5 (adaptor related protein complex 5): AP5 is a clathrin
independent heterotetrameric adaptor complex consisting of 4
subunits (AP5Z1/ζ, AP5B1/β5, AP5M1/μ5, and AP5S1/σ5).
Mutation in the AP5Z1/ζ subunit results in hereditary spastic
paraparesis [2730]. AP5 is involved in Golgi retrieval and
autophagic degradation [2731, 2732].
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APC (activated protein C): APC (PROC that has been acti
vated by thrombin) modulates cardiac metabolism and aug
ments autophagy in the ischemic heart by inducing the
activation of AMPK in a mouse model of ischemia/reperfu
sion injury [2733].
Ape1 (aminopeptidase I): A resident vacuolar hydrolase that
can be delivered in its precursor form (prApe1) to the vacuole
through either the cytoplasm-to-vacuole targeting (Cvt) path
way or autophagy, in vegetative or starvation conditions,
respectively [177]. The propeptide of prApe1 is removed
upon vacuolar delivery, providing a convenient way to moni
tor localization of the protein and the functioning of these
pathways, although it must be noted that delivery involves a
receptor and scaffold so that its transit involves a type of
selective autophagy even in starvation conditions. See also
Atg11, Atg19 and cytoplasm-to-vacuole targeting pathway.
Ape1 complex/prApe1 complex: A large protein complex
comprised of multiple prApe1 dodecamers localized in the
cytosol [180].
Ape4: A vacuolar aspartyl aminopeptidase that binds the
Atg19 receptor and is transported to the vacuole through
the Cvt pathway [2734].
Apicoplast: Multimembrane nonphotosynthetic plastid pre
sent in several apicomplexan parasites. ATG8 is recruited to
its outermost membrane using the same conjugation machin
ery as for its recruitment to the phagophore membrane, and
there it plays an essential role for maintaining the homeostasis
of this organelle, which is clearly distinct from the canonical
degradative autophagy pathway [2735].
APMA (autophagic macrophage activation): A collection of
autophagy-related processes in cells of the reticulo-endothelial
system. APMA includes (1) convergence of phagocytosis and
the autophagic machinery, (2) enhanced microbicidal proper
ties of autolysosomes in comparison to standard phagolyso
somes, (3) autophagic modulation of pathogen recognition
receptor signaling, (4) cooperation between immunity-related
GTPases and ATG proteins in attacking parasitophorus
vacuoles, and (5) enhanced antigen presentation. APMA is
thus recognized as a complex outcome of autophagy stimula
tion in macrophages, representing a unique composite process
that brings about a heightened state of immunological activa
tion [2736].
APOL9 (apolipoprotein L 9): A phosphatidylethanolaminebinding mouse protein, which interacts preferentially with the
lipidated form of LC3/GABARAP proteins, associates with
microtubules and localizes to mitochondria and lysosomes
in autophagy-arrested cells [2737].
Apoptosis: Apoptosis is a programmed cell death process that
controls autophagy. Conversely, autophagy can also regulate
apoptosis [2738]. See also caspases.
Appressorium: A specialized infection structure produced by
pathogenic fungi to rupture the outer layer of their host and
gain entry to host cells. In plant pathogenic fungi, such as the
rice blast fungus M. oryzae, formation of appressoria follows
autophagy in conidia and recycling of the spore contents to
the developing infection cell [373, 2197].
AR-12 (OSU-03012): A broad-specificity anti-viral celecoxibderivative that stimulates autophagosome formation and viral
protein degradation [2580].

ARD1: See NAA10.
Are1: See Ayr1.
Are2: See Ayr1.
Arl1: A small GTP-binding protein involved in formation of
the autophagosome in yeast [2739].
ARRB1/β-arrestin-1 (arrestin beta 1): Members of the
arrestin/beta-arrestin protein family are thought to participate
in agonist-mediated desensitization of G-protein-coupled recep
tors and cause specific dampening of cellular responses to sti
muli such as hormones, neurotransmitters, or sensory signals.
ARRB1 is a cytosolic protein and acts as a cofactor in the
ADRBK/BARK (adrenergic, beta, receptor kinase)-mediated
desensitization of beta-adrenergic receptors. Besides the central
nervous system, it is expressed at high levels in peripheral blood
leukocytes, and thus the ADRBK/beta-arrestin system is thought
to play a major role in regulating receptor-mediated immune
functions. This protein plays a neuroprotective role in the con
text of cerebral ischemia through regulating BECN1-dependent
autophagosome formation [2740].
ARHI: See DIRAS3.
ARIH1/HHARI/UBCH7BP (ariadne RBR E3 ubiquitin
protein ligase 1): An E3 ligase that belongs to the RBR family
(including PRKN) that is involved in the regulation of mito
phagy in a PINK1-dependent manner. ARIH1-dependent
mitophagy plays a key role in the response of cancer cells to
chemotherapy [2741].
Arl8: A small GTPase binding partner of the homotypic
fusion and vacuole protein sorting (HOPS) tethering complex
that positively regulates lysosomal fusion events including
autophagosome-lysosome fusions [2742].
ARN5187: Lysosomotropic compound with dual inhibitory
activity against the circadian regulator NR1D2/REV-ERBβ
and autophagy. Although ARN5187 and CQ have similar
lysosomotropic potency and are equivalent with regard to
autophagy inhibition, ARN5187 has a significantly improved
in vitro anticancer activity [2582].
Arsenic trioxide: A compound used currently to treat leuke
mia, which triggers cell death and autophagy [2743].
ASB10 (ankyrin repeat and SOCS box containing 10): The
ASB family of proteins mediate ubiquitination of protein
substrates via their SOCS box and as such have been impli
cated as negative regulators of cell signaling. ASB10 coloca
lizes with aggresome biomarkers and pre-autophagic
structures and may form ALIS [2744].
AT-101: (-)-Gossypol, a polyphenolic compound from cotton
seed that induces mitophagy via the mitochondrial perme
ability transition pore in human glioblastoma cells and in the
filamentous fungus Podospora anserina [2745, 2746].
AtEH/Pan1: The Arabidopsis EH proteins (AtEH1/Pan1 and
AtEH2/Pan1) are components of the endocytic TPLATE com
plex, which is essential for endocytosis. Both proteins are
homologs of the yeast Arp2/3 complex activator, Pan1. The
depletion of AtEH1/Pan1 impairs autophagosome formation
and pollen development [2747].
ATF4 (activating transcription factor 4): A transcription
factor that is induced by hypoxia, amino acid starvation and
ER stress during the integrated stress response. The induction
of ATF4 depends on translational control mediated by the
EIF2S1/eIF2α pathway and involves a mechanism involving
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upstream open reading frames that promote translation of
ATF4 in the face of global reduction of translation [2748].
ATF4 is involved in the unfolded protein response, playing a
critical role in stress adaptation and progression of neuro- and
retinal degeneration [2749, 2750]; ATF4 binds to a cAMP
response element binding site in the LC3B promoter, resulting
in upregulation of LC3B [2751], and also directs an autophagy
gene transcriptional program in response to amino acid
depletion and ER stress [473, 570].
ATF5 (activating transcription factor 5): A transcription
factor that is upregulated by the BCR-ABL protein tyrosine
kinase, an autophagy repressor, through the PI3K-AKT path
way that inhibits FOXO4, a repressor of ATF5 transcription;
one of the targets of ATF5 is MTOR [2752].
ATF6: ATF6 is a 90-kDa type II transmembrane protein of
the ER, that is released from HSPA5/Grp78 binding upon ER
stress and translocates to the Golgi apparatus where it is
cleaved by site 1 and site 2 proteases. Subsequently, the
activated ATF6 is translocated to the nucleus where it func
tions in transactivating the DDIT3 gene and thus contributes
to induction of those autophagy genes whose expression
depends on DDIT3.
Atg (autophagy-related): Abbreviation used for most of the
components of the protein machinery that are involved in
selective and nonselective macroautophagy and in selective
microautophagy [2753].
Atg1: A serine/threonine protein kinase that functions in
recruitment and release of other Atg proteins from the PAS
[2754]. The functional homologs in more complex eukaryotes
are ULK1 and ULK2, and in C. elegans is UNC-51.
Atg2: A protein that interacts with Atg18 via an N-terminal
domain [2755] and binds PtdIns3P via an APT1 domain in a
calcium-dependent manner [2756]. Atg2 also interacts with Atg9,
and in atg2∆ mutant cells Atg9 accumulates primarily at the PAS
[2757]. Atg2 tethers the ER to the phagophore along with Atg18
[2758]; Atg2 is able to transfer lipids from one membrane to the
other via a hydrophobic channel similar to Vps13, which may
contribute to expansion of the phagophore [2759–2762].
Atg3: A ubiquitin-conjugating enzyme (E2) analog that con
jugates Atg8-family proteins to phosphatidylethanolamine
(PE) after activation of the C-terminal residue by Atg7
[2763, 2764]. ATG3 can also be conjugated to ATG12 in
more complex eukaryotes [2679]. See also 12-ylation.
Atg4: A cysteine protease that processes Atg8-family proteins by
removing the amino acid residue(s) that are located on the Cterminal side of what will become the ultimate glycine. Atg4 also
removes PE from Atg8-family proteins in a step referred to as
“deconjugation” [288]. Mammals have four ATG4 proteins
(ATG4A to ATG4D) [2765], but ATG4B appears to be the
most relevant for autophagy and has the broadest range of
activity for all of the Atg8 homologs [237, 2766]. C. elegans has
2 proteins, atg-4.1 and atg-4.2, which perform partially redun
dant, but distinct functions in conjugation and deconjugation,
with different phenotypes concerning the biogenesis and accu
mulation of autophagosomes [471]. See also deconjugation.
Atg5: A protein containing ubiquitin folds that is part of the
Atg12–Atg5-Atg16 complex, which acts in part as an E3 ligase
for Atg8-family protein conjugation to PE [2767].
Atg6: See Vps30.
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Atg7: A ubiquitin activating (E1) enzyme homolog that acti
vates both Atg8-family proteins and Atg12 in an ATP-depen
dent process, leading to the lipidation of Atg8-family proteins
[2768, 2769]. In addition to a full-length ATG7, several
human tissues also express an isoform encoding an ATG7
protein that lacks the binding site with LC3 and is unable to
facilitate its lipidation [2770].
Atg8: A ubiquitin-like protein that is conjugated to PE;
involved in cargo recruitment into phagophores, and biogen
esis of autophagosomes. Autophagosomal size is regulated by
the amount of Atg8 [149], possibly by controlling the mem

brane asymmetry of the phagophore [2771]. Because Atg8 is
selectively enclosed into autophagosomes, its breakdown
allows measurement of the rate of autophagy. Mammals
have several Atg8 homologs that are members of the LC3
and GABARAP subfamilies, which are also involved in auto
phagosome formation and/or maturation [32, 199, 204, 914].
The C. elegans homologs are LGG-1 and LGG-2.
Atg9: A transmembrane protein that may act as a lipid carrier
for expansion of the phagophore. In mammalian cells, ATG9A
localizes to the trans-Golgi network and endosomes, whereas in
fungi this protein localizes in part to peripheral sites (termed
Atg9 reservoirs or tubulovesicular clusters) that are localized
near the mitochondria, and to the PAS [807, 2772]. Mouse
ATG9A has functions independent of autophagy, such as those
in innate immune response and cell death [2773, 2774].Whereas
mammalian ATG9A is ubiquitously expressed, ATG9B is almost
exclusively expressed in the placenta and pituitary gland [2775].
See also Atg9 peripheral sites/structures.
Atg9 peripheral sites/structures: In yeast, these are perimitochondrial sites where Atg9 localizes, which are distinct
from the phagophore assembly site [807, 808]. The Atg9
peripheral sites may be the precursors of the phagophore.
Atg10: A ubiquitin conjugating (E2) enzyme analog that
conjugates Atg12 to Atg5 [2776].
ATG10S (short ATG10): A short protein isoform of
ATG10 with 184 amino acids, in which 36 amino acids
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MVB-derived and other subvacuolar vesicles) and the turn
over of lipid droplets [2789–2791].
Atg16: A component of the Atg12–Atg5-Atg16 complex.
Atg16 dimerizes to form a large complex [2792]. There are
two mammalian homologs, ATG16L1 and ATG16L2; muta
tions in either of the corresponding genes correspond to risk
alleles associated with Crohn disease [2793, 2794].
Atg17: A yeast protein that is part of the Atg1 kinase com
plex. Atg17 is not essential for autophagy, but modulates the
magnitude of the response; smaller autophagosomes are
formed in the absence of Atg17 [148, 743]. In yeast, Atg17
exists as part of a stable ternary complex that includes Atg31
and Atg29; this complex functions as a dimer [2795–2797].
The functional counterpart of this complex in mammalian
cells may be RB1CC1.
Atg18: A yeast protein that binds to PtdIns3P (and PtdIns
[3,5]P2) via its WD40 β-propeller domain. Atg18 interacts
with Atg2, and in atg18∆ cells Atg9 accumulates primarily at
the PAS. Atg18 has additional nonautophagic functions, such
as in retrograde transport from the vacuole to the Golgi
complex, and in the regulation of PtdIns(3,5)P2 synthesis;
the latter function affects the vacuole’s role in osmoregulation
[831]. See also WIPI.
Atg19: A receptor for the Cvt pathway that binds Atg11, Atg8
and the propeptide of precursor aminopeptidase I. Atg19 is
also a receptor for Ams1/α-mannosidase, another Cvt path
way cargo [2798, 2799]. See also Ams1.
Atg20/Snx42: A yeast PtdIns3P-binding sorting nexin that is
part of the Atg1 kinase complex and associates with Snx4/
Atg24 [2800]. Atg20 is a hybrid protein mixing IDPRs with
the PX-BAR domain-containing architecture [2801]. Atg20 is

(encoded in exon 4 of the ATG10 transcript variant 3
sequence in human chromosome 5) are lost via alternative
splicing of ATG10 mRNA. ATG10S functions in autolyso
some formation by promoting autophagosome fusion to
lysosomes, and inactivation of type III interferon transcrip
tion by binding to the promoter of IFNL2/type III inter
feron 2 [2437, 2777, 2778] (M.-q. Zhang, Q. Zhao, J.-p.
Zhang, unpublished data).
Atg11: A scaffold protein that acts in selective types of auto
phagy including the Cvt pathway, mitophagy and pexophagy.
Atg11 binds Atg19, K. phaffii/P. pastoris Atg30 (PpAtg30) and
Atg32 as part of its role in specific cargo recognition. Atg11
also binds Atg9 and is needed for its movement to the PAS
[2779]. Atg11 in conjunction with receptor-bound targets
may activate Atg1 kinase activity during selective autophagy
[2780]. Homologs of Atg11 include RB1CC1 in mammals
(Atg11 has significant homology to the C terminus of
RB1CC1, although the latter does not appear to function as
an Atg11 ortholog) [2781, 2782], EPG-7 in C. elegans [2783],
and ATG11 in Arabidopsis [2781], as well as some sequence
and functional homology to HTT [2784].
Atg12: A ubiquitin-like protein that modifies an internal
lysine of Atg5 by covalently binding via its C-terminal glycine
[2767]. In mouse and human cells, ATG12 also forms a
covalent bond with ATG3, and this conjugation event plays
a role in mitochondrial homeostasis [2679]. The C. elegans
homolog is LGG-3.
Atg13: A component of the Atg1 complex that is needed for
Atg1 kinase activity. Atg13 is highly phosphorylated in a
PKA- and TOR-dependent manner in nutrient-rich condi
tions. During starvation-induced autophagy in yeast, Atg13
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is partially dephosphorylated. In mammalian cells, at least
MTOR and ULK1 phosphorylate ATG13. The decreased
phosphorylation of Atg13/ATG13 that results from TOR/
MTOR inhibition is partly offset in terms of the change in
molecular mass by the ULK1-dependent phosphorylation that
occurs upon ULK1 activation [745, 2785]. The C. elegans
ortholog is EPG-1.
Atg14: A component of the class III PtdIns3K complex that is
necessary for the complex to function in autophagy [2786].
ATG14 also tethers to the ER-mitochondria contact site and
facilitates lipophagy-mediated ER stress regulation [2787].
Also known as ATG14/ATG14L/BARKOR in mammals
[799], or EPG-8 in C. elegans [2788].
Atg15: A yeast vacuolar protein that contains a lipase/esterase
active site motif and is needed for the breakdown of auto
phagic and Cvt bodies within the vacuole lumen (as well as

involved in the Cvt pathway and pexophagy, and facilitates
nonselective autophagy. M. oryzae Snx41 (MoSnx41) is homo
logous to both yeast Atg20 and Snx41, and carries out func
tions in both pexophagy and nonautophagy vesicular
trafficking [2203].
Atg21: A yeast PtdIns3P binding protein that is a homolog of,
and partially redundant with, Atg18 [443]. See also WIPI.
Atg22: A yeast vacuolar amino acid permease that is required
for efflux after autophagic breakdown of proteins [2802,
2803].
Atg23: A yeast peripheral membrane protein that associates
and transits with Atg9 [809, 2804, 2805]. Atg23 (together with
Atg27) contributes to the efficient formation of the Atg9
peripheral sites/structures, and thus affects Atg9 trafficking
to the PAS [2806, 2807]. See also Atg9, Atg27.
Atg24: See Snx4.
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Atg25: A coiled-coil protein required for macropexophagy in
H. polymorpha [2808].
Atg26: A sterol glucosyltransferase that is required for microand macropexophagy in K. phaffii/P. pastoris, but not in S.
cerevisiae [2809, 2810].
Atg27: A yeast integral membrane protein that is required for
the movement of Atg9 to the PAS; together with Atg23 it
contributes to the efficient formation of the Atg9 peripheral
sites/structures [2806, 2807]. The absence of Atg27 results in a
reduced number of autophagosomes under autophagy-indu
cing conditions [2811]. See also Atg9, Atg23.
Atg28: A coiled-coil protein involved in micro- and macro
pexophagy in K. phaffii/P. pastoris [2812].
Atg29: A yeast protein required for efficient nonselective
autophagy in fungi. Part of the yeast Atg17-Atg31-Atg29
complex that functions at the PAS for protein recruitment
[2795–2797, 2813]. See also Atg17, Atg31.
Atg17-Atg31-Atg29 complex.

Atg30: A pexophagy receptor required for the recognition of
peroxisomes during micro- and macropexophagy. KpAtg30
localizes to the membrane of peroxisomes in K. phaffii/P.
pastoris, and binds the peroxisomal membrane proteins
KpPex3 and PpPex14 [1068]. KpAtg30 also interacts with
KpAtg37, the peroxisomal acyl-CoA-binding protein, which
regulates the phosphorylation status of KpAtg30, as well as to
KpAtg17, KpAtg8 and the scaffold protein KpAtg11, that link
KpAtg30 to the core autophagy machinery [458, 2814, 2815].
See also Atg37.
Atg31: A yeast protein required for nonselective autophagy in
fungi. Part of the yeast Atg17-Atg31-Atg29 complex that func
tions at the PAS for protein recruitment and initiation of pha
gophore formation [2795–2797, 2816]. See also Atg17, Atg29.
Atg32: A mitochondrial outer membrane protein that is
required for mitophagy in yeast. Atg32 binds Atg8 and
Atg11 preferentially during mitophagy-inducing condi
tions [1049, 1050]. See also BCL2L13. See also casein
kinase 2.
Atg33: A mitochondrial outer membrane protein that is
required for mitophagy in yeast [1048].
Atg34: A protein that functions as a receptor for import of
Ams1/α-mannosidase during autophagy (i.e., under starvation
conditions) in yeast [2817]. This protein was initially referred to
as Atg19-B based on predictions from in silico studies [2818].
Atg35: The Atg35 protein relocates to the peri-nuclear struc
ture and specifically regulates MIPA formation during micro
pexophagy; the atg35∆ mutant is able to form
pexophagosomes during macropexophagy [2819].
Atg36: Atg36 is a pexophagy receptor, which localizes to the
membrane of peroxisomes in S. cerevisiae. Atg36 binds Atg8
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and the scaffold protein Atg11 that links receptors for selec
tive types of autophagy to the core autophagy machinery
[2820].
Atg37: KpAtg37 is a conserved acyl-CoA-binding protein
that is required specifically for pexophagy in K. phaffii/P.
pastoris at the stage of phagophore formation [458].
KpAtg37 regulates the interaction between the pexophagy
receptor, KpAtg30, and the KpHrr25 kinase required for the
recruitment of the selective autophagy scaffold protein,
KpAtg11, as well as KpAtg8 and consequently the core auto
phagy machinery, to KpAtg30 [2814]. KpAtg37 interacts also
with the peroxin KpPex3 [458]. See also ACBD5.
Atg38: Atg38 physically interacts with Atg14 and Vps34 via
its N terminus. Atg38 is required for autophagy as an integral
component of the PtdIns3K complex I in yeast, and Atg38
functions as a linker connecting the
Vps15-Vps34 and Vps30/Atg6-Atg14
subcomplexes to facilitate complex I
formation [2821].
Atg39: A receptor for selective autop
hagic degradation of nuclear mem
brane in yeast [1334].
Atg40: A receptor that functions in
yeast reticulophagy [1334]. See also
RETREG1.
Atg41/Icy2: A small protein that inter
acts with the transmembrane protein
Atg9, and plays a role in autophagosome formation. Atg41
expression increases substantially under autophagy-inducing
conditions; its upregulation is required for efficient autopha
gy, and it is regulated by the transcription factor Gcn4 [2822].
See also Atg9.
Atg42/Ybr139w: A resident soluble vacuolar glycoprotein
acting as a serine carboxypeptidase, induced in nitrogenpoor conditions or following rapamycin treatment; par
tially redundant with Prc1/carboxypeptidase Y. Atg42
plays a role in the breakdown of autophagic bodies in
the vacuole lumen and in the maintenance of cytosolic
amino acid pools under conditions of nitrogen starvation
[2823].
Atg43: A mitochondrial outer membrane protein in S. pombe
that functions as a mitophagy receptor.
Atg44: A mitochondrial fission factor that functions in
mitophagy.
ATG101: An ATG13-binding protein conserved in various
eukaryotes but not in S. cerevisiae. Forms a stable complex
with ULK1/2-ATG13-RB1CC1 (i.e., not nutrient-depen
dent) required for autophagy and localizes to the phago
phore [2824, 2825]. Note that the official name for this
protein in rodents is 9430023L20Rik, and in C. elegans it
is EPG-9.
Atglistatin (ASTAT): N’-[4ʹ-(dimethylamino)[1,1ʹ-biphenyl]3-yl]-N,N-dimethyl-urea is a potent, selective, and competi
tive inhibitor of PNPLA2/ATGL. This peptide is highly selec
tive for PNPLA2 and does not inhibit other lipases, thus
serving as a novel therapeutic tool to modulate lipolysis
[2826]. See also PNPLA2.
ATI1/2 (ATG8-interacting protein 1/2): Two closely related
ATG8-binding transmembrane proteins in Arabidopsis,
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which are unique to plants and define a stress-induced and
ER-associated compartment that may function in a direct,
Golgi-independent, ER-to-vacuole trafficking pathway
[2827]. AT2G45980/ATI1 and AT4G00355/ATI2 interact
with ER-associated AT1G48410/AGO1/ARGONAUTE 1,
and are involved in its degradation in response to the viral
suppressor of RNA-silencing protein P0 [2828]. ATI1 is also
found in plastids following abiotic stress where it interacts
with both ATG8 and plastid-localized proteins to act in their
delivery to the central vacuole in an ATG5-dependent manner
[1245, 2829].
ATL3 (atlastin GTPase 3): An ER-resident LC3-binding
protein that functions in mammalian reticulophagy [1372].
ATM/ataxia telangiectasia mutated (ATM serine/threo
nine kinase): A protein kinase that is activated in the cytosol
and activates TSC2 via the STK11/LKB1-AMPK cascade in
response to elevated ROS, resulting in inhibition of MTOR
and activation of autophagy [1208, 1209]. In addition, ATM
is known as a DNA damage checkpoint kinase responsible
for maintenance of genome integrity [2830]. ATM also reg
ulates autophagy by sustaining the levels and activity of
ATG4C in cancer stem cells [2831]. The interaction between
ATM and autophagy is required to promote senescence in
response to the 20A G-quadruplex ligand [2832]. See also
senescence.
ATP2A2/SERCA: A sarco/endoplasmic reticulum type 2
calcium ATPase, a member of a family of calcium pumps
important in intracellular calcium signaling. ATP2A/
SERCA activity is regulated by the ER-localized autophagy
protein EPG-3/VMP1 to modulate ER contacts with other
organelles [2833].
ATP6V0A1 (ATPase H+ transporting V0 subunit a1): A
component of the vacuolar proton ATPase that mediates
acidification of intracellular organelles, including the lysoso
mal lumen, and regulates autophagosome-to-lysosome fusion
[2834]. Genomic variability at the ATP6V0A1 locus has been
associated with an increased risk of PD [2835].
ATP13A2 (ATPase type 13A2): A transmembrane lysosomal
type 5 P-type ATPase that is mutated in recessive familial
atypical parkinsonism, with effects on lysosomal function
[2836]. Loss of ATP13A2 function inhibits the clearance of
dysfunctional mitochondria [2837].
Ats-1 (Anaplasma translocated substrate-1): A type IV
secretion effector of the obligatory intracellular bacterium
Anaplasma phagocytophilum that binds BECN1 and
induces autophagosome formation; the autophagosomes
traffic to, and fuse with, A. phagocytophilum-containing
vacuoles, delivering autophagic cargoes into the vacuole,
which can serve as nutrients for bacterial growth [2838,
2839].
ATRA (all-trans retinoic acid): A signaling molecule derived
from vitamin A that actives autophagy and cell differentiation
as demonstrated in leukemia cells [577, 2743, 2840, 2841].
ATTEC (autophagosome-tethering compound): A small
molecule that binds a disease-causing protein and LC3, link
ing the former to a phagophore [2842]
AtTSPO (Arabidopsis thaliana TSPO-related): An ER- and
Golgi-localized polytopic membrane protein transiently
induced by abiotic stresses. AtTSPO binds ATG8 and heme

in vivo and may be involved in scavenging of cytosolic por
phyrins through selective autophagy [2843].
ATXN3 (ataxin 3): A deubiquitinating enzyme that positively
regulates autophagy [2844, 2845]). ATXN3 contains a poly
glutamine repeat that, when expanded, causes the neurode
generative disorder Machado-Joseph disease also known as
spinocerebellar ataxia type-3 (SCA-3). Autophagy is dysregu
lated in this disease [2846].
AUTEN-67 (autophagy enhancer-67): An inhibitor of
MTMR14, which enhances autophagy [2847].
Autogramins: Small-molecule autophagy inhibitors, which
selectively target the cholesterol transport protein
GRAMD1A (GRAM domain containing 1A), an essential
protein for biogenesis of autophagosomes, via competing
with cholesterol to limit the binding to the StAR-related
lipid transfer (StART) domain, thereby inhibiting the choles
terol transfer activity of GRAMD1A [2848, 2849].
Autolysosome (AL): A degradative compartment formed by
the fusion of an autophagosome (or initial autophagic
vacuole/AVi) or amphisome with a lysosome (also called
degradative autophagic vacuole/AVd). Upon completion of
degradation the autolysosome can become a residual body
[2716, 2850], or the autolysosomal membrane can be recycled
to generate mature lysosomes during autophagic flux. This
regenerative process, referred to as autophagic lysosome
reformation (ALR), relies on the scission of extruded auto
lysosomal membrane tubules by the mechanoenzyme DNM2
(dynamin 2) [781, 2851].
Autophagic body (AB): The single-membrane vesicle present
within the vacuole lumen that results from the fusion of an
autophagosome with a vacuole limiting membrane. In S.
cerevisiae, autophagic bodies can be stabilized by the addi
tion of the proteinase B inhibitor PMSF to the medium or by
the deletion of the PEP4 or ATG15 genes. Visualization of
the accumulating autophagic bodies by differential interfer
ence contrast using light microscopy is a convenient, but not
easily quantified, method to follow autophagy [135], whereas
visualization by TEM allows the measurement of their size
and number.
Autophagic lysosome reformation (ALR): A self-regulating
tubulation process in which the autophagic generation of
nutrients reactivates MTOR, suppresses autophagy and allows
for the regeneration of lysosomes that were consumed as
autolysosomes [781]. See also autolysosome.
Autophagic cell death: A historically ambiguous term describ
ing cell death with morphological features of increased auto
phagic vacuoles. This term is best reserved for cell death
contexts in which specific molecular methods, rather than
only pharmacological or correlative methods, are used to
demonstrate increased cell survival following inhibition of au
tophagy [1757].
Autophagic stress: A pathological situation in which
induction of autophagy exceeds the cellular capacity to
complete lysosomal degradation and recycling of constitu
ents; may involve a combination of bioenergetics, acidifi
cation and microtubule-dependent trafficking deficits, to
which neurons may be particularly vulnerable [16].
Autophagic vacuole: A term typically used for mammalian
cells that collectively refers to autophagic structures at all

AUTOPHAGY

stages of maturation. We recommend using this term when
the specific identity of autophagosomes, amphisomes and
autolysosomes are not distinguished.
AutophagamiR: A term to describe miRNAs that function in
the regulation of autophagy [2852].
Autophagolysosome (APL): A degradative compartment
formed by the fusion of an LC3-containing phagosome (see
LAP) or an autophagosome that has sequestered a partial or
complete phagosome with a lysosome. In contrast to a phago
lysosome, formation of the autophagolysosome involves com
ponents of the autophagic machinery. Note that this term is not
interchangeable with “autophagosome” or “autolysosome”
[1480]. See also autolysosome and phagosome.
Autophagoproteasome: A cytosolic membrane-bound com
partment denoted by a limiting single, double or multiple
membrane, which contains both LC3 and UPS antigens. The
autophagoproteasome may be derived from the inclusion of
ubiquitin-proteasome structures within either early or late
autophagosomes containing cytoplasmic material at various
stages of degradation [100]. Thus, the concept of the auto
phagoproteasome refers to an ultrastructural organelle. From
a functional point of view the autophagoproteasome may
feature empowered substrate clearance through the conco
mitant activity of both autophagy and the proteasome. In
fact, the autophagoproteasome contains both LC3 and UPS
antigens, which are detected by TEM and show co-immuno
precipitation, as well as proteasome enzymatic activity
[2853]. In other cases the proteasome component itself
may be destroyed under the process later defined as
proteaphagy.
Autophagosome (AP): A cytosolic membrane-bound com
partment denoted by a limiting double membrane (also
referred to as initial autophagic vacuole, AVi, or early auto
phagosome). The early autophagosome contains cytoplasmic
inclusions and organelles that are morphologically
unchanged because the compartment has not fused with a
lysosome and lacks proteolytic enzymes. Notably, the dou
ble-membrane structure may not be apparent with certain
types of fixatives. Although in most cases the term autopha
gosome refers to a double-membrane compartment, the late
autophagosome or late autophagic vacuole (AVl) may also
appear to have a single membrane (also referred to as an
intermediate or intermediate/degradative autophagic
vacuole, AVi/d) [2716, 2850].
Autophagy: This term summarizes all processes in which
intracellular material is degraded within the lysosome/vacuole
and where the macromolecular constituents are recycled.
Autophagy: A journal devoted to research in the field of
autophagy (http://www.tandfonline.com/toc/kaup20/cur
rent#.VdzKoHjN5xu).
Autophagy adaptor: An Atg8-family-interacting protein that
is not itself a cargo for autophagy.
Autophagy-dependent cell death: A type of RCD that
depends on the autophagic machinery [1266].
Autophagy India Network: The autophagy and lysosome
researchers of India meet annually to promote collaboration
and share research ideas (https://autophagyindianetwork.wee
bly.com/).
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Autophagy receptor: An Atg8-family-interacting protein
that targets specific cargo for degradation and is itself
degraded by autophagy (e.g., SQSTM1, NBR1, OPTN,
Atg19) [2854].
Autophagy receptor: An Atg8-family-interacting protein
that targets specific cargo for degradation and is itself
degraded by autophagy (e.g., SQSTM1, NBR1, OPTN,
Atg19) [2854].
Autophagy-like vesicles (ALVs): Double-membraned vesi
cles (70–400 nm) that accumulate in cells infected by a num
ber of different viruses. These vesicles also have been referred
to as compound-membrane vesicles (CMVs) or as doublemembraned vesicles (DMVs).
Autosis: A form of autophagy-dependent cell death that
requires Na+,K+-ATPase activity (in addition to the autopha
gy machinery) [2638]. Morphologically, autosis has
increased numbers of autophagosomes and autolysosomes,
and nuclear convolution during its early stages, followed by
focal swelling of the perinuclear space. Autosis occurs in
response to various types of stress including starvation and
hypoxia-ischemia.
Axonal autophagy pathway: Neurons are polarized cells
consisting of a highly extended long axon. One widelyaccepted model is that mature lysosomes are mainly distrib
uted in the soma, so that newly formed autophagosomes in
the distal axon need to be transported in a retrograde man
ner into the soma for degradation [880, 881]. However,
studies suggest a second pathway through which degradative
lysosomes are delivered into axons. This pathway has been
characterized by applying a set of fluorescent probes that
selectively label active forms of lysosomal hydrolases in
developing and mature neurons in microfluidic devices.
Soma-derived degradative lysosomes rapidly influx into dis
tal axons and target to autophagosomes for local degradation
[2855, 2856]. Disrupting axon-targeted delivery of degrada
tive lysosomes induces axonal autophagic stress. Thus, the
axon is also an active compartment for local degradation of
autophagosomes.
Ayr1: A triacylglycerol lipase involved in autophagy in
yeast [2857]. Enzymes that participate in the metabolism
of lipid droplets including Dga1 and Lro1 (acyltransferases
involved in triacylglycerol synthesis) and Are1/2 (AcylCoA:sterol acyltransferases) that generate the major com
ponents of lipid droplets, triacylglycerols and steryl esters,
are required for efficient autophagy. Deletion of the genes
encoding Yeh1 (a steryl ester hydrolase), Ayr1 or Ldh1 (an
enzyme with esterase and triacylglycerol lipase activities)
also partially blocks autophagy. Finally, Ice2 and Ldb16,
integral membrane proteins that participate in formation
of ER-lipid droplet contact sites that may be involved in
lipid transfer between these sites are also needed for effi
cient autophagy.
AZD8055: A novel ATP-competitive inhibitor of MTOR
kinase activity. AZD8055 shows excellent selectivity against
all class I PI3K isoforms and other members of the PI3Klike kinase family. Treatment with AZD8055 inhibits
MTORC1 and MTORC2 and prevents feedback to AKT
[1945].
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Azithromycin: A well-known antibiotic that blocks autopha
gy through inhibition of V-ATPase activity and subsequent
blocking of autophagosome-lysosome fusion [2858].
β-oxidation: A multi-step process by which fatty acids are
broken down to produce energy (ATP) in mitochondria.
Deficiency in selective autophagy is associated with suppres
sion of lipid oxidation. Positive-stranded RNA viruses such as
DENV utilize the autophagy-dependent lipid metabolism for
their efficient replication [2859, 2860].
Bafilomycin A1 (BAFA1/BAF): An inhibitor of the V-type
ATPase as well as certain P-type ATPases that prevents acid
ification and alters the membrane potential of certain com
partments; treatment with bafilomycin A1 ultimately results in
a block in fusion of autophagosomes with lysosomes, thus
preventing the maturation of autophagosomes into autolyso
somes [218, 219, 303]. Bafilomycin A1 can also inhibit some
forms of non-canonical autophagy [760, 2861]. Note that the
abbreviation for bafilomycin A1 is not “BFA,” as the latter
is the standard abbreviation for brefeldin A; nor should
BAF be confused with the abbreviation for the caspase
inhibitor boc-asp(o-methyl)fluoremethylketone. See also
concanamycin A.
BAG3 (BCL2-associated athanogene 3): A stress-induced
co-chaperone that utilizes the specificity of HSP70 molecu
lar chaperones toward non-native proteins as the basis for
targeted, ubiquitin-independent autophagic degradation in
mammalian cells (“BAG3-mediated selective macroauto
phagy”); BAG3 is induced by stress and during cell aging,
and interacts with HSP70 and dynein to target misfolded
protein substrates to aggresomes, leading to their selective
degradation [1838, 1839]. BAG3 also interacts with HSPB6
and HSPB8 to target substrates for chaperone-assisted
selective autophagy via a ubiquitin-dependent mechanism
[1828].
BAG6/BAT3 (BCL2-associated athanogene 6): BAG6 tightly
controls autophagy by modulating EP300 intracellular loca
lization, affecting the accessibility of EP300 to its substrates,
TP53 and ATG7. In the absence of BAG6 or when this
protein is located exclusively in the cytosol, autophagy is
abrogated, ATG7 is hyperacetylated, TP53 acetylation is
abolished, and EP300 accumulates in the cytosol, indicating
that of BAG6 regulates the nuclear localization of EP300
[2862].
BapH: See AN4171.
BAPTA-AM
(1,2-bis[2-aminophenoxy]ethane-N,N,N′,N
′-tetraacetic acid tetrakis[acetoxymethyl ester]): BAPTAAM is a potent cell permeant calcium-chelating agent that is
an analog of BAPTA with fast, high-affinity calcium-buffering
properties, typically applied in the 10-20 µM range. BAPTAAM suppresses starvation-, rapamycin- and resveratrolinduced autophagic flux [1983, 1985, 1991]). BAPTA-AM is
useful for manipulation of intracellular free calcium levels
[2863–2865]; however, once inside cells, BAPTA-AM can
also exert calcium-independent effects such as inhibition of
the Na+/K+ ATPase [2002, 2003].
BARA (β-α repeated, autophagy-specific): A domain at the
C terminus of Vps30/Atg6 that is required for targeting
PtdIns3K complex I to the PAS [2866]. The BARA domain
is also found at the C terminus of BECN1.

Barkor: See ATG14.
Basal autophagy: Constitutive autophagic degradation that
proceeds in the absence of any overt stress or stimulus.
Basal autophagy is important for the clearance of damaged
proteins and organelles in normal cells (especially fully differ
entiated, nondividing cells).
BATS
(Barkor/Atg14[L]
autophagosome
targeting
sequence) domain: A protein domain within ATG14 that is
required for the recruitment of the class III PtdIns3K to LC3containing puncta during autophagy induction; the predicted
structure of the BATS domain suggests that it senses mem
brane curvature [824].
Bck1: A MAPKKK downstream of Pkc1 and upstream of
Mkk1/2 and Slt2 that controls cell integrity in response to
cell wall stress; Bck1 is required for pexophagy [1045] and
mitophagy [747]. See also Slt2 and Hog1.
BCL2-family proteins: There are 3 general classes of BCL2
proteins: anti-apoptotic proteins include BCL2, BCL2L1/BclXL, BCL2L2/BCL-W and MCL1 that inhibit autophagy; the
pro-apoptotic BH3-only proteins include BAD, BIK,
PMAIP1/NOXA, BBC3/PUMA and BCL2L11/Bim/BimEL
that induce autophagy; and the pro-apoptotic effector pro
teins BAX and BAK1. Interaction of BCL2 with BECN1 pre
vents the association of the latter with the class III PtdIns3K;
however, anti-apoptotic BCL2 proteins require BAX and
BAK1 to modulate autophagy [2867].
BCL2L13/BCL-RAMBO (BCL2 like 13): BCL2L13 is a mam
malian homolog of Atg32, which is located in the mitochon
drial outer membrane and has an LC3-interacting region.
BCL2L13 induces mitochondrial fission and mitophagy
[2868]. See also Atg32.
BCL10 (BCL10 immune signaling adaptor): The adaptor
protein BCL10 is a critically important mediator of T cell
receptor (TCR)-to-NFKB signaling. After association with
the receptor SQSTM1, BCL10 is degraded upon TCR
engagement. Selective autophagy of BCL10 is a pathwayintrinsic homeostatic mechanism that modulates TCR sig
naling to NFKB in effector T cells [2869].
BDNF (brain derived neurotrophic factor): BDNF is a
member of the nerve growth factor family of proteins that
plays a key role in neuronal survival [2870–2872]. BDNF can
promote neuronal survival via modulation of autophagy
through the MTORC1 pathway [2873]. Under conditions
where apoptosis is still functional, BDNF can promote neu
ronal survival by promoting autophagy, and activating the
MTORC2-PI3K-AKT pathway in a neurotoxic cell model of
mitochondrial complex II inhibition (R. Sathyanarayanan and
M.M. Srinivas Bharath, unpublished data).
BEC-1: The C. elegans ortholog of BECN1.
Beclin 1: See BECN1.
BECN1/Beclin 1 (beclin 1): A mammalian homolog of yeast
Vps30/Atg6 that forms part of the class III PtdIns3K complex
involved in activating autophagy [2874]. BECN1 interacts
with many proteins including BCL2, VMP1, ATG14,
UVRAG, PIK3C3 and RUBCN through its BH3, flexible heli
cal, coiled-coil, and BARA domains; the latter two domains
are also referred to as the evolutionarily conserved domain
(ECD) based on high sequence conservation of this region
[2875]. The C. elegans ortholog is BEC-1.
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BECN1 binding domains (not all proteins shown bind at the same time)

BECN1:

BCL2

ATG14

PIK3C3

BH3

CCD

BARA

VMP1

UVRAG

RUBCN

BECN1s (BECN1 short isoform): A splice variant of BECN1 regulating mitophagy during serum starvation by association
that lacks the sequence corresponding to exons 10 and 11; with ubiquitin [2883].
BECN1s associates with the mitochondrial outer membrane BIRC5/Survivin (baculoviral IAP repeat containing 5): As
and is required for mitophagy [2876] BECN1s can bind a member of the inhibitor-of-apoptosis proteins (IAPs) family,
ATG14 and activate PIK3C3/VPS34, but does not bind BIRC5 interacts with ATG7 and the ATG12–ATG5 conjugate
UVRAG.
to interrupt the formation of the ATG12–ATG5-ATG16L1
BECN2/Beclin 2 (beclin 2): A mammalian-specific homolog protein complex, thus limiting autophagy. This BIRC5-directed
of yeast Vps30/Atg6 that forms part of the class III PtdIns3K autophagy inhibition maintains DNA integrity in human can
complex involved in activating autophagy and that also func cer and mouse embryonic fibroblast cells [821]. BIRC5 can
tions in the endolysosomal degradation of several cellular G bind to LC3 via a canonical LIR, but its mechanism of auto
protein-coupled receptors (GPCRs; independently of the class phagy inhibition does not utilize this interaction [2884].
III PtdIns3K complex) [2877] and a virally encoded GPCR BIRC6/BRUCE (baculoviral IAP repeat containing 6): An
[2878].
anti-apoptotic protein and an E2 ubiquitin enzyme that directly
Betulinic acid: Betulinic acid and its derivatives activate ubiquitinates substrates without E3 ubiquitin ligases. BIRC6 is
autophagy as a rescue mechanism to deal with damaged required to complete fusion of autophagosomes with lysosomes;
mitochondria [314, 1901, 1902, 2879]; however, betulinic BIRC6 forms a complex with STX17 and SNAP29 [2885].
acid impairs lysosomal integrity and converts autophagy into BIX01294: An inhibitor of EHMT2/G9a histone methyltrans
a detrimental process, leading to accumulation of nonfunc ferase (that introduces H3K9me2 and H3K27me3 repressive
tional autolysosomes that can be detected over a long time marks) that triggers autophagy or autophagy-associated cell
frame [314].
death in several tumor cells, including human glioma cells as
BH domain: BCL2 homology domain [2880]. There are 4 well as glioma stem-like cells (GSCs) isolated from an estab
domains of homology, consisting of BH1, BH2, BH3 lished cell line and patient-derived cultures [2886–2889].
and BH4.
EHMT2 binds to the promoters of autophagy- (LC3B,
BH3 domain: A BCL2 homology (BH) domain that is found WIPI1) and differentiation-related (GFAP, TUBB3) genes in
in all BCL2 family proteins, whether they are pro-apoptotic or GSCs; BIX01294 treatment upregulates the expression of these
anti-apoptotic. A BH3 domain is also present in BECN1 and genes in GSCs by counteracting EHMT2 activity [2889].
binds to a hydrophobic surface groove on anti-apoptotic BLOC1S1/GCN5L1 (biogenesis of lysosomal organelles
BCL2 proteins such as human BCL2, BCL2L1/bcl-xL, complex 1 subunit 1): A component of the mitochondrial
BCL2L2/BCL-W and MCL1, as well as γ-herpesvirus 68 acetyltransferase activity that modulates mitophagy and mito
M11 [2881].
chondrial biogenesis [2890].
BH3-only proteins: A series of proteins that contain a BH3 BNIP3 (BCL2 interacting protein 3): Identified in a yeast
domain (but not any other BCL2 homology domains). two-hybrid screen as interacting through its N-terminal 40
Several BH3-only proteins (BAD, BIK, PMAIP1/NOXA, amino acids with BCL2 and adenovirus E1B [2891].
BBC3/PUMA and BCL2L11/Bim/BimEL) can competitively Previously classified as a pro-apoptotic protein, BNIP3
disrupt the inhibitory interaction between BCL2 and promotes mitophagy through direct interaction with
BECN1, which is also a BH3-only protein [2881], to allow LC3B-II mediated by a conserved LIR motif that overlaps
the latter to act as an allosteric activator of PtdIns3K and to with its BCL2-interacting region [2892, 2893]. BNIP3 also
activate autophagy.
modulates mitochondrial fusion through inhibitory inter
Bif-1: See SH3GLB1.
actions with OPA1 via its carboxy terminal 10 amino acids
BIPASS (BAG-instructed proteasomal-to-autophagosomal [2894]. BNIP3 is transcriptionally regulated by HIF1A
switch and sorting): Upon proteasomal impairment, cells
switch to autophagy to ensure proper clear
BNIP3
ance of substrates (the proteasome-to-auto
BCL2-BCL2L1
phagy switch). Following this proteasome
interaction domain
impairment, increasing the BAG3:BAG1
LC3 interacting-region
Transmembrane domain
ratio ensures the initiation of BIPASS
[2882].
NH2
TM
BIRC2/cIAP1/hiap-2 (baculoviral IAP repeat
49
164
194
containing 2): Canonically regarded as an anti- 1 W18
184
apoptotic protein, BIRC2 is also involved in
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[2895], E2Fs [2896], FOXO3 [662], TP53 [2897] and NFKB
[2898] and is most highly expressed in adult heart and liver
[2899, 2900].
BNIP3L/NIX (BCL2 interacting protein 3 like): Identified as
a BNIP3 homolog, BNIP3L is required for mitophagy in red
blood cells [2170, 2171], three factors-induced reprogram
ming [2901], and neuronal differentiation in the mouse retina
[1151]. As with BNIP3, BNIP3L is hypoxia-inducible and also
interacts with LC3B-II and GABARAP through a conserved
LIR motif in its amino terminus [284]. BNIP3L also interacts
with RHEB at the mitochondria and the LC3-BNIP3L-RHEB
complex promotes mitochondrial turnover and efficient mito
chondrial function [2902]. In CCCP-induced mitophagy,
BNIP3L is required for the activation of autophagy by pro
moting CCCP-induced mitochondrial depolarization and
ROS generation, which inhibits MTORC1 [2903].
Bre5: A cofactor for the deubiquitinating enzyme Ubp3. See
also Ubp3.
C/EBPβ: See CEBPB.
C9orf72: C9orf72 plays an important role in the regulation of
endosomal trafficking, and interacts with RAB proteins
involved in autophagy and endocytic transport. C9orf72 con
tains a DENN (differentially expressed in normal and neopla
sia)-like domain, suggesting that it may function as a GDPGTP exchange factor for a RAB GTPase, similar to other
DENN proteins. The normal function of C9orf72 remains
unknown, but it is highly conserved and expressed in many
tissues, including the cerebellum and cortex. Hexanucleotide
(GGGGCC) repeat expansions in a noncoding region of the
C9orf72 gene are the major cause of familial ALS and fronto
temporal dementia [2904]. Recent studies suggest that
C9orf72 is an important regulator of autophagic functions
[715, 1300, 2905–2908] including lipophagy via TFEB and
its cofactor CARM1 [1299]. See also CARM1 and TFEB.
C12orf5: See TIGAR.
C12orf44: See ATG101
Ca-P60A/dSERCA: The Drosophila ER calcium-translocating
ATPase. Inhibition of Ca-P60A with bafilomycin A1 blocks
autophagosome-lysosome fusion [303].
CA7-4: A lncRNA that is upregulated by a high concentration
of glucose. CA7-4 facilitates endothelial autophagy and apop
tosis as a competing endogenous RNA (ceRNA) by decoying
MIR877-3P and MIR5680, promoting the expression of
CTNNBIP1 and DPP4, decreasing the level of CTNNB1 and
increasing AMPK phosphorylation [2909].
Cad96Ca/Stit/Stitcher (Cadherin 96Ca): A Drosophila
receptor tyrosine kinase that is orthologous to the human
proto-oncogene RET. Cad96Ca suppresses autophagy in
epithelial tissues through Akt1-TORC1 signaling in parallel
to InR (Insulin-like receptor). This endows epithelial tissues
with starvation resistance and anabolic development during
nutritional stress [2910].
Caf4: A component of the mitochondrial fission complex that
is recruited to degrading mitochondria to facilitate mito
phagy-specific fission [2911].
CAL-101: A small molecule inhibitor of the PIK3CD/p110δ
subunit of class 1A phosphoinositide 3-kinase; treatment of
multiple myeloma cells results in autophagy induction [2912].
Calcineurin: See PPP3.

CALCOCO2/NDP52 (calcium binding and coiled-coil
domain 2): An autophagy receptor that binds to the bacterial
ubiquitin coat and Atg8-family proteins to target invasive
bacteria, including S. typhimurium and Streptococcus pyo
genes for autophagosomal sequestration [1470]. CALCOCO2 also regulates autophagosome maturation through its
interaction with TOM1-bound MYO6 (myosin VI) on endo
somes, and LC3A/B or GABARAPL2 on autophagosomes
[2913, 2914].
CALM (calmodulin): A calcium-receptor protein in all
eukaryotic cells containing four EF-hand calcium-binding
sites. CALM transduces signals mediated by transient changes
in the concentration of free calcium within the cytosol and the
nucleus, upon binding and regulating a large number of
enzymes, channels, signaling, adaptor and structural proteins.
CALM also regulates a minor group of target proteins in its
calcium-free form. Autophagy is among the multiple cellular
functions regulated by CALM through modulating key pro
teins involved in this process [2915].
Calpain-dependent autophagy: A form of caspase-indepen
dent programmed cell death that occurs in neurons during
normal development and in certain neurological diseases
[2916].
Calpains: A class of calcium-dependent, non-lysosomal
cysteine proteases that cleaves and inactivates ATG5 and the
ATG12–ATG5 conjugate, hence establishing a link between
reduced calcium concentrations and induction of autophagy
[2917].
Calpeptin: A potent calpain inhibitor compound that induces
autophagy, including increased production of autophago
somes [2918], in an MTOR-independent manner [1951].
CALR (calreticulin): A chaperone that is mainly associated
with the ER lumen, where it performs important functions
such as calcium buffering, and participates in protein folding
and maturation of, as well as antigen loading on, MHC
molecules [2919]. An extracellular role for CALR has emerged
where it acts as an “eat me” signal on the surface of cancer
cells [2920]. Importantly, in the context of Hyp-PDT, auto
phagy suppresses CALR surface exposure by reducing ERassociated proteotoxicity [1724, 1729, 2921]. Disruption of
LAMP2A also affects CALR surface exposure [1729].
CaMKKβ: See CAMKK2.
CAMKK2 (calcium/calmodulin-dependent protein kinase
kinase 2, beta): Activates OGT and AMPK in response to an
increase in the cytosolic calcium concentration [2922], resulting
in the induction of autophagy [1007, 1984].
Cannabidiol (CBD): A major nonpsychoactive constituent of
cannabis, recently considered an antineoplastic compound on the
basis of its in vitro and in vivo activity against tumor cells of
different histogenesis. CBD is able to induce autophagy. In parti
cular, CBD induces programmed cell death in breast cancer cells
by coordinating the cross-talk between apoptosis and autophagy
[2923]. In leukemic cells CBD was revealed to induce autophagy
and cell death by directly targeting mitochondria [2924].
Canonical autophagy: Engagement of the hierarchically
ordered activity of ATG proteins at the phagopore for the
formation of double-membraned autophagosomes. The noncanonical use, in contrast, does not require the organized
intervention of all ATG proteins, does not necessarily initiate
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from a single source, and a set of ATG proteins can be
recruited to a pre-existing membrane that is different from
the phagophore [2925].
CAPNS1 (calpain, small subunit 1): The regulatory subunit
of micro- and millicalpain; CAPNS1-deficient cells are auto
phagy defective and display a substantial increase in apoptotic
cell death [2926].
CAPZA1 (capping actin protein of muscle Z-line alpha
subunit 1): The α subunit of F-actin capping protein that
regulates actin polymerization and cell motility via binding
to the barbed ends of actin filaments; CAPZA1 inhibits
LAMP1 expression via binding to the LRP1 intracellular
domain (LRP1-ICD) in the nuclei. The binding of CAPZA1
to the LRP1-ICD prevents LRP1-ICD binding to the LAMP1
proximal promoter. Thus, in CAPZA1-overexpressing gastric
epithelial cells infected with H. pylori, autolysosome forma
tion is inhibited [2927]. See also LRP1.
CAR3 (carbonic anhydrase 3): An isoform of carbonic anhy
drase that interacts with BAG3 and suppresses CASA in
skeletal muscle cells [2928].
Cardiolipin: A phospholipid found in bacteria and mito
chondria that regulates transmembrane protein complexes
including the mitochondrial respiratory chain. Cardiolipin is
translocated to the outer mitochondrial membrane during
mitochondrial injury and binds Atg8-family proteins to trig
ger mitophagy [201, 1190].
CARM1 (coactivator associated arginine methyltransferase
1): CARM1, a histone-arginine methyltransferase, is a coacti
vator of TFEB. The AMPK-SKP2-CARM1 signaling axis is
involved in the transciptional regulation of autophagy [980].
The C9orf72-CARM1 axis regulates lipophagy induction after
nutrient starvation [1299].
CASA (chaperone-assisted selective autophagy): A selective
macroautophagy pathway that utilizes the co-chaperone
BAG3 or its Drosophila homolog stv/starvin to direct the
ubiquitination and lysosomal degradation of substrates
through the action of HSPA8, HSPB8, STUB1/CHIP (or
other ubiquitin ligases), SYNPO2/myopodin, and SQSTM1
[1828, 1837]. CASA routes substrates to the lysosome via an
autophagosome. The process is thought to take place at the
microtubule organizing center to which the CASA complex is
transported in a retrograde manner by dynein associated
directly with a PxxP motif of BAG3 [1840, 2929]. If HSPB8BAG3 are displaced by the co-chaperone BAG1, the cargoes
are routed by HSPA8-STUB1 to the proteasome. CASA
should not be confused with CMA, which also uses chaper
ones for lysosome-dependent degradation.
Casein kinase 2 (CK2): CK2 is a serine/threonine protein
kinase complex that is involved in many cellular activities.
CK2 phosphorylates Atg32 and induces mitophagy in yeast
[2930]. See also Atg32.
Caspases (cysteine-dependent aspartate-directed proteases):
A class of cysteine proteases that play essential roles in apop
tosis (formerly called programmed cell death type I) and
inflammation. Several pro-apoptotic caspases directly interact
with and cleave essential ATG proteins, resulting in the inhi
bition of autophagy [611, 2931]. For example, CASP3 and
CASP8 cleave BECN1 and inhibit autophagy [2932, 2933].
The active form of CASP8 is essential for upregulation of

193

apoptosis in some types of autophagy-deficient cells under
conditions of nutrient limitation [2934].
CASR (calcium sensing receptor): A class C G-protein
coupled receptor that senses extracellular levels of calcium
ion, with a primary function in calcium homeostasis regula
tion. CASR stimulation is associated with increased autophagy
[1563, 2594, 2595, 2935], whereas its inhibition is linked to
decreased autophagy [2936–2938].
CCCP (carbonyl cyanide m-chlorophenyl hydrazone):
Protonophore and uncoupler of oxidative phosphorylation
in mitochondria; stimulates general autophagy [2593] and
mitochondrial degradation inducing mitophagic activ
ity [339].
CCDC88A/GIV (coiled-coil domain containing 88A): A
guanine nucleotide exchange factor for GNAI3 that acts to
downregulate autophagy [2939]. CCDC88A disrupts the
GPSM1-GNAI3 complex in response to growth factors,
releasing the G protein from the phagophore or autophago
some membrane; GNAI3-GTP also activates the class I PI3K,
thus inhibiting autophagy. See also GNAI3.
CCI-779 (temsirolimus): A water-soluble rapamycin ester
that induces autophagy.
CCND1 (cyclin D1): CCND1 functions as a regulator of
cyclin-dependent kinases, and is a protein required for pro
gression through the G1 phase of the cell cycle. CCND1 is
overexpressed in various cancers, including hepatocellular
carcinoma, and is selectively recruited and degraded in a
process mediated by SQSTM1 after ubiquitination [2940,
2941].
CCNY (cyclin Y): A substrate of AMPK that interacts with
and activates CDK16 to promote autophagy [762]. See also
CDK16.
CCPG1 (cell cycle progression 1): An ER-resident LC3- and
RB1CC1-binding protein that functions in ER stress-induced
mammalian reticulophagy [1376].
CD5L (CD5 molecule like): A 40-kDa soluble protein,
expressed and secreted mainly by tissue macrophages, that
controls macrophage inflammatory responses and polariza
tion through the activation of autophagy. CD5L induces
macrophage autophagy through the CD36 receptor [2942–
2944].
CD38 (CD38 molecule): CD38 is a powerful disease marker
for human leukemias and myelomas and is involved in the
development of many disease such as chronic lymphocytic
leukemia, type II diabetes mellitus, atherosclerosis. As a multi
functional enzyme, CD38 can cleave NAD+ and NADP+ to
generate cyclic ADP-ribose/cADPR and NAADP, which reg
ulate autophagy by lysosomal calcium release events that
promote fusion of the lysosome with autophagosomes [2945,
2946].
Cdc48: Yeast homolog of VCP that is a type II AAA+-ATPase
that extracts ubiquitinated proteins from the membrane as
part of the ER-associated protein degradation pathway and
during ER homeotypic fusion [2947], but is also required for
nonselective autophagy [2948]. Disease-associated mutant
forms of Cdc48 are also targeted for autophagic degradation
in plants and yeast [1359]. See also Shp1 and VCP.
CD46: A cell-surface glycoprotein that interacts with the
scaffold protein GOPC to mediate an immune response to
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invasive pathogens including Neisseria and Group A
Streptococcus. Interaction of pathogens via the Cyt1 cytosolic
tail induces autophagy, which involves GOPC binding to
BECN1. CD46 is also used as a cellular receptor by several
pathogens [2949].
CDC42BPA/MRCKA/MRCKα (CDC42 binding protein
kinase alpha): An actin-myosin regulatory kinase required
for TP53-dependent autophagy induced by MDM2/HDM2
inhibition [2950].
Cdk5 (cyclin dependent kinase 5): An unusual member of
the cyclin-dependent kinase family, having no known func
tion in the cell cycle, that is primarily active in postmitotic
neurons. CDK5-mediated downregulation of autophagy is
associated with neurodegeneration primarily through over
activation of the innate immune response [2951], and
CDK5-mediated autophagy has been linked with PD [2952,
2953]. This protein regulates autophagy by phosphorylation of
different substrates such as PIK3C3/VPS34 [411], SH3GLB1/
endophilin B1 [2940, 2952] and ACIN1/acinus [2691].
CDK16 (cyclin dependent kinase 16): CDK16, a member of
the PCTAIRE kinase family, associates with CCNY (cyclin Y),
which is a substrate of AMPK. Phosphorylation of CCNY at
S326 stimulates interaction with CDK16 and activates the
kinase, which promotes autophagy. CDK16 seems not to
have a major impact on the cell cycle; rather, it is associated
with cellular differentiation and with intracellular transport
processes [762].
CDKN1A/p21/Cip1 (cyclin dependent kinase inhibitor 1A):
A cyclin-dependent kinase inhibitor that is associated with the
induction of autophagy in melanoma cells upon exposure to a
telomeric G-quadruplex stabilizing agent [2954].
CDKN1B/p27/Kip1 (cyclin dependent kinase inhibitor 1B):
A cyclin-dependent kinase inhibitor that is phosphorylated
and stabilized by an AMPK-dependent process and stimulates
autophagy [2955].
CDKN2A (cyclin dependent kinase inhibitor 2A): The
CDKN2A locus encodes two overlapping tumor suppressors
that do not share reading frame: p16INK4a and p14ARF. The
p14ARF tumor suppressor protein (p19ARF in mouse) can loca
lize to mitochondria and induce autophagy. Tumor-derived
mutant forms of p14ARF that do not affect the p16INK4a coding
region are impaired for autophagy induction, thus implicating
this activity in tumor suppression by this commonly mutated
locus [2956]. This gene also encodes a lower molecular weight
variant called smARF. See also smARF.
CEBPB/C/EBPβ (CCAAT enhancer binding protein beta):
A transcription factor that regulates several autophagy genes;
CEBPB is induced in response to starvation, and the protein
levels display a diurnal rhythm [989].
Cell differentiation: This is a process through which a cell
commits to becoming a more specialized cell type having a
distinct form and a specific function(s). Autophagy is acti
vated during the differentiation of various normal and can
cerous cells, as revealed, for example, in adipocytes,
erythrocytes, lymphocytes and leukemia cells [636, 2957].
CEP-1 (C. elegans P-53-like protein): See TP53.
Ceramide: Ceramide is a bioactive sphingolipid, which plays
a mitochondrial receptor role to recruit LC3-II-associated
phagophores to mitochondria for degradation in response to

ceramide stress and DNM1L-mediated mitochondrial fission;
the direct binding between ceramide and LC3-II involves F52
and I35 residues of LC3B [896, 901]. Ceramide is also a key
synthetic building block that occupies the central metabolic
branchpoint for anabolic production of sphingolipids such as
sphingomyelin, ceramide-1-phosphate, and glucosylceramide,
which are needed for complex glycosphingolipid synthesis
(including gangliosides) [885, 887].
Ceramide-1-phosphate (C1P): C1P is a bioactive sphingoli
pid that is synthesized by CERK (ceramide kinase) in the
trans-Golgi and promotes some of the same anti-apoptotic
responses as sphingosine-1-phosphate. Exogenous C1P treat
ment of cells or elevation of C1P at the Golgi apparatus by
downregulation of CPTP (ceramide-1-phosphate transfer pro
tein) induces eicosanoid production initiated by PLA2G4/
cytoplasmic phospholipase A2 as well as autophagy in various
cells, and inflammasome assembly in surveillance cells that
drives pro-inflammatory interleukin release [2958–2960]. It is
noteworthy that UVRAG contains a putative C1P binding site
predicted to enhance membrane interaction [2958, 2961]. See
also lipid transfer proteins.
CFATG (Club Francophone de l’AuTophaGie): A club cre
ated in 2011 under the impetus of Patrice Codogno to bring
together the French scientific community around the theme
of autophagy and to favor synergy between scientists coming
from different backgrounds. A dedicated website (www.cfatg.
org) has been created and a national meeting is organized
every year since 2011.
CFLAR/c-FLIP: An inactive CASP8 homolog that inhibits
death receptor-mediated apoptosis and necroptosis. In addi
tion, CFLAR and its viral homologs bind to ATG3 and inhibit
autophagy [1965]. CFLAR-mediated autophagy modulation is
also observed in T cells [2962]. Moreover, v-FLIP of the
Kaposi sarcoma-associated herpesvirus (KSHV) inhibits auto
phagy during viral latency [2963].
CGAS/MB21D1 (cyclic GMP-AMP synthase): A cytosolic
sensor that produces cGMP to initiate IFN production via
STING1/TMEM173 upon binding microbial DNA [2964].
MB21D1 also binds to BECN1, releasing RUBCN, resulting
in the induction of autophagy to eliminate cytosolic patho
gens and cytosolic DNA; the latter serves to downregulate the
immune response to prevent overactivation.
CH5132799 (PA-799): An inhibitor of class I PI3Ks and
particularly PIK3CA/PI3Kα. The role of the PI3K-AKTMTOR signaling pathway in autophagy inhibition is a well
established [2965].
Chaperone-mediated autophagy (CMA): An autophagic
process in most mammalian cells, and some birds and reptile
species by which proteins containing a particular pentapeptide
motif related to KFERQ are transported across the lysosomal
membrane and degraded [1809, 2966, 2967]. The transloca
tion process requires the action of the integral membrane
protein LAMP2A and both cytosolic and lumenal HSPA8
[1816, 2968].
CHEK2 (checkpoint kinase 2): The serine/threonine kinase
CHEK2 is a key component of the DNA damage response.
Autophagy is involved in proper CHEK2 activation, whereas
its inhibition results in CHEK2 inactivation through a protea
some-dependent mechanism [2832, 2969].
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CHKB (choline kinase beta): A kinase involved in phospha
tidylcholine synthesis; mutations in CHKB cause mitochon
drial dysfunction leading to mitophagy and megaconial
congenital muscular dystrophy [2970].
Chloroquine (CQ): CQ and its derivatives (such as 3-hydro
xychloroquine) raise the lysosomal pH and ultimately inhibit
the fusion between autophagosomes and lysosomes [302],
thus preventing the maturation of autophagosomes into auto
lysosomes, and blocking a late step of autophagy [302, 2971].
CHMP1A (charged multivesicular body protein 1A):
CHMP1A is a member of the CHMP family of proteins that
are involved in multivesicular body sorting of proteins to the
interiors of lysosomes. CHMP1A regulates the autophagic
turnover of plastid constituents in A. thaliana [1246].
Chlorophagy: A selective autophagy pathway to degrade
chloroplasts in plant cells. In leaves of A. thaliana, starvation
or aging induces autophagic degradation of chloroplast stro
mal protein-containing vesicles termed Rubisco-containing
bodies (RCBs) [1241]. Damaged chloroplasts are eliminated
in their entirety via microautophagic incorporation into the
vacuole [1243, 1244].
Cholesterol: A sterol synthesized by all animal cells, which is an
essential structural component of cell membranes and a precursor
for the biosynthesis of steroid hormones, bile acid and vitamin D.
Increased cholesterol levels enhance autophagosome formation by
promoting the oxidative inactivation of ATG4, but impair lyso
somal fusion ability by altering RAB7A and SNAREs content and
distribution in lysosome membranes [2972, 2973].
CHOP: See DDIT3.
Chromatophagy: A form of autophagy that involves nuclear
chromatin/DNA leakage captured by autophagosomes or
autolysosomes [1248].
Chromosomal instability: Abnormal chromosomal segrega
tion during cell division leads to chromosomal instability, one
of the hallmarks of cancer. Inhibition of autophagy and lyso
some acidification capacity in mitotic cells induces chromo
somal instability, which can be followed by the formation of
toroidal nuclei in daughter cells [2974].
Ciliophagy: Degradation by autophagy of cilia components and
proteins involved in the process of ciliogenesis (formation of
primary cilia) [2975–2977]. Ciliophagy can modulate ciliogenesis
positively or negatively depending on whether the subset of pro
teins degraded via autophagosomes are activators or inhibitors of
the formation of primary cilia [2978]. See also primary cilium.
CIP2A/KIAA1524 (cellular inhibitor of PP2A): KIAA1524/
CIP2A suppresses MTORC1-associated PPP2/PP2A activity
in an allosteric manner thereby stabilizing the phosphoryla
tion of MTORC1 substrates and inhibiting autophagy. CIP2A
can be degraded by autophagy in an SQSTM1-dependent
manner [2979].
circ-DNMT1 (hsa_circRNA_102439): A circRNA that stimu
lates autophagy and increases breast cancer cell proliferation
[2980].
circEIF6 (hsa_circ_0060060): A circRNA that promotes cis
platin-induced autophagy in papillary thyroid carcinoma and
anaplastic thyroid carcinoma cells [2981].
circ-GATAD2A (circular RNA GATA zinc finger domain
containing 2A): A circRNA that inhibits autophagy and pro
motes the replication of H1N1 [2982].
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circHECTD1: A circRNA that inhibits astrocyte activation via
autophagy [2983].
circHECW2: A circRNA that contributes to the nonautophagic
role of ATG5 in endothelial-mesenchymal transition [2984].
circHIPK2: A circRNA that regulates astrocyte activation via
the interplay between autophagy and ER stress [2985].
circHIPK3 (circular homeodomain interacting protein
kinase 3): A circRNA prognostic factor that regulates auto
phagy in lung cancer [2986].
circRNA.2837: A circRNA that regulates neuronal autophagy
and acts as a competing endogenous RNA/ceRNA [2987].
circRNA ACR (autophagy-related circular RNA): A
circRNA that represses myocardial infarction by inhibiting
autophagy [2988].
CircRNAs (circular RNAs): CircRNAs as novel endogenous
noncoding RNAs exhibit cell-type-specific and tissue-specific pat
terns. These covalently closed RNAs are implicated in diseases and
play crucial roles in autophagy regulation [2989–2991].
ciRS-7: A circRNA that inhibits autophagy in esophageal
squamous cell carcinoma [2992].
CISD2/NAF-1 (CDGSH iron sulfur domain 2): An integral
membrane component that associates with the ITPR complex;
CISD2 binds BCL2 at the ER, and is required for BCL2 to bind
BECN1, resulting in the inhibition of autophagy [2993]. CISD2
was reported to be associated with the ER, but the majority of the
protein is localized at mitochondria, and mutations in CISD2 are
associated with Wolfram syndrome 2; accelerated autophagy in
cisd2−/− mice may cause mitochondrial degradation, leading to
neuron and muscle degeneration [2994].
Cka (Connector of kinase to AP-1): A scaffold protein that is
a core component of the striatin-interacting phosphatase and
kinase (STRIPAK) complex in Drosophila, that is essential for
autophagosome transport in neurons. Cka mediates attach
ment of autophagosomes to the dynein-dynactin transport
machinery through direct binding to Atg8a [2147].
CLEAR (coordinated lysosomal expression and regulation)
gene network: A regulatory pathway involving TFEB, which
regulates the biogenesis and function of the lysosome and
associated pathways including autophagy [969]. See also
PPP3 and TFEB.
CLEC16A (C-type lectin domain family 16, member A):
See Ema.
Clg1: A yeast cyclin-like protein that interacts with Pho85 to
induce autophagy by inhibiting Sic1 [2995].
CLN3 (CLN3 lysosomal/endosomal transmembrane pro
tein, battenin): An endosomal/lysosomal protein whose defi
ciency causes inefficient autolysosome clearance and
accumulation of autofluorescent lysosomal storage material and
ATP5G/subunit c (ATP synthase, H+ transporting, mitochondrial
Fo complex, subunit C) [2996, 2997]. In human, recessive CLN3
mutations cause juvenile neuronal ceroid lipofuscinosis (JNCL;
Batten disease). Recessive CLN3 mutations have also been
reported in cases of autophagic vacuolar myopathy and nonsyndromic retinal disease [2998, 2999].
CLN7: See MFSD8.
Clockophagy: A type of selective autophagy that degradates
the key circadian clock protein ARNTL/BMAL1 (aryl hydro
carbon receptor nuclear translocator-like) during RSL3induced ferroptosis [1249].
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CMA: See chaperone-mediated autophagy.
COG (conserved oligomeric Golgi) complex: A cytosolic
tethering complex that functions in the fusion of vesicles within
the Golgi complex, but also participates in autophagy and facil
itates the delivery of Atg8 and Atg9 to the PAS [3000].
Complete autophagy: Also termed productive autophagy,
this refers to the entire process of autophagy, from formation
of a phagophore, maturation of an autophagosome encom
passing the cargo, delivery of the cargo to lysosomes/vacuole
and subsequent degradation and efflux [3001, 3002]. See also
incomplete autophagy.
Concanamycin A: Vacuolar-type H+-translocating ATPase
inhibitor that raises vacuolar pH and impedes hydrolase activ
ity in this cellular compartment [3003]. See also bafilomy
cin A1.
Connexins: See gap junction proteins/connexins.
Cordycepin (3ʹ-deoxyadenosine): A bioactive compound
that activates autophagy, independently of the MTOR path
way [3004].
CORM (CO-releasing molecule): Carbon monoxide, partly
through activation of autophagy, exerts cardioprotective
effects in a mouse model of metabolic syndrome-induced
myocardial dysfunction [3005].
Cornification: A form of programmed cell death during
which many intracellular proteins are degraded by autophagy
while others are covalently cross-linked [1043]. Cornified cells
remain connected by intercellular junctions and function as
mechanically resistant components of the epidermis, hair and
nails.
Corynoxine/Cory: An oxindole alkaloid isolated from
Uncaria rhynchophylla (Miq.) Jacks (Gouteng in Chinese)
that is a Chinese herb, which acts as an MTOR-dependent
autophagy inducer [3006].
Corynoxine B/Cory B: An isomer of corynoxine, also isolated
from the Chinese herb Uncaria rhynchophylla (Miq.) Jacks
that acts as a BECN1-dependent autophagy inducer [3007].
COST Action TRANSAUTOPHAGY: The European
Cooperation in Science and Technology site for autophagy
research (http://cost-transautophagy.eu) [3008].
COST1 (CONSTITUTIVELY STRESSED 1): A plant-speci
fic DUF641/COST-family protein that negatively regulates
autophagy by direct interaction with the key autophagy adap
tor ATG8E [3009]. The cost1 mutant has strong drought
tolerance with constitutive induction of autophagy and
broad expression of normally stress-responsive genes, as well
as great retardation of plant growth and development, thus
controlling the tradeoff between plant growth and stress
tolerance.
CpATG8: A Cryphonectria parasitica homolog of Atg8 [3010].
CpdA: A nonsteroidal selective NR3C1/glucocorticoid recep
tor modulator with anti-inflammatory actions that can work
independently of NR3C1 in macrophages. Herein, the auto
phagy receptor SQSTM1 but not NR3C1 mediates the antiinflammatory action of CpdA. SQSTM1 target gene upregula
tion by CpdA involves a mechanism whereby the NFE2L2
transcription factor is recruited to its promoter. CpdA can be
useful to include as a positive control of an autophagy-pro
moting agent in assays, alongside an enhancement of gene
and protein levels of SQSTM1 [3011].

Crinophagy: Selective degradation of secretory granules by
fusion with the lysosome, independent of autophagy [120,
1251, 1255, 1256]. See also SINGD and zymophagy.
CRM1: See XPO1.
CRYAB/HSPB5 (crystallin alpha B): Member of the small
heat shock protein family abundantly expressed in lens, car
diac and skeletal muscle and involved in the maintaining of
cytoskeletal integrity by chaperoning DES (desmin) and VIM
(vimentin). Its R120G missense mutation causes cataract,
cardiomyopathy and myofibrillar myopathy. At the cellular
level CRYABR120G leads to protein aggregation and activates
an NFKB-dependent autophagy [1107].
Cryptides: Peptides with a cryptic biological function that are
released from cytoplasmic proteins by partial degradation or
processing through autophagy (e.g., neoantimocrobial peptide
released from ribosomal protein FAU/RPS30) [2058].
CSNK2 (casein kinase 2): A serine/threonine protein kinase
that disrupts the BECN1-BCL2 complex to induce autophagy
[3012]. CSNK2 also phosphorylates ATG16L1, in particular
on Ser139, to positively regulate autophagy. See also PPP1.
Csp37: A mitochondrial outer membrane protein used in C.
albicans as an indicator of mitophagy [3013].
Ctl1: A multi-transmembrane protein in the fission yeast
Schizosaccharomyces pombe that binds to Atg9 and is required
for autophagosome formation [3013].
CTLH complex: See Gid complex.
CTNS (cystinosin, lysosomal cystine transporter): CTNS is
a proton-driven lysosomal cotransporter that actively exports
cystine out of the lysosomes. The functional loss of CTNS, as
encountered in the lysosomal disease cystinosis due to reces
sive mutations in the CTNS gene, leads to lysosomal dysfunc
tion. This impairs the cellular clearance of autophagosomes
containing damaged mitochondria, causing oxidative stress,
disruption of tight junction integrity and abnormal signaling
events leading to epithelial dysfunction in kidney tubules
[3014, 3015].
Ctr9: A component of the yeast Paf1 complex (Paf1C) that
downregulates the expression of ATG11 and ATG32 and
represses mitophagy in growing conditions [3016].
CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex
component): A component of the mammalian Paf1-RNA poly
merase II complex that regulates mitophagy through a PINK1and PRKN-dependent pathway [3016]. See also Ctr9.
CTSD (cathepsin D): CTSD is an endolysosomal enzyme that
exhibits pepsin-like activity and plays a role in protein turn
over and in the proteolytic activation of hormones and growth
factors [3017].
Cue5: A yeast receptor similar to mammalian SQSTM1 that
binds ubiquitin through its CUE domain, and Atg8 via its Cterminal AIM [627]. Some Cue5-dependent substrates are
ubiquitinated by Rsp5. See also CUET.
CUET (Cue5/TOLLIP): A family of autophagy receptor pro
teins containing a CUE domain that are involved in autopha
gic clearance of protein aggregates. See also Cue5 [627].
CUP-5 (coelomocyte uptake defective mutant-5): The
ortholog of human MCOLN1, in C. elegans CUP-5 localizes
to lysosomes, and is required for endo-lysosomal transport,
lysosomal degradation [3018–3020], and proteolytic degrada
tion in autolysosomes [3021].
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CUPS (compartment for unconventional protein secre
tion): A compartment located near ER exit sites that is
involved in the secretion of Acb1; Grh1 is localized to the
CUPS membrane, and Atg8 and Atg9 are subsequently
recruited under starvation conditions [3022]. Atg8 and Atg9
function in Acb1 secretion, but rapamycin-induced autophagy
does not result in CUPS formation.
Curcumin: Major bioactive constituent of turmeric and pop
ular dietary supplement [3023]. Curcumin is a natural poly
phenol from turmeric herbs. Depending on the context,
curcumin can induce or inhibit autophagy in a variety of in
vitro and in vivo models [3024, 3025].
Cvt body: The single-membrane vesicle present inside the
vacuole lumen that results from the fusion of a Cvt vesicle
with the vacuole [180].
Cvt complex: A cytosolic protein complex consisting primarily
of prApe1 dodecamers in the form of an Ape1 complex that are
bound to the Atg19 receptor. This complex may also contain
Ams1 and Ape4, but prApe1 is the predominant compo
nent [180].
Cvt pathway: See cytoplasm-to-vacuole targeting (Cvt) pathway.
Cvt vesicle: The double-membrane sequestering vesicle of the
Cvt pathway [180].
CXCR4 (C-X-C chemokine receptor 4): CXCR4 belongs to
the GPCR superfamily of proteins, the largest class of integral
membrane proteins. It is involved in hematopoietic stem cell
migration and in T-cell entry for HIV-1 infection [3026].
CYBB/NOX2 (cytochrome b-245 beta chain): The activity of
this enzyme is essential for LAP [801].
CYP46A1)/cholesterol 24-hydroxylase (cytochrome P450
family 46 subfamily A member 1): A key enzyme of brain
cholesterol metabolism; its overexpression in the brain acti
vates autophagy in the context of neurodegenerative diseases
[3027].
Cysmethynil: A small-molecule inhibitor of ICMT (isopre
nylcysteine carboxyl methyltransferase); treatment of PC3
cells causes an increase in LC3-II and cell death with auto
phagic features [3028].
Cystatin C (CysC): A cysteine protease inhibitor [3029].
Injections of CysC to the substantia nigra of SNCAA53T transgenic
mice results in a significant increase in VEGF, NR4A2/NURR1
and LC3B, and a decrease in SNCA and cleaved CASP3 in
different brain regions. CysC-induced VEGF attenuates 6OHDA-lesioned PC12 cell degeneration by regulating pPRKCA-p-MAPK/ERK-NR4A2 signaling and inducing enhanced
autophagy. In addition, VEGF-mediated angiogenesis is markedly
enhanced in the conditioned media of 6-OHDA-lesioned PC12
cells with CysC-overexpression, whereas blockage of autophagy
downregulates VEGF expression and associated angiogenesis.
Therefore, CysC exerts a neuroprotective effect by regulating
VEGF-mediated autophagy.
Cytoplasm-to-vacuole targeting (Cvt) pathway: A constitu
tive, biosynthetic pathway in yeast that transports resident
hydrolases to the vacuole through a selective autophagy-like
process [3030]. See also Ams1, Ape1, Ape4 and Atg19.
DAF-2 (abnormal dauer formation): Encodes the C. elegans
INSR (insulin receptor)/IGF1R (insulin like growth factor 1 recep
tor) homolog that acts through a conserved PI3K pathway to
negatively regulate the activity of DAF-16/FOXO and limit life
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span. DAF-2 inhibits autophagy by a mechanism that remains to
be elucidated [367, 3031, 3032]. Reduced INS-DAF-2 signaling in
daf-2 mutant C. elegans protects against SNCA/α-synucleinmediated rupture of endomembranes [3033].
DAF-16: A C. elegans FOXO transcription factor ortholog.
DALIS (dendritic cell aggresome-like induced structures):
Large polyubiquitinated protein aggregates formed in dendri
tic cells. These are similar to aggresomes, but they do not
localize to the microtubule-organizing center. DALIS are tran
sient in nature and small DALIS have the ability to move and
form larger aggregates; they require proteasome activity to
clear them [421]. See also ALIS.
DAMP (danger/damage-associated molecular pattern):
DAMPs are endogenous molecules released by dead or
damaged cells that bind to pattern recognition receptors
(DDX58/RIG-I-like receptors [RLRs] Toll-like receptors
[TLRs], NOD-like receptors [NLRs] and C-type lectin recep
tors [CLRs]) of the innate surveillance response system to
activate the inflammatory response and autophagy [3034].
“Non-self” or exogenous molecules such as viral RNA that
activate the same receptors are termed pathogen-associated
molecular patterns (PAMPs) or microorganism-associated
molecular patterns (MAMPs), the latter of which are derived
from any microbe, not necessarily pathogenic [3035].
DAP (death associated protein): A conserved phosphopro
tein that is a substrate of MTOR and inhibits autophagy;
inhibition of MTOR results in dephosphorylation of DAP
and inhibition of autophagy, thus limiting the magnitude of
the autophagic response [3036].
DAPK1 (death associated protein kinase 1): A kinase that
phosphorylates Thr119 of BECN1 to activate it by causing
dissociation from BCL2L1/Bcl-xL and BCL2, thus activating
autophagy [3037].
DAPK3 (death associated protein kinase 3): See Sqa.
DAXX/DAP6 (death domain associated protein): DAXX
interacts with SQSTM1 to promote SQSTM1 phase condensa
tion and puncta formation [3038].
DBeQ: A reversible ATP-competitive inhibitor of VCP/p97.
DBeQ inhibits the degradation of ubiquitinated proteins, the
ERAD pathway, and the maturation of autophagosomes [3039].
DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding
protein): A phylogenetically conserved protein that is released
from cells during autophagy. DBI affects intracellular lipid
mechanisms but also acts as a paracrine and endocrine reg
ulator of autophagy and general metabolism at the wholebody level, notably as a stimulator of appetite [3040].
DCN (decorin): An archetypical member of the small leucine
rich proteoglycans that functions as a soluble pro-autophagic
and pro-mitophagic signal. DCN acts as a partial agonist for
KDR/VEGFR2 and MET for endothelial cell autophagy and
tumor cell mitophagy, respectively. DCN elicits these pro
cesses in a PEG3-dependent manner to induce endothelial
cell autophagy, and in a TCHP/mitostatin-dependent manner
for tumor cell mitophagy. It is postulated that induction of
these fundamental cellular programs underlies the oncostatic
and angiostatic properties of DCN [3041]. DCN itself is
responsive to autophagic stimuli, as starvation significantly
increases cardiac Dcn mRNA and protein. Moreover, DCN
induction is required for proper autophagy, as measured by
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LC3-II formation and puncta formation, in the murine heart
[3042].
Dcp-1 (death caspase-1): A Drosophila caspase that localizes
to mitochondria and positively regulates autophagic flux
[3043].
Dcp2/DCP2 (decapping mRNA 2): A decapping enzyme
involved in the downregulation of ATG transcripts [3044].
See also Dhh1.
DCT-1: The C. elegans homolog of BNIP3 and BNIP3L,
which functions downstream of PINK-1 and PDR-1 to reg
ulate mitophagy under conditions of oxidative stress [2122].
DDIT3/CHOP (DNA damage inducible transcript 3):
DDIT3 is a member of the CEBP family of transcription
factors that appears to have a dual role in both inducing
apoptosis and limiting autophagy by the promotion of the
transcription of autophagy genes through cooperation with
ATF4 and/or CEBPB during ER stress. DDIT3 is involved in
the formation, elongation and function of the phagophore.
DDIT4/DIG2/RTP801/REDD1 (DNA damage inducible
transcript 4): The DDIT4 protein is notably synthesized in
response to stress hormones, glucocorticoids and adrenaline
or hypoxia, and inhibits MTOR, resulting in the induction of
autophagy and enhanced cell survival [1691, 3045].
Additionally, induction of the DDIT4-MTOR-autophagy axis
is correlated with NETosis-driven IL1B autoinflammation
[1691, 1693]. See also NETosis.
Deconjugation: The Atg4/ATG4-dependent cleavage of lipi
dated Atg8-family proteins (e.g., Atg8–PE, LC3-II) that releases
the protein from PE (illustrated for the nascent yeast protein
that contains a C-terminal arginine). The liberated Atg8-family
proteins can subsequently go through another round of con
jugation. Mammalian ATG4 also deconjugates LC3 from pro
teins. See also 12-ylation. Atg8*, activated Atg8.

Conjugation and deconjugation of yeast Atg8.
Atg4
Atg8 R

Atg7
Atg8

Atg3 + PE Atg4
Atg8 *
Atg8 PE
Atg8 + PE

Conjugation

Deconjugation

Decorin: See DCN.
Decoupled signaling: When limited for an auxotrophic
requirement, yeast cells fail to induce the expression of auto
phagy genes even when growing slowly, which contributes to
decreased cell viability [3046].
DEDD (death effector domain containing): DEDD acts as an
endogenous suppressor of tumor growth and metastasis
through the epithelial-mesenchymal transition process [3047,
3048]. DEDD binds directly to the class III PtdIns3K core
complex to stabilize PIK3C3 and promote the interaction of
this enzyme with BECN1 to induce autophagy activation as
well as subsequent degradation of SNAI and TWIST, two
master modulators of the epithelial-mesenchymal transition.
Deferiprone (DFP): Deferiprone is an iron chelator that has
strongly induces mitophagy in a PINK1- and PRKN-indepen
dent manner [460].

Deforolimus (AP39573): This chemical promotes autophagy
through inhibition of MTORC1 [3049].
DEGS1 (delta 4-desaturase, sphingolipid 1): The enzyme
that catalyzes the last step of ceramide biosynthesis converting
dihydroceramides into ceramides. DEGS1 inhibition enhances
dihydroceramide levels and induces autophagy, as well as
autophagy-mediated
cancer
cell
death.
See
also
dihydroceramide.
Desat1: A Drosophila lipid desaturase that localizes to autop
hagosomes under starvation conditions; the Desat mutant is
defective in autophagy induction [3050].
DFCP1: See ZFYVE1.
DFP: See deferiprone.
Dga1: See Ayr1.
Dhh1: An RCK member of the RNA-binding DExD/H-box
proteins involved in mRNA decapping and translational reg
ulation; Dhh1 in S. cerevisiae and Vad1 in Cryptococcus neo
formans bind certain ATG transcripts, leading to the
recruitment of the Dcp2 decapping enzyme and mRNA
degradation to suppress autophagy in nutrient-rich conditions
[3044]. Conversely, Dhh1 switches its role to become a posi
tive regulator, coordinating with an EIF4E-binding protein,
Eap1, and is required for efficient translation of Atg1 and
Atg13 induced by nitrogen starvation [3051]. See also Dcp2
and Eap1.
Diacylglycerol: A lipid second messenger that contributes to
autophagic targeting of Salmonella-containing vacuoles
[3052].
DIG2: See DDIT4.
Dihydroceramide: A metabolite that constitutes the penulti
mate step of ceramide biosynthesis. Dihydroceramide has
been implicated in the regulation of autophagy [905] and
specifically in autophagy-mediated cell death [906]. See also
DEGS1.
DIRAS3 (DIRAS family GTPase 3): A protein that interacts
with BECN1, displacing BCL2 and blocking BECN1 dimer
formation, thus promoting the interaction of BECN1 with
PIK3C3 and ATG14, resulting in autophagy induction
[3053]. DIRAS3 is a weight loss target gene in adipose stem/
progenitor cells, inducing autophagy [3054] and protecting
against premature senescence [3055].
DMVs (double-membraned vesicles): See autophagy-like
vesicles.
DNautophagy: An autophagic process by which DNA is
transported across the lysosomal membrane and degraded
[1395]. The translocation process is mediated by lysosomal
integral membrane proteins LAMP2C and SIDT2 [1395]. See
also LAMP2C, RNautophagy and SIDT2.
Dnm1: A dynamin-related GTPase that is required for both
mitochondrial and peroxisomal fission. Dnm1 is recruited to
degrading mitochondria by Atg11, or to degrading peroxisomes
by both Atg11 and Atg36 (or PpAtg30), to mediate mitophagyor pexophagy-specific fission [2911, 3056]. See also DNM1L.
DNM1L/Drp1 (dynamin 1 like): The mammalian homolog
of yeast Dnm1. PRKA-mediated phosphorylation of rat
DNM1L on Ser656 (Ser637 in humans) prevents both mito
chondrial fission and some forms of mitophagy in neurons
[3057]. See also Dnm1.
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DNM2 (dynamin 2): DNM2 is recruited to extruded auto
lysosomal membranes during the process of autophagic lyso
some reformation and catalyzes their scission, promoting the
regeneration of nascent protolysosomes during autophagic
flux [2851]. See also autophagic lysosome reformation.
dom (domino): A Drosophila SWI2/SNF2 chromatin remo
deling protein. A loss-of-function mutation at the dom locus
synergizes with genotypes depressed in autophagy pathway
activity [3058].
Dopamine: A neurotransmitter whose accumulation outside
vesicles induces autophagy and cell degeneration [3059].
Dopamine receptor: The function of dopamine is mediated
by dopamine receptors (DRs). There are five different DR
subtypes, named DRD1 to DRD5. Activation of DRD5
induces autophagic cell death in human cancer cells, and
inhibition of DRD4 impedes autophagic flux in glioblastoma
stem cells [3060, 3061]. Activation of DRD3, but not DRD2,
induces autophagy, while maintaining protein synthesis
[3062].
DOR: See TP53INP2.
Doryphagy: The selective degradation of centriolar satellites
(CS) by autophagy. Selectivity to this process is provided by
the LIR-mediated interaction between the CS component
PCM1 and GABARAP/GABARAPL2 [1258]. This process
regulates centrosomal composition and stability, thereby
maintaining functional centrosomes required for proper cell
division.
DQ-BSA (dequenched bovine serum albumin): A derivative
of BSA that is heavily labeled by fluorescent dyes, leading to
self-quenching. After being endocytosed by cells, it is traf
ficked by the endosomal system to the lysosome for degrada
tion, which releases smaller fragments of the fluorophore as
cleavage products. This degradation produces a fluorescent
signal that is proportional to the proteolytic activity of the
cellular lysosomes and thus can serve as a readout for
functional endocytosis and lysosomal hydrolase activity
[2388].
DRAM1 (DNA damage regulated autophagy modulator 1):
DRAM1 is a small hydrophobic protein with six transmem
brane domains colocalizing with GOLGB1/giantin and
GOLGA2/GM130, and also in early and late endosomes and
lysosomes, colocalizing with EEA1 and LAMP2 [3063], and
interacting with BAX [3064]. DRAM1 gene expression is
induced by TP53 in response to DNA damage that results in
cell death by a mechanism that involves autophagy, which is
induced in a DRAM1-dependent manner [2675, 3065].
DRAM1 gene expression is induced by NFKB in response to
mycobacterial infection, and is required for host defense by
selective autophagy [2435].
DRAM2/TMEM77 (DNA damage regulated autophagy
modulator 2): DRAM2 is closely related to DRAM1 and
contributes
to
induction
of
autophagy
[3066].
Overexpression of DRAM2 induces cytosolic GPF-LC3
puncta and increases the level of endogenous LC3-II, whereas
its silencing interferes with starvation-induced autophagy
[3067]. DRAM2 interacts with BECN1, UVRAG, LAMP1
and LAMP2, and enhances phagosome maturation and anti
microbial activity during mycobacterial infection [3068].
Defects in the DRAM2 gene cause a type of retinal dystrophy.
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DRAM2 has been linked to HOTAIRM1-mediated regulation
of autophagy. See also HOTAIRM1.
DRAM3: See TMEM150B.
drpr/draper: A Drosophila homolog of the C. elegans engulf
ment receptor CED-1 that is required for autophagy asso
ciated with cell death during salivary gland degradation, but
not for starvation-induced autophagy in the fat body [3069].
Drs: See SRPX.
Dsk2: A nuclear-enriched ubiquitin-like polyubiquitin-bind
ing protein in budding yeast, which transports ubiquitinated
proteins to the proteasome for degradation. In budding yeast,
Dsk2 is dispensable for proteasome-dependent degradation of
mutated HTT with polyQ expansion (HTT103Q), but it is
required for efficient clearance of HTT103Q through auto
phagy [1099]. In A. thaliana, DSK2 acts as a ubiquitin recep
tor for autophagy-mediated degradation of AT1G19350/BES1,
a transcription factor mediating plant steroid hormone bras
sinosteroid regulation of plant growth and stress response
[3070].
DsRed tetramer mouse: Tetrameric DsRed, a mammalian
derivative of red fluorescent protein of the coral Discosoma
was generated originally for imaging applications. DsRed tet
ramers form aggregates, and the transgenic mouse expressing
DsRed tetramers was generated as a spontaneous in vivo
cardiac fibrosis and heart failure model caused by chronic
autophagy and proteasome degradation insufficiency.
Skeletal muscles of this mouse tolerate the toxicity of DsRed
aggregation, suggesting that additional factors such as oxida
tive stress and renewal capability determine tissue vulnerabil
ity to proteopathy [3071].
DUSP4/MKP2 (dual specificity phosphatase 4): A member
of the dual specificity protein phosphatase subfamily, which is
induced in a MAPK1/3-dependent manner and establishes
feedback inhibition. Inhibition of histone methyltransferase
EHMT2/G9a induces autophagic cell death in head and neck
squamous cell carcinoma/HNSCC via a DUSP4-dependent
MAPK1/3 inactivation mechanism [2888]. Overexpression of
DUSP4 induced by MAPK1/3 positively regulates AKTMTOR signaling resulting in impaired autophagy in hearts
of a mouse model of LMNA (lamin A/C) cardiomyopathy
[3072]. See also MAPK1.
E2F1: A mammalian transcription factor that upregulates the
expression of BNIP3, LC3, ULK1 and DRAM1 directly, and
ATG5 indirectly [938]. E2F1 plays a role during DNA
damage- and hypoxia-induced autophagy.
E64d/Pepstatin: An inhibitor of aspartic and cysteine pro
teases that can block late steps of autophagy through the
reduction of lysosomal degradation [2352].
Eap1: A eukaryotic translation initiation factor 4 E (EIF4E)
binding protein that interacts with Dhh1 to promote ATG1
and ATG13 mRNA translation under nitrogen-starvation con
ditions [3051]. See also Dhh1.
EAT (early autophagy targeting/tethering) domain: The Cterminal domain of Atg1, which is able to tether vesicles
[3073]. This part of the protein also contains the binding
site for Atg13.
EAT-2 (EATing: abnormal pharyngeal pumping): A ligandgated ion channel subunit closely related to the non-alpha
subunit of nicotinic acetylcholine receptors, which functions
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to regulate the rate of pharyngeal pumping in C. elegans. eat-2
loss-of-function mutants are dietary restricted and require
autophagy for the extension of life span [3031, 3074, 3075].
EDTP: See MTMR14.
EEA1 (early endosome antigen 1): A RAB5 effector used as a
common marker for early endosome vesicles.
EEF1A1/EF1A/eF1α (eukaryotic translation elongation fac
tor 1 alpha 1): Multifunctional member of the family of Gproteins with different cellular variants. The lysosomal variant
of this protein acts coordinately with GFAP at the lysosomal
membrane to modulate the stability of the CMA translocation
complex. Release of membrane bound EEF1A1 in a GTPdependent manner promotes disassembly of the translocation
complex and consequently reduces CMA activity [3076].
eF1α: See EEF1A1.
EGFR (epidermal growth factor receptor): A tyrosine kinase
receptor that negatively regulates autophagy through PI3K,
AKT, and MTOR modulation [775].
EGO (exit from rapamycin-induced growth arrest) com
plex: The Meh1/Ego1, Ego2, Slm4/Ego3, Gtr1 and Gtr2 pro
teins form a pentameric complex that mediates amino acid
signals to control TORC1, and positively regulates microau
tophagy in yeast [3077, 3078].
eIF2α kinase: See EIF2S1 kinase.
EIF2AK2/PKR (eukaryotic translation initiation factor 2
alpha kinase 2): A mammalian EIF2S1/EIF2 alpha kinase
that induces autophagy in response to viral infection [836].
EIF2AK3/PERK (eukaryotic translation initiation factor 2
alpha kinase 3): A mammalian EIF2S1/EIF2 alpha kinase that
induces autophagy in response to ER stress [473, 918] and
mycolactone exposure [2021].
EIF2AK4/GCN2 (eukaryotic translation initiation factor 2
alpha kinase 4): A mammalian EIF2S1/EIF2 alpha kinase that
induces autophagy in response to mycolactone exposure
[2021].
EIF2S1 (eukaryotic translation initiation factor 2 subunit
alpha): An initiation factor that is involved in stress-induced
translational regulation of autophagy.
EIF2S1/eIF2α kinase: There are four mammalian EIF2S1/
EIF2 alpha kinases that respond to different types of stress,
inducing a so-called integrated stress response. EIF2AK2 and
EIF2AK3 induce autophagy in response to virus infection and
ER stress, respectively [918, 3079], and/or mycolactone expo
sure [2021]. See also Gcn2, EIF2AK2 and EIF2AK3.
EIF5A (eukaryotic translation initiation factor 5A): A
translation factor that is hypusinated, and promotes transla
tion elongation, and regulates the synthesis of TFEB [958]. See
also spermidine.
ELA11: An 11-residue FURIN-cleaved fragment of mature
APELA/ELABELA (apelin receptor early endogenous ligand),
a hormone that mediates endoderm development and heart
morphogenesis [3080, 3081]. This peptide inhibits autophagy
in murine and cell models of renal ischemia/reperfusion
injury [3082].
Elaiophylin: A natural compound late-stage autophagy inhi
bitor that results in lysosomal membrane permeabilization
and decreased cell viability [3083]. See also LMP.
ELAVL1/HuR (ELAVL like RNA binding protein 1): This
RNA-binding protein regulates SQSTM1 expression at the

post-transcriptional level by binding to SQSTM1 mRNA and
favoring its translation when autophagy is triggered
[359, 586].
ema (endosomal maturation defective): ema is required for
phagophore expansion and for efficient mitophagy in
Drosophila fat body cells. It is a transmembrane protein that
relocalizes from the Golgi to phagophores following starvation
[3084]. The vertebrate ortholog CLEC16A regulates mito
phagy and is a susceptibility locus for many autoimmune
disorders [3085, 3086].
Embryoid bodies/EBs: Three-dimensional aggregates of plur
ipotent stem cells including embryonic stem cells and induced
pluripotent stem cells.
EMC6/TMEM93 (ER membrane protein complex subunit
6): A novel ER-localized transmembrane protein, which inter
acts with both RAB5A and BECN1 and colocalizes with the
omegasome marker ZFYVE1/DFCP1 [3087]. EMC6 enhances
autophagosome formation when overexpressed.
EndoA/SH3GL2/Endophilin
A1
(Endophilin
A):
Phosphorylation of the serine residue 75 in Drosophila
EndoA (an ortholog of human SH3GL2) promotes autophagy
by creating highly curved membranes that attract Atg3 onto
the phagophore [3088]. In mammals, SH3GL2 interacts with
FBXO32 (F-box protein 32), and both proteins colocalize
transiently with phagophores and are necessary for autopha
gosome formation [3089].
Endorepellin: The anti-angiogenic C-terminal cleavage pro
duct of HSPG2/perlecan. Endorepellin engages KDR/VEGFR2
and ITGA2/α2β1 integrin in a novel mechanism termed dual
receptor antagonism for achieving endothelial cell specificity
and function. Endorepellin evokes endothelial cell autophagy
downstream of KDR and in a PEG3-dependent manner
[3090], and protracted endothelial cell mitochondria depolar
ization downstream of KDR with a concurrent induction and
colocalization of TCHP/mitostatin and PRKN [3091].
Endosomal microautophagy (e-MI): A form of autophagy in
which cytosolic proteins are sequestered into late endosomes/
MVBs through a microautophagy-like process. Sequestration
can be nonselective or can occur in a selective manner
mediated by HSPA8. This process differs from chaperonemediated autophagy as it does not require substrate unfold
ing, and it is independent of the CMA receptor LAMP2A
[1823]. This process occurs during MVB formation and
requires the ESCRT-I and ESCRT-III protein machinery;
accordingly, this can be referred to as ESCRT-mediated sort
ing at the endosome. See also endosome and multivesicular
body.
Endosome: The endosomal compartments receive molecules
engulfed from the extracellular space and are also in commu
nication with the Golgi apparatus. The endosomal system can
be viewed as a series of compartments starting with the early
endosome. From there, cargos can be recycled back to the
plasma membrane; however, more typically, internalized
cargo is transported to the late endosome/MVB. These latter
compartments can fuse with lysosomes. Endosomal matura
tion from early endosomes is a dynamic process that involves
a progressive reduction in lumenal pH. In mammalian cells,
early and/or multivesicular endosomes fuse with autophago
somes to generate amphisomes.
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EP300/p300 (E1A binding protein p300): An acetyltransfer
ase that inhibits autophagy by acetylating ATG5, ATG7,
ATG12 and/or LC3 [1005]. EP300 is also involved in the
GLI3-dependent transcriptional activation of VMP1 in cancer
cells [967]. See also GLI3.
EPAC1: See RAPGEF3.
EPAC2: See RAPGEF4.
EPAS1/HIF2A/Hif-2α (endothelial PAS domain protein 1):
Part of a dimeric transcription factor in which the α subunit is
regulated by oxygen; the hydroxylated protein is degraded by
the proteasome. EPAS1 activation in mouse liver augments
peroxisome turnover by pexophagy, and the ensuing defi
ciency in peroxisomal function encompasses major changes
in the lipid profile that are reminiscent of peroxisomal dis
orders [1207].
Ependymoma: Ependymoma is a prodigious pediatric brain
tumor. Children with ependymoma have high mortality rates
because ependymoma challenges all forms of conventional
therapy. An oncogenic role of nuclear pore protein/nucleo
porin TPR (translocated promoter region, nuclear basket pro
tein) in regulating HSF1 (heat shock transcription factor 1)
mRNA trafficking, maintaining MTORC1 activity to phos
phorylate ULK1 and preventing autophagy induction in epen
dymoma has been described [3092].
epg (ectopic PGL granules) mutants: C. elegans mutants that
are defective in the autophagic degradation of PGL-1, SEPA-1
and/or SQST-1 [965]. The EPG-3, EPG-7, EPG-8 and EPG-9
proteins are homologs of VMP1, Atg11/RB1CC1, ATG14 and
ATG101, respectively, whereas EPG-1 may be a homolog of
ATG13 [1734].
EPG-1: The highly divergent homolog of Atg13 in C. elegans.
EPG-1 directly interacts with the C. elegans Atg1 homolog
UNC-51 [3093]. See also Atg13.
EPG-2: A nematode-specific coiled-coil protein that functions
as a scaffold protein mediating the autophagic degradation of
PGL granule in C. elegans. EPG-2 directly interacts with
SEPA-1 and LGG-1. EPG-2 itself is also degraded by autopha
gy [965].
EPG-3: A metazoan-specific autophagy protein that is the
homolog of human VMP1. EPG-3/VMP1 are involved in an
early step of autophagosome formation [965].
EPG-4: An ER-localized transmembrane protein that is the
homolog of human EI24/PIG8. EPG-4 is conserved in multi
cellular organisms, but not in yeast. EPG-4 functions in the
progression of omegasomes to autophagosomes [965]. EI24
also mediates the crosstalk between the UPS and autophagy
by mediating the autophagic degradation of RING domain E3
ligases in human cells [3094, 3095].
EPG-5: A novel autophagy protein that is conserved in multi
cellular organisms. EPG-5 regulates lysosome degradative
capacity and thus could be involved in other pathways that
terminate at this organelle [965]. Mutations in the human
EPG5 gene lead to Vici syndrome [3096].
EPG-6: A WD40 repeat PtdIns3P-binding protein that
directly interacts with ATG-2 [845]. EPG-6 is the C. ele
gans functional homolog of yeast Atg18 and probably of
mammalian WDR45/WIPI4. EPG-6 is required for the
progression of omegasomes to autophagosomes. See also
Atg18.
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EPG-7: A scaffold protein mediating the autophagic degrada
tion of the C. elegans SQSTM1 homolog SQST-1 [2783]. EPG7 interacts with SQST-1 and also with multiple ATG proteins.
EPG-7 itself is degraded by autophagy.
EPG-8: An essential autophagy protein that functions as the
homolog of yeast Atg14 in C. elegans [2788]. EPG-8 is a
coiled-coil protein and directly interacts with the C. elegans
BECN1 homolog BEC-1. See also Atg14.
EPG-9: A protein with significant homology to mammalian
ATG101 in C. elegans [3097]. EPG-9 directly interacts with
EPG-1/Atg13. See also ATG101.
EPG-11: An arginine methyltransferase in C. elegans that is
the homolog of PRMT1 [3098]. EPG-11 regulates the associa
tion of PGL granules with EPG-2 and LGG-1 puncta. EPG-11
directly methylates arginine residues in the RGG domain of
PGL-1 and PGL-3.
EPM2A/laforin (EPM2A glucan phosphatase, laforin): A
member of the dual specificity protein phosphatase family
that acts as a positive regulator of autophagy probably by
inhibiting MTOR, as EPM2A deficiency causes increased
MTOR activity [3099]. Mutations in the genes encoding
EPM2A or the putative E3-ubiquitin ligase NHLRC1/
malin, which form a complex, are associated with the
majority of defects causing Lafora disease, a type of pro
gressive neurodegeneration. EPM2A is well conserved
among mammals [3100], and may also act as a regulator
of autophagy, considering that an impairment of EPM2Amediated autophagy may lead to cell death [3099, 3101].
See also NHLRC1.
ER-mitochondria contact sites: The contact sites that the ER
forms with mitochondria in mammalian cells. Also known as
mitochondria-associated membranes (MAMs) when bio
chemically isolated by fractionation. ER-mitochondria contact
sites regulate exchange of lipids and calcium between orga
nelles and are implicated in autophagosome formation. See
also mitochondria-associated ER membranes.
ER-phagy: See reticulophagy.
ERAD (endoplasmic reticulum-associated degradation): A
process that can operate in parallel to ERLAD (including
reticulophagy, ER-exit site microautophagy and vesicular
transport) to degrade misfolded proteins from the ER. In
ERAD, misfolded proteins are translocated across the ER
membrane, polyubiquitinated, and degraded by the 26S pro
teasome [1378, 3102].
ERAS (ES cell-expressed Ras): A small GTPase of the RAS
family involved both in PRKN-dependent and -independent
mitophagy. Unlike the situation in humans, ERAS is consti
tutively expressed in domestic animals [3103].
ERBB2/HER2/EGFR2 (erb-b2 receptor tyrosine kinase 2):
A transmembrane receptor tyrosine kinase that is amplified in
approximately 20% of breast cancers. ERBB2 binds to BECN1
and inhibits autophagy [2659, 2660].
ERES (ER exit sites): The COPII-coated subcompartments
that specialize in loading and exporting cargo bound for the
Golgi apparatus from the ER [3104–3106].
ERGIC (ER-Golgi intermediate compartment): A donor
compartment that produces small vesicles that are active for
LC3 lipidation [1540].
ERK1: See MAPK3.
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ERK2: See MAPK1.
ERLAD (ER-to-lysosome-associated degradation): Processes
activated to deliver ERAD-resistant misfolded proteins to
endolysosomes for clearance. In ERLAD, misfolded proteins
are segregated in ER subdomains or in ER exit sites and are
delivered to lysosomal compartments via reticulophagy [1380]
and vesicular transport [1379], where an involvement of the
ER-resident LC3-binding protein RETREG1 has been shown,
or by mechanistically ill-defined ER-exit site microautophagy
[1388]. See also RETREG1.
ERMES (ER-mitochondria encounter structure): A complex
connecting the endoplasmic reticulum and the mitochondrial
outer membrane in yeast. The core components of ERMES
are the mitochondrial outer membrane proteins Mdm10 and
Mdm34, the ER membrane protein Mmm1, and the periph
eral membrane protein Mdm12. ERMES plays an important
role in yeast mitophagy presumably by supporting the mem
brane lipid supply for the growing phagophore membrane
[3107]. ERMES involvement in mitophagy requires the ubi
quitination of Mdm34 by the E3 ligase Rsp5 [3108]. See also
Rsp5 and Mdm34.
ERN1/IRE1α (endoplasmic reticulum to nucleus signaling
1): A component of the unfolded protein response (ER stress
response). Deletion of Ern1 in podocytes leads to reduction of
autophagy and induction of injury in these cells [3109].
Etf-1 (Ehrlichia translocated factor-1): A type IV secretion
effector of the obligatory intracellular bacterium Ehrlichia
chaffeensis that binds RAB5-GTP and the autophagy-initiating
class III PtdIns3K complex containing PIK3C3/VPS34, and
BECN1, and induces RAB5-regulated autophagosome forma
tion; the immature autophagosomes traffic to, and fuse with,
E. chaffeensis-containing vacuoles, delivering autophagic car
goes into the vacuole, which can serve as nutrients for bacter
ial growth [3110–3112].
Everolimus/RAD001 (40-O-[2-hydroxyethyl]): An orally
administered MTOR inhibitor that is a derivative of rapamy
cin that induces autophagy.
ESC8: A autophagy inducer that bears a cationic estradiol
moiety and causes downregulation of p-MTOR and its down
stream effectors including p-RPS6KB [3113].
ESCRT (endosomal sorting complex required for trans
port): ESCRT is composed of multiple subcomplexes. The
ESCRT complexes are required for the formation of MVBs,
membrane damage repair and phagophore closure [360,
3114]. Components of the ESCRT machinery are also
involved in endosomal microautophagy (e-MI, type 3) [1806,
1851]. See also phagophore closure.
EVA1A/FAM176A/TMEM166 (eva-1 homolog A, regulator
of programmed cell death): An integral membrane protein
that induces autophagy and cell death when overexpressed
[3115, 3116]. EVA1A interacts with the WD repeats of
ATG16L1 through its C terminus and promotes ATG12–
ATG5-ATG16L1 complex recruitment to the phagophore
membrane, and enhances the formation of the autophago
some [3115]. See also TMEM166.
EX-527: SIRT1 inhibitor.
EXOC2/SEC5L1 (exocyst complex component 2): A compo
nent of the exocyst complex; EXOC2 binds RALB, BECN1,
MTORC1, ULK1 and PIK3C3 under nutrient-rich conditions

and prevents these components from interacting with
EXOC8/EXO84, thus inhibiting autophagy [3117]. See also
RALB and EXOC8.
EXOC8/EXO84 (exocyst complex component 8): A compo
nent of the exocyst complex, and an effector of RALB that is
involved in nucleation and/or expansion of the phagophore;
EXOC8 binds RALB under nutrient-poor conditions, and
stimulates the formation of a complex that includes ULK1
and the class III PtdIns3K [3117]. See also RALB and EXOC2.
Exocyst: An octameric complex that helps in tethering secre
tory vesicles to the plasma membrane. The exocyst also plays
a role during autophagosome biogenesis by regulating Atg9
trafficking [3118].
Exophagy: A process in yeast and mammalian cells that is
used for protein secretion that is independent of the secretory
pathway (i.e., unconventional secretion), and dependent on
Atg proteins and the Golgi protein Grh1; Acb1 (acyl-coen
zyme A-binding protein) uses this route for delivery to the cell
surface [2476, 2477, 3119]. See also secretory autophagy.
EZR (Ezrin): As a member of the EZR (ezrin)-RDX
(radixin)-MSN (moesin) (ERM) family, EZR is a membranebound cytoskeleton linker protein, which has been associated
with poor outcome in several cancer types [3120]. Hypoxiainduced autophagy drives colorectal cancer initiation and
progression by activating the PRKC/PKC-EZR pathway
[3121].
FABP1 (fatty acid binding protein 1): FABP1 constitutes 5%
of cytosolic proteins in the liver that localize to lysosomes, and
negatively regulates autophagic flux and lipid metabolism in
hepatic steatosis [3122].
FADD (Fas associated via death domain): An adaptor pro
tein transmitting apoptotic signals from death receptors.
FADD also suppressess autophagy by downregulating expres
sion of the small GTP binding protein RHEB and subsequent
MTOR activation in human breast adenocarcinoma cells
[3123]. FADD also interacts with the ATG12–ATG5 complex
to limit excessive autophagy during T cell proliferation [3124].
See also RHEB.
FAM48A: See SUPT20H.
FAM134B: See RETREG1.
FAM134B2: An N-terminal truncated isoform of RETREG1/
FAM134B. FAM134B2 is a predominant isoform in the liver
and is induced during starvation through the induction of
CEBPB [3125].
FAM176A: See EVA1A.
Fasudil: A ROCK (Rho-associated coiled-coil containing pro
tein kinase) inhibitor that enhances autophagy [3126].
Far11: A MAP kinase target that is involved in the de
phosphorylation of Atg13 and the induction of autophagy
[3127]. Far11 interacts with Pph21, Pph22 and Pph3 and
may coordinate different cellular stress responses by regulat
ing phosphatase activity.
Far complex: The Far complex consists of Far3, Far7, Far8,
Vps64/Far9, Far10, and Far11, and is essential for Ppg1 to
prevent phosphorylation of Atg32 [3128].
Fascaplysin: A marine sponge (Fascaplysinopsis sp.)-derived
product with anti-cancer activities. Fascaplysin induces
NUPR1/p8-dependent but MTOR signaling-independent au
tophagy in vascular endothelial cells [3129].
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FBXW7/Sel10/hCDC4/hAgo (F-box and WD repeat
domain containing 7): FBXW7 is a member of the F-box
protein family, which functions as the substrate recognition
component of the SCF E3 ubiquitin ligase and is a positive
regulator of autophagy through inhibition of MTOR; knock
down of FBXW7 inhibits autophagic flux in SMB-S15 cells
[3130]. In addition, GSK3B-mediated phosphorylation of
MCL1 induces axonal autophagy, which promotes axonal
degeneration. Phosphorylated MCL1 is ubiquitinated by
FBXW7 and degraded by the proteasome, which is necessary
for the induction of axonal autophagy. GSK3B-MCL1 signal
ing to regulate autophagy might be important for the success
ful completion of axonal degeneration [3131]. See also GSK3B
and MCL1.
FBXW11/β-TrCP2 (F-box and WD repeat domain contain
ing 11): BTRC/β-TrCP1 (beta-transducin repeat containing
E3 ubiquitin protein ligase) and FBXW11/β-TrCP2 are para
logs that regulate several cellular physiological processes.
FBXW11 activates MTORC1 by preferentially degrading the
MTORC1 inhibitors DEPTOR and DDIT4/REDD1 which
leads to the inhibition of autophagy and cell growth.
FBXW11 also ubiquitinates and degrades the AMPK kinasephosphorylated BTRC under glucose-deprived conditions.
Ferritinophagy: The selective degradation of ferritin through
an autophagy-like process [1264] that involves a specificity
receptor, NCOA4.
FEZ1/zygin I (fasciculation and elongation protein zeta 1):
FEZ1 interacts with ULK1 or UVRAG, and forms a trimeric
complex with either component by also binding SCOC
[3132]. FEZ1 appears to be a negative regulator of autophagy
when it is bound only to ULK1, and this inhibition is relieved
upon formation of the trimeric complex containing SCOC.
Similarly, the SCOC-FEZ1-UVRAG complex is inhibitory;
dissociation of UVRAG under starvation conditions allows
the activation of the class III PtdIns3K complex. See also
SCOC.
FGFR1 (fibroblast growth factor receptor 1): FGFR1 is a
member of the FGFR family, which comprises four receptor
tyrosine kinases that cooperate with extracellular FGFs (fibro
blast growth factors) in the transduction of signals influencing
organogenesis, angiogenesis, metabolism and tissue repair.
FGFR1 abnormalities recur in multiple developmental and
acquired diseases including Hartsfield syndrome, Kallmann
syndrome, nonsyndromic hypogonadotropic hypogonadism,
Pfeiffer syndrome, and osteoglophonic dysplasia, and appear
to induce autophagy [3133].
FIP200: See RB1CC1.
FIG4 (FIG4 phosphoinositide 5-phosphatase): A phospho
lipid phosphatase that controls the levels of the PtdIns(3,5)P2
phosphoinositide. Loss of FIG4 causes a decrease of PtdIns
(3,5)P2 levels, enlargement of late endosomes and lysosomes,
and cytosolic vacuolization [3134]. Recessive FIG4 mutations
in humans are responsible for Yunis-Varón syndrome, famil
ial epilepsy with polymicrogyria, and Charcot-Marie-Tooth
type 4J neuropathy. In addition, FIG4 haploinsufficiency
may be a risk factor for ALS.
FIP-gts: A fungal immunomodulatory protein from
Ganoderma tsugae, FIP-gts induces autophagy, which leads
to caspase-independent cell death [3135].
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Fis1: A component of the mitochondrial fission complex.
Fis1 also plays a role in peroxisomal fission by recruiting
Dnm1 to peroxisomes; it interacts with Atg11 to facilitate
mitophagy- and pexophagy-specific fission [2911, 3056]. See
also Dnm1.
FKBP1A (FKBP prolyl isomerase 1A): An immunophilin
that forms a complex with rapamycin and inhibits MTOR.
FKBP4/FKBP52 (FKBP prolyl isomerase 4): An immuno
philin that forms a complex with FK506 and rapamycin;
FKBP4 physiologically localizes with the endolysosomal sys
tem in human and rodent brain neurons. This immunophilin
frequently colocalizes with pathological MAPT/tau in the
autophagy-endolysosomal system in Alzheimer brain neurons
[3136].
FKBP5/FKBP51 (FKBP prolyl isomerase 5): An immuno
philin that forms a complex with FK506 and rapamycin;
FKBP5 promotes autophagy in irradiated melanoma cells,
thus enhancing resistance to radiation therapy [3137].
FKBP5 also associates with BECN1 and shows synergistic
effects with antidepressants on autophagy in cells, mice and
humans, possibly explaining its requirement in antidepressant
action [3138].
FKBP8/FKBP38 (FKBP prolyl isomerase 8): An immuno
philin that contains a single transmembrane domain at the C
terminus and localizes predominantly to the mitochondrial
outer membrane. FKBP8 is a noncanonical FKBP and pepti
dyl-prolyl cis-trans isomerase because its enzymatic activity is
triggered only when it is bound to calcium-bound CALM
(calmodulin). FKBP8 is an inhibitor of MTOR that is antag
onized by RHEB in response to growth factors or nutrients
[3139]. Additionally, FKBP8 acts as a mitophagy receptor in
PRKN-independent mitophagy [196]. FKBP8 contains a LIR
motif in its N terminus, which mediates strong binding to
LC3A, and thus recruits LC3A to damaged mitochondria.
Notably, FKBP8 escapes from degradation when mitophagy
is activated.
FKBP12: See FKBP1A.
FKBP38: See FKBP8.
FKBP51: See FKBP5.
FKBP52: See FKBP4.
FLCN (folliculin): A tumor suppressor mutated in BirtHogg-Dubé syndrome [3140]. FLCN interacts with
GABARAP, and this association is modulated by the presence
of either FNIP1 (folliculin interacting protein 1) or FNIP2.
ULK1 can induce FLCN phosphorylation, which modulates
the FLCN-FNIP-GABARAP interaction [712]. FLCN is also
linked to MTOR modulation through its interaction with the
RRAG GTPases on lysosomes [3141, 3142].
Fluspirilene: A diphenylbutylpiperidine typical antipsychotic
drug, used for the treatment of schizophrenia. Fluspirilene
reduces intracellular calcium-dependent CAPN1 (calpain 1)
activity and leads to autophagy induction by preventing
CAPN1-mediated cleavage of ATG5 [2917].
FM 4-64: A lipophilic dye that primarily stains endocytic
compartments and the yeast vacuole limiting membrane.
FNBP1L (formin binding protein 1 like): An F-BAR-con
taining protein that interacts with ATG3 and is required for
the autophagy-dependent clearance of S. typhimurium, but
not other types of autophagy [3143].
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FNIP1 (folliculin interacting protein 1): An interactor with
the tumor suppressor FLCN. FNIP1 [658] and its homolog
FNIP2 [712] can also interact with GABARAP.
FOXO1 (forkhead box O1): A mammalian transcription
factor that regulates autophagy independent of transcriptional
control; the cytosolic form of FOXO1 is acetylated after dis
sociation from SIRT2, and binds ATG7 to allow induction of
autophagy in response to oxidative stress or starvation [3144].
FOXO1 can also be deacetylated by SIRT1, which leads to
upregulation of RAB7 and increased autophagic flux [3145].
The C. elegans ortholog is DAF-16. See also SIRT1.
FOXO3 (forkhead box O3): A transcription factor that sti
mulates autophagy through transcriptional control of auto
phagy-related genes [984, 3146]. The C. elegans ortholog is
DAF-16.
Frataxin: See FXN.
Fsc1: A type I transmembrane protein localizing to the
vacuole membrane in the fission yeast S. pombe; required
for the fusion of autophagosomes with vacuoles [3147].
Fullerene C60 nanocrystals: A type of water-suspended car
bon nanomaterial that activates autophagy as a chemosensiti
zation mechanism [3148]. Fullerene C60 nanocrystals induce
cytoprotective autonomous CAMK2A/CaMKIIα activity.
Inhibition of CAMK2A activity enhances blocking of autop
hagic degradation through lysosomal dysfunction induction,
leading to an increase in fullerene C60 nanocrystals-elicited
cytotoxicity [3149].
FUNDC1 (FUN14 domain containing 1): A mitochondrial
outer membrane protein that functions as a receptor for
hypoxia-induced mitophagy [1169]. FUNDC1 contains a LIR
and binds LC3, and plays a role in disposal of paternal
mitochondria in the post-fertilization embryo [3150].
FUS (FUS RNA binding protein): A DNA/RNA binding
protein involved in DNA repair, gene transcription, and
RNA splicing. FUS has also been implicated in tumorigenesis
and RNA metabolism, and multiple missense and nonsense
mutations in FUS are associated with ALS. Autophagy reduces
FUS-positive stress granules [1281].
FXN (frataxin): A nuclear-encoded protein involved in ironsulfur cluster protein biogenesis. Reduced expression of the C.
elegans homolog, FRH-1, activates autophagy in an evolutio
narily conserved manner [2121].
FYCO1 (FYVE and coiled-coil domain autophagy adaptor
1): A protein that interacts with LC3, PtdIns3P and RAB7 to
move autophagosomes toward the lysosome through micro
tubule plus end-directed transport [3151].
Gαi3: See GNAI3.
GABA (γ-aminobutyric acid): GABA inhibits the selective
autophagy pathways mitophagy and pexophagy through Sch9,
leading to oxidative stress, which can be mitigated by the Tor1
inhibitor rapamycin [3152].
GABARAP (GABA type A receptor-associated protein): A
homolog of Atg8 and LC3 [786, 3153]. The GABARAP family
includes GABARAP, GABARAPL1/Atg8L/GEC1, and
GABARAPL2/GATE-16/GEF2. The GABARAP proteins are
involved in autophagosome formation and cargo recruitment
[32, 199].
GADD34: See PPP1R15A.
GAIP: See RGS19.

Gap junction proteins/connexins: Multispan membrane pro
teins that directly connect the cytoplasm of adjacent cells
through the formation of gap junction channels composed
by the docking of two hemi-channels or gap junctions at the
plasma membrane. In invertebrates, these channels are con
stituted by innexins, whereas in vertebrates they are formed
by GJ (gap junction protein)/connexin proteins [3154]. GJs
act as endogenous inhibitors of autophagosome formation by
directly interacting and sequestering at the plasma membrane
essential ATG proteins required for autophagosome biogen
esis [3155, 3156]. At the same time, gap junction proteins/
connexins themselves are degraded through autophagy, con
tributing to their rapid turnover [3157].
GAS5 (growth arrest specific 5): A lncRNA that is a positive
regulator of autophagy through microRNA sponging [3158].
Depletion of GAS5 decreases autophagy in non-small-cell
lung carcinoma cells [3159], and knockdown of GAS5 in
epithelial cells suppresses the expression of LC3-II, ATG3,
and ATG12–ATG5 complex formation, whereas the levels of
SQSTM1 are promoted [3160].
GATA1: A hematopoietic GATA transcription factor,
expressed in erythroid precursors, megakaryocytes, eosino
phils, and mast cells, that provides the differentiating cells
with the requisite autophagy machinery and lysosomal com
ponents to ensure high-fidelity generation of erythrocytes
[981]. See also ZFPM1/FOG1.
GATE-16: See GABARAP.
Gaucher disease (GD): Caused by mutations in the gene
encoding GBA (glucosylceramidase beta), Gaucher disease is
the most common of the lysosomal storage disorders, and
GBA mutations in the heterozygous state can increase sus
ceptibility to PD and other neurodegenerative synucleinopa
thies [3161–3163]. See also GBA.
GBA/GBA1/GCase/glucocerebrosidase (glucosylceramidase
beta): A lysosomal enzyme that breaks down glucosylcera
mide and glucosylsphingosine to glucose and ceramide, or
glucose and sphingosine, respectively. Mutations cause
Gaucher disease and are associated with increased risk of
PD. Loss of GBA is also associated with impaired autophagy
and failure to clear dysfunctional mitochondria, which accu
mulate in the cell [3164]. See also Gaucher disease.
GBM Studiengruppe Autophagie (German Autophagy
Association): See the organization website (http://autopha
gie-gbm.de/)
GCA (grancalcin): GCA activates TRAF6 ubiquitin ligase
activity to induce Lys63 ubiquitination of ULK1, a crucial
regulator of autophagy, resulting in its stabilization and acti
vation [649].
Gcn2: A mammalian and yeast EIF2S1/eIF2α serine/threo
nine kinase that causes the activation of the integrated stress
response, including induction of Gcn4 in response to amino
acid depletion, thus positively regulating autophagy [3079].
Gcn2 is homologous to EIF2AK4 in humans. See also Gcn4.
Gcn4: A yeast transcriptional activator that controls the
synthesis of amino acid biosynthetic genes and positively
regulates autophagy in response to amino acid depletion
[3079]. Gcn4 directly targets ATG1 and ATG41 to promote
transcription during nitrogen starvation [910, 2822]. See also
Gcn2.
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GCN5L1: See BLOC1S1.
GEEC (GPI-enriched endocytic compartments) pathway: A
form of clathrin-independent endocytosis that contributes
membrane for phagophore expansion [3165].
Genotoxin-induced targeted autophagy (GTA): A selective
autophagy pathway that is induced specifically in response to
genotoxic stress in S. cerevisiae. GTA is dependent on the core
autophagy machinery in yeast, as well as Atg11 and the DNA
damage response kinases Mec1/ATR and Tel1/ATM [1093].
GFAP (glial fibrillary acid protein): Intermediate filament
protein ubiquitously distributed in all cell types that bears
functions beyond filament formation. Monomeric and
dimeric forms of this protein associate with the cytosolic
side of the lysosomal membrane and contribute to modulating
the stability of the CMA translocation complex in a GTPdependent manner coordinated with EEF1A/eF1α also at the
lysosomal membrane [3076].
GFER/ERV1 (growth factor, augmenter of liver regenera
tion): A flavin adenine dinucleotide-dependent sulfhydryl
oxidase that is part of a disulfide redox system in the mito
chondrial intermembrane space, and is also present in the
cytosol and nucleus. Downregulation of GFER results in ele
vated levels of the mitochondrial fission GTPase DNM1L, and
decreased mitophagy [3166].
Ghrelin: An endogenous small peptide produced from the
GHRL gene that activates autophagy and mediates caloric
restriction-induced autophagy in rat cortical neurons [3167].
Ghrelin also modulates autophagy in metabolic, cardiac and
neurodegenerative disorders associated with impaired auto
phagy [3168]. See also NPY.
GID (glucose induced degradation deficient) complex: A
highly evolutionary conserved ubiquitin ligase that targets
key enzymes of gluconeogenesis (Fbp1, Mdh2, Pck1) for
polyubiquitination and subsequent proteasomal degrada
tion in S. cerevisiae [3169–3172]. Individual subunits of
the yeast Gid complex are conserved throughout the eukar
yotic kingdom and Vid30/Gid1, Rmd5/Gid2, Vid24/Gid4,
Vid28/Gid5, Gid7, Gid8 and Fyv10/Gid9 [3173] have their
closest human orthologs in RANBP9 (RAN binding protein
9)-RANBP10, RMND5A (required for meiotic nuclear divi
sion 5 homolog A)-RMND5B, GID4 (GID complex subunit
4 homolog), ARMC8 (armadillo repeat containing 8),
MKLN1 (muskelin 1) or WDR26 (WD repeat domain 26),
GID8 (GID complex subunit 8 homolog) and MAEA
(macrophage erythroblast attacher), respectively. These
subunits are also part of the human equivalent to the
yeast GID complex (CTLH complex) [3174–3176]. The
vertebrate GID-complex regulates AMPK activity through
ubiquitination [3177].
GILT: See IFI30.
Ginkgolic acids: Ginkgolic acids are a group of alkyl phenols
found in crude extracts of Ginkgo biloba leaves, an ancient
gymnosperm species. The incubation of tumoral cells with
ginkgolic acids blocks the sumo pathway and, as a conse
quence, induces autophagy-mediated cancer cell death [2673].
GIV/Girdin: See CCDC88A.
GLI3 (GLI family zinc finger 3): A C2H2 type of zinc finger
transcription factor that plays a role in the transcriptional
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activation of VMP1 during the induction of autophagy by
the oncogene KRAS [2673]. See also EP300.
Glutamoptosis: Cell death induced during nutritional imbal
ance due to the inhibition of autophagy mediated by glutami
nolysis [3178, 3179].
Glycophagy (glycogen autophagy): The selective sequestra
tion of glycogen and subsequent vacuolar hydrolysis of glyco
gen to produce glucose; this can occur by a micro- or
macroautophagic process and has been reported in mamma
lian newborns and adult cardiac tissues as well as filamentous
fungi [58, 2184, 2185, 3180–3182].
GMI: A fungal immunomodulatory protein from Ganoderma
microsporum, GMI induces autophagic cell death via calciumTP53 and AKT-MTOR signaling pathways [3183].
GNAI3 (G protein subunit alpha i3): A heterotrimeric G
protein that activates autophagy in the GDP-bound (inactive)
form, and inhibits it when bound to GTP (active state) [3184,
3185]. See also GPSM1, RGS19, MAPK1/3 and CCDC88A.
Golgi membrane-associated degradation (GOMED): A
non-canonical Golgi membrane-mediated process that is acti
vated by the disruption of PtdIns4P-dependent anterograde
trafficking, which occurs in both yeast and mammals [3186].
GOPC/PIST/FIG/CAL (golgi associated PDZ and coiledcoil motif containing): GOPC interacts with BECN1, and
the SNARE protein STX6 (syntaxin 6). GOPC can induce
autophagy via a CD46-Cyt-1 domain-dependent pathway fol
lowing pathogen invasion [2949].
GORASP2/GRASP55 (golgi reassembly stacking protein 2):
A Golgi apparatus peripheral membrane protein originally
identified as a Golgi apparatus stacking protein in the med
ial-trans Golgi apparatus. Under growth condition, GORASP2
is modified by a reversible, cytosolic glycosylation called OGlcNAcylation, and plays a critical role in Golgi apparatus
stack and ribbon formation by forming trans oligomers
[3187]. Upon energy or nutrient deprivation, GORASP2 is
de-O-GlcNAcylated and partially targeted to the autophago
some-lysosome interface by interacting with LC3 and LAMP2.
GORASP2 facilitates autophagosome-lysosome fusion by phy
sically linking the two membrane organelles and by recruiting
the UVRAG-containing PtdIns3K complex to autophago
somes [3188, 3189]. See also secretory autophagy.
Gossypol: See AT-101.
Gp78: See AMFR.
GPSM1/AGS3 (G protein signaling modulator 1): A gua
nine nucleotide dissociation inhibitor for GNAI3 that promotes
autophagy by keeping GNAI3 in an inactive state [2939].
GPSM1 directly binds LC3 and recruits GNAI3 to phagophores
or autophagosomes under starvation conditions to promote
autophagosome biogenesis and/or maturation. See also GNAI3.
GRAMD1A (GRAM domain containing protein 1A): Upon
starvation, the cholesterol transfer protein GRAMD1A accu
mulates during autophagosome initiation, which has been
found to affect cholesterol distribution, a process required
for autophagosome biogenesis [2848].
Granulophagy: The process of bulk autophagic degradation
of mRNP granules, particularly stress granules, although
autophagic degradation of P-granules and P-bodies in C.
elegans and human cells has also been described [1275,
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1276]. Granulophagy of stress granules has been characterized
in S. cerevisiae and mammalian cells and is dependent on
Cdc48/VCP/p97 in addition to the core autophagic machin
ery. Mutations in VCP associated with various neurodegen
erative diseases also impair granulophagy [1274]. SQSTM1
facilitates granulophagy of stress granules in human cells
[1275, 1277, 3190]. See also granulostasis and MSP.
Granulostasis: The process of chaperone-mediated quality
control of RNP granules. This process involves the HSPB8/
BAG3/HSP70 chaperone complex [1278, 1279] and autophagy
factors such as Cdc48/VCP/p97 and SQSTM1, which mediate
granulophagy of aberrant RNP granules. Impairment of gran
ulostasis through mutations or chemical inhibition of granu
lostasis factors leads to the formation of aberrant RNP
granules that may cause disease [3191, 3192]. See also
granulophagy.
GRB2 (growth factor receptor bound protein 2): GRB2
binds EGFR and contains one SH2 domain and two SH3
domains, working as a signal adaptor protein. The two SH3
domains bind to proline-rich regions of other proteins, and its
SH2 domain binds phosphorylated-tyrosine sequences. GRB2
promotes degradation of mutant HTT by augmenting auto
phagy in a Huntington disease cell model [3193, 3194].
GRN/PGRN (granulin precursor): GRN is an 88-kDa
secreted multi-functional glycoprotein. Human GRN is com
posed of 7.5 repeats of a highly conserved twelve-cysteine
granulin motif. GRN loss-of-function mutations cause fronto
temporal dementia and neuronal ceroid lipfuscinosis, type 11
(CLN11). GRN is trafficked to the lysosome amd processed
into stable, bio-active 6-kDa granulin proteins [3195].
Deficiency of GRN and granulins impairs autophagy and
lysosome function [3196, 3197].
GSK3/GSK-3 (glycogen synthase kinase 3): A regulator of
autophagy. GSK3A and GSK3B are highly similar isoforms.
GSK3 may act positively by inhibiting MTORC1 through the
activation of TSC1/2 and by activating ULK1 through KAT5
[3198]. GSK3 modulates protein aggregation through the phos
phorylation of the autophagy receptor NBR1 [2664]. GSK3,
however, is also reported to be a negative regulator of autopha
gy. GSK3-mediated phosphorylation of MCL1 induces axonal
autophagy,
which
promotes
axonal
degeneration.
Phosphorylated MCL1 is ubiquitinated by the FBXW7 ubiqui
tin ligase and degraded by the proteasome [3131]. GSK3 also
inhibits autophagy independently of MTORC1 through phos
phorylation and cytosolic retention of the transcription factor
TFEB [3199, 3200]. See also FBXW7, KAT5, MCL1 and TFEB.
Guanine quadruplex (G4) ligands: A range of compounds
that recognize unusual nucleic acid structures formed by
guanine-rich sequences; some of them activate autophagy
[2832, 2954].
H1-2/HIST1H1C (H1.2 linker histone, cluster member): A
variant of linker histone H1, which regulates autophagic gene
expression in the retina of diabetic rodents and high-glucosecultured cells [3201].
H2AX/H2AFX (H2A.X variant histone): Histone H2AX
phosphorylation on a serine located four residues from the
C terminus (producing γH2AX) is a sensitive marker for
DNA double-strand breaks [3202].

HA15: A new thiazol benzenesulfonamide compound that
directly targets HSPA5/GRP78 to induce a strong ER stress
and cancer cell death by concomitant autophagy and apopto
sis mechanisms [3203, 3204].
HDAC4 (histone deacetylase 4): A deacetylase distributed in
both the cytoplasm and nuclei that interacts with MAP1S and
the aggregation-prone mutant HTT protein (mHTT) that
causes Huntington disease; this interaction regulates the
MAP1S-mediated
autophagic
turnover
of
mHTT.
Spermidine reduces the distribution of HDAC4 in the cytosol
and enhances MAP1S-mediated autophagy to prolong life
span and prevent liver fibrosis and hepatocellular carcinomas
[956, 3205].
HDAC6 (histone deacetylase 6): A microtubule-associated
deacetylase that interacts with ubiquitinated proteins. HDAC6
stimulates autophagosome-lysosome fusion by promoting the
remodeling of F actin, and the quality control function of
autophagy, and also acts as a mediator between autophagy
and the UPS [1024, 1025, 3206, 3207]. HDAC6 is also a
biomarker of aggresomes [1781].
HDAC10 (histone deacetylase 10): A lysine deacetylase that
promotes lysosomal exocytosis supporting drug resistance in
aggressive tumor cells [3208, 3209].
HDX-MS (hydrogen deuterium exchange mass spectrome
try): A mass-spectrometry-based method, which can be used
to examine protein-protein, protein-lipid, protein-nucleic
acid, and protein-chemical interactions, as well as to estimate
regions of intrinsic disorder. HDX-MS measures rate of sol
vent exchange at the amide positions of the protein backbone
through the isotopic exchange of hydrogen with deuterium.
When using this procedure, it is highly recommended to
follow the guidelines established by the HDX-MS community
[3210].
HER2: See ERBB2.
Hfl1: A vacuole membrane protein that interacts with Atg8
and mediates the lipidation-independent vacuolar functions
of Atg8 in both fission yeast and budding yeast; Hfl1 uses a
non-canonical type of Atg8-interacting motif, termed a helical
AIM, to interact with Atg8 [3211].
HIF1A/HIF-1α (hypoxia inducible factor 1 subunit alpha):
A dimeric transcription factor in which the α subunit is
regulated by oxygen and other stimuli, including inflamma
tion [3212] and increases in tonicity [3213]; the hydroxylated
protein is degraded by the proteasome. HIF1A-mediated
expression of BNIP3 results in the disruption of the BCL2BECN1 interaction, thus inducing autophagy [3214, 3215].
HIF1A also regulates xenophagic degradation of intracellular
E. coli [3216].
Histone H3K56 acetylation: H3K56ac is one of the histone
modifications governing gene expression and regulation.
H3K56ac plays a primary role in maintaining genomic stabi
lity and the DNA damage response [3217]. The role of this
mark in regulating the autophagy epigenome has also been
demonstrated by POLR2/RNA polymerase 2 occupancy in
H3K56ac regions [986]. H3K56ac could influence the expres
sion of mitophagy-related genes including PINK1, PRKN and
AKT. In the neurotoxic model of mitochondrial complex II
inhibition, elevated H3K56ac is associated with autophagy/
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mitophagy genes (R. Sathyanarayanan and M.M. Srinivas
Bharath, unpublished data).
HK2 (hexokinase 2): The enzyme responsible for phosphor
ylation of glucose at the beginning of glycolysis; during glu
cose starvation, HK2 switches from a glycolytic role and
directly binds to and inhibits MTORC1 to induce autophagy
[3218].
HLH-30: C. elegans ortholog of the helix-loop-helix transcrip
tion factor TFEB.
HMGA1 (high mobility group AT-hook 1): An architectural
chromatin protein, whose overexpression is a common feature
of several malignant neoplasias, and that has a causal role in
cancer initiation and progression. In skin cancer and HeLa
cells, HMGA1 knockdown increases autophagosome forma
tion by constraining the activity of the MTOR pathway, and
transcriptionally upregulating ULK1, without inducing a pro
portionate increase in autophagosome maturation. The autop
hagosome accumulation induced by HMGA1 depletion is
associated with a decrease in cell proliferation and viability
[922]. HMGA1 is able to activate the PI3K-AKT signaling
pathway, and thus MTORC1, also in pancreatic adenocarci
noma cells, ultimately inducing anoikis resistance [3219].
HMGB1 (high mobility group box 1): A chromatin-asso
ciated nuclear protein that translocates out of the nucleus in
response to stress such as ROS; HMGB1 binds to BECN1,
displacing BCL2, thus promoting autophagy and inhibiting
apoptosis [398]. In addition, autophagy promotes the release
of HMGB1 from the nucleus and the cell, and extracellular
HMGB1 can further induce autophagy through binding
AGER [3220, 3221]. In a different context, autophagy-defi
ciency in hepatocytes can also trigger the active secretion of
HMGB1 via an NFE2L2-CASP1 signaling pathway. Released
HMGB1 promotes ductular reaction, a repair/regeneration
response to liver injury, and tumor progression, in the
absence of autophagy function [3222]. See also AGER.
Hog1: A yeast MAPK involved in hyperosmotic stress, which
is a homolog of mammalian MAPK/p38; Hog1 is required for
mitophagy, but not other types of selective autophagy or
nonselective autophagy [747]. See also MAPK, Pbs2 and Slt2.
HMOX1 (heme oxygenase 1): An inducible enzyme involved
in heme metabolism and cell protection from oxidative
damage. HMOX1 is required for activation of nonselective
autophagy and mitophagy in response to oxidative stress
[3223].
HOPS (homotypic fusion and vacuole protein sorting): The
HOPS complex is a six-subunit tethering complex that is
required for the fusion of autophagosomes, late endosomes
and biosynthetic vesicles with lysosomes from yeast to mam
mals [3224–3226].
HOTAIRM1 (HOXA transcript antisense RNA, myeloidspecific 1): A lncRNA that is downregulated in acute pro
myelocytic leukemia/APL patients. HOTAIRM1 regulates au
tophagy by acting as a microRNA sponge of MIR20A,
MIR106B, MIR125B and their targets ULK1, E2F1 and
DRAM2. Knocking down HOTAIRM1 can inhibit ATRAtriggered autophagosome formation [3227]. See also DRAM2.
hrm (hermes): A Drosophila proton-coupled pyruvate trans
porter that is required for autophagy associated with cell
death during salivary gland degradation [3228].

207

Hrr25: A protein kinase (homologous to CSNK1D/E) regu
lating diverse cellular processes such as DNA repair and
vesicular trafficking. Hrr25 phosphorylates the C terminus
of Atg19, which is essential for Atg19 binding to Atg11 and
subsequent Cvt vesicle formation [3229]. Hrr25 also phos
phorylates Atg36, and this phosphorylation is required for
the interaction of Atg36 with Atg11 (and subsequent pexo
phagy) [3230], and with Atg34 [3231]. The KpHrr25 ortholog
in K. phaffii/P. pastoris phosphorylates KpAtg30 [2814], for
subsequent KpAtg11 recruitment and selective autophagy
initiation. See also Atg11.
HS1BP3 (HCLS1 binding protein 3): A negative regulator of
autophagy. HS1BP3 regulates autophagy by modulating the
phosphatidic acid content of the ATG16L1-positive autopha
gosome precursor membranes through PLD1 (phospholipase
D1) activity and localization [3232].
HSC70: See HSPA8.
Hsp83 (Heat shock protein 83): The Drosophila ortholog of
human HSP90AA1/HSP90. Loss of Hsp83 results in reduced
proteasomal activity and enhanced autophagic flux that is
dependent on the Drosophila effector caspase Dcp-1 [3233].
HSPA1A: The major cytosolic stress-inducible version of the
HSP70 family. This protein localizes to the lysosomal lumen
in cancer cells, and pharmacological inhibition leads to lyso
some dysfunction and inhibition of autophagy [3234].
HSPA5/GRP78/BiP (heat shock protein family A (Hsp70)
member 5): A master regulator of the UPR. This chaperone,
maintaining ER structure and homeostasis, can also facilitate
autophagy [3235]. Cellular stresses such as cytosolic DNA
induce N-terminal arginylation of HSPA5/BiP (arginylated
HSPA5/R-Bip), which is selectively recognized by the ZZ
domain of SQSTM1 and targeted to phagophores together
with SQSTM1 and associated cargoes [463, 3236, 3237]. See
also SQSTM1.
HSPA8/HSC70 (heat shock protein family A (Hsp70) mem
ber 8): This multifunctional cytosolic chaperone is the con
stitutive member of the HSP70 family of chaperones and
participates in targeting of cytosolic proteins to lysosomes
for their degradation via chaperone-mediated autophagy
[3238]. The cytosolic form of the protein also regulates the
dynamics of the CMA receptor, whereas the lumenal form
(lys-HSPA8) is required for substrate translocation across the
membrane [3239]. This chaperone plays a role in the targeting
of aggregated proteins (in a KFERQ-independent manner) for
degradation through chaperone-assisted selective autophagy
[1828], and in KFERQ-dependent targeting of cytosolic pro
teins to late endosomes for microautophagy [1823]. See also
chaperone-assisted selective autophagy, chaperone-mediated
autophagy, and endosomal microautophagy.
HSP70 (heat shock protein 70): The major cytosolic heat
shock-inducible member of the HSP70 family. This form
accumulates in the lysosomal lumen in cancer cells. HSP70
is also a biomarker of aggresomes [3240]. See also HSPA1A.
HSP90: See HSP90AA1.
HSP90-ROF1 complex: AT4G24690/NBR1 targets HSP90
and AT3G25230/ROF1, a member of the FKBP family, and
mediates their degradation by autophagy, which represses the
expression of heat shock proteins regulated by the
AT2G26150/HSFA2 transcription factor and the response to
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heat stress in Arabidopsis [3241] (V.P. Thirumalaikumar, M.
Gorka, M. Schulz, C. Masclaux-Daubresse, A. Sampathkumar,
A. Skirycz, R.D. Vierstra and S. Balazadeh, unpublished data).
See also NBR1.
HSP90AA1/HSP90/HSPC1 (heat shock protein 90 alpha
family class A member 1): A cytosolic chaperone that is
also located in the lysosome lumen. The cytosolic form
helps to stabilize BECN1, and promotes autophagy [3242].
The lysosomal form of HSP90AA1 contributes to the stabili
zation of LAMP2A during its lateral mobility in the lysosomal
membrane [3243].
HSPB1/HSP27 (heat shock protein family B (small)
member 1): A stress-responsive molecular chaperone that
interacts with the oligomerization domain of SQSTM1.
Neuropathy-causing mutations in HSPB1 lead to autophagy
impairment by disrupting the interaction with SQSTM1
[3244].
HSPB8/HSP22 (heat shock protein family B (small) mem
ber 8): A stress-induced chaperone that associates with BAG3
forming the CASA complex [1828, 1841, 3245, 3246] with
HSPA8-STUB1, DNAJB6 and SQSTM1. Once formed and
cargo is recognized, STUB1 (an E3-ubiquitin ligase) ubiquiti
nates the substrate allowing its SQSTM1-mediated insertion
into the phagophore. At variance with CMA, which routes
cargoes directly to lysosomes, CASA routes substrates to the
lysosome via an autophagosome. The process is thought to
take place at the microtubule organizing center to which the
CASA complex is transported in a retrograde manner by
dynein associated directly with a PxxP motif of BAG3 [1840,
2929]. If HSPB8-BAG3 are displaced by the co-chaperone
BAG1, the cargoes are routed by HSPA8-STUB1 to the
proteasome.
HSPC1: See HSP90AA1.
HTRA2/Omi (HtrA serine peptidase 2): A nuclear-encoded
mitochondrial serine protease that was reported to degrade
HAX1, a BCL2 family-related protein, to allow autophagy
induction [3247]. In this study, knockdown of HTRA2, or
the presence of a protease-defective mutant form, results in
decreased basal autophagy that may lead to neurodegenera
tion. Separate studies, however, indicate that mitochondrial
HTRA2 plays a role in mitochondrial quality control; in this
case loss of the protein leads to increased autophagy and in
particular mitophagy [3248–3250].
HTT (huntingtin): Expanded polyglutamine repeats in
mutant HTT (repeat number beyond 36) lead to Huntington
disease, a neurodegenerative disorder involving loss of striatal
medium spiny neurons [1649, 3251, 3252]. The mutant HTT
protein fragment can be degraded by autophagy via adaptor
proteins such as WDFY3/Alfy and upregulated by HTT acet
ylation at K444 and K9, and phosphorylation at S13 by IKK
[1024, 3251, 3253–3257]. In addition, targeting the autophagic
pathway is beneficial in multiple models of HD [1951, 2036,
3251, 3258, 3259]. HTT can also directly regulate autophagy
either by modulating autophagosome axonal transport in
neurons via its interaction with DYNC1I (dynein cytoplasmic
1 intermediate chain) [3260, 3261] or as a scaffold for selective
autophagy [2784, 3262].
Hypersensitive response: A rapid and locally restricted form
of programmed cell death as part of the plant immune

response to pathogen attack. The hypersensitive response is
activated by different immune receptors upon recognition of
pathogen-derived effector proteins, and can be positively
regulated by autophagy [1760, 1764, 3263].
HYPK (huntingtin interacting protein K): HYPK was iden
tified as an HTT-interacting intrinsically disordered protein
with chaperone-like activity, which activates autophagy in a
HD cell model [3264].
IAPP (islet amyloid polypeptide): A 37 amino acid polypep
tide derived from processing of an 89 amino acid precursor,
which is coexpressed with INS (insulin) by pancreatic β-cells.
IAPP aggregation is implicated in the pathogenesis of type 2
diabetes. Autophagy regulates IAPP levels through SQSTM1dependent lysosomal degradation [3265–3267].
iC-MA (immune cell-mediated autophagy): IL2-activated
natural killer cell- and T cell-induced autophagy [3268].
Ice2: See Ayr1.
ICP0 (infected cell protein 0): An immediate-early gene
product of herpes simplex virus 1 that functions as a promis
cuous transactivator of genes introduced into the cells by
infection or transfection. This protein carries a zinc-binding
RING finger domain and functions as an E3 ubiquitin ligase
targeting for degradation proteins that are hostile to the cell.
ICP0 localizes in the nucleus immediately after its production
and translocates to the cytoplasm, after accomplishing its
nuclear functions. The autophagy receptors SQSTM1 and
OPTN are downregulated by cytoplasmic ICP0, in a protea
some-dependent manner [1422].
ICP34.5: A neurovirulence gene product encoded by the
herpes simplex virus type 1 that blocks EIF2S1-EIF2AK2
induction of autophagy [3079]. ICP34.5-dependent inhibition
of autophagy depends upon its ability to bind to BECN1
[1418].
IcsB: A T3SS effector found in Shigella spp. that acylates the
protein CHMP5 and enables escape of secreting S. flexneri
cells from LC3-positive vacuoles [3269, 3270]. IcsB is also
proposed to prevent recognition of VirG by ATG5. See also
VirG.
IDP (Intrinsically disordered protein): A protein that does
not possess unique structure and exists as a highly dynamic
ensemble of interconverting conformations [3271–3273].
IDPs are very common in nature [3274] and have numerous
biological functions that complement the functional repertoire
of ordered proteins [3275–3278]. Many proteins involved in
autophagy are IDPs [3279, 3280].
IDPR (intrinsically disordered protein region): A protein
region without unique structure that may be biologically
important. IDPRs are considered as a source of functional
novelty [3281], and they are common sites of protein-protein
interactions [3282] and posttranslational modifications
[3283].
IFI30/GILT (IFI30 lysosomal thiol reductase): A thiol
reductase that controls ROS levels; in the absence of IFI30
there is an increase in oxidative stress that results in the
upregulation of autophagy [3284].
IFT (intraflagellar transport): Bidirectional transport of
multimolecular complexes, called IFT particles, that shuttle
ciliary cargo along axonemal microtubules through the asso
ciation with molecular motors (i.e., kinesins and dyneins).
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The IFT system plays an essential role in the assembly and
function of motile cilia and flagella as well as in the modula
tion of cilium-dependent signaling pathways at the primary
cilium. Moreover, some IFT proteins have been involved in
the regulation of vesicular trafficking with relevant implica
tions in different vesicle-based processes, including autopha
gy. In ciliated cells, IFT20 (intraflagellar transport 20) and
IFT88 contribute to autophagosome formation by promoting
ATG16L1 recruitment to and into the primary cilium under
starvation conditions [3285]. In non-ciliated lymphocytes,
IFT20 controls lysosome biogenesis and function, and there
fore lysosomal degradation of autophagic cargo, by modulat
ing the TFEB-driven transcriptional program and regulating
IGF2R/cation-independent mannose-6-phosphate receptor
recycling [3286]; this lysosome-related function of IFT20 is
conserved in ciliated cells. See also ciliophagy and primary
cilium.
IKBKE (Inhibitor of nuclear factor kappa B kinase subunit
epsilon): IKBKE is frequently amplified or overexpressed in
a number of human cancers, in particular of the breast, and
is implicated in their tumorigenic process. It induces the
autophagic process, when overexpressed, and oncogenic
pathways typically involved in breast cancer, namely
ERBB2 and PI3K-AKT-MTOR, also rely on its activity to
control autophagy and, in turn, cancer cell proliferation
[2680].
IKK (IκB kinase): An activator of the classical NFKB path
way composed of three subunits (CHUK/IKKα/IKK1, IKBKB/
IKKβ/IKK2, IKBKG/IKKγ/NEMO) that are required for
optimal induction of autophagy in human and mouse cells
[3287].
IKKβ/ird5 (I-kappaB kinase β): Drosophila homolog of
IKBKB/IKKβ that is selectively degraded by autophagy
through its interacting partner key/kenny [2162]. See
also key.
iLIR: A web resource for prediction of Atg8-family-interact
ing proteins (http://repeat.biol.ucy.ac.cy/iLIR) [2510].
iLIR database: A database listing all the putative canonical
LIR-motif-containing proteins identified in silico in the pro
teomes of eight model organisms combined with a Gene
Ontology (GO) term analysis (https://ilir.warwick.ac.uk)
[2513].
iLIR@viral: A database listing all the putative canonical LIR
motifs identified in viral proteins (http://ilir.uk/virus/) [2513].
ILK (integrin linked kinase): ILK is involved with integrinmediated signal transduction. This enzyme is activated by
autophagy during TGFB-induced epithelial-mesenchymal
transition [3288].
Iml1 complex: A protein complex containing Iml1, Npr2 and
Npr3 that regulates non-nitrogen-starvation-induced auto
phagosome formation; the complex partially localizes to the
PAS [3289]. See also non-nitrogen-starvation (NNS)-induced
autophagy.
Immunoamphisomes: An organelle derived from the fusion
of endosomes/phagosomes with autophagosomes that regulate
dendritic cell-mediated innate and adaptive immune
responses [3290].
Immunophagy: A sum of diverse immunological functions of
autophagy [3291].
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IMPA (inositol monophosphatase): An enzyme that regu
lates the inositol 1,4,5-triphosphate (IP3) levels. Inhibition of
IMPA stimulates autophagy independent of MTOR [1976].
Incomplete autophagy: A process involving activation of
autophagy but without increasing autophagic degradation.
Some RNA viruses and bacteria utilize this mechanism to
facilitate their replication [3001].
Inflammasome: The inflammasome is an intracellular
inflammatory machinery that can switch on the inflammatory
response of tissues to a variety of stimuli. Autophagy and
several types of the inflammasome such as AIM2 and
NLRP3 inflammasomes are functionally interconnected. This
crosstalk between autophagy and the inflammasome machi
neries plays important roles in the control of cell homeostatic
processes including cell metabolism, organelle maintenance,
clearance of pathogens, and inflammatory response [3292–
3295].
Inflammation: A stereotyped and protective immune, vascu
lar and tissue response to exogenous or endogenous harmful
stimuli that is spontaneously extinguished and resolved after
elimination or termination of the damage by means of the
bioaction of several proteins and lipid mediators [3296–3298].
The cellular degradative pathway of autophagy has a funda
mental role in controlling the elimination of inflammatory
insults and simultaneously in contributing to immune cell
development and in limiting inflammatory pathologies
[3299].
InlK: An internalin family protein on the surface of L. mono
cytogenes that recruits vault ribonucleoprotein particles to
escape xenophagy [3300].
Innate immune surveillance: Recognition and response sys
tem for the sensing of DAMPs, including pathogens and
products of somatically mutated genes. Innate surveillance
responses include activation of autophagy to degrade
DAMPs [3034].
INSR (insulin receptor): Upregulation of INSR induces pro
tective autophagy and assists in mitigating poly(Q)-mediated
neurodegeneration in Drosophila [3301].
Integrated stress response: A highly conserved adaptation to
stress centered upon phosphorylation of the alpha subunit of
EIF2S1/eIF2α [3301]. Four EIF2S1 kinases sense distinct
stress conditions: EIF2AK1/HRI, EIF2AK2/PKR, EIF2AK3/
PERK and EIF2AK4/GCN2. Phosphorylation of EIF2S1 inhi
bits global translation, conserving cellular resources and
facilitating
reprogramming
of
gene
expression.
Simultaneously, p-EIF2S1 directs preferential translation of
a subset of “stress response” mRNAs, including ATF4, via a
delayed translation reinitiation that allows ribosome scan
ning through inhibitory upstream open reading frames
(uORFs) [2748].
Ionomycin: A calcium ionophore that releases calcium from
intracellular stores, thus increasing the intracytosolic level of
this ion [3302].
IP3K2 (inositol 1,4,5-trisphosphate kinase 2): A target of
mir-14 that regulates calcium signaling and autophagy in
Drosophila salivary glands [3303]. See also mir-14.
IP3R: See ITPR.
IRGM (immunity related GTPase M): Involved in the autophagic control of intracellular pathogens [3304]. IRGM
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interacts with core autophagy proteins ULK1, BECN1 and
ATG16L1 to govern antimicrobial autophagy [3305], and
limits NLRP3 inflammasome activation by impeding its
assembly and by mediating its selective degradation by auto
phagy [3306]. IRGM is a common target of RNA viruses to
subvert autophagy [3307]. In mouse, there are three IRGM
homologs named IRGM1, IRGM2, and IRGM3. Mouse
IRGM1 has the most extensive shared functions with human
IRGM.
IRGM1 (immunity-related GTPase family M member 1):
See IRGM.
Irs4: Irs4 and Tax4 localize to the PAS under autophagyinducing conditions in yeast and play a role in the recruit
ment of Atg17 [3308]. These proteins have partially overlap
ping functions and are required for efficient nonselective
autophagy and pexophagy.
Isolation membrane: See phagophore.
ITM2A (integral membrane protein 2A): A target of PRKA/
PKA-CREB that interacts with the V-ATPase and interferes
with autophagic flux [3309].
ITPR1/2/3 (inositol 1,4,5-trisphosphate receptor type 1/2/
3): A large tetrameric intracellular calcium-release channel
present in the ER and Golgi apparatus membranes that is
responsible for the initiation/propagation of intracellular
calcium signals augmenting free calcium concentrations in
the cytosol and/or organelles such as mitochondria [2001].
The ITPR is activated by inositol 1,4,5-trisphosphate/IP3
produced in response to extracellular agonists. Many pro
teins regulate the properties of ITPR including anti-apopto
tic BCL2-family proteins and BECN1 [3310, 3311]. The
ITPR can inhibit autophagy by scaffolding BECN1 as well
as by driving ATP production through transfer of calcium
from the ER to mitochondria, and consequent stimulation of
mitochondrial metabolism [668, 1976, 2063, 3312], whereas
BECN1-dependent sensitization of ITPR-mediated calcium
release (e.g., in response to starvation) can promote autop
hagic flux [1983]. The latter process is a direct effect of
BECN1 on ITPRs and appears not to be mediated via
ITPR-associated BCL2 recruiting BECN1 [1983]. Under the
conditions of physiological starvation, ITPR-mediated cal
cium release activates the CAMK2-OGT-ULK cascade that
initiates autophagy [1007]. ITPRs and calcium signaling not
only contribute to driving autophagic flux upon starvation
but also in response to chemical MTOR inhibitors such as
rapamycin [1985], to resveratrol [1991] and to chemical
inducers of ER stress such as the proline analog L-azeti
dine-2-carboxylic acid [1992]. An integrated discussion on
the complex role of intracellular calcium signaling in auto
phagy has been provided elsewhere [1994].
JNK1: See MAPK8.
Jumpy: See MTMR14.
JUN/c-Jun/JunB (Jun proto-oncogene, AP-1 transcription
factor subunit): A mammalian transcription factor that inhi
bits starvation-induced autophagy [3313].
Karyoptosis: A form of CASP3-independent cell death pro
posed to be directly associated with the nucleophagy process,
leading to cell atrophy, nuclear degeneration and DNA
damage [1750].

KAT5/TIP60 (lysine acetyltransferase 5): In response to
growth factor deprivation, KAT5 is phosphorylated and acti
vated by GSK3 and then acetylates and activates ULK1 [3198].
Kcs1: A yeast inositol hexakisphosphate/heptakisphosphate
kinase; the kcs1∆ strain has a decrease in autophagy that
may be associated with an incorrect localization of the PAS
[3314].
KDM1A/LSD1 (lysine demethylase 1A): A mammalian
demethylase that modulates autophagy via multiple mechan
isms including modulation of MTORC1 activity and SQSTM1
stability [3315–3317].
KDM2B (lysine demethylase 2B): A histone lysine demethy
lase that promotes H3K4 demethylation. The downregulation
of KDM2B in gastric cancer cells induces autophagy and
inhibits cell proliferation via PI3K-AKT-MTOR inhibition
and MAPK1/3 activation [3318].
KDM4A (lysine demethylase 4A): A mammalian demethy
lase that regulates the expression of a subset of ATG genes
[912, 913]. See also Rph1.
KEAP1 (kelch like ECH associated protein 1): An E3 ubi
quitin ligase responsible for the degradation of transcription
factor NFE2L2/NRF2 and the NFKB activator IKBKB/IKKβ.
KEAP1 is a substrate for SQSTM1-dependent sequestration.
SQSTM1 influences oxidative stress-related gene transcription
and regulates the NFKB pathway via its interaction with
KEAP1 [596, 3319, 3320]. See also NFE2L2.
key/kenny: Drosophila homolog of IKBKG/IKKγ that inter
acts with Drosophila Atg8a via a LIR motif and is selectively
degraded by autophagy. key is the selective autophagy recep
tor for the degradation of the IKK complex (key and IKKβ/
ird5) [2162]. See also IKKβ.
KFSDA pentapeptide (“KFERQ” mutant): A mutant form
of the KFERQ-like recognition motif as a negative reference
substrate peptide in CMA activity assays. Mutagenesis of the
CMA recognition motif is based on altering the physical
properties of amino acids in the targeting motif [3321]. The
resultant changes in individual amino acid are: “KFERQ” to
“KFSDA” (“KFERQ” mutant): First and second amino acids:
unchanged; third amino acid: E (acidic) to S (polar); fourth
amino acid: R (basic) to D (acidic); fifth amino acid: Q (polar)
to A (hydrophobic). An immunoprecipitation study shows
that a CMA substrate carrying a KFSDA mutant peptide
does not bind HSPA8, a key step prior to CMA degradation
[1814].
KIAA0226: See RUBCN.
KIAA1524: see CIP2A.
KIFC3 (kinesin family member C3): A minus-end directed
motor protein, member of the C-kinesin family, highly
enriched in lysosomes and required for the motility of the
lysosomal compartment [3322].
KillerRed: A red fluorescent protein that produces a high
amount of superoxide upon excitation. The construct with a
mitochondria targeting sequence (mitoKillerRed) can be used
to induce mitochondria damage and subsequent mitophagy
[462, 1173].
KL (klotho): A protein involved in the crosstalk between
autophagy and apoptosis. A reduction of KL intensifies oxi
dative stress and inflammatory response, resulting in genomic
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instability, p-EIF2A/eIF2α-mediated ER stress, retardation of
autophagy, and induction of apoptosis [3323, 3324].
KLHL20 (kelch like family member 20): A substrate adaptor
of CUL3 (cullin 3) ubiquitin ligase that targets autopho
sphorylated ULK1 and phagophore-localized PIK3C3/VPS34
and BECN1 for degradation to contribute to autophagy ter
mination [648].
Klp98A (Kinesin-like protein at 98A): Drosophila homolog
of KIF16B, which promotes microbutule plus end-directed
transport of autophagic vesicles toward the cell periphery as
well as autophagosome-lysosome fusion, through interactions
with Atg8a and Rab14 [3325].
Knockdown: An experimental technique to reduce protein
level without altering the endogenous gene encoding that
protein, through the means of short DNA or RNA oligonu
cleotides (miRNA, RNAi, shRNA, siRNA) that are comple
mentary to the corresponding mRNA transcript.
Knockout: Targeted inactivation of an endogenous genetic
locus (or multiple loci) via homologous recombination or
gene targeting technology.
KPT-185: A small molecule selective inhibitor of nuclear
export, that blocks XPO1-mediated nuclear export. KPT-185
is able to induce apoptosis in mantle cell lymphoma, and
autophagy declines post-treatment [3326].
KRAS: KRAS is the critical genetic driver of pancreatic ductal
adenocarcinoma (PDAC) initiation and progression, and is
essential for maintenance of PDAC tumorigenic growth.
Suppression of KRAS induces autophagic flux through acti
vating phosphorylation of AMPK and upregulation of total
BECN1 [3327].
Ku-0063794: A catalytic MTOR inhibitor that increases
autophagic flux to a greater level than allosteric inhibitors
such as rapamycin; short-term treatment with Ku-0063794
can inhibit both MTORC1 and MTORC2, but the effects on
flux are due to the former [453]. See also WYE-354.
KU55933: An inhibitor of the class III PtdIns3K, which
inhibits autophagosome formation at concentrations not
affecting the class I PI3K [331]. Also inhibits ATM.
LACRT (lacritin): A prosecretory mitogen primarily in tears
and saliva that transiently accelerates autophagic flux in
stressed cells [3328]. Lacritin targets heparanase-deglycanated
SDC1 (syndecan 1) on the cell surface [3329], and accelerates
flux by stimulating the acetylation of FOXO3 as a novel ligand
for ATG101 and by promoting the coupling of stress acety
lated FOXO1 with ATG7 [3330].
Laforin: See EPM2A.
Lalistat (LSTAT): 4-(Piperidin-1-yl)-1,2,5-thiadiazol-3-yl
morpholine-4-carboxylate is a potent and selective LIP (lipase,
lysosomal acid type) inhibitor. Lalistat exhibits no discernible
activity against LPL (lipoprotein lipase) and PNLIP (pancrea
tic lipase) [3331].
LAMP1 (lysosomal associated membrane protein 1):
LAMP1 shares common functions with LAMP2 [1829], is
largely used as marker of late autophagic and endocytic orga
nelles [3332], and is a target of TFEB. Activation of the TFEBmediated autophagy-lysosome pathway greatly increases
LAMP1 levels [3333].
LAMP2 (lysosomal associated membrane protein 2): A
widely expressed and abundant single-span lysosomal
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membrane protein. Three spliced variants of the LAMP2
gene have been described. Knockout of the entire gene results
in altered intracellular vesicular trafficking, defective lysoso
mal biogenesis, inefficient autophagosome clearance and
alterations in intracellular cholesterol metabolism [1829,
1830, 3334]. In human, deficiency of LAMP2 causes a cardi
oskeletal autophagic vacuolar myopathy, called Danon disease
[3335].
LAMP2A (lysosomal associated membrane protein 2A):
One of the spliced variants of the LAMP2 gene that functions
as a lysosomal membrane receptor for chaperone-mediated
autophagy [1816]. LAMP2A forms multimeric complexes that
allow translocation of substrates across the lysosome mem
brane [3243]. Regulation of LAMP2A is partly achieved by
dynamic movement into and out of lipid microdomains in the
lysosomal membrane [3239].
LAMP2C (lysosomal associated membrane protein 2C):
One of the spliced variants of the LAMP2 gene that functions
as a lysosomal membrane receptor for RNautophagy and
DNautophagy [1395–1398]. LAMP2C also perturbs CMA
and autophagy in mammalian cells [1832, 1833].
LAMP5 (lysosomal associated membrane protein family
member 5): A LAMP family member that is specifically and
highly expressed in patients with MLL leukemia. LAMP5 is a
novel autophagic suppressor that interacts with ATG5.
Knockdown of LAMP5 expression dramatically enhances the
protein level of ATG5 but not the mRNA level [3336].
LANDO: See LC3-associated endocytosis.
LAP: See LC3-associated phagocytosis.
LAP-like non-canonical autophagy (LNCA): Non-canonical
autophagy with properties similar to LAP, including singlemembrane LC3 conjugation. Whereas LAP is specific to pha
gosomes [247], LNCA describes a similar phenomenon invol
ving other types of organelles (e.g., macropinosomes [244]),
entotic bodies [244] and endocytic vacuoles in exocrine secre
tory cells [760]. See also LC3-associated phagocytosis.
LAPosome (LAP-engaged phagosome or LC3-associated
phagosome): A structure used for conjugation of LC3 to
single-membrane phagosomes. LC3 on LAPosomes promotes
phagosome maturation and processing of the engulfed cargo
[801, 2446]. In mammalian cells and C. elegans, LAPosomes
are observed during midbody remnant degradation and cell
corpse clearance [244, 758, 2450, 2451].
Late nucleophagy: A process in which bulk nucleoplasm is
delivered to the vacuole after prolonged periods of nitrogen
starvation and subsequently degraded within the vacuole
lumen [1081].
LC3: See MAP1LC3.
LC3/GABARAP-ylation: The modification of protein sub
strates by covalent conjugation to LC3/GABARAP, first used
to describe the autocatalytic conjugation of LC3/GABARAP
to ATG3 [262]. This process is counteracted by ATG4 pro
teases. See also deconjugation and 12-ylation.
LC3-associated endocytosis (LANDO): An LC3-dependent
process that requires ATG5 and RUBCN, but is independent
of RB1CC1 [2458].
LC3-associated phagocytosis (LAP): Phagocytosis that
involves the conjugation of LC3 to single-membrane phago
somes, a process that promotes phagosome maturation [247,
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801, 2446]. Signaling by pattern recognition receptors such as
TLRs [247, 3337] CLEC7A/Dectin-1 [3338–3340], CLEC6A/
Dectin-2 [3341] and ITGAM/Mac-1/CR3/integrin αmβ2 [904],
IgG receptors such as FCGR/FcγR [3342] and receptors
recognizing dead cells such as TIMD4/Tim4 [245] is required
for LAP and leads to the recruitment of the BECN1 complex
to phagosomes. See also NADPH oxidase.
LCN2/NGAL (lipocalin 2): First isolated from the superna
tant of human neutrophils, LCN2 has a major role in the
innate immune response, and in human cancer. In oral can
cer, LCN2 expression is downregulated and the silencing of
LCN2 suppresses autophagy via the MTOR pathway [3343].
Ldb16: See Ayr1.
Ldh1: See Ayr1.
LDS (LIR/AIM-docking site): Two conserved hydrophobic
pockets on the surface of Atg8-family proteins into which
bind the bulky hydrophobic residues found in WXXL-type
AIM/LIR sequences [658, 1359]. See also AIM, LIR, and
WXXL motif.
LGALS3 (galectin 3): LGALS3 is a galactose-specific lectin
that recognizes and relocates to damaged endo-lysosomal
vesicles. Therefore, LGALS3 is used as a reporter for endoso
mal membrane rupture in a so called “galectin puncta assay”
[3344]. Together with TRIM16, LGALS3 recruits the core
autophagy initiating factors ATG16L1 and ULK1 to clear
damaged endosomes [3345].
LGALS8 (galectin 8): A carbohydrate binding protein that
recognizes damaged membranes resulting from Salmonella
infection and subsequently recruits the cargo receptor
CALCOCO2 [1468]. LGALS8 consists of 2 separate carbohy
drate-recognition domains (CRDs; N-CRD and C-CRD); the
N-CRD binds to the galactose exposed from the damaged
membrane, whereas the C-CRD binds specifically to the
CALCOCO2 autophagy receptor [3346].
LGG-1: A C. elegans homolog of Atg8.
LGG-2: A C. elegans homolog of Atg8.
LGG-3: A C. elegans homolog of Atg12.
Licochalcone: Licochalcone A (LicA) is present in the root of
Glycyrrhiza inflata Batalin (licorice). LicA-induced early auto
phagy is reliant on the induction of autophagosomes, the
conversion of LC3-I to LC3-II, the induction of ATG5,
ATG7, ATG12 and BECN1, and the inhibition of BCL2
[3347].
Lipid peroxidation: Lipid peroxidation is one of the major
consequences of oxidative stress, characterized by raised levels
of its subproducts, such as thiobarbituric acid-reactive sub
stances (TBARS) [3348]. 4-hydroxynonenal (4-HNE), is a
TBARS that induces autophagy [3349].
Lipid rafts: Supramolecular structures of the cell membranes
that contain combinations of glycosphingolipids, sphingo
myelin, cholesterol and proteins organized in glycolipoprotein
microdomains. Lipid rafts are involved in the regulation of
signal transduction and in autophagosome formation [908]
and, through activation of the NADPH oxidase CYBB/Nox2,
also LAP [904, 3350].
Lipid transfer proteins: Formation and maturation of auto
phagosomes requires mobilization of various lipids to produce
and remodel these double-membrane organelles. Atg2/ATG2
is a lipid transfer protein [2759–2761, 3351] (for a more

detailed description, see Atg2). Other lipid transfer proteins
such as CERT1 (ceramide transporter 1) [3352], PITP (phos
phatidyl inositol transfer protein) [3353], and CPTP (cera
mide-1-phosphate transfer protein) [2958, 2959] have also
been implicated as regulators of autophagy. See also Atg2.
Liponecrosis: A lipotoxicity-related mode of regulated cell
death in which different autophagy-related processes within
budding yeast have opposing roles; the non-selective autopha
gy pathway for massive degradation of various cellular orga
nelles and macromolecules executes liponecrosis [1755],
whereas the cargo-specific mitophagy pathway for elimination
of damaged and dysfunctional mitochondria protects yeast
cells from liponecrotic death [1755, 1756]. Note that lipone
crosis is an aging-associated cell death mode whose agerelated onset in yeast can be postponed by certain agingdecelerating dietary and pharmacological interventions
[3354, 3355].
Lipophagy: Selective degradation of lipid droplets by lyso
somes contributing to lipolysis (breakdown of triglycerides
into free fatty acids). In mammals, this selective degradation
has been described to occur via autophagy (macrolipophagy)
[1288], whereas in yeast, microlipophagy of cellular lipid
stores has also been described. This process is distinct from
the PNPLA5-dependent mobilization of lipid droplets as con
tributors of lipid precursors to phagophore membranes. An
association of SQSTM1 with lipid turnover reveals a novel
pathway for the breakdown of lipid droplets. Accordingly,
lipophagy promotes the clearance of lipids from myocytes
and switches to an alternative, SQSTM1-mediated, lysoso
mal-independent pathway in the context of chronic lipid
overload [3356].
Liposomes: These are artificial vesicles that are categorized by
their size into three groups: small unilamellar vesicles (SUVs,
20-100 nm), large unilamellar vesicles (LUVs, 100-1000 nm),
and giant unilamellar vesicles (GUVs, 1-200 μm).
Lipoxygenases: A family of iron-containing enzymes that
catalyze the dioxygenation of polyunsaturated fatty acids in
different carbon atoms. Two specific lipoxygenases, ALOX5
and ALOX15, inhibit IFNG-induced autophagy in macro
phages [783].
LIR/LRS (LC3-interacting region): This term refers to the
WXXL-like sequences (consensus sequence [W/F/Y]-X-X-[I/
L/V]) found in proteins that bind to the Atg8/LC3/
GABARAP-family proteins (see also AIM and WXXL-motif)
[496]. The core LIR residues interact with two hydrophobic
pockets of the ubiquitin-like domain of the Atg8 homologs,
which are known collectively as the LIR/AIM docking site
(LDS). The functional LIR has been classified as an IDPRbased short linear motif [3357] because it is always located in
an intrinsically disordered region of an autophagy-related
protein. See also LDS.
LITAF (lipopolysaccharide induced TNF factor): An acti
vator of inflammatory cytokine secretion in monocytes that
has other functions in different cell types; LITAF is a
positive regulator of autophagy in B cells [3358]. LITAF
associates with autophagosomes, and controls the expres
sion of LC3B.
Lithium: This drug is primarily used as a psychiatric medica
tion. Lithium inhibits IMPA and promotes autophagy by
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increasing the levels of BECN1-containing PIK3C3/VPS34
complexes [1976].
LKB1: See STK11.
LMNB1 (lamin B1): A protein of the nuclear lamina that
directly binds LC3 molecules and directs the process of
nucleophagy in mammalian cells [1335].
LMP (lysosome membrane permeabilization): The process
by which lysosomal membranes become disrupted through
the action of lysosomotropic agents, detergents or toxins
[3359]. LMP blocks lysosomal activity and thus autophagy,
and induces the release of lysosomal content to the cytoplasm
including cathepsins that can induce cell death [1611, 3360].
LNCA: See LAP-like non-canonical autophagy.
LON2 (LON protease 2): A protease localized to the peroxi
some matrix that impedes pexophagy in Arabidopsis [2343].
Long-lived protein degradation (LLPD): Autophagy is a
primary mechanism used by cells to degrade long-lived pro
teins, and a corresponding assay can be used to monitor
autophagic flux [4, 25]; a useful abbreviation is LLPD [688].
LONP1 (lon peptidase 1, mitochondrial): Mitochondrial
matrix protease that reduces PINK1 accumulation. A reduc
tion of LONP1 induces mitophagy by increasing PINK1 accu
mulation. LONP1 protein is reduced in fibroblasts from PD
patients (with or without LRRK2 mutations), inducing mito
phagy [1006].
LPS (lipopolysaccharide): An endotoxin derived from the
outer membrane of Gram-negative bacteria [3361]. LPS treat
ment leads to a dramatic increase in autophagosome forma
tion and autophagic flux in different cell types [3362, 3363].
LpSpl: Legionella pneumophila sphingosine-1-phosphate
lyase, has SGPL1 activity and prevents an increase in sphin
gosine levels in infected host cells, thereby inhibiting autopha
gy during macrophage infection.
Lro1: See Ayr1.
Lucanthone: An anti-schistosome compound that inhibits a
late stage of autophagy; treatment results in deacidification of
lysosomes and the accumulation of autophagosomes [3364].
LRBA (LPS responsive beige-like anchor protein): A human
protein that facilitates fusion between autophagosomes and
the late endosomes. LRBA-deficient B cells have a significantly
reduced ability to induce autophagy in response to starvation
[3365].
LRP1/TM219/IGFBP3R1 (LDL receptor related protein 1):
A member of the low-density lipoprotein receptor family of
proteins and the receptor for VacA exotoxin produced by H.
pylori to induce autophagy; after binding of VacA to LRP1,
the LRP1-ICD is translocated to the nucleus. Nuclear translo
cated LRP1-ICD enhances LAMP1 expression by binding to
the proximal LAMP1 promoter region, leading to autolyso
some formation [2927]. LRP1 contains a di-arginine motif
and GFBP3 signaling module that activates processing of
proCASP8, inducing CASP8-dependent autophagy; blocking
LRP1 signaling leads to inhibition of autophagy [3366]. See
also CAPZA1.
LRPPRC (leucine rich pentatricopeptide repeat contain
ing): A mitochondrion-associated protein that binds BCL2
and PRKN to control the initiation of general autophagy
and mitophagy [3367, 3368].
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LRRK2 (leucine rich repeat kinase 2): A large multidomain,
membrane-associated kinase and GTPase whose PD-asso
ciated mutations affect the regulation of autophagy and mito
phagy, potentially through derepression of ULK1 or
mitochondrial calcium dysregulation [264, 3369, 3370].
LRRK2 is also recruited to stressed lysosomes (e.g., after CQ
treatment), where it then recruits and phosphorylates its sub
strate, small RAB GTPases [3371], to maintain lysosomal
homeostasis [3372].
LRS (LC3 recognition sequence): See LIR/LRS.
LRSAM1 (leucine rich repeat and sterile alpha motif con
taining 1): A human leucine-rich repeat protein that poten
tially interacts with GABARAPL2; knockdown of LRSAM1
results in a defect in anti-Salmonella autophagy [3373].
LS2 (Life Sciences Switzerland) Section Autophagy: See
https://www.ls2.ch for more information.
Lst1: A component of the COPII-cargo adaptor complex
Lst1-Sec23 that interacts with the reticulophagy receptor
Atg40 to allow specific domains of the ER to be sequestered
within phagophores [1382].
Ltn1: See Rkr1.
LY294002: An inhibitor of phosphoinositide 3-kinases and
PtdIns3K that inhibits autophagy [3374].
LYNUS (lysosomal nutrient sensing): A complex including
MTORC1 and the V-ATPase located on the lysosomal surface
that senses nutrient conditions [1296]. The LYNUS complex
regulates TFEB activity.
Lys05: A dimeric CQ derivative that accumulates in the lyso
some and inhibits autophagy [3375, 3376].
Lysophagy: The autophagic removal of damaged lysosomes
[1321, 3313, 3314].
Lysosome: A degradative organelle in more complex eukar
yotes that compartmentalizes a range of hydrolytic enzymes
and maintains a highly acidic pH. A primary lysosome is a
relatively small compartment that has not yet participated in a
degradation process, whereas secondary lysosomes are sites of
present or past digestive activity. The secondary lysosomes
include autolysosomes and telolysosomes. Autolysosomes/
early secondary lysosomes are larger compartments actively
engaged in digestion, whereas telolysosomes/late secondary
lysosomes do not have significant digestive activity and con
tain residues of previous digestions. Both may contain mate
rial of either autophagic or heterophagic origin.
Lysosomotropism: The property of some compounds (such
as weak bases) to diffuse across the lysosomal membrane and
to accumulate in the acidic interior of lysosomes. Once
inside the lysosome, these compounds become protonated,
and, due to the charge, incapable of diffusing back into the
cytosol. Such compounds are referred to as lysosomotropic
[3377].
Macroautophagy: The forms of autophagy that involve pha
gophores and autophagosomes, distinguishing it from other
major forms of autophagy that do not involve these compart
ments, such as microautophagy and CMA. Autophagy can be
selective and nonselective. For selective autophagy, the auto
phagosomes can be termed according to their content (for
instance “mitophagosome” for autophagosomes that selec
tively sequester mitochondria).
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MAGEA3 (MAGE family member A3): MAGEA3 and
MAGEA6 form a complex with the E3 ligase TRIM28, result
ing in the degradation of AMPK and the subsequent increase
in MTOR activity, which in turn causes a downregulation of
autophagy [3378]. See also TRIM28.
MAP1L C3/LC3 (microtubule associated protein 1 light
chain 3): A homolog of yeast Atg8, which is frequently used
as a phagophore or autophagosome marker. Cytosolic LC3-I
is conjugated to phosphatidylethanolamine to become phago
phore-, autophagosome- or LAPosome-associated LC3-II
[365]. The LC3 family includes LC3A, LC3B, LC3B2 and
LC3C. These proteins are involved in the biogenesis of autophagosomes, and in cargo recruitment [199]. Vertebrate LC3
is regulated by phosphorylation of the N-terminal helical
region by PRKA/PKA [293]. The LC3A gene has six exons,
which encode two variants: LC3A-V1 formed by the inclusion
of exons 3 to 6, which translate into 121 amino acids
(NM_032514.4); LC3A-V2 is formed by the inclusion of
exons 1, 2, and 4 to 6, which translates into 125 amino
acids. LC3A-V1 is frequently inactivated in cancer by promo
ter methylation [3379, 3380].
MAP1S (microtubule associated protein 1S): A ubiquitously
distributed homolog of the neuron-specific MAP1A and
MAP1B with which LC3 was originally copurified. It is
required for autophagosome trafficking along microtubular
tracks [3381, 3382].
MAP3K7/MEKK7/TAK1 (mitogen-activated protein kinase
kinase kinase 7): A MAP3K activated by a variety of extra
cellular stimuli such as LPS, IL1, TNF, TGFB, and TNFSF10/
TRAIL. MAP3K7 plays a central role in TLR-activation of
NFKB and AP-1. MAP3K7 is required for TNFSF10-induced
activation of AMPK and also activates MAPK/JNK, both of
which are required for microbial pathogen-induced autophagy
[3383–3385]. MAP3K7 is required for optimal autophagy
induction by multiple stimuli [3386], and it phosphorylates
SQSTM1 at multiple sites [3387, 3388]. See also RPS6KB1.
MAP4K3/GLK3 (mitogen-activated protein kinase kinase
kinase kinase 3): An amino-acid dependent activator of
MTORC1. MAP4K3 physically interacts with TFEB, and,
under conditions of amino acid satiety, MAP4K3 phosphor
ylates TFEB at serine 3 to suppress autophagy; MAP4K3
inhibition of TFEB is upstream of MTORC1 inhibition, as
MAP4K3 phosphorylation of TFEB at serine 3 is required for
MTORC1’s inhibitory phosphorylation of TFEB at serine 211
[3389]. Hence, MAP4K3 inhibition is sufficient to induce
productive autophagy.
MAPK1 (mitogen-activated protein kinase 1): A kinase that
along with MAPK3 phosphorylates and stimulates RGS19/
Gα-interacting protein/GAIP, which is a GTPase activating
protein (GAP) for the trimeric GNAI3 protein that activates
autophagy [3390], and which may be involved in BECN1independent autophagy [118]. Constitutively active MAPK1/
3 also traffics to mitochondria to activate mitophagy [1138].
MAPK3: See MAPK1.
MAPK8/JNK1: A stress-activated kinase that phosphorylates
BCL2 at Thr69, Ser70 and Ser87, causing its dissociation from
BECN1, thus inducing autophagy [853].
MAPK8IP1/JIP1 (mitogen-activated protein kinase 8 inter
acting protein 1): A LIR-containing LC3-binding protein that

mediates the retrograde movement of RAB7-positive auto
phagosomes in axons [3391]. Movement toward the proximal
axon involves activation of dynein, whereas binding of LC3 to
MAPK8IP1 prevents activation of kinesin. The DUSP1/MKP1
phosphatase may dephosphorylate Ser421, promoting binding
to dynein.
MAPK9/JNK2: A stress-activated kinase that prevents the
accumulation of acidic compartments in cells undergoing
autophagic flux, thus keeping stressed cells alive [3392].
MAPK14 (mitogen-activated protein kinase 14): A signaling
component that negatively regulates the interaction of ATG9
and SUPT20H/FAM48A, and thus inhibits autophagy. In
addition, MAPK14-mediated phosphorylation of ATG5 at
T75 negatively regulates autophagosome formation [3393].
The widely used pyridinyl imidazole class inhibitors of
MAPK14 including SB202190 interfere with autophagy in a
MAPK/p38-independent manner and should not be used to
monitor the role of this signaling pathway in autophagy
[3394, 3395]. The yeast homolog is Hog1. See also Hog1.
MAPK15/ERK7/ERK8 (mitogen-activated protein kinase
15): MAPK15 is a LIR-containing protein that interacts with
LC3B, GABARAP and GABARAPL1 [272]. This kinase is
localized in the cytoplasm and can be recruited to autophagic
membranes through its binding to Atg8-family proteins.
MAPK15 responds to starvation stimuli by self-activating
through phosphorylation on its T-E-Y motif, and its activa
tion contributes to the regulation of autophagy. MAPK15 also
interacts with components of the ULK complex and controls
ULK1/2 activity to regulate early phases of the autophagic
process [3396].
MAPKAPK2 (MAPK activated protein kinase 2):
MAPKAPK2 is a Ser/Thr protein kinase downstream of
MAPK/p38. Its activation contributes to starvation-induced au
tophagy by phosphorylating BECN1/Beclin 1 [2658]. See also
BECN1.
MAPKAPK3 (MAPK activated protein kinase 3):
MAPKAPK3 shares a similar function with MAPKAPK2 in
autophagy [2658]. See also MAPKAPK2 and BECN1.
Matrine: A natural compound extract from traditional
Chinese medicine that inhibits autophagy by elevating lysoso
mal pH and interfering with the maturation of lysosomal
proteases [3397].
MB21D1: See CGAS.
MCL1 (MCL1 apoptosis regulator, BCL2 family member):
A member of the BCL2 family of proteins, which reciprocally
controls BECN1 proteasomal degradation and thus protein
levels through competitive binding to the USP9X deubiquiti
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nating enzyme [3398, 3399]. GSK3B-mediated phosphoryla
tion of MCL1 induces axonal autophagy [3131]. See also
FBXW7, GSK3B and USP9X.
MCOLN1/TRPML1 (mucolipin 1): A lysosomal channel
belonging to the transient receptor potential gene family that
is permeable to several cations including calcium [3400, 3401].
MCOLN1-mediated calcium release from lysosomes can mod
ulate autophagy in a multistep manner. Acute MCOLN1 acti
vation induces autophagosome biogenesis by increasing the
generation of PtdIns3P through the activation of PIK3C3/
VPS34, and the recruitment of essential PtdIns3P-binding pro
teins to the nascent phagophore in a TFEB-independent man
ner, whereas prolonged channel activation induces TFEB
nuclear translocation, triggered by its PPP3/calcineurin-depen
dent dephosphorylation [2000, 3402]. In addition, MCOLN1
mediates calcium-CALM (calmodulin)-dependent MTORC1
reactivation in conditions of prolonged starvation [1999,
3403]. MCOLN1 also localizes to late endosomes [3404].
MDC (monodansylcadaverine): A lysosomotropic autofluor
escent compound that accumulates in acidic compartments of
live cells such as autolysosomes, and also labels (but is not
specific for) autophagosomes [2, 1866]. MDC also accumu
lates in hydrophobic environments, which stimulates fluores
cent light emission (solvent polarity probe) and labels late
autophagosomes in formaldehyde-fixed cells [1603].
MDH (monodansylpentane): A structural homolog of MDC
that has lost its lysosomotropic properties but accumulates in
hydrophobic environments and labels late autophagosomes in
live and formaldehyde-fixed cells [1603].
MDK-ALK axis: MDK (midkine) is a growth factor for which
increased levels are associated with a poor prognosis in malig
nant tumors. MDK promotes resistance to cannabinoidevoked autophagy-mediated cell death via stimulation of
ALK (ALK receptor tyrosine kinase). Targeting of the MDKALK axis could help to improve the efficacy of antitumoral
therapies based on the stimulation of autophagy-mediated
cancer cell death [3405, 3406].
Mdm10: A component of the ERMES complex in yeast that is
required for mitophagy. See also ERMES [3107].
Mdm12: A component of the ERMES complex in yeast.
Mdm12 colocalizes with Atg32-Atg11 and is required for
mitophagy. See also Atg11, Atg32, and ERMES [2911, 3107].
Mdm34: A component of the ERMES complex in yeast.
Mdm34 colocalizes with Atg32-Atg11 and is required for
mitophagy. The ubiquitination of Mdm34 by the E3 ligase
Rsp5 is also required for efficient mitophagy. See also Atg11,
Atg32, Rsp5 and ERMES [2911, 3107, 3108].
Mdv1: A component of the mitochondrial fission complex
that plays a role in mediating mitophagy-specific fission
[2911]. See also Dnm1.
MEFV/TRIM20/pyrin/Mediterannean fever (MEFV innate
immunity regulator, pyrin): The gene encoding MEFV is a
site of polymorphisms associated with familial Mediterranean
fever; MEFV/TRIM20 acts as a receptor for selective autopha
gy of several inflammasome components [3407].
Mega-autophagy: The final lytic process during developmen
tal programmed cell death in plants that involves tonoplast
permeabilization and rupture, resulting in the release of
hydrolases from the vacuole, followed by rapid disintegration
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of the protoplast at the time of cell death [2349, 3408, 3409].
This term has also been used to refer to the rupture of the
yeast vacuole during sporulation, which results in the destruc
tion of cellular material, including nuclei that are not used to
form spores [3410].
Megaphagosomes: Very large (5-10 μm) double-membraned,
autophagy-related vesicles that accumulate in cells infected by
coxsackievirus and, possibly, influenza virus [260].
Melatonin (N-acetyl-5-methoxy tryptamine): A sleep-wake
cycle regulating and antioxidant hormone that inhibits auto
phagy in animal models of fibrosis [2612], cancer [2613] and
acute organ failure [2614].
Membrane curvature: Membrane curvature is the geometri
cal measure or characterization of the physical bending of
membranes to accommodate various cell morphology changes
as well as the formation of membrane-bound transport inter
mediates such as spherical vesicles or tubules. An increase in
membrane curvature facilitates insertion of ATG3 into mem
branes [2106]. Bilayer curvature modulates Atg8-family pro
tein-mediated model phagophore elongation [552].
Membrane fission/scission and membrane fusion:
Topological transformations of the membrane, which involve
nonbilayer states of the membrane molecules [9, 10].
Membrane scission (also called membrane fission) refers to
the process where one membrane separates into two distinct
membranes and occurs during closure of the phagophore.
Membrane fusion refers to the reverse change where two
separate bilayers merge and form a single continuous bilayer,
as seen for example with the fusion of the autophagosome
outer membrane with a vacuole or lysosome.
Mcr (Merlin): A Drosophila complement-related protein that
is required for autophagy in neighboring cells during salivary
gland degradation and wound healing [3411].
Metformin: An anti-diabetic drug that induces autophagy
through AMPK pathway activation [3412].
MFN2 (mitofusin 2): An outer mitochondrial membrane
GTPase with dual, mutually exclusive roles in mitochondrial
fusion and mitophagy; upon phosphorylation by PINK1
kinase in damaged mitochondria, MFN2 is functionally trans
formed from being fusogenic to a mitochondrial binding
protein for PRKN, thus promoting sequestering and targeting
the damaged organelle for degradation [3413, 3414]. MFN2 is
also localized at the ER membrane and modulates ER-mito
chondria tethering; the absence of MFN2 leads to impaired
autophagy [3415, 3416].
MFSD8/CLN7 (major facilitator superfamily domain con
taining 8): A polytopic endosomal/lysosomal membrane gly
coprotein of unknown function. Mutations in the MFSD8/
CLN7 gene lead to the CLN7 disease (MIM 610951) with
late infantile phenotype, which belongs to the neuronal ceroid
lipofuscinoses (NCLs) [3417]. In an mfsd8/cln7 knockout
mouse model, accumulation of autofluorescent lipopigments,
lysosomal dysfunction and impaired autophagy are observed
[3418].
MG132: Reversible inhibitor of the chymotrypsin- and cas
pase-like activities of the proteasome that induces the forma
tion of protein aggregates and activates the autophagic flux in
an NFKB-dependent manner [1107].
MGEA5: See OGA.
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Microautophagy: An autophagic process involving direct
uptake of cytosol, inclusions (e.g., glycogen) and organelles
(e.g., ribosomes, peroxisomes) at the lysosome/vacuole by
protrusion, invagination or septation of the sequestering orga
nelle membrane.
MIPA (micropexophagic apparatus): A curved doublemembrane structure formed by the PAS that may serve as a
scaffold for completion of the sequestration of peroxisomes
during micropexophagy; fusion with the vacuolar sequestering
membranes encloses the organelles within an intralumenal
vesicle [3419]. See also vacuolar sequestering membranes.
mir-14 (mir-14 stem loop): A microRNA that is necessary
and sufficient for autophagy in Drosophila salivary glands
[3303].
MIR9 (microRNA 9): A human miRNA that influences
autophagy by inhibiting SIRT1 expression in chondrocytes
[3420].
MIR29 (microRNA 29): A miRNA that knocks down
LAMTOR1/p18 and leads to limited MTORC1 recruitment
to lysosomes when overexpressed in retinal pigment epithelial
cells. Consequently, MIR29 enhances autophagy, which aids
in removal of protein aggregates in the RPE cells [3421].
MIR21 (microRNA 21): A miRNA that is overexpressed in
almost all types of solid tumors and is involved in cancer
chemoresistance. MIR21 modulates autophagy and the sensi
tivity of tumor cells towards drugs that induce autophagy
[3422].
Mir31 (microRNA 31): A mouse miRNA that targets
PPP2/PP2A to inhibit IFNG-induced autophagy in macro
phages during mycobacterial infection [783]. See also
Mir155.
MIR95: A human miRNA that inhibits autophagy and blocks
lysosome function via repression of SUMF1 [332].
MIR101: A human miRNA that inhibits autophagy and the
expression of STMN1, RAB5A and ATG4D [334].
Mir155: A mouse miRNA that targets PPP2/PP2A to inhi
bit IFNG-induced autophagy in macrophages during
mycobacterial infection [783]. Human MIR155 counteracts
the autophagic flux in chondrocytes by downregulating
various autophagy factors (ULK1, FOXO3, ATG14,
ATG5, ATG3, GABARAPL1, and LC3) [3423]. See also
Mir31.
MIR205: A microRNA precursor that impairs the autophagic
flux in castration-resistant prostate cancer cells by downregu
lating the lysosome-associated proteins RAB27A and LAMP3
[3424].
Mir224 (microRNA 224): Mir224 is an oncogenic microRNA
in hepatocellular cellular carcinoma (HCC) through targeting
Smad4. Mir224 is selectively recruited and degraded by the
autophagy degradative machinery; however, the underlying
mechanism remains unclear [3425, 3426].
MIR4465: A microRNA that, in HEK293, HeLa, and SHSY5Y cells, inhibits the expression of PTEN, upregulates
phosphorylated AKT and inhibits autophagy by activating
MTOR [3427].
MIRLET7 (microRNA let-7): A microRNA capable of mod
ulating autophagy [3428–3432]. Mirlet7 microRNA activates
autophagy in primary neurons in culture, in adult-born
olfactory bulb neurons and mammalian brain and peripheral

tissue by coordinately downregulating the amino acid sen
sing pathway to prevent MTORC1 activation [3428, 3429].
However, in vascular smooth muscle cells pretreated with
the HsMIRLET7G isoform, an inhibition of autophagy has
been reported [3432]. Mirlet7/let-7 is also able to modulate
autophagy in neurodegenerative disorders associated with an
autophagic impairment [3430, 3431]. In Alzheimer adrenal
pheochromocytoma PC12 and human neuroblastoma SK-NSH cell models, MIRLET7A isoform overexpression further
upregulates autophagy induced by treatment with β-amyloid
protein 40 [3430]. Moreover, it has been reported that the
Mirlet7f isoform is also able to activate autophagy in the
brain of an in vivo mouse model of spinocerebellar ataxiatype 3/Machado-Joseph disease, whereas an anti-Mirlet7
decreases autophagy in a Huntington disease mouse model
[3428]. Nevertheless, in a C. elegans model of Parkinson
disease expressing human SNCA, it has been reported that
a loss of the let-7 miRNA leads to an increase in autophagy
[3431].
MITF (melanocyte inducing transcription factor): A tran
scription factor belonging to the microphthalmia/transcrip
tion factor E (MiT/TFE) family, along with TFEB and TFE3;
MITF binds to symmetrical DNA sequences (E-boxes; 5CACGTG-3), and regulates lysosomal biogenesis and auto
phagy (including the genes BCL2, UVRAG, ATG16L1,
ATG9B, GABARAPL1, and WIPI1). MITF shares a common
mechanism of regulation with TFEB and TFE3; MITF can
partially compensate when TFEB is lost upon specific stimuli
or in specific cell types [977, 3433]. See also TFEB.
mito-QC: A mitophagy reporter construct expressed in
mouse and Drosophila models that constitutively and ubi
quitously expresses a mitochondrial outer membrane-loca
lized mCherry-GFP tag. This model allows visualization of
mitochondrial quality control (QC) by mitophagy, in addi
tion to mitochondrial network architecture in vivo
[38, 466].
Mitochondria-associated
ER
membranes
(MAMs):
Functional domains that reversibly connect the ER to mito
chondria with a significant role in the maintenance of calcium
homeostasis and mitochondria biogenesis; these membranes
also participate in autophagosome formation [908]. See also
ER-mitochondria sites.
Mitochondrial spheroid: A mitochondrial structure formed
in PRKN-deficient cells treated with a mitochondrial uncou
pler (such as CCCP) [1135, 1136]. Under this condition,
mitophagy fails to occur and a damaged mitochondrion
can transform into a spheroid containing cytosolic compo
nents in the newly formed lumen. PRKN and MFNs can
reciprocally regulate mitophagy and mitochondrial spheroid
formation.
Mitolysosome: This term refers to the product of a mitopha
gosome fused with a lysosome [3434, 3435].
Mitophagic body: The single-membrane vesicle present
inside the vacuole lumen following the fusion of a mitopha
gosome with a vacuole.
Mitophagosome: An autophagosome containing mitochon
dria and no more than a small amount of other cytoplasmic
components, as observed during selective macromitophagy
[55, 1113].
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Mitophagy: The selective autophagic sequestration and
degradation of mitochondria; can occur by a micro- or autop
hagic process [3436].
Mitostatin: See TCHP.
MitoTimer: A mitochondria-targeted time-sensitive fluor
escent protein for which emission shifts from green to red.
Constructs that encode an inducible form of the protein
can be used to study mitochondrial turnover [1177, 1178,
1180], and constructs that encode a constitutively active
form of the protein can be used to study mitochondrial
structure, oxidative stress and mitophagy [1179, 1181–
1187].
MitoTracker® Dyes: Commercially available fluorescent
probes that can stain mitochondria in both fixed or living
samples [3437]; these can be dependent or independent of the
mitochondrial membrane potential.
Mkk1/2: A MAPKK downstream of Bck1 that is required for
mitophagy and pexophagy in yeast [747]. See also Bck1 and
Slt2.
MLN4924: An inhibitor of NAE1 (NEDD8 activating enzyme
E1 subunit 1) that is required for CUL (cullin)-RING E3 ligase
activation; treatment with MLN4924 induces autophagy
through the accumulation of the MTOR inhibitory protein
DEPTOR [2620].
Mmm1: A component of the ERMES complex in yeast that is
required for mitophagy. See also ERMES [3107].
MoAtg24: MoAtg24 is directly involved in mitophagy in a
way similar to the function of yeast Atg32 [1069]. During the
pathogenesis process, carbon starvation induces the break
down of the mitochondrial network and leads to more punc
tate mitochondria in M. oryzae. This nutrient-based
regulation of organellar dynamics precedes MoAtg24mediated mitophagy, which is essential for proper biotrophic
development and invasive growth of M. oryzae in planta
[3438].
MoMkk1/2 (Magnaporthe oryzae Mkk1/2): Homologs of S.
cerevisiae Mkk1/2 (MAP kinase kinases) that are phosphory
lated by MoAtg1 to activate the cell wall integrity pathway
under conditions of ER stress, which is essential for virulence
during infection [2195]. MoMkk1 Ser115 is an identified
phosphorylation site.
Mon1-Ccz1: A dimeric guanine-nucleotide exchange factor
for the GTPase Ypt7 in yeast [3439] and RAB7 in
metazoan cells [3440, 3441]; the complex has a third sub
unit in human cells [35]. Mon1-Ccz1 is recruited by Atg8
and PtdIns3P to the autophagosomal surface, and activates
Ypt7/RAB7 for fusion with the vacuole/lysosome [3442].
Monensin: A polyether antibiotic, which interferes with
autophagosome-lysosome fusion and consequently inhibits
autophagy [3443].
MoRF (molecular recognition feature): A short (10-70 resi
dues) IDPR in proteins, including Atg20, that undergo a
disorder-to-order transition upon binding to its partners
[2801, 3281, 3444–3447].
MORN2 (MORN repeat containing 2): MORN2 is a mem
brane occupation and recognition nexus (MORN)-motif
protein that was identified in mouse testis. The gene loca
lizes on chromosome 17E3, spanning approximately 7 kb;
Morn2 contains 669 nucleotides of open reading frame, and
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encodes 79 amino acids [3448]. MORN domains have the
sequence GKYQGQWQ. MORN2 promotes the recruit
ment of LC3 in LAP, and MORN2 co-immunoprecipitates
with LC3 [2452].
MRAP (MCU regulating acidic patch): An electronegatively
charged surface region on the matrix-residing amino terminal
domain of MCU (mitochondrial calcium uniporter) [3449].
Binding of divalent cations such as Mg2+ and Ca2+ to MRAP
disrupts MCU assembly and function [3449]. Inhibition of
MCU perturbs cellular bioenergetics and promotes autophagy
[3450].
MREG (melanoregulin): A cargo sorting protein that associ
ates with MAP1LC3 in LC3- associated phagocytosis [2383,
3451].
MRT68921: A small molecule inhibitor of ULK1 and ULK2
kinases that blocks autophagy in cells [3452].
MSP: Multiple system proteinopathy (an inherited pleio
tropic degenerative disorder of skeletal muscle, bone, and
the central nervous system) that is thought to be due to
abnormal granulophagy (autophagic degradation of RNP
granules). Five different MSP subtypes are known thus far,
three due to mutations in RNA-binding proteins and two
(MSP1 and MSP4) due to mutations in autophagic pro
teins (VCP/p97 and SQSTM1, respectively) [3190]. See
also granulophagy.
mt-Keima: A mitochondrially-targeted version of the coral
Keima protein that has a pH-sensitive fluorescence spectrum,
useful for monitoring mitophagy events [1036].
MTDH/AEG-1 (metadherin): An oncogenic protein that
induces noncanonical (BECN1- and class III PtdIns3Kindependent) autophagy as a cytoprotective mechanism
[3453].
MTM-3: A C. elegans myotubularin lipid phosphatase that is
an ortholog of human MTMR3 and MTMR4; MTM-3 acts
upstream of EPG-5 to catalyze the turnover of PtdIns3P and
promote autophagosome maturation [3454].
MTM1 (myotubularin 1): A PtdIns3P and PtdIns(3,5)P2 3phosphatase [3455]. Mutations affecting MTM1 lead to myo
tubular myopathy and alteration of autophagy.
MTMR3 (myotubularin related protein 3): This protein
localizes to the phagophore and negatively regulates autopha
gy. See also MTMR14 [3456].
MTMR6 (myotubularin related protein 6): A PtdIns 3-phos
phatase; knockdown of MTMR6 increases the level of LC3-II
[3457].
MTMR7 (myotubularin related protein 7): A PtdIns 3-phos
phatase; knockdown of MTMR7 increases the level of LC3-II
[3457].
MTMR8 (myotubularin related protein 8): A phosphoino
sitide phosphatase with activity toward PtdIns3P and
PtdIns(3,5)P2; MTMR8 in a complex with MTMR9 inhi
bits autophagy based on the formation of WIPI1 puncta
[3458].
MTMR9 (myotubularin related protein 9): A catalytically
inactive myotubularin that increases the activity of other
members of the MTMR family and controls their substrate
specificity; MTMR8-MTMR9 preferentially dephosphorylates
PtdIns3P and thus inhibits autophagy [3458].
MTMR13: See SBF2.
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MTMR14/Jumpy (myotubularin related protein 14): A
member of the myotubularin family that is a PtdIns 3-phos
phatase; knockdown increases autophagic activity [3457,
3459]. MTMR14 regulates the interaction of WIPI1 with the
phagophore. The Drosophila homolog is EDTP.
MTOR (mechanistic target of rapamycin kinase): The
mammalian ortholog of TOR. Together with its binding part
ners it forms either MTOR complex 1 (MTORC1) or MTOR
complex 2 (MTORC2). See also TORC1 and TORC2.
MTORC1/2 (MTOR complex 1/2): See TORC1 and TORC2.
MUL1 (mitochondrial E3 ubiquitin protein ligase 1): A
mitochondria-targeted E3 ligase that mediates the ubiquitina
tion and the subsequent degradation of MFN2, thus acting as
a negative regulator of PRKN-mediated neuronal mitophagy
[3460, 3461]. Chronic mitochondrial stress is associated with
major neurodegenerative diseases; thus, the recovery of those
mitochondria constitutes a critical step of energy maintenance
in early stages of neurodegeneration. The MUL1-MFN2 path
way acts as an early checkpoint to maintain mitochondrial
integrity by regulating mitochondrial morphology and inter
play with the endoplasmic reticulum (ER). This mechanism
ensures that degradation of stressed mitochondria through
mitophagy is restrained in neurons under early stress condi
tions. Failure of the MUL1-MFN2 pathway activates mito
phagy to eliminate damaged mitochondria.
Multivesicular body (MVB)/multivesicular endosome: An
endosome containing multiple 50- to 80-nm vesicles that are
derived from invagination of the limiting membrane. Under
some conditions the MVB contains hydrolytic enzymes in
which case it may be considered to be a lysosome or auto
lysosome with ongoing microautophagy.
Multivesicular body sorting pathway: A process in which
proteins are sequestered into vesicles within the endosome
through the invagination of the limiting membrane. This
process is usually, but not always, dependent upon ubiquitin
tags on the cargo and serves as one means of delivering
integral membrane proteins destined for degradation into
the vacuole/lysosome lumen. ESCRT complexes are required
for the formation of MVBs, for autophagosome maturation
[3462], and they cooperate with autophagy to repair mem
brane damage to their compartment inflicted by pathogenic
mycobacteria [1322].
Mycolactone:
The
exotoxin
virulence
factor
of
Mycobacterium ulcerans [3463] that acts as an inhibitor of
SEC61-dependent translocation of polypeptides into the
endoplasmic reticulum [2022]. Mycolactone induces autopha
gy by a mechanism that involves the integrated stress response
and is dependent on its ability to block protein translocation
[2020, 2021].
MYO1C (myosin IC): A class I myosin that functions as an
actin motor protein essential for the trafficking of cholesterolrich lipid rafts from intracellular storage compartments to the
plasma membrane; MYO1C is important for efficient auto
phagosome-lysosome fusion [3464].
MYO6 (myosin VI): A unique, minus-end directed actin
motor protein required for autophagosome maturation and
fusion with a lysosome via delivery of early endosomes to
autophagosomes; mediated by the interaction of MYO6 with
the alternative ESCRT-0 protein TOM1 [1471, 3465].

N1,N3-bis(2-[2,4,6-triaminopyrimidin-5-yl]ethyl)isophtha
limidamide (AQAMAN): A bisamidine-based small molecule
that can prevent expanded polyglutamine (polyQ) protein
aggregation and dissociate preformed polyQ aggregates. The
cytoprotective effect of AQAMAN on polyQ toxicity depends
on autophagy activation [3466].
NAA10/ARD1 (N-alpha-acetyltransferase 10, NatA cataly
tic subunit): A protein that interacts with and stabilizes TSC2
by acetylation, resulting in repression of MTOR and induc
tion of autophagy [3467].
NACC1/NAC1 (nucleus accumbens associated 1): A tran
scription factor that increases the expression and cytosolic
levels of HMGB1 in response to stress, thereby increasing
autophagy activity [3468].
NAD+: A small natural molecule necessary for cellular
energy homeostasis that is involved in broad cellular path
ways, including aging and neurodegeneration. NAD+ reg
ulates both nonselective autophagy and specific autophagy,
such as mitophagy, through the NAD+-dependent sirtuins,
SARM1, CD38 and other proteins [3469, 3470].
NADPH oxidases: These enzymes contribute to autophagic
targeting of Salmonella in leukocytes and epithelial cells
through the generation of reactive oxygen species [3342].
The CYBB/NOX2 NADPH oxidase in macrophages is
required for LC3-associated phagocytosis.
NAF-1: See CISD2.
NAMPT/visfatin (nicotinamide phosphoribosyltransfer
ase): NAMPT is a protein that catalyzes the condensation of
nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield
nicotinamide mononucleotide, one step in the biosynthesis of
nicotinamide adenine dinucleotide. The protein belongs to the
nicotinic acid phosphoribosyltransferase (NAPRTase) family
and is thought to be involved in many important biological
processes, including metabolism, stress response and aging.
NAMPT promotes neuronal survival through inducing auto
phagy via regulating the TSC2-MTOR-RPS6KB1 signaling
pathway in a SIRT1-dependent manner during cerebral ische
mia [3471].
Nanoparticles (NPs): Small particles in the size range of 1–
100 nm that can modulate autophagy [1919, 3472, 3473]
and have been used for autophagy monitoring [3474,
3475]. Furthermore, nanoparticles are able to efficiently
deliver autophagy inducers/inhibitors into cells [3476,
3477].
NAPA/αSNAP (NSF attachment protein alpha): A key reg
ulator of SNARE-mediated vesicle fusion. Loss of NAPA
promotes noncanonical autophagy in human epithelial cell
by interrupting ER-Golgi vesicle trafficking and triggering
Golgi fragmentation [3478].
NBR1 (NBR1 autophagy cargo receptor): A selective sub
strate of autophagy with structural similarity to SQSTM1.
NRB1 functions as a receptor that binds ubiquitinated pro
teins and LC3 to allow the degradation of the former by an
autophagy-like process [496]. NBR1 shows specificity for sub
strates including peroxisomes [459] and ubiquitinated aggre
gates [496]. Phosphorylation of NBR1 by GSK3A/B prevents
the aggregation of ubiquitinated proteins [2664]. Arabidopsis
AT4G24690/NBR1 is involved in regulating abiotic and biotic
stresses [1354, 3479].
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NCKAP1/NAP1 (NCK associated protein 1): NCKAP1 is a
component of the SCAR/WAVE complex, which activates the
ARP2/3 complex and actin branching. In plants, AT2G35110/
NAP1 regulates mechanical pressure-induced autophagosome
formation. The T-DNA knockout mutant of NAP1 is more
susceptible to low nutrient and high salt stresses [3480, 3481].
NCOA4 (nuclear receptor coactivator 4): A selective cargo
receptor that is involved in iron homeostasis through the
recycling of ferritin by autophagy [1264]. See also
ferritinophagy.
NDP52: See CALCOCO2.
Necroptosis: A form of regulated necrotic cell death [3482];
induction of autophagy-dependent necroptosis is required for
childhood acute lymphoblastic leukemia cells to overcome
glucocorticoid resistance [3483]. Suppression of autophagic
flux contributes to RIPK1-RIPK3 interaction and necroptosis
of cardiomyocytes [3484].
NEDD4 (NEDD4 E3 ubiquitin protein ligase): An E3 ubi
quitin protein ligase that interacts with Atg8-family pro
teins and forms a complex with ULK1 and BECN1.
NEDD4 increases the stability of BECN1 and promotes
autophagy as well as various infections-induced xenophagy
by mediating K6- and K27-linkage ubiquitination of
BECN1 [3485].
NETosis: NETosis is a specialized form of neutrophil cell
death that is characterized by the release of decondensed
nuclear chromatin and neutrophil granule contents to the
extracellular space; autophagy regulates NET formation. See
also DDIT4.
NFAT5/TonEBP (nuclear factor of activated T cells 5): The
transcription factor NFAT5 can be activated by hypertonic
stress [3486] in addition to other stimuli [3487] such as
inflammation [3488]. NFAT5 does not directly promote the
expression of genes related to autophagy [3489], but facilitates
autolysosomal formation and targeting of cargo to autolyso
somes [3213].
NFATC2/NFAT1 (nuclear factor of activated T cells 2): The
transcription factor NFATC2 can be activated by ROS and
binds directly to the Lamp2a proximal promoter region,
leading to an increase of LAMP2A expression and CMA
activation, which is required for a proper T cell activation
through degradation of negative regulators, ITCH and
RCAN [3490].
NFE2L2/NRF2 (nuclear factor, erythroid 2 like 2): A stress
responsive transcription factor that regulates a complex pro
gram of cytoprotective responses, including the expression of
the autophagy-related genes Sqstm1, Calcoco2, Ulk1, Atg2b,
Atg4d, Atg5, Atg7 and Gabarapl1 and the CMA-related gene
Lamp2a [140, 419, 596, 597, 987, 988, 3320, 3491]. NFE2L2 is
inactivated by KEAP1. See also KEAP1.
NFKB/NF-κB (nuclear factor kappa B): NFKB activates
MTOR to inhibit autophagy upon TNF stimulation [3492].
In contrast, the RELA subunit of NFKB induces BECN1
gene expression in T cells [3493], and NFKB enhances
BAG3 and HSPB8 expression to induce aggrephagy [1107,
3494].
NH4Cl (ammonium chloride): A weak base that is proto
nated in acidic compartments and neutralizes them; inhibits
the clearance of autophagosomes and amphisomes.
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NHLRC1/EPM2B/malin (NHL repeat containing E3 ubi
quitin protein ligase 1): A putative E3-ubiquitin ligase,
which forms a complex with EPM2A/laforin. Recessive muta
tions in the genes EPM2A, or NHLRC1/EMP2B are found in
the majority of cases of Lafora disease, a very rare type of
progressive neurodegeneration associated with impaired auto
phagy [3495].
NIBAN1/FAM129/C1orf24 (niban apoptosis regulator 1):
NIBAN1 is highly expressed in a number of human cancers,
in particular of the thyroid, and it may play a dual role in the
regulation of autophagy in thyroid cells. While NIBAN1 can
increase baseline autophagy in response to nutrient and
growth factor depletion, it can inhibit autophagy in thyroid
carcinoma cells in the presence of oncogenes, such as RET/
PTC1 fusion. Therefore, NIBAN1 regulates autophagy in thyr
oid cells in an oncogene-dependent manner, possibly through
the AKT-MTOR axis [3496].
NID-1 (novel inducer of cell death 1): A small molecule that
induces activation of an ATG5- and CTSL-dependent cell
death process reminiscent of autophagy [2453].
NIPSNAP1/2 (nipsnap homolog 1/2): Two small mito
chondrial matrix proteins, NIPSNAP1 and NIPSNAP2,
that act as “eat-me” signals for damaged mitochondria.
NIPSNAP1 and NIPSNAP2 accumulate on the mitochon
drial outer membrane following mitochondrial depolariza
tion, recruiting autophagy receptors and adaptors, as well
as human Atg8-family proteins to facilitate mitophagy
[3497].
Nitric oxide: A gas and a messenger that has complex reg
ulatory roles in autophagy, depending on its concentration
and the cell type [455, 3498–3500].
NIX: See BNIP3L.
NLRX1 (NLR family member X1): The only mitochondrial
member of the NLR family that is characterized by structural
homology in a central nucleotide-binding oligomerization
domain, a C-terminal leucine-rich repeat domain, and an Nterminal effector domain. NLRX1 promotes autophagy and
mitophagy by serving as a scaffold protein to recruit ATG12–
ATG5 and ATG16L1. NLRX1 also contains a LIR and directly
associates with LC3 [3501–3504]. See also TUFM.
NME4/NDPKD/NM23-H4 (NME/NM23 nucleoside di
phosphate kinase 4): NME4 is the group I member of the
NDPK/NME family. It forms large homohexameric com
plexes localized in mitochondria. NME4 has two different
topologies [3505, 3506]. In healthy mitochondria, NME4 is
in the topology with nucleoside diphosphate kinase activity
and is mainly bound to the mitochondrial inner membrane.
When the mitochondria membrane potential collapses and
mitochondria depolarize, NME4 becomes nucleoside dipho
sphate kinase-inactive but gains intermembrane phospholipid
transfer activity. It is then localized in the mitochondrial
intermembrane space where it binds simultaneously to both
the mitochondrial inner and outer membrane. In this topol
ogy, NME4 mediates the redistribution of cardiolipin to the
mitochondrial outer membrane, which functions as a signal
for the elimination of damaged mitochondria via mitophagy
[1189].
NOD (nucleotide-binding oligomerization domain): An
intracellular peptidoglycan (or pattern recognition) receptor
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that senses bacteria and induces autophagy, involving
ATG16L1 recruitment to the plasma membrane during bac
terial cell invasion [1487]. NOD1 causes direct inflammasome
NLRP3 scaffold protein interaction with LC3, inducing auto
phagy flux [1489].
Non-nitrogen-starvation (NNS)-induced autophagy: A type
of autophagy that is induced when yeast cells are shifted from
rich to minimal medium in the presence of a respiratory
carbon source such as lactate; this process is controlled in
part by the Iml1 complex/SEACIT (SEh1-Associated
subComplex Inhibiting TORC1), which consists of Iml1,
Npr2 and Npr3, and which functions as a GTPase activator
complex for the Rag GTPase Gtr1 [3289, 3507, 3508].
Noncanonical autophagy: A functional autophagy pathway
that only uses a subset of the characterized ATG proteins to
generate an autophagosome. BECN1-independent [118,
2486], and ATG5-ATG7-independent [31] forms of autopha
gy have been reported.
Nordic Autophagy Society (NAS): The NAS (https://nordi
cautophagy.org/) acts to promote autophagy-related research
in its nine membership countries (Norway, Sweden,
Denmark, Finland, Iceland, Estonia, Latvia, Lithuania, The
Netherlands). The society aims to increase the interaction of
Nordic autophagy researchers with researchers from other
countries, by, among others, providing lab exchange and
conference grants, and by being open for all nationalities to
become members (also from outside the nine membership
countries). Moreover, Nordic Autophagy Conferences are
held yearly (since 2012), and have featured prominent invited
speakers from Europe, USA, and Japan. The NAS developed
from the Nordic Autophagy Network.
NPC1 (NPC intracellular cholesterol transporter 1): Defects
in autophagy in the lysosomal storage disease Niemann-Pick
type C1 disease due to pathogenic NPC1 gene variants cause
cholesterol accumulation in hepatocytes and neural cells and
defective xenophagy in macrophages [3509–3511].
NPY (neuropeptide Y): An endogenous neuropeptide pro
duced mainly by the hypothalamus that mediates caloric
restriction-induced autophagy [3512] and autophagy stimula
tion induced by ghrelin in rat cortical neurons [3167]. Along
these lines, different neuropeptides (such as SST [somatosta
tin], ADCYAP1 [adenylate cyclase activating polypeptide 1],
TAAC1/substance P [tachykinin precursor 1] and others)
have been described to control autophagy, likely being
involved in the outcome of many pathological conditions,
including neurodegeneration, metabolic disorders, and cancer
[3513, 3514]. See also ghrelin.
NR1D1/Rev-erba (nuclear receptor subfamily 1 group D
member 1): A nuclear receptor that modulates autophagy
and lysosomal biogenesis in a tissue-specific manner.
NR1H4/FXR (nuclear receptor subfamily 1 group H mem
ber 4): A ligand-activated transcription factor that plays a role
in lipophagy [921]. NR1H4 is a bile acid nuclear receptor and
is necessary and sufficient to suppress lipophagy by the
mechanisms of either a genomic competition with PPARA/
PPARα/NR1C1 or inhibition of the CREB-CRTC2 complex,
which leads to the altered expression of many autophagyrelated genes [936].

NRBF2 (nuclear receptor binding factor 2): NRBF2 is the
mammalian homolog of yeast Atg38, and is a binding partner
of the BECN1-PIK3C3 complex; NRBF2 is required for the
assembly of the ATG14-BECN1-PIK3C3/VPS34-PIK3R4/
VPS15 complex and regulates autophagy [3515, 3516]. nrbf2
knockout mice display impaired ATG14-linked PIK3C3 lipid
kinase activity and impaired autophagy.
NSP2: A nonstructural protein of chikungunya virus that
interacts with human CALCOCO2 (but not the mouse ortho
log) to promote viral replication. In contrast, binding of
SQSTM1 to ubiquitinated capsid leads to viral degradation
through autophagy [3517].
NT219: A highly efficient IGF1 signaling inhibitor that pro
tects nematodes from toxic protein aggregation [3518].
NT219 reduces autophagy in cultured cells as detected by
the accumulation of SQSTM1 foci in treated cells [3519].
Nt-R/Nt-Arg/arginylated substrates: Proteins bearing the
amino-terminal arginine residue that are degraded by auto
phagy. Binding of Nt-R substrates to the ZZ domain of
SQSTM1 stimulates SQSTM1 aggregation and autophagy
[463]. Known Nt-R substrates (including R-HSPA5/R-Bip,
R-CALR/CRT, R-PDI, and R-CDC6) are generated through
N-terminal arginylation [3236, 3520].
NTRK1/TrkA (neurotrophic receptor tyrosine kinase): A
receptor tyrosine kinase for NGF (nerve growth factor).
Genetic mutations in NTRK1 cause congenital insensitivity
to pain with anhidrosis (CIPA). Some CIPA mutations cause
mental retardation because they induce protein aggregation
and inhibit autophagic flux in neurons [3521].
Nucleolar stress: Perturbation of the nucleolar structure and
function (e.g., by chemotherapeutic drugs, genetic
approaches, RNAi and others) triggers this cellular stress
response, which is characterized by impaired ribosome bio
genesis. Nucleolar stress can be propagated in a TP53-depen
dent and -independent manner. Nucleolar stress emerges as a
stress signal for autophagy [2027].
Nucleolus: Subnuclear, membrane free compartment and site
for ribosome biogenesis. Also, a hub in the cellular stress
response.
Nuclear pore complex (NPC): A nano-pore located on the
nuclear membrane that consists of a conserved set of ~30
different proteins, termed nucleoporins, and serves as a gate
keeper for the exchange of materials between the cytoplasm
and nucleus [3522]. Studies have revealed transcriptional fac
tors passing through the NPC entering the nucleus that con
trol autophagy. The identification of closely controlled
transcription factors (such as TFEB and ZKSCAN3),
microRNAs and histone marks (especially acetylated Lys16
of histone 4 [H4K16ac] and dimethylated H3K9
[H3K9me2]) associated with the autophagic process suggest
an attractive conceptual framework to understand the shortterm transcriptional response and potential long-term
responses to autophagy [3523].
Nucleophagy: The selective autophagic degradation of the
nucleus or parts of the nucleus. Depletion of the nuclear
pore protein TPR induces LC3-II nuclear translocation.
TPR, LC3-II, LMNB1, and chromatin nuclear budding
complexes are formed, which induce nucleophagy, in both
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TPR-depleted or rapamycin-treated brain tumor cells
[3092].
Nucleus-vacuole junction (NVJ): A junction formed by the
interaction between Nvj1, a membrane protein of the outer
nuclear membrane, and Vac8 of the vacuole membrane, that
are necessary for PMN/micronucleophagy [1079]. See also
piecemeal microautophagy of the nucleus.
NUFIP1 (nuclear FMR1 interacting protein 1): An autopha
gy receptor for ribosomes during starvation-induced ribo
phagy [3524].
Nup159: A component of the NPC in yeast that acts as a
receptor for selective degradation of NPCs [3525].
NUPR1/p8 (nuclear protein 1, transcriptional regulator): A
transcriptional regulator that controls autophagy by repres
sing the transcriptional activity of FOXO3 [3526].
Nvj1: An outer nuclear envelope protein that interacts with
Vac8 to form nucleus-vacuole junctions during the process of
PMN/micronucleophagy [1079].
NVP-BGT226 (8-[6-methoxy-pyridin-3-yl]-3-methyl-1-[4piperazin-1-yl-3-trifluoromethyl-phenyl]-1,3-dihydroimi
dazo[4,5-c]quinolin-2-one maleate): A class I PI3K and
MTOR dual inhibitor that induces autophagy [3527].
NVT (Nbr1-mediated vacuolar targeting): A pathway used
for the delivery of cytosolic hydrolases (Lap2 and Ape2) into
the vacuole in S. pombe that involves interaction with Nbr1
and relies on the ESCRT machinery [1851].
OATL1: See TBC1D25.
OCRL (OCRL inositol polyphosphate-5-phosphatase): A
PtdIns(4,5)P2 5-phospatase. OCRL knowdown reduces auto
phagy flux by impairing the activity of MCOLN1/TRPML1
[3528].
OCT3: See POU5F1.
OCT4: See POU5F1.
OGA/MGEA5/NCOAT/oga-1
(O-GlcNAcase):
OGA
removes the O-GlcNAc modification and regulates the au
tophagy machinery by countering the action of OGT
[3529].
OGT/ogt-1 (O-linked N-acetylglucosamine [GlcNAc] trans
ferase): OGT is a nutrient-dependent signaling transferase
that regulates the autophagy machinery by adding the OGlcNAc modification. Similar to phosphorylation, this mod
ification is involved in signaling [3529, 3530]. OGT is
required for glucagon-stimulated liver autophagy and meta
bolic adaptation to starvation. Upon glucagon-induced cal
cium signaling, CAMK2 phosphorylates OGT, which in turn
promotes O-GlcNAc modification and activation of ULK
proteins by potentiating AMPK-dependent phosphorylation
[1007]. Furthermore, O-GlcNAc modification of SNAP29
regulates autophagosome maturation [3531].
Oligomycin: A mitophagy inducer used in combination with
AMA to promote a potent mitochondrial depolarization; oli
gomycin inhibits F1Fo-ATP synthase, and its reverse hydro
lysis activity that is activated as a compensatory mechanism
when AMA is used alone [1224].
Omegasome: ZFYVE1-containing structures located at the
ER that are involved in autophagosome formation during
amino acid starvation [884].
Omi: See HTRA2.
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Oncophagy: A general term describing cancer-related auto
phagy [3532].
OPTN (optineurin): An autophagy receptor that functions
in the elimination of Salmonella, bulk protein aggregates and
mitochondria; OPTN has an N-terminal TBK1-binding
motf, a LIR and a ubiquitin-binding UBAN domain, allow
ing it to link tagged bacteria and ubiquitinated mitochondria
and protein aggregates to the autophagy machinery [1140,
1472, 3533–3537]. Phosphorylation of OPTN by TBK1 not
only increases its affinity for LC3 but also promotes its
binding ability to ubiquitinated proteins [1472, 3535, 3538].
OPTN may function together with CALCOCO2 and
TAX1BP1/CALCOCO3. OPTN can also regulate autophago
some maturation [2913]. OPTN mutations are associated
with ALS [3539]. See also CALCOCO2, TAX1BP1 and
TBK1.
Organellophagy: General terminology for autophagic pro
cesses selective for organelles such as the peroxisome, mito
chondrion, nucleus, and portions of the ER [1067, 3540].
Oxiapoptophagy: A type of cell death induced by oxysterols
that involves OXIdation + APOPTOsis + autophagy [1344,
1345]. See also oxysterols.
Oxidized phospholipids: Oxidized phospholipids induce au
tophagy, and in ATG7-deficient keratinocytes and melano
cytes the levels of phospholipid oxidation are elevated [3541,
3542].
Oxysterols: Oxysterols are oxide derivatives of cholesterol.
They are formed by auto-oxidation, enzymatic oxidation
or by both processes (http://www.lipidhome.co.uk/lipids/
simple/chol-der/index.htm). Some oxysterols (including 7ketocholesterol, 7β-hydroxycholesterol and 24[S]-hydroxy
cholesterol) can induce a complex type of cell death
named
oxiapoptophagy
[1343–1345].
See
also
oxiapoptophagy.
P0: A plant virus-encoded F-box protein that targets AGO1/
ARGONAUTE1 to autophagy in order to suppress RNA
silencing [1391].
p8: See NUPR1.
p14ARF: See CDKN2A.
p27/p27Kip1: See CDKN1B.
p38α: See MAPK14.
p38IP: See SUPT20H.
p53: See TP53.
p62: see SQSTM1.
p66SHC: See SHC1.
p97: See VCP.
Pacer: See RUBCNL.
Paclitaxel (PTX): A chemotherapeutic drug used to treat a
number of different cancer types. Paclitaxel act as a micro
tubule stabilizer that inhibits autophagy through induction of
inhibitory phosphorylation of PIK3C3/VPS34 at T159 and
blocking the fusion of autophagosomes with lysosomes
[3543].
Paf1: A component of the yeast Paf1 complex (Paf1C) that
downregulates the expression of ATG11 and ATG32 and
represses mitophagy in growing conditions [3016].
PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex
component): A component of the mammalian Paf1/RNA
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polymerase II complex that regulates mitophagy through a
PINK1-PRKN-dependent pathway [3016]. See also Paf1.
Paf1C: The yeast polymerase-associated factor 1 complex that
is composed of multiple subunits and suppresses glucose
starvation-induced autophagy. Deletion of the genes encoding
two components of Paf1C, PAF1 and CTR9, increase ATG32
and ATG11 expression and facilitate mitophagy activity
[3016].
PARK2/parkin: See PRKN.
PARK7/DJ-1 (Parkinsonism associated deglycase): An
oncogene product whose loss of function is associated with
PD; overexpression suppresses autophagy through the
MAPK8/JNK pathway [3544].
Parkin: See PRKN.
PARL (presenilin associated rhomboid like): The mamma
lian ortholog of Drosophila rho-7 (rhomboid-7), a mitochon
drial intramembrane protease; regulates the stability and
localization of PINK1 [3545–3547]. A missense mutation in
the N terminus has been identified in some patients with PD
[3548]. See also PINK1.
Paraptosis: A form of nonapoptotic programmed cell death
characterized by cytoplasmic vacuolation and resistance to
apoptosis inhibitors [1783].
PARP1 (poly[ADP-ribose] polymerase 1): A nuclear enzyme
involved in DNA damage repair; doxorubicin-induced DNA
damage elicits an autophagic response that is dependent on
PARP1 [3549]. In conditions of oxidative stress, PARP1 pro
motes autophagy through the STK11/LKB1-AMPK-MTOR
pathway [3550].
PAS: See phagophore assembly site.
PAWR/par-4 (pro-apoptotic WT1 regulator): A cancer
selective apoptosis-inducing tumor suppressor protein that
functions as a positive regulator of autophagy when over
expressed [3551, 3552].
PBPE: A selective and high affinity ligand of the microsomal
antiestrogen-binding site (AEBS). PBPE induces protective
autophagy in cancer cells through an AEBS-mediated accu
mulation of zymostenol (5α-cholest-8-en-3β-ol) [2031, 3553].
Pbs2: A yeast MAPKK upstream of Hog1 that is required for
mitophagy [747].
Pcl1: A yeast cyclin that activates Pho85 to stimulate auto
phagy by inhibiting Sic1 [2995].
Pcl5: A yeast cyclin that activates Pho85 to inhibit autophagy
through degradation of Gcn4 [2995].
PCYT1A (phosphate cytidylyltransferase 1, choline, alpha):
A rate-limiting enzyme in the Kennedy pathway for the
synthesis of phosphatidylcholine. Activation of PCYT1A and
increased de novo choline phospholipid production are found
in cancer cells undergoing drug-induced autophagy. The loss
of PCYT1A activity results in the inability of cells to maintain
autophagosome biogenesis [3554].
PDCD6/ALG-2 (programmed cell death 6): An EF-hand
calcium-binding protein that is a lysosomal calcium sensor,
which enables the calcium-dependent movement of lysosomes
to the perinuclear region where autophagosomes accumulate
following induction of autophagy. This retrograde lysosomal
transport involves the signaling through the lysosomal-loca
lized phosphoinositide PtdIns(3,5)P2, the lysosomal calcium

channel MCOLN1/TRPML1 and dynein; PDCD6 is a direct
binding partner to both MCOLN1 and dynein [3555].
PDCD6IP (programmed cell death 6 interacting protein):
PDCD6IP is an ESCRT-associated protein that interacts with
the ATG12–ATG3 conjugate to promote basal autophagy
[3556]. See also 12-ylation.
PDPK1/PDK1 (3-phosphoinositide dependent protein
kinase 1): An activator of AKT. Recruited to the plasma
membrane and activated by PtdIns(3,4,5)P3 which is gener
ated by the class I PI3K.
PEA15/PED (proliferation and apoptosis adaptor protein
15): A death effector domain-containing protein that mod
ulates MAPK8 in glioma cells to promote autophagy
[3557].
PEBP1/RKIP (phosphatidylethanolamine binding protein
1): PEBP1 inhibits autophagy through the modulation of
LC3 lipidation and MTORC1 signaling [3558]. This protein
also shows a functional linkage with some autophagy gene
products such as WDR45, PIK3CB or PIK3C3 during the
development of prostate cancer [3559]
PEG3 (paternally expressed 3): A DCN (decorin)- and
endorepellin-induced, genomically imprinted tumor suppres
sor gene that is required for autophagy in endothelial cells
[3041]. PEG3 colocalizes with and physically binds to cano
nical autophagic markers such as BECN1 and LC3. Moreover,
loss of PEG3 ablates the DCN- or endorepellin-mediated
induction of BECN1 or MAP1LC3A; basal expression of
BECN1 mRNA and BECN1 protein requires PEG3 as well as
autophagic flux (measured by LC3-II formation and concur
rent THBS1 (thrombospondin 1) expression [3560].
Mechanistically, PEG3 is upstream of TFEB and is required
for proper TFEB expression and nuclear localization in
endothelial cells [3561]. See also DCN and endorepellin.
PER1 (period circadian clock 1): Per1 is a gene in the clock
gene family that includes members of the basic helix-loophelix-PAS (PER-ARNT-SIM) transcription factor family. The
PER1 protein has a central role in driving circadian rhythm
over a period of approximately 24 h. During periods of injury
in the brain such as stroke, autophagy in the hippocampus
can be depressed during the absence of PER1 that may
increase injury in the brain, suggesting a protective pathway
with PER1 and autophagy [3562].
Peripheral structures: See Atg9 peripheral structures.
PERK: See EIF2AK3.
PES/pifithrin-µ (2-phenylethynesulfonamide): A small
molecule inhibitor of HSPA1A/HSP70-1/HSP72; PES inter
feres with lysosomal function, causing a defect in autophagy
and chaperone-mediated autophagy [3234].
peup (peroxisome unusual positioning): Mutants isolated in
A. thaliana that accumulate aggregated peroxisomes [2344].
The peup1, peup2 and peup4 mutants correspond to muta
tions in ATG3, ATG18A and ATG7.
PEX2 (peroxisomal biogenesis factor 2: A peroxisomal ring
finger E3 ubiquitin ligase that mediates pexophagy [1204].
PEX13: An integral membrane protein on the peroxisome
that regulates peroxisomal matrix protein import during per
oxisome biogenesis and plays a role in both virophagy and
mitophagy [3563].
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Pexophagic body: The single-membrane vesicle present
inside the vacuole lumen following the fusion of a pexopha
gosome with a vacuole.
Pexophagosome: An autophagosome containing peroxi
somes, but largely excluding other cytoplasmic components;
a pexophagosome forms during macropexophagy [3564].
Pexophagy: A selective type of autophagy involving the
sequestration and degradation of peroxisomes; it can occur
by a micro- or macroautophagy-like process (micro- or
macropexophagy) [179].
PexRD54: Effector of Phytophthora infestans that specifically
binds host autophagy protein ATG8CL of the Atg8-family of
proteins to stimulate autophagosome formation [2350].
PFKFB3
(6-phosphofructo-2-kinase/fructose-2,6-bipho
sphatase 3): PFKFB3 controls the synthesis and degradation
of fructose-2,6-bisphosphate, a key regulator of glycolysis in
eukaryotes. The inhibition of PFKFB3 decreases glucose
uptake and promotes autophagy in cancer cells [3565].
PGAM5 (PGAM family member 5, mitochondrial serine/
threonine protein phosphatase): PGAM5 is a protein phos
phatase responsible for the activation of DNM1L in fed cells
[878] and for the activation of the mitophagy receptor
FUNDC1 in mitophagy [1196]. See also STX17.
PGRP (peptidoglycan recognition protein): A cytosolic
Drosophila protein that induces autophagy in response to
invasive L. monocytogenes [3566].
Phagolysosome: The product of a single-membrane phago
some fusing directly with a lysosome in a process that does
not involve macroautophagy (we include this definition here
simply for clarification relative to autolysosome, autophago
some and autophagolysosome) [1480].
Phagophore (PG): Membrane cisterna that has been impli
cated in an initial event during formation of the autophago
some. Thus, the phagophore may be the initial sequestering
compartment of macroautophagy [3567]. The phagophore has
previously been referred to as the “isolation membrane” [7].

Phagophore (2D)

Phagophore (3D)

Phagophore assembly site (PAS): A perivacuolar compart
ment or location that is involved in the formation of Cvt
vesicles, autophagosomes and other sequestering compart
ments used in macroautophagy and related processes in
fungi. The PAS may supply membranes during the formation
of the sequestering vesicles or may be an organizing center
where most of the autophagic machinery resides, at least
transiently. The PAS or its equivalent is yet to be defined in
mammalian cells [242, 3568].
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Phagophore closure: Sealing of the phagophore to generate
an autophagosome. Vps21/RAB5 in yeast was first
reported to be required for phagophore closure [3569].
The ESCRT complex in both yeast and mammalian cells
is also required for phagophore closure [360, 3114].
Furthermore, Vps21/RAB5 controls the interaction
between Atg17 and the ESCRT subunit Snf7 to recruit
the ESCRT complex to the phagophore for closure
[3114]. Also see RAB5 and ESCRT.
Phagosome: A single-membrane vesicle formed in the cyto
plasm of a cell, containing a phagocytosed particle enclosed
within a part of the cell membrane. A phagosome can fuse
directly with a lysosome, independently from the autophagic
machinery, to form a phagolysosome (PL). During LC3-asso
ciated phagocytosis, an LC3-decorated phagosome can fuse
with a lysosome, and in this case the fusion product is called
an autophagolysosome (APL). In a separate scenario, a pha
gosome may be engulfed within an autophagosome; when
such a structure fuses with a lysosome, the fusion product is
again called an autophagolysosome [245, 1480, 2446, 3570].
Note that when an autophagosome that does not contain a
phagosome fuses with a lysosome, the product is an autolyso
some (AL). See also autolysosome and autophagolysosome.
PHB2 (prohibitin 2): PHB2 is a highly conserved inner
mitochondrial membrane scaffold protein that acts as mito
phagy receptor required for PRKN-mediated mitophagy.
PHB2 facilitates PINK1 (PTEN induced kinase 1) stabilization
on, and PRKN/Parkin recruitment to, mitochondria, and
interacts with LC3 after rupture of the outer mitochondrial
membrane [1176, 3571].
Phenothiazine: An FDA-approved antipsychotic phenothia
zine derivative that induces autophagy through AKT-mediated
MTOR inhibition [1979, 1980], and also by modulating the
WNT-CTNNB1/β-catenin signaling pathway [1981].
Pho8: A yeast vacuolar phosphatase that acts upon 3ʹ nucleo
tides generated by Rny1 to generate nucleosides [3572]. A
modified form of Pho8, Pho8∆60, is used in an enzymatic
assay for monitoring autophagy in yeast. See also Rny1. See
also Pho8∆60 assay.
Pho23: A component of the yeast Rpd3L histone deacetylase
complex that negatively regulates the expression of ATG9 and
other ATG genes [917].
Pho80: A yeast cyclin that activates Pho85 to inhibit auto
phagy in response to high phosphate levels [2995].
Pho8∆60 assay: An enzymatic assay used to monitor auto
phagy in yeast. Deletion of the N-terminal cytosolic tail and
transmembrane domain of Pho8 prevents the protein from
entering the secretory pathway; the cytosolic mutant form is
delivered to the vacuole via autophagy, where proteolytic
removal of the C-terminal propeptide by Prb1 generates the
active enzyme [355, 356, 1038].
Pho85: A multifunctional cyclin-dependent kinase that inter
acts with at least ten different cyclins or cyclin-like proteins to
regulate the cell cycle and responses to nutrient levels. Pho85
acts to negatively and positively regulate autophagy, depend
ing on its binding to specific cyclins [2995]. See also Clg1,
Pcl1, Pcl5, Pho80 and Sic1.
Phosphatidylinositol 3-kinase (PtdIns3K): A family of
enzymes that add a phosphate group to the 3ʹ hydroxyl
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on the inositol ring of phosphatidylinositol. The 3ʹ phos
phorylating lipid kinase isoforms are subdivided into
three classes (I-III) and the class I enzymes are further
subdivided into class IA and IB. The class III phosphati
dylinositol 3-kinases (see PIK3C3 and Vps34) are stimu
latory for autophagy, whereas class I enzymes (referred to
as phosphoinositide 3-kinases, PI3Ks) are inhibitory
[3573]. The class II PtdIns3K substantially contributes to
PtdIns3P generation and autophagy in Pik3c3 knockout
MEFs, also functioning as a positive factor for autophagy
induction [3574]. In yeast, Vps34 is the catalytic subunit
of the PtdIns3K complex. There are two yeast PtdIns3K

PtdIns3K complex I

Vps30

Atg14 Atg38
Atg38
Vps15

Vps34

complexes, both of which contain Vps34, Vps15 (a reg
ulatory kinase), and Vps30/Atg6. Complex I includes
Atg14 and Atg38 and is involved in autophagy, whereas
complex II contains Vps38 and is involved in the vacuolar
protein sorting (Vps) pathway. The X-ray crystal structure
of yeast complex II has a Y-shape, where one arm of the
Y is the regulatory/adaptor arm and the other arm is the
catalytic arm [800]. The kinase domains of Vps15 and
Vps34 engage each other at the tip of the catalytic arm.
The regulatory/adaptor arm has elements from Vps30,
Vps38 and the C-terminal region of Vps15, and the
Vps30 BARA domain in this arm is critical for activity
of the kinase on membranes. Electron microscopy sug
gests that mammalian complex II has a similar organiza
tion, except that the catalytic arm shows extensive
conformational diversity [3575–3577]. See also phosphoi
nositide 3-kinase.
Phosphatidylinositol-3-phosphate (PtdIns3P): The product
of the PtdIns3K and the target of myotubularin phosphatases.
PtdIns3P is present at the PAS, and is involved in the recruit
ment of components of the autophagic machinery. It is
important to note that PtdIns3P is also generated at the
endosome (e.g., by the yeast PtdIns3K complex II).
Additionally, FYVE-domain probes block PtdIns3P-depen
dent signaling, presumably by sequestering the molecule
away from interactions with downstream effectors or prevent
ing its interconversion by additional kinases [3578]. Thus,

general PtdIns3P probes such as GFP-tagged FYVE and PX
domains are generally not good markers for the autophagyspecific pool of this phosphoinositide.
Phosphatidylinositol-3,5-bisphosphate
(PtdIns[3,5]P2):
This molecule is generated by PIKFYVE (phosphoinositide
kinase, FYVE finger containing) and targeted by several myo
tubularin phosphatases, and is abundant at the membrane of
the late endosome. Its function is relevant for the replication
of intracellular pathogens such as the bacteria Salmonella
[3579], and ASFV [3580]. PtdIns(3,5)P2 also plays a role in
regulating autophagy [3581]. In addition, PtdIns(3,5)P2 plays
a crucial role in lysosome homeostasis where it is required for
lysosome fission, autophagosome-lysosome fusion, and traf
ficking of molecules into lysosomes, events that are essential
for autophagy [3582].
Phosphatidylinositol-4,5-bisphosphate
(PtdIns[4,5]P2):
Phosphoinositide lipid generated by both the type I canonical
phosphinositide-4-phosphate 5-kinases (PI4P5Ks) and the
type II non-canonical PI4P5Ks. PtdIns(4,5)P2 function has
been implicated in many stages of the autophagic process
[3583, 3584].
Phosphatidylserine (PS): This glycerophospholipid contains
two fatty acyl hydrocarbon chains attached via ester linkages
to the first and second carbons of glycerol, along with serine
attached via a phosphodiester linkage to the third carbon of
the glycerol. In healthy cells, PS is actively restricted to the
cytosolic (inner) side of the cell plasma membrane by ATPrequiring flippases. This localization for PS becomes disrupted
when cells undergo autophagy or apoptosis due to scram
blases catalyzing rapid PS transbilayer exchange between the
two sides of the membrane [3585]. The exposure of PS in the
extracellular (outer) surface of the cell acts as a signal for
macrophages to engulf the cells, and autophagy mediates PS
exposure and phagosome degradation during apoptosis
[3586]. PS exposure is also involved in axonal autophagy.
GSK3B-mediated phosphorylation of MCL1 regulates auto
phagy to promote axonal degeneration. The GSK3B-MCL1
pathway affects ATP production locally in degenerating
axons, and the exposure of PS as an “eat-me” signal for
phagocytes that degrade these axons; defects in this process
result in the failed engulfment of axonal debris in vivo [3585].
See also FBXS7, GSK3B and MCL1.
Phosphoinositide 3-kinase (PI3K): The class I family of
enzymes that add a phosphate group to the 3ʹ hydroxyl on
the inositol ring of phosphoinositides. PI3K activity results in
the activation of MTOR and the inhibition of autophagy.
Phosphoinositide-4-phosphate 5-kinases (PI4P5Ks): The
type II non-canonical family of lipid kinases that phosphorylate
the 4-position of the minor lipid phosphatidylinositol-5-phos
phate (PtdIns5P) to generate a small yet significant pool of
PtdIns(4,5)P2 at intracellular locations. The PI5P4Ks are required
for autophagosome-lysosome fusion [3587].
Phosphoinositides (PI) or inositol phosphates: These are
membrane phospholipids that control vesicular traffic and
physiology. There are several different PIs generated by
quick interconversions by phosphorylation/dephosphoryla
tion at different positions of their inositol ring by a number
of kinases and phosphatases. The presence of a particular PI
participates in conferring membrane identity to an organelle.
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Phosphorylated ubiquitin/p-S65-Ub: Phosphorylated ubi
quitin is essential for PINK1-PRKN-mediated mitophagy
and plays a dual role in the initial activation and recruitment
of PRKN to damaged mitochondria (reviewed in [1194]).
Specific antibodies can be used to faithfully detect PINK1PRKN-dependent mitophagy at early steps [1191, 1193]; how
ever, the exact functions of p-S65-Ub during the different
phases of mitophagy remain unclear.
Phycocyanin: Phycocyanin promotes autophagy-mediated
cell death by inhibiting PI3K-AKT-MTOR signaling pathways
in pancreatic cancer cells [3588].
Piecemeal microautophagy of the nucleus (PMN)/micronu
cleophagy: A process in which portions of the yeast nuclear
membrane and nucleoplasm are invaginated into the vacuole,
scissioned off from the remaining nuclear envelope and
degraded within the vacuole lumen [157, 1077]. This process
is dependent on Vac8 and Nvj1. See also nucleus-vacuole
junction.
PI3Kγ: See PIK3CG.
PI4K2A/PI4KIIα (phosphatidylinositol 4-kinase type 2
alpha): A lipid kinase that generates PtdIns4P, which plays a
role in autophagosome-lysosome fusion [3589]. PI4K2A is
recruited to autophagosomes through an interaction with
GABARAP or GABARAPL2 (but the protein does not
bind LC3).
PIK3C2B/PI3KC2β (phosphatidylinositol-4-phosphate 3kinase catalytic subunit type 2 beta): A ubiquitously
expressed class II phosphatidylinositol 3-kinase and phos
phoinositide 3-kinase isoform that is recruited to late endo
somes and lysosomes in serum-starved cells to locally produce
phosphatidylinositol-3,4-bisphosphate (PtdIns[3,4]P2), result
ing in repression of nutrient signaling via MTORC1.
PIK3C2B-depleted cells in addition to elevated MTORC1
activity accumulate LC3-positive autophagosomes and unde
graded SQSTM1, suggesting that protein turnover via the
autophagy-lysosome pathway requires PIK3C2B activity
[3590].
PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit
type 3): The mammalian homolog of yeast Vps34, a class III
PtdIns3K that generates PtdIns3P, which is required for auto
phagy [3573]. In mammalian cells there are at least three
PtdIns3K complexes that include PIK3C3/VPS34, PIK3R4/
VPS15 and BECN1, and combinations of ATG14, UVRAG,
AMBRA1, SH3GLB1 and/or RUBCN. See also phosphatidyli
nositol 3-kinase.
PIK3CB/p110β (phosphatidylinositol-4,5-bisphosphate 3kinase catalytic subunit beta): A catalytic subunit of the
class IA phosphoinositide 3-kinase; this subunit plays a posi
tive role in autophagy induction that is independent of MTOR
or AKT, and instead acts through the generation of PtdIns3P,
possibly by acting as a scaffold for the recruitment of phos
phatases that act on PtdIns(3,4,5)P3 or by recruiting and
activating PIK3C3 [3591].
PIK3CG/PI3Kγ/p110γ (phosphatidylinositol-4,5-bisphos
phate 3-kinase catalytic subunit gamma): Catalytic subunit
of the only class IB PI3K member; this subunit is enriched in
specific cell subtypes, such as leukocytes and cardiomyo
cytes. In the heart, PIK3CG is activated under stress condi
tions and inhibits autophagy by triggering the AKT-MTOR-
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ULK1 signaling pathway. In hearts from mice treated with
doxorubicin, PIK3CG is activated downstream of TLR9 by
the mitochondrial DNA contained within autolysosomes,
and drives a feedback inhibition of autophagy, ultimately
contributing to doxorubicin-induced cardiomyopathy
[2583]. See also TLR9.
PIK3R4/p150/VPS15 (phosphoinositide-3-kinase regula
tory subunit 4): The mammalian homolog of yeast Vps15,
PIK3R4 is a core component of all complexes containing
PIK3C3 and is required for autophagy [3592]. PIK3R4 inter
acts with the kinase domain of PIK3C3, to regulate its activity
and also functions as a scaffold for binding to NRBF2 and
ATG14 [3515, 3516]. While PIK3R4 is classified as a protein
serine/threonine kinase, it possesses an atypical catalytic
domain and lacks catalytic activity, at least in vitro (J.
Murray, personal communication). PIK3R4 also interacts
with RAB GTPases, including RAB5 [3593] that may be
responsible for recruitment of PIK3C3-PIK3R4-complexes to
sites of autophagosome formation.
PINK1/PARK6 (PTEN induced kinase 1): A mitochondrial
protein kinase (mutated in autosomal recessive forms of PD)
that is normally processed in a membrane potential-depen
dent manner to maintain mitochondrial structure and func
tion [82, 3546], suppressing the need for mitophagy [1137].
Upon mitochondrial depolarization, mitochondrial import
blockade, accumulation of unfolded proteins in the mitochon
drial matrix or ablation of the inner membrane protease
PARL, PINK1 is stabilized and activated, phosphorylating
ubiquitin and PRKN for full activation and recruitment of
PRKN (reviewed in [1194]) to facilitate mitophagy [1155,
3545, 3594–3597]. Processed PINK1 can also interact with
VCP/p97 to regulate PRKA activation [1742], with indirect
effects on autophagy. See also PARL and phosphorylated
ubiquitin/p-S65-Ub.
PKA (protein kinase A): A serine/threonine kinase that
negatively regulates autophagy in yeast [3598]; composed of
the Tpk1/2/3 catalytic and Bcy1 regulatory (inhibitory) sub
units. The mammalian PKA homolog, PRKA, directly phos
phorylates LC3 to negatively regulate phagophore recruitment
[293]. Bacterial toxins that activate mammalian PRKA can
also inhibit autophagy [3599]. In addition, cAMP inducers,
such as β2-adrenergic agonists (D.A.P. Gonçalves, personal
communication), CALC/calcitonin gene-related peptide (J.
Machado, personal communication) and forskolin plus iso
butilmethylxantine (W.A. Silveira, personal communication),
block the conversion of LC3-I to LC3-II in C2C12 myotubes
and adult skeletal muscles. Phosphorylation of the fission
modulator DNM1L by mitochondrially-localized PRKA
blocks mitochondrial fragmentation and autophagy induced
by loss of endogenous PINK1 or by exposure to a neurotoxin
in neuronal cell cultures [3057]. Conversely, forskolin treat
ment in glucose-starved cancer cells, specifically NIH3T3
KRAS transformed mouse fibroblasts, MDA-MB-231 (breast
cancer cells) and Mia Paca2 (pancreatic cancer cells), is able to
sustain cell survival by increasing mitochondrial activity,
intracellular ATP levels, mitochondrial interconnection and
glutamine metabolism as well as autophagy [3600, 3601].
Indeed, as measured by MDC staining and LC3 localization
and cleavage, forskolin induces a PRKA-dependent
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appearance of autophagosomes. Such appearance has been
confirmed by combined treatment with forskolin and CQ,
with the PRKA/PKA inhibitor H89 as well as upon the knock
down of the catalytic PRKACA/PKAα subunit, all causing an
inhibition of the positive effect of forskolin on autophagy.
Importantly such a positive effect of PRKA on autophagy is
also observed in starved and detached cancer cells. Indeed, in
this harsh conditions, endogenous PRKA activation favors
cancer cell survival by activating mitochondrial function, glu
tamine metabolism and autophagy [3601]. See also DNM1L.
PKB: See AKT.
Pkc1: A yeast serine/threonine kinase involved in the cell wall
integrity pathway upstream of Bck1; required for pexophagy
and mitophagy [747]. See also Bck1 and Slt2.
PKCδ: See PRKCD.
PKR: See EIF2AK2.
PLA2G4A/cPLA2 (phospholipase A2 group IVA): A cyto
plasmic phospholipase that can translocate to lysosomes upon
activation, where it can mediate cleavage of lysosomal mem
brane phospholipids to generate lysosphospholipids.
Accumulation of lysophospholipids affects membrane struc
ture and properties, leading to LMP [1606] See also lysosomal
membrane permeabilization.
Plasmodium-associated
autophagy-related
(PAAR)
response: An intracellular host cell response towards an infec
tion with Plasmodium sporozoites, clearly differing from
canonical autophagy, typical xenophagy and LAP [3602,
3603].
Plastolysome: A plant plastid that transforms into a lytic
compartment, with acid phosphatase activity, engulfing
and digesting cytoplasmic regions in particular cell types
and under particular developmental processes [1282–
1285].
PLD1 (phospholipase D1): PLD1 is a membrane-associated
enzyme that enhances autophagic flux by promoting vesicular
fusion through phosphatidic acid generation and recruitment
of PIP5K1/PtdIns4P 5-kinase to mediate fusion and inner
membrane curvature [3604]. Blockade of PLD1 blocks auto
phagic flux and increases the aggregation and retention of
proteins such as MAPT/tau and polyglutamines [3605].
PLD1 also has putative roles as a downstream regulator of
PIK3C3/VPS34 and, paradoxically, RHEB-mediated activation
of MTOR [3605, 3606].
PLEKHG5 (pleckstrin homology and RhoGEF domain con
taining G5): A guanine nucleotide exchange factor activating
RAB26 for the removal of synaptic vesicles by autophagy.
Disruption of this pathway in mice results in swollen axon
terminals in motoneurons leading to a motoneuron disease
with late onset. Mutations in the human PLEKHG5 gene have
been linked to several forms of motoneuron disease [3607].
See also RAB26.
PLEKHM1: An autophagic adaptor protein that contains a
LIR motif, which directs binding to all of the LC3/
GABARAP proteins. PLEKHM1 also interacts with GTPbound RAB7 and the HOPS complex. PLEKHM1 is present
on the cytosolic face of late endosomes, autophagosomes,
amphisomes and lysosomes, and serves to coordinate endocytic
and autophagic pathway convergence at, and fusion with, the
lysosome [3608].

PLGA-aNPs: Poly(DL-lactide-co-glycolide)/PLGA acidic
nanoparticles/aNPs are approved by the US Food and Drug
Administration and have been reported to (1) traffic to lyso
somes and (2) act on the lysosomal pH.
PLK1 (polo like kinase 1): A serine/threonine kinase that
inhibits MTORC1’s lysosomal association and enhances auto
phagy under conditions of nutrient starvation and sufficiency
in mammalian cells and C. elegans. Whereas PLK1 is widely
recognized as a controller of mitosis, it controls autophagy
during interphase [3609].
PMT7: A phloroglucinol derivative used as a chemotherapeu
tic drug to target glycolytic cancer cells [3610].
PND (programmed nuclear destruction): A yeast cell
death-related process that occurs during gametogenesis
involving a noncanonical type of vacuole-dependent degra
dation [3410].
PNPLA1 (patatin like phospholipase domain containing 1):
An enzyme that plays a key role in epidermal omega-Oacylceramide synthesis and localizes on the surface of lipid
droplets. Mutations in the PNPLA1 gene are associated with
autosomal recessive congenital ichthyosis (ARCI). Mutant or
knocked down PNPLA1 leads to decreased autophagic flux
and impaired lipophagy [1310] in fibroblasts.
PNPLA2/ATGL (patatin like phospholipase domain con
taining 2): A lipase that catalyzes the catabolism of triglycer
ides in lipid droplets. PNPLA2 acts to hydrolyze large lipid
droplets [1312] and acts upstream of SIRT1 to promote lipo
phagy [1311]. PNPLA2 also interacts with LC3, which facil
itates PNPLA2 targeting to lipid droplets [3611].
PNPLA3 (patatin like phospholipase domain containing 3):
A triglyceride lipase/acyl transferase enzyme mainly expressed
in the liver. The I148M variant of the protein represents a
genetic risk factor for developing nonalcoholic fatty liver
disease (NAFLD) and leads to decreased autophagic flux and
reduced lipophagy in the human hepatocyte cell line HepG2
[1313].
PNPLA5 (patatin like phospholipase domain containing 5):
A lipase that mobilizes neutral lipid stores (e.g., triglycerides
in lipid droplets) to enhance autophagic capacity of the cell by
contributing lipid precursors for membrane biogenesis (thus
enhancing autophagic capacity) and signaling [3612]. This
process should not be confused with the process of lipophagy,
which is the uptake of lipid droplets for triglyceride degrada
tion in autolysosomes.
PNPLA8/calcium-independent phospholipase A2γ/iPLA2γ
(patatin like phospholipase domain containing 8): Global
deletion of Pnpla8 leads to mitochondrial damage and
enhanced autophagy in podocytes [3613].
PNS (peri-nuclear structure): A punctate structure in K.
phaffii/P. pastoris marked by Atg35, which requires Atg17
for recruitment and is involved in micropexophagy; the PNS
may be identical to the PAS [2819].
Podocytes: Podocytes are post-mitotic highly differentiated
epithelial cells with limited capacity for self renewal.
Podocytes are located in the glomerulus, a network of capil
laries, which constitutes the filtering unit of the kidney. The
blood is filtered across the glomerular capillary walls includ
ing the podocytes. Podocytes wrap around capillaries; thus,
they are extracapillary pericytes, essential to the survival of the
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underlying glomerular endothelium. The healthy glomerulus
filters water-soluble, non-protein-bound metabolic bypro
ducts into the urine but prevents the passage of ALB (albu
min) and other larger essential molecules. Podocytes
contribute to such permeability-selectivity (or permselectivity)
of the glomerulus. Dysfunction or loss of podocytes leads to
urinary ALB leakage and eventually to loss of glomeruli and
subsequent kidney failure. Podocytes exhibit a remarkably
high autophagy flux at baseline that protects them in a num
ber of pathological conditions. Variations of podocyte auto
phagy are found in diseases, the mechanisms of which remain
to be determined.
Polyphenol: A class of plant phytochemicals that have been
described as autophagy regulators in different disease models,
such as neurodegenerative disease (reviewed in ref. [3614])
including PD [3615] and cancer (reviewed in ref. [3616]).
PolyQ: Polyglutamine or glutamine-rich repeats whose pre
sence leads to the formation of cytoplasmic aggregates
[627,715]. Expansions of polyQ repeats occur in HD and
have been found in certain viruses [1427], although their
potential pathogenic role in the latter is not clear. See also
HTT, Dsk2, and AQAMAN [3466]).
Post-fertilization sperm mitophagy: Ubiquitin- and auto
phagy (SQSTM1)-dependent mechanism for selective degra
dation of paternal, sperm-borne mitochondria in the
mammalian zygote, promoting clonal, maternal inheritance
of mitochondrial DNA [3617]. See also allophagy.
POU5F1/Oct3/Oct4 (POU class 5 homeobox 1): A transcrip
tion factor in embryonic stem cells associated with their plur
ipotency, proliferative potential and self-renewal capacity [3618];
basal autophagy is needed to maintain cancer stem cell pluripo
tency, and knockdown of POU5F1 inhibits autophagy [3619].
PP242: A pharmacological catalytic kinase inhibitor of TOR;
inhibits TORC1 and TORC2.
PPAN (peter pan homolog): A ribosome biogenesis factor
regulating the maturation of the 60S ribosomal precursor.
Loss of PPAN triggers TP53-independent nucleolar stress,
abrogates mitochondrial homeostasis and enhances autopha
gic flux [2028, 3620].
PPARs (peroxisome proliferator activated receptors):
Ligand-activated transcription factors, members of the
nuclear receptor superfamily, consisting of 3 isotypes:
PPARA/PPARα/NR1C1 (peroxisome proliferator activated
receptor alpha), PPARD/PPARδ/NR1C2, and PPARG/
PPARγ/NR1C3 [1202]. PPAR-mediated signaling pathways
regulate, or are regulated by, molecules involved in autophagy
[3621, 3622].
Ppg1: Ppg1 is a PP2A-like protein phosphatase that counter
acts CK2-mediated phosphorylation of the mitophagy recep
tor Atg32 to inhibit mitophagy in yeast. See also casein kinase
2 and Far complex [3128].
PPI (protein-protein interaction): Proper biological activity
of many proteins depends on physical interactions with other
proteins. Specific PPI has a functional objective. Therefore,
complete understanding of protein function requires consid
eration of proteins in the context of their binding partners
[3623, 3624]. Often, interactions between proteins and protein
complexes are presented in a form of large densely connected
networks (PPI networks). Such network-based representation
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of PPIs provide the means for a more complete understanding
of physiological and pathogenic mechanisms [3625].
PPM1D/Wip1 (protein phosphatase, Mg2+/Mn2+ depen
dent 1D): A protein phosphatase that negatively regulates
ATM and autophagy [3626].
PPP1 (protein phosphatase 1): A serine/threonine protein
phosphatase that regulates ATG16L1 by dephosphorylation of
CSNK2-modified Ser139 to inhibit autophagy. See also
CSNK2 [3012].
PPP1R13L/iASPP (protein phosphatase 1 regulatory sub
unit 13 like): PPP1R13L is a TP53 inhibitor that is usually
upregulated in human cancers. Known as an important reg
ulator of epidermal homeostasis, PPP1R13L also inhibits au
tophagy in keratinocytes. TP53BP2/ASPP-depletion in these
cells results in elevated levels of LC3B indicating the activa
tion of autophagy. PPP1R13L levels can serve as an indicator
of the level of autophagy in keratinocytes [3627].
PPP1R15A/GADD34 (protein phosphatase 1 regulatory
subunit 15A): A protein that is upregulated by growth arrest
and DNA damage; PPP1R15A binds to and dephosphorylates
TSC2, leading to MTOR suppression and autophagy induc
tion [3628].
PPP2 (protein phosphatase 2): A serine/threonine protein
phosphatase that negatively regulates autophagy via de
phosphorylation of BECN1 at Ser90 [3629].
PPP2R5A (protein phosphatase 2, regulatory subunit B’
alpha): B56 subunit of PPP2/PP2A, a phosphatase that binds
to and dephosphorylates GSK3B at Ser9 to make it active and
thus activate autophagy [783].
PPP3/calcineurin (protein phosphatase 3): A calciumdependent phosphatase. In response to a calcium pulse via
the lysosomal calcium channel MCOLN1, PPP3 dephosphor
ylates Ser142 and Ser211 of TFEB, leading to nuclear localiza
tion and upregulation of the CLEAR network [2000]. See also
CLEAR and TFEB.
prApe1 (precursor Ape1): See Ape1.
Pre-autophagosomal structure (PAS): See phagophore
assembly site.
Primary cilium: A single, non-motile appendage that
emerges, with few exceptions (e.g., in hematopoietic cells),
from the surface of most vertebrate cell types. Autophagyrelated proteins localize at cilia or periciliary regions: Both
mature autophagosome markers and autophagy proteins act
ing on the initial steps of autophagosome formation show
discrete puncta at basal bodies and cilia axonemes [3285].
The primary cilium functions as a specialized signaling device
involved in the transduction of multiple signaling pathways
(e.g., Hedgehog, WNT, PDGFR, NOTCH, TGFB and other
GPCR-associated pathways) [3630]. Defects in the assembly
and function of primary cilia are associated with genetic
diseases, collectively known as ciliopathies [3631]. Ciliopathy
proteins are involved in the regulation of autophagy: 1)
INPP5E (inositol polyphosphate-5-phosphatase E), which
localizes both at primary cilia and at lysosomes, is required
for autophagosome-lysosome fusion [3632]; 2) FLCN (follicu
lin), which is localized both at primary cilia and lysosomes,
physically interacts with autophagic proteins (e.g., GABARAP
and ULK1), playing a positive role in autophagy [712]; 3)
RPGRIP1L (RPGRIP1 like) positively regulates proteasomal
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activity at the ciliary base and autophagy, independently of
each other [2978, 3633]. A reciprocal interaction between
primary cilia and autophagy has emerged, and common
players have only started to be identified. The primary cilium
is a site of autophagosome formation, where components of
the autophagic machinery are recruited and initiate autophagy
in response to chemical and mechanical stimuli, or during
neuroectodermal differentiation [3285, 3634, 3635]. In turn,
autophagy controls ciliogenesis and cilia length, even though
the outcome of the autophagic degradation on primary cilia is
cell specific and context dependent [2975, 3633, 3636–3638].
See also ciliophagy and intraflagellar transport.
PRKA (protein kinase cAMP-dependent): The mammalian
homolog of yeast PKA. See also PKA.
PRKCD/PKCδ (protein kinase C delta): PRKCD regulates
MAPK8 activation. PRKCD also activates NADPH oxidases,
which are required for antibacterial autophagy [3052].
PRKD1 (protein kinase D1): A serine/threonine kinase that
activates PIK3C3/VPS34 by phosphorylation; recruited to
phagophore membranes [3639].
PRKDC (protein kinase, DNA-activated, catalytic subunit):
A positive regulator of autophagy via phosphorylation of
PRKAG1/AMPKγ1 [652].
PRKN (parkin RBR E3 ubiquitin protein ligase): An E3
ubiquitin ligase (mutated in autosomal recessive forms of
PD) that is recruited from the cytosol to mitochondria follow
ing mitochondrial depolarization, mitochondrial import
blockade or accumulation of unfolded proteins in the mito
chondrial matrix or ablation of the rhomboid protease PARL,
to promote their clearance by mitophagy [339, 3545, 3594–
3596]. PINK1-dependent phosphorylation of Ser65 in the
ubiquitin-like domain of PRKN and in ubiquitin itself (see
phosphorylated ubiquitin/p-S65-Ub) promotes activation and
recruitment of PRKN to mitochondria (reviewed in ref.
[1194]) [1155], and USP8 deubiquitination of K6-linked ubi
quitin on PRKN to promote its efficient recruitment [3640].
Programmed cell death (PCD): Regulated self-destruction of
a cell. Type I is associated with apoptosis and is marked by
cytoskeletal breakdown and condensation of cytoplasm and
chromatin followed by fragmentation. Type II is associated
with autophagy and is characterized by the presence of auto
phagic vacuoles (autophagosomes) that sequester organelles.
Type III is marked by the absence of nuclear condensation,
and the presence of a necrotic morphology with swelling of
cytoplasmic organelles (oncosis). These categories of cell
death are based on morphological criteria, and the
Nomenclature Committee on Cell Death now recommends
the use of terms that are more precise and refer to different
types of RCD [1759].
PROM1/CD133 (prominin 1): PROM1 is a transmembrane
glycoprotein, residing cytosolically in retinal pigment epithe
lium that gets upregulated along with an increase in autopha
gy induced by stress signals. Knockout of Prom1 results in
SQSTM1 accumulation and decreased autophagosome traf
ficking [2403].
PROPPINs (β-propellers that bind phosphoinositides): A
WD40-protein family conserved from yeast to human [3641].
These proteins fold as seven-bladed β-propellers, and each
blade contains four antiparallel β-strands. With two lipid

binding sites at the circumference of their propeller they
bind PtdIns3P and PtdIns(3,5)P2 [3642–3644]. The S. cerevi
siae PROPPINs are Atg18, Atg21 and Hsv2, and the mamma
lian counterparts are termed WIPIs.
Proteaphagy: The autophagic degradation of the 26S protea
somes, which is mediated by two routes; bulk, nonselective
degradation under starvation conditions, and selective degra
dation of inactive proteasomes [1352–1355, 1357]. Extensive
polyubiquitination of the proteasome accompanies protea
phagy in yeast, plants, and mammals.
Proteasome: A large, multi-subunit proteolytic complex
responsible for degrading individual proteins tagged with
polyubiquitin chains; consists of a barrel-shaped core protease
containing six proteolytic active sites, capped with a regula
tory particle that contains activities for substrate recognition,
deubiquitination, unfolding and delivery into the core particle
chamber [3645].
Proteasome storage granules (PSGs): Membraneless cyto
plasmic condensates containing proteasome core proteases
and regulatory particles that form in yeast, mammals and
plants in response to carbon starvation; sequestration into
these structures protects proteasomes from autophagic degra
dation [1358].
Protein translation: Nutrient deprivation and some other
stress stimuli that promote autophagy inhibit MTOR and
limit protein synthesis. Reduced translation of essential auto
phagy proteins and their degradation under such stress con
ditions contributes to the limitation of autophagy
amplification [3646].
Proteostasis: Proteostasis is the maintenance of proteome
homeostasis, thereby regulating protein translation, folding,
trafficking, subcellular localization, and degradation.
Proteostasis interacts with essential components of the auto
phagy-lysosomal pathways, thus regulating autophagy and
mitophagy, and also participates in tumorigenesis or cancer
progression [3647].
Proto-lysosomes: Vesicles derived from autolysosomes that
mature into lysosomes during autophagic lysosome reforma
tion [781]. See also autophagic lysosome reformation.
Protophagy: Autophagy-like processes in microbial popula
tions. The term summarizes all self-destructing patterns in
prokaryotic colonies including bacterial cannibalism, autoly
sis, programmed cell death, and other processes, in which a
part of the colony is lysed and consumed by neighboring
prokaryotic cells to recycle matter and energy [3648].
PSEN1/2 (presenilin 1/2): Catalytic components of the γ-secre
tase complex. Both PSEN1 and PSEN2 are necessary for correct
autophagy in a γ-secretase-independent manner [3649].
Moreover, mutations in PSEN1 and PSEN2 (linked to familial
forms of AD) result in the accumulation of autophagosomes. In
the presence of PSEN1 mutations, one of the V-ATPase subunits
does not target properly to the lysosome, leading to defective
lysosomal acidification and calcium deregulation [80, 81, 3649].
PSEN2 mutations instead cause a reduced cytosolic calcium
signal that induces a defective recruitment of RAB7 to autopha
gosomes, blocking fusion of the latter with lysosomes [2589,
3416]. Recent studies in a tractable model system, D. discoideum,
suggest that both the human PSEN1 protein, and its D. discoi
deum ortholog, function to regulate phagosomal proteolysis, as
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well as autophagosomal acidification and autophagic flux
through a non-catalytic mechanism [1768, 1769].
Psp2: An RGG motif protein that positively regulates auto
phagy through promoting the translation of ATG1 and
ATG13. During nitrogen starvation conditions, unmethylated
Psp2 interacts with the 5′ UTR of ATG1 and ATG13 mRNA in
an RGG motif-dependent manner in conjunction with trans
lation initiation factors. The switch of this regulation is argi
nine methylation controlled by TOR signaling through Hmt1
[3650].
PT21: A potential PIK3C3/VPS34 kinase inhibitor.
Autophagy initiation is regulated by the activity of the class
III PtdIns3K complex, which can be inhibited by PT21, which
promotes the degradation of these complexes [3651].
Ptc2/3: Redundant PP2C phosphatases that interact with and
are involved in the dephosphorylation of the Atg1 kinase
complex in S. cerevisiae, to promote autophagy as well as
the Cvt pathway [3652].
PTEN (phosphatase and tensin homolog): A 3ʹ phosphoi
nositide phosphatase that dephosphorylates PtdIns(3,4,5)P3,
thereby inhibiting PDPK1/PDK1 and AKT activity.
PTEN-L: A long isoform of PTEN with the addition of 173
amino acids at the N terminus, which functions as a negative
regulator of mitophagy by dephosphorylating p-Ser65-Ub
and p-Ser65-PRKN via its protein phosphatase activity
[1192].
PTK2B/PYK2 (protein tyrosine kinase 2 beta): A nonreceptor kinase of the PTK2/FAK family, involved in several
cellular processes, including oxidative stress, calcium home
ostasis, proliferation, cytoskeleton organization, and cell moti
lity. PTK2B has tumor suppressive functions in prostate
cancer cells, and the expression of a PTK2B kinase-dead
mutant in the prostate epithelial EPN cell line sensitizes the
cells to the pro-autophagic effects of the polyphenol resvera
trol, and induces an increase in the number and size of
autophagosomes as well as an enlargement of the lysosomal
compartment [3653]. A deeper connection between PTK2B
and autophagy regulation is suggested by the observation that
RB1CC1, a known inhibitor of PTK2B, is a regulatory partner
of the ULK–ATG13–RB1CC1 complex [3654].
PTM (posttranslational modification): After biosynthesis,
many proteins undergo covalent modifications that are often
catalyzed by special enzymes that recognize specific target
sequences in particular proteins. PTMs provide dramatic
extension of the structures, properties, and physico-chemical
diversity of amino acids, thereby diversifying structures and
functions of proteins [3655]. There are more than 300 phy
siological PTMs [3656]. Some PTMs (e.g., phosphorylation,
acetylation, glycosylation, etc.) are reversible by the action of
specific deconjugating enzymes. The interplay between mod
ifying and demodifying enzymes allows for rapid and eco
nomical control of protein function [3655]. PTMs clearly play
a role in regulating the autophagy machinery [998, 3657].
PTP4A3 (protein tyrosine phosphatase 4A3): A plasma
membrane- and endosome-localized prenylated protein phos
phatase that stimulates autophagy; PTP4A3 is also an auto
phagic substrate [3658].
PTPRS/PTPσ (protein tyrosine phosphatase receptor type
S): A dual domain protein tyrosine phosphatase that
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antagonizes the action of the class III PtdIns3K; loss of
PTPRS results in hyperactivation of basal and induced auto
phagy [3659].
PULKA (p-ULK1 assay): This acronym describes the analysis
of Ser317 phosphorylated (activated) ULK1 puncta by fluor
escence microscopy [3660].
PUX7/8/9/13 (Plant UBX domain-containing protein 7/8/
9/13): A family of plant ubiquitin regulatory X (UBX)
domain-containing proteins that act as autophagy receptors
for inhibited or mutant forms of CDC48 in Arabidopsis; they
bind the UDS of ATG8 via a UIM-like sequence [1359]. See
also Cdc48, UDS and UIM.
PYK2: See PTK2B.
Quercetin (3,5,7,3′,4′-pentahydroxyflavone): A broadly stu
died phenolic compound, belonging to the class of flavonoids,
sub-class flavonols. Quercetin is the most abundant flavonol
in food and it is largely used as a dietary supplement [3661].
The multifaceted outcomes of quercetin in cancer cell lines
indicate its capacity to induce protective and non-protective
forms of autophagy [3662]. In addition, quercetin, in associa
tion with dasatinib, has been recognized as a senolytic com
pound [3663], providing a tool for studying how basal,
selective autophagy can act as an antisenescence mechanism
[3664].
RAB1: See Ypt1.
RAB2: A small GTPase that is required for ER-to-Golgi
transport. RAB2 is also required for the fusion between
autophagosomes and lysosomes through interaction with
the HOPS complex [3665, 3666] and for the formation of
autophagosomes and lysosomes [3667]. Knockout of
RAB2 in the U2OS cell line results in a significant reduc
tion in LC3B levels both under autophagy-stimulated and
-unstimulated conditions. RAB2 modulates ULK1 activity
to generate signals for autophagy initiation [3667].
RAB4A: This small GTPase was previously called HRES1/Rab4, as it is encoded by the antisense strand of the
HRES-1 human endogenous retroviral locus in region q42
of human chromosome 1 [3668]. It has been recently
designated as RAB4A to distinguish it from RAB4B on
human chromosome 19. RAB4A regulates the endocytic
recycling of surface proteins, such as CD4, CD247/CD3ζ,
and CD2AP, and TFRC/CD71, which control signal trans
duction through the immunological synapse in human T
lymphocytes [3668, 3669]. Among these proteins, CD4
and CD247 are targeted by RAB4A for lysosomal degra
dation via autophagy [3668–3670]. Beyond T lympho
cytes, RAB4A generally promotes the formation of LC3+
autophagosomes and the accumulation of mitochondria
during autophagy [3671]. During accelerated autophagy,
RAB4A also promotes the lysosomal degradation of intra
cellular proteins, such as DNM1L that initiates the fission
and turnover of mitochondria [1573, 3672]. Thus,
RAB4A-mediated depletion of DNM1L selectively inhibits
mitophagy and causes the accumulation of mitochondria
in patients and mice with lupus [3670]. The formation of
interconnected mitochondrial tubular networks is
enhanced by constitutively active RAB4AQ72L upon star
vation, which may contribute to the retention of mito
chondria during autophagy [3671].
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RAB5: A small GTPase that is required for early endosome
biogenesis. RAB5 is also involved in ESCRT-mediated seques
tration of mitochondria [3673] and closure of the phagophore
[3114]. See also phagophore closure.
RAB6: Small RAS family GTPase required for delivery of
lysosomal hydrolases and normal localization of InR/insulin
receptor in Drosophila [3674].
RAB7: A small GTPase of the RAS oncogene family func
tioning in transport from early to late endosomes and from
late endosomes to lysosomes [3675]. RAB7 is also needed for
the clearance of autophagic compartments, most likely for
the fusion of amphisomes with lysosomes [1510, 1511].
RAB7 recruitment to autophagosomes, needed for their
fusion with lysosomes, is calcium regulated [3416]. In
RAB7 knockout mammalian cells, autolysosomes, rather
than autophagosomes, may accumulate [3676]. Organelles
positive for lysosomal markers may also label for RAB7
[3677], indicating hybrid vesicles [3678] as well as the
dynamic and interconnected nature of trafficking organelles.
Mutations in the RAB7A gene cause Charcot-Marie-Tooth
type 2B (CMT2B) disease, a dominant axonal peripheral
neuropathy. In neurons, RAB7A also controls neuronal-spe
cific processes such as NTF (neurotrophin) trafficking and
signaling, neurite outgrowth and neuronal migration. All
CMT2B-causing RAB7A mutants cause a reduced autopha
gic flux and inhibit basal and starvation-induced autophagy,
suggesting that alteration of the autophagic flux could be
responsible for neurodegeneration [271]. The yeast homolog
is Ypt7. See also PSEN2.
RAB8: A small GTPase of the RAS oncogene family. RAB8A
functions in secretory autophagy [1700], whereas RAB8B
plays a role in degradative autophagy [3679].
RAB9: A member of the Ras superfamily of small RAB
GTPases involved in the transport between late endosomes
and the trans Golgi network. A growing body of evidence
indicates that mitochondria can be eliminated through a
RAB9-dependent, but LC3-independent, noncanonical auto
phagy pathway that utilizes autophagosomes derived from the
trans-Golgi and late endosomes. This pathway is essential
during erythrocyte maturation or in stress conditions such
as ischemia/reperfusion injury in the heart [3680, 3681].
RAB9 may also play a role in the formation of group A
Streptococcus (GAS)-containing autophagosome-like vacuoles
[3682].
RAB10: A small GTPase that binds to the autophagy receptor
OPTN, promotes OPTN accumulation on depolarized mito
chondria and facilitates mitophagy. RAB10 is a substrate of
the PD-linked kinase LRRK2 [3371]. Phosphorylation of
RAB10 by LRRK2 interferes with RAB10 binding to OPTN
and mitophagy [3683].
RAB11: A small GTPase that localizes on multivesicular
bodies (MVBs), recycling endosomes and late endosomes
[3684]. RAB11 plays an important role both at the early and
late stages of autophagy [3685, 3686]. RAB11 is required for
autophagosome formation; ULK1 and ATG9 localize in part
to RAB11-positive recycling endosomes [3685]. Upon auto
phagy induction, RAB11 promotes the fusion between endo
somes and autophagosomes removing HOOK from mature
late endosomes, which is a negative regulator of endosome

maturation, and translocates to autophagosomes [3687]. See
also TBC1D9B and TBC1D14.
RAB12: A small GTPase that controls degradation of the
amino acid transporter SLC36A4 (solute carrier family 36
member 4)/PAT4 and indirectly regulates MTORC1 activity
and autophagy [3688].
RAB13: A small GTPase that is required for autophagosome
formation. The active form of RAB13 promotes its interaction
with GRB2 (growth factor receptor bound protein 2), which
in turn activates AMPK, leading to MTOR inhibition and the
induction of autophagy [3689].
RAB21: A small GTPase that is required for autophagosomelysosome fusion. Starvation induces RAB21 activity that pro
motes VAMP8 trafficking to the lysosome, where VAMP8 is
needed to mediate fusion. See also SBF2 [3690].
RAB24: A small GTPase with unusual characteristics that
associates with autophagic vacuoles and is needed for the
clearance of autolysosomes under basal conditions [3691,
3692].
RAB26: A small GTPase enriched on synaptic vesicles that
interacts with ATG16L1 in its GTP-bound form and directs
synaptic vesicles to autophagosomes [3693]. RAB26 is acti
vated by PLEKHG5, a GEF, which has been linked to moto
neuron disease [3607]. See also PLEKHG5.
RAB32: A small GTPase that localizes to the ER, and
enhances autophagosome formation under basal conditions
[3694].
RAB33B: A small GTPase of the medial Golgi complex that
binds ATG16L1 and plays a role in autophagosome matura
tion by regulating fusion with lysosomes [3695]. RAB33B is a
target of TBC1D25/OATL1, which functions as a GAP [3696].
RAB37: A small GTPase that functions as a key organizer of
autophagosomal membrane biogenesis. RAB37 interacts with
ATG5 and promotes autophagosome formation by modulat
ing ATG12–ATG5-ATG16L1 complex assembly [3697, 3698].
RABG3B: A RAB GTPase that functions in the differentiation
of tracheary elements of the Arabidopsis xylem through its
role in autophagy; this protein is a homolog of RAB7/Ypt7
[1762].
RACK1 (receptor for activated C kinase 1): During auto
phagy ATG5 is bound by RACK1 to initiate the formation of
autophagosomes. Knockdown of RACK1 or inhibition of the
RACK1-ATG5 interaction inhibits autophagy. Therefore,
RACK1, as an interacting partner of ATG5, could be one a
reliable marker to study autophagy through colocalization
[3699].
RAD001: See everolimus.
RAG: See RRAG.
RAGE: See AGER.
RAL: An RRAS-like subfamily in the RAS family, RAL small
GTPases typically function downstream of the RRAS effector
RALGDS/RalGEF and are inhibited by RALGAP, a heterodi
meric GAP structurally analogous to TSC1/2 that functions as
a GAP for RHEB [3700, 3701]. The RAL subfamily includes
mammalian RALA and RALB, Drosophila Rala, and C. ele
gans RAL-1. Mammalian RALB regulates exocytosis, the
immune response and an anabolic/catabolic switch. In nutri
ent-rich conditions RALB-GTP binds EXOC2/Sec5 and
EXOC8/Exo84, and through the latter associates with
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MTORC1 to promote anabolic metabolism [3702]. Under
starvation conditions RALB-GTP nucleates phagophore for
mation through assembly of a ULK1-BECN1-PIK3C3 com
plex, also via interaction with the EXOC8/Exo84 protein
[3117]. Although RALB direct activation and indirect inacti
vation (through MTORC1) of autophagy appears contradic
tory, RALB may function as a critical anabolic/catabolic
switch in response to global and local nutrient contexts.
RALB may be an analog of yeast Sec4 [3703]. See also
EXOC2, Sec4/RAB40B and EXOC8.
RALGAP: A heterodimeric complex consisting of catalytic
alpha and regulatory beta subunits, RALGAP inactivates RAL
small GTPases. RALGAP is structurally analogous to the TSC1/2
GAP, and like TSC1/2 is phosphorylated and inhibited by AKT
[3700, 3704]. An additional partner of the RALGAP complex,
NKIRAS1/kappaB-Ras, also inhibits RAL function [3705].
RANS (required for autophagy induced under non-nitro
gen-starvation conditions) domain: Also referred to as
domain of unknown function 3608 (DUF3608; PFAM:
PF12257,
http://pfam.xfam.org/family/PF12257),
this
sequence in Iml1 is required for non-nitrogen starvationinduced autophagy [3289]. This domain is spread throughout
the eukaryotes (see for example, http://pfam.xfam.org/family/
PF1tabview=tab72257#tabview=tab7) and frequently reported
in combination with a DEP (Dishevelled, Egl-10, and
Pleckstrin) domain (PFAM: PF00610), which is also the case
with Iml1 [3289]. See also non-nitrogen starvation (NNS)induced autophagy.
Rapamycin/sirolimus: Allosteric TOR (in particular, TOR
complex 1) inhibitor, which induces autophagy. TOR complex
2 is much less sensitive to inhibition by rapamycin.
RAPGEF3/EPAC1 (Rap guanine nucleotide exchange fac
tor 3): RAPGEF3/EPAC1 and its downstream effector RAP2B
are recruited to the Staphylococcus aureus-containing phago
some and involved in regulation of pore-forming toxin αhemolysin (Hla)-induced autophagy through CAPN (calpain)
activation [3706, 3707]. In cardiomyocytes, RAPGEF3, acting
through the CAMK2B/CaMKKβ-AMPK pathway, promotes
autophagy. Deletion of Rapgef3 in mice protects against
ADRB/β-adrenergic receptor-induced cardiac remodeling
and autophagy [3708].
RAPGEF4/EPAC2: Oleate stimulates autophagy in pancreatic
β-cells by reducing intracellular cAMP. The effect of oleate is
mediated by RAPGEF4/EPAC2, as oleate-mediated autophagy
can be potentiated or suppressed by RAPGEF4 knockdown or
activation, respectively [3709].
RAPTOR: See RPTOR.
Ras: See RRAS.
RASSF1/RASSF1A (Ras association domain family mem
ber 1): RASSF1 is a tumor suppressor and frequently inacti
vated by promoter hypermethylation in multiple types of
cancers. RASSF1 enhances autophagy initiation by suppres
sing PI3K-AKT-MTOR through the Hippo pathway-regula
tory component MST1 and promotes autophagy maturation
by recruiting autophagosomes on RASSF1-stabilized acety
lated microtubules through MAP1S [3710].
RavZ: A Legionella pathogen effector protein that is part of a
survival strategy employed by intracellular pathogens to evade
clearance through autophagic recognition [3711]. RavZ
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consists of a catalytic domain, a membrane-targeting domain,
and flexible N- and C-terminal regions [3712]; the latter
allows recognition of Atg8-family proteins via three LIR
motifs (two at the N terminus and one at the C terminus)
[1968]. RavZ specifically localizes on phagophores and irre
versibly deconjugates Atg8-family proteins from phosphatidy
lethanolamine; RavZ functions as a cysteine protease that
competes with the host protease ATG4B and cleaves the
amide bond before the C-terminal glycine [1967]. RavZcleaved Atg8-family proteins cannot be relipidated nor uti
lized in the autophagy pathway [1968].
RB1-E2F1 (RB transcriptional corepressor 1-E2 transcrip
tion factor 1): RB1 is a tumor suppressor that promotes
growth arrest, and protects against apoptosis. E2F1 regulates
the transition from the G1 to the S phase in the cell cycle,
and is a pro-apoptotic member of the E2F transcription
family. In addition to controlling the cell cycle and apopto
sis, the interaction between RB1 and E2F1 regulates auto
phagy; RB1 and E2F1 downregulate and upregulate BCL2,
respectively, resulting in the induction of autophagy or
apoptosis [937].
RB1CC1/FIP200 (RB1 inducible coiled-coil 1): A putative
mammalian functional counterpart of yeast Atg17 and Atg11
[1376, 2782, 3713, 3714]. RB1CC1 is a component of the
ULK1 complex [699]. In addition, RB1CC1 interacts with
other proteins in several signaling pathways, suggesting the
possibility of autophagy-independent functions, and a poten
tial role in linking other cellular functions and signaling path
ways to autophagy.
RCB (Rubisco-containing body): Generated by the budding
of chloroplast, stromal protein-containing material into dis
tinct autophagic vesicles [1241].
RCD: See regulated cell death.
Reactive oxygen species (ROS): Reactive molecules that con
tain oxygen, including hydrogen peroxide, the hydroxyl radi
cal OH·, and the superoxide radical O2·−. Hydrogen peroxide
transiently inhibits delipidation of LC3 by ATG4, which is
permissive for starvation-induced autophagy [767].
Superoxide is essential for triggering injury-induced mito
chondrial fission and mitophagy [1137]. ROS are also essen
tial for induction of LAP [2446].
ref(2)P: The Drosophila homolog of SQSTM1.
Regulated cell death (RCD): A form of cell death that results
from the activation of one or more signal transduction path
ways. RCD insures organismal homeostasis in both physiolo
gical and pathological conditions, being involved in two
opposed scenarios. First, RCD can occur in the absence of
any exogenous perturbation in physiological conditions. This
form is related to physiological programs during development
or tissue turnover and hence is referred to as programmed cell
death (PCD).The second scenario is caused by perturbations
in intracellular or extracellular microenvironments, and is
refered to as stress-driven RCD [1266].
Residual body: A lysosome that contains indigestible material
such as lipofuscin [3715].
ReSiN (redox-responsive silica nanoprobe): A biocompati
ble, plant cell wall-penetrable, biothiol-responsive silica
nanoprobe for the fluorescence imaging of starvation-induced
vesicle trafficking [3716].
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Resveratrol: An allosteric activator of SIRT1 and inhibitor of
several other cellular proteins [2627] that induces autophagy
[3717].
Reticulophagy: The selective degradation of ER by an auto
phagy-like process [3718]. Autophagy counterbalances ER
expansion during the unfolded protein response. Activation
of the UPR in yeast induces reticulophagy.
RETREG1/FAM134B (reticulophagy regulator 1): An ERresident receptor that functions in reticulophagy through
interaction with LC3 and GABARAP [74]. RETREG1 also
participates in ER-to-lysosome-associated degradation
(ERLAD) of proteasome-resistant misfolded proteins from
the ER [1379, 1380]. See also ERLAD.
RGS19/GAIP (regulator of G protein signaling 19): A
GTPase activating protein that inactivates GNAI3 (converting
it to the GDP-bound form) and stimulates autophagy [3719].
See also GNAI3.
RHEB (Ras homolog, mTORC1 binding): A small GTPbinding protein that activates MTOR when it is in the GTPbound form [377].
RHOT1/Miro1 (ras homolog family member T1): Member
of the mitochondrial Rho family of proteins implicated in the
regulation of mitochondrial trafficking [3720, 3721]. RHOT1
is an early target of PRKN ubiquitination and degradation
after mitochondrial damage [3722, 3723], which is proposed
to be a mechanism for uncoupling mitochondria from the
transport machinery. In addition, RHOT1 is implicated in the
regulation of mitophagy [3724].
RHOT2/Miro2 (ras homolog family member T2): Member
of the mitochondrial Rho family of proteins which has been
implicated in the regulation of mitophagy by recruiting and
serving as a docking site for PRKN on damaged mitochondria
[3724].
Ribophagy: The selective sequestration and degradation of
ribosomes by a autophagy-like process [1389].
Ribosomopathy: A diverse class of diseases connected to
impaired ribosome biogenesis. Patients carry haploinsuffi
ciency mutations in ribosomal proteins or ribosome biogen
esis factors. Common phenotypes include anemia, craniofacial
cartilage defects and an elevated cancer risk. Classically, TP53
activation is observed as a consequence of nucleolar stress
induction. Recent studies report an implication of autophagy
in ribosomopathy models [2027].
RILP (Rab interacting lysosomal protein): A cytoplasmic
dynein adaptor protein that controls autophagy progression and
transport in more complex eukaryotic neurons as well as non
neuronal cells. RILP interacts sequentially through distinct sites
with ATG5 on the phagophore, LC3 on the autophagosome, and
RAB7 on the late endosome/amphisome. Dynein displaces ATG5
from autophagosomes post-closure, to ensure transport of only
fully formed structures. MTOR inhibition upregulates RILP
expression, dramatically stimulating its recruitment to autopha
gosomes and subsequent autophagic clearance [3725].
Rim15: A yeast kinase that regulates transcription factors in
response to nutrients. Rim15 positively regulates autophagy
and is negatively regulated by several upstream kinases
including TOR, PKA, Sch9 and Pho85 [2995, 3726].
RIPK1 (receptor interacting serine/threonine kinase 1):
RIPK1 inhibits basal autophagy independent of its kinase

function, through activation of MAPK1/3 and inhibition of
TFEB [3727].
Rkr1: A yeast ubiquitin ligase that antagonizes ribophagy
[1390].
RNautophagy: An autophagic process by which RNA is
transported across the lysosomal membrane and degraded
[1397]. The translocation process is mediated by lysosomal
integral membrane proteins LAMP2C and SIDT2 [1397,
1400]. See also DNautophagy, LAMP2C and SIDT2.
RNASET2/RNS2 (ribonuclease T2): A conserved class II
RNase of the T2 family that localizes to the lumen of the ER
(or an ER-related structure) and vacuole in Arabidopsis, and
to lysosomes in zebrafish and nematodes; RNASET2 is
involved in rRNA turnover, and rns2 mutants display consti
tutive autophagy, likely due to a defect in nucleoside home
ostasis [3728–3731].
RNF216 (ring finger protein 216): An E3 ubiquitin ligase
that mediates the ubiquitination and the subsequent degrada
tion of BECN1, thus acting as a negative regulator of auto
phagy [3732].
Rny1: A yeast vacuolar RNase that hydrolyzes RNA that has
been delivered to the vacuole via autophagy into 3ʹ nucleo
tides [3572]. See also Pho8.
ROCK (Rho associated coiled-coil containing protein
kinase): ROCK is a serine/threonine kinase and a major
downstream effector of the small GTPase RHOA. The
ROCK family consists of two isoforms, ROCK1 and ROCK2.
ROCK1 activates BECN1-mediated autophagy initiation
through phosphorylating BECN1 in the starvation-stimulated
autophagic response [3733, 3734] or doxorubicin-induced
autophagic response in mouse hearts [3735]. In addition,
due to the impact of ROCKs on actin cytoskeleton dynamics,
ROCK activity can activate or inhibit autophagy through
multiple mechanisms depending on the cellular context
[3734].
Rpd3: A yeast histone deacetylase that negatively regulates
the expression of ATG8 [2011]. See also Sin3/SIN3 and
Ume6.
Rph1: A histone demethylase that negatively regulates the
expression of ATG7; demethylase activity is not required for
transcriptional repression [912, 913].
RPN10: A component of the 26S proteasome lid. In its free
form, RPN10 acts as a receptor that links ubiquitinated (inac
tive) 26S proteasomes to ATG8 during proteaphagy in
Arabidopsis [1352]. Binding to ATG8 is mediated by a
UIM-like sequence [1359]. See also proteaphagy, UIM,
and UDS.
RPS6KB1/p70S6 kinase/S6K1 (ribosomal protein S6 kinase
B1): A substrate of MTORC1, in mammalian cells
RPS6KB1/2 inhibits INSR (insulin receptor), which in
turn causes a reduction in the activity of the class I PI3K
and subsequently MTORC1; this may represent a feedback
loop to help maintain basal levels of autophagy [1876,
1974]. Conversely, under conditions of long-term starva
tion RPS6KB1/2 levels may fall sufficiently to allow reacti
vation of MTORC1 to prevent excessive autophagy. In
Drosophila, the RPS6KB1/2 ortholog S6k may act in a
more direct manner to positively regulate autophagy
[377]. In human cells, RPS6KB1 is indispensable for
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autophagosome maturation during stress conditions
[3736]. RPS6KB1 interacts with MAP3K7 and suppresses
its activity; RPS6KB1 suppression activates MAP3K7 result
ing in subsequent AMPK activation, leading to autophagy
induction [3737–3740]. See also MAP3K7.
RPS6KB2: See RPS6KB1.
RPTOR/raptor (regulatory associated protein of MTOR
complex 1): A component of MTORC1. RPTOR interacts
with ULK1, allowing MTORC1 to phosphorylate both ULK1
and ATG13, and thus repress ULK1 kinase activity and auto
phagy [698, 700, 701]. This interaction also permits a negative
feedback loop to operate, whereby ULK1 phosphorylates
RPTOR to inhibit MTORC1 activity [711, 718].
RRAG (Ras related GTP binding): A GTPase that activates
MTORC1 in response to amino acids [3741]. There are
RRAGA, B, C and D isoforms.
RRAS/RAS (RAS related): The small GTPase RRAS is an
oncogene involved in the regulation of several cellular signal
ing pathways. RRAS can upregulate or downregulate autopha
gy through distinct signaling pathways that depend on the
cellular contexts [3742].
Rsp5: A yeast E3 ubiquitin ligase that is responsible for the
autophagic clearance of certain cytosolic proteins via Cue5
[627]. Rsp5 also triggers mitophagy through the ubiquitina
tion of the ERMES component Mdm34 [3108]. See also Cue5,
ERMES and Mdm34.
RTN3 (reticulon 3): A receptor that functions in starvationinduced mammalian reticulophagy [1371].
RUBCN/Rubicon/KIAA0226 (rubicon autophagy regula
tor): RUBCN is part of a PtdIns3K complex (RUBCNUVRAG-BECN1-PIK3C3-PIK3R4) that localizes to the late
endosome/lysosome, inhibits autophagy, and promotes LC3associated phagocytosis [798, 801].
RUBCNL/C13orf18/Pacer (rubicon like autophagy
enhancer): A component of the PtdIns3K and UVRAGHOPS complexes that targets them to the autophagosome
to positively regulate autophagosome maturation; RUBCNL
binds to STX17 on the autophagosome [2667]. RUBCNL
acts in an opposite manner to that of RUBCN. MTORC1
phosphorylates RUBCNL at S157 to negatively regulate its
activity in autophagosome maturation [3743]. RUBCNL
appears to be an autophagy protein involved in ALS patho
genesis [3744].
RUNX2 (RUNX family transcription factor 2): A transcrip
tional regulator essential for osteoblastic cell differentiation,
RUNX2 promotes autophagy and autophagosome trafficking
in metastatic cancer breast cells by increasing acetylation of
the α-tubulin subunits of microtubules [3745].
RYR1/2/3 (ryanodine receptor 1/2/3): RYRs are the second
major group of large intracellular calcium-release channels
besides ITPRs that are located at the ER (or sarcoplasmic
reticulum in muscle cells). Spontaneous RYR-mediated
calcium-release events suppress basal autophagic flux at
the level of the lysosomes in a variety of cell systems
[3746].
SAHA/vorinostat (suberoylanilide hydroxamic acid): An
HDAC inhibitor that induces autophagy [3747]; however,
SAHA/vorinostat treatment has also been reported to sup
press autophagy (e.g., see ref. [3748]), suggesting context
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dependency. For example, the presence of the TP53 protein
is essential for the suppression of SAHA-induced autophagy
in several tumor cell lines [3749]. See also TP53/p53.
Saikosaponin d: An ATP2A/SERCA inhibitor that induces
autophagy and autophagy-dependent cell death in apoptosisdefective cells [1909].
Sanguinarine (SNG): A benzophenanthridine alkaloid iso
lated from Sanguinaria canadensis, that exhibits anticancer
activity against a wide variety of cancer cells, both in vitro
and in vivo [3750]. SNG is highly effective in suppressing the
growth of human malignant glioma cells via inducing auto
phagic cell death, which is associated with ROS-dependent
upregulation of MAPK1/3 activity [3751].
SASP (senescence-associated secretory phenotype): The
secretome of senescent cells. In the case of autophagy-defi
cient prematurely senescent murine melanocytes, the SASP
includes oxidized phospholipid signaling mediators [3752].
SBF2/MTMR13 (SET binding factor 2): A catalytically inac
tive myotubularin that is also a RAB21 guanine nucleotide
exchange factor (GEF) required with RAB21 for autophago
some-lysosome fusion. Starvation induces SBF2 RAB21 GEF
activity that promotes VAMP8 trafficking to the lysosome,
where VAMP8 is needed to mediate fusion. See also RAB21
[3690]. The Drosophila homolog is Sbf.
Sch9: A yeast kinase that functions in parallel with PKA to
negatively regulate autophagy. Sch9 appears to function in
parallel with TOR, but is also downstream of the TOR kinase
[3726].
SCOC (short coiled-coil protein): A protein in the Golgi that
interacts with FEZ1 in a complex with either ULK1 or
UVRAG; the ternary complex with ULK1 promotes autopha
gy, whereas the complex with UVRAG has a negative effect by
sequestering the latter from the BECN1-containing PtdIns3K
complex [3132]. See also FEZ1.
SEA (Seh1-associated) protein complex: A complex found in
yeast that includes the Seh1 nucleoporin and the COPII
component Sec13 (also a nucleoporin), in addition to Npr2
and Npr3, and four other relatively uncharacterized proteins;
the SEA complex associates with the vacuole, potentially act
ing as a membrane coat and is involved in protein trafficking,
amino acid biogenesis, and the starvation response including
autophagy [3753].
Seasonality-dependent autophagy: The autophagy pathway
is influenced by seasonality in reproduction. The highest
intensity of gene and protein expression is observed in the
period after reproductive activity, which reflects cell protec
tion and control of the normal spermatogenesis process
[3754].
Sec1: Functions with the plasma membrane SNAREs Sso1,
Sso2 and Sec9 to form the site for vesicle-mediated exocytosis;
as with Sso1/Sso2 and Sec9, temperature sensitive sec1 muta
tions also abrogate autophagic delivery of GFP-Atg8 [3755].
See also Sso1/Sso2.
Sec2: A guanine nucleotide exchange factor for Sec4 that
normally functions in exocytosis. Upon the induction of au
tophagy, Sec2 function is diverted to promote membrane
delivery to the PAS [3703].
Sec4: A Rab family GTPase that normally functions in exo
cytosis; under autophagy-inducing conditions yeast Sec4 is
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needed for the anterograde movement of Atg9 to the PAS
[3703]. The mammalian homolog is RAB40B.
SEC5L1: See EXOC2.
Sec9: Plasma membrane SNARE light chain that forms a
complex with Sso1/Sso2 to generate the target complex of
vesicle exocytosis; as with Sso1/Sso2, loss of Sec9 function
blocks autophagy at an early stage by disrupting targeting of
Atg9 to the Atg9 peripheral sites and PAS [3755]. See also
Sso1/Sso2 and Atg9 peripheral sites/structures.
Sec18: Homolog of mammalian NSF, an ATPase globally
responsible for SNARE disassembly. Loss of function inhibits
SNARE-dependent early and late events of autophagy (i.e.,
vesicular delivery of Atg9 to the Atg9 peripheral sites and PAS
[3755] and fusion of autophagosomes with the vacuole
[3756]). See also Atg9 peripheral sites/structures.
Sec22: A vesicle SNARE involved in ER and Golgi transport;
mutations in Sec22 also block Atg9 trafficking to the Atg9
peripheral sites and PAS. Crosslinking experiments suggest
Sec22 may be the v-SNARE responsible for the autophagy
functions of the ordinarily plasma membrane Sso1/Sso2Sec9 t-SNARE complex [3755]. See also Sso1/Sso2 and Atg9
peripheral sites/structures.
SEC24C (SEC24 homolog C, COPII coat complex compo
nent): A mammalian paralog of yeast Lst1, which forms a
COPII cargo adaptor complex with Sec23, which is essential
for reticulophagy [1382]. COPII plays a role in providing
membrane for autophagosome biogenesis.
SEC62: An ER-resident LC3-binding protein that functions in
mammalian reticulophagy during recovery from ER stress
[1375, 3757].
Secretory autophagy: A biosynthetic mode of autophagy that
occurs in mammalian cells [1700, 3758]. Secretory autophagy
depends on the ATG proteins, RAB8A and the Golgi protein
GORASP2/GRASP55, and is used for the extracellular deliv
ery (via unconventional secretion) of proteins such as the
cytokines IL1B and IL18, and HMGB1. ATG4B has also
been described to be required for secretory autophagy in
two different cell types: epithelial cells of the inner ear during
its development, and Paneth cells [3759–3761]. In the intes
tine, Paneth cells use secretory autophagy to secrete lysozyme
in order to maintain host defense during bacterial invasion.
This process is activated in Paneth cells by the ER stress
response pathway and signals from the innate immune sys
tem; secretory autophagy is defective in mice carrying a
Crohn disease-associated variant in Atg16l1 [3762, 3763].
See also exophagy, GORASP2.
SEFAGIA (Sociedad Española de Autofagia): Started as an
intiative of Jose Luis Crespo and Patricia Boya, the Spanish
Autophagy Society has held annual meetings since 2013. See
https://autofagia.org.
Selenite: A naturally occurring sulfate mineral that induces
mitophagy through a mechanism that involves the E3 ubiqui
tin-protein ligase MUL1 (mitochondrial E3 ubiquitin protein
ligase 1) [3764].
Senescence: Cellular senescence is a terminal arrest of cell
proliferation. Depending on the context, autophagy can act as
an activator or a repressor of senescence [3664, 3765]. For
example, autophagy contributes to the senescence onset in
cancer cells exposed to the 20A G-quadruplex ligand [2832].

SENP3 (SUMO specific peptidase 3): A SUMO2- and
SUMO3-specific deSUMOylation enzyme that regulates both
mitophagy and autophagy [3766].
SEPA-1 (suppressor of ectopic P granule in autophagy
mutants-1): A C. elegans protein that is involved in the
selective degradation of P granules through an autophagylike process [1276]. SEPA-1 self-oligomerizes and functions
as the receptor for the accumulation of PGL-1 and PGL-3
aggregates. SEPA-1 directly binds PGL-3 and LGG-1.
Septins: Septins are GTP-binding proteins that assemble into
nonpolar filaments (characterized as unconventional cytoske
leton), often acting as scaffolds for the recruitment of other
proteins. Septin cages form in response to infection by
Shigella, and serve to recruit autophagy components such as
SQSTM1 and LC3 [3767]. In yeast, septins form ring-like
structures around Atg8 and are involved in autophagosome
biogenesis [810]. Under autophagy conditions, septins form
multiple puncta that colocalize with several organelles such as
mitochondria, the Golgi apparatus, plasma membrane, and
endosomes [3768].
Sequestration membrane: See Phagophore.
SERPINA1/A1AT (serpin family A member 1): SERPINA1
is the most abundant circulating protease inhibitor and is
synthesized in the liver. A point mutation in the SERPINA1
gene alters protein folding of the gene product, making it
aggregation prone; the proteasomal and autophagic pathways
mediate degradation of mutant SERPINA1 [3769].
sesB (stress-sensitive B): A Drosophila mitochondrial ade
nine nucleotide translocase that negatively regulates autopha
gic flux, possibly by increasing cytosolic ATP levels [3043].
See also Dcp-1.
SESN2 (sestrin 2): A stress-inducible protein that reduces
oxidative stress, inhibits MTORC1 and induces autophagy,
also acting as an AMPK activator [3770, 3771]. SESN2 physi
cally associates with ULK1 and SQSTM1, promotes ULK1dependent phosphorylation of SQSTM1, and facilitates auto
phagic degradation of SQSTM1 targets such as KEAP1 [2668,
3491]. SESN2-mediated ULK1 activation also upregulates
mitophagy through BECN1 phosphorylation and mitochon
drial translocation of PRKN [3772]. SESN2-bound SQSTM1
promotes its association with ubiquitinated mitochondria,
thereby activating mitophagy [3773]. SESN2 suppresses
MTORC1 in response to diverse stresses including DNA
damage [3774], ER stress [3775], nutritional stress [1293,
3776] or energetic stress [3777].
SET/IPP2A2 (SET nuclear proto-oncogene): SET is a regu
lator of intracellular redox state by controlling APEX1/APE1
(apurinic/apyrimidinic endodeoxyribonuclease 1) localization
with an impact on autophagy and cell survival [3778].
SEX chlorophagy (starch excess-associated chloroplast au
tophagy): A vacuolar degradation process for clearance of
dysfunctional chloroplasts in plants caused by excessive leaf
starch accumulation, which is independent of several clas
sical ATG genes, such as ATG5, ATG6 and ATG7 [3779].
SH3BP4 (SH3 domain binding protein 4): SH3BP4 is a
negative regulator of amino acid-RRAG GTPase-MTORC1
signaling. SH3BP4 binds to the inactive RRAG GTPase com
plex through its Src homology 3 (SH3) domain under condi
tions of amino acid starvation and inhibits the formation of
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an active RRAG GTPase complex [3780]. SH3BP4 is also a
WNT signaling target gene acting as a negative feedback
regulator of WNT signaling through modulating CTNNB1/
β-catenin’s subcellular localization through its ZU5 domain
[3781].
SH3GL2/Endophilin A1 (SH3 domain containing GRB2
like 2, endophilin A1): See EndoA.
SH3GLB1/Bif-1 (SH3 domain containing GRB2 like, endo
philin B1): A protein that interacts with BECN1 via UVRAG
and is required for autophagy. SH3GLB1 has a BAR domain
that may be involved in deforming the membrane as part of
autophagosome biogenesis [3782]. SH3GLB1 activity is regu
lated by phosphorylation at residue T145, which in starved
neurons occurs via CDK5 [2952]. SH3GLB1 regulates auto
phagic degradation of EGFR [3783], NTRK1 [2952], and
CHRNA1 [2940, 3784]. Turnover of CHRNA1 is coregulated
by TRIM63 and CDK5 [2940, 3784].
SH3P2/AT4G34660 (SH3 Domain-Containing Protein 2):
A. thaliana SH3P2 contains a BAR domain and functions in
mediating autophagosome formation. Particularly, SH3P2
forms a complex with the PtdIns3K components and interacts
with ATG8 [2586]. Upon autophagic induction, SH3P2 is
translocated to the phagophore membrane, whereas knock
down of SH3P2 may disrupt the delivery of autophagosomes
into the vacuole in plant cells.
SH3PX1 (SH3 and PX domain containing 1): The ortholog
of human SNX9, SNX18, and SNX33. In Drosophila adult
midgut, SH3PX1 restrains intestinal stem cell division
through an endocytosis-autophagy network that includes
shi/dynamin, Rab5, Rab7, Atg1, Atg5, Atg6, Atg7, Atg8a,
Atg9, Atg12, Atg16 and Syx17. Upon SH3PX1-dependent
autophagy loss of function, the ligand-bound Egfr will be
recycled to the cell surface via Rab11-endosomes rather than
degraded via autophagosomes. This hyperactivates rl/MAPK/
ERK and autonomously stimulates intestinal stem cell prolif
eration [2144, 3785].
SHC1/p66SHC (SHC adaptor protein 1): The 66-kDa iso
form of the Src homology 2 domain containing (SHC)
family of protein adaptors. Mitochondria-associated SHC1
primes B lymphocytes for autophagy by inducing an ROSdependent dissipation of the mitochondrial transmembrane
potential, and ensures degradation of depolarized mito
chondria through its ability to interact with LC3-II and
active AMPK [3786].
Shear stress: Shear stress is induced by the blood flow in the
circulatory system, and by the urinary flow in the kidney
tubules. Shear stress-dependent autophagy is atheroprotective
in endothelial cells [3787] and regulates epithelial cell size and
ATP production in kidney proximal tubules [3634].
SHH (sonic hedgehog signaling molecule): A ligand of the
sonic hedgehog pathway. Activation of this pathway sup
presses IFNG-induced autophagy in macrophages during
mycobacterial infection [783].
Shp1/Ubx1: A yeast Ubx (ubiquitin regulatory x)-domain
protein that is needed for the formation of autophagosomes
during nonselective autophagy; Shp1 binds Cdc48 and Atg8–
PE, and may be involved in extracting the latter during
phagophore expansion [2948].
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Sic1: A yeast cyclin-dependent kinase inhibitor that blocks
the activity of Cdc28-Clb kinase complexes to control entry
into the S phase of the cell cycle. Sic1 is a negative regulator of
autophagy that inhibits Rim15 [2995].
SIDT2 (SID1 transmembrane family member 2): The lyso
somal vertebrate ortholog of the C. elegans RNA channel SID1. SIDT2 is a transmembrane protein that mainly localizes to
the lysosomal membrane and mediates the transport of
nucleic acids into lysosomes in the processes of
RNautophagy and DNautophagy [1399–1401]. See also
LAMP2C.
Signalphagy: A type of autophagy that degrades active signal
ing proteins [3788].
Sin3/SIN3: Part of the Rpd3L regulatory complex including
Rpd3 and Ume6 in yeast, which downregulates transcription
of ATG8 in growing conditions [2011]. In mammalian cells
knockdown of both SIN3A (SIN3 transcription regulator
family member A) and SIN3B is needed to allow increased
expression of LC3. See also Rpd3 and Ume6.
Sirolimus: An immunosuppressant also referred to as rapa
mycin. See also rapamycin.
SIRT1 (sirtuin 1): A NAD+-dependent protein deacetylase
that is activated by caloric restriction or glucose deprivation;
SIRT1 can induce autophagy through the deacetylation of
autophagy-related proteins and/or FOXO transcription fac
tors [3789]. Deacetylation of K49 and K51 of nuclear LC3
leads to localization in the cytosol and association with pha
gophores [1004]. See also SIRT2.
SIRT2 (sirtuin 2): A NAD+-dependent protein deacetylase
sharing homology with SIRT1 that is involved in neurodegen
eration and might play a role in autophagy activation through
regulation of the acetylation state of FOXO1 [3144]. Under
prolonged stress, the SIRT2-dependent regulation of FOXO1
acetylation is impaired, and acetylated FOXO1 can bind to
ATG7 in the cytoplasm and directly affect autophagy.
SIRT3 (sirtuin 3): A mitochondrial NAD+-dependent protein
deacetylase sharing homology with SIRT1, which is responsi
ble for deacetylation of mitochondrial proteins and modula
tion of mitophagy [3790, 3791].
SIRT5: A mitochondrial SIRT1 homolog with NAD+-depen
dent protein desuccinylase/demalonylase activity; SIRT5 mod
ulates ammonia-induced autophagy [3792].
SIRT6: A member of the sirtuin family with nuclear localiza
tion, that is associated with chromatin and promotes the
repair of DNA. The involvement of SIRT6 in senescence has
been proposed, possibly by the modulation of IGF-AKT sig
naling; a role for SIRT6 in autophagy linked to senescence has
been determined [3793].
SIRT7: A member of the sirtuin family that is highly
expressed in the nucleus/nucleolus where it interacts with
POLR1 (RNA polymerase I) as well as with histones. Many
lines of evidence point to a role for SIRT7 in oncogenic
transformation and tumor growth. The involvement of
SIRT7 in autophagy was recently suggested in a model of
acute cardiovascular injury, where loss of SIRT7 activates
autophagy in cardiac fibroblasts [3793].
SLAPs (spacious Listeria-containing phagosomes): SLAPs
can be formed by L. monocytogenes during infection of
macrophages or fibroblasts if bacteria are not able to escape
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into the cytosol [3794]. SLAPs are thought to be immature
autophagosomes in that they bear LC3 but are not acidic and
do not contain lysosomal degradative enzymes. The poreforming toxin listeriolysin O is essential for SLAPs formation
and is thought to create small pores in the SLAP membrane
that prevent acidification by the V-ATPase. SLAP-like struc
tures have been observed in a model of chronic L. monocyto
genes infection in immunocompromised mice [3795],
suggesting that autophagy may contribute to the establish
ment/maintenance of chronic infection.
SLC1A5 (solute carrier family 1 member 5): A high affinity,
Na+-dependent transporter for L-glutamine; a block of trans
port activity leads to inhibition of MTORC1 signaling and the
subsequent activation of autophagy [452]. See also SLC7A5.
SLC3A2/CD98hc/4F2hc (solute carrier family 3 member 2):
A transmembrane protein that acts as a heterodimerization
partner and a chaperone for a group of L-type amino acid
transporters from the SLC7 family by mediating their recruit
ment to the plasma membrane. These heterodimeric amino
acid transporters have broad substrate specificity and regulate
MTOR and autophagy [3796]. See also SLC7A5.
SLC7A5 (solute carrier family 7 member 5): A bidirectional
transporter that allows the simultaneous efflux of L-glutamine
and influx of L-leucine; this transporter works in conjunction
with SLC1A5 to regulate MTORC1 [452].
SLC9A3R1 (SLC9A3 regulator 1): A scaffold protein that
competes with BCL2 for binding to BECN1, thus promoting
autophagy [3797].
SLC25A1 (solute carrier family 25 member 1): This protein
maintains mitochondrial activity and promotes the movement
of citrate from the mitochondria to the cytoplasm, providing
cytosolic acetyl-coenzyme A. Inhibition of SLC25A1 results in
the activation of autophagy and mitophagy [3798].
SLC38A9 (solute carrier family 38 member 9): A multispanning membrane protein that localizes to the lysosome as
part of the RRAG-Ragulator complex. SLC38A9 functions as a
transceptor (transporter-receptor) to link amino acid status
with MTORC1 activity [3798–3800].
Slg1/Wsc1: A yeast cell surface sensor in the Slt2 MAPK
pathway that is required for mitophagy [3800]. See also Slt2.
SLR (sequestosome 1/p62-like receptor): Proteins that act as
autophagy receptors, and in proinflammatory or other types
of signaling [3801].
Slt2: A yeast MAPK that is required for pexophagy and
mitophagy [747]. See also Pkc1, Bck1 and Mkk1/2.
smARF (short mitochondrial ARF): A small isoform of
CDKN2A/p19ARF that results from the use of an alternate
translation initiation site, which localizes to mitochondria and
disrupts the membrane potential, leading to a massive
increase in autophagy and cell death [3802].
SNAP29 (synaptosome associated protein 29): A SNARE
protein required for fusion of the completed autophagosome
with a lysosome in metazoans [870, 871, 874]. SNAP29 is
cleaved upon enterovirus infection, leading to impaired
autophagosome-lysosome fusion [3803, 3804].
SNAPIN (SNAP associated protein): An adaptor protein
involved in dynein-mediated late endocytic transport;
SNAPIN is needed for the delivery of endosomes from distal

processes to lysosomes in the neuronal soma, allowing
maturation of autolysosomes [206].
SNCA/α-synuclein (synuclein alpha): A presynaptic protein
relevant for PD pathogenesis due to the presence of several
mutations and its deposition into Lewy bodies (intracellular
protein and lipid aggregates), characteristic of this disease.
SNCA degradation in neuronal cells involves the autophagylysosomal pathway via autophagy and chaperone-mediated
autophagy [3805]. Conversely, SNCA accumulation over
time might impair autophagy function, and an inhibitory
interaction of SNCA with HMGB1 has been reported
[3806]. This interaction can be reversed by the natural auto
phagy inducer corynoxine B. Similarly, in human T lympho
cytes the aggregated form of SNCA, once generated, can be
degraded by autophagy, whereas interfering with this pathway
can result in the abnormal accumulation of SNCA. Hence,
SNCA can be considered as an autophagy-related marker of
peripheral blood lymphocytes [2226]. SNCA also impairs
ferritinophagy in retinal pigment epithelial cells by inhibiting
lysosomal function [3807]. Lysosomal dysfunction might be a
result of SNCA-mediated rupture of lysosomes [3808, 3809],
which can be suppressed by reduced INS-DAF-2 signaling in
daf-2 mutant C. elegans [3033].
Snx4/Atg24: A yeast PtdIns3P-binding sorting nexin studied
in H. sapiens, Trypanosoma brucei, yeast, and other fungi. It is
involved in membrane trafficking, protein sorting and recy
cling and is important for mitophagy, pexophagy and the Cvt
pathway [380, 1069, 2800, 3564, 3810–3812]. Through its
interaction with Atg20 it is part of the Atg1 kinase complex.
Snx4/Atg24 is also involved in recycling from early endo
somes. In the filamentous fungus M. oryzae, Atg24 is required
for mitophagy [1069].
SNX18 (sorting nexin 18): A PX-BAR domain-containing
protein involved in phagophore expansion [3813].
SOD1/Cu,Zn-superoxide dismutase (superoxide dismutase
1): An enzyme responsible for conversion of the ROS
superoxide into hydrogen peroxide. Numerous point
mutations in SOD1 are associated with 20% of familial
ALS. Evidence suggests that autophagy can degrade
mutated SOD1 in vitro. Activated autophagy is observed
in the spinal cord of SOD1G93A mice, and the G85R and
G93A mutated forms lead to protein aggregation and
activate autophagic flux in an NFKB-dependent manner
[1107], indicating a possible role of mutated SOD1induced autophagy in the pathogenesis of ALS.
SopF: A Salmonella T3SS effector that blocks the V-ATPaseATG16L1 axis that critically mediates autophagic recognition
of intracellular pathogens [1476]. SopF is an ADP-ribosyl
transferase that modifies Q124 of ATP6V0C to prevent its
interaction with, and recruitment of, ATG16L1 to bacteriacontaining vacuoles.
Sorafenib: An antitumoral inhibitor of tyrosine kinase recep
tors whose sustained administration induces a shift from early
induction of survival autophagic processes to apoptosis [2634].
SORT1 (sortilin 1): A related member of the VPS10 sorting
receptor family that transports proteins across the plasma
membrane or subcellular compartments. SORT1 transports
soluble proteases into lysosomes. [3814].
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SOX2 (SRY-box transcription factor 2): A key stem cell
maintanence factor that promotes the development of squa
mous cell carcinomas. SOX2 promotes the degradation of an
innate immune sensing adaptor, STING1, to encourage tumor
evasion from immunosurveillance [3815].
SpeB: A cysteine protease secreted by Streptococcus pyogenes
that degrades autophagy components at the bacterial surface,
leading to autophagy escape [3816]. The lack of SpeB allows
capture and killing of cytoplasmic S. pyogenes by the autopha
gy system [175, 3816].
Spautin-1 (specific and potent autophagy inhibitor-1): An
inhibitor of USP10 and USP13, identified in a screen for
inhibitors of autophagy, which promotes the degradation of
the PIK3C3/VSP34-BECN1 complex [2635].
Spermidine: A natural polyamine that induces autophagy
through the inhibition of histone acetylases such as EP300
[955, 1635], the inhibition of HDAC4 [956], and hypusination
of the translation initiation factor EIF5A, which in turn con
trols the translation of TFEB [958].
SPG11 (SPG11 vesicle trafficking associated, spatacsin):
Mutations in SPG11 are associated with a complicated form
of hereditary spastic paraparesis (SPG11). SPG11 interacts
with AP5 and ZFYVE26/spastizin to form a complex [3817].
SPG11 has a role in ALR, and protein loss results in the
accumulation of autophagosomes and enlarged lysosomes in
SPG11-mutated cells [3818]. See also autophagic lysosome
reformation and ZFYVE26.
Sphingolipids: Sphingolipids are a major class of lipids char
acterized by the presence of the long-chain aliphatic aminoal
cohol sphingosine (2-amino-4-trans-octadecene-1,3-diol) or
sphinganine (2-amino-octadecane-1,3-diol). Sphingomyelin,
the most abundant cellular sphingolipid, inhibits autophago
some formation [812], whereas its metabolites including cer
amide and sphingosine-1-phosphate are positive regulators of
autophagy [886, 3819–3822].
Sphingosine-1-phosphate (S1P): S1P is a signaling sphingo
lipid synthesized by SPHK (sphingosine kinase), an enzyme
ubiquitously found in the cytosol [3823], endoplasmic reticu
lum or nuclear membranes [3824] of various types of cells.
S1P is a key component of the “sphingolipid rheostat” that
regulates cell fate by inducing autophagy to counter the deathpromoting effects of ceramide [891, 3820, 3825], as well as
important autophagy-dependent cell processes [888, 3826,
3827]. See also SPHK2.
SPHK2 (sphingosine kinase 2): SPHK2 phosphorylates
sphingosine to S1P to maintain balance in sphingolipid meta
bolites. In mammals, there are two major isoforms of SPHK,
SPHK1 and SPHK2. SPHK2 in neurons could activate auto
phagy and elicit neuroprotection against ischemic injury.
Notably, SPHK2-mediated autophagy is independent of S1P.
SPHK2 interacts with BCL2 via its BH3 domain to dissociate
the BECN1-BCL2 complex, thereby promoting the release of
BECN1 to activate autophagy [3828–3830].
SPM (specialized pro-resolving mediators): Super family of
endogenous bioactive lipids formed in cells by the metabolism
of omega-6 and omega-3 polyunsaturated fatty acids that
actively promote the resolution of inflammation and restora
tion of tissue homeostasis [3831, 3832]. SPM induce
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autophagy by promoting LC3-I to LC3-II processing and the
degradation of SQSTM1 as well as the formation of LC3positive autophagosomes and autophagic vesicles [3833].
SPNS/spinster: A putative lysosomal efflux carbohydrate
transporter required for autophagic lysosome reformation
[3834].
SPP1/OPN/osteopontin (secreted phosphoprotein 1): SPP1
is an autophagy-enhancing glycoprotein that is widely
expressed by bone, immune cells, smooth muscle, epithelial
and endothelial cells, neurons, adipocytes and Kupffer cells.
Nasal administration of recombinant SPP1 increases the
expression of BECN1 and LC3 in neurons after subarachnoid
hemorrhage, and attenuates early brain injury [3835].
SPRED2 (sprouty-related EVH1 domain containing 2):
SPRED2 was initially described as an inhibitor of the receptor
tyrosine kinase-RAS-RAF-MAPK pathway and more recently
as an interaction partner of NBR1, SQSTM1, and LC3 both in
transfected cells as well as in mouse heart lysates [563].
Spt4-Spt5: A transcription factor complex in S. cerevisiae that
downregulates the expression of ATG8 and ATG41 during
active growth; upon starvation, this inhibition is removed
via Spt5 phosphorylation by the Sgv1/Bur1-Bur2 kinase
[3836]. The mammalian homologs are SUPT4H1 and
SUPT5H, and the kinase homolog is P-TEFb.
Sqa (spaghetti-squash activator): A myosin light chain
kinase-like protein that is a substrate of Atg1 in Drosophila,
and is required for starvation-induced autophagosome forma
tion; the mammalian homolog DAPK3 is also involved in
ATG9 trafficking [716].
SQST-1: The C. elegans homolog of SQSTM1.
SQSTM1/p62 (sequestosome 1): An autophagy receptor that
links ubiquitinated proteins to LC3. SQSTM1 accumulates in
cells when autophagy is inhibited. SQSTM1 interaction with
LC3 requires a WXXL or a LIR motif analogous to the inter
action of Atg8 with Atg19 [119]. SQSTM1 also interacts with
HDAC6 to regulate microtubule acetylation and autophago
some turnover [3837]. The ZZ domain of SQSTM1 recognizes
arginylated (Nt-R) substrates and mediates autophagic degra
dation of misfolded proteins [463, 3236, 3237, 3838]. The
oligomerization of SQSTM1 via the N-terminal PB1 domain
is a critical process for its function as an autophagy receptor
[3237, 3839–3841]. In addition, SQSTM1 forms condensates
with ubiquitinated proteins via the C-terminal UBA domain
[3842, 3843]. In AML, SQSTM1 is essential for cell growth
and survival, presumably due to autophagic degradation of
mitochondria and ubiquinated proteins [569, 3844]. Finally,
SQSTM1 is targeted for degradation during enterovirus infec
tion [3804, 3845] to generate a fragment that is dominantnegative against the function of the native protein [3846]. See
also HDAC6, LIR/LRS and Nt-R.
SRC (SRC proto-oncogene, non-receptor tyrosine kinase):
A member of the family of non-receptor tyrosine kinases.
Autophagy promotes the activation of SRC, and SRC phos
phorylation of CTNNB1/β-catenin at Y654 in TGFB-induced
epithelial-mesenchymal transition [3288].
SRPX/Drs (sushi repeat containing protein X-linked): An
apoptosis-inducing tumor suppressor that is involved in the
maturation of autophagosomes [3847].
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SseL: A Salmonella deubiquitinating enzyme secreted by a type
III secretion system; deubiquitination of aggregates and ALIS
decreases host macrophage autophagic flux and results in an
environment more favorable to bacterial replication [3848].
SSi6 (C23H30N4O7): A semisynthetic compound produced
from structural modification made to the natural product
[6]-gingerol (C17H26O4, CAS Number: 23513-14-6), by the
nucleophilic addition of a 2,4-dinitrophenylhydrazine reagent.
This compound can induce ROS in vitro, which leads to the
activation of autophagy in the first hour of treatment followed
by caspase-dependent apoptosis in longer treatment times in
the triple-negative cell line MDA-MB-231 [3849].
Ssk1: A yeast component of the Hog1 signaling cascade that
is required for mitophagy [747]. See also Hog1.
Sso1/Sso2: Highly homologous plasma membrane syntaxins
(SNAREs) of S. cerevisiae involved in exocytosis; the Sso1/
Sso2 proteins also control the movement of Atg9 to the Atg9
peripheral sites and PAS during autophagy and the Cvt path
way [3755].
STAT3 (signal transducer and activator of transcription 3):
A transcription factor that also functions in the cytosol as a
suppressor of autophagy [3850]. STAT3 binds EIF2AK2/PKR
and inhibits the phosphorylation of EIF2S1.
Stationary phase lipophagy: A type of lipophagy that occurs
in yeast cells entering quiescence [1856, 3851].
STED (stimulated emission depletion) nanoscopy: A
powerful super-resolution instrument for capturing abundant
nanoscopic spatial details. Super-resolution microscopy tech
niques offer subdiffraction limited resolution that is ten-fold
better-quality compared to conventional confocal microscopy,
and STED nanoscopy has contributed to new findings in
autophagy [3092].
STIM1/2 (stromal interaction molecule 1/2): An ER calcium
sensor. STIM1/2 is degraded as a result of proteasome inhibitioninduced autophagy, whereas STIM2 is also degraded through ER
stress-induced autophagy. Thus, proteasome inhibition or reduc
tion of ER stress may modify the dendrite arbor, implicating
dysfunction of the store-operated calcium channel at the early
stage of neurodegeneration [3852, 3853].
STING1/STING/TMEM173: A highly conserved intracellular
pattern recognition receptor that detects cytosolic nucleic
acids and in turn activates type I interferon responses.
STING1 activates anti-microbial autophagy downstream of
bacterial and viral infections in mammals and Drosophila
[1384, 3854, 3855]. STING1 is hypersensitive in autophagydeficient cells and is linked to increased cell death in atg16l1deleted intestinal epithelial cells [3856, 3857]. STING1 itself
can also activate autophagic processes from the ERGIC in an
IRF3-independent manner [1384, 3858]. STING1 possesses
LIRs and interacts with LC3 to activate autophagy, resulting
in self-degradation. STING1 also induces ATG5-dependent
non-canonical autophagy. Poly (dA:dT) and cGAMP are acti
vators of the STING1 pathway, and they increase LC3-II
conversion. See also SOX2.
STK3/MST2 (serine/threonine kinase 3): The mammalian
homolog of the Ste20/hpo (hippo) kinase, which can phos
phorylate LC3B on Thr50; this modification is needed for the
fusion of autophagosomes with lysosomes [3859].

STK4/MST1 (serine/threonine kinase 4): As with STK3,
STK4 can phosphorylate LC3B, and is needed for the fusion
of autophagosomes with lysosomes [3859]. STK4 also phos
phorylates Thr108 of BECN1, promoting the interaction of
BECN1 with BCL2 or BCL2L1, inhibiting autophagy [3860].
STK11/LKB1 (serine/threonine kinase 11): A kinase that is
upstream of, and activates, AMPK [2955]. STK11/LKB1 reg
ulates starvation-induced autophagy at the organismal level
[2417].
STK26/MST4 (serine/threonine kinase 26): STK26 activates
MAPK/ERK to induce cell growth and transformation. STK26
also phosphorylates ATG4B at serine residue 383, which sti
mulates ATG4B activity and increases autophagic flux [3861].
STK38/NDR1/trc (serine/threonine kinase 38): A kinase
that promotes autophagy initiation in mammals and
Drosophila by associating with BECN1/Atg6 [3862].
STO-609: STO-609 (7-oxo-7H-benzo[de]benzo[4,5]imidazo
[2,1-a]isoquinoline-3-carboxylic acid) inhibits both the
CAMKK1/CaMKKα and the CAMKK2/CaMKKβ isoforms,
but CAMKK2 is more sensitive to this inhibitor. CAMKKs
phosphorylate and activate CAMK1/CaMKI and CAMK4/
CaMKIV, which directly activate transcription factors
[3863–3865].
Stress-induced nascent granule degradation (SINGD): An
autophagy-independent crinophagic pathway that counters
autophagy through localized activation of MTORC1 in INS
(insulin)-producing β cells. The SINGD pathway leads to the
depletion of secretory granules together with the inhibition of
autophagy, thus protecting against unwanted INS release dur
ing fasting [120]. Erroneous activation of the SINGD pathway
contributes to β-cell failure in type 2 diabetes [1256]. See also
crinophagy.
STX3 (syntaxin 3): A Qa SNARE plasma membrane syntaxin
involved in the intracellular trafficking pathway for secretory
autophagy [3866].
STX5 (syntaxin 5): A Golgi-localized SNARE protein
involved in vesicular transport of lysosomal hydrolases, a
process that is critical for lysosome biogenesis; STX5 is thus
needed for the later stages of autophagy [2858].
STX12/STX13/STX14 (syntaxin 12): A genetic modifier of
mutant CHMP2B in frontotemporal dementia that is required
for autophagosome maturation; STX12 interacts with VTI1A
[3867].
STX17 (syntaxin 17): An autophagosomal SNARE protein
required for fusion of the completed autophagosome with an
endosome or lysosome in metazoans [870, 871]. STX17 also
recruits PtdIns3K complex to the ER-mitochondria contact
sites through interaction with the complex component
ATG14 [872, 873], but the interaction between STX17 and
ATG14 is also important for autophagosome-lysosome fusion
[3868]. In fed cells, the interaction of STX17 with ATG14 is
prevented by MAP1B/LC1 with phosphorylation at Thr217,
and starvation causes the dephosphorylation of MAP1B,
allowing STX17 to dissociate from MAP1B and associate
with ATG14 [3869]. In autophagosome formation, STX17
interacts not only with the PtdIns3K complex but also with
several ULK1 complex components [877, 3870]. During
autophagosome maturation, the PtdIns3K complex remains
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associated with autophagosomes via STX17 with the help of
RUBCNL/C13orf18/Pacer [3743]. For autophagosome fusion
with lysosomes, STX17 recruits the HOPS complex [3225,
3226] perhaps through interaction with the SM protein
VPS33 [3871]. STX17’s cognate was originally reported to be
VAMP8, but other studies suggest that its cognate is probably
VAMP7 [3871, 3872]. STX17 function is intricately regulated
by interactions with many binding proteins such as ULK1
[3870], IRGM [3873], ANXA2 [3874] and the IAP family
member BIRC6/BRUCE [2885]. STX17 also participates in
PRKN-dependent and -independent mitophagy [878, 879],
fusion of mitochondria-derived vesicles with lysosomes
[3875], mitochondrial fission by interacting with DNM1L
and PGAM5 [873, 878], and lipid droplet formation [3876].
After autophagosome-lysosome fusion, STX17 is retrieved
from autolysosomal membranes in a TLR9-induced clathrindependent vesicle budding process [3528]. See also PGAM5.
STYK1 (serine/threonine/tyrosine kinase 1): A member of
the receptor tyrosine kinase (RTK) family that acts as a proautophagic molecule by promoting the assembly of the class I
PI3K complex and its kinase activity; STYK1 also phosphor
ylates BECN1 as a substrate [3877].
Sui2: The yeast homolog of EIF2S1/eIF2α.
Sulforaphane: A bioactive isothiocyanate from Brassicaceae
plants that induces autophagy in a variety of in vitro and in
vivo models [1905, 2636, 2637, 3878–3880].
Sulforaphene: Sulforaphene (LFS-01) is obtained from
Raphanus sativus, a medicinal plant, and it concomitantly
induces both mitophagy and apoptosis in lymphoma cells
through selective upregulation of SQSTM1 [3881].
SUPT20H/FAM48A (SPT20 homolog, SAGA complex
component): A protein that interacts with the C-terminal
domain of ATG9; this interaction is negatively regulated by
MAPK14 [3882].
Sunitinib: An autofluorescent multitarget tyrosine kinase
inhibitor with lysosomotropic properties; sunitinib interferes
with autophagic flux by blocking trafficking to lysosomes
[3883]. In contrast to lower (tolerable) doses that are asso
ciated with impeded autophagy, cytotoxic doses of sunitinib
trigger autophagy [3884, 3885].
Symbiophagy: A process in which invertebrates such as the
coralline demosponge Astrosclera willeyana degrade part of
their symbiotic bacterial community, as part of a biominer
alization pathway that generates the sponge skeleton [2293].
Synaptic autophagy: The selective autophagic degradation of
synaptic components (including synaptic proteins, synaptic
vesicles, postsynaptic receptors and organelles such as mito
chondria) at the synapse to safeguard synaptic and neuronal
homeostasis [3886–3893].
Synj (Synaptojanin): Synj, the Drosophila homolog of
human SYNJ1 is required for autophagy. A mutation in the
SAC1 phosphatase domain of Synj leads to the accumulation
of Atg18a/WIPI2 on nascent synaptic autophagosomes, block
ing autophagosome maturation at Drosophila synapses and in
neurites of human patient induced pluripotent stem cellderived neurons [3894].
Syx13 (Syntaxin 13): The Drosophila homolog of human
STX12 that is required for autophagosome maturation [3867].
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TAB2 (TGF-beta activated kinase 1 [MAP3K7] binding pro
tein 2): MAP3K7-binding protein that, in the MAP3K7free state, binds to BECN1 and inhibits autophagy [3895,
3896]. Upon autophagy induction, TAB2 dissociates from
BECN1 and binds MAP3K7. The TAB2-containing
MAP3K7 complex also promotes autophagy through mul
tiple signaling cascades.
TAB3 (TGF-beta activated kinase 1 [MAP3K7] binding
protein 3): TAB2 homolog, with cellular functions similar to
TAB2. See also TAB2.
TAG (Targeting by AutophaGy proteins): targeting of IFNinduced effectors onto pathogen-containing vacuoles by the
autophagic ubiquitin-like conjugation system, including
ATG7, ATG3, and the ATG12–ATG5-ATG16L1 complex
[2468, 3897].
TAK1: See MAP3K7.
TAKA (transport of Atg9 after knocking out ATG1) assay:
An epistasis analysis that examines the localization of Atg9GFP in a double mutant, where one of the mutations is a
deletion of ATG1 [106]. In atg1∆ mutants, Atg9-GFP is
restricted primarily to the PAS; if the second mutation
results in a multiple puncta phenotype, the corresponding
protein is presumably required for anterograde transport of
Atg9 from peripheral sites to the PAS [1088]. This analysis
can be combined with localization of RFP-Ape1 to deter
mine if any of the Atg9-GFP puncta reach the PAS, in which
case that punctum would colocalize with the RFP-Ape1 PAS
marker.
Tamoxifen (TAM): A triphenylethylenic compound widely
used for the management of estrogen receptor-positive breast
cancers. This drug is a dual modulator of ESR (estrogen
receptor) and a high affinity ligand of the microsomal anti
estrogen binding site (AEBS). TAM induces protective auto
phagy in cancer cells through an AEBS-mediated
accumulation of zymostenol (5α-cholest-8-en-3β-ol) [2031,
3553, 3898]. TAM is considered as an agonist of membrane
G protein-coupled estrogen receptors (GPER). TAM was
reported to induce autophagy in leukemic T cells (Jurkat),
negative for both ESR1/ERα and ESR2/ERβ nuclear estrogen
receptors, in a GPER-dependent manner [3899].
TARDBP/TDP-43 (TAR DNA binding protein): A DNA/
RNA binding protein that stabilizes Atg7 mRNA [3900].
Mutations in TARDBP are found in ALS, and deposition of
this protein is a characteristic neuropathology in ALS-FTD.
TASCC (TOR-autophagy spatial coupling compartment): A
compartment located at the trans-Golgi where autolysosomes
and MTOR accumulate during RRAS-induced senescence to
provide spatial coupling of protein secretion (anabolism) with
degradation (catabolism); for example, amino acids generated
from autophagy would quickly reactivate MTOR, whereas
autophagy would be rapidly induced via MTOR inhibition
when nutrients are again depleted [782].
TAX1BP1/CALCOCO3 (Tax1 binding protein 1): An auto
phagy receptor that contains a SKIP carboxyl homology
(SKICH) domain, a LIR motif and a C-terminal double
zinc-finger ubiquitin binding domain [3901]. TAX1BP1 inter
acts with ubiquitinated substrates, such as S. typhimurium,
and recruits LC3-positive autophagosomal membranes [1471,
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3465, 3902]. TAX1BP1 also regulates autophagosome matura
tion [3903].
Tax4: See Irs4 [3308].
TBC1D7 (TBC1 domain family member 7): This protein is
the third functional subunit of the TSC1-TSC2 complex
upstream of MTORC1. Loss of function of TBC1D7 results
in an increase of MTORC1 signaling, delayed induction of
autophagy and enhancement of cell growth under poor
growth conditions [3904]. Mutations in TBC1D7 have been
associated with intellectual disability, macrocrania, and
delayed autophagy [3905, 3906].
TBC1D9B (TBC1 domain family member 9B): This protein
was found to interact with several members of the mamma
lian Atg8 homologs, including LC3 in mammalian cells
[3907]. The Atg8-family protein interaction domain in
TBC1D9B is different from the LIR previously detected in
other LC3-interacting molecules. TBC1D9B can be found in
colocalization with LC3 in autophagosomes. When the
expression of TBC1D9B is inhibited, cellular autophagy activ
ity is reduced, suggesting that this molecule may positively
regulate autophagic flux. TBC1D9B can interact with
RAB11A, RAB11B and RAB4A, but has a GAP activity only
for RAB11A in the presence of Mg2+ [3908]. See also RAB11.
TBC1D14 (TBC1 domain family member 14): TBC1D14
colocalizes and interacts with ULK1, and upon overexpression
causes tubulation of ULK1-positive endosomes, inhibiting
autophagosome formation [3685]. TBC1D14 binds activated
RAB11, but does not function as a GAP. TBC1D14 localizes
to the Golgi complex during amino acid starvation. See also
RAB11.
TBC1D25/OATL1 (TBC1 domain family member 25): A Tre2Bub2-Cdc16 (TBC) domain-containing GAP for RAB33B;
TBC1D25 is recruited to the outer membrane of phagophores
and autophagosomes [3909] via direct interaction with the Atg8
family proteins (via a LIR/LRS-like sequence), and it regulates the
interaction of autophagosomes with lysosomes by inactivating
RAB33B [3695]. Overexpression of TBC1D25 inhibits autopha
gosome maturation at a step prior to fusion, suggesting that it
might interfere with a tethering/docking function of RAB33B. See
also RAB33B and LIR/LRS.
TBK1 (TANK binding kinase 1): A serine/threonine protein
kinase that is similar to IKK involved in the activation of
NFKB [3910]. TBK1 binds and directly phosphorylates
OPTN at Ser177 (in humans) within the LIR, increasing the
affinity of the latter for LC3 [1472].
TCHP/mitostatin (trichoplein keratin filament binding): A
DCN (decorin)-inducible tumor suppressor gene that func
tions in, and is required for, tumor cell mitophagy. TCHP/
mitostatin responds to DCN as well as canonical cues (e.g.,
nutrient deprivation and rapamycin) for mitophagic induc
tion. DCN regulates mitostatin in a PPARGC1A/PGC-1αdependent manner. Moreover, DCN-induced mitophagy is
entirely dependent on TCHP for angiogenic inhibition [3911].
TDP-43: See TARDBP.
TECPR1 (tectonin beta-propeller repeat containing 1): A pro
tein that interacts with ATG5 and WIPI2, and localizes to the
phagophore (localization is dependent on WIPI2); TECPR1 is
needed for phagophore formation during autophagic elimination
of Shigella, but not for starvation-induced autophagy [3912].

TECPR1 also localizes to autophagosomes that target other patho
genic microbes such as group A Streptococcus, to depolarized
mitochondria and to protein aggregates, suggesting a general
role in selective autophagy. TECPR1 also plays a role in fusion
of the autophagosome with the lysosome by competing with
ATG16L1 to bind ATG5 and PtdIns3P, recruiting ATG5 to the
lysosome membrane [3913].
TECPR2: A WD repeat- and TECPR domain-containing
protein that plays a role in autophagy; mutation of TECPR2
results in a form of monogenic hereditary spastic paraparesis
[3914, 3915].
TEX264 (testis expressed gene 264): Colocalization of
TEX264, an ER-resident protein, with LC3B, WIPI2,
RB1CC1 and LAMP1 confirm its role in autophagy. In addi
tion, TEX264-depleted HeLa cells show impaired reticulo
phagy, validating TEX264 as a reticulophagy receptor [464,
1373, 3916]. See also reticulophagy.
TFE3 (transcription factor binding to IGHM enhancer 3):
A transcription factor belonging to the microphthalmia/tran
scription factor E (MiT/TFE) family, along with TFEB and
MITF [977, 3433]. See also TFEB and MITF.
TFEB (transcription factor EB): A transcription factor that
positively regulates the expression of genes involved in lysosomal
biogenesis (those in the CLEAR network [969]), and also several
of those involved in autophagy (including UVRAG, WIPI,
MAP1LC3B and ATG9B); the use of a common transcription
factor allows the coordinated expression of genes whose pro
ducts are involved in the turnover of cytoplasm [949]. TFEB and
MTORC1 can form a regulatory loop in which TFEB can pro
mote, but itself can be suppressed by, MTORC1 activation,
which may result in oscillating autophagy functions and patho
logical consequences [3913]. See also CLEAR and PPP3.
TGA9/AT1G08320 (TGACG [TGA] motif-binding protein
9): A transcription factor that positively regulates the expres
sion of genes involved in autophagy in A. thaliana [3917].
TGFB1/TGF-β (transforming growth factor beta 1): A cyto
kine that activates autophagy through the SMAD and MAPK8
pathways. TGFB1 induces the expression of several ATG
genes including BECN1.
TGFB2-OT1: A newly discovered long noncoding RNA
(lncRNA) derived from the 3ʹ UTR of TGFB2. The level of
TGFB2-OT1 is markedly increased by LPS and oxidized lowdensity lipoprotein, two vascular endothelial cell (VEC)
inflammation triggers. TGFB2-OT1 can regulate autophagy
in VECs by sequestering MIR3960, MIR4488, and MIR4459,
and increasing the levels of downstream target genes, includ
ing CERS1, NAT8L, ATG13 and LARP1 [3918].
TGM2/TG2/TGase 2 (transglutaminase 2): An enzyme that
catalyzes the formation of an isopeptide bond between a free
amine group (e.g., protein- or peptide-bound lysine) and the
acyl group at the end of the side chain of protein- or peptidebound glutamine (protein crosslinking); TGM2 interacts with
SQSTM1 and is involved in the autophagic clearance of ubi
quitinated proteins [1212, 3919].
Thapsigargin: A cell-permeable inhibitor of ATP2A/SERCA.
Thapsigargin inhibits autophagy as a non-competitive inhibi
tor of ATP2A, which inhibits the fusion of autophagosomes
with lysosomes and leads to the accumulation of autophago
somes in the cytosol [2640].
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THC (∆9-tetrahydrocannabinol): The main psychoactive
component of the hemp plant Cannabis sativa. The anticancer
activity of THC in several animal models of cancer relies on
its ability to stimulate autophagy-mediated cancer cell death.
This effect occurs via THC binding to cannabinoid receptors,
and the subsequent triggering of an ER stress-related
response, which leads in turn to the inhibition of the AKTMTORC1 axis [3920–3922].
Thiamet G (2-ethylimino-5-[hydroxymethyl]-1,3a,5,6,7,7ahexahydropyrano[3,2-d][1,3]thiazole-6,7-diol): A potent (Ki
= 2 nM) small molecule inhibitor that selectively inhibits
OGA (O-GlcNAcase), the sole enzyme catalyzing the removal
of O-GlcNAc from nuclear and cytoplasmic proteins.
Treatment of cells and tissues with Thiamet G results in
increased levels of global cellular O-GlcNAc [3923]. This
orally available compound stimulates autophagy in neuroblas
toma N2a cells, primary rat neurons, and mouse brain
through an MTOR-independent pathway without obvious
toxicity [3924].
TIGAR/C12orf5 (TP53 induced glycolysis regulatory phos
phatase): A protein that modulates glycolysis, causing an
increase in NADPH, which results in a lower ROS level; this
reduces the sensitivity to oxidative stress and apoptosis, but
also has the effect of lowering the level of autophagy [3925].
Timosaponin A-III: A medicinal saponin that induces a type
of autophagy with some features that are distinct from rapa
mycin-induced autophagy [3926].
Tlg2: A yeast endocytic SNARE light chain involved in early
stages of the Cvt pathway [1089] and in autophagosome
membrane formation [3755]. Deletion of TLG2 results in a
modest impairment in Atg9 delivery to the PAS.
TLR (toll like receptor): A family of receptors that induces
autophagy following binding to a variety of pathogen- and
damage-associated molecules as ligands. TLR2 mediates
SQSTM1-dependent activation of autophagy, which plays a
protective role in DEN-induced tumorigenesis through clear
ing of intracellularly accumulated ROS and SQSTM1 aggre
gates [3927, 3928]. DAMPs release from injured liver cells
activates TLR4 signaling, which initiates or supports senes
cence and autophagy to retard genotoxic carcinogen-induced
hepatocellular carcinoma initiation and progression via
removing accumulated ROS, repairing DNA damage and
decreasing SQSTM1 aggregates [3929, 3930]. Moreover,
TLR2 activity is critically involved in the pathogenesis of
cardiac dysfunction and fibrosis via mediating extracellular
HMGB1 (functions as a DAMP molecule)-dependent auto
phagy suppression in failing hearts [3931].
TLR9 (toll like receptor 9): This isoform of the TLR family
translocates from the endoplasmic reticulum to the lysosomal
membrane upon induction of autophagy. It is activated by
unmethylated CpG DNA sequences, including not only bac
terial genomes and viral DNA, but also mitochondrial DNA
(mtDNA). Mitochondrial DNA that escapes from autophagy
activates TLR9 resulting in cardiac inflammation and heart
failure [3932]. Furthermore, mtDNA-activated TLR9 triggers
PIK3CG and the downstream AKT-MTOR-ULK1 signaling
pathway, eventually resulting in feedback inhibition of auto
phagy and cardiomyopathy [2583].
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TM9SF1 (transmembrane 9 superfamily member 1): A pro
tein with 9 transmembrane domains that induces autophagy
when overexpressed [3933].
TM9SF4 (transmembrane 9 superfamily member 4):
TM9SF4 facilitates inactivation of MTOR under starvation
conditions to promote autophagy induction [3934].
TMED2 (transmembrane p24 trafficking protein 2):
TMED2 is thought to be a cargo receptor involved in vesicular
protein trafficking; it mainly functions in the early secretory
pathway but also in post-Golgi membranes. Diseases asso
ciated with TMED2 include Charcot-Marie-Tooth disease,
axonal, type 2L, and Crohn disease. An important paralog of
this gene is TMED7. Overexpression of TMED2 triggers au
tophagy and is likely to be involved in autophagy-dependent
secretion [3935].
TMEM41B (transmembrane protein 41B): A protein that
is required for the formation of autophagosomes [3936–
3938]. TMEM41B is structurally related to VMP1 and phy
sically and functionally interacts with VMP1. See also
VMP1.
TMEM59 (transmembrane protein 59): A type-I transmem
brane protein able to induce an unconventional autophagic
process involving LC3 labeling of single-membrane endo
somes through direct interaction with the C-terminal WD40
domain of ATG16L1 [3939]. Binding between TMEM59 and
ATG16L1 is impaired by the T300A mutation encoded by a
single-nucleotide polymorphism (rs2241880) that increases
the risk of Crohn disease [3940].
TMEM74 (transmembrane protein 74): An integral mem
brane protein that induces autophagy when overexpressed
[3115, 3116]. TMEM74 promotes autophagy via interactions
with ATG16L1 and ATG9A [3941].
TMEM150B/DRAM3 (transmembrane protein 150B):
TMEM150B/DRAM3 is a transmembrane protein related to
DRAM1 and DRAM2, which enhances autophagic flux and
cell survival under glucose-starvation conditions [3942, 3943].
TMEM166: See EVA1A.
TMEM173: See STING1.
TNFAIP3/A20 (TNF alpha induced protein 3): An E3 ubi
quitin ligase that also functions as a deubiquitinating enzyme
that removes K63-linked ubiquitin from BECN1, thus limiting
autophagy induction in response to TLR signaling [3944]. In
contrast, TNFAIP3 restricts MTOR signaling, acting as a
positive factor to promote autophagy in CD4 T cells [3945].
TNFAIP3/A20 interacts with the WD40 domain of ATG16L1
to control intestinal homeostasis [3946].
TNFSF10/TRAIL (TNF superfamily member 10): Induces
autophagy by activating AMPK, thus inhibiting MTORC1
during lumen formation.
TOLLIP (toll interacting protein): A vertebrate ubiquitinbinding receptor protein similar to yeast Cue5 that contains a
CUE domain and plays a role in the autophagic removal of
protein aggregates [627]. TOLLIP regulates innate immune
responses to intracellular pathogens in the lung [3947, 3948].
See also Cue5, CUET and TOM1.
TOM1 (target of myb1 membrane trafficking protein): A
MYO6 (myosin VI) cargo adaptor protein that mediates the
delivery of endosomes to lysosomes. TOM1 functions in
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autophagosome maturation and fusion with lysosomes, and
binds TOLLIP [3465]. See also TOLLIP.
TOR (target of rapamycin): A serine/threonine protein
kinase that negatively regulates yeast autophagy. Present in
two complexes, TORC1 and TORC2. TORC1 is particularly
sensitive to inhibition by rapamycin. TORC1 regulates auto
phagy in part through Tap42-protein phosphatase 2A, and
also by phosphorylating Atg13 and Atg1.
TORC1 (TOR complex I): A rapamycin-sensitive protein
complex of TOR that includes at least Tor1 or Tor2
(MTOR), Kog1 (RPTOR), Lst8 (MLST8), and Tco89 [3949].
MTORC1 also includes DEPTOR and AKT1S1/PRAS40
[3950]. In mammalian cells, sensitivity to rapamycin is con
ferred by RPTOR. TORC1 directly regulates autophagy, and,
at the lysosomes, MTORC1 targets TPCN2 inhibiting its
channel activity. Inhibition of MTORC1 promotes autophagy
and protects cardiomyocytes from necroptosis by a TFEBdependent mechanism [3951].
TORC2 (TOR complex II): A relatively rapamycin-insensi
tive protein complex of TOR that includes at least Tor2
(MTOR), Avo1 (MAPKAP1/SIN1), Avo2, Avo3 (RICTOR),
Bit61, Lst8 (MLST8) and Tsc11; MTORC2 also includes
FKBP8/FKBP38, and PRR5/Protor-1 [3949, 3950, 3952]. A
critical difference in terms of components relative to TORC1
is the replacement of RPTOR by RICTOR. TORC2 is primar
ily involved with regulation of the cytoskeleton, but this
complex functions to positively regulate autophagy during
amino acid starvation [3953]. Finally, studies also support
the idea that TORC2 activity is required to sustain autopha
gosome biogenesis [3954], whereas it exerts an inhibitory
effect on CMA [3955], suggesting that a switch in TORC2
substrates may contribute to coordinating the activity of these
two types of autophagy.
Torin1: A selective catalytic ATP-competitive MTOR inhibi
tor that directly inhibits both TORC1 and TORC2 [802].
TP53/p53 (tumor protein 53): A tumor suppressor. Nuclear
TP53 activates autophagy, at least in part, by stimulating
AMPK and DRAM1, whereas cytoplasmic TP53 inhibits au
tophagy [2120]. The presence of TP53 protein was found to be
essential for the suppression of SAHA-induced autophagy in
several tumor cell lines [3749]. TP53 may also mediate auto
phagy induction upon proteasome inhibition [3956].
Conversely, the TP53-dependent increase of AMPK activity
is the major factor responsible for autophagy disruption in
melanoma cells (likely inducing excessive accumulation of
autophagosomes that are unable to be degraded), although
the MTOR pathway unrelated to the TP53-AMPK axis also
plays a role [3957]. Note that the official name for this protein
in rodents is TRP53. The TP53 C. elegans ortholog, cep-1, also
regulates autophagy [2119, 2121]. See also SAHA/vorinostat.
TP53INP1 (tumor protein p53 inducible nuclear protein
1): A stress-response protein that promotes TP53 transcrip
tional activity; cells lacking TP53INP1 display reduced basal
and stress-induced autophagy, whereas its overexpression
enhances autophagic flux [3958]. TP53INP1 interacts directly
with LC3 via a functional LIR, and stimulates autophagosome
formation [3958]. Cells lacking TP53INP1 display reduced
mitophagy; TP53INP1 interacts with PRKN and PINK1, and

thus could be a recognition molecule involved in mitophagy
[3959].
TP53INP2/DOR (tumor protein p53 inducible nuclear pro
tein 2): A mammalian and Drosophila regulatory protein that
shuttles from the nucleus, passing through the nucleolus, to
reach the cytosol [3960]; the nuclear protein interacts with
deacetylated LC3 [1004] and GABARAPL2, and stimulates
autophagosome formation [3961]. TP53INP2 also interacts
with GABARAP and VMP1, and is needed for the recruit
ment of BECN1 and LC3 to phagophores. TP53INP2 translo
cates from the nucleus to phagophores during autophagy
induction and binds VMP1 and LC3 directly [3962]. In addi
tion, TP53INP2 modulates muscle mass in mice through the
regulation of autophagy [3963], and regulates adiposity by
activating CTNNB1/β-catenin in preadipocytes through auto
phagy-dependent sequestration of GSK3B [3964].
TPCN/two-pore channel (two pore segment channel):
TPCNs are endolysosomal cation channels that maintain the
proton gradient and membrane potential of endosomal and
lysosomal membranes. TPCN2 mediates lysosomal Ca2+
release and physically interacts with MTOR, providing bidir
ectional control between the two. On the one hand, MTORC1
inhibits TPCN2, whereby channel opening can be provoked
by nutrient starvation [1997] and rapamycin, which provokes
lysosomal TPCN2-mediated Ca2+ release [1998]. On the other
hand, TPCN2 regulates MTOR activity and reactivation, and
autophagic flux in skeletal muscle [1997, 3965].
TPR (translocated promoter region, nuclear basket pro
tein): TPR is a component of the nuclear pore complex that
presumably localizes at intranuclear filaments or nuclear bas
kets. Nuclear pore complex components, including TPR, are
jointly referred to as nucleoporins. TPR was originally identi
fied as the oncogenic activator of the MET and NTRK1/trk
proto-oncogenes. Knockdown of TPR facilitates autophagy.
TPR depletion is not only responsible for TP53 nuclear accu
mulation, which activates the TP53-induced autophagy mod
ulator DRAM, but also contributes to HSF1 and HSP70
mRNA trafficking, and transcriptional regulation of ATG7
and ATG12 [3522, 3966]. See also ependymoma.
TRAF2 (TNF receptor associated factor 2): An E3 ubiquitin
ligase that plays an essential role in mitophagy in unstressed
cardiac myocytes, as well as those treated with TNF or CCCP
[1226].
TRAF6 (TNF receptor associated factor 6): An E3 ubiquitin
ligase that ubiquitinates BECN1 to induce TLR4-triggered
autophagy in macrophages [3944].
TRAIL: See TNFSF10.
Transgenic: Harboring genetic material of another species/
organism or extra copies of an endogenous gene, usually
gained through transfer by genetic engineering.
Transmitophagy/transcellular mitophagy: A process in
which axonal mitochondria are degraded in a cell-nonauto
nomous mechanism within neighboring cells [1237].
TRAPPII (transport protein particle II): A guanine nucleo
tide exchange factor for Ypt1 and perhaps Ypt31/32 that
functions in autophagy in yeast [3967]. TRAPPII is composed
of Bet3, Bet5, Trs20, Trs23, Trs31, Trs33 and the unique
subunits Trs65, Trs120 and Trs130.
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TRAPPIII (transport protein particle III): A guanine
nucleotide exchange factor for Ypt1 that functions in auto
phagy in yeast [2202]. TRAPPIII is composed of Bet3, Bet5,
Trs20, Trs23, Trs31, Trs33 and a unique subunit, Trs85.
Trehalose: A small disaccharide, which induces autophagy
and autophagy flux in cells in an MTOR-independent manner
[2036]. In hepatic cells, trehalose induces autophagy through
a pseudo-starvation response by inhibiting SLC2A [3968]. In
macrophages, trehalose activates the PIKFYVE-MCOLN1/
TRPML1-TFEB pathway to induce autophagy, autophagy
flux and also xenophagy flux against Mycobacterium tubercu
losis. Additionally, in primary macrophages, the synthetic
analog trehalose-6,6´-dibehenate promotes lysosome biogen
esis and autophagy, through MYD88-mediated activation of
the PtdIns3K pathway, which contributes to its antimicrobial
properties against M. tuberculosis [3969].
TRIB3 (tribbles pseudokinase 3): A pseudokinase that plays
a crucial role in the mechanism by which various antic
ancer agents (and specifically cannabinoids, the active com
ponents of marijuana and their derived products) activate
autophagy in cancer cells. Cannabinoids elicit an ER stressrelated response that leads to the upregulation of TRIB3
whose interaction with AKT impedes the activation of this
kinase, thus leading to a decreased phosphorylation of
TSC2 and AKT1S1/PRAS40. These events trigger the inhi
bition of MTORC1 and the induction of autophagy [3921].
Conversely, TRIB3 binding to SQSTM1 via its UBA and
LIR motifs interferes with autophagic flux, in particular of
ubiquitinated proteins, and also reduces the efficiency of
the UPS, resulting in tumor and fibrosis progression due to
the accumulation of tumor- and fibrosis-promoting factors
[3920, 3970–3972].
Trichostatin A: An inhibitor of class I and class II HDACs
that induces autophagy [3973].
Triclosan: Induces autophagy via the AMPK-ULK1 and
MAPK/JNK-MAPK/ERK-MAPK/p38 pathways independent
of MTOR in a dose-dependent manner in HeLa cells and in
macrophages, and may play a role in the clearance of MAPT/
tau oligomers in HEK293 cells [3974, 3975].
TRIM5/TRIM5α (tripartite motif containing 5): A pro
posed selective autophagy receptor for cell context-specific
xenophagy of incoming retroviruses [3660, 3976, 3977].
TRIM5 binds retroviral capsids [3660, 3978] and separately
interacts with multiple autophagy factors including SQSTM1,
and with Atg8-family proteins via a helical LIR-motif located
in the central coiled-coil region of the tripartite-motif [3979].
This helical-LIR has the consensus [DEST]-X3-[WFY]-X6[LIVQ].
TRIM16 (tripartite motif containing 16): TRIM16 interacts
with LGALS3 and recognizes endomembrane damage with
mobilization of the core autophagy regulators ATG16L1,
ULK1, and BECN1 to protect cells from lysosomal damage
and Mycobacterium tuberculosis invasion [3345]. TRIM16
controls assembly and degradation of protein aggregates by
modulating the SQSTM1-NFE2L2 axis and autophagy [3980].
TRIM17 (tripartite motif containing 17): TRIM17 recruits
MCL1 to BECN1 and negatively regulates autophagy [3660,
3981].
TRIM20: See MEFV.

243

TRIM21: An antigen in autoimmune diseases such as sys
temic lupus erythematosus, and Sjögren syndrome, TRIM21 is
a receptor for selective autophagy of IRF3 dimers, a key
transcriptional activator of type I interferon responses [3407].
TRIM28 (tripartite motif containing 28): TRIM28 is an E3
ligase that is part of a ubiquitin ligase complex that targets
PRKAA1, leading to ubiquitination and proteasomal degrada
tion in part through the upregulation of MTOR activity
[3378]. See also MAGEA3.
TRIM32 (tripartite motif containing 32): TRIM32 is an E3
ubiquitin ligase that interacts with AMBRA1 and ULK1 to
stimulate ULK1 activity in muscle cells upon atrophy induc
tion via unanchored K63-linked polyubiquitin chains [73].
TRIM32 mutations lead to muscular dystrophy.
TRIM37 (tripartite motif containing 37): TRIM37 gene
mutations cause mulibrey (muscle-liver-brain-eye) nanism, a
severe growth disorder, and predispose to tumor develop
ment. Loss of TRIM37 induces autophagy in an MTORC1dependent manner [3982].
TRIM50 (tripartite motif containing 50): TRIM50 is a cyto
plasmic E3 ubiquitin ligase [3983], which interacts and colo
calizes with SQSTM1 and promotes the formation and
clearance of aggresome-associated polyubiquitinated proteins
through HDAC6-mediated interaction and acetylation [3984,
3985].
TRIM63/MURF-1 (tripartite motif containing 63): Musclespecific atrophy-related E3 ubiquitin ligase [3986, 3987] that
cooperates with SH3GLB1 to regulate autophagic degradation
of CHRNA1 in skeletal muscle, particularly upon muscleatrophy induction [3784].
TRPC4 (transient receptor potential cation channel sub
family C member 4): A cation channel in human umbilical
vascular endothelial cells; upregulation of TRPC4 increases
the intracellular Ca2+ concentration resulting in activation of
CAMKK2, which leads to MTOR inhibition and the induction
of autophagy [2641].
TRPML1: See MCOLN1.
Trs85: A component of the TRAPPIII complex that is
required specifically for autophagy [1062].
Trs130: A component of the TRAPPII complex that is
required for the transport of Atg8 and Atg9 to the PAS
[3967].
TSC1/2 (tuberous sclerosis 1/2): A stable heterodimer (com
posed of TSC1/hamartin and TSC2/tuberin) inhibited by AKT
and MAPK1/3 (phosphorylation causes dissociation of the
dimer), and activated by AMPK. TSC1/2 acts as a GAP for
RHEB, thus inhibiting MTORC1.
TSPO (translocator protein): TSPO is a mitochondrial pro
tein that interacts with VDAC1 to modulate the efficiency of
mitophagy [3988].
Tubastatin A: An HDAC inhibitor that interferes with lyso
somes, thereby also affecting autophagy [3208, 3209].
TUBGCP4 (tubulin gamma complex associated protein 4):
TUBGCP4 can inhibit autophagy by competing with ATG3 to
interact with ATG7, thus interfering with lipidation of LC3B
in the retina [2396].
Tubulovesicular autophagosome (TVA): Cationic lipoplex
and polyplex carriers used for nonviral gene delivery enter
mammalian cells by endocytosis and fuse with

244

D. J. KLIONSKY ET AL.

autophagosomes, generating large tubulovesicular structures
(tubulovesicular autophagosomes) that immunostain for LC3;
these structures do not fuse efficiently with lysosomes and
interfere with gene expression [2109].
Tubulovesicular cluster (TVC): A structure identified mor
phologically in yeast that corresponds to the Atg9 peripheral
sites [808]. See also Atg9 peripheral sites/structures.
TUFM (Tu translation elongation factor, mitochondrial):
An autophagy-promoting protein that resides in mitochon
dria. TUFM associates with NLRX1 to establish a protein
scaffold recruiting ATG12–ATG5, ATG16L1, and LC3
[3501, 3504, 3989]. See also NLRX1.
TXA1: A thioxanthone that decreases the viability of human
melanoma cells by modulation of autophagy and which may
serve as a lead compound for the development of autophagy
modulators with antitumor activity [3990]. Importantly,
TXA1 was previously shown to be an inhibitor of the drugefflux pump ABCB1/P-glycoprotein [3991].
U0126: U0126 is a selective inhibitor of MAP2K/MEK, which
specifically inhibits the ability of MAP2K to phosphorylate
MAPK/ERK [3992].
UBE2N (ubiquitin conjugating enzyme E2 N): A ubiquitinconjugating enzyme involved in PRKN-mediated mitophagy
[3993, 3994]. UBE2N activity may be only partly redundant
with that of UBE2L3, UBE2D2 and UBE2D3, as it is also
involved during later steps of mitophagy.

UBQLN (ubiquilin): Ubiquilins are receptor proteins that
deliver ubiquitinated substrates to the proteasome.
Ubiquilins may aid in the incorporation of protein aggre
gates into autophagosomes, and also promote the maturation
of autophagosomes at the stage of fusion with lysosomes
[3997, 3998].
Ubx5: A ubiquitin regulatory X (UBX) domain-containing
protein from yeast that acts as an autophagy receptor for
mutant forms of Cdc48; it binds the UDS of Atg8 via a
UIM-like sequence [1359]. See also Cdc48, UDS, UIM
and VCP.
UDS (UIM-docking site): A binding domain on Arabidopsis
ATG8 that interacts with UIM-like sequences from the protea
phagy receptor RPN10, and multiple other proteins [1359]. This
site is also present in yeast and human Atg8-family proteins. See
also RPN10.
UIM (ubiquitin-interacting motif)-like sequences: UIM-like
sequences participate in high-affinity binding to an alternative
(i.e., non-LDS) Atg8-family protein interaction site [1359].
See also UDS.
ULK family (unc-51 like autophagy activating kinase): The
ULK proteins are homologs of yeast Atg1. In mammalian cells
the family consists of five members, ULK1, ULK2, ULK3, ULK4
and STK36/ULK5. ULK1 and ULK2 are required for autophagy,
and ULK3 for oncogene-induced senescence [805, 3999, 4000].
See also Atg1. Figure modified from Fig. 2 of ref. [697].

ULK1 domains
ULK1: Kinase Domain

Serine Proline Rich

C-terminal Domain (CTD)

GABARAP

ATG13

GABARAPL2

RB1CC1

LC3

Ubiquitin: A 76-amino acid protein that is conjugated to lysine
residues. Ubiquitin is traditionally considered part of the ubi
quitin-proteasome system, and polyubiquitin chains tag pro
teins for degradation; however, ubiquitin is also linked to
various types of autophagy including aggrephagy (see
SQSTM1 and NBR1). Lysine linkage-specific monoclonal anti
bodies, which are commercially available, can be used to inves
tigate the degradation pathway usage [3995]. Proteins
covalently tagged with polyubiquitin chains via K48 are mostly
destined for proteasomal degradation, whereas proteins tagged
with K63-linked ubiquitin are predominantly degraded via the
autophagy pathway. In addition, phosphorylated forms of ubi
quitin have been identified including p-S65-Ub, which is spe
cifically generated during PINK1-PRKN-mediated mitophagy.
Potentially, several PTMs of the modifier ubiquitin may turn
out to be highly relevant and specific for distinct forms of
selective autophagy (reviewed in [1194]).
Ubp3: A yeast deubiquitinating enzyme that forms a complex
with Bre5 and is required for proteaphagy [1358] and ribo
phagy [1389]. Conversely, the Ubp3-Bre5 complex inhibits
mitophagy [3996].

ULK1.DN: A dominant-negative form of ULK1 expressing
only the C-terminal domain of the kinase, that inhibits auto
phagy via competitive inhibition of endogenous ULK1 in vitro
and in vivo [645, 646].
ULK-101: A potent and selective small molecule inhibitor
of ULK1/ULK2 that reduces basal and induced autophagy
in cancer cells and sensitizes to nutrient stress
[4001].
Ume6: A component of the Rpd3L complex that binds to the
URS1 sequence in the ATG8 promoter and downregulates
transcription in growing conditions [2011]. See also Rpd3
and Sin3/SIN3.
UNC-51: The C. elegans Atg1/ULK1/ULK2 homolog. UNC51 is an autophagy-associated serine/threonine kinase that
functions to regulate axon outgrowth and elongation [4002].
RNAi knockdown of unc-51 is associated with accumulation
of a human SNCA-GFP fusion in a C. elegans PD model
[4003]. See also Atg1.
UNC13D: A regulator of endocytic maturation and endo
somal function that binds to the SNARE proteins STX7
and VAMP8 [4003] and whose downregulation induces
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TFEB-mediated upregulation of autophagic genes and au
tophagy [4004].
UPR (unfolded protein response): A coordinated process to
adapt to ER stress, providing a mechanism to buffer fluctua
tions in the unfolded protein load. The activation of this
pathway is often related with autophagy. UPR-mediated auto
phagy positively regulates replication of viruses such as hepa
titis C virus and foot-and-mouth disease virus by inhibitory
action on innate immunity [2722].
UPRmt (mitochondrial unfolded protein response): An
inducible stress response activated to maintain mitochondrial
protein homeostasis upon folding stress that is also connected
to induction of mitophagy [3596, 4005].
USP8 (ubiquitin specific peptidase 8): A deubiquitinating
enzyme that removes K6-linked ubiquitin chains from
PRKN to promote its recruitment to depolarized mito
chondria and mitophagy [3640]. Inhibition of USP8 ame
liorates PD phenotypes caused by Pink1 deficiency in
Drosophila [4006].
USP9X (ubiquitin specific peptidase 9 X-linked): A deubi
quitinating enzyme that regulates BECN1 proteasomal degra
dation. Competitive binding between BECN1 and MCL1 to
USP9X mediates the reciprocal inverse regulation of the two
proteins [3398, 3399]. See also MCL1.
USP14 (ubiquitin specific peptidase 14): A proteasomeassociated deubiquitinase. USP14 is a substrate of autophagy,
and interacts with LC3 and SQSTM1 [606]. In autophagydeficient cells, USP14 regulates DNA repair, an effect that can
be blocked by inhibition of USP14 or AKT; AKT phosphor
ylates USP14 on Ser432, and USP14 is constitutively active in
PTEN-deficient cells [2670].
USP15 (ubiquitin specific peptidase 15): A deubiquitinating
enzyme that antagonizes PRKN-mediated mitophagy [4007].
See also USP30.
USP24 (ubiquitin specific peptidase 24): A deubiquitinating
enzyme that negatively regulates autophagy by affecting ULK1
ubiquitination and protein stability. The USP24 gene is
located in the PARK10 locus suggesting potential involvement
in PD [4008].
USP30: A deubiquitinating enzyme that antagonizes PRKNmediated mitophagy [4009, 4010] and PEX2-mediated pexo
phagy [1205, 1206]. USP30 is also a substrate of PRKN and is
subject to proteasome-mediated degradation. See also USP15.
USP35: A deubiquitinating enzyme that antagonizes PRKNmediated mitophagy [4011].
USP36: A deubiquitinating enzyme that negatively regu
lates selective autophagy in Drosophila and human cells
[4012].
UVRAG (UV radiation resistance associated): A Vps38
homolog that can be part of the class III PtdIns3K complex.
UVRAG functions in several ways to regulate autophagy: 1) It
disrupts BECN1 dimer formation and forms a heterodimer
that activates autophagy. 2) It binds to SH3GLB1 to allow
activation of class III PtdIns3K to stimulate autophagy. 3) It
interacts with the class C Vps/HOPS proteins involved in
fusion of autophagosomes or amphisomes with the lysosome.
4) It competes with ATG14 for binding to BECN1, thus
directing the class III PtdIns3K to function in the maturation
step of autophagy [797]. MTORC1 phosphorylates UVRAG to
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inhibit autophagy [2671]. In contrast, MTORC1 can also
phosphorylate UVRAG to stimulate PIK3C3 activity and
autophagic lysosome reformation [2672]. UVRAG also has
an autophagy-independent function, interacting with mem
brane fusion machinery to facilitate the cellular entry of
enveloped viruses [4013].
Vac8: A yeast peripheral vacuolar membrane protein, impli
cated in vacuolar inheritance, the Cvt pathway, pexophagy
and the formation of NVJs [157, 745, 4014, 4015]. Vac8
binding to the nuclear membrane protein Nvj1 promotes the
formation of NVJs and PMN. Vac8 binding to Atg13 is
required for the Cvt pathway and efficient autophagy. In
addition, Vac8 binding to Atg13 localizes the Atg1 initiation
complex to the vacuolar periphery for PAS formation. See also
nucleus-vacuole junction, Nvj1 and PMN.
Vacuolar cell death: One of the two major types of cell death
in plants (another type is necrosis), wherein the content of the
dying cell is gradually engulfed by growing lytic vacuoles
without loss of protoplast turgor, and culminates in vacuolar
collapse [1761]. Vacuolar cell death is commonly observed
during plant development, for example in the embryo-sus
pensor and xylem elements, and critically depends on auto
phagy [1763]. Atg1-dependent but Atg7-independent
autophagy is also required for vacuolar cell death in
Dictyostelium development [4016, 4017].
Vacuolar compartment (VAC): The T. gondii equivalent of
the lysosome [2366, 2367].
Vacuolar H+-translocating ATPase (V-ATPase): A ubiqui
tously expressed proton pump that is responsible for acid
ifying lysosomes and the yeast or plant vacuole, and
therefore is important for the normal progression of auto
phagy. Inhibitors of the V-ATPase (e.g., bafilomycin A1)
are efficient autophagy inhibitors [218, 219]. Upon bac
teria-induced vacuolar damage, the V-ATPase recruits
ATG16L1 to the bacteria-residing vacuole to initiate LC3
lipidation [1476].
Vacuolar sequestering membranes (VSM): Extensions/pro
trusions of the vacuole limiting membrane along the sur
face of peroxisomes that occur during macropexophagy
[4014].
Vacuole: The fungal and plant equivalent of the lysosome;
this organelle also carries out storage and osmoregulatory
functions [4018]. The bona fide plant equivalent of the lyso
some is the lytic vacuole.
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Vacuole import and degradation (Vid): A degradative path
way in yeast in which a specific protein(s) is sequestered into small
(30- to 50-nm) single-membrane cytosolic vesicles that fuse with
the vacuole allowing the contents to be degraded in the lumen
[1407, 1411]. This process has been characterized for the catabo
lite-induced degradation of the gluconeogenic enzyme Fbp1 (fruc
tose-1,6-bisphosphatase) in the presence of glucose, and
sequestration is thought to involve translocation into the com
pleted vesicle. An alternate pathway for degradation of Fbp1 by
the ubiquitin-proteasome system has also been described [4019].
Vacuolin-1: A small chemical that potently and reversibly
inhibits the fusion between autophagosomes or endosomes
with lysosomes by activating RAB5A [2647].
Valinomycin: A K+ ionophore that destroys the electrochemical
gradient across the mitochondrial membrane and is widely used
as a stimulator of mitophagy, similar to CCCP [4020].
Vam3: A yeast syntaxin homolog needed for the fusion of
autophagosomes with the vacuole [4021].
VAMP3 (vesicle associated membrane protein 3): A SNARE
protein that facilitates the fusion of MVBs with autophago
somes to generate amphisomes [4022].
VAMP7 (vesicle associated membrane protein 7): VAMP7 is
a SNARE protein that colocalizes with ATG16L1-positive vesi
cles and phagophores, and is required, along with STX7 (syn
taxin 7), STX8 (syntaxin 8) and VTI1B, for autophagosome
formation [4023]. VAMP7 is also involved in the maturation of
autophagosomes by facilitating fusion with a lysosome [4022].
VAMP8 (vesicle associated membrane protein 8): A SNARE
protein that, in conjunction with VTI1B, is needed for the
fusion of autophagosomes with lysosomes [4024].
VAP27 (Vesicle-Associated Protein): Plant homologs of
VAPA. The Arabidopsis VAP27 family contains 10 members
(VAP27-1 to VAP27-10). VAP27-1 interact with AtEH/Pan1
and regulates autophagosome biogenesis. Plants with reduced
expression of VAP27-1 and VAP27-3 are more susceptible to
low nutrient stress [2747]. See also AtEH/Pan1.
VAPA (VAMP associated protein A): VAPA and VAPB, are
generally involved in forming ER contacts with other mem
branes by directly interacting with the FFAT motif. VAPA/B
directly interact with RB1CC1 and ULK1 at the phagophore
initiation stage and stabilize the ULK1-RB1CC1 complex on
the ER. VAPA/B also interact with WIPI2 to tether the ERphagophore for phagophore expansion. Depletion of VAPA/B
impairs autophagosome formation [4025].
VAPB (VAMP associated protein B and C): See VAPA.
VCP/p97 (valosin containing protein): A type II AAA+ATPase that is a protein segregase required for autophago
some maturation under basal conditions or when the protea
somal system is impaired; mutations of VCP result in the
accumulation of immature, acidified autophagic vacuoles
that contain ubiquitinated substrates [4026–4028]. VCP is
also required for granulophagy, lysophagy and mitophagy
[1153, 1274, 4029]. See also Cdc48.
VDAC2 (voltage dependent anion channel 2): VDAC2 can
inhibit autophagy through stabilizing the interaction between
BECN1 and BCL2L1 [4030].
Verteporfin: An FDA-approved drug that is used in photo
dynamic therapy; however, it inhibits the formation of auto
phagosomes in vivo without light activation [2648].

Vesicophagy: Sequestration and degradation of hormonecontaining secretory vesicles by phagophores in endocrine
cells. Different from crinophagy or zymophagy, the process
is dependent on autophagy proteins ATG5, ATG7, and
BECN1, but not VMP1 [4031].
VHL (von Hippel-Lindau tumor suppressor): VHL serves as
the substrate recognition subunit of a ubiquitin ligase that targets
the α subunit of the heterodimeric transcription factor HIF1 for
degradation. This interaction requires the hydroxylation of
HIF1A on one or both of two conserved prolyl residues by
members of the EGLN family of prolyl hydroxylases [4032].
VirA: A T3SS effector found in Shigella spp. whose Rab
GTPase activating protein function enables escape of secreting
S. flexneri cells from LC3-positive vacuoles [3269, 4033]. See
also VirG and IcsB.
VirG/IcsA: A Shigella protein that is required for intracellular
actin-based motility. VirG binds ATG5, which induces xeno
phagy; IcsB, a protein secreted by the type III secretion system,
competitively blocks this interaction [4034]. See also IcsB and
VirA.
Virophagy: The selective autophagic clearance of viruses
[1432]. Virophagy is a form of xenophagy in which virions
and viral components are captured and directed to phago
phores for lysosomal degradation [1458].
VMP1 (vacuole membrane protein 1): A multispanning mem
brane protein that is required for autophagy [964, 4035]. VMP1
regulates the levels of PtdIns3P [4036], binding of the ATG12–
ATG5-ATG16L1 complex, lipidation of LC3 [4037], and mem
brane contact sites between the ER and other organelles includ
ing phagophores [966]. VMP1 also interacts with the structurally
related ER protein TMEM41B. See also TMEM41B.
Vps1: A dynamin-like GTPase required for peroxisomal fis
sion. Vps1 interacts with Atg11 and Atg36 on peroxisomes
that are being targeted for degradation by pexophagy [3056].
See also Dnm1.
Vps11: A member of the core subunit of the HOPS and class
C core vacuole/endosome tethering (CORVET) complexes,
originally found in yeast but also conserved in more complex
eukaryotes [4038]. These complexes are important for correct
endolysosomal trafficking, as well as the trafficking of black
pigment cell organelles, melanosomes; zebrafish Vps11 is
involved in maintaining melanosome integrity, possibly
through an autophagy-dependent mechanism [4039].
VPS13A: Mutations in this protein leads to chorea-acantho
cytosis, a rare neurodegenerative disease. This protein is a
lipid transfer protein that regulates the interface between
mitochondria-endosomes and mitochondria-ER and affects
the degradative capacity of lysosomes [4040, 4041]. Disease
mutations that limit binding of the yeast Vps13 APT1 domain
to PtdIns3P result in loss of function [4042]. This mutation
also reduces the binding of the APT1 domain of VPS13A to
PtdIns3P and PtdIns5P [4043].
VPS13D: A protein that is required for autophagy and that
regulates mitochondrial size [4044].
VPS15: See PIK3R4.
Vps30/Atg6: A component of the class III PtdIns3K complex.
Vps30/Atg6 forms part of two distinct yeast complexes (I and
II) that are required for the Atg and Vps pathways, respectively.
See also BECN1 and phosphatidylinositol 3-kinase [2786].
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Vps34: The yeast phosphatidylinositol 3-kinase; the lipid kinase
catalytic component of the PtdIns3K complex I and II [3573].
See also phosphatidylinositol 3-kinase and PIK3C3.
Vps38: A yeast component of the class III PtdIns3K complex
II, which directs it to function in the vacuolar protein sorting
pathway.
Vps41: A major component of the HOPS complex responsi
ble for the tethering of late endosomes and autophagosomes
to lysosomes [3226, 3608, 4045]. This protein also directly
interacts with Rab7 and Arl8 to coordinate the interaction of
motor proteins for vesicular transport [4046, 4047]. Human
VPS41 exhibits a protective role against neurodegeneration in
both transgenic C. elegans and in SH-SY5Y neuroblastoma
cell models of PD [4048, 4049].
VTC (vacuolar transporter chaperone): A complex com
posed of Vtc1, Vtc2, Vtc3 and Vtc4 that is required for
microautophagy in yeast [4050].
Vti1: A yeast soluble SNARE that, together with Sec18/NSF,
is needed for the fusion of autophagosomes with the vacuole
[3756]. In mammalian cells, the SNARE proteins VAMP8 and
VTI1B mediate the fusion of antimicrobial and canonical
autophagosomes with lysosomes [4024].
VTRNA1-1 (vault RNA 1-1): A small non-coding RNA that
negatively regulates selective autophagy by binding SQSTM1
and interfering with its oligomerization [4051].
WAC (WW domain containing adaptor with coiled-coil): A
positive regulator of autophagy that interacts with BECN1,
WAC also negatively regulates the UPS [3132].
WAPL (WAPL cohesion release factor): Accessory sub
unit of the cohesin complex involved in the resolution of
sister chromatids during mitotic entry, which is necessary
for correct chromosome partition during mitotic exit.
WAPL binds to SQSTM1 and is enriched in mitotic frac
tions after inhibition of lysosome function during cell
division [2974].
WDFY3/ALFY (WD repeat and FYVE domain containing
3): A scaffold protein that targets cytosolic protein aggregates
and damaged mitochondria for selective autophagic degrada
tion [4052, 4053]. WDFY3 interacts directly with ATG5
[3255], GABARAP proteins [202] and SQSTM1 [4054].
WDR45/WIPI4 (WD repeat domain 45): See WIPI.
WHAMM (WASP homolog associated with actin, golgi
membranes and microtubules): A nucleation-promoting fac
tor that directs the activity of the actin related protein 2/3
complex subunits (ARPC) to function in autophagosome for
mation [4055]. WHAMM colocalizes with LC3, ZFYVE1 and
SQSTM1 and acts in autophagosome biogenesis through a
mechanism dependent on actin comet tail formation.
WHAMM also instigates autolysosome tubulation by promot
ing actin polymerization during autophagic lysosome refor
mation [4056]. See also autophagic lysosome reformation.
WIPI (WD repeat domain, phosphoinositide interacting):
The WIPI proteins are putative mammalian homologs of
yeast Atg18 and Atg21. There are four WIPI proteins in mam
malian cells. WIPI1/WIPI49 and WIPI2 localize with LC3 and
bind PtdIns3P. WIPI2 is required for starvation-induced auto
phagy [837]. WDR45/WIPI4 is also involved in autophagy. In
humans, WDR45 is localized on the X-chromosome and so far
only de novo loss-of-function mutations are described.
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Heterozygous and somatic mutations cause neurodegeneration
with brain iron accumulation [4057], whereas hemizygous
mutations result in early-onset epileptic encephalopathy
[4058]. Impaired autophagy has been shown in lymphoblastoid
cell lines derived from affected patients, showing abnormal
colocalization of LC3-II and ATG9A. Furthermore, lympho
blastoid cell lines from affected subjects, show increased levels
of LC3-II, even under normal conditions [4059]. Surprisingly,
complete wdr45 knockout mice develop normally, but show
neurodegeneration, as of nine months of age, thereby indicat
ing overlapping activity of the four WIPI proteins in mammals
[4060]. WDR45/WIPI4 appears to be the member of the mam
malian WIPI protein family that binds ATG2 [658, 845].
WNK1 (WNK lysine deficient protein kinase 1): The pro
tein kinase WNK1 is an inhibitor of autophagy, as well as
the upstream class III PtdIns3K complex. WNK1 physi
cally interacts with the PtdIns3K component UVRAG
[4061].
WNT family: Cysteine-rich glycosylated secreted proteins that
determine multiple cellular functions such as neuronal devel
opment, angiogenesis, tumor growth, and stem cell prolifera
tion. Signaling pathways of WNT such as those that involve
CTNNB1/beta-catenin can suppress autophagy [4062, 4063].
WNT5A: A ligand of the WNT signaling pathway. Activation of
the WNT5A-CTNNB1 pathway suppresses IFNG-induced auto
phagy in macrophages during mycobacterial infection [783].
Wortmannin (WM): An inhibitor of PI3K and PtdIns3K;
wortmannin inhibits autophagy due to the downstream effect
on PtdIns3K [3374].
WXXL motif: An amino acid sequence present in proteins
that allows an interaction with Atg8/LC3/GABARAP proteins;
the consensus is [W/F/Y]-X-X-[I/L/V]. Also see AIM and
LIR/LRS [2509].
WYE-354: A catalytic MTOR inhibitor that increases autophagic
flux to a greater level than allosteric inhibitors such as rapamycin
(and may be used to induce autophagy in cell lines that are
resistant to rapamycin and its derivatives); short-term treatment
with WYE-354 can inhibit both MTORC1 and MTORC2, but the
effects on flux are due to the former [453]. See also Ku-0063794.
Xanthohumol: Prenylated chalconoid that blocks VCP/p97
and inhibits the maturation of autophagosomes.
Xanthohumol impairs autophagosome maturation and leads
to accumulation of LC3-II [4064].
XBP1 (X-box binding protein 1): A component of the ER
stress response that may activate autophagy. The XBP1 yeast
ortholog is Hac1 [4065].
Xenophagy: Cell-autonomous innate immunity defense,
whereby cells eliminate intracellular microbes (e.g., bacteria,
fungi, parasites and/or viruses) by sequestration into phago
phores with subsequent delivery to the lysosome [4066].
Xestospongin B: An antagonist of the ITPR that dissociates
the inhibitory interaction between ITPR and BECN1 and
induces autophagy [4067]. Xestopongin B additionally works
as a competitive inhibitor of ITPR, blocking calcium release
from the ER and inducing MTORC1-independent and
AMPK-dependent autophagy [668].
XIAP (X-linked inhibitor of apoptosis): XIAP is a ubiquitin
ligase downstream of NOD2. It is involved in the antimicrobial
process of LC3-associated phagocytosis. XIAP deficiency is
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associated with defective antimicrobial activity in macrophages
and intestinal inflammation [3511]. XIAP also regulates auto
phagy through TP53 and SQSTM1 [4068, 4069].
XPO1/CRM1 (exportin 1): XPO1 is phosphorylated by
STK38 (serine/threonine kinase 38) and regulates the
nuclear exit of BECN1 and YAP1 (Yes1 associated transcrip
tional regulator); XPO1 is actively involved in efflux of more
than 200 proteins. Inhibition of the XPO1 nuclear export
pathway by leptomycin B (a compound produced by
Streptomyces) blocks the nuclear export of BECN1 leading
to interference in nutrient-deprivation induced autophagy
and the suppression of mammary cell tumorigenesis [4070,
4071].
Xrn1: An exoribonuclease that hydrolyzes RNA in the 5ʹ to 3ʹ
direction. Xrn1 functions as a post-transcriptional negative reg
ulator of autophagy in yeast [4072]. Some viruses target XRN1 for
downregulation to facilitate autophagy-dependent replication.
YBR139W: See Atg42.
Yeh1: See Ayr1.
Ykt6: A prenylated vesicle SNARE involved in Golgi trans
port and fusion with the vacuole (including Cvt vesicle deliv
ery to the vacuole [4073]); in yeast and metazoan cells Ykt6/
YKT6 is required on autophagosomes as the R-SNARE for
fusion with lysosomes and vacuoles [507, 4073]. In
Drosophila, Ykt6 may act as a cofactor with Syx17 [4074,
4075]. One temperature sensitive ykt6 mutation also prevents
closure of the yeast phagophore [3755], whereas another only
blocks autophagosome-vacuole fusion in yeast [507].
Ymr1: A yeast PtdIns3P-specific phosphatase involved in
autophagosome maturation [4076, 4077]. Ymr1 is an ortholog
of myotubularins. See also MTM-3, MTM1, MTMR3, phos
phatidylinositol-3-phosphate,
phosphatidylinositol
3,5bisphosphate, and SBF2.

Ypk1 signaling
pathway.
Amino acid
starvation

TORC2

Ypk1

calcineurin
Cmd1

Gcn2

Macroautophagy

Ypk1: A downstream effector of TORC2 that stimulates au
tophagy under conditions of amino acid depletion [3953].
TORC2 activation of Ypk1 results in inhibition of the PPP3/
calcineurin-Cmd1/calmodulin phosphatase, which otherwise
dephosphorylates and inhibits Gcn2, a positive regulator of
autophagy. See also Gcn2.
Ypt1: A yeast GTPase that functions in several forms of
autophagy [2202]. Ypt1 is needed for correct localization of
Atg8 to the PAS. The mammalian homolog, RAB1, is required
for autophagosome formation and for autophagic targeting of
Salmonella [4078, 4079]. See also TRAPPIII.
Ypt6: A small GTP-binding protein involved in formation of
the autophagosome in yeast [2739].
Ypt7: A yeast homolog of mammalian RAB7, needed for the
fusion of autophagosomes with the vacuole.
YWHAZ/14-3-3ζ (tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein zeta): A member of
the 14-3-3 family of proteins that inhibits autophagy; direct
interaction with PIK3C3 negatively regulates kinase activity,
and this interaction is disrupted by starvation or C2-ceramide
[2739].
ZFPM1/FOG1 (zinc finger protein, FOG family member 1):
A cofactor of GATA1, a positive regulator of autophagy gene
transcription [981]. See also GATA1.
ZFYVE1/DFCP1 (zinc finger FYVE-type containing 1): A
PtdIns3P-binding protein that localizes to the omegasome
[884]. Knockdown of ZFYVE1 does not result in an autopha
gy-defective phenotype.
ZFYVE26/spastizin/SPG15 (zinc finger FYVE-type contain
ing 26): Mutations in ZFYVE26 result in a complicated form
of hereditary spastic paraparesis (SPG15); this protein inter
acts with the autophagy complex BECN1-UVRAG-RUBCN
and is required for autophagosome maturation [4080].
ZFYVE26 interacts also with the AP5 complex and is involved
in autophagic lysosome reformation [3818]. The loss of
ZFYVE26 function results in the accumulation of autophago
somes and enlarged lysosomes. See also AP5, autophagic
lysosome reformation and SPG11.
ZIPK: See Sqa.
ZKSCAN3/ZNF306 (zinc finger with KRAB and SCAN
domains 3): A zinc finger family transcription factor harbor
ing Kruppel-associated box and SCAN domains that functions
as a master transcriptional repressor of autophagy and lyso
some biogenesis. ZKSCAN3 represses the transcription of
more than 60 genes integral to, or regulatory for, autophagy
and lysosome biogenesis and/or function and a subset of these
genes, including MAP1LC3B and WIPI2, are its direct targets.
Starvation and torin1 treatment induce translocation of
ZKSCAN3 from the nucleus to the cytoplasm [985].
Zoledronic acid: A bisphosphonate that induces autophagy
and may result in autophagic cell death in prostate and breast
cancer cells [985, 4081]. Zoledronic acid-induced autophagy is
inhibited by anti-oxidants; hence autophagy can also be
modulated by oxidative stress [4081].
Zymophagy: The selective degradation of activated zymogen
granules by an autophagy-like process that is dependent on
VMP1, SQSTM1 and the ubiquitin protease USP9X [1497].
See also crinophagy.
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Quick guide
1. Whenever possible, use more than one assay to moni
tor autophagy.
2. Whenever possible, include flux measurements for au
tophagy (e.g., using timed inhibitor studies to estimate
cargo degradation rates or using tandem fluorochrome
assays for maturation such as RFP-EGFP-LC3 or, pre
ferably, cargo-specific variations thereof).
3. Whenever possible, use genetic inhibition of autopha
gy to complement studies with nonspecific pharmaco
logical inhibitors such as 3-MA.
4. For analysis of genetic inhibition, a minimum of two
ATG genes (including for example BECN1, ATG7, LC3/
GABARAP or ULK1) should be targeted to help ensure
the phenotype is due to inhibition of autophagy.
5. When monitoring GFP-LC3 puncta formation, provide
quantification, ideally in the form of number of puncta
per cell. In cells that are difficult to transfect, endogenous
LC3 puncta can be monitored by immunofluorescence.
6. Whenever possible, use antibodies that detect specific
isoforms of LC3 and GABARAP proteins.
7. For the interpretation of decreased SQSTM1 levels,
measure mRNA levels and use strong lysis reagents
(such as SDS), proteasome inhibitors and a pan-cas
pase inhibitor to ensure that the reduced SQSTM1
amount is not due to reduced biosynthesis, accumula
tion of detergent-resistant aggregates that are not solu
bilized in Triton X-100, proteasomal degradation or a
caspase-induced cleavage of the protein.
8. Whenever possible, monitor autophagic responses
using both short-term and long-term assays.
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